20-F

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 20-F

(Mark One)

o Registration Statement Pursuant to Section 12(b) or (g) of the Securities Exchange Act of 1934

x Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the Fiscal Year Ended December 31, 2017

o Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

o Shell Company Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Commission file number 001-37669

Nomad Foods Limited

(Exact Name of Registrant as Specified in Its Charter)

British Virgin Islands

(Jurisdiction of Incorporation or Organization)

No. 1 New Square

Bedfont Lakes Business Park

Feltham, Middlesex TW14 8HA

(Address of Principal Executive Offices)

Jason Ashton

No. 1 New Square

Bedfont Lakes Business Park

Feltham, Middlesex TW14 8HA

Telephone:+(44) 208 918 3200

Facsimile:+(44) 208 918 3491

(Name, Telephone, E-mail and/or Facsimile Number and Address of Company Contact Person)

Securities registered or to be registered pursuant to Section 12(b) of the Act:

Title of Each Class	Name of Each Exchange on which Registered
Ordinary Shares, no par value	New York Stock Exchange

Securities registered or to be registered pursuant to Section 12(g) of the Act: None

Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act: Preferred Shares, no par value

Indicate the number of outstanding shares of each of the issuer’s classes of capital or common stock as of the close of the period covered by the annual report. 165,291,546 Ordinary Shares and 1,500,000 Preferred Shares

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.  oYes    x  No

If this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.  o  Yes    x  No

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  x  Yes     o  No

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  x  Yes    o  No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or an emerging growth company. See definition of “large accelerated filer, accelerated filer, and emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer        x            Accelerated filer      o               Non-accelerated filer     oEmerging growth company o

If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards† provided pursuant to Section 13(a) of the Exchange Act. o

†The term “new or revised financial accounting standard” refers to any update issued by the Financial Accounting Standards Board to its Accounting Standards Codification after April 5, 2012.

Indicate by check mark which basis of accounting the registrant has used to prepare the financial statements included in this filing:

   U.S. GAAPo International Financial Reporting Standards as Issued by the International Accounting Standards Boardx Othero

If “Other” has been checked in response to the previous question, indicate by check mark which financial statement item the registrant has elected to follow.  o  Item 17    o  Item 18

If this is an annual report, indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  o  Yes    x  No

TABLE OF CONTENTS

TERMS USED IN THIS REPORT			1
PRESENTATION OF FINANCIAL AND OTHER INFORMATION			1
INDUSTRY AND MARKET DATA			1
TRADEMARKS			2
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS			2
PART I			4
	Item 1:	Identity of Directors, Senior Management and Advisors	4
	Item 2:	Offer Statistics and Expected Timetable	4
	Item 3:	Key Information	4
	Item 4.	Information on the Company	25
	Item 4A.	Unresolved Staff Comments	38
	Item 5.	Operating and Financial Review and Prospects	38
	Item 6.	Directors, Senior Management and Employees	53
	Item 7.	Major Shareholders and Related Party Transactions	62
	Item 8.	Financial Information	63
	Item 9.	The Offer and Listing	64
	Item 10.	Additional Information	65
	Item 11.	Quantitative and Qualitative Disclosures About Market Risk	74
	Item 12.	Description of Securities Other than Equity Securities	74
	Item 13.	Defaults, Dividend Arrearages and Delinquencies	74
	Item 14.	Material Modifications to the Rights of Security Holders and Use of Proceeds	74
	Item 15.	Controls and Procedures	74
	Item 16A.	Audit Committee Financial Expert	75
	Item 16B.	Code of Ethics	75
	Item 16C.	Principal Accountant Fees and Services	75
	Item 16D.	Exemptions from the Listing Standards for Audit Committees	76
	Item 16E.	Purchases of Equity Securities by the Issuer and Affiliated Purchasers	76
	Item 16F.	Change in Registrants’ Certifying Accountant	77
	Item 16G.	Corporate Governance	77
	Item 16H.	Mine Safety Disclosure	82
	Item 17.	Financial Statements	83
	Item 18.	Financial Statements	84
	Item 19.	Exhibits

i

TERMS USED IN THIS REPORT

Unless the context otherwise requires, in this annual report, the term(s) (1) “we,” “us,” “our,” “Company,” “Nomad” and “our business” refer to Nomad Foods Limited (formerly known as Nomad Holdings Limited) and its consolidated subsidiaries, (2) “Iglo” and “the Iglo Group” refer solely to Nomad Foods Europe Holdings Limited (previously named Iglo Foods Holdings Limited) and its consolidated subsidiaries which we purchased on June 1, 2015 and (3) “Findus” and “the Findus Group” refers to Findus Sverige AB (and its consolidated subsidiaries) which we purchased from Lion/Gem Luxembourg 3 S.a.r.l. (the “Findus Parent”) on November 2, 2015 (the “Findus Acquisition”). All references in this annual report to the “Predecessor” refer to Iglo for all periods prior to its acquisition by the Company (the “Iglo Acquisition”) and all references to the “Successor” refer to the Company for all periods after the Iglo Acquisition.

PRESENTATION OF FINANCIAL AND OTHER INFORMATION

In this annual report, references to “Euro” and “€” are to the single currency adopted by participating member states of the European Union relating to Economic and Monetary Union, references to “$”, “US$” and “U.S. Dollars” are to the lawful currency of the United States of America, and references to “Pound Sterling”, “Sterling” and “£” are to the lawful currency of the United Kingdom (UK).

The historical financial information for the Company and the Iglo Group has been prepared in accordance with International Financial Reporting Standards as issued by the International Accounting Standards Board (“IFRS IASB”) and International Financial Reporting Standards as endorsed by the European Union (together “IFRS”) which can differ in certain significant respects from U.S. GAAP.

Unless otherwise noted, all financial information for the Company and Iglo provided in this annual report is denominated in Euros.

Historical Financial Information

This annual report includes our consolidated financial statements at and as of the year ended December 31, 2017 (the “Fiscal 2017 Period”), at and as of the year ended December 31, 2016 (the “Fiscal 2016 Period”), as of the nine months ended December 31, 2015 (the “Fiscal 2015 Transition Period”), as of the twelve months ended March 31, 2015 (the “Fiscal 2015 Period”) and for the Predecessor, as of the five months ended May 31, 2015 (the “Fiscal 2015 Predecessor Stub Period”).

Non-IFRS Financial Measures

In this annual report, we present certain supplemental financial measures that are not recognized by IFRS. These financial measures are unaudited and have not been prepared in accordance with IFRS, SEC requirements or the accounting standards of any other jurisdiction. The non-IFRS financial measures used in this annual report are Adjusted EBITDA and Adjusted EBITDA margin. For additional information on why we present non-IFRS financial measures, the limitations associated with using non-IFRS financial measures and reconciliations of our non-IFRS financial measures to the most comparable applicable IFRS measure, see Item 5: Operating and Financial Review and Prospects.

INDUSTRY AND MARKET DATA

We obtained the industry, market and competitive position data throughout this annual report from our own internal estimates and research as well as from industry and general publications and research, surveys and studies conducted by Euromonitor. Industry surveys and publications generally state that the information contained therein has been obtained from sources believed to be reliable, but the accuracy and completeness of the information contained in industry publications is not guaranteed. While we believe that each of these studies and publications is reliable, we have not independently verified market and industry data from third-party sources. While we believe our internal company research is reliable and the definitions of our market and industry are appropriate, neither this research nor these definitions have been verified by any independent source. Further, while we believe the market opportunity information included in this annual report is generally reliable, such information is inherently imprecise. In addition, projections, assumptions and estimates of the future performance of the industry in which we operate and our future performance are necessarily subject to a high degree of uncertainty and risk due to a variety of factors, including those described in Item 3D: Key Information - Risk Factors. These and other factors could cause results to differ materially from those expressed in the estimates made by the independent parties and by us. See Cautionary Note Regarding Forward-Looking Statements.

1

Market share data presented throughout this annual report is measured by retail sales value. The frozen food market data we refer to throughout this annual report includes the following categories: Frozen Processed Meat, Frozen Processed Seafood, Frozen Meat Substitutes, Frozen Pizza, Frozen Ready Meals, Frozen Noodles, Frozen Soup, Frozen Baked Goods and Processed Frozen Vegetables.

TRADEMARKS

We operate under a number of trademarks, including, among others, “Iglo,” “Birds Eye” and “Findus”, all of which are registered under applicable intellectual property laws. This annual report contains references to our trademarks and service marks and to those belonging to other entities. Solely for convenience, trademarks and trade names referred to in this annual report may appear without the ® or TM symbols, but such references are not intended to indicate, in any way, that we will not assert, to the fullest extent possible under applicable law, our rights or the rights of the applicable licensor to these trademarks and trade names. We do not intend our use or display of other companies’ trade names, trademarks or service marks to imply a relationship with, or endorsement or sponsorship of us by, any other companies.

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

Some of the statements in this annual report constitute forward-looking statements that do not directly or exclusively relate to historical facts. You should not place undue reliance on such statements because they are subject to numerous uncertainties and factors relating to our operations and business environment, all of which are difficult to predict and many of which are beyond our control. Forward-looking statements include information concerning our possible or assumed future results of operations, including descriptions of our business strategy. These statements often include words such as “may,” “will,” “should,” “believe,” “expect,” “anticipate,” “intend,” “plan,” “estimate” or similar expressions. Forward-looking statements included in this annual report include statements regarding:

• our beliefs and intentions regarding our strategic initiatives and their impact on the growth and

profitability of our business;

• our intent to profitably grow our business through our strategic initiatives;

• our intent to seek additional acquisition opportunities in food products and our expectation regarding competition for acquisitions;

• our expectations concerning the timing for completion of the Green Isle Foods Ltd. acquisition and source of funding for the acquisition;

• our expectations concerning the impact of such acquisition;

• our expectations concerning our ability to fund our liquidity requirements and to raise cash through equity and debt offerings;

• our expectations concerning our capital expenditures in 2018;

• our beliefs regarding our competitive strengths and ability to successfully compete in the markets in which we participate;

• our expectations concerning consumer demand for our products, our future growth opportunities, market share and sales channels, including online channels;

• our beliefs and intentions regarding the impact of key industry trends on our business, our actions in response to such trends and the resulting impact on our profitability and competitive position;

• our future operating and financial performance;

• our intent to settle any Founder Preferred Shares Annual Dividend Amount (as defined herein) with equity;

• our belief that we have sufficient spare capacity to accommodate future growth in our main product categories and to accommodate the seasonal nature of some of our products;

• our intent to rely on some of the available foreign private issuer exemptions to the New York Stock Exchange (the “NYSE”) corporate governance rules; and

• the accuracy of our estimates and key judgments regarding certain tax matters and accounting valuations.

2

The forward-looking statements contained in this annual report are based on assumptions that we have made in light of our management’s experience in the industry as well as our perceptions of historical trends, current conditions, expected future developments and other factors that we believe are appropriate under the circumstances. As you read and consider this annual report, you should understand that these statements are not guarantees of performance or results. They involve known and unknown risks, uncertainties and assumptions. Although we believe that these forward-looking statements are based on reasonable assumptions, you should be aware that many factors could affect our actual financial results or results of operations and could cause actual results to differ materially from those in these forward-looking statements. These factors include but are not limited to:

• our ability to successfully implement our strategic initiatives;

• if the transaction closes, the anticipated benefits from the Green Isle Foods Ltd. acquisition may take longer to realize and may cost more to achieve than expected;

• the loss of any of our executive officers or members of our senior management team or other key employees;

• the loss of any of our major customers or a decrease in demand for our products;

• our ability to effectively compete in our markets;

• changes in consumer preferences and our failure to anticipate and respond to such changes or to successfully develop and renovate products;

• our ability to successfully interpret and respond to key industry trends and to realize the expected benefits of our responsive actions;

• our ability to protect our brand names and trademarks;

• economic conditions that may affect our future performance including exchange rate fluctuations;

• fluctuations in the availability of food ingredients and packaging materials that we use in our products;

• disruptions in our information technology systems, supply network, manufacturing and distribution facilities or our workforce or the workforce of our suppliers;

• our ability to continue to comply with covenants and the terms of our credit instruments and our ability to obtain additional financing, as needed, to fund our liquidity requirements and capital expenditures;

• availability of debt and equity financing under favorable terms;

• increases in operating costs, including labor costs, and our ability to manage our cost structure;

• the incurrence of liabilities not covered by our insurance;

• the loss of our foreign private issuer status;

• the effects of reputational damage from unsafe or poor quality food products, particularly if such issues involve products we manufactured or distributed;

• our failure to comply with, and liabilities related to, environmental, health and safety laws and regulations;

• the potential adverse impact of Brexit on currency exchange rates, global economic conditions and cross-border agreements that affect our business; and

• changes in applicable laws or regulations.

These and other factors are more fully discussed in Item 3D: Key Information - Risk Factors and elsewhere in this annual report. These risks could cause actual results to differ materially from those implied by forward-looking statements in this annual report.

All information contained in this annual report is materially accurate and complete as of the date of this annual report. You should keep in mind, however, that any forward-looking statement made by us in this annual report, or elsewhere, speaks only as of the date on which we make it. New risks and uncertainties come up from time to time, and it is impossible for us to predict these events or how they may affect us. We do not undertake any obligation to update or revise any forward-looking statements after the date of this annual report, whether as a result of new information, future events or otherwise, except as required by law. In light of these risks and uncertainties, you should keep in mind that any event described in a forward-looking statement made in this annual report or elsewhere might not occur.

3

PART I

Item 1: Identity of Directors, Senior Management and Advisers

A. Directors and Senior Management

Not applicable.

B. Advisers

Not applicable.

C. Auditors

Not applicable.

Item 2: Offer Statistics and Expected Timetable

A. Offer Statistics

Not applicable.

B. Method and Expected Timetable

Not applicable.

Item 3: Key Information

A. Selected Financial Data

The following table sets forth selected historical consolidated financial and other data for the Company and Iglo for the periods presented. The selected historical consolidated financial data below should be read in conjunction with our Audited Consolidated Financial Statements and related notes (Item 18), as well as Item 4: Information on the Company and Item 5: Operating and Financial Review and Prospects of this annual report.

Following the Iglo Acquisition, Iglo is considered to be our Predecessor under applicable SEC rules and regulations.

In June 2015, the Board of Directors approved a change in Nomad’s fiscal year end from March 31 to December 31 in order to align Nomad’s fiscal year with the Iglo Group’s historical reporting calendar. As a result of this change, the consolidated statements include presentation of the Successor twelve month periods to December 31, 2017 and 2016 and the nine month period from April 1, 2015 to December 31, 2015.

The statement of income data for the Fiscal Period 2017, Fiscal Period 2016, Fiscal 2015 Transition Period, Fiscal 2015 Period, and Fiscal 2015 Predecessor Stub Period and the balance sheet data as of December 31, 2017 and 2016 have been derived from our audited consolidated financial statements included elsewhere in this annual report. Balance sheet information for Nomad for December 31, 2015 and financial information for Iglo for the years ended December 31, 2014 and 2013 have been derived from audited financial statements not included elsewhere in this annual report.

Neither the Successor nor the Predecessor declared or paid cash dividends in the periods presented. All results are continuing.

4

	Successor		Successor		Successor		Successor		Predecessor		Predecessor		Predecessor
	Year ended Dec 31 2017		Year ended Dec 31 2016		9 months ended Dec 31 2015		Year ended Mar 31 2015		5 months ended May 31 2015		Year ended Dec 31 2014		Year ended Dec 31 2013
	€m		€m		€m		€m		€m		€m		€m
Statement of Income data:
Revenue	1,956.6		1,927.7		894.2		—		640.3		1,500.9		1,505.8
Cost of sales	(1,357.2	)	(1,356.7	)	(663.0	)	—		(417.9	)	(970.9	)	(1,001.8	)
Gross profit	599.4		571.0		231.2		—		222.4		530.0		504.0
Other operating expenses	(319.3	)	(298.4	)	(138.6	)	(0.7	)	(109.5	)	(254.2	)	(231.8	)
Exceptional items	(37.2	)	(134.5	)	(58.1	)	(0.7	)	(84.3	)	(52.9	)	(83.8	)
Charge related to Founder Preferred Shares Annual Dividend Amount	—		—		(349.0	)	(165.8	)	—		—		—
Credit/(Charge) related to Warrant Redemption Liability	—		—		0.4		(0.4	)	—		—		—
Operating profit/(loss)	242.9		138.1		(314.1	)	(167.6	)	28.6		222.9		188.4
Net finance (costs)/income	(74.4	)	(62.1	)	(35.5	)	0.1		(115.7	)	(290.2	)	(227.6	)
Profit/(loss) before tax	168.5		76.0		(349.6	)	(167.5	)	(87.1	)	(67.3	)	(39.2	)
Taxation	(32.0	)	(39.6	)	12.3		—		(40.9	)	(41.8	)	(2.0	)
Profit/(loss) for the period attributable to Parent Company	136.5		36.4		(337.3	)	(167.5	)	(128.0	)	(109.1	)	(41.2	)
Basic weighted number of shares	176,080,272		183,518,743		145,590,810		50,025,000		n.p.		n.p.		n.p.
Diluted weighted number of shares	184,786,162		183,528,621		145,590,810		50,025,000		n.p.		n.p.		n.p.
Basic earnings/(loss) per share	0.78		0.20		(2.32	)	(3.35	)	n.p.		n.p.		n.p.
Diluted earnings/(loss) per share	0.74		0.20		(2.32	)	(3.35	)	n.p.		n.p.		n.p.
Balance Sheet data:
Total assets	4,601.7		4,709.5		4,929.7		447.4		n.p.		3,543.4		3,461.2
Total equity	1,852.6		1,902.5		1,888.1		274.9		n.p.		(657.5	)	(550.4	)
Share capital	—		—		—		—		n.p.		0.1		0.1

n.p. not presented

Currency and Exchange Rates. Our reporting currency is the Euro. The following table sets forth, for the periods and dates indicated, the period end average, high and low exchange rates in U.S. Dollars per €1.00.

	Average
Year ended December 31, 2017	$	1.1393
Year ended December 31, 2016	$	1.1036
Year ended December 31, 2015	$	1.1032
Year ended December 31, 2014	$	1.3207
Year ended December 31, 2013	$	1.3300

5

	High $		Low $
March 2018 (as of March 20, 2018)	$	1.2446	$	1.2155
February 2018	$	1.2555	$	1.2188
January 2018	$	1.2537	$	1.1916
December 2017	$	1.2026	$	1.1718
November 2017	$	1.1961	$	1.1554
October 2017	$	1.1880	$	1.1575
September 2017	$	1.2092	$	1.1717

Our inclusion of these exchange rates and other exchange rates specified elsewhere in this annual report should not be construed as representations that the Euro amounts actually represent such U.S. Dollar amounts or could have been or could be converted into U.S. Dollars at any particular rate, if at all. The Euro foreign exchange reference rate used in this annual report is the Bloomberg Generic Composite Rate. On March 21, 2018, this rate was $1.2242 per €1.00. These exchange rates may differ from the exchange rate in effect on and as of the date of this annual report.

B. Capitalization and Indebtedness

Not applicable.

C. Reasons for the Offer and Use of Proceeds

Not applicable.

D. Risk Factors

An investment in our ordinary shares carries a significant degree of risk. You should carefully consider the following risks and other information in this annual report, including our consolidated financial statements and related notes included elsewhere in this annual report, before you decide to purchase our ordinary shares. Additional risks and uncertainties of which we are not presently aware or that we currently deem immaterial could also affect our business operations and financial condition. If any of these risks actually occur, our business, financial condition, results of operations or prospects could be materially affected. As a result, the trading price of our ordinary shares could decline and you could lose part or all of your investment.

Risks Related to Our Business and Industry

We operate in a highly competitive market and our failure to compete effectively could adversely affect our results of operations.

The market for frozen food is highly competitive. Our competitors include retailers who promote private label products and well-established branded producers that operate on both a national and an international basis across single or multiple frozen food categories. We also face competition more generally from chilled food, distributors and retailers of fresh products, baked goods and ready-made meals. Our competitors generally compete with us on the basis of price, actual or perceived quality of products, brand recognition, consumer loyalty, product variety, new product development and improvements to existing products. We may not successfully compete with our existing competitors and new competitors may enter the market. Discounters are supermarket retailers which offer a narrow range of food and grocery products at discounted prices and which typically focus on non-branded rather than branded products. The increase in discounter sales may adversely affect the sales of our branded products. Further, we are increasing our investment in online sales (sales made through retailers’ online platforms). However, there is no guarantee we will achieve our expected return on investment from this strategy. The growth of online retailers, and the corresponding growth in our online sales, may also adversely affect our competitive position.

6

In addition, we cannot predict the pricing or promotional actions of our competitors or their effect on consumer perceptions or the success of our own advertising and promotional efforts. Our competitors develop and launch products targeted to compete directly with our products. Our retail customers, most of which promote their own private label products, control the shelf space allocations within their stores. As a result, they may allocate more shelf space to private label products or to our branded competitors’ products in accordance with their respective promotional strategies. Decreases in shelf space allocated to our products, increases in competitor promotional activity, aggressive marketing strategies by competitors or other factors may require us to reduce our prices or invest greater amounts in advertising and promotion of our products to ensure our products remain competitive.

Furthermore, some of our competitors may have substantially greater financial, marketing and other resources than we have. This creates competitive pressures that could cause us to lose market share or require us to lower prices, increase advertising expenditures or increase the use of discounting or promotional campaigns. These competitive factors may also restrict our ability to increase prices, including in response to commodity and other cost increases. If we are unable to continue to respond effectively to these and other competitive pressures, our customers may reduce orders of our products, may insist on prices that erode our margins or may allocate less shelf space and fewer displays for our products. These or other developments could materially and adversely affect our sales volumes and margins and result in a decrease in our operating results, which could have a material adverse effect on our business, financial condition and results of operations.

Sales of our products are subject to changing consumer preferences and trends; if we do not correctly anticipate such changes, our sales and profitability may decline.

There are a number of trends in consumer preferences which have an impact on us and the frozen food industry as a whole. These include, among others, preferences for speed, convenience and ease of food preparation; natural, nutritious and well-proportioned meals; and products that are sustainably sourced and produced and are otherwise environmentally friendly. Concerns as to the health impacts and nutritional value of certain foods may increasingly result in food producers being encouraged or required to produce products with reduced levels of salt, sugar and fat and to eliminate trans-fatty acids and certain other ingredients. Consumer preferences are also shaped by concern over waste reduction and the environmental impact of products. The success of our business depends on both the continued appeal of our products and, given the varied backgrounds and tastes of our customer base, our ability to offer a sufficient range of products to satisfy a broad spectrum of preferences. Any shift in consumer preferences in the United Kingdom, Germany, France, Italy, Sweden or any other material market in which we operate could have a material adverse effect on our business. Consumer tastes are also susceptible to change. In addition, consumers with increasingly busy lifestyles are choosing the online grocery channel as a more convenient and faster way of purchasing their food products, and are also increasingly using the internet for meal ideas. Our competitiveness therefore depends on our ability to predict and quickly adapt to consumer preferences and trends, exploiting profitable opportunities for product development without alienating our existing consumer base or focusing excessive resources or attention on unprofitable or short-lived trends. If we are unable to respond on a timely and appropriate basis to changes in demand or consumer preferences and trends, our sales volumes and margins could be adversely affected.

Our future results and competitive position are dependent on the successful development of new products and improvement of existing products, which is subject to a number of difficulties and uncertainties.

Our future results and ability to maintain or improve our competitive position depend on our capacity to anticipate changes in our key markets and to successfully identify, develop, manufacture, market and sell new or improved products in these changing markets. We aim to introduce new products and re-launch and extend existing product lines on a timely basis in order to counteract obsolescence and decreases in sales of existing products as well as to increase overall sales of our products. The launch and success of new or modified products are inherently uncertain, especially as to the products’ appeal to consumers, and there can be no assurance as to our continuing ability to develop and launch successful new products or variations of existing products. The failure to launch a product successfully can give rise to inventory write-offs and other costs and can affect consumer perception of our other products. Market factors and the need to develop and provide modified or alternative products may also increase costs. In addition, launching new or modified products can result in cannibalization of sales of our existing products if consumers purchase the new product in place of our existing products. If we are unsuccessful in developing new products in response to changing consumer demands or preferences in an efficient and economical manner, or if our competitors respond more effectively than we do, demand for our products may decrease, which could materially and adversely affect our business, financial condition and results of operations.

7

We are exposed to economic and other trends that could adversely impact our operations in our key geographies.

We conduct operations in our key markets of the United Kingdom, Italy, Germany, Sweden, France, and Norway, from which approximately 80% of our revenue was generated during the last fiscal period. We are particularly influenced by economic developments and changes in consumer habits in those countries.

The geographic markets in which we compete have been affected by negative macroeconomic trends which have affected consumer confidence. For example, Brexit has created political and economic uncertainty both in the United Kingdom and the other European Union member states. A deterioration in economic conditions could result in increased unemployment rates, increased short and long term interest rates, consumer and commercial bankruptcy filings, a decline in the strength of national and local economies, and other results that negatively impact household incomes. This can result in consumers purchasing cheaper private label products instead of equivalent branded products. Such macroeconomic trends could, among other things, negatively impact global demand for branded and premium food products, which could result in a reduction of sales or pressure on margins of our branded products or cause an increasing transfer to lower priced product categories.

Our inability to source raw materials or other inputs of an acceptable type or quality, could adversely affect our results of operations.

We use significant quantities of food ingredients and packaging materials and are therefore vulnerable to fluctuations in the availability and price of food ingredients, packaging materials, other supplies and energy costs. In particular, raw materials such as fish, livestock and crops have historically represented a significant portion of our cost of sales, and accordingly, adverse changes in raw material prices can impact our results of operations.

Specifically, the availability and the price of fish, vegetables and other agricultural commodities, including poultry and meat, can be volatile. We are also affected by the availability of quality raw materials, most notably fish, which can be impacted by the fishing and agricultural policies of the European Union including national or international quotas that can limit volume of raw materials. General economic conditions, unanticipated demand, problems in manufacturing or distribution, natural disasters, weather conditions during the growing and harvesting seasons, plant, fish and livestock diseases and local, the impact of Brexit, national or international quarantines can also adversely affect availability and prices of commodities in the long and short term.

While we attempt to negotiate fixed prices for certain materials with our suppliers for periods ranging from one month to a full year, we cannot guarantee that our strategy will be successful in managing input costs if prices increase for extended periods of time. Moreover, there is no market for hedging against price volatility for certain raw materials and accordingly such materials are bought at the spot rate in the market.

Our ability to avoid the adverse effects of a pronounced, sustained price increase in raw materials is limited. Any increases in prices or scarcity of ingredients or packaging materials required for our products could increase our costs and disrupt our operations. If the availability of any of our inputs is constrained for any reason, we may not be able to obtain sufficient supplies or supplies of a suitable quality on favorable terms or at all. Such shortages could materially adversely affect our market share, business, financial condition and results of operations.

Our inability to pass on price increases for materials or other inputs to our customers could adversely affect our results of operations.

Our ability to pass through increases in the prices of raw materials to our customers depends, among others, on prevailing competitive conditions and pricing methods in the markets in which we operate, and we may not be able to pass through such price increases to our customers. Even if we are able to pass through increases in prices, there is typically a time lag between cost increases impacting our business and implementation of product price increases during which time our profit margin may be negatively impacted. Recovery of cost inflation, driven by both commodity cost increases or changes in the foreign exchange rate of the currency the commodity is denominated in, can also lead to disparities in retailers’ shelf-prices between different brands which can result in a competitive disadvantage and volume decline. During our negotiations to increase our prices to recover cost increases, customers may take actions which exacerbate the impact of such cost increases, for example by ceasing to offer our products or deferring orders until negotiations have ended. Our inability to pass through price increases in raw materials and preserve our profit margins in the future could materially adversely affect our business, financial condition and results of operations.

8

We rely on sales to a limited number of large food retailers and should they perform poorly or give higher priority to private label or other brands or products or if the concentration and buying power of these large retailers increase, our business could be adversely affected.

Our customers include supermarkets and large chain food retailers in the United Kingdom, Germany, France, Italy and Sweden. Throughout our markets, the food retail segments are highly concentrated. For the year ended December 31, 2017, our top 10 customers account for 41% of sales. In recent years, the major multiple retailers in those countries have increased their share of the grocery market and price competition between retailers has intensified. This price competition has led the major multiple retailers to seek lower prices from their suppliers, including us. The strength of the major multiple retailers’ bargaining position gives them significant leverage over their suppliers in negotiating pricing, product specification and the level of supplier participation in promotional campaigns and offers, which can reduce our margins. Further consolidation among the major multiple retailers or disproportionate growth in relation to their competitors could increase their relative negotiating power and allow them to force a negative shift in our trade terms. Our results of operations could also be adversely affected if these retailers suffer a significant deterioration in sales performance, if we are required to reduce our prices or increase our promotional spending activity as a consequence, if we are unable to collect accounts receivable from our customers, if we lose business from a major customer or if our relationship with a major customer deteriorates.

Our retail customers also offer private label products that compete directly with our products for retail shelf space and consumer purchases. Private label products typically have higher margins for retailers than other branded products. Accordingly, there is a risk that our customers may give higher priority to private label products or the branded products of our competitors, which would adversely affect sales of our products. Our major multiple retail customers are also expanding into non-food product lines in their stores, thereby exerting pressure on available shelf space for other categories such as food products. We may be unable to adequately respond to these trends and, as a result, the volume of our sales may decrease or we may need to lower the prices of our products, either of which could adversely affect our business, financial condition and results of operations.

Increased distribution costs or disruption of transportation services could adversely affect our business and financial results.

Distribution costs have historically fluctuated significantly over time, particularly in connection with oil prices, and increases in such costs could result in reduced profits. In addition, certain factors affecting distribution costs are controlled by our third party carriers. To the extent that the market price for fuel or freight or the number or availability of carriers fluctuates, our distribution costs could be affected. Furthermore, temporary or long-term disruption of transportation services due to weather-related problems, strikes or other events could impair our ability to supply products affordably and in a timely manner or at all. Failure to deliver our perishable food products promptly could also result in inventory spoilage. These factors could impact our commercial reputation and result in our customers reducing their orders or ceasing to order our products. Any increases in the cost of transportation, and any disruption in transportation, could have a material adverse effect on our business, financial condition and results of operations. We require the use of refrigerated vehicles to ship our products and such distribution costs represent an important element of our cost structure. We are dependent on third parties for almost all of our transportation requirements. In Italy, our distribution network is shared with Unilever’s ice cream business, which provides us with an advantage over smaller market participants. Our arrangement with Unilever is governed by a distribution agreement which expires in 2022.

We do not have long-term contractual agreements with our key customers, which exposes us to increased risks with respect to such customers.

As is typical in the food industry, sales to our key customers in our major markets are made on a daily demand basis. We generally do not have long-term contractual commitments to supply such customers and must renegotiate supply and pricing terms of our products on a regular basis. Customarily, trade terms are renegotiated annually; however, ad-hoc changes are often made on an informal basis, such as by email, to reflect discounts and promotional arrangements. Amounts paid are subject to end of period reconciliations to reflect these informal arrangements. In some cases, our customers have claimed reimbursement for informal discount arrangements going back multiple periods. In addition, we do not have written contractual arrangements with a number of our other customers. Most of our customer relationships or arrangements could be terminated or renegotiated at any time and, in some cases, without reasonable notice.

9

Our customers may not be creditworthy.

Our business is subject to the risks of nonpayment and nonperformance by our customers. We manage our exposure to credit risk through credit analysis and monitoring procedures, and sometimes use letters of credit, prepayments and guarantees. However, these procedures and policies cannot fully eliminate customer credit risk, and to the extent our policies and procedures prove to be inadequate, it could negatively affect our financial condition and results of operations. In addition, some of our customers may be highly leveraged and subject to their own operating and regulatory risks and, even if our credit review and analysis mechanisms work properly, we may experience financial losses in our dealings with such parties. We do not maintain credit insurance to insure against customer credit risk. If our customers fail to fulfill their contractual obligations, it may have an adverse effect on our business, financial condition and results of operation.

Failure to protect our brand names and trademarks could materially affect our business.

Our principal brand names and trademarks (such as Birds Eye, Iglo and Findus) are key assets of our business and our success depends upon our ability to protect our intellectual property rights. We rely upon trademark laws to establish and protect our intellectual property rights, but cannot be certain that the actions we have taken or will take in the future will be adequate to prevent violation of our proprietary rights. Litigation may be necessary to enforce our trademark or proprietary rights or to defend us against claimed infringement of the rights of third parties. In addition, the Birds Eye brand, which we use in the United Kingdom, is used by other producers in the United States and Australia. Even though the brands have different logos, adverse publicity from such other markets may negatively impact the perception of our brands in our respective markets. Adverse publicity, legal action or other factors could lead to substantial erosion in the value of our brands, which could lead to decreased consumer demand and could have a material adverse effect on our business, financial condition and results of operations.

Health concerns or adverse developments with respect to the safety or quality of products of the food industry in general, or our own products specifically, may damage our reputation, increase our costs of operations and decrease demand for our products.

Food safety and the public’s perception that our products are safe and healthy are essential to our image and business. We sell food products for human consumption, which subjects us to safety risks such as product contamination, spoilage, misbranding or product tampering. Product contamination, including the presence of a foreign object, substance, chemical or other agent or residue or the introduction of a genetically modified organism, could require product withdrawals or recalls or the destruction of inventory, and could result in negative publicity, temporary plant closures and substantial costs of compliance or remediation. For example, while it did not significantly impact our Predecessor’s business, many food companies including our Predecessor had to deal with the reputational impact of the industry-wide horsemeat contamination issue that arose across most European food markets in January 2013. In addition, food producers, including us, have been targeted by extortion attempts that threatened to contaminate products displayed in supermarkets. Such attempts can result in the temporary removal of products from shelf displays as a precautionary measure and result in lost revenue. We may also be impacted by publicity concerning any assertion that our products caused illness or injury. In addition, we could be subject to claims or lawsuits relating to an actual or alleged illness stemming from product contamination or any other incidents that compromise the safety and quality of our products. Any significant lawsuit or widespread product recall or other events leading to the loss of consumer confidence in the safety and quality of our products could damage our brand, reputation and image and negatively impact our sales, profitability and prospects for growth. In addition, product recalls are difficult to foresee and prepare for and, in the event we are required to recall one or more of our products, such recall may result in loss of sales due to unavailability of our products and may take up a significant amount of our management’s time and attention. We maintain systems designed to monitor food safety risks and require our suppliers to do so as well. However, we cannot guarantee that our efforts will be successful or that such risks will not materialize. In addition, although we attempt, through contractual relationships and regular inspections, to control the risk of contamination caused by third parties in relation to the several manufacturing and distribution processes we outsource, we cannot guarantee that our efforts will be successful or that contamination of our products by third parties will not materialize.

We are also subject to further risks affecting the food industry generally, including risks posed by widespread contamination and evolving nutritional and health-related concerns. Regulatory authorities may limit the supply of certain types of food products in response to public health concerns and consumers may perceive certain products to be unsafe or unhealthy. In addition, governmental regulations may require us to identify replacement products to offer to our customers or, alternatively, to discontinue certain offerings or limit the range of products we offer. We may be unable to find substitutes that are as appealing to our customer base, or such substitutes may not be widely available or may be available only at increased costs. Such substitutions or limitations could also reduce demand for our products.

10

We could also be subject to claims or lawsuits relating to an actual or alleged illness or injury or death stemming from the consumption of a misbranded, altered, contaminated or spoiled product, which could negatively affect our business. Awards of damages, settlement amounts and fees and expenses resulting from such claims and the public relations implications of any such claims could have an adverse effect on our business. The availability and price of insurance to cover claims for damages are subject to market forces that we do not control, and such insurance may not cover all the costs of such claims and would not cover damage to our reputation. Even if product liability claims against us are not successful or fully pursued, these claims could be costly and time consuming, increase our insurance premiums and divert our management’s time and resources towards defending them rather than operating our business. In addition, any adverse publicity concerning such claims, even if unfounded, could cause customers to lose confidence in the safety and quality of our products and damage our reputation and brand image.

Potential liabilities and costs from litigation could adversely affect our business.

There is no guarantee that we will be successful in defending ourselves in civil, criminal or regulatory actions, including under general, commercial, employment, environmental, food quality and safety, anti-trust and trade, advertising and claims, and environmental laws and regulations, or in asserting our rights under various laws. For example, our marketing or claims could face allegations of false or deceptive advertising or other criticisms which could end up in litigation and result in potential liabilities or costs. In addition, we could incur substantial costs and fees in defending ourself or in asserting our rights in these actions or meeting new legal requirements. The costs and other effects of potential and pending litigation and administrative actions against us, and new legal requirements, cannot be determined with certainty and may differ from expectations.

We are exposed to local business and tax risks in many different countries.

We operate in various countries in Europe, predominantly in the United Kingdom, Germany, France, Italy, Sweden and Norway. As a result, our business is subject to risks resulting from differing legal, political, social and regulatory requirements, economic conditions and unforeseeable developments in these markets, all or any of which could result in disruption of our activities. These risks include, among others, political instability, differing economic cycles and adverse economic conditions, unexpected changes in regulatory environments, currency exchange rate fluctuations, inability to collect payments or seek recourse under or comply with ambiguous or vague commercial or other laws, changes in distribution and supply channels, foreign exchange controls and restrictions on repatriation of funds, and difficulties in attracting and retaining qualified management and employees. Our overall success in the markets in which we operate depends, to a considerable extent, on our ability to effectively manage differing legal, political, social and regulatory requirements, economic conditions and unforeseeable developments. We cannot guarantee that we will succeed in developing and implementing policies and strategies which will be effective in each location where we do business.

We must comply with complex and evolving tax regulations in the various jurisdictions in which we operate, which subjects us to international tax compliance risks. Some tax jurisdictions in which we operate have complex and subjective rules regarding income tax, value-added tax, sales or excise tax and transfer tax. From time to time, our foreign subsidiaries are subject to tax audits and may be required to pay additional taxes, interest or penalties should the taxing authority assert different interpretations, or different allocations or valuations of our services which could be material and could reduce our income and cash flow from our international subsidiaries. We currently have several pending tax assessments and audits in various jurisdictions including Germany, France and Italy. The agreement by which we acquired the Findus Group provides for certain indemnifications of tax liabilities which may arise in certain jurisdictions which we believe are sufficient to address these specific tax matters as far as they relate to the Findus Group. We have also established, where appropriate, reserves and provisions for tax assessments which we believe to be adequate to address potential tax liabilities. However, it is possible that the tax audits referred to above could result in the volatility of timings of cash tax payment and recoveries.

11

Our business is dependent on third-party suppliers and changes or difficulties in our relationships with our suppliers may harm our business and financial results.

We outsource some of our business functions to third-party suppliers, such as the processing of certain vegetables and other products, the manufacturing of packaging materials and distribution of our products. Our suppliers may fail to meet timelines or contractual obligations or provide us with sufficient products, which may adversely affect our business. Certain of our contracts with key suppliers, such as for the raw materials we use in our products, are short term, can be terminated by the supplier upon giving notice within a certain period and restrict us from using other suppliers. Also, a number of our supply contracts, including for fish and vegetables, may be terminated by the supplier upon a change in our ownership. Failure to appropriately structure or adequately manage our agreements with third parties may adversely affect our supply of products. We are also subject to credit risk with respect to our third-party suppliers. If any such suppliers become insolvent, an appointed trustee could potentially ignore the service contracts we have in place with such party, resulting in increased charges or the termination of the service contracts. We may not be able to replace a service provider within a reasonable period of time, on as favorable terms or without disruption to our operations. Any adverse changes to our relationships with third-party suppliers could have a material adverse effect on our image, brand and reputation, as well as on our business, financial condition and results of operations.

In addition, to the extent that our creditworthiness is impaired, or general economic conditions decline, certain of our key suppliers may demand onerous payment terms that could materially adversely affect our working capital position, or such suppliers may refuse to continue to supply to us. A number of our key suppliers have taken out trade credit insurance on our ability to pay them. To the extent that such trade credit insurance becomes unobtainable or more expensive due to market conditions, we may face adverse changes to payment terms by our key suppliers or they may refuse to continue to supply us.

The nature of the exit of the UK from the EU could adversely impact our business, results of operations and financial condition.

For the year ended December 31, 2017, 94% of our revenue was derived from the European Union as a whole and 21% was derived from the United Kingdom. On June 23, 2016 the UK electorate voted in favor of leaving the European Union (commonly referred to as “Brexit”), and on March 29, 2017 the UK government formally initiated the withdrawal process. The terms of any withdrawal are subject to a negotiation period that could last at least two years thus the referendum has created significant uncertainty about the future relationship between the United Kingdom and the European Union, and has given rise to calls for certain regions within the United Kingdom to preserve their place in the European Union by separating from the United Kingdom as well as for the governments of other EU Member States to consider withdrawal.

Brexit has resulted in volatility in the value of the Pound Sterling, and Euro currencies and we may experience adverse impacts on consumer demand and suppliers’ profitability in the UK and other markets, and general uncertainty in the overall business environment in which we operate. Depending on the terms of Brexit, the United Kingdom could also lose access to the single EU market resulting in an impact on the general and economic conditions in the United Kingdom. Changes may occur in regulations that we are required to comply with as well as amendments to treaties governing tax, duties, tariffs, etc. which could adversely impact our operations and require us to modify our financial and supply arrangements. Additionally, political instability in the European Union as a result of Brexit may result in a material negative effect on credit markets and foreign direct investments in the EU and UK. This deterioration in economic conditions could result in increased unemployment rates, increased short and long term interest rates, consumer and commercial bankruptcy filings, a decline in the strength of national and local economies, and other results that negatively impact household incomes. Further, a number of our employees in the UK are not UK citizens and, depending on the terms negotiated, may no longer have the right to work in the UK following the UK’s formal withdrawal from the EU. Any of these factors could have a material adverse effect on our business, financial condition and results of operations.

12

The price of energy we consume in the manufacture, storage and distribution of our products is subject to volatile market conditions.

The price of electricity and other energy resources required in the manufacture, storage and distribution of our products is subject to volatile market conditions. These market conditions are often affected by political and economic factors beyond our control, including, for instance, the energy policies of the countries in which we operate. For example, the German government’s decision to phase out nuclear power generation by 2022 could cause electricity prices and price volatility in Germany to increase. Any sustained increases in energy costs could have an adverse effect on the attractiveness of frozen food products for our customers and consumers and could affect our competitive position if our competitors’ energy costs do not increase at the same rate as ours. In addition, disruptions in the supply of energy resources could temporarily impair our ability to manufacture products for our customers. Such disruptions may also occur as a result of the loss of energy supply contracts or the inability to enter into new energy supply contracts on commercially attractive terms. Furthermore, natural catastrophes or similar events could affect the electricity grid. Any such disruptions, or increases in energy costs as a result of the aforementioned factors or otherwise, could have a material adverse effect on our business, financial condition and results of operations.

Any disruptions, failures or security breaches of our information technology systems could harm our business and reduce our profitability.

We rely on our information technology systems for communication among our suppliers, manufacturing plants, distribution functions, headquarters and customers. Our performance depends on the availability of accurate and timely data and other information from key software applications to aid day-to-day business and decision-making processes. We may be adversely affected if our controls designed to manage information technology operational risks fail to contain such risks. If we do not allocate and effectively manage the resources necessary to build and sustain the proper technology infrastructure and to maintain the related automated and manual control processes, we could be subject to adverse effects including billing and collection errors, business disruptions, in particular concerning our manufacturing and logistics functions, and security breaches. Any disruption caused by failings in our information technology infrastructure equipment or of communication networks, could delay or otherwise impact our day-to-day business and decision-making processes and negatively impact our performance. In addition, we are reliant on third parties to service parts of our IT infrastructure. Failure on their part to provide good and timely service may have an adverse impact on our information technology network. Furthermore, we do not control the facilities or operations of our suppliers. An interruption of operations at any of their or our facilities or any failure by them to deliver on their contractual commitments may have an adverse effect on our business, financial condition and results of operations.

In addition, if we are unable to prevent physical and electronic break-ins, cyber-attacks and other information security breaches, we may suffer financial and reputational damage, be subject to litigation or incur remediation costs or penalties because of the unauthorized disclosure of confidential information belonging to us or to our customers, suppliers or employees. The mishandling or inappropriate disclosure of non-public sensitive or protected information could lead to the loss of intellectual property, negatively impact planned corporate transactions or damage our reputation and brand image. Misuse, leakage or falsification of legally protected information could also result in a violation of data privacy laws and regulations and have a negative impact on our reputation, business, financial condition and results of operations.

Our supply network and manufacturing and distribution facilities could be disrupted by factors beyond our control such as extreme weather, fire, terrorist activity and natural disasters.

Severe weather conditions and natural disasters, such as storms, floods, droughts, frosts, earthquakes or pestilence, may affect the supply of the raw materials that we use for the manufacturing of our products. For example, changing climate may cause flooding and drought in crop growing areas or changes in sea temperatures affecting marine biomass, fishing catch rates and overall fishing conditions. In addition, drought or floods may affect the feed supply for red meat and poultry, which in turn may affect the quality and availability of protein sources for our products. Competing food producers can be affected differently by weather conditions and natural disasters depending on the location of their supply sources. If our supplies of raw materials are reduced, we may not be able to find adequate supplemental supply sources, if at all, on favorable terms, which could have a material adverse effect on our business, financial condition and results of operation.

13

In addition, our manufacturing facilities may be subject to damage or disruption resulting from fire terrorist activity, natural disasters or other causes. For example, our Lowestoft and Bremerhaven manufacturing facilities are situated in regions which have historically been prone to flooding. Extensive damage to any of our nine major manufacturing facilities as a result of any of the foregoing reasons, could, to the extent that lost production could not be compensated for by unaffected facilities, severely affect our ability to conduct our business operations and, as a result, adversely affect our business, financial condition and results of operations.

Furthermore, as we lease parts of our Boulogne, Bremerhaven, Lowestoft, Tonsberg and Valladolid sites, the use of these properties is subject to certain terms and conditions, the breach of which could affect our ability to continue use of these properties which in turn may disrupt our operations and may materially adversely affect our results of operations.

We may be unable to realize the expected benefits of actions taken to align our resources, operate more efficiently and control costs.

When required we take actions, such as workforce reductions, plant closures and consolidations, and other cost reduction initiatives, to align our resources with our growth strategies, operate more efficiently and control costs. As these plans and actions are complex, unforeseen factors could result in expected savings and benefits to be delayed or not realized to the full extent planned, could negatively impact labor relations, including causing work stoppages, and could lead to disruptions in our business and operations and higher short-term costs related to severance and related capital expenditures. In 2016, we announced the closure of our factory and pea processing operations in Bjuv, Sweden, and operations ceased in the first half of 2017 with production transfered to other factories in the Group’s network. In January 2018, we sold the factory building and parts of the premises. We may be unable to realize the expected benefits of these actions which could potentially adversely affect our profitability and operations.

Significant disruption in our workforce or the workforce of our suppliers could adversely affect our business, financial condition and results of operations.

As of December 31, 2017, we employed approximately 3,875 employees, of which approximately 1,267 were located in Germany, 801 were located in the United Kingdom, 335 were located in France, 451 were located in Italy, 536 were located in Sweden/Norway and 485 employees in other locations. Approximately 67% of our employees work in our manufacturing operations. We have in the past, and may in the future, experience labor disputes and work stoppages at one or more of our manufacturing sites due to localized strikes or strikes in the larger retail food industry sector. We have also been involved in negotiations on collective bargaining agreements. A labor stoppage or other interruption at one of our nine manufacturing sites would impact our ability to supply our customers and could have a pronounced effect on our operations. Further, a number of our employees in the UK are not UK citizens and, depending on the terms negotiated, may no longer have the right to work in the UK following the UK’s formal withdrawal from the EU. Future labor disturbance or work stoppage at any of our or our suppliers’ facilities in Germany, the United Kingdom, Italy or elsewhere may have an adverse effect on such facility’s operations and, potentially, on our business, financial condition and results of operations.

Higher labor costs could adversely affect our business and financial results.

We compete with other producers for good and dependable employees. The supply of such employees is limited and competition to hire and retain them may result in higher labor costs. Furthermore, a substantial majority of our employees are subject to national minimum wage requirements. If legislation is enacted in these countries that has the effect of raising the national minimum wage requirements, requires additional mandatory employee benefits or affects our ability to hire or dismiss employees, we could face substantially higher labor costs. In the UK, the National Minimum Wage and National Living Wage are set to increase from April 2018. High labor costs could adversely affect our profitability if we are not able to pass them on to our customers.

We are dependent upon key executives and highly qualified managers and we cannot assure their retention.

Our success depends, in part, upon the continued services of key members of our management. Our executives’ and managers’ knowledge of the market, our business and our company represents a key strength of our business, which cannot be easily replicated. The success of our business strategy and our future growth also depend on our ability to attract, train, retain and motivate skilled managerial, sales, administration, development and operating personnel.

14

There can be no assurance that our existing personnel will be adequate or qualified to carry out our strategy, or that we will be able to hire or retain experienced, qualified employees to carry out our strategy. The loss of one or more of our key management or operating personnel, or the failure to attract and retain additional key personnel, could have a material adverse effect on our business, financial condition and results of operations.

Costs or liabilities relating to compliance with applicable directives, regulations and laws could have a material adverse effect on our business, financial condition and results of operations.

As a producer of food products for human consumption, we are subject to extensive regulation in the United Kingdom, Germany, France, Italy, Sweden, Norway and other countries in which we operate, as well as the European Union, that governs production, composition, manufacturing, storage, transport, advertising, packaging, health, quality, labeling, safety and distribution standards. In addition, national regulations that have implemented European directives applicable to frozen products establish highly technical requirements regarding labeling, manufacturing, transportation and storage of frozen food products. For example, regulations of the European Parliament and Council published in October 2011 changed rules relating to the presentation of nutritional information on packaging and other rules on labeling. It is unclear how this will be impacted under Brexit but there may be changes and further regulations that the company has to adhere to. Local governmental authorities also set out health and safety related conditions and restrictions. Any failure to comply with applicable laws and regulations could subject us to civil remedies, including fines, injunctions, product recalls or asset seizures, as well as potential criminal sanctions, any of which could have a material adverse effect on our business, financial condition and results of operations.

In addition, our facilities and our suppliers’ facilities are subject to licensing, reporting requirements and official quality controls by numerous governmental authorities. These governmental authorities include European, national and local health, environmental, labor relations, sanitation, building, zoning, and fire and safety departments. Difficulties in obtaining or failure to obtain the necessary licenses or approval could delay or prevent the development, expansion or operation of a given production or warehouse facility. Any changes in those regulations may require us to implement new quality controls and possibly invest in new equipment, which could delay the development of new products and increase our operating costs.

All of our products must comply with strict national and international hygiene regulations. Our facilities and our suppliers’ facilities are subject to regular inspection by authorities for compliance with hygiene regulations applicable to the sale, storage and manufacturing of foodstuffs and the traceability of genetically modified organisms, meats and other raw materials. Additionally, in certain jurisdictions, food business operators, including those in the food storage, processing and distribution sectors, are required to trace all food, animal feed, and food-producing animals under their control using registration systems that track the source of the products through the supply chain. Despite the precautions we undertake, should any non-compliance with such regulations be discovered during an inspection or otherwise, authorities may temporarily shut down any of our facilities and levy a fine for such non-compliance, which could have a material adverse effect on our business, financial condition and results of operations.

We could incur material costs to address violations of, or liabilities under, health, safety and environmental regulations.

Our facilities and operations are subject to numerous health, safety and environmental regulations, including local and national laws, and European directives and regulations governing, among other things, water supply and use, water discharges, air emissions, chemical safety, solid and hazardous waste management and disposal, clean-up of contamination, energy use, noise pollution, and workplace health and safety. Health, safety and environmental legislation in Europe and elsewhere have generally become more comprehensive and restrictive and more rigid over time and enforcement has become more stringent. Failure to comply with applicable requirements, or the terms of required permits, can result in penalties or fines, clean-up costs, third party property damage and personal injury claims, which could have a material adverse effect on our brand, business, financial condition and results of operations. In addition, if health, safety and environmental laws and regulations in the United Kingdom, Germany, France, Italy, Sweden, Norway and the other countries in which we operate or from which we source raw materials and ingredients become more stringent in the future, the extent and timing of investments required to maintain compliance may exceed our budgets or estimates and may limit the availability of funding for other investments.

Furthermore, under some environmental laws, we could be liable for costs incurred in investigating or remediating contamination at properties we own or occupy, even if the contamination was caused by a party unrelated to us or was not caused by us, and even if the activity which caused the contamination was legal at the time it occurred. The discovery of previously unknown contamination, or the imposition of new or more burdensome obligations to investigate or remediate contamination at our properties or at third-party sites, could result in substantial unanticipated costs which could have a material adverse effect on our business, financial condition and results of operations.

15

In certain jurisdictions, we are also subject to legislation designed to significantly reduce industrial energy use, carbon dioxide emissions and the emission of ozone depleting compounds more generally. If we fail to meet applicable standards for energy use reduction or are unable to decrease, and in some cases eliminate, certain emissions within the applicable period required by relevant laws and regulations, we could be subject to significant penalties or fines and temporary or long-term disruptions to production at our facilities, all of which could have a material adverse effect on our business, financial condition and results of operations.

We are subject to a variety of regulatory schemes; failure to comply with applicable rules and regulations could adversely affect our business, results of operations and reputation.

Our operations are subject to a variety of regulatory schemes which require us to implement processes, procedures and controls to provide reasonable assurance that we are operating in compliance with applicable regulations, including the UK Bribery Act, the Modern Slavery Act 2015, the Foreign Corrupt Practices Act of 1977, the Trade Sanctions and Export Controls and the EU General Data Protection Regulation. Failure to comply (or any alleged failure to comply) with the regulations referenced above or any other regulations could result in civil and criminal, monetary and non-monetary penalties, and any such failure or alleged failure (or becoming subject to a regulatory enforcement investigation) could also damage our reputation, disrupt our business, result in loss of customers and cause us to incur significant legal and investigatory fees. In addition, our business, including our ability to operate and continue to expand internationally, could be adversely affected if local and foreign laws or regulations are adopted, interpreted, or implemented in a manner that is inconsistent with our current business practices and that require rapid changes to these practices or our products, services, policies and procedures.  If we are not able to adapt our business practices or strategies to changes in laws or regulations, it could subject us to liability, increased costs and reduced product demand. Additionally, the costs of compliance with laws and regulations may increase in the future as a result of changes in interpretation.  Any failure by us to comply with applicable laws and regulations may subject us to significant liabilities and could adversely affect our business, results of operations and reputation.

A failure in our cold chain could lead to unsafe food conditions and increased costs.

“Cold chain” requirements setting out the temperatures at which our ingredients and products are stored are established both by statute and by us to help guarantee the safety of our food products. Our cold chain is maintained from the moment the ingredients arrive at, or are frozen by, our suppliers, through our manufacturing and transportation of products and ultimately to the time of sale in retail stores. These standards ensure the quality, freshness and safety of our products. A failure in the cold chain could lead to food contamination, risks to the health of consumers, fines and damage to our brands and reputation, each of which could have an adverse effect on our business, financial condition and results of operations.

Seasonality impacts our business, and our revenue and working capital levels may vary quarter to quarter.

Our sales and working capital levels have historically been affected to a limited extent by seasonality. In general, sales volumes for frozen food are slightly higher in cold or winter months, partly because there are fewer fresh alternatives available for vegetables and because our customers typically allocate more freezer space to the ice cream segment in summer or hotter months. In addition, variable production costs, including costs for seasonal staff, and working capital requirements associated with the keeping of inventories, vary depending on the harvesting and buying periods of seasonal raw materials, in particular vegetable crops. For example, stock (and therefore net working capital) levels typically peak in August to September just after the pea harvest. If seasonal fluctuations are greater than anticipated, our business, financial condition and results of operations could be adversely affected.

We have risks related to our indebtedness, including our ability to withstand adverse business conditions and to meet our debt service obligations.

Our ability to make payments on and to refinance our indebtedness, and to fund our operations, working capital and capital expenditures, depends on our ability to generate cash. To a certain extent, our cash flow is subject to general economic, industry, financial, competitive, operating, legislative, regulatory and other factors, many of which are beyond our control.

We cannot assure you that our business will generate sufficient cash flow from operations or that future sources of cash will be available to us in an amount sufficient to enable us to pay amounts due on our indebtedness or to fund our other liquidity needs.

16

Additionally, if we incur additional indebtedness in connection with any future acquisitions or development projects or for any other purpose, our debt service obligations could increase. We may need to refinance all or a portion of our indebtedness before maturity. Our ability to refinance our indebtedness or obtain additional financing will depend on, among other things:

• our financial condition and market conditions at the time;

• restrictions in the agreements governing our indebtedness;

• general economic and capital market conditions;

• the availability of credit from banks or other lenders;

• investor confidence in us; and

• our results of operations.

In addition, a significant part of our indebtedness includes provisions with respect to maintaining and complying with certain financial and operational covenants. Our ability to comply with these covenants may be affected by events beyond our control. A breach of one or more of these covenants could result in an event of default and may give rise to an acceleration of the debt. In the longer term, such breach of covenants could have a material adverse effect on our operations and cash flows.

Our variable rate indebtedness subjects us to interest rate risk, which could cause our debt service obligations to increase significantly.

An increase in market interest rates would increase our interest expense arising on our existing and future floating rate indebtedness. Pursuant to the terms of our Senior Facilities Agreement, the interest rate that we pay on indebtedness incurred under our term loan facilities or revolving credit facility varies based on a fixed margin over a base rate which references the LIBOR or EURIBOR rates. As a result, we are exposed to interest rate risk. If interest rates increase, our debt service obligations on the variable rate indebtedness will increase even though the amount borrowed remained the same, and our net income and cash flows, including cash available for servicing our indebtedness, will correspondingly decrease. In the future, we may enter into interest rate swaps that involve the exchange of floating for fixed rate interest payments in order to reduce interest rate volatility. However, we may not maintain interest rate swaps with respect to all of our variable rate indebtedness, and any swaps we enter into may not fully mitigate our interest rate risk.

We are exposed to exchange rate risks and such rates may adversely affect our results of operations.

We are exposed to exchange rate risk. Our reporting currency is the Euro and yet a significant proportion of our sales and EBITDA are in Pound Sterling through our United Kingdom based business and Norwegian Krone and Swedish Krona through our Norwegian and Swedish based businesses. We are exposed to foreign exchange impacts as we convert the Pound Sterling results of our United Kingdom business and the Norwegian Krone and Swedish Krona results of our Norwegian and Swedish business into our reporting currency of Euro. We have swapped a portion of our USD term loan to GBP using cross currency interest rate swaps which act as a natural hedge for our United Kingdom business. We are also exposed to exchange rate risk due to the fact that a significant portion of our raw material purchases, mainly fish, are denominated in U.S. Dollars and our Swedish business also has a significant exposure on purchases denominated in Euro. Our policy is to reduce this risk by using foreign exchange forward contracts with a maturity of less than one year which are designated as cash flow hedges. However, such hedging arrangements may not fully protect us against currency fluctuations. Fluctuations and sustained strengthening of the U.S. Dollar exchange rate against our operating currencies may materially adversely affect our business, financial condition and results of operations.

Changes to our payment terms with both customers and suppliers may materially adversely affect our operating cash flows.

We may experience significant pressure from both our competitors and our key suppliers to reduce the number of days of our accounts payable. At the same time, we may experience pressure from our customers to extend the number of days before paying our accounts receivable. Any failure to manage our accounts payable and accounts receivable may have a material adverse effect on our business, financial condition and results of operations.

17

Changes in accounting standards and subjective assumptions, estimates and judgments by management related to complex accounting matters could significantly affect our financial results.

Generally accepted accounting principles and related accounting pronouncements, implementation guidelines and interpretations with regard to a wide range of matters that are relevant to our business, including but not limited to revenue recognition, leases, estimating valuation allowances and accrued liabilities (including allowances for returns, doubtful accounts and obsolete and damaged inventory), accounting for income taxes, valuation of long-lived and intangible assets and goodwill, stock-based compensation and loss contingencies, are highly complex and involve many subjective assumptions, estimates and judgments by our management. Changes in these rules or their interpretation or changes in underlying assumptions, estimates or judgments by our management could significantly change our reported or expected financial performance, and could have a material adverse effect on our business. As an example, the impact of the adoption of IFRS 16 ‘Leases’ may have a material impact on the Statements of Financial Position and Profit or Loss. Management is assessing this and other new accounting pronouncements and its impact on the Company prior to their adoption dates.

We may incur liabilities that are not covered by insurance.

While we seek to maintain appropriate levels of insurance, not all claims are insurable and we may experience major incidents of a nature that are not covered by insurance. Our insurance policies cover, among other things, employee-related accidents and injuries, property damage and liability deriving from our activities. In particular, our Lowestoft and Bremerhaven manufacturing facilities are situated in regions that have historically been affected by flooding. We may not be able to obtain flood insurance on reasonable terms or at all with respect to those facilities. We maintain an amount of insurance protection that we believe is adequate, but there can be no assurance that such insurance will continue to be available on acceptable terms or that our insurance coverage will be sufficient or effective under all circumstances and against all liabilities to which we may be subject. We could, for example, be subject to substantial claims for damages upon the occurrence of several events within one calendar year. In addition, our insurance costs may increase over time in response to any negative development in our claims history or due to material price increases in the insurance market in general.

An impairment of the carrying value of goodwill or other intangible assets could negatively affect our consolidated operating results and net worth.

Goodwill represents amounts arising from acquisitions and is the difference between the cost of the acquisition and the fair value of the net identifiable assets acquired. Intangible assets can include computer software, brands, customer relationships and other acquired intangibles as of the acquisition date. Goodwill and other intangibles expected to contribute indefinitely to our cash flows are not amortized, but must be evaluated by management at least annually for impairment. If carrying value exceeds its recoverable amount, the intangible is considered impaired and is reduced to fair value via a charge to earnings. Factors which could result in an impairment include, but are not limited to: (i) reduced demand for our products; (ii) higher commodity prices; (iii) lower prices for our products or increased marketing as a result of increased competition; and (iv) significant disruptions to our operations as a result of both internal and external events. Should the value of one or more of the acquired intangibles become impaired, our consolidated profit or loss and net assets may be materially adversely affected. As of December 31, 2017, the carrying value of intangible assets totaled €3,470.0 million, of which €1,745.6 million was goodwill and €1,724.4 million represented brands, computer software, customer relationships and other acquired intangibles compared to total assets of €4,601.7 million.

We face risks associated with certain pension obligations.

The Company has a mixture of partially funded and unfunded post-employment defined benefit plans in Germany, Sweden and Austria as well as defined benefit indemnity arrangements in Italy and France. Deterioration in the value or lower than expected returns on investments may lead to an increase in our obligation to make contributions to these plans.

The obligations that arise from these plans are calculated using actuarial valuations which are based on assumptions linked to the performance of financial markets, interest rates and legislation which changes over time. Adverse changes to these assumptions will impact the obligations recognized and would lead to higher cash payments in the long term.

Our obligation to make contributions to the pension plans could reduce the cash available for operational and other corporate uses and may have a materially adverse impact on our operations, financial condition and liquidity.

18

If we fail to or are unable to implement and maintain effective internal controls over financial reporting, the accuracy and timeliness of our financial reporting may be adversely affected.

We are subject to reporting obligations under U.S. securities laws. The SEC, as required under Section 404 of the Sarbanes-Oxley Act of 2002, has adopted rules requiring every public company to include a report of management on the effectiveness of such company's internal control over financial reporting in its annual report. In addition, an independent registered public accounting firm must issue an attestation report on the effectiveness of the company's internal control over financial reporting.

We recognize that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives, and our management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. If we fail to maintain effective internal control over financial reporting in the future, we and our independent registered public accounting firm may not be able to conclude that we have effective internal control over financial reporting at a reasonable assurance level. This could in turn result in the loss of investor confidence in the reliability of our financial statements. Furthermore, we have incurred and anticipate that we will continue to incur considerable costs and use significant management time and other resources in an effort to comply with Section 404 and other requirements of the Sarbanes-Oxley Act. If we are not able to continue to meet the requirements of Section 404 in a timely manner or with adequate compliance, we might be subject to sanctions or investigation by the SEC, the NYSE or other regulatory authorities. Any such action could adversely affect the accuracy and timeliness of our financial reporting.

Risks Related to Our Structure and Acquisition Strategy

We may not be able to consummate future acquisitions or successfully integrate acquisitions into our business, which could result in unanticipated expenses and losses.

Our strategy is largely based on our ability to grow through acquisitions of additional businesses to build an integrated group. Consummating acquisitions of related businesses, or our failure to integrate such businesses successfully into our existing businesses, could result in unanticipated expenses and losses. Furthermore, we may not be able to realize any of the anticipated benefits from acquisitions, including the Findus Acquisition and the Green Isle Foods Ltd. acquisition, if consummated.

We anticipate that any future acquisitions we may pursue as part of our business strategy may be partially financed through additional debt or equity. If new debt is added to current debt levels, or if we incur other liabilities, including contingent liabilities, in connection with an acquisition, the debt or liabilities could impose additional constraints and requirements on our business and operations, which could materially adversely affect our financial condition and results of operation. In addition, to the extent our ordinary shares are used for all or a portion of the consideration to be paid for future acquisitions, dilution may be experienced by existing shareholders.

In connection with our completed and future acquisitions, the process of integrating acquired operations into our existing group operations may result in unforeseen operating difficulties and may require significant financial resources that would otherwise be available for the ongoing development or expansion of existing operations. Some of the risks associated with acquisitions include:

• unexpected losses of key employees or customers of the acquired company;

• conforming the acquired company’s standards, processes, procedures and controls with our operations;

• coordinating new product and process development;

• hiring additional management and other critical personnel;

• negotiating with labor unions; and

• increasing the scope, geographic diversity and complexity of our current operations.

We may encounter unforeseen obstacles or costs in the integration of businesses that we may acquire. In addition, general economic and market conditions or other factors outside of our control could make our operating strategies difficult or impossible to implement. Any failure to implement these operational improvements successfully and/or the failure of these operational improvements to deliver the anticipated benefits could have a material adverse effect on our results of operations and financial condition.

19

We may be subject to antitrust regulations with respect to future acquisition opportunities.

Many jurisdictions in which we operate have antitrust regulations which involve governmental filings for certain acquisitions, impose waiting periods and require approvals by government regulators. Governmental authorities may seek to challenge potential acquisitions or impose conditions, terms, obligations or restrictions that may delay completion of the acquisition or materially reduce the anticipated benefits (financial or otherwise). Our inability to consummate potential future acquisitions or to receive the full benefits of such acquisitions because of antitrust regulations could limit our ability to execute on our acquisition strategy which could have a material adverse effect on our financial condition and results of operations.

We may face significant competition for acquisition opportunities.

There may be significant competition in some or all of the acquisition opportunities that we may explore. Such competition may for example come from strategic buyers, sovereign wealth funds, special purpose acquisition companies and public and private investment funds, many of which are well established and have extensive experience in identifying and completing acquisitions. A number of these competitors may possess greater technical, financial, human and other resources than us. We cannot assure investors that we will be successful against such competition. Such competition may cause us to be unsuccessful in executing any acquisition or may result in a successful acquisition being made at a significantly higher price than would otherwise have been the case.

Any due diligence by us in connection with potential future acquisition may not reveal all relevant considerations or liabilities of the target business, which could have a material adverse effect on our financial condition or results of operations.

We intend to conduct such due diligence as we deem reasonably practicable and appropriate based on the facts and circumstances applicable to any potential acquisition. The objective of the due diligence process will be to identify material issues which may affect the decision to proceed with any one particular acquisition target or the consideration payable for an acquisition. We also intend to use information revealed during the due diligence process to formulate our business and operational planning for, and our valuation of, any target company or business. While conducting due diligence and assessing a potential acquisition, we may rely on publicly available information, if any, information provided by the relevant target company to the extent such company is willing or able to provide such information and, in some circumstances, third party investigations.

There can be no assurance that the due diligence undertaken with respect to an acquisition will reveal all relevant facts that may be necessary to evaluate such acquisition including the determination of the price we may pay for an acquisition target or to formulate a business strategy. Furthermore, the information provided during due diligence may be incomplete, inadequate or inaccurate. As part of the due diligence process, we will also make subjective judgments regarding the results of operations, financial condition and prospects of a potential target. If the due diligence investigation fails to correctly identify material issues and liabilities that may be present in a target company or business, or if we consider such material risks to be commercially acceptable relative to the opportunity, and we proceed with an acquisition, we may subsequently incur substantial impairment charges or other losses.

In addition, following an acquisition, including the Iglo Acquisition and the Findus Acquisition, we may be subject to significant, previously undisclosed liabilities of the acquired business that were not identified during due diligence and which could contribute to poor operational performance, undermine any attempt to restructure the acquired company or business in line with our business plan and have a material adverse effect on our financial condition and results of operations.

We are a holding company whose principal source of operating cash is the income received from our subsidiaries.

We are dependent on the income generated by our subsidiaries in order to make distributions and dividends on the ordinary shares. The amount of distributions and dividends, if any, which may be paid to us from any operating subsidiary will depend on many factors, including such subsidiary’s results of operations and financial condition, limits on dividends under applicable law, its constitutional documents, documents governing any indebtedness, and other factors which may be outside our control. If our operating subsidiaries do not generate sufficient cash flow, we may be unable to make distributions and dividends on the ordinary shares.

20

The Founders and/or the Founder Entities may in the future enter into related party transactions with us, which may give rise to conflicts of interest between us and some or all of the Founders and/or the Directors.

Our founders, Martin Franklin and Noam Gottesman (the “Founders”) and/or one or more of their affiliates, including Mariposa Acquisition II, LLC and TOMS Acquisition I LLC (the “Founder Entities”) may in the future enter into agreements with us that are not currently under contemplation. While we have implemented procedures to ensure we will not enter into any related party transaction without the approval of our Audit Committee, it is possible that the entering into of such an agreement might raise conflicts of interest between us and some or all of the Founders and/or the directors.

Risks Related to our Ordinary Shares

We have various equity instruments outstanding that would require us to issue additional ordinary shares. Therefore, you may experience significant dilution of your ownership interests and the future issuance of additional ordinary shares, or the anticipation of such issuances, could have an adverse effect on our share price.

We currently have various equity instruments outstanding that would require us to issue additional ordinary shares for no or a fixed amount of additional consideration. Specifically, as of March 14, 2018, we had outstanding the following:

• 1,500,000 Founder Preferred Shares held by the Founder Entities, which are controlled by the Founders. The preferred shares held by the Founder Entities (the “Founder Preferred Shares”) will automatically convert into ordinary shares on a one for one basis (subject to adjustment in accordance with our Memorandum and Articles of Association) on the last day of the seventh full financial year following completion of the Iglo Acquisition and some or all of them may be converted following written request from the holder;

• 125,000 options held by certain current and former of our Directors which are exercisable to purchase ordinary shares, on a one-for-one basis, at any time at the option of the holder; and

• 4,927,000 equity awards issued under the LTIP, which may be converted into ordinary shares subject, in most cases, to meeting certain performance conditions.

We also have 12,472,744 ordinary shares currently available for issuance under our LTIP.

Holders of the Founder Preferred Shares are entitled to receive annual dividend amounts subject to certain performance conditions (the “Founder Preferred Shares Annual Dividend Amount”). The payment of the Founder Preferred Shares Annual Dividend Amount became mandatory after January 1, 2015 if certain share price performance conditions are met for any given year. At our discretion, we may settle the Founder Preferred Shares Annual Dividend Amount by issuing shares or by cash payment, but we intend to equity settle. On December 29, 2017, we approved a 2017 Founder Preferred Share Dividend in an aggregate of 8,705,890 ordinary shares. The dividend price used to calculate the 2017 Founder Preferred Shares Annual Dividend Amount was $16.6516 (calculated based upon the volume weighted average price for the last ten trading days of 2017) and the Ordinary Shares were issued on January 2, 2018. In subsequent years, the Annual Dividend Amount will be calculated based upon the volume weighted average share price for the last ten trading days of the financial year and the resulting appreciated average share price compared to the highest price previously used in calculating the Annual Dividend Amount. The issuance of ordinary shares pursuant to the terms of the Founder Preferred Shares will reduce (by the applicable proportion) the percentage shareholdings of those shareholders holding ordinary shares prior to such issuance which may reduce your net return on your investment in our ordinary shares.

Our ordinary share price may be volatile, and as a result, you could lose a significant portion or all of your investment.

The market price of the ordinary shares on the NYSE may fluctuate as a result of several factors, including the following:

• variations in our quarterly operating results;

• volatility in our industry, the industries of our customers and suppliers and the global securities markets;

• risks relating to our business and industry, including those discussed above;

• strategic actions by us or our competitors;

21

• reputational damage from unsafe or poor quality food products;

• actual or expected changes in our growth rates or our competitors’ growth rates;

• investor perception of us, the industry in which we operate, the investment opportunity associated with the ordinary shares and our future performance;

• addition or departure of our executive officers;

• changes in financial estimates or publication of research reports by analysts regarding our ordinary shares, other comparable companies or our industry generally;

• trading volume of our ordinary shares;

• future sales of our ordinary shares by us or our shareholders;

• domestic and international economic, legal and regulatory factors unrelated to our performance; or

• the release or expiration of lock-up or other transfer restrictions on our outstanding ordinary shares.

Furthermore, the stock markets often experience significant price and volume fluctuations that have affected and continue to affect the market prices of equity securities of many companies. These fluctuations often have been unrelated or disproportionate to the operating performance of those companies. These broad market and industry fluctuations, as well as general economic, political and market conditions such as recessions or interest rate changes may cause the market price of ordinary shares to decline.

If securities or industry analysts do not publish or cease publishing research reports about us, if they adversely change their recommendations regarding our ordinary shares or if our operating results do not meet their expectations, the price of our ordinary shares could decline.

The trading market for our ordinary shares will be influenced by the research and reports that industry or securities analysts may publish about us, our business, our market or our competitors. Securities and industry analysts currently publish limited research on us. If there is limited or no securities or industry analyst coverage of our company, the market price and trading volume of our ordinary shares would likely be negatively impacted. Moreover, if any of the analysts who may cover us downgrade our ordinary shares, provide more favorable relative recommendations about our competitors or if our operating results or prospects do not meet their expectations, the market price of our ordinary shares could decline. If any of the analysts who may cover us were to cease coverage or fail to regularly publish reports on us, we could lose visibility in the financial markets, which in turn could cause our share price or trading volume to decline.

As a foreign private issuer, we are subject to different U.S. securities laws and NYSE governance standards than domestic U.S. issuers. This may afford less protection to holders of our ordinary shares, and you may not receive corporate and company information and disclosure that you are accustomed to receiving or in a manner in which you are accustomed to receiving it.

As a foreign private issuer, the rules governing the information that we disclose differ from those governing U.S. corporations pursuant to the Exchange Act. Although we report quarterly financial results and certain material events, we are not required to file quarterly reports on Form 10-Q or provide current reports on Form 8-K disclosing significant events within four days of their occurrence and our quarterly or current reports may contain less information than required for domestic issuers. In addition, we are exempt from the SEC’s proxy rules, and proxy statements that we distribute will not be subject to review by the SEC. Our exemption from Section 16 rules regarding sales of ordinary shares by insiders means that you will have less data in this regard than shareholders of U.S. companies that are subject to the Exchange Act. As a result, you may not have all the data that you are accustomed to having when making investment decisions with respect to U.S. public companies.

As a foreign private issuer, we are exempt from complying with certain corporate governance requirements of the NYSE applicable to a U.S. issuer, including the requirement that a majority of our board of directors consist of independent directors. As the corporate governance standards applicable to us are different than those applicable to domestic U.S. issuers, you may not have the same protections afforded under U.S. law and the NYSE rules as shareholders of companies that do not have such exemptions. See Item 16G: Corporate Governance.

22

We may lose our foreign private issuer status in the future, which could result in significant additional costs and expenses.

We could cease to be a foreign private issuer if a majority of our outstanding voting securities are directly or indirectly held of record by U.S. residents and we fail to meet additional requirements necessary to avoid loss of foreign private issuer status. The regulatory and compliance costs to us under U.S. securities laws as a U.S. domestic issuer may be significantly higher than costs we incur as a foreign private issuer, which could have a material adverse effect on our business and financial results.

As the rights of shareholders under British Virgin Islands law differ from those under United States law, you may have fewer protections as a shareholder.

Our corporate affairs are governed by our Memorandum and Articles of Association, the BVI Business Companies Act, 2004 (as amended, the “BVI Act”) and the common law of the British Virgin Islands. The rights of shareholders to take legal action against our directors, actions by minority shareholders and the fiduciary responsibilities of our directors under British Virgin Islands law are to a large extent governed by the common law of the British Virgin Islands and by the BVI Act. The common law of the British Virgin Islands is derived in part from comparatively limited judicial precedent in the British Virgin Islands as well as from English common law, which has persuasive, but not binding, authority on a court in the British Virgin Islands. The rights of our shareholders and the fiduciary responsibilities of our directors under British Virgin Islands law are not as clearly established as they would be under statutes or judicial precedents in some jurisdictions in the United States. In particular, the British Virgin Islands has a less developed body of securities laws as compared to the United States, and some states (such as Delaware) have more fully developed and judicially interpreted bodies of corporate law. As a result of the foregoing, holders of our ordinary shares may have more difficulty in protecting their interests through actions against our management, directors or major shareholders than they would as shareholders of a U.S. company. See Item 16G: Corporate Governance.

The laws of the British Virgin Islands provide limited protection for minority shareholders, so minority shareholders will have limited or no recourse if they are dissatisfied with the conduct of our affairs.

Under the laws of the British Virgin Islands, there is limited statutory law for the protection of minority shareholders other than the provisions of the BVI Act dealing with shareholder remedies (as summarized under Item 16G: Corporate Governance). The principal protection under statutory law is that shareholders may bring an action to enforce the constituent documents of the company and are entitled to have the affairs of the company conducted in accordance with the BVI Act and the memorandum and articles of association of the company. As such, if those who control the company have persistently disregarded the requirements of the BVI Act or the provisions of the company’s memorandum and articles of association, then the courts will likely grant relief. Generally, the areas in which the courts will intervene are the following: (i) an act complained of which is outside the scope of the authorized business or is illegal or not capable of ratification by the majority; (ii) acts that constitute fraud on the minority where the wrongdoers control the company; (iii) acts that infringe on the personal rights of the shareholders, such as the right to vote; and (iv) acts where the company has not complied with provisions requiring approval of a special or extraordinary majority of shareholders, which are more limited than the rights afforded minority shareholders under the laws of many states in the United States.

To the extent allowed by law, the rights and obligations among or between us, any of our current or former directors, officers and employees and any current or former shareholder will be governed exclusively by the laws of the British Virgin Islands and subject to the jurisdiction of the British Virgin Islands courts, unless those rights or obligations do not relate to or arise out of their capacities as such. Although there is doubt as to whether United States courts would enforce these provisions in an action brought in the United States under United States securities laws, these provisions could make judgments obtained outside of the British Virgin Islands more difficult to enforce against our assets in the British Virgin Islands or jurisdictions that would apply British Virgin Islands law.

23

British Virgin Islands companies may not be able to initiate shareholder derivative actions, thereby depriving shareholders of one avenue to protect their interests.

British Virgin Islands companies may not have standing to initiate a shareholder derivative action in a federal court of the United States. The circumstances in which any such an action may be brought, and the procedures and defenses that may be available in respect of any such action, may result in the rights of shareholders of a British Virgin Islands company being more limited than those of shareholders of a company organized in the United States. Accordingly, shareholders may have fewer alternatives available to them if they believe that corporate wrongdoing has occurred. The British Virgin Islands courts are also unlikely to recognize or enforce judgments of courts in the United States based on certain liability provisions of United States securities law or to impose liabilities, in original actions brought in the British Virgin Islands, based on certain liability provisions of the United States securities laws that are penal in nature. There is no statutory recognition in the British Virgin Islands of judgments obtained in the United States, although the courts of the British Virgin Islands will generally recognize and enforce the non-penal judgment of a foreign court of competent jurisdiction without retrial on the merits. This means that even if shareholders were to sue us successfully, they may not be able to recover anything to make up for the losses suffered.

Dividend payments on our ordinary shares are not expected.

We do not currently intend to pay dividends on our ordinary shares. We intend only to pay such dividends at such times, if any, and in such amounts, if any, as the board determines appropriate and in accordance with applicable law, and then only if we receive dividends on shares held by us in our operating subsidiaries. Therefore, we cannot give any assurance that we will be able to pay or will pay dividends going forward or as to the amount of such dividends, if any.

Shareholders may experience a dilution of their percentage ownership if we make non-pre-emptive offers of ordinary shares in the future.

We have opted-out of statutory pre-emptive rights pursuant to the terms of our Memorandum and Articles of Association. No pre-emption rights therefore exist in respect of future issuance of ordinary shares whether or not for cash. Should we decide to offer additional ordinary shares on a non-pre-emptive basis in the future, this could dilute the interests of shareholders and/or have an adverse effect on the market price of the ordinary shares.

Risks Related to Taxation

Changes in tax law and practice may reduce any net returns for shareholders.

The tax treatment of the Company, our shareholders and any subsidiary of ours (including Iglo and its subsidiaries), any special purpose vehicle that we may establish and any other company which we may acquire are all subject to changes in tax laws or practices in the British Virgin Islands, the United Kingdom, the U.S. and any other relevant jurisdiction. Any change may reduce the value of your investment in our ordinary shares.

Failure to maintain our tax status may negatively affect our financial and operating results and shareholders.

If we were to be considered to be resident in or to carry on a trade or business within the United States for U.S. taxation purposes or in any other country in which we are not currently treated as having a taxable presence, we could be subject to U.S. income tax or taxes in such other country on all or a portion of our profits, as the case may be, which may negatively affect our financial and operating results.

Taxation of returns from subsidiaries may reduce any net return to shareholders.

We and our subsidiaries are subject to taxes in a number of jurisdictions. It is possible that any return we receive from any present or future subsidiary may be reduced by irrecoverable withholding or other local taxes and this may reduce the value of your investment in our ordinary shares.

24

If any dividend is declared in the future and paid in a foreign currency, U.S. holders may be taxed on a larger amount in U.S. Dollars than the U.S. Dollar amount actually received.

U.S. holders will be taxed on the U.S. Dollar value of dividends at the time they are received, even if they are not converted to U.S. Dollars or are converted at a time when the U.S. Dollar value of the dividends has fallen. The U.S. Dollar value of the payments made in the foreign currency will be determined for tax purposes at the spot rate of the foreign currency to the U.S. Dollar on the date the dividend distribution is deemed included in such U.S. holder’s income, regardless of whether or when the payment is in fact converted into U.S. Dollars.

We may be a “passive foreign investment company” for U.S. federal income tax purposes and adverse tax consequences could apply to U.S. investors.

The U.S. federal income tax treatment of U.S. holders will differ depending on whether or not the Company is considered a passive foreign investment company (“PFIC”).

In general, we will be considered a PFIC for any taxable year in which: (i) 75 percent or more of our gross income consists of passive income; or (ii) 50 percent or more of the average quarterly market value of our assets in that year are assets that produce, or are held for the production of, passive income (including cash). For purposes of the above calculations, if we, directly or indirectly, own at least 25 percent by value of the stock of another corporation, then we generally would be treated as if we held our proportionate share of the assets of such other corporation and received directly our proportionate share of the income of such other corporation. Passive income generally includes, among other things, dividends, interest, rents, royalties, certain gains from the sale of stock and securities, and certain other investment income.

We do not believe that we will be a PFIC for the current year. However, we can provide no assurance that we will not be a PFIC for any subsequent year.

Item 4. Information on the Company

A. History and Development of the Company

We are the leading manufacturer and distributor of branded frozen foods in Western Europe based on net sales value. We were incorporated with limited liability under the laws of the British Virgin Islands under the BVI Companies Act on April 1, 2014 under the name Nomad Holdings Limited by the Founder Entities. We were formed to undertake an acquisition of a target company or business. We completed our initial public offering in the United Kingdom on April 15, 2014 (the “2014 Offering”), raising gross proceeds of $500 million, and were listed on the London Stock Exchange (“LSE”). In connection with the 2014 Offering, we issued 48,500,000 ordinary shares and 1,500,000 Founder Preferred Shares, at a price of $10.00 per ordinary share and Founder Preferred Share. Purchasers in the 2014 Offering also received one warrant (the “Warrants”) to purchase ordinary shares for every ordinary share purchased in the 2014 Offering. The Warrants were exercisable on the basis of three warrants per ordinary share at an exercise price of $11.50 per whole ordinary share.

On June 1, 2015, we consummated our initial acquisition by purchasing Iglo Foods Holdings Limited, a leading frozen food company in Europe from a private equity fund advised by Permira Advisers LLP (the "Permira Funds"), for €2.6 billion, and subsequently changed our name to Nomad Foods Limited. The Iglo Group traces its roots back to the 1920s when Clarence Birdseye patented the Birds Eye Plate Froster for freezing fish. After the acquisition of the Birds Eye patents by General Foods in the 1930s, the Birds Eye brand was launched. In the 1940s, Unilever acquired the rights to the Birds Eye brand throughout the world, except for the United States, and in the 1950s Birds Eye became 100% Unilever owned. The Iglo brand was launched in Belgium in 1956 and was introduced by Unilever in Germany in 1961. In the 1960s, Unilever acquired the Findus brand in Italy and San Marino. In 2006, the Permira Funds acquired the Birds Eye and Iglo brands and frozen foods businesses from Unilever, which, at the time, retained the Italian frozen food business under the Findus brand. Following the buyout, the Iglo Group refocused its business on its main product categories, initiated improvements in its supply chain and implemented cost savings. In October 2010, the Iglo Group acquired C.S.I. Compagnia Surgelati Italiana S.p.A., the owner of the Findus brand in Italy and San Marino, from Unilever.

25

On November 2, 2015, we purchased the Findus Group which comprises the continental European businesses of the Findus Parent in Sweden, Norway, Finland, Denmark, France, Spain and Belgium relating to the Findus, Lutosa and La Cocinera brands for approximately £500 million, consisting of £415 million in cash and 8,378,380 ordinary shares (the “Findus Consideration Shares”). This transaction allowed us to unify the Findus brand (excluding Switzerland), and together with the strong Iglo platform, further our efforts to drive innovation, introduce new meal options, and conduct marketing initiatives aimed at bringing more consumers across Europe to the frozen foods aisles. In addition, the geographic footprint of the operations included in the Findus Acquisition complements and extends our footprint throughout Europe.

On January 17, 2018 we entered into an agreement to acquire Green Isle Foods Ltd. including the Goodfella's and San Marco brands, in an all cash deal valued at £200 million (approximately €225 million). We anticipate this acquisition to be completed in the second quarter 2018 and we expect this will enlarge our portfolio of brands to include the number one and number two market share positions within the frozen pizza category in Ireland and the UK, a successful frozen private label pizza business, and two frozen pizza manufacturing facilities.

Our principal executive offices are located at No. 1 New Square, Bedfont Lakes Business Park, Feltham, Middlesex, TW14 8HA. Our telephone number is +(44) 208 918 3200 and our fax number is +(44) 208 918 3491. Our registered office is located at Nemours Chambers, Road Town, Tortola, British Virgin Islands and its telephone number is (284) 852-7900. Our registered agent in the United States is Mariposa Capital, LLC, 500 South Pointe Drive, Suite 240 Miami Beach, Florida 33139.

See Item 5B: Operating and Financial Review and Prospects—Liquidity and Capital Resources for information regarding our capital expenditures for the past three fiscal years and principal capital expenditures currently in progress.

26

B. Business Overview

Our Company

We are the leading branded frozen food player in Western Europe with a portfolio of best-in-class food brands within the frozen category, including fish, vegetables, poultry and meals (excluding ice cream). Our products are sold primarily through large grocery retailers under the brand “Birds Eye” in the United Kingdom and Ireland, “Findus” in Italy, San Marino, France, Spain, Sweden and Norway, “Iglo” in Germany and other continental markets and “La Cocinera” in Spain. According to Euromonitor, our share of the frozen food market in Western Europe stood at 13.8% in 2017 (2.4 times greater than the nearest competitor). We maintain the number one position in ten European geographies, namely the United Kingdom, Italy, Germany, Sweden, France, Austria, Spain, Belgium, Portugal, and Hungary. The countries representing our top six markets, collectively-United Kingdom, Italy, Germany, Sweden, Norway and France, represented approximately 68% of the total Western European frozen food markets. For a description of the principal markets in which we compete and related revenue, see Note 5 “Segment reporting” to our audited consolidated financial statements which appear elsewhere in this annual report.

Frozen Food Market

The European frozen food market is served by a number of national and international producers, both with branded and private label offerings, and within single or multiple product categories. We have the broadest participation by category and geography in Europe.

According to Euromonitor, the total frozen food market in Western Europe is estimated to have generated €25 billion in retail sales value in 2017. The frozen food business requires specialized manufacturing, logistics and distribution functions. There is also a high cost associated with building brand health, brand awareness and consumer trust. As a result, there are high barriers for profitable entry into the frozen food market in general and the branded segment in particular.

Frozen food products are particularly attractive because they address important global food trends. Consumers increasingly prefer products that allow them to prepare meals quickly and with confidence, and expect products to be healthy and good value for money. In addition, consumers are increasingly focused on reducing food waste. Frozen food products can have all of these characteristics. They are easy to prepare, they reduce the need for artificial preservatives, they are often better value for money than chilled alternatives and they reduce waste at all points in the supply chain and also in-home (due to the long shelf life, and the ease of portionability).

Over the last five years, notwithstanding the volatile macro-economic environment, the Western European frozen food market has grown on average 0.9% per year, driven by the aforementioned ability to address global food consumption trends. Furthermore, the amount of space that frozen food as a category occupies within the grocery retail environment is relatively stable due to the fixed amount of freezer space at the retailer that is not exposed to reductions in shelf space in favor of other categories or formats, as can be the case in shelf-stable parts of the retailer.

Our Brands

Our brands are household names with long histories and local heritage in their respective markets.  Our Birds Eye brand was established in 1922 and is primarily marketed in the United Kingdom and Ireland. The Findus brand, which is marketed in Italy, France, Spain, Sweden and Norway, was formed in Italy in 1941 and has a loyal following in each of its respective geographies. Iglo, founded in 1956, has a long-standing history and is marketed in Germany and other continental European countries. La Cocinera has allowed us to establish ourselves in Spain through a brand that was founded in 1962.

Our Competitive Strengths

We believe the following competitive strengths differentiate us from our competitors and contribute to our ongoing success.

27

Market leader with solid European platform and strong acquisition opportunities.

As the leading branded frozen food producer in Western Europe, we benefit from economies of scale and have developed a strong platform for our products throughout Europe, resulting in leadership positions in ten geographies and a 13.8% market share of the total Western European frozen food market. We benefit from longstanding relationships with our customers which provide access to our diversified distribution channels, including supermarkets, discount retailers, the foodservice channel and other food retailers that sell directly to consumers. We benefit from a diverse category and geographic mix and believe our strong existing platforms facilitate our expansion within a large addressable market and provide a broad set of potential acquisition targets in various food categories and geographic markets.

Effective brand equity strategy to leverage and expand well-known brands.

Our brands are well-established household names with long histories and local heritage in their respective markets. We possess several iconic brand assets and focus on our local hero platforms that are designed to leverage these iconic assets such as the “Captain”. Each of the Birds Eye, Iglo and Findus brands hold the leading position in terms of spontaneous brand awareness in several European markets. Our leading brand recognition, broad product offering, and local provenance of these brands are key drivers of consumer trust and result in demand for our products.

Experienced management team and Board with a proven track record.

Our management team has extensive experience in the food industry and other fast moving consumer goods markets and has worked with leading multinational consumer goods companies globally. Our management team is complemented by an experienced Board of Directors, and collectively, they have a proven track record of successfully acquiring, integrating and managing consumer businesses. We believe our management team and Board of Directors’ collective industry knowledge, coupled with our track record of achieving growth and responding to challenging market conditions, will enable us to continue to generate profitable growth.

Optimized sourcing through established platform and diversified supplier base.

We operate an efficient and centralized procurement and supply chain function which is closely aligned with our geographic footprint, allowing us to optimize our supply arrangements and reduce distribution costs. We source our products globally from a diverse supplier base and, as a result, are not dependent on any one supplier. Our relationships with diverse suppliers enable us to safeguard the security of our supply and raw materials as well as enhance the quality and sustainability of such materials, while also delivering competitive pricing and limiting exposure to geographic risk and adverse currency movements.

Strategic and geographically diversified manufacturing facilities.

We own and operate an efficient network of nine manufacturing facilities with low capital expenditure requirements, all of which are located near the major markets we serve, providing for a balance between manufacturing and logistics costs and allowing for high levels of customer service. These facilities produce approximately 451 kilotonnes of frozen product per year and have what we believe to be sufficient spare capacity to accommodate future growth in our main product categories.

Commitment to innovation and research and development.

We focus our new product efforts and our investment in market research on our Core products -- fish, vegetables, meals and poultry -- to ensure that the products we launch and re-launch overcome penetration barriers. For example, we recently introduced our “crispier crumb”, which were renovations of existing Core products. To ensure the development and introduction of products that fit this criteria, we follow a structured process through which we take new products from idea generation, through concept screening, concept/product laboratories and early volume sizing, to final validation.

28

Our Strategy

We have developed and made significant progress in implementing the following strategic initiatives:

Build an integrated group of best-in-class food companies and brands within existing and related food categories and expand our geographic footprint through strategic acquisitions.

Our goal is to transform our company into an integrated best-in-class, global manufacturer, marketer and distributor of food products, within and outside of the frozen food category and the broader food sector. We believe there are significant growth opportunities in the European and North American markets and that the Iglo Acquisition and the Findus Acquisition provide a strong platform on which to grow our business and expand and enhance our market share in the food industry in key geographic markets.

Focus on “Core” products as a foundation for long-term growth.

We continue our strategy which is rooted in relentless focus on our Core products which currently represent approximately 69% of our sales. These strategies include improving product quality, packaging renovation and executing in-store initiatives such as ensuring the right product assortment, display strategies and promotional efficiencies. We believe focusing on these Core product initiatives will accelerate growth, lead to margin expansion and improve our return on investment. To further accelerate growth, we will also turn our attention to innovation which leverage consumer trends such as health, wellness and convenience, but which are anchored in our core categories.

Align our business with consumer preferences and trends.

Our goal is to create and acquire food businesses and brands that strongly align with consumer needs and preferences that have high growth and margin potential and that leverage our existing portfolio of brands.  In addition, we seek to align our product innovation strategies with consumer trends such as increased demand for nutrition-packed meals that can be prepared in shorter times, vegetarian options and sustainably sourced and produced food.

Leverage our acquisition expertise, strong management team and access to capital to identify and evaluate attractive growth opportunities.

Our Founders and CEO have significant experience and expertise, and have been highly successful, in identifying, acquiring and integrating value-added businesses. We believe that this expertise, our access to capital and the deep industry knowledge of our management team will position us to acquire related and complementary food businesses that can enhance our market position, create synergies and fully leverage our existing marketing, manufacturing and supply chain capabilities, which we believe will allow us to deliver sustained profitable growth and maximize shareholder value. For example, on January 17, 2018, we entered into an agreement to acquire Green Isle Foods Ltd. including the Goodfella's and San Marco brands, in an all cash deal valued at £200 million (approximately €225 million). We anticipate this acquisition to be completed in the second quarter of 2018 and we expect this will enlarge our portfolio of brands to include the number one and number two market share positions within the frozen pizza category in Ireland and the UK, a successful frozen private label pizza business, and two frozen pizza manufacturing facilities.

Respond to changing consumer shopping habits.

We are responding to the growing consumer shift to digital and mobile technologies, particularly in the United Kingdom, by investing in technology platforms and partnering with retailers that are executing their own e-commerce strategies to meet changing consumer habits. Online sales represented 4% of our total sales as of December 31, 2017. We believe that the online sales channel will continue to provide further opportunities to drive market share gains through improved product content and upselling of our mealtime solution programs. In addition, our strategies are evolving in response to other consumer shopping trends such as increased purchases through the hard discounter channel, which has been growing significantly in the United Kingdom and Southern Europe.

29

Generate strong margins and cash flow through disciplined net revenue management, supply chain optimization and disciplined cost management.

We continue to increase our margins and cash flows by strengthening our net revenue management capabilities and focusing on supply chain optimization and disciplined cost management. These efforts, which will be implemented over time, will include developing stronger promotional programs, price pack architecture and trade terms as well as continuing our focus on lean manufacturing, factory footprint optimization, and procurement productivity.

Products

We manufacture, market and distribute the following frozen food products:

Fish: includes frozen fish products such as fish fingers, coated fish and natural fish. These products were the largest contributor to our revenues in 2017.

Vegetables: includes ready to eat vegetable products such as peas and spinach.

Meals: includes ready to cook noodles, pasta, lasagne, pancakes and other ready-made meals under the Iglo, Findus Italy and La Cocinera brand names.

Poultry: includes frozen poultry and meat products such as nuggets, grills and burgers.

Others: includes a variety of other offerings such as soups, pizza and bakery goods.

We now place a strong emphasis on renovation of our existing Core products, which include fish, vegetables, meals and poultry, in order to overcome penetration barriers and continue to build loyalty. We manage renovation and innovation centrally on European common product platforms and have more local involvement where products are differentiated and country specific. Our research and development continues to be centralized, allowing us to leverage our research and development investment across our markets and focus on our largest Core products.

Customers

Our customers are typically supermarkets and large food retail chains supplying food products directly to consumers. Each key market in which we operate has its own distinct retail landscape. We consider our key retailer clients to be, in the UK, Tesco, Asda and Sainsbury’s; in Italy, Coop, Auchan and L5 Esselunga; in Germany, Rewe and Edeka; in Sweden, ICA, Axfood and Coop; and in France, Carrefour, Auchan and E.Leclerc. For the year ended December 31, 2017, our top ten customers (in terms of revenue) accounted for 41% of revenues.

The majority of our sales are to traditional retailers and we expect this channel to remain our most significant channel for the foreseeable future. We partner with traditional retailers when we identify commercial or marketing opportunities that can be of interest for both businesses. We continue to review the presence and impact of the discounter channel, particularly the hard discounters, in each of our key geographic markets and will pursue opportunities to increase our presence in the discounter channel.

We are increasing our investment in online sales which represented 4% of our total sales as of December 31, 2017. The online grocery retail channel is growing faster than traditional grocery retail formats across developed markets. Frozen foods particularly benefit from the online channel as the advantages to the consumer of outsourcing transportation of frozen food to the retailer are greater than in other categories, and also because some of the barriers to purchasing in-store (e.g. colder aisles) are removed for the consumer online.

Approximately 7% of our sales for the twelve month period ended December 31, 2017 were through the foodservice channel. The majority of these sales were in Sweden and consist primarily of sales of institutional and public sector customers such as schools and hospitals as well as privately run work canteens and quick service restaurants.

30

Sales, Marketing and Pricing

Our commercial strategy is centered around our Core products and our growth model focuses on three core elements: creating distinctive brands through leveraging our iconic brand assets, innovating to break penetration barriers balanced between renovation and innovation, and out executing in store through category leadership driving the right assortment, display and promotional efficiency.

Our brand equity strategy aims to further increase brand awareness. We will utilize our core iconic assets at all consumer touchpoints including traditional media, digital media, point of sale and packaging. Furthermore we seek to invest at sufficient levels of media on all our Core products.

We maintain sales teams in each of our key markets and all other markets in which our products are sold with the exception of the Central and Eastern Europe markets where we operate via a distribution model. Our sales force is resourced to provide good store coverage. We are the “category captain” for several leading supermarkets in each of our main product categories and have developed innovative presentations of our frozen food products and in-store marketing concepts with supermarkets in a number of our markets in order to increase shopper traffic and sales. Most recently, we are developing our “Perfect Store” concept which focuses on improving a consumer’s in-store shopping experience through presentation, layout and signage.

Manufacturing

We own and operate nine manufacturing facilities which are located in Lowestoft (United Kingdom), Bremerhaven (Germany), Reken (Germany), Cisterna (Italy), Loftahammar (Sweden), Tonsberg and Larvik (Norway), Boulogne-sur-Mer (France) and Valladolid (Spain). These facilities produce approximately 451 kilotons of frozen product per year, representing approximately 75% of the total volumes of our sales. The manufacturing facilities are located near the major markets we serve, providing for a balance between manufacturing and logistics costs and customer service. Our manufacturing facilities are focused on in house manufacturing of our main product categories and emphasize quality and efficiency through scale. We have invested in new automated lines, such as fish fingers, poultry and spinach lines and because our plants are well invested and maintained, our capital expenditure requirements are well controlled.

Although capacity differs per product line and facility, we estimate that we have sufficient spare capacity available to accommodate future growth in our main product categories and as necessary to accommodate the seasonal nature of some of our products, particularly vegetables.

In 2016, we announced the closure of our factory and pea processing operations in Bjuv, Sweden, and operations ceased on March 30, 2017 with production transferred to other factories in the Group’s network. The consolidation of operations is expected to create a more efficient supply chain. In early 2018, we signed an agreement with Foodhills AB, who has acquired the buildings and parts of the premises.

Procurement

Our procurement functions are structured around primes (materials used in manufacturing which form a part of the end product, such as fish, vegetables, meat, other ingredients and packaging), non-production items (items purchased and services used to design, market and distribute the product, such as logistics, operations, including maintenance, sales and marketing) and co-pack (finished products bought from third parties, such as most vegetables other than peas and spinach).

We have an efficient and centralized supply chain which is closely aligned with our geographic footprint, allowing us to optimize our supply arrangements and reduce distribution costs. We operate a centralized procurement function, with all procurement of primes and the majority of non-production items and co-pack procurement activities centralized to maximize scale efficiencies.

We operate a global sourcing platform. Fish is sourced mainly from the United States, Russia and China, vegetables are sourced predominantly from Europe and poultry is sourced largely from South America (but also from Thailand and Eastern Europe). We have contracts in place with pea and spinach growers and third party pea processors in regions close to the location of pea growers. In addition, we utilize various co-pack suppliers for vegetables other than peas and spinach. The contract terms we enter into with various suppliers differ extensively with respect to length and provisions. 

31

We aim to maintain an appropriately diverse supplier base to safeguard the security of our supply of raw materials as well as enhance the quality and sustainability of such materials, while also delivering competitive pricing.

We segregate vendors into “strategic” and “tactical” categories based on criteria such as bargaining power or opportunistic procurement. On that basis, we have identified a number of strategic suppliers with whom we maintain close relationships, particularly in relation to main product categories for which security of supply is critical. Raw materials are mostly directly shipped to our manufacturing facilities.

We limit our exposure to price increases of raw materials by contractually securing prices for periods ranging from one month to a full year. Prices of raw materials that are harvested annually are generally fixed for a full year. Prices for certain other products, such as fish, dairy products and potatoes, are fixed for several months in line with industry practice.

Logistics

Our distribution network is made up of our manufacturing facilities, warehouses, local distribution centers and third party providers of services (such as transport). We outsource the majority of our distribution processes to third parties seeking to collaborate with shared sites and integrated transport networks. Our distribution network is well consolidated and aligned with our manufacturing footprint in the United Kingdom, Germany, Italy, Sweden, France, Norway and Spain. From our manufacturing plants, our products are sent to regional distribution centers to be further distributed to local markets. Our primary distribution centers are used to consolidate both local production and imported products to be sold locally. These sites include Wisbech in the United Kingdom, Reken in Germany, Vitulazio, Latina and Parma in Italy, Lognes in France, Tonsberg and Moss in Norway and Marcilla in Spain.

Seasonality

Our sales and working capital levels have historically been affected to a limited extent by seasonality. In general, sales volumes for frozen food are slightly higher in colder or winter months, partly because there are fewer fresh alternatives available for vegetables and because our retailers typically allocate more freezer space to the ice cream segment in hotter or summer months. In addition, variable production costs, including costs for seasonal staff, and working capital requirements associated with the keeping of inventories, vary depending on the harvesting and buying periods of seasonal raw materials, in particular vegetable crops. For example, stock levels typically peak in August to September just after the pea harvest, and as a result, we require more working capital during those months.

Corporate Social Responsibility

We operate a Corporate Social Responsibility program which is an important part of our brand positioning. It captures our commitment and vision of the role that we must play in bringing food to our consumers while tackling fundamental challenges in our environment and society. There are four primary focus areas:

• Reduction of food waste. Frozen food can offer a more sustainable food choice because it can cut food spoilage and food waste due to the portion control and to an extended shelf-life.

• Nutrition. Our products and innovations can help consumers make healthier meal choices.

• Sustainable sourcing. We aim to source and prepare our food products in a responsible way. We have a long lasting relationship with MSC, securing sustainable fish and seafood and are proud to report more than 90% of the wild captured fish we use is MSC certified.

• Lower carbon footprint. We seek to lower our carbon footprint, including reducing our absolute CO2 emissions from manufacturing, to conduct our business in a more environmentally responsible manner.

We will extend the program in 2018 to secure further progress, maintaining a strong focus on sustainable sourced seafood and nutrition and dialing up our focus on environment and waste.

32

Fisheries

We have continued a long-term leadership position to pioneer the certification of global sustainable and responsible fisheries. Our Sustainable Fisheries Development Policy requires us to use the world’s most robust independent sustainable fisheries verification process, the Marine Stewardship Council standard (MSC).

It is also our policy to only source farmed seafood from responsibly managed farms which operate to independent third party standards such as the Global Aquaculture Alliance (GAA), Global GAP and Aquaculture Stewardship Council (ASC) standards.

Agriculture & Vegetables

Together with over 700 growers, we currently manage approximately 17,000 hectares of land and our standards match or go beyond those required by most agricultural assurance schemes.

Our Agricultural Code of Practice requires us to produce crops with high yield and nutritional quality, while keeping resource demands as low as possible, thus minimizing adverse effects on soil fertility, water, air quality and biodiversity.

Poultry

All of our poultry is responsibly sourced from suppliers that comply with a Code of Practice under closely monitored conditions which covers feed, animal medicines usage, welfare and social standards.

Information Technology

Our IT systems are of key importance to our business and in particular to our general operations and logistics functions and associated management reporting across countries and our plants. A single SAP tool is the primary business software to support all of our operations and management reporting across countries and our supply chain.

This environment is designed as a consolidation platform for future acquisitions. A program is underway to transition the acquired Findus business onto the IT platform.

The ability to integrate potential new acquisitions quickly with little or no adverse business impact, while maintaining the low cost of ownership, is a fundamental requirement of our IT strategy. Additionally, we utilize an outsourced infrastructure service provider, maintaining best in class IT cost alongside improved capability to scale in line with business developments.

Intellectual Property

Maintaining adequate brand protection is of significant importance to our business as we rely on our brands to implement our master brand strategy. We have a substantial trademark portfolio with nearly 2,000 trademarks across all of our markets. Our intellectual property is managed centrally, and we work closely with a third party agency in respect of filings, renewals, recordings and the prosecution and enforcement of intellectual property matters internationally.

We own a European Union trademark for our Birds Eye brand as well as national trademarks for our Birds Eye brand in the United Kingdom, Ireland and other EU countries, and in other parts of Europe outside the European Union, parts of the Middle East, Asia and Africa. For historical reasons, the Birds Eye trademark is owned by third parties in North America and Australia.

We own a European Union Trade Mark for our Iglo brand as well as national trademarks in many EU countries and in other parts of Europe outside the European Union, Australasia, Israel, parts of Asia, the United States, South America and Africa. We have trademark applications pending for the Iglo brand in, among others, Canada, India and Brazil.

We own the Findus trademark in many countries globally, other than in Switzerland, as well as (among others) the brands Lutosa in Belgium (until 2020) and La Cocinera in Spain and Andorra.

33

Material Contracts

Each material contract to which we have been a party for the preceding two years, other than those entered into in the ordinary course of business, is listed as an exhibit to the registration statement to which this annual report is a part and is summarized elsewhere herein.

Pensions

We operate a number of different pension schemes across our various countries of operation, the majority of which are defined contribution schemes. We operate defined benefit pension plans in Germany, Sweden, Italy and Austria which are all closed to new entrants, as well as various defined contribution plans in other countries, the largest of which include Sweden and the United Kingdom. In Germany, France, Italy and Norway, long term service awards are in operation and various other countries provide other employee benefits.

Regulatory Matters

Our activities are subject to laws and regulations regarding food safety, the environment and occupational health and safety.

Food Safety Regulation

As a manufacturer of foods intended for human consumption, we are subject to extensive legislation and regulation both from the European Union, the EU Member States and European free trade association (EFTA) members, in which we operate. These regulations govern the composition, manufacture, storage, handling, packaging, labeling, marketing and safety of our products. These regulations generally impose on food business operators an obligation to ensure that the operations under their control satisfy the relevant food law requirements and impose a mandatory traceability requirement along the food chain. The tracing information must be kept for a period of five years and upon request, must be made available to the relevant authorities.

In addition, we are subject to specific food hygiene legislation that establishes rules and procedures governing the hygiene of food products. This legislation sets forth specific rules governing the proper hygiene for food products of animal origin and sets forth microbiological criteria for food products. In addition there are a number of other specific EU requirements relating to specific matters such as contaminants, packaging materials and additives.

We are also subject to a broad range of European directives and regulations regarding the manufacture and sale of frozen foods for human consumption. These directives and regulations define technical standards of production, transport and storage of frozen foods intended for human consumption and require us to assure internal quality control at each stage of the “cold chain” and to implement any standards, as established by public authorities.

Listed below are the various internal due diligence procedures we have established to ensure continuous compliance with all relevant regulatory and food safety standards:

• implementing food hygiene principles across all production sites in accordance with food hygiene regulations;

• annual external auditing of our production sites conducted by independent compliance companies applying the British Retail Consortium Global Standard for Food Safety Issue 7, its European equivalent, the International Food Standard or the Global Food Safety Initiative. Currently 84% of our suppliers are also certified to one or more of these food safety management systems and it is our long term objective to achieve 100% certification;

• ensuring that our Group’s Quality Management Systems comply with ISO 9001 with external audits to ISO or BRC standard;

• conducting internal audits covering all production sites as part of our internal audit program; we do not carry out cross-audits where one site's audit team audits another's system;

34

• maintaining a risk-based microbiological and contaminant screening program, including screening for allergens, that covers raw materials and finished products; and

• holding monthly regulatory updates to assess emerging risk areas, update policies and review outstanding issues as part of the quality forum meeting which is attended by functional heads.

Tariffs and Trade

We are subject to specific trade requirements regarding fish and poultry, two main ingredients for our products.

Food Labeling Regulation

Pre-packaged food products must comply with provisions on labeling, which are harmonized throughout the European Union. Pre-packaged food products must also comply with provisions on nutrition labeling, which are also harmonized throughout the European Union. Under the Food Information for Consumers Regulation nutrition labeling is mandatory unless exempted.

In addition to general and nutrition requirements, pre-packaged food products must bear a lot mark declaration via a manufacturing or packaging lot reference, which is also a harmonized system throughout the European Union. The lot reference allows consumers and businesses to trace the product in the event of a product withdrawal or recall.

There are also specific labeling requirements for certain ingredients we use in our products.

Environmental Law

The European Union has issued numerous directives relating to environmental protection, including those aimed at improving the quality of water, addressing air and noise pollution, assuring the safety of chemicals and setting standards for waste disposal and clean-up of contamination. European directives are given effect by specific regulations in Member States and applicable regulations have been implemented in each of the countries in which we conduct our manufacturing activities. Accordingly, our facilities must obtain permits for certain operations and must comply with requirements relating to, among others, water supply and use, water discharges and air emissions, solid and hazardous waste storage, management and disposal of waste, clean-up of contamination and noise pollution.

We are also subject to legislation designed to reduce energy usage and carbon dioxide emissions and also restrictions on the use of ozone depleting substances such as hydrochlorofluorocarbons (HCFCs). HCFCs are used in refrigeration systems and their use will be phased out as part of our normal maintenance, repair and replacement activities and we do not expect a need for significant incremental capital expenditures for this purpose.

Compliance with environmental laws and regulations is managed at the facility level. Our manufacturing facilities all have a detailed environmental management system which are externally audited on an annual basis for compliance with ISO 14001 or BRC.

In addition, under some environmental laws and regulations, we could be responsible for contamination we may have caused and investigating or remediating contamination at properties we own or occupy, even if the contamination was caused by a prior owner or other third party or was not due to our fault, and even if the activity which resulted in the contamination was legal at the time it occurred.

Occupational Health and Safety

We have a legal responsibility to protect the health and safety of our employees, customers and any other persons who may be affected by our operations. We strive to provide a safe workplace; controlling and eliminating risks to health and wellbeing; ensuring that our facilities and the equipment within them are safe and that the environmental, health and safety procedures are both established and adhered to. We ensure that dangerous articles and substances are transported, stored and used safely; provide adequate welfare facilities; provide workers the information, instruction, training and supervision necessary to preserve and improve their health and safety; and consult with workers on health and safety matters.

35

We aim to meet the European Framework Directive on Safety and Health at Work (89/391 EEC) ensuring we comply with all the local and European legislation in all the countries we have a presence, ensuring we share best practices and procedures across our business to continuously improve our safety and environmental performance whilst driving a positive safety culture.

We have established a Health and Safety Management System modeled on the international Occupational Health & Safety management system specification OHSAS 18001. Our manufacturing facilities in the United Kingdom, Spain, Italy and Germany have achieved full accreditation to OHSAS 18001.

Compliance Programs

We have established policies and procedures aimed at compliance with applicable legislation and regulations, including policies for Anti-Bribery and Corruption as well as Trade Sanctions and Export Controls. In addition, our Code of Business Principles includes policies designed to ensure compliance with applicable legal and regulatory requirements and guidelines to drive a strong compliance culture. A breach of the Code of Business Principles can lead to sanctions, including termination of employment.

Our Safe Call Line, which is operated by an external service provider, allows employees to report issues anonymously. Compliance at the local level is based in large part on building strong local companies and developing a proper approach in coping with dilemmas within the boundaries of applicable laws and responsible conduct. Local management, assisted by the Internal Audit department, carries out reviews to identify compliance risks and to ensure that adequate systems to manage those risks are in place. Changes in applicable laws and regulations are actively analyzed and assessed, and when necessary appropriate adaptations are implemented.

Insurance

We maintain comprehensive insurance coverage, where appropriate, with respect to liability of our directors and officers, property damage, business interruption, cold storage facilities, public liability, products liability, product recall, damage to vehicles, personal accident and travel. We undertake periodic risk reviews to assess whether our insurance is in line with our business risks and whether the developments in insurance policies are reflective of the changes in our business.

36

C. Organizational Structure

We (Nomad Foods Limited) are a holding company with 41 subsidiaries, all of which are wholly-owned by us. The following table provides a list of all of our significant subsidiaries and country of incorporation.

Name	Activity	Country of incorporation	Ownership as of Dec 31 2017
Nomad Foods Europe Holdings Limited	Holding	England	100%
Nomad Foods Europe Holdco Limited	Holding	England	100%
Nomad Foods Europe Finco Limited	Holding	England	100%
Nomad Foods Europe Midco Limited	Holding/Finance	England	100%
Nomad Foods Bondco Plc	Finance	England	100%
Nomad Foods Lux S.à.r.l.	Finance	Luxembourg	100%
Nomad Foods Europe Limited	Management	England	100%
Birds Eye Limited	Trading	England	100%
Nomad Foods Europe Finance Limited	Finance	England	100%
Birds Eye Ireland Limited	Trading	Republic of Ireland	100%
Iglo Holding GmbH	Holding	Germany	100%
Iglo Nederland B.V.	Trading	Netherlands	100%
Iglo Belgium S.A.	Trading	Belgium	100%
Iglo Portugal	Trading	Portugal	100%
Iglo Austria Holdings GmbH	Holding	Austria	100%
C.S.I. Compagnia Surgelati Italiana S.R.L.	Trading	Italy	100%
Findus Sverige Holdings AB	Holding	Sweden	100%
Iglo GmbH	Trading	Germany	100%
Frozen Fish International GmbH	Trading	Germany	100%
Liberator Germany Newco GmbH	Property	Germany	100%
Iglo Austria GmbH	Trading	Austria	100%
Findus Sverige AB	Trading	Sweden	100%
Frionor Sverige AB	Holding	Sweden	100%
Findus Holdings France SAS	Holding	France	100%
Findus France SAS	Trading	France	100%
Findus Espana SLU	Trading	Spain	100%
Findus Danmark A/S	Trading	Denmark	100%
Findus Finland Oy	Trading	Finland	100%
Findus Norge AS	Trading	Norway	100%

37

D. Property, Plant and Equipment

The following table sets forth information on the main manufacturing sites used by us in our business:

Facility	Products	Production (tons)	Utilization %	Freehold/ Leasehold
Bjuv, Sweden (closed H1 2017)	Vegetables, Free Flow Meals, Ready Meals	9,600 volume per year	9%	Mixed
Boulogne, France	Fish Products	21,000 volume per year	65%	Leasehold
Bremerhaven, Germany	Fish Products	92,000 volume per year	85%	Leasehold
Cisterna, Italy	Vegetables, Free Flow Meals, Fish Fingers, Sofficini	79,000 volume per year	55%	Freehold
Larvik, Norway	Vegetables, Free Flow Meals, Ready Meals	7,200 volume per year	42%	Freehold
Loftahammar, Sweden	Baked Goods	3,200 volume per year	38%	Freehold
Lowestoft, UK	Vegetables, Fish Products, Poultry, Potato, Beef Burgers	109,500 volume per year	81%	Mixed
Reken, Germany	Vegetables, Free Flow Meals	87,200 volume per year	62%	Freehold
Tonsberg, Norway	French Fries, Vegetables, Free Flow Meals	25,800 volume per year	59%	Leasehold
Valladolid, Spain	Vegetables, Free Flow Meals, Ready Meals, Pastry Products, Pizza	16,500 volume per year	31%	Leasehold

For more information on property, plant and equipment see Note 12 “Property, plant and equipment”.

Item 4A. Unresolved Staff Comments

None.

Item 5. Operating and Financial Review and Prospects

The following is a discussion of the financial condition and results of operations for the year ended December 31, 2017, the year ended December 31, 2016, the nine months ended December 31, 2015 and the twelve months ended March 31, 2015 of the Company, and the five months ended May 31,2015.

We were formed on April 1, 2014 and had no trading operations until we acquired Iglo on June 1, 2015.

Some of the information contained in this discussion and analysis or set forth elsewhere in this annual report, including information with respect to our plans and strategy for our business and related financing, includes forward-looking statements that involve risks and uncertainties. As a result of many factors, including those factors set forth in Item 3 Key Information-D. Risk Factors of this annual report, our actual results could differ materially from the results described in or implied by the forward-looking statements contained in the following discussion and analysis. This discussion should be read in conjunction with our audited historical consolidated financial statements and other financial information included elsewhere in this annual report.

The historical financial information has been prepared in accordance with IFRS. In May 2015, the Company changed its fiscal year end from March 31 to December 31.

38

Overview

We were incorporated with limited liability under the laws of the British Virgin Islands under the BVI Companies Act on April 1, 2014 under the name Nomad Holdings Limited. After the Iglo Acquisition on June 1, 2015, we changed our name to Nomad Foods Limited. The Company is a “foreign private issuer” as defined in Rule 3b-4 promulgated by the U.S. Securities and Exchange Commission (“SEC”) under the U.S. Securities Exchange Act of 1934 (the “1934 Act”) and in Rule 405 under the U.S. Securities Act of 1933. As a result, it is eligible to file its annual reports pursuant to Section 13 of the 1934 Act on Form 20-F and to file its interim reports on Form 6-K. The Ordinary shares of the Company are listed on the New York Stock Exchange (“NYSE”).

Nomad operates in the European frozen food market, selling its products primarily to large grocery retailers either directly or through distribution arrangements primarily in the United Kingdom, Italy, Germany, Sweden, France and Norway.

The countries representing our top six markets collectively represented approximately 68% of the total Western European frozen food markets (in terms of retail sales value) and generated 81% of our revenue in 2017. We also sell our products in Ireland, Austria, Belgium (including the Lutosa brand), Finland, Greece, Hungary, Ireland, Portugal, Switzerland, Denmark, The Netherlands and Spain (including the La Cocinera brand). The brands under which we sell our products are “Birds Eye” in the United Kingdom and Ireland, “Findus” in Italy, San Marino, France, Spain, Sweden and Norway and “Iglo” in Germany and other continental markets.

We currently operate nine manufacturing plants, two in Germany, one in Sweden, two in Norway and one in each of the United Kingdom, Spain, Italy and France.

Financings and Acquisitions

On April 28, 2017, we amended and restated our Senior Facilities Agreement (as defined herein) to, among other things, repay our existing term loan facilities and establish new term loan facilities of €500.0 million and $610.0 million, both with maturity dates extended to May 2024. We also extended the maturity date of our €80.0 million revolving credit facility to May 2023.

On May 3, 2017 we issued €400.0 million of 3.250% senior secured notes due 2024 (the "Fixed Rate Senior Secured Notes") and used the proceeds received in connection with the notes offering and the amended and restated Senior Facilities Agreement to repay our existing floating rate senior secured notes due 2020.

On December 20, 2017 we further amended and restated our Senior Facilities Agreement to reprice our $610.0 million and €500.0 million term loan facilities. The margin was reduced by 50 basis points on the U.S. Dollar-denominated term loan and 25 basis points on the Euro-denominated term loan. There were no changes to the maturity dates of the term loan facilities as a result of this amendment. We also established a $50.0 million incremental term loan facility and a €58.0 million incremental term loan facility. On January 31, 2018, the $50.0 million incremental term loan facility was fully drawn and on February 9, 2018, the €58.0 million incremental term loan facility was fully drawn.

In May 2015, we issued 75,666,669 of our ordinary shares in a private placement at a price of $10.50 per ordinary share (the “May 2015 Offering”). In April 2015, we amended the Warrants issued in the 2014 Offering to accelerate the expiration date to the closing of the Iglo Acquisition (subject to certain limited exceptions) and, in order to incentivize the Warrant holders to exercise their Warrants prior to the new expiration date, we reduced the exercise price of the Warrants from $11.50 to $10.50 per whole ordinary share for all Warrants exercised before the new expiration date. Between May and June 2015, we issued an aggregate of 16,673,307 ordinary shares pursuant to the exercise of the Warrants. There are no Warrants currently outstanding.

On June 1, 2015, we consummated our initial acquisition by purchasing Iglo Foods Holdings Limited (now known as Nomad Foods Europe Holdings Limited), a leading frozen food manufacturer and distributor in Europe. We paid an aggregate purchase price of €2.6 billion, including assumed debt of €1.2 billion and the issuance of 13,743,094 ordinary shares (the “Iglo Seller Shares”) to the seller, Permira Funds. On June 12, 2017, we repurchased 9,779,729 of our shares beneficially owned by Permira Funds at a purchase price of $10.75 (approximately €9.60) per share, which represents a 25% discount to the closing price of our ordinary shares on June 9, 2017, for an aggregate purchase price of $105.1 million (approximately €93.9 million), in final settlement of indemnity claims against an affiliate of Permira Funds, of legacy tax matters that predated the Iglo Acquisition. The aggregate purchase price was funded from our cash on hand and the ordinary shares were retired. The ordinary shares were previously held in escrow since the closing of the acquisition pending resolution of such claims.

39

In the July 2015 Offering, we issued 15,445,346 ordinary shares at a price of $20.75 per ordinary share. The number of ordinary shares issued in the July 2015 Offering represented, in aggregate, approximately 9.99% of our issued ordinary share capital immediately prior to the offering.

On November 2, 2015, we acquired the Findus Group for approximately £500 million, consisting of £415 million in cash and the Findus Consideration Shares. Through the Findus Acquisition, we acquired the continental European businesses of the Findus Parent in Sweden, Norway, Finland, Denmark, France, Spain and Belgium relating to the Findus, Lutosa, and La Cocinera brands. Findus revenues for the fiscal year ended September 30, 2015 were £471 million.

On September 11, 2017, in connection with the registered underwritten public offering of 33,333,334 of our ordinary shares by certain funds managed by Pershing Square Capital Management, L.P., we purchased 7,063,643 ordinary shares from the underwriters in the offering at a price of $14.16 (approximately €11.84), the price payable by the underwriters to the selling shareholders. We did not sell any ordinary shares in the offering and did not receive any of the proceeds from the offering. We used cash on hand to fund the repurchase of the ordinary shares.

On January 17, 2018 we entered into an agreement to acquire Green Isle Foods Ltd. including the Goodfella's and San Marco brands, in an all cash deal valued at £200 million (approximately €225 million). We anticipate this acquisition to be completed in the second quarter 2018 and we expect this will enlarge our portfolio of brands to include the number one and number two market share positions within the frozen pizza category in Ireland and the UK, a successful frozen private label pizza business, and two frozen pizza manufacturing facilities.

Accounting for the Iglo Acquisition

Effective from the date of the Iglo Acquisition, we have reflected the Iglo Acquisition in our consolidated financial statements prepared in accordance with IFRS. The Iglo Acquisition is accounted for using the purchase method as required by IFRS 3 “Business Combinations”. The net assets of the Iglo Group have been adjusted to our estimate of fair value as of June 1, 2015, the date when control of the Iglo Group passed to us. The excess of the costs of acquisition over the fair value of the assets and liabilities of the Iglo Group has been recorded as goodwill. We have completed the assessment of the purchase price allocation and such fair values are final.

Accounting for the Findus Acquisition

We have reflected the Findus Acquisition in our consolidated financial statements prepared in accordance with IFRS from the date of the acquisition, November 2, 2015. In the nine months ended December 31, 2015 we present two months of operations in our consolidated results.

We have accounted for the Findus Acquisition using the purchase method as required by IFRS 3 “Business Combinations”. The net assets of the Findus Acquisition has been adjusted to fair value as of November 2, 2015, the date when control passed to us. The excess of the costs of acquisition over the fair value of the assets and liabilities of the Findus Acquisition is recorded as goodwill. The fair values have been completed and as such the purchase price allocation and fair values are final.

Critical Accounting Estimates and Judgments

Information relating to “Critical Accounting Estimates and Judgments” are described in detail and are reported in Note 4 to the Financial Statements.

Recently Issued and Not Yet Adopted Accounting Pronouncements under IFRS

Information relating to “IFRSs not yet adopted” are described in detail and are reported in Note 3 to the Financial Statements.

40

A. Operating Results

Overview of Results

	Successor		Successor		Successor		Successor		Predecessor
	Year ended December 31, 2017		Year ended December 31, 2016		9 months ended December 31, 2015		Year ended March 31, 2015		5 months ended May 31, 2015
	€m		€m		€m		€m		€m
Statement of Income data:
Revenue	1,956.6		1,927.7		894.2		—		640.3
Cost of sales	(1,357.2	)	(1,356.7	)	(663.0	)	—		(417.9	)
Gross profit	599.4		571.0		231.2		—		222.4
Other operating expenses	(319.3	)	(298.4	)	(138.6	)	(0.7	)	(109.5	)
Exceptional items	(37.2	)	(134.5	)	(58.1	)	(0.7	)	(84.3	)
Charge related to Founder Preferred Shares Annual Dividend Amount	—		—		(349.0	)	(165.8	)	—
Credit/(Charge) related to Warrant Redemption Liability	—		—		0.4		(0.4	)	—
Operating profit/(loss)	242.9		138.1		(314.1	)	(167.6	)	28.6
Finance income	7.2		24.2		8.7		0.1		2.0
Finance costs	(81.6	)	(86.3	)	(44.2	)	—		(117.7	)
Net finance (costs)/income	(74.4	)	(62.1	)	(35.5	)	0.1		(115.7	)
Profit/(loss) before tax	168.5		76.0		(349.6	)	(167.5	)	(87.1	)
Taxation	(32.0	)	(39.6	)	12.3		—		(40.9	)
Profit/(loss) for the period	136.5		36.4		(337.3	)	(167.5	)	(128.0	)

The table below presents certain additional key performance indicators:

	Successor		Successor		Successor		Successor		Predecessor
	Year ended December 31, 2017		Year ended December 31, 2016		9 months ended December 31, 2015		Year ended March 31, 2015		5 months ended May 31, 2015
(€ in millions, except percentages)	€m		€m		€m		€m		€m
Gross margin(1)	30.6	%	29.6	%	25.9	%	—	%	34.7	%
Adjusted EBITDA(2)	328.1		324.9		156.3		(0.7	)	125.4
Adjusted EBITDA margin(3)	16.8	%	16.9	%	17.5	%	n.p.		19.6	%

(1) Gross Margin. Gross margin represents gross profit as a percentage of revenue for the relevant period.

(2) Adjusted EBITDA. EBITDA is profit or loss for the period before taxation, net financing costs, depreciation and amortization. Adjusted EBITDA is EBITDA adjusted to exclude (when they occur) exited markets, chart of account (“CoA”) alignments and exceptional items such as restructuring charges, goodwill and intangible asset impairment charges, the impact of share based payment charges, charges relating to the Founder Preferred Shares Annual Dividend Amount, charges relating to the redemption of warrants and other unusual or non-recurring items. The Company believes Adjusted EBITDA provides important comparability of underlying operating results, allowing investors and management to assess operating performance on a consistent basis. Accordingly, the information has been disclosed in this annual report to permit a more complete and comprehensive analysis of our operating performance. You should exercise caution in comparing our Adjusted EBITDA with similarly titled measures of other companies, as the definition may not be comparable. Adjusted EBITDA should not be considered as an alternative to profit/(loss) for the period, determined in accordance with IFRS, as an indicator of the Company’s operating performance.

(3) Adjusted EBITDA Margin. Adjusted EBITDA margin represents Adjusted EBITDA as a percentage of revenue for the relevant period. Adjusted EBITDA and Adjusted EBITDA margin are non-IFRS measures and you should not consider them an alternative or substitute to operating profit or operating margin as a measure of operating performance.

41

The following table reconciles profit/(loss) for the period to Adjusted EBITDA for the relevant period as follows:

	Successor	Successor	Successor		Successor		Predecessor
	Year ended December 31, 2017	Year ended December 31, 2016	9 months ended December 31, 2015		Year ended March 31, 2015		5 months ended May 31, 2015
	€m	€m	€m		€m		€m
Profit/(loss) for the period	136.5	36.4	(337.3	)	(167.5	)	(128.0	)
Taxation	32.0	39.6	(12.3	)	—		40.9
Net financing costs/(income)	74.4	62.1	35.5		(0.1	)	115.7
Depreciation and amortization	42.4	51.1	21.8		—		12.5
Exceptional items (1)	37.2	134.5	58.1		0.7		84.3
Other add-backs (2)	5.6	1.2	—		—		—
Net purchase-price adjustment-inventory step up (3)	—	—	37.0		—		—
Net purchase-price adjustment for cash flow hedge accounting (4)	—	—	4.9		—		—
Change in Founder Preferred Shares Annual Dividend Amount and Warrant redemption (5)	—	—	348.6		166.2		—
Adjusted EBITDA	328.1	324.9	156.3		(0.7	)	125.4

(1) Adjustment to eliminate exceptional items which management believes are non-recurring and do not have a continuing impact. Details of what has been identified as exceptional is included in the Results of Operations for each reporting period as set out in this item.

(2) Other add-backs include the elimination of share-based payment charges of €2.6 million and elimination of M&A related investigation costs, professional fees, transaction costs and purchase accounting related valuations of €3.0 million. We exclude these costs because we do not believe they are indicative of our normal operating costs, can vary significantly in amount and frequency, and are unrelated to our underlying operating performance.

(3) Adjustment to add back the one-off impact of accounting for inventory purchased in an acquisition at fair value rather than cost.

(4) Adjustment to add back the one-off impact of derivatives acquired in an acquisition for which the previous hedging relationship can no longer be continued.

(5) Adjustment to add back charges related to Founder Preferred Shares Annual Dividend Amount and Warrant redemption which are not considered to be operational costs. Further details are contained in the Results of Operations for each reporting period as set out in this item.

Description of Key Line Items and Certain Key Performance Indicators

Set forth below is a brief description of key items from our consolidated statements of income. For additional information, see Note 3 to our audited consolidated financial statements which appear elsewhere in this annual report.

Revenue. Revenue is comprised of sales of goods after deduction of discounts and sales taxes. It does not include sales between Nomad subsidiaries. Discounts given by us include rebates, price reductions and incentives given to customers, promotional couponing and trade communication costs. At each end date of a reporting period, any discount incurred, but not yet invoiced, is estimated and accrued. Revenue is recognized when the risks and rewards of the underlying products have been transferred to the customer. This is usually upon either the dispatch of a shipment or the delivery of goods to the customer but is dependent upon contractual terms that have been agreed with a customer. Sales discounts incurred but not yet invoiced are established based on management’s best estimate at the end of the reporting period.

Other Operating Expenses. Other operating expenses are comprised of advertising and promotions, exchange movements and indirect costs. Indirect costs include staff costs, selling and marketing expenses, administration expenses, research and development expenses, amortization of software, amortization of brands and other expenses.

42

Charges related to Founder Preferred Shares Annual Dividend Amount. The charges relate to the Founder Preferred Shares Annual Dividend Amount by which the holders of Founder Preferred Shares are entitled to receive dividends, subject to certain performance conditions. The instrument and its component parts were analyzed under IFRS 2. The Company intends that any future Founder Preferred Shares Annual Dividend Amount will be equity settled. Accordingly as of June 1, 2015, the liability was classified as an equity reserve with no further revaluations through the Statement of Profit or Loss to be expected. Should a Founder Preferred Share Annual Dividend Amount become due and payable, the market value of any dividend paid will be deducted from the Founder Preferred Shares Dividend reserve, with any excess deducted from the accumulated profit/(deficit) reserve within equity.

Charges relating to Warrant redemption. The charges relate to the redemption rights of any outstanding Warrants which were fair valued at each balance sheet date with any changes in fair value charged to the income statement. The remaining warrants that were issued by the Company in conjunction with its initial public offering in April 2014 were redeemed in the nine months ended December 31, 2015 and a credit of €0.4 million was recognized in the Consolidated Statement of Profit or Loss. There are no Warrants currently outstanding.

Exceptional items. The separate reporting of exceptional items which are presented as exceptional within the relevant income statement category helps provide an indication of our underlying business performance. Exceptional items have been identified and adjusted by virtue of their size, nature or incidence. In determining whether an event or transaction is exceptional, management considers quantitative as well as qualitative factors such as the frequency or predictability of occurrence.

Finance Income. Finance income is comprised of interest income, other financing related income and net foreign exchange gains on translations of financial assets and liabilities held in currencies other than the Company’s functional currency.

Finance Costs. Finance costs are comprised of interest expenses, net interest on net defined pension plan obligations, amortization of borrowing costs, net foreign exchange costs on translations of financial assets and liabilities held in currencies other than the Company’s functional currency and financing costs incurred as a result of amendments of debt terms.

Taxation. Taxation is comprised of current tax expenses and deferred tax movements.

Gross Margin. Gross margin is gross profit as a percentage of revenue.

We also utilize certain additional key performance indicators, as described below. We believe these measures provide an important alternative measure with which to assess our underlying trading performance on a constant basis. Our calculation of Adjusted EBITDA and Adjusted EBITDA margin may be different from the calculations used by other companies and therefore comparability may be limited. Adjusted EBITDA and Adjusted EBITDA margin are non-IFRS measures and you should not consider them an alternative or substitute to operating profit or operating margin as a measure of operating performance.

Adjusted EBITDA. EBITDA is profit or loss for the period before taxation, net financing costs, depreciation and amortization. Adjusted EBITDA is EBITDA adjusted to exclude (when they occur) exited markets, chart of account (“CoA”) alignments and exceptional items such as restructuring charges, goodwill and intangible asset impairment charges, the impact of share based payment charges, charges relating to the Founder Preferred Shares Annual Dividend Amount, charges relating to the redemption of warrants and other unusual or non-recurring items. The Company believes Adjusted EBITDA provides important comparability of underlying operating results, allowing investors and management to assess operating performance on a consistent basis.

Adjusted EBITDA Margin. Adjusted EBITDA margin is Adjusted EBITDA as a percentage of revenue.

Currency

Our consolidated financial statements have been presented in Euro, which is our functional currency. Unless specifically stated otherwise herein, transactions in foreign currencies have been translated at the foreign exchange rate at the date of the relevant transaction.

Changes in foreign currency rates have a translation impact on our reported operating results.

43

A significant portion of our operations have functional currencies other than Euro (principally Pound Sterling). In preparing its financial statements, translations in currencies other than our functional currency are recognized at the rates of exchange prevailing at the dates of transaction. Accordingly, our results for each of the periods presented below have been impacted by fluctuations in foreign exchange rates. Where material, the impact of translation of currency on results has been provided. 

Results of Operations for the Year Ended December 31, 2017 and the Year ended December 31, 2016

	Successor		Successor
	Year ended December 31, 2017		Year ended December 31, 2016
Statement of Income data:	€m		€m
Revenue	1,956.6		1,927.7
Cost of sales	(1,357.2	)	(1,356.7	)
Gross profit	599.4		571.0
Other operating expenses	(319.3	)	(298.4	)
Exceptional items	(37.2	)	(134.5	)
Operating profit	242.9		138.1
Finance income	7.2		24.2
Finance costs	(81.6	)	(86.3	)
Net finance costs	(74.4	)	(62.1	)
Profit before tax	168.5		76.0
Taxation	(32.0	)	(39.6	)
Profit for the period	136.5		36.4

Revenue for the year ended December 31, 2017 was €1,956.6 million (year ended December 31, 2016: €1,927.7 million). The 1.5% revenue increase is driven from both a 3% increase due to volume and mix and a 1% increase in revenue due to pricing in our Italy, Germany and United Kingdom markets, offset by unfavorable currency translation movements of 2% and one less trading day of 0.5%.

Gross profit, defined as revenue less cost of sales, increased €28.4 million to €599.4 million for the year ended December 31, 2017 from €571.0 million for the year ended December 31, 2016. Gross Margin, defined as gross profit as a percentage of revenue, grew 100 basis points to 30.6% from 29.6% in the year ended December 31, 2016 primarily due to:

• Mix benefit between categories and countries generated a 110 basis point benefit, largely driven by growth in German and Italian markets which have a higher than average gross margin;

• 80 basis point benefit from pricing and promotional efficiencies; partially offset by

• 80 basis point decrease from unfavorable foreign exchange driven cost increases, primarily in the United Kingdom post the Brexit announcement.

• 10 basis point reduction due to unfavorable translational foreign exchange.

Other operating expenses increased to €319.3 million for the year ended December 31, 2017 (year ended December 31, 2016: €298.4 million). The increase of €20.9 million was driven by the reinstatement of the employee bonus, partly offset by savings in our overhead cost base. Advertising and promotion decreased 1% to €113.1m, despite increased consumer facing media activity, which benefited from a favorable foreign exchange impact of 2%.

44

Exceptional items of €37.2 million were incurred in the year ended December 31, 2017 (year ended December 31, 2016: €134.5 million). Included in this charge are costs incurred in relation to the implementation of the Nomad strategic vision, which primarily relates to changes to the organizational structure to align behind core products and implement net revenue management initiatives of €18.8 million (year ended December 31, 2016: €7.0 million). Supply chain reconfiguration costs primarily related to restructuring activities in Sweden of €14.0 million (year ended December 31, 2016: €84.3 million). Costs of the Findus Group integration which in the current period primarily relates to the rollout of the Nomad ERP system of €15.1 million (year ended December 31, 2016: €29.6 million). Costs related to transactions of €3.2 million which relates to enhanced control compliance procedures in territories, including significant non-recurring consultant and audit costs (year ended December 31, 2016: €4.8 million relating predominantly to the Iglo and Findus Acquisitions). Offsetting these costs are a net income on settlement of legacy matters relating to periods prior to acquisition of the Findus and Iglo businesses of €5.6 million (year ended December 31, 2016: charge of €1.8 million) and net income related to the re-measurement of indemnification assets of €8.3 million (year ended December 31, 2016: charge of €10.4 million).

Net finance costs of €74.4 million in the year ended December 31, 2017 (year ended December 31, 2016: €62.1 million) include €50.1 million of interest payable on long term borrowings and other cash pay interest expenses net of hedges (year ended December 31, 2016: €68.7 million), €20.1 millionof financing costs incurred in order to refinance and amend debt facilities, €4.8 million of other interest and finance costs (year ended December 31, 2016: €8.3 million), €2.7 million of amortization of capitalized borrowing costs (year ended December 31, 2016: €5.0 million) and a loss of €3.9 million resulting from the translation of foreign currency-denominated financial assets and liabilities into Euros (year ended December 31, 2016: gain of €18.3 million). This is offset by gains on derivatives designated as fair value through profit and loss of €7.0 million (year ended December 31, 2016: loss of €4.3 million) and other finance income of €0.2 million (year ended December 31, 2016: €5.9 million).

There was a tax charge in the year ended December 31, 2017 of €32.0 million based on the underlying taxable profits. A taxation charge of €39.6 million was booked in the year ended December 31, 2016 which included charges for the provision for historic exposures. The difference was due to non-taxable items (such as non tax-deductible interest and provisions that are not tax effected), partially offset by the non-recognition of deferred tax assets on certain tax losses.

Results of Operations for the Year ended December 31, 2016 and the nine months ended December 31, 2015

	Successor		Successor
	Year ended December 31, 2016		9 months ended December 31, 2015
Statement of Income data:	€m		€m
Revenue	1,927.7		894.2
Cost of sales	(1,356.7	)	(663.0	)
Gross profit	571.0		231.2
Other operating expenses	(298.4	)	(138.6	)
Exceptional items	(134.5	)	(58.1	)
Charge related to Founder Preferred Shares Annual Dividend Amount	—		(349.0	)
Credit related to Warrant Redemption Liability	—		0.4
Operating profit/(loss)	138.1		(314.1	)
Finance income	24.2		8.7
Finance costs	(86.3	)	(44.2	)
Net finance costs	(62.1	)	(35.5	)
Profit/(loss) before tax	76.0		(349.6	)
Taxation	(39.6	)	12.3
Profit/(loss) for the period	36.4		(337.3	)

The figures for the year ended December 31, 2016 represent a full twelve months of operations of both the Iglo Group and the Findus acquisition compared with the nine months ended December 31, 2015 representing seven months of operations of the Iglo Group from June 2015 through to December 2015 and two months of operations of the Findus Acquisition from November through to December 2015. The comments below are on that basis.

45

Revenue for the year ended December 31, 2016 was €1,927.7 million (nine months to December 31, 2015: €894.2 million).

Gross profit for the year ended December 31, 2016 was €571.0 million and gross margin was 29.6%. (Nine months to December 2015: €231.2 million and a gross margin of 25.9%).

Other operating expenses increased to €298.4 million for the year ended December 31, 2016 (nine months to December 31, 2015: €138.6 million). The increase of €159.8 million primarily relates to a full twelve months of operation for both the Iglo Group and the Findus acquisition operating expenses.

Charges related to the Founder Preferred Shares Annual Dividend Amount was €nil for the year ended December 31, 2016 (nine months to December 31, 2015: €349.0 million). The comparative period charge relates to the periodic fair value through the Statement of Profit or Loss of the Founder Preferred Shares Annual Dividend Amount liability up to June 1, 2015. From June 1, 2015, we expect to equity settle any Founder Preferred Shares Annual Dividend Amount and therefore, as of June 1, 2015, the liability was classified as an equity reserve with no further revaluations through the Statement of Profit or Loss to be expected. Should a Founder Preferred Share Annual Dividend Amount become due and payable, the market value of any dividend paid will be deducted from the Founder Preferred Shares Dividend reserve, with any excess deducted from the accumulated profit/(deficit) reserve within equity.

The charges relate to the redemption rights of any outstanding Warrants which were fair valued at each balance sheet date with any changes in fair value charged to the income statement. The remaining warrants that were issued by the Company in conjunction with its initial public offering in April 2014 were redeemed in the nine months ended December 31, 2015 and a credit of €0.4 million was recognized in the Consolidated Statement of Profit or Loss. There are no Warrants currently outstanding.

Exceptional items of €134.5 million were incurred in the year ended December 31, 2016 (nine months to December 31, 2015: €58.1 million). Included in this charge are supply chain reconfiguration costs of €84.3 million (nine months to December 31, 2015: €nil), primarily related to restructuring activities in Sweden, Findus Group integration costs of €29.6 million (nine months to December 31, 2015: €4.5 million), losses on re-measurement of indemnification assets costs of €10.4 million (nine months to December 31, 2015: €nil), investigation of strategic opportunities of €7.0 million (nine months to December 31, 2015: €7.7 million), costs related to transactions of €4.8 million as a result of the New York Stock Exchange listing (nine months to December 31, 2015: €34.1 million relating predominantly to the Iglo and Findus Acquisitions), costs related to long-term management incentive plans of €1.9 million (nine months to December 31, 2015: €3.5 million) and a charge of €1.8 million for settlement of legacy matters relating to periods prior to acquisition of the Findus and Iglo businesses, primarily for legacy tax audits (nine months to December 31, 2015: €1.9 million). These are offset by an income for other restructuring costs of €1.0 million (nine months to December 31, 2015: charge of €8.9 million) and net income related to the Cisterna fire of €4.3 million (nine months to December 31, 2015: €2.5 million).

Net finance costs of €62.1 million in the year ended December 31, 2016 (nine months ended December 31, 2015: €35.5 million) include €68.7 million of interest payable on long term borrowings and other cash pay interest expenses (nine months ended December 31, 2015: €38.8 million), €8.3 million of other interest and finance costs (nine months ended December 31, 2015: €2.8 million), €5.0 million of amortization of capitalized borrowing costs (nine months to December 31, 2015: €2.1 million) and losses on derivatives designated as fair value through profit and loss of €4.3 million (nine months ended December 31, 2015: gain of €4.3 million). This is offset by a gain of €18.3 million resulting from the translation of foreign currency-denominated financial assets and liabilities into Euros (nine months to December 31, 2015: loss of €0.5 million) and finance income of €5.9 million (nine months ended December 31, 2015: €4.4 million).

A tax charge in the year ended December 31, 2016 of €39.6 million was due to increased profitability and provision for historic exposures. A taxation credit of €12.3 million was booked in the nine months ended December 31, 2015 relating to seven months of Iglo and two months of Findus operations.

46

Results of Operations for the Nine months ended December 31, 2015 and the Year ended March 31, 2015

	Successor		Successor
	9 months ended December 31 2015		Year ended March 31, 2015
Statement of Income data:	€m		€m
Revenue	894.2		—
Cost of sales	(663.0	)	—
Gross profit	231.2		—
Other operating expenses	(138.6	)	(0.7	)
Exceptional items	(58.1	)	(0.7	)
Charge related to Founder Preferred Shares Annual Dividend Amount	(349.0	)	(165.8	)
Credit/(Charge) related to Warrant Redemption Liability	0.4		(0.4	)
Operating loss	(314.1	)	(167.6	)
Finance income	8.7		0.1
Finance costs	(44.2	)	—
Net finance (costs)/income	(35.5	)	0.1
Loss before tax	(349.6	)	(167.5	)
Taxation	12.3		—
Loss for the period	(337.3	)	(167.5	)

The figures for the nine months ended December 31, 2015 represent seven months of operations of the Iglo Group from June 2015 through to December 2015 and two months of operations of the Findus Acquisition from November through to December 2015 compared with the year ended March 31, 2015. Prior to the Iglo Acquisition, Nomad had no operations.

Revenue for the nine months ended December 31, 2015 was €894.2 million representing seven months of operations of the Iglo Group from June 2015 through to December 2015 and two months of operations of the Findus Acquisition. Prior to the Iglo Acquisition, Nomad had no operations.

Gross profit for the nine months ended December 31, 2015 was €231.2 million and gross margin was 25.9%. The results for the nine months ended December 31, 2015 include a one-time €37.0 million fair value charge relating to a step-up in inventory values and a €4.9 million charge in relation to cash flow hedge accounting as part of the Iglo and Findus Acquisitions.

Other operating expenses increased to €138.6 million for the nine months ended December 31, 2015 in comparison to €0.7 million in the year ended March 31, 2015. The increase of €137.9 million primarily relates to seven months of Iglo and two months of Findus operating expenses.

Charges related to the Founder Preferred Shares Annual Dividend Amount increased to €349.0 million for the nine months ended December 31, 2015 in comparison to €165.8 million in the year ended March 31, 2015. The charge relates to the Founder Preferred Shares Annual Dividend Amount which was fair valued as of June 1, 2015. We expect to settle any Founder Preferred Shares Annual Dividend Amount with equity and therefore the liability has been reclassified as an equity reserve as of June 1, 2015 and no further revaluations are expected.

Exceptional items of €58.1 million in the nine months ended December 31, 2015 relate to the transaction-related costs incurred by Nomad in connection with the Iglo Acquisition and the Findus Acquisition of €28.2 million, other costs related to transactions of €5.9 million, investigation of strategic opportunities of €7.7 million, other restructuring costs of €8.9 million, the Findus Group integration costs of €4.5 million, costs related to management incentive plans of €3.5 million, a charge of €1.9 million for liabilities relating to periods prior to acquisition of the Findus and Iglo businesses, primarily for legacy tax audits and net income related to the Cisterna fire of €2.5 million.

Net finance costs of €35.5 million in the nine months ended December 31, 2015 relate to €38.8 million of interest payable on debt assumed as part of the Iglo Acquisition, €4.9 million of other interest and finance costs and €0.5 million resulting from the translation of foreign currency-denominated financial assets and liabilities into Euros offset by finance income of €4.4 million and a gain on derivatives designated as fair value through profit and loss of €4.3 million.

47

A taxation credit of €12.3 million was booked in the nine months ended December 31, 2015 relating to seven months of Iglo and two months of Findus operations.

B. Liquidity and Capital Resources

Overview

We believe that cash flow from operating activities, available cash and cash equivalents and our access to our revolving credit facility will be sufficient to fund our liquidity requirements for at least the next 12 months. At December 31, 2017, we had €385.0 million of total liquidity, comprising €219.2 million in cash, €66.0 million of available borrowings under our revolving credit facility, as well as available borrowings of €58.0 million and $50.0 million (€41.8 million) from the Facility B5 and B6 loans. We also expect to continue to raise cash through equity and debt offerings when it is advisable to do so. Our principal liquidity requirements have been, and we expect will be, for working capital and general corporate purposes, including capital expenditures and debt service, as well as to identify and effect strategic acquisitions.

Restricted Cash

Nomad had cash and cash equivalents of €219.2 million at December 31, 2017, of which €0.2 million was restricted. This compares with cash and cash equivalents of €329.5 million at December 31, 2016 of which €4.2 million was restricted. Cash may be restricted due to cash held in ring fenced accounts as collateral for guarantees or funds held in escrow accounts.

Cash Flows

Our primary sources of liquidity for the periods reported were cash flow from operations and financing activities. Cash flows from financing activities have in the past included, among other things, borrowings under credit facilities, high yield notes and shareholder loan notes. Our liquidity requirements arise primarily from the need to meet debt service requirements, to fund capital expenditures, to meet working capital requirements and to fund pension and tax obligations. Cash flows generated from operating activities, together with cash flows generated from financing activities, have historically been sufficient to meet our liquidity needs.

The following table summarizes net cash flows with respect to our operating, investing and financing activities for the periods indicated:

	Successor	Successor	Successor	Successor	Predecessor
	Year ended December 31, 2017	Year ended December 31, 2016	9 months ended December 31, 2015	Year ended March 31, 2015	5 months ended May 31, 2015
		€m	€m	€m	€m
Net cash provided by / (used in) operating activities	193.8	282.1	48.0	(0.5)	78.7
Net cash used in investing activities	(42.6)	(50.4)	(959.8)	(295.6)	(6.3)
Net cash (used in) / provided by financing activities	(241.8)	(67.7)	952.5	353.5	(29.4)
Net (decrease)/increase in cash and cash equivalents	(90.6)	164.0	40.7	57.4	43.0
Cash and cash equivalents at end of the period	219.2	329.5	186.1	126.8	268.4

Net Cash from Operating Activities

Net cash from operating activities was €193.8 million for the year ended December 31, 2017, down from €282.1 million for the year ended December 31, 2016. The €88.3 million decrease was primarily the result of cash flows related to exceptional items of €99.5 million compared to €49.2 million in the year ended December 31, 2016, as well as cash flows relating to tax of €65.2 million compared to €24.9 million in the year ended December 31, 2016.

Net cash from operating activities was €282.1 million for the year ended December 31, 2016, up from €48.0 million for the nine months ended December 31, 2015. The €234.1 million increase was primarily the result of including twelve months of Iglo and Findus operations compared to the nine months ended December 31, 2015, which include seven months of Iglo operations and two months of Findus operations.

48

Net cash used in operating activities for the year ended March 31, 2015 was primarily related to ongoing costs and expenses prior to the Iglo Acquisition.

Net cash used in operating activities for the five months ended May 31, 2015 related to ongoing operations.

Net Cash Used in Investing Activities

Net cash used in investing activities was €42.6 million for the year ended December 31, 2017, compared to net cash used in investing activities of €50.4 million for the year ended December 31, 2016. The outflow in the year ended December 31, 2017 was due to capital expenditures.

Net cash used in investing activities was €50.4 million for the year ended December 31, 2016, compared to net cash used in investing activities of €959.8 million for the nine months ended December 31, 2015. The outflow for the year ended December 31, 2016 included capital expenditures as well as a payment of €8.0 million of deferred consideration for the Frudesa brand. The outflow in the nine months ended December 31, 2015 was primarily due to the Iglo Acquisition of €693.6 million, the Findus Acquisition of €556.9 million and offset by redemption of portfolio investments of €312.1 million.

Net cash used in investing activities was €295.6 million for the year ended March 31, 2015, relating to investment of our cash prior to the Iglo Acquisition.

Net cash used in investing activities was €6.3 million for the five months ended May 31, 2015 primarily related to capital expenditures.

Net Cash Provided by Financing Activities

Net cash used in financing activities was €241.8 million for the year ended December 31, 2017 compared to net cash used in financing activities of €67.7 million for the year ended December 31, 2016. The outflow for the year ended December 31, 2017 relates primarily to payments of €177.6 million for the repurchase of the Company's own shares and payments of €16.7 million for fees incurred as part of the refinancing of the Company's debt arrangements, partially offset by decreased cash interest expense.

Net cash used in financing activities was €67.7 million for the year ended December 31, 2016 compared to net cash provided by financing activities of €952.5 million for the nine months ended December 31, 2015. The outflow for the year ended December 31, 2016 relates primarily to interest payments. The inflow in the nine months ended December 31, 2015 was primarily from the sale of shares in the May and July 2015 Offerings of €1,171.8 million and €325.0 million drawn on the senior facilities to fund the Iglo Acquisition and the Findus Acquisition, offset by a repayment of loan principal of €490.0 million and €40.8 million of interest paid.

Net cash provided by financing activities was €353.5 million for the year ended March 31, 2015, primarily resulting from the issuance of ordinary shares in the 2014 Offering.

Net cash used in financing activities was €29.4 million for the five months ended May 31, 2015 primarily related to interest payable on the senior debt.

Capital Expenditures

Our capital expenditures in 2017 consisted, and in 2018 we expect to consist of, primarily expenditures for factory capacity expansion and maintenance, cost savings projects, information systems, innovation, regulatory compliance, acquisitions, including the Green Isle Foods Ltd. acquisition and other items.

The following table sets forth our capital expenditures for the periods indicated, including as a percentage of revenue:

	Successor	Successor	Successor	Successor	Predecessor
	Year ended December 31, 2017	Year ended December 31, 2016	9 months ended December 31, 2015	Year ended March 31, 2015	5 months ended May 31, 2015
	€m	€m	€m	€m	€m
Capital expenditures	42.6	42.4	21.4	—	6.3
Capital expenditure as a % of revenue	2.2%	2.2%	2.4%	—	1.0%

49

Debt

Senior Facilities Agreement.  

On April 28, 2017, we entered into an Amendment and Restatement Agreement with Nomad Foods Europe Midco Limited, Credit Suisse AG, London Branch, as security agent and agent on behalf of certain other finance parties thereto, and the other lenders and parties thereto relating to that certain Senior Facilities Agreement dated July 3, 2014 (as amended and restated from time to time, including pursuant to amendment and restatement agreements dated October 23, 2015, April 28, 2017 and December 20, 2017, the "Senior Facilities Agreement"). Pursuant to the Amendment and Restatement Agreement, as of the closing of the refinancing on May 3, 2017, the Senior Facilities Agreement was amended and restated to, among other things (i) refinance the existing term loan facilities by establishing a €500.0 million term loan facility and a $610.0 million term loan facility, both with maturity dates extending to May 2024, (ii) extend the maturity of its €80.0 million revolving credit facility until May 2023 and (iii) renegotiate the terms of certain covenants contained therein, each as more fully described in the Senior Facilities Agreement. The Euro denominated term loan bears interest at a rate per annum equal to EURIBOR plus 3.00% and each of the USD denominated term loan and revolving facility bears interest at a rate per annum equal to LIBOR/EURIBOR (as applicable) plus 2.75%. If EURIBOR or LIBOR is less than zero, EURIBOR or LIBOR (as the case may be) shall be deemed to be zero. Pursuant to the Amendment and Restatement Agreement, at the closing, we also entered into an amended and restated Intercreditor Agreement originally dated July 3, 2014 with Credit Suisse AG, London Branch, as security agent and certain other parties thereto.

In order to match its underlying cash flows the Company has entered into a number of cross-currency interest rate swaps. In exchange for $610.0 million the Company has received €299.3 million and £226.7 million. The derivatives are designed to minimize the exposure to movements in foreign currency exchange rates and movements in interest rates. In exchange for receiving cash flows in USD matching the payments of principal and interest due under the Senior USD debt, the Company will pay fixed amounts of interest and principal on notional amounts of GBP and EUR. All of the USD to EUR swaps have been designated as a cash flow hedge whilst EUR to GBP swaps to the value of £187.6 million have been designated as a net investment hedge.

On December 20, 2017, we entered into an Amendment and Restatement Agreement with Credit Suisse AG, London Branch, as security agent and agent on behalf of certain other finance parties thereto, and the other lenders and parties thereto relating to the Senior Facilities Agreement to, among other things, (i) reprice the €500.0 million term facility (the "Facility B3 Loan") and the $610.0 million term facility (the "Facility B4 Loan" and together with the Facility B3 Loan, the "New Facility Loans") and (ii) establish a €58.0 million incremental term facility (the "Facility B5 Loan") and a $50.0 million incremental term facility (the "Facility B6 Loan" and together with the New Facility Loans and the Facility B5 Loan, the "Facility Loans"), each as more fully described in the Senior Facilities Agreement. Following the closing, the margin on the Facility B3 Loan is 25 basis points lower than that on the existing €500.0 million term facility (the "Facility B1 Loan") and the margin on the Facility B4 Loan is 50 basis points less than that on the existing $610.0 million term facility (the "Facility B2 Loan" and together with the Facility B1 Loan, the "Existing Facility Loans"). This reduction is expected to result in approximately €3.7 million of annual cash interest savings.

Concurrently with the creation of the New Facility Loans, the Existing Facility Loans (to the extent they were not rolled into the New Facility Loans) were paid in full. Each of the Facility Loans has a maturity date of May 2024, which is the same as the maturity date of the Existing Facility Loans. Each of the Euro denominated term loans bears interest at a rate per annum equal to EURIBOR plus 2.75% per annum and each of the USD denominated term loans bears interest at a rate per annum equal to LIBOR (as applicable) plus 2.25% per annum. If EURIBOR or LIBOR is less than zero, EURIBOR or LIBOR (as the case may be) shall be deemed to be zero. Except as set forth in the Senior Facilities Agreement and as described above and subject to the re-setting of the 6 month soft-call period (i) the Facility B3 Loan and the Facility B5 Loan had identical terms as the existing Facility B1 Loan and (ii) the Facility B4 Loan and the Facility B6 Loan had identical terms as the existing Facility B2 Loan and, in each case, are (or were) otherwise subject to the provisions of the Senior Facilities Agreement. On January 31, 2018, the $50.0 million incremental term facility was fully drawn and on February 9, 2018, the €58.0 million incremental term facility was fully drawn.

In addition, the Senior Facilities Agreement has an €80.0 million revolving credit facility of which up to €22.0 million can be used for the issuance of letters of credit.

The revolving credit facility matures on May 15, 2023 and bears interest at a rate per annum equal to LIBOR or, in relation to any loan in Euro, EURIBOR, plus the applicable margin. The applicable margin is 2.75% per annum. Interest on the revolving credit facility is payable at the end of each interest period which, at the option of the borrower, may be one, two, three or six months or any other period agreed with the facility agent.

50

As of December 31, 2017, we had approximately €1,009.5 million (December 31, 2016; €964.2 million) of indebtedness outstanding under our term loan facilities and no amounts outstanding under our revolving credit facility, other than €14.0 million (December 31, 2016; €13.2 million) in stand-by letters of credit.

The Senior Facilities Agreement contains certain customary negative operating covenants (certain of which are not applicable depending on the ratio of Consolidated Total Net Debt to Consolidated EBITDA) and other customary provisions relating to events of default, including non-payment of principal, interest or fees, misrepresentations, breach of covenants, creditor process, cross default to other indebtedness of the borrowers and its subsidiaries in excess of€35.0 million, cessation of business, and material adverse change. We shall ensure that if, in respect of any Relevant Period ending after the Closing Date, the aggregate amount of: (i) all Revolving Facility Loans; (ii) drawn Letters of Credit; and (iii) Ancillary Outstanding’s (but excluding Ancillary Outstanding’s by way of undrawn letters of credit and undrawn bank guarantees under the relevant Ancillary Facility), (together the “RCF Drawings”) calculated as at the last day of each such Relevant Period, is equal to or exceeds 40% of the Total Revolving Facility Commitments as at such date, Debt Cover in respect of that Relevant Period shall not exceed 8.00:1.

Fixed Rate Senior Secured Notes due 2024.  On May 3, 2017, we entered into an indenture with Nomad Foods Bondco Plc, our indirect, wholly-owned subsidiary, our direct and indirect subsidiaries named as guarantors therein (together with us, the "Guarantors") and Deutsche Trustee Company Limited, as trustee thereunder, pursuant to which we issued €400.0 million aggregate principal amount of 3.250% Fixed Rate Senior Secured Notes. The Fixed Rate Senior Secured Notes will mature on May 15, 2024. Interest on the Fixed Rate Senior Secured Notes will accrue at the rate of 3.25% per annum and is payable semi-annually in arrears. The Fixed Rate Senior Secured Notes are fully and unconditionally guaranteed on a senior basis by the Guarantors, subject to the limitations set forth in the indenture. The Fixed Rate Senior Secured Notes are currently admitted to the Official List of the Luxembourg Stock Exchange and for trading on the Euro MTF Market. We used the proceeds received in connection with the Fixed Rate Senior Secured Notes offering and the Senior Facilities Agreement, as amended on May 3, 2017, to repay the €500.0 million floating rate senior secured notes due 2020.

The indenture contains customary events of default and customary covenants including limitations on indebtedness, restricted payments, liens, restrictions on distributions from restricted subsidiaries, sales of assets and subsidiary stock, affiliate transactions, our activities, such as merger, conveyance, transfer or lease of all or substantially all of our assets, and compliance requirements with respect to additional guarantees, reporting, additional intercreditor agreements, payment of notes, withholding taxes, change of control, compliance certificate, payments for consent and listing requirements.

The Fixed Rate Senior Secured Notes are redeemable at our option in whole or in part, from time to time, upon not less than 10 nor more than 60 days' prior notice on or after May 15, 2020 at redemption prices specified in the indenture plus accrued and unpaid interest to the redemption date.

Pension Plans

We maintain defined benefit pension plans in Germany, Sweden, Italy and Austria as well as various defined contribution plans in other countries. The defined benefit pension plans are partially funded in Germany and Austria and unfunded in Sweden and Italy. All defined benefit pension plans are closed to new entrants and there is no current requirement to fund the deficit in any plan. We also maintain various defined contribution pension plans in other countries, the largest of which include Sweden and the United Kingdom. In most countries, long term service awards are in operation.

For accounting purposes, as of December 31, 2017 (based on the assumptions used), the deficit for the net employee benefit obligations equaled €188.4 million (December 31, 2016: €190.9 million).

For the year ended December 31, 2017 pension costs related to defined benefit, defined contributions and long-term benefit plans equated to €18.2 million. For the year ended December 31, 2016 pension costs related to defined benefit, defined contributions and long-term benefit plans equated to €17.3 million. For the nine months ended December 31, 2015, such costs equaled €8.2 million. This includes all costs related to the pension schemes and other long-term benefits plans as well as associated interest costs.

For additional information, see Note 23 “Employee benefits” to our audited consolidated financial statements which appear elsewhere in this annual report.

A description of our principal accounting policies, critical accounting estimates and key judgments is set out in Note 3 and Note 4 to our audited consolidated statements which appear elsewhere in this annual report.

51

C. Research and development, patents and licenses, etc.

We focus our efforts on renovation of core products and our investment in market research on ensuring that the products we launch overcome penetration barriers. In addition, we operate a structured stage gate process through which we take new products from idea generation, through concept screening, concept/products laboratories and early volume sizing, to final validation.

We operate one central “Category Marketing Operational Review Board” (“CMOR”) which is responsible for reviewing and approving innovations across the Company. Our research and development team is centralized, allowing us to leverage our investment in research development across our markets, thus maximizing our ability to generate successful innovations efficiently.

We spent €15.4 million for the year ended December 31, 2017, €13.3 million in the year ended December 31, 2016, €12.1 million for the nine months ended December 31, 2015, €nil in the year ended March 31, 2015 and €7.2 million in the five months ended May 31, 2015 on company-sponsored research and development activities.

D. Trend information

We are subject to the following key industry trends and challenges which have impacted, and may continue to impact, our business, operations and financial performance:

1. Consumer Preferences. Consumer preferences drive demand for our products. There are a number of trends in consumer preferences which are having an impact on us and the frozen food industry as a whole. These include preferences for speed, convenience and ease of food preparation; natural, nutritious and well-proportioned meals; and products that are sustainably sourced and produced and are otherwise environmentally friendly. Our results of operation depend in large part on the continued appeal of our products and, given the varied backgrounds and tastes of our customer base, our ability to offer a sufficient range of products to satisfy a broad spectrum of preferences. In order to address consumer needs and ensure the continued success of our products, we aim to introduce new products, renovate core products and extend existing product lines on a timely basis.

2. Competition. In addition to the competition we face from traditional, well-established branded frozen food manufacturers, over the last few years we have seen increased competition from the discounter channel. Discounters are supermarket retailers which offer food and grocery products at discounted prices and which typically focus on non-branded rather than branded products. The discounter channel has been growing at a faster rate than the traditional retailer channels over the last several years. To address this growing trend, we intend to pursue opportunities to increase our presence with the discounter channel, particularly the hard discounter channel. With the growth of the discounter channel, in an effort to compete, our traditional retail customers have increased their offering of their own private label products. Because these customers control the shelf space allocations within their stores, they may allocate more shelf space to their private label products in accordance with their respective promotional strategies. To address decreases in shelf space allocated to our products, we have expanded our focus on “category captaincy”. As a “category captain”, we cooperate with retailers and invest in the strategic development of our food categories. As we increase our influence with retailers, we expect this will translate into an increased share of shelf space and provide more favorable positioning of our products relative to the competition.

3. Shopping Habits. The online grocery retail channel is growing faster than traditional grocery retail formats across developed markets. Consumers with increasingly busy lifestyles are choosing the online grocery channel as a more convenient and faster way of purchasing their food products, and are also increasingly using the internet for meal ideas. Frozen foods particularly benefit from the online channel as the advantages to the consumer of outsourcing transportation of frozen food to the retailer are greater than in other categories, and also because some of the barriers to purchasing in-store (e.g. colder aisles) are removed for the consumer online. We are responding to the growing consumer shift to digital and mobile technologies, particularly in the United Kingdom, by

52

investing in technology platforms and partnering with retailers that are executing their own e-commerce strategies to meet changing consumer habits.

E. Off-balance sheet arrangements

We did not have any material off-balance sheet arrangements during the reported periods.

F. Tabular disclosure of contractual obligations

The following table summarizes our estimated material contractual cash obligations and commercial commitments as of December 31, 2017, and the future periods in which such obligations are expected to be settled in cash:

	Cash payments due by period
(€ in millions)	Total	Less than 1 year	1-3 years	3-5 years	After 5 years
Long term debt	1,409.5	5.1	10.2	10.2	1,384.0
Long term debt—interest (1)	292.4	46.3	92.0	91.2	62.9
Cross currency interest rate swap payments (2)	916.2	29.1	57.3	829.8	—
Cross currency interest rate swap receipts (2)	(885.5)	(32.0)	(63.0)	(790.5)	—
Forward contracts - Sell (2)	484.0	484.0	—	—	—
Forward contracts - Buy (2)	(479.6)	(479.6)	—	—	—
Operating leases (3)	168.3	17.8	26.1	17.8	106.6
Purchase commitments (4)	300.8	183.2	72.7	44.9	—
Total (5)	2,206.1	253.9	195.3	203.4	1,553.5

(1) Represents estimates of future interest payable, which will depend upon the timing of cash flows as well as fluctuations in the applicable interest rates and the Company’s debt structure. These forecasts have been compiled using the debt structure as at December 31, 2017 with constant foreign exchange and interest rates until the debt matures in 2024.

(2) Cross currency interest rate swap payments and forward contracts are presented alongside receipts to show the net liability.

(3) Excludes contractual annual increases linked to inflation indices. A proportion of these contractual commitments are included in the consolidated balance sheet within provisions where no future economic benefit will be received.

(4) Represents capital and raw material expenditures as well as and long term service contracts which we have committed to make but which are not yet payable. Amounts also exclude provisions already included within the consolidated balance sheet.

(5) Retirement benefit obligations of €188.4 million are not presented above as the timing of the settlement of these obligations is uncertain. Certain long-term liabilities related to income taxes, insurance accruals, and other accruals included on the consolidated balance sheet are excluded from the above table as we are unable to estimate the timing of payments for these items.

G. Safe harbor

See the section entitled “Cautionary Statement Regarding Forward-Looking Statements” at the beginning of this annual report.

53

Item 6. Directors, Senior Management and Employees

A. Executive Officers and Directors

The following table lists each of our executive officers and directors and their respective ages and positions as of March 22, 2018.

Name	Director since	Age	Position
Martin E. Franklin	April 4, 2014	53	Co-Chairman
Noam Gottesman	April 4, 2014	56	Co-Chairman
Ian G.H. Ashken	June 16, 2016	57	Director
Jason Ashton	N/A	50	Interim Chief Financial Officer
Stéfan Descheemaeker	May 28, 2015	57	Chief Executive Officer and Director
Mohamed Elsarky	August 22, 2017	60	Director
Jeremy Isaacs CBE	February 16, 2016	54	Director
Paul Kenyon	August 8, 2017	54	Director
James E. Lillie	May 28, 2015	56	Director
Lord Myners of Truro CBE	April 4, 2014	69	Lead Independent Director
Victoria Parry	February 16, 2016	52	Director
Simon White	November 30, 2016	59	Director

Set forth below is a brief biography of each of our executive officers and directors.

Martin E. Franklin, our co-founder and co-Chairman has been a director of Nomad since April 2014. Martin E. Franklin is the founder and CEO of Mariposa Capital LLC and Chairman and controlling shareholder of Royal Oak Enterprises, LLC. Currently, Mr. Franklin is also Founder and Chairman of Platform Specialty Products Corporation, a director of Restaurant Brands International Inc. and a Director of J2 Acquisition Limited. Mr. Franklin was the founder and Chairman of Jarden Corporation ("Jarden") from 2001 until April 2016 when Jarden merged with Newell Brands Inc ("Newell"). Mr. Franklin became Chairman and Chief Executive Officer of Jarden in 2001, and served as Chairman and Chief Executive Officer until 2011, at which time he began service as Executive Chairman. Prior to founding Jarden in 2001, Mr. Franklin served as the Chairman and/or Chief Executive Officer of three public companies: Benson Eyecare Corporation, Lumen Technologies, Inc., and Bollé Inc. between 1992 and 2000. In the last five years, Mr. Franklin served as a director of the following public companies: Newell Brands, Inc., Burger King Worldwide, Inc. (until its transaction with Tim Hortons, Inc. and the creation of Restaurant Brands in December 2014) and Promotora de Informaciones, S.A.

Noam Gottesman, our co-founder and co-Chairman has been a director of Nomad since April 2014. Mr. Gottesman is the Founder and Managing Partner of TOMS Capital LLC, which he founded in 2012. Mr. Gottesman is also a co-founder and non-executive director of Landscape Acquisition Holdings Limited, an acquisition vehicle that completed its $500 million initial public offering and listing on the London Stock Exchange in November 2017. Mr. Gottesman was the co-founder of GLG Partners Inc. and its predecessor entities where he served in various chief executive capacities until January 2012. Mr. Gottesman served as GLG’s chief executive officer from September 2000 until September 2005, and then as its co-chief executive officer from September 2005 until January 2012. Mr. Gottesman was also chairman of the board of GLG following its merger with Freedom and prior to its acquisition by Man Group plc. Mr. Gottesman co-founded GLG as a division of Lehman Brothers International (Europe) in 1995 where he was a Managing Director. Prior to 1995, Mr. Gottesman was an executive director of Goldman Sachs International, where he managed global equity portfolios in the private client group.

Ian G.H. Ashken was the co-founder of Jarden and served as its Vice Chairman and President until the consummation of Jarden’s business combination with Newell in April 2016. Mr. Ashken was appointed to the Jarden board on June 25, 2001 and served as Vice Chairman, Chief Financial Officer and Secretary from September 24, 2001. Mr. Ashken was Secretary of Jarden until February 15, 2007 and Chief Financial Officer until June 12, 2014. Prior to Jarden, Mr. Ashken served as the Vice Chairman and/or Chief Financial Officer of three public companies, Benson Eyecare Corporation, Lumen Technologies, Inc. and Bollé Inc. between 1992 and 2000. Mr. Ashken also serves as a director of Platform Specialty Products Corporation and is a director or trustee of a number of private companies and charitable institutions. During the last five years, Mr. Ashken also previously served as a director of Newell Brands, Inc. and Phoenix Group Holdings.

54

Jason Ashtonbecame Interim Chief Financial Officer in August 2017. An experienced Finance Director, Jason joined Iglo Group in September 2013 and was most recently Group Finance Director at Nomad Foods Europe. A qualified chartered accountant, Jason spent twelve years at Cadbury, subsequently Mondelez International from 2001 to 2013 where he had a variety of senior finance and management roles. This included the role of Strategy Director for Central and Eastern Europe where he was responsible for mergers and acquisitions. Jason also spent a year as Chief Executive Officer and Chief Financial Officer of the private equity led baby food company, Plum Baby. His early management career included positions at Diageo, Tetley and KPMG. Mr. Ashton is a Fellow of the Institute of Chartered Accountants in England and Wales.

Stéfan Descheemaeker was appointed as the Chief Executive Officer of the Company and of Iglo on June 1, 2015. He was previously at Delhaize Group SA, the international food retailer, where he was Chief Financial Officer between 2008 and 2011 before becoming Chief Executive Officer of its European division until October 2013. Since leaving Delhaize Group SA, Mr. Descheemaeker has taken on board positions with Telenet Group Holdings N.V. and Group Psychologies, served as an industry advisor to Bain Capital and been a professor at the Université Libre de Bruxelles. Between 1996 and 2008, Mr. Descheemaeker was at Interbrew (now Anheuser-Busch InBev) where he was Head of Strategy & External Growth responsible for managing M&A and strategy, during the time of the merger of Interbrew and AmBev in 2004, and prior to that he held operational management roles as Zone President in the U.S., Central and Eastern Europe, and Western Europe. Mr. Descheemaeker started his career with Cobepa, at that time the Benelux investment company of BNP-Paribas. Mr. Descheemaeker currently serves as a Director on the Board of Anheuser-Busch InBev, a position he has held since 2008.

Mohamed Elsarky was President and CEO of Godiva Chocolatier Inc. from 2014 to 2017, based in New York and London; he was also a member of the Board. Godiva Chocolatier is the leading global premium chocolate brand and Mr Elsarky was responsible or the company’s global sales spanning more than 100 countries, with 800 retail stores, and several thousand points of sale in global travel retail and domestic market channels. Mr Elsarky joined Godiva in 2010 when he served as President International, directing the company’s strategy and operations across all markets outside US and Canada.Prior to that, Mr Elsarky served as an Operating Partner of Lion Capital, a leading private equity company based in London specializing in consumer brands. He was Executive Chairman of portfolio companies, identifying businesses for acquisition and developing strategies to develop them. He has direct responsibility for two such portfolio companies, Vaasan & Vaasan Group, the leading fresh bakery business in Finland and the Baltic region, and Ad van Gelovan, the market leader in frozen snacks in the Benelux. He was executive Chairman of both companies. From 2004-2006 Mr Elsarky served as President, Northern Europe, based in Paris, for United Biscuits, where he was appointed to lead the turnaround of its Northern European businesses. This included overseeing well-known brands including BN, Delacre, Sultana, McVities and Carr’s crackers. As Managing Director of Jacob’s Bakery from 2002-2004, then under ownership by Danone, Mr Elsarky’s key focus was to return the business to sustainable growth. He eventually recommended to the Danone Board the sale of Jacobs and opted to remain with the Jacobs’ team as it transitioned to United Biscuits. Earlier in his career, from 1988-2001, Mr Elsarky held a number of positions with Kellogg Company, in Australia, Asia and USA. He latterly became Chairman and CEO, Australia and New Zealand. Mr Elsarky is currently a Non-Executive Director of The East India Company in the U.K. He also served as Non-Executive Chairman of British Canoeing, member of the British Olympic Association, member of Australian Council for Children and Parenting and Kids Helpline Charity (Australia).

Jeremy Isaacs is a Founding Partner of JRJ Group. At JRJ Group, Mr. Isaacs is closely involved with the implementation and guidance of fund strategy, as well as the development and execution of portfolio company strategy. Prior to establishing JRJ Group, in late 2008, Mr. Isaacs held senior executive positions with Lehman Brothers with responsibility for businesses outside North America. Mr. Isaacs serves as a non-executive director of Marex Spectron, Food Freshness Technology and Landscape Acquisition Company. He participates in numerous philanthropic activities, holding a range of positions, including Trustee of The J Isaacs Charitable Trust, member of the Bridges Development Fund Advisory Board, and Trustee of the Noah’s Ark Children’s Hospice. Mr. Isaacs is an Honorary Fellow of the London Business School. He served as non-executive director of Imperial College Healthcare NHS Trust from October 2013 to September 2016, and was a member of the British Olympic Advisory Board between 2007 and 2012. Mr. Isaacs was appointed Commander of the Order of the British Empire (CBE) in the 2015 Queen’s Birthday Honours for his services to the NHS.

Paul Kenyon is Chief Financial Officer of C&J Clark Limited, the leading casual shoe brand with retail, online and wholesale operations in around 100 countries. He was previously Chief Financial Officer of Nomad Foods Limited from June 2015 until August 2017, having previously served as Chief Financial Officer of Iglo from June 2012. Mr. Kenyon joined the Iglo Group from AstraZeneca PLC where his most recent role was CFO for AstraZeneca’s Global Commercial business. Prior to that, Mr. Kenyon spent three years as Senior Vice President, Group Finance and for a period held the role of Chairman of AstraTech, AstraZeneca’s medical technology subsidiary, concluding with its

55

successful disposal. Mr. Kenyon’s prior career includes a broad range of senior finance roles at Allied Domecq PLC as well as experience gained at Mars, Incorporated and Courtaulds PLC. Mr. Kenyon is a Fellow of the Chartered Institute of Management Accountants.

James E. Lillie served as Jarden’s Chief Executive Officer from June 2011 until the consummation of Jarden’s business combination with Newell in April 2016. He joined Jarden in 2003 as Chief Operating Officer and was named President in 2004 and CEO in June 2011. From 2000 to 2003, Mr. Lillie served as Executive Vice President of Operations at Moore Corporation, Limited. From 1999 to 2000, he served as Executive Vice President of Operations at Walter Industries, Inc., a Kohlberg, Kravis, Roberts & Company (KKR) portfolio company. From 1990 to 1999, Mr. Lillie held a succession of senior level management positions across a variety of disciplines including human resources, manufacturing, finance and operations at World Color, Inc., another KKR portfolio company. Mr. Lillie serves on the board of the US-China Business Council (USBC), a private, nonpartisan, nonprofit organization of American companies that do business in China. Since February 2017, Mr. Lillie has served on the board of directors of Tiffany & Co. and since October 2017 has served on the board of directors of J2 Acquisition Limited.

Lord Myners is Chancellor of the University of Exeter and a member of Court and Council of the London School of Economics and Political Science. He served as the Financial Services Secretary in Her Majesty’s Treasury, the United Kingdom’s finance ministry, from October 2008 to May 2010. Prior to his service at the Treasury, Lord Myners served as chairman or a member of the board of several organizations, including as chairman of Guardian Media Group from 2000 to 2008, director of GLG Partners Inc. from 2007 to 2008, Director of Land Securities Group plc from 2006 to 2008 (chairman from 2007 to 2008), chairman of Marks & Spencer plc from 2004 to 2006, and chairman of Aspen Insurance Holdings Ltd from 2002 to 2007. Lord Myners served as chairman of Platform Acquisition Holdings Limited (now known as Platform Specialty Products Corporation) from April 2013 until its business combination with MacDermid, Incorporated in October 2013. He also served as the chairman of Justice Holdings Limited, a special purpose acquisition company, from February 2011 until its business combination with Burger King Worldwide, Inc. in June 2012. From 1986 to 2001, he served as a director of Gartmore Investment Management Limited. He has also served in an advisory capacity to the United Kingdom Treasury and the United Kingdom Department of Trade & Industry, with particular focus on corporate governance practices. Other positions held by Lord Myners have included chairman of the Trustees of Tate, chairman of the Low Pay Commission, a member of the Court of the Bank of England, a member of the Investment Board of GIC, Singapore’s sovereign wealth fund. Lord Myners is currently serving as a non-executive director of Windmill Hill Asset Management. He is vice chairman of Global Counsel, the non-executive chairman of Autonomous Research LLP, chairman and a partner of Cevian Capital LLP and Chairman of Daniel J Edelman (UK). Lord Myners is a graduate, with honors, from University of London and has an honorary doctorate from the University of Exeter. He is a Visiting Fellow at Nuffield College, Oxford and an Executive Fellow at London Business School. He is a crossbench member of the UK’s House of Lords, the senior chamber in Parliament.

Victoria Parry was Global Head of Product Legal for Man Group plc until April 2013 and now acts as an independent non-executive director and consultant to the funds industry. Prior to the merger of Man Group plc with GLG Partners, Inc. in 2010, she was Senior Legal Counsel for GLG Partners LP. Ms. Parry joined Lehman Brothers International (Europe) in April 1996 where she was Legal Counsel with responsibility for inter alia the activities of the GLG Partners division and left Lehman Brothers in September 2000 upon the establishment of GLG Partners LP. Prior to joining Lehman Brothers in 1996 Ms. Parry practiced as a solicitor with a leading London based firm of solicitors. Ms. Parry graduated from University College Cardiff, with a LLB (Hons) in 1986. Ms. Parry is a solicitor and a member of the Law Society of England and Wales. Ms. Parry is a director of a number of other companies.

Simon White was, until 2014, Chief Operating Officer of Man Group PLC where he was a member of the Executive Committee. Prior to the merger of Man Group PLC with GLG Partners, Inc. in 2010, Mr. White served as Chief Operating Officer of GLG Partners, Inc. from its inception and was also Chief Financial Officer until mid-2008. From 1993 to 2000 he worked at Lehman Brothers in a number of different roles. Since 2014, Mr. White has been involved in leadership roles in a range of early stage businesses with a special focus on FinTech, and is currently a director of Axim Holdings Limited. In 2017 he became a non-executive director of Ask Inclusive Finance and in January 2018 became a non-executive director of Bridge Invest Limited. Mr. White is a Fellow of the Institute of Chartered Accountants in England and Wales.

56

B. Compensation of Executive Officers and Directors

This section sets forth for the year ended December 31, 2017: (i) the compensation and benefits provided to our executive officers, (ii) a brief description of the bonus programs in which our executive officers participated, and (iii) the total amounts set aside for pension, retirement and similar benefits for our executive officers. This section also describes the Nomad Long Term 2015 Incentive Plan (“LTIP”) including a summary of the material terms of the LTIP, a description of current executive employment agreements and equity awards granted thereunder, and a description of our director compensation program.

Executive Compensation

Executive Officer Compensation and Benefits for the year ended December 31, 2017

For the year ended December 31, 2017, Nomad’s executive officers received total compensation, including base salary, cash and equity bonus, and certain perquisites, equal to €3.2 million in the aggregate.

Pension, Retirement and Similar Benefits

Our executive officers who participate in our money purchase pension plans do so on generally the same terms as our other employees. The aggregate amount of the employer contributions to this plan for our executive officers during the year ended December 31, 2017 was less than €0.1 million.

Employment Agreements

Chief Executive Officer.  Stéfan Descheemaeker was appointed as the Chief Executive Officer of the Company and as a Director of the Company effective on June 1, 2015. He entered into his Service Agreement with us on June 17, 2015. Under the agreement, Mr. Descheemaeker will receive an annual salary that will be reviewed, but not necessarily increased, on an annual basis .The first review took place in 2017 which increased Mr. Descheemaeker's salary to £714,000. Mr. Descheemaeker is entitled to receive the following benefits under the terms of his agreement:

(a) an annual contribution of £70,000, paid either to a pension plan or to Mr. Descheemaeker directly (as he so directs);

(b) eligibility for performance-related discretionary cash bonuses (up to 100% of salary), subject to the achievement of financial and other performance targets as we may decide;

(c) an award of 2,000,000 ordinary shares in the Company, 50% of which will vest on the Company exceeding an agreed EBITDA target and 50% of which will vest subject to the Company’s shares achieving a specified target price. Both tranches of shares are also subject to further vesting conditions relating to Mr. Descheemaeker’s tenure as Chief Executive Officer; and

(d) an annual car allowance of £14,400, death in service benefit (three times salary), permanent health insurance (£500,000) and family medical insurance.

We have the right to place Mr. Descheemaeker on paid leave for up to six months of his 12 month notice period. Mr. Descheemaeker is subject to confidentiality provisions and to non-competition and non-solicitation restrictive covenants for a period of between six and 12 months after the termination of his employment, subject to an off-set for paid leave.

Nomad Foods 2015 Long Term Incentive Plan (“LTIP”)

Eligibility

The LTIP is discretionary and will enable the Compensation Committee to make grants (“Awards”) to any director or employee of the Company, although the current intention of the Committee is that Awards be granted only to directors and senior management.

Awards

Under the LTIP, the Committee or Board may grant Awards in the form of rights over ordinary shares. Where an Award vests, the participant will receive ordinary shares free and clear of any restrictions, other than those imposed by applicable securities laws.

57

Performance conditions

The vesting of Awards will be subject to conditions determined by the Committee. The current policy of the Committee is for vesting to be both time-based and related to the financial performance of the Company. Generally, the vesting period (i.e. the period over which performance is to be measured) will be between three and five years, and the ordinary shares subject to the Award will vest subject to the participant remaining an employee of the Company at the vesting date and any performance targets relating to the Award having been fulfilled.

Permitted dilution

No Award may be granted on any date if, as a result, the total number of ordinary shares issued or remaining issuable pursuant to Awards or options granted in the previous ten years under the LTIP or any other employees’ share plan operated by the Company would exceed 10% of the issued ordinary share capital of the Company on that date.

Awards may at the discretion of the Committee be satisfied out of new issue shares, treasury shares or shares provided out of an employee trust. Ordinary shares issued will rank pari passu with ordinary shares in issue at that time, save in relation to rights arising by reference to a record date before the date of issue. Participants will not be entitled to votes or dividends on the ordinary shares subject to Awards until such Awards vest.

Early vesting

Unless otherwise determined by the Committee, if a participant ceases to be employed by the Company due to death, disability, or otherwise as a good leaver, as determined by the Committee Awards will vest to the extent performance targets (adapted, if necessary, at the discretion of the Committee, to take into account the shortened vesting period) have been achieved and subject to the Committee’s discretion to waive the performance targets in whole or in part. If a participant ceases employment for any other reason their Award(s) will lapse to the extent unvested at the date of cessation.

Change of Control

Unless otherwise determined by the Committee, in the event of a Change of Control or winding up of the Company (including by reason of an offer or scheme of arrangement), Awards will vest in accordance with the performance targets applied up the date of the Change of Control, subject to the Committee’s discretion to waive such targets in whole or in part.

Variation in share capital

The Committee may make such adjustments to Awards as it considers appropriate to preserve their value in the event of any variation in the ordinary share capital of the Company or to take account of any demerger or special dividend paid (or similar event which materially affects the market price of ordinary shares).

Amendments

The Committee may amend the LTIP as it considers appropriate, subject to the written consent of participants to changes to their disadvantage to existing Awards. Shareholder approval is required to increase the permitted dilution limits.

General

Benefits under the LTIP will not be pensionable. Awards are not transferable except to the participant’s personal representatives on death.

Director Compensation

In 2017, each of our non-executive directors (other than Messrs. Gottesman and Franklin) received, and are entitled to receive in 2018 $50,000 per year together with an annual restricted stock grant issued under the LTIP equal to $100,000 of ordinary shares valued at the date of issue, which vest on the earlier of the date of the following year’s annual meeting of shareholders or 13 months from the issuance date. For those Directors who are members of board committees, each member is entitled to receive an additional $2,000 per year. The chairman of the Audit Committee, currently, is entitled to receive $10,000 per year and the chairmen of the Compensation and Nominating and

58

Corporate Governance Committees, currently and respectively, are entitled to receive $7,500 per year. Messrs. Gottesman and Franklin will not receive a fee in relation to their services as Directors.

Director fees are payable quarterly in arrears. In addition, all of the Directors are entitled to be reimbursed by us for travel, hotel and other expenses incurred by them in the course of their directors’ duties.

C.    Board Practices

Board Composition and Election of Directors

Our board of directors currently consists of eleven members. Our Memorandum and Articles of Association provides that our board of directors must be composed of at least one director. The number of directors is determined from time to time by resolution of our board of directors. Messrs. Gottesman and Franklin serve as Co-Chairmen of our board of directors. The Co-Chairmen have primary responsibility for providing leadership and guidance to our board and for managing the affairs of our board. Lord Myners is our lead independent director.

Pursuant to our Memorandum and Articles of Association, our directors are appointed at the annual meeting of shareholders for a one year term, with each director serving until the annual meeting of shareholders following their election. In addition, for so long as an initial holder of Founder Preferred Shares holds 20% or more of the Founder Preferred Shares in issue, such holder is entitled to nominate, and the directors are required to appoint, a person as director. For additional information regarding our board of directors, see Item 6A: Directors, Senior Management and Employees—Executive Officers and Directors.

Our non-executive directors do not have service contracts with us or any of our subsidiaries providing for benefits upon termination of employment.

Committees of the Board of Directors

Our board of directors has three standing committees: an Audit Committee, a Compensation Committee and a Nominating and Corporate Governance Committee.

Audit Committee

Our Audit Committee consists of three directors: Messrs. Lillie and White and Ashken, and Mr. Lillie serves as its chairman. Our Audit Committee is responsible for, among other things, assisting the board of directors in its oversight of the integrity of our financial statements, of our compliance with legal and regulatory requirements, and of the independence, qualifications and performance of our independent auditors. In addition, it focuses on compliance with accounting policies and ensuring that an effective system of internal and external audit and financial controls is maintained, and oversees our policies and procedures with respect to risk assessment and risk management. Our Audit Committee will meet at least quarterly with management and the independent auditors and report on such meetings to the board of directors. The responsibilities of our Audit Committee as set forth in its charter include oversight of the following: external audit, financial reporting, public disclosure, internal controls, risk management and compliance and whistleblowing.

Compensation Committee

Our Compensation Committee consists of three directors: Messrs. Isaacs, Ashken, and Ms. Parry, and Mr. Isaacs serves as its chairman. Our Compensation Committee is responsible for determining the compensation of our executive officers. The responsibilities of our Compensation Committee as set forth in its charter include the following: assisting the board in evaluating potential candidates for executive positions, determining the compensation of our chief executive officer, making recommendations to the board with respect to the compensation of other executive officers, reviewing our incentive compensation and other equity-based plans, and reviewing, on a periodic basis, director compensation.

Nominating and Corporate Governance Committee

Our Nominating and Corporate Governance Committee (the “N&CG Committee”) consists of three directors: Ms. Parry and Mr. Elsarky, and Lord Myners, and Lord Myners serves as its chairman.

59

Our N&CG Committee is responsible for considering and making recommendations to the board of directors in respect of appointments to the board. The responsibility of our N&CG Committee as set forth in its Charter include the following: recommending directors to the board to serve as members of each committee, developing and recommending a set of corporate governance principles applicable to our company and overseeing board evaluations. It is also responsible for regularly reviewing the structure, size and composition of the board and making recommendations to the board with regard to any changes it deems necessary.

D. Employees

As of December 31, 2017, we had approximately 3,875 employees, with such workers being supplemented with temporary staff during peak periods. Approximately 67% of our employees work in our manufacturing operations, with the remaining employees involved in sales, marketing, finance, administration, procurement, logistics, product development, IT and other areas. As of December 31, 2017, we had approximately 801 employees in the United Kingdom, approximately 1,267 employees in Germany, approximately 335 employees in France, approximately 451 employees in Italy and approximately 536 employees in Sweden/Norway. Following are the number of employees by region for the last three years:

Region	2017	2016	2015
United Kingdom	801	809	876
Germany	1,267	1,208	1,258
Italy	451	454	476
Sweden/Norway	536	932	987
France	335	338	371
Other	485	425	427
Total	3,875	4,166	4,395

A substantial number of our employees are members of trade unions in the United Kingdom, Germany or Italy. In total, approximately 50% of our employees are members of a trade union. Our plants are all governed by collective agreements with the respective unions. Our relationships with the trade unions are currently stable.

E. Share Ownership

The following table sets forth, as of March 20, 2018, certain information regarding the beneficial ownership of our ordinary shares by:

• each of our current directors;

• each of our named executive officers officers for the fiscal year ended December 31, 2017; and

• all of our current directors and current executive officers as a group.

Percentages are based on the 173,968,388 ordinary shares that were issued and outstanding on March 13, 2018.

60

Director and Executive Officers:	Number		Percentage
Martin E. Franklin	7,162,966	(1)	4.1
Noam Gottesman	10,044,153	(2)	5.8
Ian G.H. Ashken	708,197	(3)	*
Jason Ashton	18,862	(4)	*
Stéfan Descheemaeker	2,380,953	(5)	1.4
Mohamed Elsarky	—	(6)	-
Tania Howarth	11,235		*
Jeremy Isaacs	11,136	(7)	*
Paul Kenyon	10,688	(8)	*
James E. Lillie	708,302	(9)	*
Lord Myners of Truro CBE	83,164	(10)	*
Victoria Parry	6,444	(11)	*
Simon White	26,666	(12)	*
Directors and Executive Officers as a Group (12 persons)	21,172,766		12.2

* Represents beneficial ownership of less than one percent of ordinary shares outstanding.

(1) Consists of (i) 4,089,428 ordinary shares held indirectly through the Martin E. Franklin Revocable Trust, (ii) 750,000 Founder Preferred Shares held indirectly through Mariposa Acquisition II, LLC (which are convertible at any time at the option of the holder into ordinary shares on a one-for-one basis) and (iii) 2,323,538 ordinary shares held indirectly through RSMA, LLC. Mr. Franklin holds sole voting and investment power over such shares. Mr. Franklin may be deemed to beneficially own 69% of Mariposa Acquisition II, representing 517,500 Founder Preferred Shares. Mr. Franklin disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.

(2) Includes (i) 9,294,153 ordinary shares of which 7,413,200 are held by TOMS Acquisition I LLC and 1,880,953 are held by TOMS Capital Investments LLC and (ii) 750,000 Founder Preferred Shares which are convertible at any time at the option of the holder into ordinary shares on a one-for-one basis and all of which are held by TOMS Acquisition I LLC. Mr. Gottesman is the managing member and majority owner of TOMS Acquisition I LLC and TOMS Capital Investments LLC and may be considered to have beneficial ownership of TOMS Acquisition I LLC’s and TOMS Capital Investments LLC’s interests in the Company. Mr. Gottesman owns or controls, directly or indirectly, 76% of TOMS Acquisition I LLC and 100% of TOMS Capital Investments LLC. Mr. Gottesman disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.

(3) Includes 697,061 ordinary shares held by Tasburgh, LLC, of which Mr. Ashken is the Manager and has a controlling interest and excludes an indirect pecuniary interest in 56,250 Founder Preferred Shares (which are convertible at any time at the option of the holder into ordinary shares on a one-for-one basis) held by Mariposa Acquisition II, LLC. Also excludes 6,954 ordinary shares issuable under currently outstanding equity awards issued under the LTIP, all of which will vest on the earlier of (i) the date of the Company’s annual meeting of shareholders in 2018 or (ii) July 19, 2018.

(4) Includes 18,750 ordinary shares issuable under currently outstanding equity awards issued under the LTIP which will vest no earlier than January 1, 2018 subject to the Company's shares achieving a specified target price. Excludes 56,250 ordinary shares issuable under currently outstanding equity awards issued under the LTIP, 37,500 of which will vest on the Company exceeding an agreed EBITDA target and 18,750 of which will vest subject to the Company’s shares achieving a specified target price, such vesting to take place no earlier than January 1, 2020.

(5) Represents an indirect interest held by Olidipoli Sprl, a company owned by Mr. Descheemaeker. Excludes 2,000,000 ordinary shares issuable under currently outstanding equity awards issued under the LTIP, 50% of which will vest on the Company exceeding an agreed EBITDA target and 50% of which will vest subject to the Company’s shares achieving a specified target price, in each case, subject to further vesting conditions relating to Mr. Descheemaeker’s tenure as Chief Executive Officer.

(6) Excludes 5,754 ordinary shares issuable under currently outstanding equity awards issued under the LTIP, all of which will vest on the earlier of (i) the date of the Company's annual meeting of shareholders in 2018 or (ii) July 19, 2018.

61

(7) Excludes 6,954 ordinary shares issuable under currently outstanding equity awards issued under the LTIP, all of which will vest on the earlier of (i) the date of the Company’s annual meeting of shareholders in 2018 or (ii) July 19, 2018.

(8) Excludes 6,020 ordinary shares issuable under currently outstanding equity awards issued under the LTIP, all of which will vest on the earlier of (i) the date of the Company's annual meeting of shareholders in 2018 or (ii) July 19, 2018.

(9) Includes 697,061 ordinary shares held by Powder Horn Hill Partners II, LLC, of which Mr. Lillie is the Managing Member, and excludes an indirect pecuniary interest in 56,250 Founder Preferred Shares (which are convertible at any time at the option of the holder into ordinary shares on a one-for-one basis) held by Mariposa Acquisition II, LLC. Also excludes 6,954 ordinary shares issuable under currently outstanding equity awards issued under the LTIP, all of which will vest on the earlier of (i) the date of the Company’s annual meeting of shareholders in 2018 or (ii) July 19, 2018.

(10) Includes 50,000 ordinary shares issuable pursuant to a five-year option that expires on June 2, 2020 at a purchase price of $11.50 per share. Excludes 6,954 ordinary shares issuable under currently outstanding equity awards issued under the LTIP, all of which will vest on the earlier of (i) the date of the Company’s annual meeting of shareholders in 2018 or (ii) July 19, 2018.

(11) Excludes 6,954 ordinary shares issuable under currently outstanding equity awards issued under the LTIP, all of which will vest on the earlier of (i) the date of the Company’s annual meeting of shareholders in 2018 or (ii) July 19, 2018.

(12) Excludes 6,954 ordinary shares issuable under currently outstanding equity awards issued under the LTIP, all of which will vest on the earlier of (i) the date of the Company's annual meeting of shareholders in 2018 or (ii) July 19, 2018.

Item 7. Major Shareholders and Related Party Transactions

A.    Major Shareholders

The following table sets forth certain information regarding the beneficial ownership of our ordinary shares by each person known by us to be a beneficial owner of more than 5% of the ordinary shares. Currently we only have one class of listed shares issued and outstanding, that being ordinary shares, which have no par value. All of our ordinary shares have the same voting rights. Percentages are based on the 173,968,388 ordinary shares that were issued and outstanding on March 13, 2018.

	Ordinary Shares Beneficially Owned
Name of Beneficial Owner:	Number		Percentage
5% Shareholders:
Boston Partners One Beacon Street, 30th Floor    Boston, MA 02108	13,583,042	(1)	7.8
T. Rowe Price Associates Inc. 100 East Pratt Street Baltimore, MD 21202	10,174,660	(2)	5.8
TOMS Acquisition I, LLC    450 W. 14th Street, 13th Floor    New York, NY 10014	10,044,153	(3)	5.8
Elliott Associates, L.P.    40 West 57th Street, 30th Floor    New York, NY 10019	9,438,601	(4)	5.4

(1) Based on a Schedule 13G filed by Boston Partners on February 13, 2018.

(2) Based on a Schedule 13G/A filed by T. Rowe Price Associates Inc. on February 14, 2018.

(3) Based on a Schedule 13D filed by TOMS Acquisition I LLC, Noam Gottesman and TOMS Capital Investments LLC on January 12, 2018.

(4) Based on a Schedule 13G filed by Elliott Associates L.P., Elliott International, L.P. and Elliott International Capital Advisors Inc., as a group, on September 18, 2017.

In addition, on September 12, 2017, Pershing Square Capital Management L.P., which as of March 28, 2017, beneficially owned 18.3% of our ordinary shares, filed a Schedule 13G/A to report that it no longer beneficially owned any of our ordinary shares (as a result of the transactions described under “Operating and Financial Review and Prospects -

62

Financings and Acquisitions”). On July 18, 2017, Birds Eye Iglo Limited Partnership Inc., which as of March 28, 2017, beneficially owned 7.6% of our ordinary shares, filed a Schedule 13G/A to report that it no longer beneficially owned any of our ordinary shares (as a result of the transaction described under “Operating and Financial Review and Prospects - Financings and Acquisitions”). On February 9, 2018, Third Point LLC, which as of March 28, 2017, beneficially owned 5.8% of our ordinary shares, filed a Schedule 13G/A to report that it no longer beneficially owned any of our ordinary shares. On February 14, 2018, Corvex Management, LP filed a Schedule 13G/A to report that its percentage ownership in our ordinary shares decreased from 9.6%, as of March 31, 2017, to 4.9%. On January 10, 2017, Wellington Management Group LLP, which, as of March 31, 2016, beneficially owned 13.9% of our ordinary shares, and as of September 12, 2016, beneficially owned 8.2% of our ordinary shares, filed a Schedule 13G/A to report that it no longer beneficially owned any of our ordinary shares. On February 7, 2017, T. Rowe Price Associates Inc. filed a Schedule 13G to report that it beneficially owned 5.7% of our ordinary shares. Except for the foregoing, no major shareholder has disclosed a significant change in its percentage ownership of our ordinary shares during the three years ended December 31, 2017.

B.    Related Party Transactions

For a description of our related party transactions, see Note 37, Related Parties, to our audited consolidated financial statements which appear elsewhere in this annual report.

Related Party Transactions Procedures

The Audit Committee Charter provides that the Audit Committee shall review all related party transactions, as defined under Item 404 of Regulation S-K under the Securities Act of 1933, as amended. Following such review, the Audit Committee determines whether such transaction should be approved based on the terms of the transaction, the business purpose for the transaction and whether the transaction is in the best interest of the Company and its shareholders.

No member of the Audit Committee shall participate in any review, consideration or approval of any related party transaction with respect to which such member or any of his or her immediate family members is the related party.

Item 8. Financial Information

A. Consolidated Statements and Other Financial Information

Financial Statements

Please see Item 18 below.

Legal Proceedings

We are not currently subject to any legal proceedings, nor to the best of our knowledge, is any proceeding threatened, the results of which would have a material impact on our properties, results of operation, or financial condition. Tax audits are taking place in a number of countries. Whenever there is a difference in view between local tax authorities and the Company, to the extent deemed necessary, provisions are made for exposures for which it will be probable that they will lead to additional tax liabilities. To the best of our knowledge, none of our officers or directors is involved in any legal proceedings in which we are an adverse party.

Dividend Policy

We have not declared or paid any dividends on our ordinary shares since our inception on April 1, 2014, and have no current plans to pay dividends on our ordinary shares. The declaration and payment of future dividends to holders of our ordinary shares will be at the discretion of our board of directors and will depend upon many factors, including our financial condition, earnings, legal requirements, restrictions in our debt agreements and other factors deemed relevant by our board of directors. In addition, as a holding company, our ability to pay dividends depends on our receipt of cash dividends from our operating subsidiaries, which may further restrict our ability to pay dividends as a result of the laws of their respective jurisdictions of organization, agreements of our subsidiaries or covenants under future indebtedness that we or they may incur. See Item 3D: Key Information—Risk Factors—Risks Related to our Ordinary Shares—Dividend payments on our ordinary shares are not expected, and for a discussion of taxation of any dividends, see Item 10E: Additional Information—Taxation.

The Founder Preferred Shares are entitled to receive an annual stock dividend based on the market price of our ordinary shares if such market price exceeds certain trading price minimums and to participate in any

63

dividends on the ordinary shares. On December 29, 2017, we approved a 2017 Founder Preferred Share Dividend in an aggregate of 8,705,890 ordinary shares. The dividend price used to calculate the 2017 Founder Preferred Shares Annual Dividend Amount was $16.6516 (calculated based upon the volume weighted average price for the last ten trading days of 2017) and the Ordinary Shares were issued on January 2, 2018. For the year ended December 31, 2016, no Founder Preferred Shares Annual Dividend Amount was payable pursuant to the terms of the Founder Preferred Shares. On January 12, 2016, we had approved the 2015 Founder Preferred Share Dividend in an aggregate of 3,620,510 ordinary shares. The dividend price used to calculate the 2015 Founder Preferred Shares Annual Dividend Amount was $11.4824 (calculated based upon the volume weighted average price for the last ten trading days of 2015) and the Ordinary Shares were issued on January 12, 2016.  In subsequent years, the Founder Preferred Shares Annual Dividend Amount will be calculated based upon the volume weighted average price for the last ten trading days of the year and the appreciated average share price compared to the highest price previously used in calculating the Founder Preferred Shares Annual Dividend Amount. We currently expect to retain all our future earnings for use in the operation and expansion of our business and do not anticipate paying any cash dividends for the foreseeable future. The declaration and payment of future dividends to holders of our ordinary shares will be at the discretion of our board of directors and will depend upon many factors, including our financial condition, earnings, legal requirements, and restrictions in our debt agreements, including the Revolving Credit Facility, and other factors deemed relevant by our board of directors. As a holding company, our ability to pay dividends depends on our receipt of cash dividends from our operating subsidiaries, which may further restrict our ability to pay dividends as a result of the laws of their respective jurisdictions of organization, agreements of our subsidiaries or covenants under future indebtedness that we or they may incur. Furthermore, under British Virgin Islands law, we may pay dividends to our shareholders only if, immediately after the dividend, the value of our assets would exceed our liabilities and we would be able to pay our debts as they fall due.

B.    Significant Changes

No significant change has occurred since the date of the annual financial statements included in this annual report.

Item 9. The Offer and Listing

A. Offer and Listing Details

Our ordinary shares are currently listed for trading on the NYSE under the symbol “NOMD”. Our ordinary shares began trading on the London Stock Exchange (the “LSE”) on April 15, 2014 and were traded on the LSE until April 20, 2015 when trading was halted through June 22, 2015 due to the announcement of the then-pending Iglo Acquisition. On January 12, 2016, the Company transferred its listing from the LSE to the NYSE. The following table sets forth the high and low reported sale prices of our ordinary shares as reported on the LSE and NYSE for the periods indicated:

64

	High		Low
Annual
2017 (January 1, 2017 – December 31, 2017)	$	17.02	$	9.61
2016 (January 5, 2016 – December 31, 2016)	$	13.40	$	6.40
2015 (April 1, 2015 – December 31, 2015) (2)	$	23.11	$	10.28
2014 (April 15, 2014 – December 31, 2015)	$	11.75	$	9.75
Quarterly
2017
Fourth Quarter (October 1, 2017 – December 31, 2017)	$	17.02	$	14.32
Third Quarter (July 1, 2017 – September 30, 2017)	$	15.49	$	13.54
Second Quarter (April 1, 2017 – June 30, 2017)	$	14.72	$	10.77
First Quarter (January 1, 2017 – March 31, 2017)	$	12.00	$	9.61
2016
Fourth Quarter (October 1, 2016 – December 31, 2016)	$	12.97	$	9.00
Third Quarter (July 1, 2016 – September 30, 2016)	$	12.39	$	7.95
Second Quarter (April 1, 2016 – June 30, 2016)	$	10.43	$	7.85
First Quarter (January 5, 2016 – March 31, 2016) (1)	$	13.40	$	6.40
2015
Third Quarter (October 1, 2015 – December 31, 2015)	$	17.40	$	11.00
Second Quarter (July 1, 2015 – September 30, 2015)	$	23.11	$	15.50
First Quarter (April 1, 2015 – June 30, 2015) (2)	$	22.10	$	10.28
Most Recent Six Months
2018
March (through March 20, 2018)	$	16.93	$	15.96
February	$	17.20	$	15.27
January	$	17.32	$	16.00
2017
December	$	17.02	$	16.18
November	$	16.90	$	14.33
October	$	15.32	$	14.49
September	$	15.49	$	14.00

(1) Issued trading on our ordinary shares began on the NYSE on January 5, 2016.

(2) Trading in our ordinary shares was suspended on the LSE from April 20, 2015 through June 22, 2015 due to the announcement of the then-pending Iglo Acquisition.

As of March 13, 2018, approximately 146,811,989 ordinary shares, representing approximately 84.4% of our outstanding ordinary shares, were held by approximately 10,035 United States record holders and all of our preferred shares were held by 2 United States record holders.

There is no public market for our preferred shares and the preferred shares will not be listed for trading on any exchange.

Item 10. Additional Information

A. Share Capital

Not applicable.

65

B. Memorandum and Articles of Association

A copy of our Memorandum and Articles of Association have been previously filed as Exhibit 99.1 to our Report of Foreign Private Issuer on Form 6-K (File No. 001-37669), filed with the SEC on January 14, 2016, and is incorporated by reference into this annual report. The information called for by this Item 10B: Additional Information—Memorandum and Articles of Association has been reported previously in our Registration Statement on Form F-1 (File No. 333-209572), filed with the SEC on February 17, 2016 (the “Registration Statement”), under the heading “Description of Share Capital,” and is incorporated by reference into this annual report. There are no limitations on the rights to own securities, including the rights of non-resident or foreign shareholders to hold or exercise voting rights on the securities imposed by the laws of the British Virgin Islands or by our Memorandum.

C. Material Contracts

Each material contract to which the Company has been a party for the preceding two years, other than those entered into in the ordinary course of business, is listed as an exhibit to the Registration Statement and is summarized elsewhere herein.

D. Exchange Controls

We are not aware of any governmental laws, decrees, regulations or other legislation in the British Virgin Islands that restrict the export or import of capital, including the availability of cash and cash equivalents for use by our affiliated companies, or that affect the remittance of dividends, interest or other payments to non-resident holders of our securities.

E. Taxation

U.S. Federal Income Taxation

General

The following discussion is a summary of certain U.S. federal income tax issues relevant to the acquisition, holding and disposition of the ordinary shares. Additional tax issues may exist that are not addressed in this discussion and that could affect the U.S. federal income tax treatment of the acquisition, holding and disposition of the ordinary shares.

This discussion does not address U.S. state, local or non-U.S. income tax consequences. The discussion applies, unless indicated otherwise, only to holders of ordinary shares who acquire the ordinary shares as capital assets. It does not address special classes of holders that may be subject to different treatment under the Internal Revenue Code of 1986, as amended (the “Code”), such as:

• certain financial institutions;

• insurance companies;

• dealers and traders in securities;

• persons holding ordinary shares as part of a hedge, straddle, conversion or other integrated transaction;

• partnerships or other entities classified as partnerships for U.S. federal income tax purposes;

• persons liable for the alternative minimum tax;

• tax-exempt organizations;

• certain U.S. expatriates;

• persons holding ordinary shares that own or are deemed to own 10 percent or more (by vote or value) of the Company’s voting stock; or

• non-U.S. Holders that do not use the U.S. Dollar as their functional currency.

This section is based on the Code, its legislative history, existing and proposed regulations, published rulings by the Internal Revenue Service (“IRS”) and court decisions, all as currently in effect. These laws are subject to change, possibly on a retroactive basis. Holders of ordinary shares should consult their own tax advisers concerning the U.S. federal, state, local and non-U.S. tax consequences of acquiring, holding and disposing of ordinary shares in their particular circumstances.

66

As used herein, a “U.S. Holder” is a beneficial owner of ordinary shares that is, for U.S. federal income tax purposes: (i) an individual who is a citizen or resident of the United States; (ii) a corporation or other entity taxable as a corporation, created or organized in or under the laws of the United States or any political subdivision thereof; (iii) an estate the income of which is subject to U.S. federal income taxation regardless of its source; or (iv) a trust if (1) a court within the United States is able to exercise primary supervision over the administration of the trust and one or more “United States persons” (within the meaning of the Code) have the authority to control all substantial decisions of the trust, or (2) it has a valid election in effect under applicable Treasury regulations to be treated as a “United States person”.

This discussion is based upon certain understandings and assumptions with respect to the business, assets and shareholders, including that the Company is not, does not expect to become, nor at any time has been, a controlled foreign corporation as defined in Section 957 of the Code (a “CFC”). The Company believes that it is not and has never been a CFC, and does not expect to become a CFC. In the event that one or more of such understandings and assumptions proves to be inaccurate, the following discussion may not apply and material adverse U.S. federal income tax consequences may result to U.S. Holders.

Passive Foreign Investment Company (“PFIC”) Considerations

The U.S. federal income tax treatment of U.S. Holders will differ depending on whether or not the Company is considered a passive foreign investment company (“PFIC”) for U.S. federal income tax purposes.

In general, the Company will be considered a PFIC for any taxable year in which: (i) 75 percent or more of its gross income consists of passive income; or (ii) 50 percent or more of the average quarterly market value of its assets in that year are assets (including cash) that produce, or are held for the production of, passive income. For purposes of the above calculations, if the Company, directly or indirectly, owns at least 25 percent by value of the stock of another corporation, then the Company generally would be treated as if it held its proportionate share of the assets of such other corporation and received directly its proportionate share of the income of such other corporation. Passive income generally includes, among other things, dividends, interest, rents, royalties, certain gains from the sale of stock and securities, and certain other investment income.

The Company believes that it is not a PFIC in the current year and is not likely to be a PFIC in future years. However, there is no assurance that the Company will not be a PFIC in future years. If the Company is a PFIC for any taxable year during which a U.S. Holder holds (or, in the case of a lower-tier PFIC, is deemed to hold) its ordinary shares, such U.S. Holder will be subject to significant adverse U.S. federal income tax rules. U.S. Holders should consult their tax advisors on the federal income tax consequences of the Company being treated as a PFIC.

Tax Consequences for U.S. Holders if the Company is not a PFIC

Dividends

In general, subject to the PFIC rules discussed above, a distribution on an ordinary share will constitute a dividend for U.S. federal income tax purposes to the extent that it is made from the Company’s current or accumulated earnings and profits as determined under U.S. federal income tax principles. If a distribution exceeds the Company’s current and accumulated earnings and profits, it will be treated as a non-taxable reduction of basis to the extent of the U.S. Holder’s tax basis in the ordinary share on which it is paid, and to the extent it exceeds that basis it will be treated as capital gain. For purposes of this discussion, the term “dividend” means a distribution that constitutes a dividend for U.S. federal income tax purposes.

The gross amount of any dividend on an ordinary share (which will include the amount of any foreign taxes withheld) generally will be subject to U.S. federal income tax as foreign source dividend income, and will not be eligible for the corporate dividends received deduction. The amount of a dividend paid in foreign currency will be its value in U.S. Dollars based on the prevailing spot market exchange rate in effect on the day the U.S. Holder receives the dividend. A U.S. Holder will have a tax basis in any distributed foreign currency equal to its U.S. Dollar amount on the date of receipt, and any gain or loss realized on a subsequent conversion or other disposition of foreign currency generally will be treated as U.S. source ordinary income or loss. If dividends paid in foreign currency are converted into U.S. Dollars on the date they are received by a U.S. Holder, the U.S. Holder generally should not be required to recognize foreign currency gain or loss in respect of the dividend income.

Subject to certain exceptions for short-term and hedged positions, a dividend that a non-corporate holder receives on an ordinary share will be subject to a maximum federal income tax rate of 20 percent if the dividend is a “qualified dividend” not including the Net Investment Income Tax, described below. A dividend on an ordinary share will

67

be a qualified dividend if (i) either (a) the ordinary shares are readily tradable on an established market in the United States or (b) the Company is eligible for the benefits of a comprehensive income tax treaty with the United States that the Secretary of the Treasury determines is satisfactory for purposes of these rules and that includes an exchange of information program, and (ii) the Company was not, in the year prior to the year the dividend was paid, and is not, in the year the dividend is paid, a PFIC. Since the ordinary shares are listed on the New York Stock Exchange, the ordinary shares should be treated as readily tradable on an established securities market in the United States. Even if dividends on the ordinary shares would otherwise be eligible for qualified dividend treatment, in order to qualify for the reduced qualified dividend tax rates, a non-corporate holder must hold the ordinary share on which a dividend is paid for more than 60 days during the 120-day period beginning 60 days before the ex-dividend date, disregarding for this purpose any period during which the non-corporate holder has an option to sell, is under a contractual obligation to sell or has made (and not closed) a short sale of substantially identical stock or securities, is the grantor of an option to buy substantially identical stock or securities or, pursuant to Treasury regulations, has diminished its risk of loss by holding one or more other positions with respect to substantially similar or related property. In addition, to qualify for the reduced qualified dividend tax rates, the non-corporate holder must not be obligated to make related payments with respect to positions in substantially similar or related property. Payments in lieu of dividends from short sales or other similar transactions will not qualify for the reduced qualified dividend tax rates.

A non-corporate holder that receives an extraordinary dividend eligible for the reduced qualified dividend rates must treat any loss on the sale of the stock as a long-term capital loss to the extent of the dividend. For purposes of determining the amount of a non-corporate holder’s deductible investment interest expense, a dividend is treated as investment income only if the non-corporate holder elects to treat the dividend as not eligible for the reduced qualified dividend tax rates. Special limitations on foreign tax credits with respect to dividends subject to the reduced qualified dividend tax rates apply to reflect the reduced rates of tax.

The U.S. Treasury has announced its intention to promulgate rules pursuant to which non-corporate holders of stock of non-U.S. corporations, and intermediaries through whom the stock is held, will be permitted to rely on certifications from issuers to establish that dividends are treated as qualified dividends. Because those procedures have not yet been issued, it is not clear whether the Company will be able to comply with them.

Non-corporate holders of ordinary shares are urged to consult their own tax advisers regarding the availability of the reduced qualified dividend tax rates with respect to dividends received on the ordinary shares in light of their own particular circumstances.

Capital Gains

Subject to the PFIC rules discussed above, on a sale or other taxable disposition of an ordinary share, a U.S. Holder will recognize capital gain or loss in an amount equal to the difference between the U.S. Holder’s adjusted basis in the ordinary share and the amount realized on the sale or other disposition, each determined in U.S. Dollars. Such capital gain or loss will be long-term capital gain or loss if at the time of the sale or other taxable disposition the ordinary share has been held for more than one year. In general, any adjusted net capital gain of an individual is subject to a maximum federal income tax rate of 20 percent, plus the Medicare Contribution Tax of 3.8%, discussed below. Capital gains recognized by corporate U.S. holders generally are subject to U.S. federal income tax at the same rate as ordinary income. The deductibility of capital losses is subject to limitations.

Any gain a U.S. Holder recognizes generally will be U.S. source income for U.S. foreign tax credit purposes, and, subject to certain exceptions, any loss will generally be a U.S. source loss. If a non-U.S. income tax is paid on a sale or other disposition of an ordinary share, the amount realized will include the gross amount of the proceeds of that sale or disposition before deduction of the non-U.S. tax. The generally applicable limitations under U.S. federal income tax law on crediting foreign income taxes may preclude a U.S. Holder from obtaining a foreign tax credit for any non-U.S. tax paid on a sale or other disposition of an ordinary share. The rules relating to the determination of the foreign tax credit are complex, and U.S. holders are urged to consult with their own tax advisers regarding the application of such rules. Alternatively, any non-U.S. income tax paid on the sale or other disposition of an ordinary share may be taken as a deduction against taxable income, provided the U.S. Holder takes a deduction and not a credit for all foreign income taxes paid or accrued in the same taxable year.

Medicare Contribution Tax

Dividends received and capital gains from the sale or other taxable disposition of the ordinary shares recognized by certain non-corporate U.S. Holders with respect to ordinary shares will be includable in computing net investment income of such U.S. Holder for purposes of the 3.8 percent Medicare Contribution Tax.

68

Tax Consequences for Non-U.S. Holders of Ordinary Shares

Dividends

A non-U.S. Holder generally will not be subject to U.S. federal income tax or withholding on dividends received from the Company with respect to ordinary shares, other than in certain specific circumstances where such income is deemed effectively connected with the conduct by the non-U.S. Holder of a trade or business in the United States. If a non-U.S. Holder is entitled to the benefits of a U.S. income tax treaty with respect to those dividends, that income is generally subject to U.S. federal income tax only if it is attributable to a permanent establishment maintained by the non-U.S. Holder in the United States. A non-U.S. Holder that is subject to U.S. federal income tax on dividend income under the foregoing exception generally will be taxed with respect to such dividend income on a net basis in the same manner as a U.S. Holder unless otherwise provided in an applicable income tax treaty; a non-U.S. Holder that is a corporation for U.S. federal income tax purposes may also be subject to a branch profits tax with respect to such item at a rate of 30 percent (or at a reduced rate under an applicable income tax treaty).

Sale, Exchange or Other Taxable Disposition of Ordinary Shares

A non-U.S. Holder generally will not be subject to U.S. federal income tax or withholding with respect to any gain recognized on a sale, exchange or other taxable disposition of ordinary shares unless:

• Certain circumstances exist under which the gain is treated as effectively connected with the conduct by the non-U.S. Holder of a trade or business in the United States, and, if certain tax treaties apply, is attributable to a permanent establishment maintained by the non-U.S. Holder in the United States; or

• the non-U.S. Holder is an individual and is present in the United States for 183 or more days in the taxable year of the sale, exchange or other taxable disposition, and meets certain other requirements.

If the first exception applies, the non-U.S. Holder generally will be subject to U.S. federal income tax with respect to such item on a net basis in the same manner as a U.S. Holder unless otherwise provided in an applicable income tax treaty; a non-U.S. Holder that is a corporation for U.S. federal income tax purposes may also be subject to a branch profits tax with respect to such item at a rate of 30 percent (or at a reduced rate under an applicable income tax treaty). If the second exception applies, the non-U.S. Holder generally will be subject to U.S. federal income tax at a rate of 30 percent (or at a reduced rate under an applicable income tax treaty) on the amount by which such non-U.S. Holder’s capital gains allocable to U.S. sources exceed capital losses allocable to U.S. sources during the taxable year of disposition of the ordinary shares.

Tax Consequences for Holders of Preferred Shares

Generally, the U.S. federal income tax consequences of holding preferred shares is the same as the U.S. federal income tax consequences of holding ordinary shares, as discussed above. Holders of preferred shares may be eligible for a distribution of ordinary shares as a dividend with respect to the holding of preferred shares. The distribution of a stock dividend may under certain circumstances be received free of U.S. federal income taxes. In that case, the adjusted tax basis of the ordinary shares distributed will be determined based on an allocation of the basis of the preferred shares in accordance with the fair market value of the preferred shares and the ordinary shares distributed. Holders of preferred shares are urged to consult their own tax advisers about the U.S. federal, state and local Tax consequences of receiving a stock dividend.

Information Reporting and Backup Withholding

Under U.S. federal income tax laws, certain categories of U.S. Holders must file information returns with respect to their investment in, or involvement in, a foreign corporation (including IRS Forms 926). Persons who are required to file these information returns and fail to do so may be subject to substantial penalties. Pursuant to Section 1298(f) of the Code, for any year in which the Company is a PFIC, each U.S. Holder will be required to file an information statement, Form 8621, regarding such U.S. Holder’s ownership interest in the Company. U.S. Holders of ordinary shares should consult with their own tax advisers regarding the requirements of filing information returns.

Furthermore, certain U.S. Holders who are individuals and to the extent provided in future regulations, certain entities, will be required to report information with respect to such U.S. Holder’s investment in “foreign financial assets” on IRS Form 8938. An interest in the Company constitutes a foreign financial asset for these purposes. Persons who are required to report foreign financial assets and fail to do so may be subject to substantial penalties.

69

Potential shareholders are urged to consult with their own tax advisers regarding the foreign financial asset reporting obligations and their application to an investment in ordinary shares.

Payments of dividends and sales proceeds that are made within the United States or through certain U.S.-related financial intermediaries generally are subject to information reporting and to backup withholding unless the U.S. Holder is a corporation or other exempt recipient or, in the case of backup withholding, the U.S. Holder provides a correct taxpayer identification number and certifies that no loss of exemption from backup withholding has occurred. The amount of any backup withholding from a payment to a U.S. Holder will be allowed as a credit against the U.S. Holder’s U.S. federal income tax liability and may entitle such U.S. Holder to a refund, provided that the required information is furnished to the IRS.

The Foreign Account Tax Compliance Act (“FATCA”) imposes withholding at a 30 percent rate on payments of interest and dividends and gross proceeds from the disposition of any asset that produces interest or dividends, if such payment is sourced in the United States, to (i) a foreign financial institution unless such foreign financial institution agrees to verify, report and disclose its U.S. accountholders and meet certain other specified requirements or (ii) a non-financial foreign entity that is treated as the beneficial owner of the payment unless such entity certifies that an exception applies or that it does not have any substantial U.S. owners (generally owners of more than 10 percent of the interests in the entity) or provides the name, address and taxpayer identification number of each substantial U.S. owner and such entity meets certain other specified requirements. Under FATCA, beginning in 2019, a new U.S. federal income tax withholding regime applies to “pass-through payments” made to certain non-U.S. persons. Broadly, pass-through payments include two categories of payments; payments of U.S. source interest, dividends and other specified types of fixed or determinable annual or periodic gains and profits and payments by non-U.S. entities to the extent deemed attributable to U.S. assets. In addition, gross proceeds from the sale of property that can give rise to U.S. source interest and dividends are also subject to withholding as a pass-through payment. If the Company has income sourced in the United States, it will be required to comply with FATCA to avoid withholding taxes.

Non-U.S. Holders generally are not subject to information reporting or backup withholding with respect to dividends paid on ordinary shares, or the proceeds from the sale, exchange or other disposition of ordinary shares, provided that each such non-U.S. Holder certifies as to its foreign status on the applicable duly executed IRS Form W-8 or otherwise establishes an exemption.

This summary is for general information only and it is not intended to be, nor should it be construed to be, tax or legal advice to any prospective shareholder. Further, this summary is not intended to constitute a complete analysis of all U.S. federal income tax consequences relating to holders of their acquisition, ownership and disposition of the ordinary shares. Accordingly, prospective holders of ordinary shares should consult their own tax advisers about the U.S. federal, state, local and non-U.S. tax consequences of the acquisition, ownership and disposition of the ordinary shares.

British Virgin Islands Taxation

The Company

We are not subject to any income, withholding or capital gains taxes in the British Virgin Islands. No capital or stamp duties are levied in the British Virgin Islands on the issue, transfer or redemption of ordinary shares.

Shareholders

Shareholders who are not tax resident in the British Virgin Islands will not be subject to any income, withholding or capital gains taxes in the British Virgin Islands, with respect to the ordinary shares of the Company owned by them and dividends received on such ordinary shares, nor will they be subject to any estate or inheritance taxes in the British Virgin Islands.

70

United Kingdom Taxation

General

The following is a general summary of material UK tax considerations relating to the ownership and disposal of our ordinary shares. The comments set out below are based on current United Kingdom tax law as of the date of this summary, which is subject to change, possibly with retrospective effect. This summary does not constitute legal or tax advice and applies only to shareholders holding our ordinary shares as an investment and who are the beneficial owners thereof, whose ordinary shares are not held through an individual savings account or a self-invested personal pension and who have not acquired their or another person’s ordinary shares by reason of their or another person’s employment. These comments may not apply to certain classes of persons, including dealers in securities, insurance companies and collective investment schemes.

This summary is for general information only and is not intended to be, nor should it be considered to be, legal or tax advice to any particular investor. It does not address all of the tax considerations that may be relevant to specific investors in light of their particular circumstances or to investors subject to special treatment under UK tax law. Potential investors should consult their own tax advisers concerning the overall tax consequences of acquiring, holding and disposing of our ordinary shares in their particular circumstances.

The Company

As previously stated, on January 12, 2016, we became centrally managed and controlled in the United Kingdom and therefore became resident in the United Kingdom for UK taxation purposes.

Accordingly, since that date, we are subject to UK taxation on our income and gains, except where an exemption applies. Dividend income will generally be exempt from UK corporation tax on income if certain conditions are met.

We may be treated as a dual resident company for UK tax purposes. As a result, our right to claim certain reliefs from UK tax may be restricted, and changes in law or practice in the United Kingdom could result in the imposition of further restrictions on our right to claim UK tax reliefs.

Shareholders

Sale, Exchange or Other Taxable Disposition of Ordinary Shares

Subject to their individual circumstances, shareholders who are resident in the United Kingdom for UK taxation purposes will potentially be liable to UK taxation, as further explained below, on any gains which accrue to them on a sale or other disposition of their ordinary shares which constitutes a “disposal” for UK taxation purposes.

A shareholder who is not resident in the United Kingdom for UK tax purposes will not generally be subject to UK tax on chargeable gains on a disposal of ordinary shares unless such a shareholder carries on a trade, profession or vocation in the United Kingdom through a branch or agency or, in the case of a corporate shareholder, a permanent establishment. For shareholders in such circumstances, a gain on a disposal of our ordinary shares may be subject to UK taxation.

An individual shareholder who acquires ordinary shares while UK resident, who temporarily ceases to be UK resident or becomes resident in a territory outside the United Kingdom for the purposes of double taxation relief arrangements, and who disposes of our ordinary shares during that period of temporary non-UK residence, may on his or her return to the United Kingdom be liable to UK capital gains tax on any chargeable gain realized on that disposal.

For an individual shareholder within the charge to capital gains tax, a disposal of ordinary shares may give rise to a chargeable gain or allowable loss for the purposes of UK capital gains tax. The rate of capital gains tax is 18% for individuals who are subject to income tax at the basic rate and 28% to the extent that an individual shareholder’s chargeable gains, when aggregated with his or her income chargeable to income tax, exceeds the basic rate band for income tax purposes. However, an individual shareholder is entitled to realize £11,100 of gains (the annual exempt amount) in each tax year without being liable to tax.

71

For a shareholder within the charge to UK corporation tax, a disposal (or deemed disposal) of ordinary shares may give rise to a chargeable gain or allowable loss for the purposes of UK corporation tax. Corporation tax is charged on chargeable gains at the rate applicable to that company, subject to any available exemption or relief. Indexation allowance may reduce the amount of chargeable gain that is subject to corporation tax (but may not give rise to or increase an allowable loss).

Dividends on Ordinary Shares

No UK tax will be withheld or deducted at source from dividends paid by us on our ordinary shares.

Shareholders who are resident in the United Kingdom for tax purposes may, subject to their individual circumstances, be liable to UK income tax or, as the case may be, UK corporation tax on dividends paid to them by us.

An individual shareholder who is within the charge to UK income tax and who receives a cash dividend from us may be entitled to a tax credit equal to one-ninth of the amount of the cash dividend received, which tax credit will be equivalent to 10% of the aggregate of the dividend received and the tax credit (the gross dividend). Such an individual shareholder will be subject to income tax on the gross dividend.

An individual shareholder who is subject to UK income tax at a rate or rates not exceeding the basic rate will be liable to tax on the gross dividend at the rate of 10%, so that the tax credit will satisfy the income tax liability of such a shareholder in full. Where the tax credit exceeds the shareholder’s tax liability, the shareholder cannot claim repayment of the tax credit from H.M. Revenue and Customs.

An individual shareholder who is subject to UK income tax at the higher rate will be liable to income tax on the gross dividend at the rate of 32.5% to the extent that such sum, when treated as the top slice of that shareholder’s income, exceeds the threshold for higher rate income tax. After setting the 10% tax credit against part of the shareholder’s liability, a higher rate tax payer will therefore be liable to account for tax equal to 22.5% of the gross dividend (or 25% of the net cash dividend), to the extent that the gross dividend exceeds the threshold for the higher rate.

An individual shareholder who is subject to UK income tax at the additional rate will be liable to income tax on the gross dividend at the rate of 37.5% of the gross dividend, but will be able to set the UK tax credit off against part of this liability. The effect of this set-off of the UK tax credit is that such a shareholder will be liable to account for additional tax equal to 27.5% of the gross dividend (or approximately 30.6% of the net cash dividend) to the extent that the gross dividend exceeds the threshold for the additional rate.

With effect from April 6, 2016, shareholders will no longer be entitled to the tax credit referred to above in respect of dividends paid on or after that date. Instead, the UK Government has introduced an annual dividend tax allowance of £5,000 per tax year. If and to the extent that an individual shareholder who is subject to UK income tax receives dividends in each tax year which, in aggregate, do not exceed that allowance, the individual will not be liable to UK income tax on those dividends. If and to the extent that an individual shareholder who is subject to UK income tax receives dividends in each tax year which, in aggregate, exceed that allowance, the individual will be subject to UK income tax on those dividends at the rate of 7.5% (in the case of basic rate taxpayers), 32.5% (in the case of higher rate taxpayers) and 38.1% (in the case of additional rate taxpayers), and the individual will not be entitled to any tax credit in respect of those dividends.

Shareholders who are within the charge to UK corporation tax are generally likely to be exempt from corporation tax on dividends they receive from us, provided the dividends fall within an exempt class and certain conditions are met.

Stamp duty/stamp duty reserve tax

(i) Issue of Ordinary Shares

No UK stamp duty or stamp duty reserve tax will be payable on the issue of ordinary shares, subject to the comments in (iii) below.

72

(ii) Transfers of Ordinary Shares

UK stamp duty will in principle be payable on any instrument of transfer of our ordinary shares that is executed in the United Kingdom or that relates to any property situated, or to any matter or thing done or to be done, in the United Kingdom. An exemption from stamp duty is available on an instrument transferring ordinary shares where the amount or value of the consideration is £1,000 or less and it is certified on the instrument that the transaction effected by the instrument does not form part of a larger transaction or series of transactions in respect of which the aggregate amount or value of the consideration exceeds £1,000. Shareholders should be aware that, even where an instrument of transfer is in principle subject to stamp duty, stamp duty is not required to be paid unless it is necessary to rely on the instrument for legal purposes, for example to register a change of ownership or in litigation in a UK court. An instrument of transfer need not be stamped in order for the British Virgin Islands register of ordinary shares to be updated, and the register is conclusive proof of legal ownership.

Provided that the ordinary shares are not registered in any register maintained in the United Kingdom by or on behalf of us and are not paired with any shares issued by a UK incorporated company, any agreement to transfer ordinary shares will not be subject to UK stamp duty reserve tax.

We currently do not intend that any register of our ordinary shares will be maintained in the United Kingdom.

(iii) Ordinary Shares held through clearance services or depositary receipt arrangements

Where ordinary shares are transferred or issued to, or to a nominee or agent for, a person whose business is or includes the provision of clearance services or issuing depositary receipts (but not including CREST), UK stamp duty or stamp duty reserve tax may be payable at a rate of 1.5% (rounded up if necessary, in the case of stamp duty, to the nearest multiple of £5) of the amount or value of the consideration payable for (or, in certain circumstances, the value of) the ordinary shares. This liability for stamp duty or stamp duty reserve tax will be payable by the clearance service or depositary receipt operator or its nominee, as the case may be, but in practice participants in the clearance service or depositary receipt scheme will generally be required to reimburse them for such cost.

Following litigation, H.M. Revenue and Customs has confirmed that it will no longer seek to apply the above 1.5% stamp duty or stamp duty reserve tax charge on the issue of shares into a clearance service or depositary receipt system established in a European Union Member State on the basis that the charge is not compatible with EU law. However, their view is that the 1.5% charge will still apply on the transfer of shares into such a clearance service or depositary receipts system where the transfer is not an integral part of the issue of share capital. This view is currently

being challenged in further litigation. Accordingly, shareholders should consult their own independent professional advisers before incurring or reimbursing the costs of such a 1.5% stamp duty or stamp duty reserve tax charge.

F. Dividends and Paying Agents

Not applicable.

G. Statements by Experts

Not applicable.

H. Documents on Display

Documents concerning us that are referred to herein may be inspected at our principal executive offices at: No. 1 New Square, Bedfont Lakes Business Park, Feltham, Middlesex, TW14 8HA. Those documents, which include our registration statements, periodic reports and other documents which were filed with the SEC, may be obtained electronically from the Investor section of our website at www.nomadfoods.com or from the SEC’s website at www.sec.gov or from the SEC public reference room at 100 F Street, N.E., Room 1580, Washington, D.C. 20549. Further information on the operation of the public reference rooms may be obtained by calling the SEC at 1-202-551-8909. Copies of documents can also be requested from the SEC public reference rooms for a copying fee at prescribed rates. We do not incorporate the information contained on, or accessible through, our website into this annual report, and you should not consider it a part of this annual report.

I. Subsidiary Information

Not applicable.

73

Item 11. Quantitative and Qualitative Disclosures About Market Risk

We are exposed to certain market risks during the normal course of our business, such as risk arising from fluctuations in foreign currency exchange rates, as well as fluctuations in interest rates. In attempts to manage these risks, we employ certain strategies to mitigate the effect of these fluctuations. For a detailed discussion of the these risks, see Note 33 “Financial risk management” to our audited consolidated financial statements which appear elsewhere in this annual report.

Item 12. Description of Securities Other than Equity Securities

Not applicable.

Item 13. Defaults, Dividend Arrearages and Delinquencies

None.

Item 14. Material Modifications to the Rights of Security Holders and Use of Proceeds

None.

Use of Proceeds

None.

Item 15. Controls and Procedures

Disclosure Controls and Procedures

We carried out an evaluation, under the supervision and with the participation of management, including our Chief Executive Officer and Interim Chief Financial Officer, our principal executive officer and principal financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as such term is defined in Rules l3a-15(e) and l5d—15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), as of the end of the period covered by this report. Based upon that evaluation, the Principal Executive Officer and Principal Financial Officer concluded that our disclosure controls and procedures were effective as of the end of the period covered by this annual report in providing a reasonable level of assurance that information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods in Securities and Exchange commission rules and forms, including providing a reasonable level of assurance that information required to be disclosed by us in such reports is accumulated and communicated to our management, including our Principal Executive Officer and our Principal Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

Changes in internal control over financial reporting

During the period covered by this report, there have been no changes to our internal controls over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Management’s annual report on internal control over financial reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rule 13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934, as amended. The Company’s internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. The Company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the Company’s assets, (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of consolidated financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the Company are being made only in accordance with authorizations of the Company’s management and directors, and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the Company’s assets that could have a material effect on the consolidated financial statements.

74

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Management has assessed the effectiveness of our internal control over financial reporting as of December 31, 2017 using criteria described in Internal Control-Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission.

Based on this assessment, management concluded that the internal control over financial reporting was effective as of December 31, 2017 based on the criteria established in this Internal Control-Integrated Framework (2013).

Attestation report of the registered public accounting firm

The independent registered public accounting firm that audited the Consolidated Financial Statements, PricewaterhouseCoopers LLP, has issued an attestation report on the effectiveness of the Company’s internal control over financial reporting as of December 31, 2017, appearing under Item 18, and such report is incorporated herein by reference.

Item 16A. Audit Committee Financial Expert

The board of directors has determined that Mr. Lillie qualifies as an audit committee financial expert as defined in Item 16A of Form 20-F, and that he is also “independent,” as defined in Rule 10A-3 under the Exchange Act and applicable NYSE standards. For more information about Mr. Lillie, see Item 6A: Directors, Senior Management and Employees—Directors and Senior Management.

Item 16B. Code of Ethics

We have adopted a Code of Ethics that applies to our Chief Executive Officer and all senior financial officers. We will provide to any person without charge, upon request, a copy of the Code of Ethics. You may obtain a copy of the Code of Ethics by sending a written request to No. 1 New Square, Bedfont Lakes Business Park, Feltham, Middlesex, TW14 8HA, Attention: Corporate Secretary.

Item 16C. Principal Accountant Fees and Services

PricewaterhouseCoopers LLP (“PwC”) acted as our independent auditor for the years ended December 31, 2017 and 2016. The table below sets out the total amount billed to us by PwC, for services performed in the years ended December 31, 2017 and 2016, and breaks down these amounts by category of service:

(€ in millions)	For the year ended December 31, 2017	For the year ended December 31, 2016
Audit fees	2.8	3.8
Audit-related fees	0.2	—
Tax fees	0.8	1.9
All other fees	—	—
Total	3.8	5.7

Audit Fees

Audit fees in the years ended December 31, 2017 and 2016 are related to the audit of our consolidated financial statements and other audit or interim review services provided in connection with statutory and regulatory filings or engagements.

75

Audit-Related Fees

Audit fees in the year ended December 31, 2017 are related to other assurance services on capital market transactions. There were no audit-related fees in the year ended December 31, 2016.

Tax Fees

Tax fees in the years ended December 31, 2017 and 2016 are related to tax compliance and other tax related services.

All Other Fees

There were no other fees in the years ended December 31, 2017 and 2016.

Pre-Approval Policies and Procedures

The advance approval of the Audit Committee or members thereof, to whom approval authority has been delegated, is required for all audit and non-audit services provided by our auditors.

All services provided by our auditors are approved in advance by either the Audit Committee or members thereof, to whom authority has been delegated, in accordance with the Audit Committee’s pre-approval policy. No such services were approved pursuant to the procedures described in Rule 2-01(c)(7)(i)(C) of Regulation S-X, which waives the general requirement for pre-approval in certain circumstances.

Item 16D. Exemptions from the Listing Standards for Audit Committees

None

Item 16E. Purchases of Equity Securities by the Issuer and Affiliated Purchasers

The following table presents information related to our repurchases of our ordinary shares during the year ended December 31,2017:

Period 2017	Total Number of Shares Purchased (1)	Average Price Paid Per Share	Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs	Maximum Number of Shares that May Yet Be Purchased Under the Plans or Programs
January 1-31	—	—	—	—
February 1-28	—	—	—	—
March 1-31	—	—	—	—
April 1-30	—	—	—	—
May 1-31	—	—	—	—
June 1-30 (1)	9,779,729	€9.60	—	—
July 1-31	—	—	—	—
August 1-31	—	—	—	—
September 1-30 (2)	7,063,643	€11.78	—	—
October 1-31	—	—	—	—
November 1-30	—	—	—	—
December 1-31	—	—	—	—

(1) On June 12, 2017, we repurchased 9,779,729 of our shares beneficially owned by Permira Funds at a purchase price of $10.75 (approximately €9.60) per share, which represents a 25% discount to the closing price of Nomad Foods ordinary shares on June 9, 2017, for an aggregate purchase price of $105.1 million (approximately €93.9 million). The transaction related to a final settlement of indemnity claims against an affiliate of Permira Funds, of legacy tax matters that predated the Iglo Acquisition.

76

(2) On September 11, 2017, in connection with the registered underwritten public offering of 33,333,334 of our ordinary shares by certain funds managed by Pershing Square Capital Management, L.P., we purchased 7,063,643 ordinary shares from the underwriters in the offering at a price of $14.157 (approximately €11.78), the price payable by the underwriters to the selling shareholders in the offering. We did not sell any ordinary shares in the offering and did not receive any of the proceeds from the offering. We used cash on hand to fund the repurchase of the ordinary shares.

Item 16F. Change in Registrants’ Certifying Accountant

Not applicable.

Item 16G. Corporate Governance

Comparison of Shareholder Rights

We were incorporated under, and are governed by, the laws of the British Virgin Islands. The following discussion summarizes material differences between the rights of holders of ordinary shares and the rights of shareholders of a typical corporation incorporated under the laws of the State of Delaware.

Director’s Fiduciary Duties

Under Delaware corporate law, a director of a Delaware corporation has a fiduciary duty to the corporation and its shareholders. This duty has two components: the duty of care and the duty of loyalty. The duty of care requires that a director act in good faith, with the care that an ordinarily prudent person would exercise under similar circumstances. Under this duty, a director must inform himself of, and disclose to shareholders, all material information reasonably available regarding a significant transaction. The duty of loyalty requires that a director act in a manner he reasonably believes to be in the best interests of the corporation. He must not use his corporate position for personal gain or advantage. This duty prohibits self-dealing by a director and mandates that the best interest of the corporation and its shareholders take precedence over any interest possessed by a director, officer or controlling shareholder and not shared by the shareholders generally. In general, actions of a director are presumed to have been made on an informed basis, in good faith and in the honest belief that the action taken was in the best interests of the corporation. However, this presumption may be rebutted by evidence of a breach of one of the fiduciary duties. Should such evidence be presented concerning a transaction by a director, a director must prove the procedural fairness of the transaction, and that the transaction was of fair value to the corporation.

British Virgin Islands law provides that every director of a British Virgin Islands company in exercising his powers or performing his duties, shall act honestly and in good faith and in what the director believes to be in the best interests of the company. Additionally, the director shall exercise the care, diligence, and skill that a reasonable director would exercise in the same circumstances taking into account the nature of the company, the nature of the decision and the position of the director and his responsibilities. In addition, British Virgin Islands law provides that a director shall exercise his powers as a director for a proper purpose and shall not act, or agree to the company acting, in a manner that contravenes British Virgin Islands law or the memorandum and articles of association of the company.

Amendment of Governing Documents

Under Delaware corporate law, with very limited exceptions, a vote of the shareholders of a corporation is required to amend the certificate of incorporation. In addition, Delaware corporate law provides that shareholders have the right to amend the corporation’s bylaws, but the certificate of incorporation may confer such right on the directors of the corporation.

Our directors may, at any time (including after the Acquisition), without shareholder consent, amend our Memorandum and Articles where the directors determine, in their absolute discretion (acting in good faith), by a resolution of directors, that such changes are necessary or desirable in connection with or resulting from the Acquisition or in connection with admission to listing on the NYSE.

Written Consent

Under Delaware corporate law, a written consent of the directors must be unanimous to take effect. Under British Virgin Islands law and our Memorandum and Articles, only a majority of the directors are required to sign a written consent.

77

Under Delaware corporate law, unless otherwise provided in the certificate of incorporation, any action to be taken at any annual or special meeting of shareholders of a corporation may be taken by written consent of the holders of outstanding stock having not less than the minimum number of votes that would be necessary to take that action at a meeting at which all shareholders entitled to vote were present and voted. Our Memorandum and Articles provides that any shareholder action permitted to be taken at a shareholder meeting may also be taken by written consent of a majority of the votes of shares entitled to vote thereon. If any shareholder resolution is adopted otherwise than by the unanimous written consent of all shareholders, a copy of such resolution shall be sent to all shareholders not consenting to such resolution.

Shareholder Proposals

Under Delaware corporate law, a shareholder has the right to put any proposal before the annual meeting of shareholders, provided it complies with the notice provisions in the governing documents. A special meeting may be called by the board of directors or any other person authorized to do so in the governing documents, but shareholders may be precluded from calling special meetings. British Virgin Islands law and our Memorandum and Articles provide that our directors shall call a meeting of the shareholders if requested in writing to do so by shareholders entitled to exercise at least 30% of the voting rights in respect of the matter for which the meeting is requested.

Sale of Assets

Under Delaware corporate law, a vote of the shareholders is required to approve a sale of assets only when all or substantially all assets are being sold to a person other than a subsidiary of the Company. Under British Virgin Islands law generally, shareholder approval is required when more than 50% of a company’s total assets by value are being disposed of or sold to any person if not made in the usual or regular course of the business carried out by the company.

Redemption of Shares

Under Delaware corporate law, any stock may be made subject to redemption by the corporation at its option, at the option of the holders of that stock or upon the happening of a specified event, provided shares with full voting power remain outstanding. The stock may be made redeemable for cash, property or rights, as specified in the certificate of incorporation or in the resolution of the board of directors providing for the issue of the stock. As permitted by British Virgin Islands law and our Memorandum and Articles, shares may be repurchased, redeemed or otherwise acquired by us. However, the consent of the shareholder whose shares are to be repurchased, redeemed or otherwise acquired must be obtained, except as specified in the terms of the applicable class or series of shares.

Squeeze-Out Merger

Under Delaware General Corporation Law § 253, in a process known as a “short form” merger, a corporation that owns at least 90% of the outstanding shares of each class of stock of another corporation may either merge the other corporation into itself and assume all of its obligations or merge itself into the other corporation by executing, acknowledging and filing with the Delaware Secretary of State a certificate of such ownership and merger setting forth a copy of the resolution of its board of directors authorizing such merger. If the parent corporation is a Delaware corporation that is not the surviving corporation, the merger also must be approved by a majority of the outstanding stock of the parent corporation. If the parent corporation does not own all of the stock of the subsidiary corporation immediately prior to the merger, the minority shareholders of the subsidiary corporation party to the merger may have appraisal rights as set forth in § 262 of the Delaware General Corporation Law.

Under the BVI Act, subject to any limitations in a company’s memorandum and articles of association, members holding 90% of the votes of the outstanding shares entitled to vote, and members holding 90% of the votes of the outstanding shares of each class of shares entitled to vote, may give a written instruction to the company directing the company to redeem the shares held by the remaining members. In our Memorandum and Articles, we have opted out of the BVI Act’s squeeze out provisions.

78

Variation of Rights of Shares

Under Delaware corporate law, a corporation may vary the rights of a class of shares with the approval of a majority of the outstanding shares of that class, unless the certificate of incorporation provides otherwise. As permitted by British Virgin Islands law and our Memorandum and Articles, we may vary the rights attached to any class with the written consent of at least 50% of the holders of each class of shares affected or by a resolution passed by at least 50% of the votes cast by eligible holders of the issued shares of the affected class at a separate meeting of the holders of that class However, notwithstanding the foregoing, the directors may make such variation to the rights of any class of shares that they, in their absolute discretion (acting in good faith) determine to be necessary or desirable in connection with or resulting from the Acquisition (including at any time after the Acquisition has been made) including in connection with admission to listing on the NYSE.

Election of Directors

Under Delaware corporate law, unless otherwise specified in the certificate of incorporation or bylaws of a corporation, directors are elected by a plurality of the votes of the shares entitled to vote on the election of directors. Subject to the BVI Act and pursuant to our Memorandum and Articles, directors shall be appointed at any time, and from time to time, by our directors, without the approval of shareholders, either to fill a vacancy or as an alternate or additional director. The shareholders may, by a majority vote, appoint any person as a director. In addition, for so long as an initial holder of Founder Preferred Shares holds 20% or more of the Founder Preferred Shares in issue, such holder is entitled to nominate, and the directors are required to appoint, a person as director. If such holder notifies the Company to remove any director nominated by him or her, the other directors shall remove such director, and the holder will have the right to nominate a director to fill the resulting vacancy. In the event an initial holder ceases to be a holder of Founder Preferred Shares or holds less than 20% of the Founder Preferred Shares in issue, such initial holder will no longer be entitled to nominate a person as a director, and the holders of a majority of the Founder Preferred Shares in issue will be entitled to exercise that initial holder’s former rights to appoint a director instead.

Removal of Directors

Under Delaware corporate law, a director of a corporation with a classified board may be removed only for cause with the approval of a majority of the outstanding shares entitled to vote, unless the certificate of incorporation provides otherwise. Our Memorandum and Articles provide that a director may be removed at any time if: (i) he resigns by written notice to the Company; (ii) he is requested to resign by written notice of all of the other directors; (iii) he ceases to be a director by virtue of any provision of law or becomes prohibited by law from or is disqualified from being a director; (iv) he becomes bankrupt or makes any arrangement or composition with his creditors generally or otherwise has any judgment executed on any of his assets; (v) he becomes of unsound mind or incapable; (vi) he is absent from meetings of directors for a consecutive period of 12 months and the other directors resolve that his office shall be vacated; (vii) he dies; or (viii) a resolution of shareholders is approved by a majority of the shares entitled to vote on such matter passed at a meeting of shareholders called for the purposes of removing the director or for purposes including the removal of the director or a written special resolution of shareholders is passed by at least 75% of the votes of shares entitled to vote thereon.

Mergers

Under Delaware corporate law, one or more constituent corporations may merge into and become part of another constituent corporation in a process known as a merger. A Delaware corporation may merge with a foreign corporation as long as the law of the foreign jurisdiction permits such a merger. To effect a merger under Delaware General Corporation Law § 251, an agreement of merger must be properly adopted and the agreement of merger or a certificate of merger must be filed with the Delaware Secretary of State. In order to be properly adopted, the agreement of merger must be adopted by the board of directors of each constituent corporation by a resolution or unanimous written consent. In addition, the agreement of merger generally must be approved at a meeting of shareholders of each constituent corporation by a majority of the outstanding stock of the corporation entitled to vote, unless the certificate of incorporation provides for a supermajority vote. In general, the surviving corporation assumes all of the assets and liabilities of the disappearing corporation or corporations as a result of the merger.

79

Under the BVI Act, two or more companies may merge or consolidate in accordance with the statutory provisions. A merger means the merging of two or more constituent companies into one of the constituent companies, and a consolidation means the uniting of two or more constituent companies into a new company. In order to merge or consolidate, the directors of each constituent company must approve a written plan of merger or consolidation, which must be authorized by a resolution of shareholders. One or more companies may also merge or consolidate with one or more companies incorporated under the laws of jurisdictions outside the British Virgin Islands if the merger or consolidation is permitted by the laws of the jurisdictions in which the companies incorporated outside the British Virgin Islands are incorporated. In respect of such a merger or consolidation, a British Virgin Islands company is required to comply with the provisions of the BVI Act, and a company incorporated outside the British Virgin Islands is required to comply with the laws of its jurisdiction of incorporation.

Shareholders not otherwise entitled to vote on the merger or consolidation may still acquire the right to vote if the plan of merger or consolidation contains any provision that, if proposed as an amendment to the memorandum and articles of association, would entitle them to vote as a class or series on the proposed amendment. In any event, all shareholders must be given a copy of the plan of merger or consolidation irrespective of whether they are entitled to vote at the meeting or consent to the written resolution to approve the plan of merger or consolidation.

Inspection of Books and Records

Under Delaware corporate law, any shareholder of a corporation may for any proper purpose inspect or make copies of the corporation’s stock ledger, list of shareholders and other books and records. Under British Virgin Islands law, members of the general public, on payment of a nominal fee, can obtain copies of the public records of a company available at the office of the British Virgin Islands Registrar of Corporate Affairs, including the company’s certificate of incorporation, its memorandum and articles of association (with any amendments), records of license fees paid to date, any articles of dissolution, any articles of merger and a register of charges if the company has elected to file such a register.

A shareholder of a company is entitled, on giving written notice to the company, to inspect:

(a)the memorandum and articles of association;

(b)the register of members;

(c)the register of directors; and

(d)the minutes of meetings and resolutions of shareholders and of those classes of shares of which he is a shareholder.

In addition, a shareholder may make copies of or take extracts from the documents and records referred to in (a) through (d) above. However, subject to the memorandum and articles of association of the company, the directors may, if they are satisfied that it would be contrary to the company’s interests to allow a shareholder to inspect any document, or part of any document, specified in (b), (c) or (d) above, refuse to permit the shareholder to inspect the document or limit the inspection of the document, including limiting the making of copies or the taking of extracts from the records. Where a company fails or refuses to permit a shareholder to inspect a document or permits a shareholder to inspect a document subject to limitations, that shareholder may apply to the court for an order that he should be permitted to inspect the document or to inspect the document without limitation.

Where a company keeps a copy of the register of members or the register of directors at the office of its registered agent, it is required to notify the registered agent of any changes to the originals of such registers, in writing, within 15 days of any change; and to provide the registered agent with a written record of the physical address of the place or places at which the original register of members or the original register of directors is kept. Where the place at which the original register of members or the original register of directors is changed, the company is required to provide the registered agent with the physical address of the new location of the records within 14 days of the change of location.

A company is also required to keep at the office of its registered agent or at such other place or places, within or outside the British Virgin Islands, as the directors determine the minutes of meetings and resolutions of shareholders and of classes of shareholders, and the minutes of meetings and resolutions of directors and committees of directors. If such records are kept at a place other than at the office of the company’s registered agent, the company is required to provide the registered agent with a written record of the physical address of the place or places at which the records are kept and to notify the registered agent, within 14 days, of the physical address of any new location where such records may be kept. The Company’s registered agent in the British Virgin Islands is: Intertrust Corporate Services (BVI) Limited, Ritter House, Wickhams Cay II, Road Town, Tortola, British Virgin Islands.

80

Conflict of Interest

Under Delaware corporate law, a contract between a corporation and a director or officer, or between a corporation and any other organization in which a director or officer has a financial interest, is not void as long as (i) the material facts as to the director’s or officer’s relationship or interest are disclosed or known and (ii) either a majority of the disinterested directors authorizes the contract in good faith or the shareholders vote in good faith to approve the contract. Nor will any such contract be void if it is fair to the corporation when it is authorized, approved or ratified by the board of directors, a committee or the shareholders.

The BVI Act provides that a director shall, forthwith after becoming aware that he is interested in a transaction entered into or to be entered into by the company, disclose that interest to the board of directors of the company. The failure of a director to disclose that interest does not affect the validity of a transaction entered into by the director or the company, so long as the director’s interest was disclosed to the board prior to the company’s entry into the transaction or was not required to be disclosed because the transaction is between the company and the director himself and is otherwise in the ordinary course of business and on usual terms and conditions. As permitted by British Virgin Islands law and our Memorandum and Articles, a director interested in a particular transaction may vote on it, attend meetings at which it is considered and sign documents on our behalf that relate to the transaction. In addition, if our directors have other fiduciary obligations, including to other companies on whose board of directors they presently sit and to other companies whose board of directors they may join in the future, to the extent that they identify business opportunities that may be suitable for us or other companies on whose board of directors they may sit, our directors are permitted to honor those pre-existing fiduciary obligations ahead of their obligations to us. Accordingly, they may refrain from presenting certain opportunities to us that come to their attention in the performance of their duties as directors of such other entities unless the other companies have declined to accept such opportunities or clearly lack the resources to take advantage of such opportunities

Transactions with Interested Shareholders

Delaware corporate law contains a business combination statute applicable to Delaware public corporations whereby, unless the corporation has specifically elected not to be governed by that statute by amendment to its certificate of incorporation, it is prohibited from engaging in certain business combinations with an “interested shareholder” for three years following the date that the person becomes an interested shareholder. An interested shareholder generally is a person or group that owns or owned 15% or more of the company’s outstanding voting stock within the past three years. This statute has the effect of limiting the ability of a potential acquirer to make a two-tiered bid for the company in which all shareholders would not be treated equally. The statute does not apply if, among other things, prior to the date on which the shareholder becomes an interested shareholder, the board of directors approves either the business combination or the transaction that resulted in the person becoming an interested shareholder.

British Virgin Islands law has no comparable provision. However, although British Virgin Islands law does not regulate transactions between a company and its significant shareholders, it does provide that these transactions must be entered into in the bona fide best interests of the company and not with the effect of constituting a fraud on the minority shareholders.

Independent Directors

There are no provisions under Delaware corporate law or under the BVI Act that require a majority of our directors to be independent.

Cumulative Voting

Under Delaware corporate law, cumulative voting for elections of directors is not permitted unless the company’s certificate of incorporation specifically provides for it. Cumulative voting potentially facilitates the representation of minority shareholders on a board of directors since it permits the minority shareholder to cast all the votes to which the shareholder is entitled on a single director, which increases the shareholder’s voting power with respect to electing such director. There are no prohibitions on cumulative voting under the laws of the British Virgin Islands, but our Memorandum and Articles do not provide for cumulative voting.

81

Shareholders’ Rights under British Virgin Islands Law Generally

The BVI Act provides for certain remedies that may be available to shareholders. Where a company incorporated under the BVI Act or any of its directors engages in, or proposes to engage in, conduct that contravenes the BVI Act or the company’s memorandum and articles of association, British Virgin Islands courts can issue a restraining or compliance order. However, shareholders cannot also bring derivative, personal and representative actions under certain circumstances. The traditional English basis for shareholders’ remedies has also been incorporated into the BVI Act: where a shareholder of a company considers that the affairs of the company have been, are being or are likely to be conducted in a manner likely to be oppressive, unfairly discriminating or unfairly prejudicial to him, he may apply to the court for an order based on such conduct. In addition, any shareholder of a company may apply to the courts for the appointment of a liquidator of the company and the court may appoint a liquidator of the company if it is of the opinion that it is just and equitable to do so.

The BVI Act also provides that any shareholder of a company is entitled to payment of the fair value of his shares upon dissenting from any of the following: (i) a merger, if the company is a constituent company, unless the company is the surviving company and the shareholder continues to hold the same or similar shares; (ii) a consolidation, if the company is a constituent company; (iii) any sale, transfer, lease, exchange or other disposition of more than 50% in value of the assets or business of the company if not made in the usual or regular course of the business carried on by the company but not including (a) a disposition pursuant to an order of the court having jurisdiction in the matter, (b) a disposition for money on terms requiring all or substantially all net proceeds to be distributed to the shareholders in accordance with their respective interest within one year after the date of disposition, or (c) a transfer pursuant to the power of the directors to transfer assets for the protection thereof; (iv) a redemption of 10% or fewer of the issued shares of the company required by the holders of 90% or more of the shares of the company pursuant to the terms of the BVI Act; and (v) an arrangement, if permitted by the court.

Generally any other claims against a company by its shareholders must be based on the general laws of contract or tort applicable in the British Virgin Islands or their individual rights as shareholders as established by a company’s memorandum and articles of association.

Foreign Private Issuer Exemption

As a “foreign private issuer,” as defined by the SEC, we are permitted to follow certain corporate governance practices of our home country, the British Virgin Islands, instead of those otherwise required under the NYSE for domestic issuers. While we voluntarily follow most NYSE corporate governance rules, we intend to take advantage of the following limited exemptions:

• Unlike NYSE corporate governance rules, under BVI law, there is no requirement that our board of directors consist of a majority of independent directors and our independent directors are not required to hold executive sessions. Currently, however only six out of our eleven board members are independent based on NYSE independence standards. Also, while our board’s non-management directors will meet regularly in executive session without management, our board does not intend to hold an executive session of only independent directors at least once a year as called for by the NYSE.

• The NYSE rules applicable to domestic issuers require disclosure within four business days of any determination to grant a waiver of the code of business conduct and ethics to directors and officers. Although we will require board approval of any such waiver, we may choose not to disclose the waiver in the manner set forth in the NYSE rules, as permitted by the foreign private issuer exemption.

• We are exempt from the rules and regulations under the Exchange Act and NYSE related to the furnishing and content of proxy statements. Therefore, we intend to hold annual shareholder meetings in accordance with the corporate governance practices of the British Virgin Islands and our Memorandum and Articles of Association. Similarly, with respect to matters on which shareholders will have a right to vote, we intend to comply with corporate governance practices of the British Virgin Islands and the voting requirements under the NYSE rules applicable to foreign private issuers.

Item 16H. Mine Safety Disclosure

None.

82

Item 17. Financial Statements

Not Applicable.

83

Item 18. Financial Statements

The following financial statements, together with the report of PricewaterhouseCoopers LLP thereon, are filed as part of this annual report:

NOMAD FOODS LIMITED AND SUBSIDIARIES

INDEX TO CONSOLIDATED FINANCIAL STATEMENTS

	Page
Report of Independent Registered Public Accounting Firm	F-1
Report of Independent Registered Public Accounting Firm	F-3
Consolidated Statements of Financial Position	F-4
Consolidated Statements of Profit or Loss	F-5
Consolidated Statements of Comprehensive Income	F-6
Consolidated Statements of Changes in Equity	F-7
Consolidated Statements of Cash Flows	F-10
Notes to the Consolidated Financial Statements	F-11

84

Report of Independent Registered Public Accounting Firm

To Board of Directors and Shareholders of Nomad Foods Limited

Opinions on the Financial Statements and Internal Control over Financial Reporting

We have audited the accompanying consolidated Statements of Financial Position of Nomad Foods Limited and its subsidiaries (Successor) as of December 31, 2017 and 2016, and the related Consolidated Statements of Profit or Loss, of Comprehensive Income, of Changes in Equity, and Cash Flows for each of the two years in the period ended December 31, 2017, for the nine months ended December 31, 2015 and for the year end March 31, 2015 including the related notes (collectively referred to as the “consolidated financial statements”). We also have audited the Company’s internal control over financial reporting as of December 31, 2017, based on criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Company as of December 31, 2017 and 2016, and the results of their operations and their cash flows for each of two years in the period ended December 31, 2017, for the nine months ended December 31, 2015 and for the year end March 31, 2015 in conformity with International Financial Reporting Standards as issued by the International Accounting Standards Board and in conformity with International Financial Reporting Standards as adopted by the European Union. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2017, based on criteria established in Internal Control - Integrated Framework (2013) issued by the COSO.

Basis for Opinions

The Company's management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in Management’s annual report on internal control over financial reporting appearing under Item 15 of the 2017 Annual Report on Form 20-F. Our responsibility is to express opinions on the Company’s consolidated financial statements and on the Company's internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) ("PCAOB") and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.

Our audits of the consolidated financial statements included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.

F-1

Definition and Limitations of Internal Control over Financial Reporting

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

/s/ PricewaterhouseCoopers LLP

London, United Kingdom

March 22, 2018

We have served as the Company’s or its predecessor's auditor since 2006.

F-2

Report of Independent Registered Public Accounting Firm

To the Board of Directors and Shareholders of Nomad Foods Limited

In our opinion, the accompanying Consolidated Statements of Profit or Loss, of Comprehensive Income, of Changes in Equity and of Cash Flows for the five months ended May 31, 2015 present fairly, in all material respects, the results of operations and cash flows of Nomad Foods Europe Holdings Limited (previously Iglo Foods Holdings Limited) and its subsidiaries (Predecessor) in conformity with International Financial Reporting Standards as issued by the International Accounting Standards Board and in conformity with International Financial Reporting Standards as adopted by the European Union. These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these financial statements based on our audits. We conducted our audits of these statements in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, and evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

/s/ PricewaterhouseCoopers LLP

London, United Kingdom

March 30, 2017

F-3

Consolidated Statements of Financial Position

		Successor		Successor
		December 31, 2017		December 31, 2016
	Note	€m		€m
Non-current assets
Goodwill	13	1,745.6		1,745.6
Intangibles	13	1,724.4		1,726.6
Property, plant and equipment	12	295.4		298.2
Other receivables	18	4.3		0.4
Derivative financial instruments	34	18.6		—
Deferred tax assets	16	64.3		64.9
Total non-current assets		3,852.6		3,835.7
Current assets
Cash and cash equivalents	20	219.2		329.5
Inventories	17	306.9		325.0
Trade and other receivables	18	147.1		135.7
Indemnification assets	19	73.8		65.5
Capitalized borrowing costs	21	—		5.0
Derivative financial instruments	34	2.1		13.1
Total current assets		749.1		873.8
Total assets		4,601.7		4,709.5
Current liabilities
Trade and other payables	22	477.5		472.7
Current tax payable		145.3		162.3
Provisions	24	68.0		116.7
Loans and borrowings	21	3.3		—
Derivative financial instruments	34	7.8		1.4
Total current liabilities		701.9		753.1
Non-current liabilities
Loans and borrowings	21	1,395.1		1,451.8
Employee benefits	23	188.4		190.9
Trade and other payables	22	1.8		1.0
Provisions	24	72.8		77.0
Derivative financial instruments	34	61.4		—
Deferred tax liabilities	16	327.7		333.2
Total non-current liabilities		2,047.2		2,053.9
Total liabilities		2,749.1		2,807.0
Net assets		1,852.6		1,902.5
Equity attributable to equity holders
Share capital	25	—		—
Capital reserve	25	1,623.7		1,800.7
Share-based compensation reserve	26	2.9		1.0
Founder Preferred Shares Dividend Reserve	27	493.4		493.4
Translation reserve	28	83.2		84.0
Cash flow hedging reserve	29	(3.0	)	8.4
Accumulated deficit reserve		(347.6	)	(485.0	)
Total equity		1,852.6		1,902.5

The accompanying notes are an integral part of these consolidated financial statements.

F-4

Consolidated Statements of Profit or Loss

		Successor		Successor		Successor		Successor		Predecessor
		Year ended December 31, 2017		Year ended December 31, 2016		9 months ended December 31, 2015		Year ended March 31, 2015		5 months ended May 31, 2015
	Note	€m		€m		€m		€m		€m
Revenue	5	1,956.6		1,927.7		894.2		—		640.3
Cost of sales		(1,357.2	)	(1,356.7	)	(663.0	)	—		(417.9	)
Gross profit		599.4		571.0		231.2		—		222.4
Other operating expenses		(319.3	)	(298.4	)	(138.6	)	(0.7	)	(109.5	)
Charge related to Founder Preferred Shares Annual Dividend Amount	27	—		—		(349.0	)	(165.8	)	—
Credit/(charge) related to Warrant Redemption Liability	25	—		—		0.4		(0.4	)	—
Exceptional items	7	(37.2	)	(134.5	)	(58.1	)	(0.7	)	(84.3	)
Operating profit/(loss)	6	242.9		138.1		(314.1	)	(167.6	)	28.6
Finance income	10	7.2		24.2		8.7		0.1		2.0
Finance costs	10	(81.6	)	(86.3	)	(44.2	)	—		(117.7	)
Net finance (costs)/income		(74.4	)	(62.1	)	(35.5	)	0.1		(115.7	)
Profit/(loss) before tax		168.5		76.0		(349.6	)	(167.5	)	(87.1	)
Taxation	11	(32.0	)	(39.6	)	12.3		—		(40.9	)
Profit/(loss) for the period		136.5		36.4		(337.3	)	(167.5	)	(128.0	)
Earnings per share:
Basic earnings/(loss) per share	30	0.78		0.20		(2.32	)	(3.35	)	n.p.
Diluted earnings/(loss) per share	30	0.74		0.20		(2.32	)	(3.35	)	n.p.

The accompanying notes are an integral part of these consolidated financial statements.

F-5

Consolidated Statements of Comprehensive Income

		Successor		Successor		Successor		Successor		Predecessor
		Year ended December 31, 2017		Year ended December 31, 2016		9 months ended December 31, 2015		Year ended March 31, 2015		5 months ended May 31, 2015
	Note	€m		€m		€m		€m		€m
Profit/(loss) for the period		136.5		36.4		(337.3	)	(167.5	)	(128.0	)
Other comprehensive (loss)/income:
Actuarial gains/(losses) on defined benefit pension plans	23	2.9		(23.6	)	19.4		—		(2.5	)
Taxation (charge)/credit on remeasurement of defined benefit pension plans	11	(2.0	)	(6.3	)	(6.1	)	—		0.7
Items not reclassified to the Consolidated Statement of Profit or Loss		0.9		(29.9	)	13.3		—		(1.8	)
Foreign currency (loss) / gain		—		—		(1.7	)	88.9		44.7
Loss on investment in foreign subsidiary, net of hedge		(0.8	)	(0.5	)	(2.7	)	—		—
Effective portion of changes in fair value of cash flow hedges	29	(16.4	)	10.1		1.6		—		—
Taxation credit/(charge) relating to components of other comprehensive income	11	5.0		(2.8	)	(0.5	)	—		—
Items that may be subsequently reclassified to the Consolidated Statement of Profit or Loss		(12.2	)	6.8		(3.3	)	88.9		44.7
Other comprehensive (loss)/income for the period, net of tax		(11.3	)	(23.1	)	10.0		88.9		42.9
Total comprehensive income/(loss) for the period attributable to Owners of the Parent Company		125.2		13.3		(327.3	)	(78.6	)	(85.1	)

The accompanying notes are an integral part of these consolidated financial statements.

F-6

Consolidated Statements of Changes in Equity

		Share capital	Capital reserve	Share-based compensation reserve	Founder preferred shares dividend reserve	Translation reserve	Cash flow hedging reserve	Accumulated deficit reserve	Total equity
SUCCESSOR	Note	€m	€m	€m	€m	€m	€m	€m	€m
Balance at April 1, 2014		—	—	—	—	—	—	—	—
Loss for the year		—	—	—	—	—	—	(167.5)	(167.5)
Other comprehensive income for the year		—	—	—	—	88.9	—	—	88.9
Total comprehensive income/(loss) for the year		—	—	—	—	88.9	—	(167.5)	(78.6)
Transactions with owners of the Company
Issue of Ordinary Shares	25	—	350.9	—	—	—	—	—	350.9
Issue of Founder Preferred Shares	25	—	10.6	—	—	—	—	—	10.6
Cost of Admission	25	—	(8.0)	—	—	—	—	—	(8.0)
Total transactions with owners, recognized directly in equity		—	353.5	—	—	—	—	—	353.5
Balance at March 31, 2015		—	353.5	—	—	88.9	—	(167.5)	274.9
SUCCESSOR
Balance at April 1, 2015		—	353.5	—	—	88.9	—	(167.5)	274.9
Loss for the period		—	—	—	—	—	—	(337.3)	(337.3)
Other comprehensive (loss)/income for the period		—	—	—	—	(4.4)	1.1	13.3	10.0
Total comprehensive (loss)/income for the period		—	—	—	—	(4.4)	1.1	(324.0)	(327.3)
Transactions with owners of the Company
Issue of Ordinary Shares	25	—	1,414.2	—	—	—	—	—	1,414.2
Cost of Admission	25	—	(5.3)	—	—	—	—	—	(5.3)
Founder Preferred Shares Annual Dividend Amount	27	—	—	—	531.5	—	—	—	531.5
Share based payment charge		—	—	0.1	—	—	—	—	0.1
Total transaction with owners, recognized directly in equity		—	1,408.9	0.1	531.5	—	—	—	1,940.5
Balance as of December 31, 2015		—	1,762.4	0.1	531.5	84.5	1.1	(491.5)	1,888.1

F-7

Consolidated Statements of Changes in Equity (continued)

		Share capital	Capital reserve	Share-based compensation reserve	Founder preferred shares dividend reserve	Translation reserve	Cash flow hedging reserve	Accumulated deficit reserve	Total equity
SUCCESSOR	Note	€m	€m	€m	€m	€m	€m	€m	€m
Balance at January 1, 2016		—	1,762.4	0.1	531.5	84.5	1.1	(491.5)	1,888.1
Profit for the year		—	—	—	—	—	—	36.4	36.4
Other comprehensive (loss)/income for the year		—	—	—	—	(0.5)	7.3	(29.9)	(23.1)
Total comprehensive (loss)/income for the year		—	—	—	—	(0.5)	7.3	6.5	13.3
Transactions with owners of the Company
Founder Preferred Shares Annual Dividend Amount		—	38.1	—	(38.1)	—	—	—	—
Issue of Ordinary Shares	25	—	0.2	—	—	—	—	—	0.2
Vesting of Non-Executive Restricted Stock award		—	—	(0.3)	—	—	—	—	(0.3)
Share based payment charge		—	—	1.2	—	—	—	—	1.2
Total transaction with owners, recognized directly in equity		—	38.3	0.9	(38.1)	—	—	—	1.1
Balance as of December 31, 2016	25	—	1,800.7	1.0	493.4	84.0	8.4	(485.0)	1,902.5

F-8

Consolidated Statements of Changes in Equity (continued)

		Share capital	Capital reserve	Share-based compensation reserve	Founder preferred shares dividend reserve	Translation reserve	Cash flow hedging reserve	Accumulated deficit reserve	Total equity
SUCCESSOR	Note	€m	€m	€m	€m	€m	€m	€m	€m
Balance at January 1, 2017		—	1,800.7	1.0	493.4	84.0	8.4	(485.0)	1,902.5
Profit for the year		—	—	—	—	—	—	136.5	136.5
Other comprehensive (loss)/income for the year		—	—	—	—	(0.8)	(11.4)	0.9	(11.3)
Total comprehensive (loss)/income for the year		—	—	—	—	(0.8)	(11.4)	137.4	125.2
Transactions with owners of the Company
Repurchase of ordinary shares	25	—	(177.1)	—	—	—	—	—	(177.1)
Listing and share transaction costs	25	—	(0.5)	—	—	—	—	—	(0.5)
Vesting of Non-Executive Restricted Stock award	26	—	0.6	(0.7)	—	—	—	—	(0.1)
Share based payment charge	26	—	—	2.6	—	—	—	—	2.6
Total transactions with owners, recognized directly in equity		—	(177.0)	1.9	—	—	—	—	(175.1)
Balance at December 31, 2017		—	1,623.7	2.9	493.4	83.2	(3.0)	(347.6)	1,852.6

The accompanying notes are an integral part of these consolidated financial statements.

F-9

Consolidated Statements of Cash Flows

		Successor		Successor		Successor		Successor		Predecessor
		Year ended December 31, 2017		Year ended December 31, 2016		9 months ended December 31, 2015		Year ended March 31, 2015		5 months ended May 31, 2015
	Note	€m		€m		€m		€m		€m
Cash generated from operations before tax and exceptional items	32	358.5		356.2		159.2		0.2		102.2
Cash flows relating to exceptional items		(99.5	)	(49.2	)	(91.6	)	(0.7	)	(6.2	)
Tax paid		(65.2	)	(24.9	)	(19.6	)	—		(17.3	)
Net cash flows from/(used in) operating activities		193.8		282.1		48.0		(0.5	)	78.7
Cash flows from investing activities
Purchase of Iglo, net of cash acquired		—		—		(693.6	)	—		—
Purchase of Findus, net of cash acquired		—		—		(556.9	)	—		—
Contingent consideration for purchase of Frudesa brand		—		(8.0	)	—		—		—
Purchase of property, plant and equipment	12	(38.0	)	(38.0	)	(19.3	)	—		(6.0	)
Purchase of intangibles	13	(4.6	)	(4.4	)	(2.1	)	—		(0.3	)
Purchase of portfolio investments		—		—		—		(478.8	)	—
Redemption of portfolio investments		—		—		312.1		183.2		—
Net cash used in investing activities		(42.6	)	(50.4	)	(959.8	)	(295.6	)	(6.3	)
Cash flows from financing activities
Proceeds from issuance of Founder Preferred Shares	25	—		—		—		10.6		—
Proceeds from issuance of Ordinary Shares	25	—		—		1,171.8		350.9		—
Costs of admission	25	—		—		(5.3	)	(8.0	)	—
Loans from Founder Entities for incorporation		—		—		—		0.1		—
Repayment of loans to Founder Entities		—		—		—		(0.1	)	—
Proceeds from new loans and notes		1,470.5		—		325.0		—		—
Repayment of loan principal		(1,469.5	)	—		(490.0	)	—		—
Payment of finance leases		(1.6	)	(0.7	)	—		—		—
Payment of financing fees		(16.7	)	—		(14.0	)	—		—
Repurchase of ordinary shares		(177.6	)	—		—		—		—
Proceeds/(loss) on settlement of derivatives		1.6		(4.0	)	4.3		—		—
Interest paid		(48.8	)	(70.9	)	(40.8	)	—		(31.4	)
Interest received		0.3		7.9		1.5		—		2.0
Net cash (used in)/from financing activities		(241.8	)	(67.7	)	952.5		353.5		(29.4	)
Net (decrease)/increase in cash and cash equivalents		(90.6	)	164.0		40.7		57.4		43.0
Cash and cash equivalents at beginning of period	20	329.5		186.1		126.8		—		219.2
Effect of exchange rate fluctuations		(19.7	)	(20.6	)	18.6		69.4		6.2
Cash and cash equivalents at end of period	20	219.2		329.5		186.1		126.8		268.4

The accompanying notes are an integral part of these consolidated financial statements.

F-10

Notes to the Consolidated Financial Statements

1) General information

Nomad Foods Limited (the “Company” or “Nomad”) was incorporated in the British Virgin Islands on April 1, 2014. The address of Nomad’s registered office is Nemours Chambers, Road Town, Tortola, British Virgin Islands. The Company is domiciled for tax in the United Kingdom.

Nomad Foods (NYSE: NOMD) is a leading frozen foods company building a global portfolio of best-in-class food companies and brands within the frozen category and in the future across the broader food sector. Nomad produces, markets and distributes brands in 17 countries and has the leading market share in Western Europe. The Company’s portfolio of leading frozen food brands includes Birds Eye, Iglo, and Findus.

2) Basis of preparation

The consolidated financial statements of Nomad and its subsidiaries (the “Company” or “Nomad”, or the “Successor”) and the consolidated financial statements of Nomad Foods Europe Holdings Limited (previously “Iglo Foods Holdings Limited”) (the “Predecessor”) have been prepared in accordance with International Financial Reporting Standards issued by the International Accounting Standards Board. These consolidated financial statements are also in accordance with International Financial Reporting Standards as adopted by the European Union.

On June 1, 2015 Nomad Foods Limited (previously “Nomad Holdings Limited”) acquired Iglo Foods Holding Ltd (the “Iglo Group” and the “Iglo Acquisition”). Nomad Foods Limited is listed on the New York Stock Exchange and Iglo Foods Holdings Limited, a direct subsidiary of Nomad, is considered to be the “Predecessor” of Nomad Foods Limited (the “Successor”), as prior to the Iglo Acquisition, Nomad Foods Limited had no operations.

On November 2, 2015 the Company acquired Findus Sverige AB and its subsidiaries (the “Findus Group” and the “Findus Acquisition”). The acquired business included operations across continental Europe with leading market positions in France, Sweden and Spain along with the intellectual and commercialization rights to the Findus, Lutosa (until 2020) and La Cocinera brands in their respective markets.

On January 1, 2017, the Company adopted the following relevant amendments to IFRS. Neither of these have any impact on the results or financial position of the Company.

– Amendments to IAS 7 “Disclosure Initiative”; for which additional disclosures have been made for changes in liabilities arising from financing activities; and

– Amendments to IAS 12 "Recognition of Deferred Tax Assets for Unrealised Losses"

Refer to 3.22 for more information on new IFRSs not yet adopted.

The Company’s financial statements and notes are presented in the reporting currency of millions of Euros. Upon the acquisition of the Iglo Group on June 1, 2015, Nomad changed its functional and presentational currency from U.S. Dollars to Euros because this is the functional and presentational currency of the Iglo Group, which comprised all of Nomad’s operations at that time. All financial information has been rounded to the nearest €0.1 million, except where otherwise indicated.

On May 28, 2015 the Company changed its year end reporting date from March 31 to December 31 to align with the historical reporting calendar of the Iglo Group. This change has no impact on the financial statements and notes included herein. Fiscal year 2015 is a nine month period for the Company, which might not be comparable to the full year comparative amounts.

The consolidated financial statements were approved for issuance by the Board of Directors of Nomad Foods Limited on March 20, 2018. The Directors have, at the time of approving the financial statements, a reasonable expectation that Nomad has adequate resources to continue in operational existence for the foreseeable future given the cash funds available and the current forecast cash outflows. Thus, Nomad continues to adopt the going concern basis of accounting in preparing the financial statements.

F-11

3) Accounting policies

The accounting policies set out below have, unless otherwise stated, been applied consistently.

Judgments made by the Directors in the application of these accounting policies that have a significant effect on the financial statements and key sources of estimation uncertainty are discussed in Note 4.

3.1 Measurement convention

The financial statements are prepared on the historical cost basis with the exception of derivative financial instruments, business combinations, share based payments, and founder preferred shares which are stated at fair value.

3.2 Business combination

The Company uses the acquisition method to account for business combinations. The consideration transferred for the acquisition of a subsidiary is the fair value of the assets transferred, the liabilities incurred and the equity interest issued by the Company. The consideration transferred includes the fair value of any asset or liability resulting from a contingent consideration arrangement. Identifiable assets acquired and liabilities and contingent liabilities assumed in a business combination are measured initially at their fair values at the acquisition date. Acquisition-related costs are expensed as incurred.

Where selling shareholders have contractually agreed to indemnify Nomad Foods Limited for contingent liabilities, an indemnification asset is recognized equivalent to the fair value of the liability recognized by Nomad. The indemnification asset is deducted from consideration transferred for the business combination. The indemnification asset value will subsequently be revised where revisions are made to the value of the liability or where there are doubts over the ability to recover losses from the selling shareholders.

3.3 Basis of consolidation

The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. Intercompany balances and transactions, and any unrealized income and expenses arising from intra-group transactions are eliminated. Accounting policies are applied consistently across the Company.

Subsidiaries are all entities (including structured entities) over which Nomad has control; directly or indirectly. The Company controls an entity when the Company is exposed to, or has rights to, variable returns from its involvement with the entity and has the ability to affect those returns through its power over the entity. Subsidiaries are fully consolidated from the date on which control is transferred to the Company. They are deconsolidated from the date that control ceases.

3.4 Foreign currency

i) Foreign currency transactions

Transactions in foreign currencies (currencies other than the functional currency) are translated into the functional currency at the foreign exchange rate ruling at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are translated into the functional currency at the foreign exchange rate ruling the financial year end. Foreign exchange gains and losses resulting from the settlement of such transactions and from the translation of monetary assets and liabilities denominated in foreign currencies at year end exchange rates are generally recognized in profit or loss. They are deferred in equity if they relate to qualifying cash flow hedges, qualifying net investment hedges or are attributable to part of a net investment in a foreign operation.

F-12

Non-monetary assets and liabilities in a foreign currency are translated into the functional currency to establish historical cost, using the exchange rate at the date of the transaction. Non-monetary assets and liabilities denominated in foreign currencies that are stated at fair value are translated at foreign exchange rates ruling at the date the fair value was determined. Translation differences on assets and liabilities carried at fair value are reported as part of the fair value gain or loss.

The revenues and expenses of foreign operations are translated at an average rate for the period (unless this is not a reasonable approximation of the cumulative effect of the rates prevailing on the transaction dates, in which case income and expenses are translated at the dates of the transaction).

ii) Assets and liabilities of foreign operations

For the purposes of presenting consolidated financial statements, the assets and liabilities of foreign operations, including goodwill and fair value adjustments arising on consolidation, are translated at foreign exchange rates ruling at the financial year endedDecember 31, 2017 of £1:€1.13 (December 31, 2016: £1:€1.17, December 31, 2015: £1:€1.36). The revenues and expenses of foreign operations are translated at an average rate for the period where this rate approximates to the foreign exchange rates ruling at the dates of the transactions.

Foreign exchange gains and losses that relate to these assets and liabilities are presented in the Consolidated Statement of Profit or Loss within ‘finance income or costs’, except where hedge accounting applies.

iii) Net investment in foreign operations

Exchange differences arising from the translation of foreign operations and of related qualifying hedges are taken directly to the translation reserve within equity. They are realized through the Consolidated Statement of Profit or Loss upon disposal of the related foreign operation.

3.5 Goodwill

Goodwill represents amounts arising on acquisition of subsidiaries. Goodwill is the difference between the cost of the acquisition and the fair value of the net identifiable assets acquired.

Goodwill is stated at cost less any accumulated impairment losses. Gains and losses on the disposal of an entity include the carrying amount of goodwill relating to the entity sold.

Goodwill is allocated to the cash-generating unit and is not monitored below the operating segment unit. Goodwill is not amortized but is tested annually for impairment. Refer to 3.7 for discussion on cash-generating units.

3.6 Other intangible assets

Intangible assets acquired separately are recorded at cost and those acquired as part of a business combination are recorded at fair value as at the date of acquisition.

F-13

i) Computer software

Capitalized software costs include the cost of acquired computer software licenses and costs that are directly associated with the design, construction and testing of such software where this relates to a major business system. Costs associated with identifying, sourcing, evaluating or maintaining computer software are recognized as an expense within other operating expenses as incurred.

The assets are stated at cost less accumulated amortization and impairment losses. Software costs are amortized by equal monthly installments over their estimated useful economic life of five to seven years once the software is capable of being brought into use.

ii) Brands

Based on the market position of the brands, the significant levels of investment in advertising and promoting the brands, and the fact that they have been established for over 50 years, the Directors consider that the Birds Eye, Iglo and Findus brands have indefinite lives. Therefore these brands are not amortized, but instead held at historical cost less provision for any impairment.

The La Cocinera and Lutosa brands (Lutosa used under license until 2020) are deemed to not have an indefinite life and are being amortized by equal monthly installments within other operating expenses over 10 and 6 years respectively.

iii) Customer relationships

Long standing Food Service customer relationships have been identified as intangible assets as part of the Findus Acquisition. These are deemed to not have an indefinite life and are being amortized by equal monthly installments within other operating expenses over 14 years.

3.7 Impairment of non-current assets

The carrying amounts of the Company’s non-current assets are reviewed annually to determine whether there is any indication of impairment. If any such indication exists, the asset’s recoverable amount is estimated. Impairment losses are recognized in the Consolidated Statement of Profit or Loss in the period in which they arise. For goodwill and assets that have an indefinite useful life an impairment review is performed at least annually.

Assets that are subject to amortization are reviewed for impairment whenever events or changes in circumstances indicate that the net carrying amount may not be recoverable. An impairment loss is recognized whenever the carrying amount of an asset or its cash-generating unit exceeds its recoverable amount.

i) Calculation of recoverable amount

Recoverable amount is the greater of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows of the business are discounted to their present value using a discount rate that reflects current market assessments of the time value of money and the risks specific to the asset. For an asset that does not generate largely independent cash inflows, the recoverable amount is determined for the cash-generating unit to which the asset belongs.

F-14

ii) Allocation of impairment losses

Impairment losses recognized in respect of cash-generating units are allocated first to reduce the carrying amount of any goodwill allocated to cash-generating units then to reduce the carrying amount of the other assets in the unit on a pro rata basis. A cash-generating unit is the smallest identifiable group of assets that generates cash inflows that are largely independent of the cash inflows from other assets or groups of assets.

iii) Reversals of impairment

An impairment loss in respect of goodwill is not reversed. In respect of other assets, an impairment loss is reversed when there is an indication that the impairment loss may no longer exist and there has been a change in the estimates used to determine the recoverable amount. An impairment loss is reversed only to the extent that the asset’s carrying amount does not exceed the carrying amount that would have been determined, net of depreciation or amortization, if no impairment loss had been recognized.

3.8 Property, plant and equipment

i) Owned assets

Property, plant and equipment are stated at cost less accumulated depreciation and impairment losses. Cost includes the original purchase price of the asset and the costs attributable to bringing the asset to its working condition for its intended use.

Where parts of an item of property, plant and equipment have different useful lives, they are accounted for as separate items of property, plant and equipment.

ii) Leased assets

Leases in which the Company assumes substantially all the risks and rewards of ownership of the leased asset are classified as ‘finance leases’. Where land and buildings are held under finance leases the accounting treatment of the land is considered separately from that of the buildings. Leased assets acquired by way of finance lease are stated at an amount equal to the lower of their fair value and the present value of the minimum lease payments at inception of the lease, less accumulated depreciation and impairment losses.

All other leases are classified as ‘operating leases’.

iii) Depreciation

Depreciation is charged to the Consolidated Statement of Profit or Loss on a straight line basis over the shorter of the lease term and the estimated useful lives of each part of an item of property, plant and equipment once the item is brought into use. Land is not depreciated. The estimated useful lives are as follows:

• Buildings 40 years

• Plant and equipment 5 to 14 years

• Computer equipment 3 to 5 years

F-15

The assets’ residual values and useful lives are reviewed on a frequent basis.

3.9 Inventories

Inventories are stated at the lower of cost and net realizable value. Cost is based on the weighted average principle and includes expenditure incurred in acquiring the inventories and bringing them to their existing location and condition. Inventories that are acquired through business combinations are fair valued at the time of acquisition. In the case of manufactured inventories and work in progress, cost includes an appropriate share of direct costs and overheads based on normal operating capacity. Provision is made for slow moving, obsolete and defective inventories.

3.10 Employee benefits

i) Defined contribution plans

Obligations for contributions to defined contribution pension plans are recognized as an expense in the Consolidated Statement of Profit or Loss as incurred. Prepaid contributions are recognized as an asset to the extent that a cash refund or reduction in the future payments is available.

ii) Defined benefit plans

The Company’s net obligation in respect of defined benefit pension plans and other post-employment benefits is calculated separately for each plan by estimating the amount of future benefit that employees have earned in return for their service in the current and prior periods. That net obligation is discounted to determine its present value. The calculation is performed by a qualified actuary using the projected unit credit method.

The current service cost of the defined benefit plan, recognized in the Consolidated Statement of Profit or Loss in staff costs included within Operating profit/(loss), except where included in the cost of an asset, reflects the increase in the defined benefit obligation resulting from employee service in the current year, benefit changes, curtailments and settlements.

Actuarial gains and losses arising from experience adjustments and changes in actuarial assumptions are charged or credited to equity in Other Comprehensive Income in the period in which they arise.

The net interest cost is calculated by applying the discount rate to the net balance of the defined benefit obligation and the fair value of plan assets. This cost is included in employee benefit expense in the Consolidated Statement of Profit or Loss.

Past service cost is recognized immediately.

iii) Share-based payment schemes

Employee benefits given through share-based payment schemes are discussed further in section 3.15 within Accounting policies.

3.11 Founder Preferred Shares

Nomad Foods issued Founder Preferred Shares to both TOMS Acquisition I, LLC and Mariposa Acquisition II, LLC (collectively the “Founder Entities”) in connection with its initial public offering in April 2014. Holders of the Founder Preferred Shares are entitled to receive annual dividend amounts subject to certain performance conditions (the “Founder Preferred Shares Dividend Amount”). The instrument and its component parts were analyzed

F-16

under IFRS 2. The Company intends that any future Founder Preferred Shares Annual Dividend Amount will be equity settled. Accordingly, the Founder Preferred Shares Annual Dividend Amount as of June 1, 2015 of €531.5 million (the “Founder Preferred Shares Dividend reserve”) was classified as equity and no further revaluations will be required or recorded.

Should a Founder Preferred Share Annual Dividend Amount become due and payable, the market value of any dividend paid will be deducted from the Founder Preferred Shares Dividend reserve, with any excess deducted from the accumulated profit/(deficit) reserve within equity.

3.12 Provisions

Provisions are recognized when the Company has a legal or constructive present obligation as a result of a past event and it is probable that the Company will be required to settle that obligation. Provisions are measured at the Directors’ best estimate of the expenditure required to settle the obligation at the financial year end date and are discounted to present value where the effect is material.

Where it is not possible to make a reliable estimate of the estimated financial effect of a provision, appropriate disclosure of the resulting contingent liability is made, but no provision is recognized.

The Company is currently in discussions with the tax authorities in one of its markets regarding the treatment of the acquisition of the Iglo Group in 2006 by the previous owners. The Company has an indemnity in respect of this tax issue, but has not recognized an indemnification asset or a provision for this matter.

3.13 Financial instruments

Financial assets and liabilities are recognized in the Company’s Statement of Financial Position when the Company becomes a party to the contractual provisions of the instrument.

i) Trade receivables

Trade receivables are measured at initial recognition at fair value and are subsequently measured at amortized cost using the effective interest method, less any impairment. Since trade receivables are due within one year, this equates to initial carrying value less any impairment.

Appropriate allowances for estimated irrecoverable amounts are recognized in the Consolidated Statement of Profit or Loss when there is objective evidence that the asset is impaired.

Trade receivables are presented net of customer rebate balances.

ii) Cash and cash equivalents

Cash and cash equivalents comprise of cash balances and call deposits.

iii) Loans and borrowings

a. Valuation

Interest bearing borrowings are recognized initially at fair value less attributable transaction costs.

F-17

Subsequent to initial recognition, interest bearing loans and borrowings are stated at amortized cost with any difference between cost and redemption value being recognized in the Consolidated Statement of Profit or Loss over the expected period of the borrowings.

b. Capitalization of transaction costs

Fees paid on the establishment of loan facilities are recognized as transaction costs of the loan to the extent that it is probable that some or all of the facility will be drawn down. In this case, the fee is deferred until the draw-down occurs.

iv) Trade payables

Trade payables are measured at initial recognition at fair value and are subsequently measured at amortized cost using the effective interest method. Since trade payables are largely due within one year, this equates to initial carrying value.

v) Derivative financial instruments and hedge accounting

Derivative financial instruments are recognized at fair value. When a derivative financial instrument is not designated in a hedge relationship that qualifies for hedge accounting, all changes in its fair value are recognized immediately in the Consolidated Statement of Profit or Loss. However, where derivatives qualify for hedge accounting, recognition of any resultant gain or loss depends on the nature of the item being hedged.

The fair value of derivative financial instruments is determined using forward rates at the balance sheet date, with the resulting value discounted back to present value.

Cross currency interest rate swaps are managed based on their net exposure to credit risks. The Company has used the exception in IFRS 13 to allow this group of derivatives to be measured on a net basis by each counterpart.

a.    Cash flow hedges

Where a derivative financial instrument is designated as a hedge of the variability in cash flows of a recognized asset or liability, or a highly probable forecast transaction, the effective part of any gain or loss on the derivative financial instrument is recognized directly in the cash flow hedging reserve. Any ineffective portion of the hedge is recognized immediately in the Consolidated Statement of Profit or Loss.

When a hedging instrument expires or is sold, terminated or exercised, or the entity revokes designation of the hedge relationship but the hedged forecast transaction is still expected to occur, the cumulative gain or loss at that point remains in equity and is recognized when the transaction occurs. If the hedged transaction is no longer expected to take place, the cumulative unrealized gain or loss recognized in equity is recognized in the Consolidated Statement of Profit or Loss immediately.

F-18

b. Net investment hedges

Foreign currency differences arising on the retranslation of a financial liability designated as a hedge of a net investment in a foreign operation are recognized in Other Comprehensive Income to the extent that the hedge is effective, and are presented in the translation reserve within equity. To the extent that the hedge is ineffective, such differences are recognized in the Consolidated Statement of Profit or Loss. When the hedged net investment is disposed of, the relevant amount in the translation reserve is transferred to the Consolidated Statement of Profit or Loss as part of the gain or loss on disposal.

3.14 Revenue

Revenue comprises sales of goods after deduction of discounts, sales taxes and excludes intra-company sales. Discounts given by the Company include rebates, price reductions and incentives given to customers, promotional couponing and trade communication costs. At each financial year end date any discount incurred, but not yet invoiced, is estimated and accrued.

Revenue is recognized when the title and risk of loss of the underlying products have been transferred to the customer, at which point the sale price is fixed or determinable. This completes the revenue-earning process specifically that an arrangement exists, delivery has occurred, ownership has transferred, the price is determined and collectability is reasonably assured. The timing of the transfer of risks and rewards varies depending on the individual terms of the sales agreement. A provision for payment discounts and product return allowances, which is estimated based upon the Company’s historical performance, management’s experience and current economic trends, is recorded as a reduction of sales in the same period that the revenue is recognized.

Trade promotions, consisting primarily of customer pricing allowances and merchandising funds and customer coupons are offered through various programs to customers and consumers. Sales are recorded net of estimated trade promotion spending, which is recognized as incurred at the time of sale. Certain retailers require the payment of slotting fees in order to obtain space for the Company’s products on the retailers’ store shelves. The fees are recognized as reductions of revenue on the date a liability to the retailer is created. These amounts are included in the determination of net sales. Accruals for expected pay-outs under these programs are included within trade receivables or trade payables in the Consolidated Statement of Financial Position. Coupon redemption costs are also recognized as reductions of net sales when the coupons are issued. Estimates of trade promotion expense and coupon redemption costs are based upon programs offered, timing of those offers, estimated redemption/usage rates from historical performance, management’s experience and current economic trends.

Trade marketing expense is comprised of amounts paid to retailers for programs designed to promote our products and are classified in the Consolidated Statement of Profit or Loss as a reduction of revenue.

3.15 Share based payments

Successor

Nomad Foods 2015 Long Term Incentive Plan

The Nomad Foods 2015 Long Term Incentive Plan (the “LTIP”), which incorporates an annual Non-Executive Directors Restricted Stock Scheme, falls within the provisions of IFRS 2 “Share-based Payment” and awards under the LTIP represent equity settled share based payments. A charge is taken to the Consolidated Statement of Profit or

F-19

Loss for the difference between the fair value of the shares at grant date and the amount subscribed, spread over the vesting period.

Share based payment arrangements in which Nomad receives goods or services as consideration for its own equity instruments are accounted for as equity-settled share based payment transactions, regardless of how the equity instruments are obtained by Nomad.

The grant date fair value of share-based payment awards granted to any Director or employee is recognized as an associated expense, with a corresponding increase in equity, over the period that any Director or employee becomes unconditionally entitled to the awards.

The fair value of the awards granted is measured using a valuation model, taking into account the terms and conditions upon which the awards were granted. The amount recognized as an expense is adjusted to reflect the actual number of awards for which the related service and non-market vesting conditions are expected to be met, such that the amount ultimately recognized as an expense is based on the number of awards that do meet the related service and non-market performance conditions at the vesting date. For share-based payment awards with non-vesting conditions, the grant date fair value of the share-based payment is measured to reflect such conditions and there is no true-up for differences between expected and actual outcomes.

See Note 8b for further information on the Company’s share-based payment arrangements and details of the valuation model used.

Predecessor

At the end of each reporting period, the Iglo Group revised its estimates of the number of interests that were expected to vest based on the non-market vesting conditions. It recognized the impact of the revision to original estimates, if any, in the Consolidated Statement of Profit or Loss, with a corresponding adjustment to equity.

Other management incentive schemes

If schemes fall outside the scope of IFRS 2, since they are not related to the price or value of equity instruments, but do fall within the scope of IAS 19 “Employee Benefits”, an annual charge is taken over the service period based on an estimate of the amount of future benefit employees will earn in return for their service.

3.16 Interest income

Interest income is recognized in the Consolidated Statement of Profit or Loss on an accruals basis using the effective interest method.

3.17 Expenses

i) Operating lease payments

Payments made under operating leases are recognized in the Consolidated Statement of Profit or Loss on a straight line basis over the term of the lease. Lease incentives received are recognized on a straight line basis in the Consolidated Statement of Profit or Loss as an integral part of the total lease expense.

ii) Borrowing costs

Unless capitalized as part of the cost of borrowing (see Note 3.13(iii)), borrowing costs are recognized in the Consolidated Statement of Profit or Loss in the period in which they are incurred.

F-20

iii) Exceptional items

The separate reporting of exceptional items which are presented as exceptional within the relevant Consolidated Statement of Profit or Loss category, helps provide an indication of the Company’s underlying business performance. Exceptional items have been identified and presented by virtue of their size, nature or incidence. In determining whether an event or transaction is specific, management considers quantitative as well as qualitative factors such as the frequency or predictability of occurrence. Exceptional items comprise restructuring costs, impairments or reversal of impairments of intangible assets, operational restructuring, integration and acquisition costs relating to new acquisitions, investigation of strategic opportunities and other items, costs relating to certain management incentive plans and other significant items (see Note 7).

iv) Research and development

Expenditure on research activities is recognized in the Consolidated Statement of Profit or Loss as an expense as incurred.

3.18 Taxation

Tax on the profit or loss for the year comprises current and deferred tax. Tax is recognized in the Consolidated Statement of Profit and Loss except to the extent that it relates to items recognized directly in equity, in which case it is recognized in equity.

Current tax is the expected tax payable on the taxable income for the year, using tax rates enacted or substantively enacted at the financial year end date, and any adjustment to tax payable in respect of previous years. Where tax exposures can be quantified, an accrual for uncertain tax positions is made based on the best estimates and management’s judgments. Given the inherent uncertainties in assessing the outcomes of these exposures (which can sometimes be binary in nature), the Company could in future periods experience adjustments to these accruals.

Deferred tax is provided on temporary differences between the carrying amounts of assets and liabilities recognized for financial reporting purposes and the amounts used for taxation purposes on an undiscounted basis. The following temporary differences are not provided for: the initial recognition of goodwill; the initial recognition of assets or liabilities that affect neither accounting nor taxable profit other than in a business combination, and differences relating to investments in subsidiaries to the extent that they will probably not reverse in the foreseeable future. The amount of deferred tax provided is based on the expected manner of realization or settlement of the carrying amount of assets and liabilities, using tax rates enacted or substantively enacted at the financial year end date.

A deferred tax asset is recognized only to the extent that it is probable that future taxable profits will be available against which the asset can be utilized.

3.19 Segment reporting

The Chief Operating Decision Maker (“CODM”) has been determined to be the Chief Executive Officer as he is primarily responsible for the allocation of resources to the segments and the assessment of performance of the segments.

Nomad’s operations are organized into one operating unit, ‘Frozen’, which comprises all the brands, as well as the factories, private label business units and certain corporate overheads. The CODM primarily uses (“Adjusted EBITDA”), disclosed in Note 5, as the key measure of the segment’s results. Adjusted EBITDA is EBITDA adjusted to exclude (when they occur) exited markets, chart of account (“CoA”) alignments and exceptional items such as restructuring charges, goodwill and intangible asset impairment charges, the impact of share based payment charges, charges relating to the Founder Preferred Shares Annual

F-21

Dividend Amount, charges relating to the redemption of warrants and other unusual or non-recurring items.

EBITDA, disclosed in Note 5, is defined as profit/(loss) for the period before taxation, net financing costs, depreciation and amortization.

3.20 Onerous contracts provisions

Where the costs of fulfilling a contract exceed the economic benefits that the Company expects to receive from it, an onerous contract provision is recognized for the net unavoidable costs. In estimating the net unavoidable costs, management estimate foreseeable income that may be received and offset this against the minimum future cash outflows from fulfilling the contract. All cash flows are discounted at an appropriate discount rate.

3.21 Unfavorable contracts

Unfavorable contracts recognized from business combinations are classified as a liability, discounted and recognized over the term of the underlying contract as a reduction in the associated expense.

3.22 IFRSs not yet adopted

At the date of authorization of these financial statements, the following Standards and Interpretations, which have not been applied in the financial statements, were in issue but not yet effective:

• IFRS 9 ‘Financial Instruments’ addresses the classification, measurement and recognition of financial assets and financial liabilities and replaces IAS 39. The standard reduces the complexity of the current rules on financial instruments as mandated in IAS 39. IFRS 9 replaces the ‘incurred loss model’ in IAS 39 with an ‘expected credit loss’ model. The standard also introduces new presentation and disclosure requirements. The standard also introduces new hedge accounting rules although the adoption of these is optional so that the hedge accounting rules under IAS 39 may continue to be applied. The effective date for the adoption of IFRS 9 is annual periods beginning on or after 1 January 2018. Except for hedge accounting, retrospective application is required but providing comparative information is not compulsory. For hedge accounting, the requirements are generally applied prospectively, with some limited exceptions.

The Group has completed its assessment of the effects of transition to IFRS 9. The impacts that have been identified on adopting IFRS 9 on the Group are detailed below.

–Classification and measurement: IFRS 9 establishes a principle based approach for classification of financial assets based on cash flow characteristics of the asset and the business model in which an asset is held as well as changes to the measurement of financial liabilities held at FVTPL. The change in classification does not affect the accounting recognition of financial assets presented in these financial statements and the impact of the change in measurement on financial liabilities as at December 31, 2017 is €nil.

–Impairment: The significant financial assets held that are affected by the impairment losses recognised under IFRS 9 are trade receivables, for which the gross balance as at December 31, 2017 is €289.0 million with an impairment provision of €5.8 million. Management has performed an assessment of the impairment of trade receivables under IFRS 9 using Expected Credit Losses derived from actual credit losses experienced in the

F-22

past. Based on this assessment, the impairment provision was found to be comparable to the existing provision, with no material difference.

–Hedge accounting: The Group has elected not to apply IFRS 9 for hedge accounting.

• IFRS 15 ‘Revenue from contracts with customers’ outlines a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance. The core principle of the new standard is for companies to recognize revenue to depict the transfer of goods or services to customers in amounts that reflect the consideration to which the company expects to be entitled in exchange for those goods or services.

Management has assessed the effects of applying the new standard on the Company’s financial statements and has identified that the presentation of contract assets and contract liabilities will need to be changed. Specifically, adoption of IFRS 15 will result in additional disclosures in our footnotes around discounts and trade marketing expenses as of 1 January 2018 in relation to trade terms which are currently included in other balance sheet line items.

The Company has quantified that there is no material impact on revenue recognition by applying this standard. The Company will apply the standard using the modified retrospective approach which means that any cumulative impact of the adoption identified would have been be recognized in retained earnings as of January 1, 2018 and that comparatives will not be restated.

• IFRS 16 ‘Leases’ sets out the principles for the recognition, measurement, presentation and disclosure of leases and replaces IAS 17 ‘Leases’. The standard introduces a single lessee accounting model and requires a lessee to recognize assets and liabilities for all leases with a term of more than 12 months, unless the underlying asset is of low value. The Standard also contains enhanced disclosure requirements for lessees. This IFRS will become effective for accounting periods starting on January 1, 2019 with early application permitted for companies applying IFRS 15 ‘Revenue from Contracts with Customers’.

The Company is still assessing the full impact of the new IFRS 16 Standard. However, it is expected that there will be an increase in assets and liabilities as a result of the adoption of the new standard.    

4) Critical accounting estimates and judgments

The preparation of financial statements in accordance with IFRS requires the use of estimates. It also requires management to exercise judgment in applying the accounting policies. The key areas involving a higher degree of judgment or complexity, or areas where assumptions are significant to the consolidated financial statements are highlighted under the relevant note. Critical accounting estimates and judgments are listed below:

a) Discounts and trade marketing expense

Discounts given by the Company include rebates, price reductions and incentives given to customers, promotional couponing and trade communication costs. Each customer has a unique agreement that is governed by a combination of observable and unobservable performance conditions.

F-23

At each financial year end date any discount incurred but not yet invoiced is estimated, based on historical trends and rebate contracts with customers, and accrued as ‘trade terms’. The balance of the reduction in trade receivables for trade terms as of December 31, 2017 is disclosed in Note 18.

In certain cases the estimate for discounts requires the use of forecast information for future trading periods and so there arises a degree of estimation uncertainty. These estimates are sensitive to variances between actual results and forecasts. The current accruals reflect the Company’s best estimate of these forecasts.

Trade marketing expense is comprised of amounts paid to retailers for programs designed to promote Company products. The ultimate costs of these programs can depend upon retailer performance and is the subject of significant management estimates. The Company records as a reduction in revenue, the estimated ultimate cost of the program in the period during which the program occurs and is based upon the programs offered, timing of those offers, estimated retailer performance based on history, management’s experience and current economic trends.

b) Business combinations

The Company is required to recognize separately, at the acquisition date, the identifiable assets, liabilities and contingent liabilities acquired or assumed in a business combination at their fair values. This involves judgment over whether intangible assets can be separately identified as well as an estimate of fair value of all assets and liabilities acquired. Such estimates are based on valuation techniques, which require considerable judgment in forecasting future cash flows and developing other assumptions. These estimates are based on information available on the acquisition date and assumptions that have been deemed reasonable by management. The following judgments, estimates and assumptions can materially affect our financial position and profit:

• The fair value of intangible and tangible assets that are subject to depreciation or amortization in future periods.

• Future changes to the assumptions used in estimating the value of assets and liabilities may result in additional expenses or income.

c) Carrying value of goodwill and brands

Determining whether goodwill and brands are impaired requires an estimation of the value in use of the cash generating unit to which goodwill and brands have been allocated. The value in use calculation requires the entity to estimate the future cash flows expected to arise from the cash generating unit and a suitable discount rate in order to calculate present value. Details of impairment reviews are provided in Note 13.

d) Employee benefit obligation

The Group operates a number of defined benefit pension schemes and post-employment benefit schemes which are valued by estimating the amount of future benefit that employees have earned in return for their service in the current and prior periods. Each Scheme has an actuarial valuation performed and is dependent on a series of assumptions See Note 23 for details of these assumptions and a sensitivity analysis on material assumptions.

e) Uncertain tax positions

Where tax exposures can be quantified, an accrual for uncertain tax positions is made based on best estimates and management’s judgments with regard to the amounts expected to be paid to the relevant tax authority. Given the inherent uncertainties in assessing the outcomes of these exposures (which can sometimes be binary in nature), the Company could in future periods experience adjustments to these accruals. The factors considered include the progress of discussions with the tax authorities and the level of documentary support for historical positions taken by previous owners.

F-24

f) Onerous contracts

Where the costs of fulfilling a contract exceed the economic benefits that the Company expects to receive from it, an onerous contract provision is recognized for the net unavoidable costs. In estimating the net unavoidable costs, management estimate foreseeable income that may be received and offset this against the minimum future cash outflows from fulfilling the contract. All cash flows are discounted at an appropriate discount rate.

Estimating future income is highly judgmental and is based on management’s best estimate. Onerous contracts are presented as provisions in Note 24.

g) Fair value of derivative financial instruments.

Note 34 includes details of the fair value of the derivative instruments that the Company holds at each balance sheet period. Management has estimated the fair value of these instruments by using valuations based on discounted cash flow calculations.

h) Share-based payments

At the end of each reporting period, the Company, in estimating its share-based payment charge, assesses and revises its estimates of the number of interests that are expected to vest based on the non-market vesting conditions. Note 8b contains details of these assumptions and of the valuation model used.

5) Segment reporting

Nomad has one reporting and operating segment, ‘Frozen’, reflected in the segment presentation below for the periods presented. Historical financial information of the predecessor has been re-presented as if it was one single operating segment for comparative purposes.

Segment Adjusted EBITDA

		Successor	Successor	Successor		Successor		Predecessor
		Year ended December 31, 2017	Year ended December 31, 2016	9 months ended December 31, 2015		Year ended March 31, 2015		5 months ended May 31, 2015
	Note	€m	€m	€m		€m		€m
Profit/(loss) for the period		136.5	36.4	(337.3	)	(167.5	)	(128.0	)
Taxation		32.0	39.6	(12.3	)	—		40.9
Net financing costs/(income)		74.4	62.1	35.5		(0.1	)	115.7
Depreciation	12	35.9	43.3	20.3		—		11.3
Amortization	13	6.5	7.8	1.5		—		1.2
EBITDA		285.3	189.2	(292.3	)	(167.6	)	41.1
Net purchase-price adjustment-inventory step up		—	—	37.0		—		—
Net purchase-price adjustment for cash flow hedge accounting		—	—	4.9		—		—
Charge related to Founder Preferred Shares Annual Dividend Amount	27	—	—	349.0		165.8		—
(Credit)/charge relating to Warrant Redemption Liability	25	—	—	(0.4	)	0.4		—
Exceptional items	7	37.2	134.5	58.1		0.7		84.3
Other add-backs		5.6	1.2	—		—		—
Adjusted EBITDA		328.1	324.9	156.3		(0.7	)	125.4
Unallocated corporate costs		—	—	2.5		0.7		—
Frozen Adjusted EBITDA		328.1	324.9	158.8		—		125.4

F-25

Other add-backs include the elimination of share-based payment charges of €2.6 million (2016: €1.2 million) and elimination of M&A related investigation costs, professional fees, transaction costs and purchase accounting related valuations of €3.0 million. We exclude these costs because we do not believe they are indicative of our normal operating costs, can vary significantly in amount and frequency, and are unrelated to our underlying operating performance.

No information on segment assets or liabilities is presented to the CODM.

Product information

Management considers the products it sells belong to one category, being ‘Frozen’.

Geographical information

External revenue by geography

	Successor	Successor	Successor	Successor	Predecessor
	Year ended December 31, 2017	Year ended December 31, 2016	9 months ended December 31, 2015	Year ended March 31, 2015	5 months ended May 31, 2015
	€m	€m	€m	€m	€m
United Kingdom	411.9	437.5	288.6	—	225.0
Italy	371.4	348.5	205.2	—	169.7
Germany	300.3	267.8	150.0	—	124.2
Sweden	208.0	218.2	35.5	—	—
France	170.0	168.9	41.0	—	—
Norway	123.3	122.6	19.6	—	—
Austria	96.7	92.9	51.8	—	45.0
Spain	81.2	82.6	13.1	—	—
Rest of Europe	193.8	188.7	89.4	—	76.4
Total external revenue by geography	1,956.6	1,927.7	894.2	—	640.3

Non-current assets by geography

	Successor	Successor
	December 31, 2017	December 31, 2016
	€m	€m
Germany	126.4	118.0
United Kingdom	94.8	77.5
Italy	55.0	59.1
Sweden	26.5	44.6
France	16.7	18.4
Norway	15.7	13.3
Rest of Europe	20.2	6.1
Total non-current assets by geography	355.3	337.0

Non-current assets exclude deferred tax assets, goodwill and brands which are not bound to one geographical area.

F-26

6) Operating profit/(loss)

Operating profit /(loss) is stated after charging:

		Successor		Successor		Successor	Successor	Predecessor
		Year ended December 31, 2017		Year ended December 31, 2016		9 months ended December 31, 2015	Year ended March 31, 2015	5 months ended May 31, 2015
	Note	€m		€m		€m	€m	€m
Staff costs	8	257.4		264.5		160.2	—	88.8
Depreciation of property, plant and equipment	12	35.9		43.3		20.3	—	11.3
Impairment of property, plant and equipment	12	0.3		1.4		3.2	—	—
Impairment of goodwill and brands	13	—		—		—	—	55.0
Amortization of software and brands	13	6.5		7.8		1.5	—	1.2
Operating lease charges		15.0		14.6		4.2	—	3.2
Exchange (gains)/losses		(1.2	)	(3.3	)	5.2	88.9	(9.0	)
Fair value loss on financial assets at fair value through profit and loss		—		—		4.9	—	—
Research & development expenditure		15.4		13.3		12.1	—	7.2
Inventories recognized as an expense within cost of goods sold		1,273.3		1,282.6		608.9	—	389.3

7) Exceptional items

Exceptional items are made up as follows:

	Successor		Successor		Successor		Successor	Predecessor
	Year ended December 31, 2017		Year ended December 31, 2016		9 months ended December 31 2015		Year ended March 31, 2015	5 months ended May 31, 2015
	€m		€m		€m		€m	€m
Investigation of strategic opportunities (1)	18.8		7.0		7.7		—	1.3
Supply chain reconfiguration (2)	14.0		84.3		—		—	—
Findus Group integration costs (3)	15.1		29.6		4.5		—	—
Costs related to transactions (4)	3.2		4.8		34.1		0.7	3.8
Costs related to long-term management incentive plans (5)	—		1.9		3.5		—	22.9
Other restructuring costs (6)	—		(1.0	)	8.9		—	—
Cisterna fire net (income)/costs (7)	—		(4.3	)	(2.5	)	—	1.3
Impairment of intangible assets (8)	—		—		—		—	55.0
Settlement of legacy matters (9)	(5.6	)	1.8		1.9		—	—
Remeasurement of indemnification assets (10)	(8.3	)	10.4		—		—	—
Total exceptional items	37.2		134.5		58.1		0.7	84.3

F-27

(1) Investigation of strategic opportunities

Successor

The Company incurred charges of €18.8 millionin the year endedDecember 31, 2017 in relation to the implementation of the Nomad strategic vision, which primarily relates to changes to the organizational structure to align behind core products and implement net revenue management initiatives (2016: €7.0 million, 2015: €7.7 million). The prior periods exclude costs associated with legacy matters which are now allocated to (9), which has reduced the 2016 charge from €8.8 million to €7.0 million and the 2015 charge from €9.6 million to €7.7 million.

Predecessor

For the five months ended May 31, 2015 the Iglo Group incurred charges of €1.3 millionin relation to a strategic review of the Iglo Group’s operations and other items. The charges include costs incurred as a result of the decision to cease marketing its products in Romania, Slovakia and Turkey on November 27, 2014, amounts in relation to tax matters from previous accounting periods and costs related to the implementation of the Better Meals Together strategy.

(2) Supply chain reconfiguration

Successor

Supply chain reconfiguration relates to large scale restructuring projects undertaken by the Company to optimize the supply chain. A charge of €14.0 million has been incurred in relation to restructuring activities for the year endedDecember 31, 2017, which relates to the closure of the Bjuv manufacturing facility.

A charge of €84.3 million was incurred in the year ended December 31, 2016, of which €54.0 million was incurred in relation to restructuring activities, primarily relating to the closure of the Bjuv manufacturing facility. A further €30.3 million was incurred for an onerous contract that relates to the renegotiation of the Company’s agreements with a third party for the use of a warehouse facility.

(3) Findus Group integration costs

Successor

Following the acquisition of the Findus Group on November 2, 2015, the Company initiated a substantial integration project. Costs of €15.1 million have been incurred in the year endedDecember 31, 2017. For the year ended December 31, 2016 costs of €29.6 million were incurred. For the nine months ended December 31, 2015 costs of €4.5 million were incurred. Costs incurred in 2017 primarily relate to the rollout of the Nomad ERP system.

(4) Costs related to transactions

Successor

The charge for the year endedDecember 31, 2017, relates to enhanced control compliance procedures in territories. For the year ended December 31, 2016 and the nine months ended December 31, 2015, costs related to transactions primarily relates to the acquisition of the Iglo Group. For the year ended March 31, 2015 the Iglo Group incurred a charge of €0.7 million in relation to acquisition and sale transactions.

Predecessor

In 2015, a €3.8 million charge was incurred relating to the payment of registration tax assessed as a result of the CSI (Findus Italy) acquisition. The Iglo Group appealed the rulings and elected to pay the assessed taxes in order to avoid incurring penalties and interest.

F-28

(5) Costs related to long-term management incentive plans

Successor

Subsequent to the sale of Iglo and specific to the terms of a Predecessor incentive scheme, management participated in an incentive scheme for which the Company incurred charges €1.9 million in the year ended December 31, 2016 and €3.5 million in the nine months ended December 31, 2015. Refer to Note 8 for more details on the management incentive scheme which ended in May 2016.

Predecessor

The Iglo Acquisition on June 1, 2015 was a triggering event under the main incentive schemes following which the majority of management incentive schemes provisions were paid. The completion of the sale was a triggering event under the cash settled schemes.

A charge of €22.9 million in the five months ended May 31, 2015 represents an accelerated charge to align the cumulative charges recognized to the amount that was paid in June 2015 of €19.7 million. In addition, as a result of the terms of the sale, vesting of the equity settled share based payment scheme was accelerated. The non-cash charge of €3.2 million in the five months ended May 31, 2015 reflects the vesting of non-forfeited interests in this scheme. There were no associated exercises made in relation to the scheme due to the fact that market performance conditions were not met.

(6) Other restructuring costs

Successor

A credit of €1.0 million was recognized in the year endedDecember 31, 2016 related to the release of provisions for restructuring activities in the UK and German factories. For the nine months ended December 31, 2015, costs related to restructuring activities in the German, UK and Italian factories were €8.9 million.

(7) Cisterna fire net (income)/costs

Successor

A €4.3 million net income was recognized for the year ended December 31, 2016 in relation to the August 2014 fire insurance claim in the Italian production facility. A €2.5 million net income was recognized for the nine months ended December 31, 2015.

Predecessor

In the five months ended May 31, 2015 , the Iglo Group incurred charges of €1.3 million in relation to a fire in August 2014 in the Italian production facility which produces Findus branded stock for sale in Italy. The charges include the cost of stock damaged by the fire, the impairment of property as well as ongoing incremental costs incurred as a result of the disruption to operations. The Company has insurance policies in place covering the stock, property and loss of earnings for which claims are almost complete. The proceeds of these claims could not be recognized until the recoverable amount was judged to be virtually certain. No further costs are expected to arise from this incident and any future income from insurance claims is expected to be insignificant.

(8) Impairment of intangible assets

Predecessor

As a result of circumstances identified during the five months ended May 31, 2015 it was noted that the recoverable amount of the Italian intangible assets held prior to the Iglo Acquisition were lower than the values previously carried in the Iglo accounts. Therefore the carrying values were adjusted and an impairment charge of €55.0 million was recognized in the five months ended May 31, 2015.

F-29

(9) Settlement of legacy matters

Successor

A net income of €5.6 million has been recognized in liabilities relating to periods prior to acquisition of the Findus and Iglo businesses by the Company (charge of €1.8 million in the year ended December 31, 2016, charge of €1.9 million in the nine months ended December 31, 2015). These were previously classified within Investigation and implementation of strategic opportunities and other items and have been reclassified into this line for all successor periods presented.

The credit includes a charge of €3.9 million associated with settlements of tax audits, offset by gains of €4.2 million from the reassessment of sales tax provisions, €1.2 million from the reassessment of interest on sales tax provisions, a €2.8 million gain on a legacy pension plan in Norway and a €1.3 million gain on disposal of a non-operational factory.

(10) Remeasurement of indemnification assets

Successor

Remeasurement of the indemnification assets relates to the movement in value of shares held in escrow as part of the consideration on the acquisition of the Findus Group as well as the release of indemnification assets associated with the acquisition of the Iglo Group as discussed in Note 19.

Tax impact of exceptional items

The tax impact of the exceptional items amounts to a credit of €13.8 million in the year endedDecember 31, 2017 (year ended December 31, 2016: credit of €8.8 million, nine months ended December 31, 2015: credit of €6.1 million, year ended March 31, 2015: €nil, five months ended May 31, 2015: credit of €22.0 million).

Cash flow impact of exceptional items

Included in the Consolidated Statements of Cash Flows for the year endedDecember 31, 2017 is €99.5 million (year ended December 31, 2016: €49.2 million, nine months ended December 31, 2015: €91.6 million, year ended March 31, 2015: €0.7 million, 5 months ended May 31, 2015: €6.2 million) of cash outflows relating to exceptional items. This includes cash flows related to the above items as well as the cash impact of the settlement of provisions brought forward from previous accounting periods.

8) Payroll costs, share based payments and management incentive schemes

(a) Payroll costs

The average number of persons employed by the Company (excluding non-Executive Directors) is analyzed and set out below:

	Successor	Successor	Successor	Successor	Predecessor
	Year ended December 31, 2017	Year ended December 31, 2016	9 months ended December 31, 2015	Year ended March 31, 2015	5 months ended May 31, 2015
Production	2,285	2,627	2,605	—	1,635
Administration, distribution & sales	1,572	1,571	1,767	—	1,047
Total number of employees	3,857	4,198	4,372	—	2,682

For the year ended March 31, 2015, the Successor did not have any operations or employees and accordingly no compensation or benefits were paid.

F-30

The table below discloses the Company’s aggregate payroll costs of these persons. Payroll costs exclude long term management incentive scheme and share based payment costs, but includes bonus costs, in particular those associated with a non-cash bonus for key management employees, whereby 13,104 Ordinary shares of the Company were issued to the recipients’ on November 27, 2015.

	Successor	Successor	Successor	Successor	Predecessor
	Year ended December 31, 2017	Year ended December 31, 2016	9 months ended December 31, 2015	Year ended March 31, 2015	5 months ended May 31, 2015
	€m	€m	€m	€m	€m
Wages and salaries	200.8	205.4	126.7	—	72.1
Social security costs	42.0	45.9	27.5	—	12.5
Other pension costs	14.6	13.2	6.0	—	4.2
Total payroll costs	257.4	264.5	160.2	—	88.8

(b) Share based payments

Successor

During 2015, the Company established a discretionary share award scheme, the LTIP, which enables the Company’s Compensation Committee to make grants (“Awards”) in the form of rights over ordinary shares, to any Director, Non-Executive Director or employee of the Company. However, it is the Committee’s current intention that Awards be granted only to Directors and senior management, whilst recognizing a separate annual Restricted Stock Award for Non-Executive Directors.

All Awards are to be settled by physical delivery of shares.

Non-Executive Director Restricted Share Awards

In accordance with the Board approved independent Non-Executive Director compensation guidelines, each independent Non-Executive Director is granted $100,000 of restricted shares annually on the date of the annual general meeting, valued at the closing market price for such shares on this date. The restricted shares vest on the earlier to occur of the date of the Company’s annual meeting of shareholders or thirteen months from the date of grant.

The Non-Executive Directors restricted share awards, granted at a share price of $11.50 on December 7, 2015, vested on June 16, 2016 and were issued in July 2016 at a share price of $8.98. Of the total 34,780 number of shares vesting, 11,568 shares were held back from issue by the Company as settlement towards personal tax liabilities arising on the vested shares.

The Non-Executive Directors restricted share awards granted on June 16, 2016, which consisted of 55,680 shares at a share price of $8.98, vested on June 19, 2017 and were issued at a share price of $14.38, resulting in a €0.3 million increase in the share based compensation reserve. Of the total 55,680 number of shares vesting, 9,384 shares were held back from issue by the Company as settlement towards personal tax liabilities arising on the vested shares.

On June 19, 2017, Non-Executive Directors were granted 41,724 restricted share awards at a share price of $14.38. On August 22, 2017, two new Non-Executive Directors were granted a pro-rata 11,774 restricted share awards at the same share price and vesting conditions as the previous grant.

The total charge for Non-Executive Director grants within the Statement of Consolidated Profit or Loss for the year endedDecember 31, 2017 for stock compensation awards was €0.8 million (year ended December 31, 2016: €0.6 million; nine months ended December 31, 2015: €0.1 million).

F-31

Director and Senior Management Share Awards

As part of its long term incentive initiatives, the Company has issued 4,927,000 restricted shares to the management team (the “Management Share Awards”). 3,837,000 shares (net of 770,000 forfeitures in the period) are currently allocated for the January 1, “2016” grant and a further 1,090,000 shares (including 485,000 new awards granted in the period) have been allocated for the January 1, “2017” grant. Relevant to each grant, half of the awards are contingent upon achieving a benchmark market share price and the other half of the awards will vest provided one of a range of cumulative EBITDA performance targets is met over a four year period. If the share price benchmark is met, the shares for this portion of the awards will vest 50% over a two year period and 50% over a four year period. For the 2016 grant, the two year period is through to January 1, 2018 and the four year period through to January 1, 2020. For the 2017 grant, the two year period is through to January 1, 2019 and the four year period through to January 1, 2021. The other half of the 2016 and 2017 awards will vest on January 1, 2020 and January 1, 2021 respectively provided one of a range of cumulative EBITDA performance targets is met over a four year period from January 1, 2016 to December 31, 2019 for the 2016 grant and from January 1, 2017 to December 31, 2020 for the 2017 grant.

The stock compensation charge reported within the Consolidated Statement of Profit or Loss for the year endedDecember 31, 2017 related to the management plan is €1.8 million (year ended December 31, 2016: €0.6 million; nine months ended December 31, 2015: €nil)

The Company calculates the cost of the Management Share Awards based upon their fair value using the Monte Carlo Model, which is considered to be the most appropriate methodology considering the restricted shares only vest once the market performance conditions have been satisfied, as well as expected exercise period and the payment of dividends by the Company. Following a revision to the January 1, 2016 award EBITDA Performance Target Conditions and updating for scheme leavers, the inputs and assumptions underlying the Monte Carlo models for both awards are now as follows:

	January 1, 2016 award			January 1, 2017 award
Grant date price	$	12.00		$	9.57
Exercise price	$	—		$	—
Expected life of restricted share	3.02 – 4.00 years			3.11 – 4.00 years
Expected volatility of the share price	20.0		%	23.0		%
Dividend yield expected	—		%	—		%
Risk free rate	1.59		%	1.83		%
Employee exit rate	16.0		%	16.0		%
EBITDA Performance Target Condition	5.0%-75.0%			5.0%-75.0%

The expected volatility of the share price inputs of 20.0% and 23.0% were estimated by referencing selected quoted companies which are considered to exhibit some degree of comparability with the Company, as the Company has only been listed for approximately two years at the time of the 2017 grant.

Based on the revised assessment in the current period of fair value and the number of shares expected to vest, the total fair value in respect of the Restricted Shares as at the January 1, 2016 grant date is $6.3 million (€5.9 million) and $0.6 million (€0.6 million) as at the January 1, 2017 grant date.

F-32

	Share based compensation reserve
	€m
Balance as of January 1, 2017	1.0
Non-Executive Director restricted share awards charge	0.8
Directors and Senior Management share awards charge	1.8
Vesting of Non-Executive Director restricted shares	(0.7)
Balance as of December 31, 2017	2.9

Initial Options

On April 11, 2014 Lord Myners, Alun Cathcart (resigned February 2016) and Guy Yamen (resigned June 2015), all Non-Executive Directors, were granted options (“Initial Options”) to purchase a maximum of 125,000 Ordinary Shares at an exercise price of $11.50 per ordinary share (subject to such adjustment to the number of Ordinary Shares and/or the exercise price as the Directors consider appropriate in accordance with the terms of the Initial Option Deeds in respect of an issue of Ordinary Shares by way of a dividend or distribution to holders of Ordinary Shares, a subdivision or consolidation or any other variation to the share capital of Nomad, as determined by the Directors).

The awards are now exercisable within a five year period, which commenced on the trading day immediately following the Iglo Group acquisition on June 1, 2015. Nomad has calculated the cost of the Initial Options based upon their fair value and taking into account the vesting period and using the Black-Scholes methodology. The valuation of the Initial Options has been based on the following assumptions:

– market value of Ordinary Shares at the grant date of $10.00;

– an exercise price of $11.50;

– 1 year expected time to acquisition;

– probability of acquisition of 61%;

– volatility of 17.03%; and

– a risk free interest rate of 0.84%.

Such securities and awards have been accounted for in accordance with “IFRS 2—Share Based Payment”. Based on the preceding assumptions, the total value for the Initial Options is €0.06 million. There were no forfeitures at the grant date and the expense was recognized over an estimated 2-year period ended on April 1, 2016.

Predecessor

In prior years for the Predecessor, certain employees of the Predecessor were offered the opportunity to participate in one of several Predecessor share schemes through which they could subscribe for shares of the Permira Partnership, the ultimate controlling party of the Predecessor. These schemes were accounted for under IFRS 2 “Share Based Payments” and represented equity settled share based payments.

Due to the sale of the Iglo Group, the vesting of the equity settled share based payment scheme was accelerated. The resulting €3.2 million charge to the Consolidated Statement of Profit or Loss for the five months ended May 31, 2015, reflected the accelerated vesting of non-forfeited interests in the scheme. The plans were equity settled.

F-33

(c) Management incentive schemes

Successor

Subsequent to the sale of Iglo and specific to the terms of a Predecessor incentive scheme, €1.9 million was charged to the Consolidated Statement of Profit or Loss during the year endedDecember 31, 2016. €3.5 million was charged in the nine month period to December 31, 2015. This scheme ended in May 2016.

Predecessor

Certain members of the Predecessor’s management team previously participated in certain incentive schemes. The completion of the sale of the Iglo Group to the Company on June 1, 2015 was a triggering event under the cash settled schemes. The resulting €19.7 million charge to the Consolidated Statement of Profit or Loss for the five months ended May 31, 2015, reflected the acceleration of the charges to align the cumulative charges recognized to the amount that was paid in June 2015.

9) Directors and Key Management compensation

	Successor	Successor	Successor	Successor	Predecessor
	Year ended December 31, 2017	Year ended December 31, 2016	9 months ended December 31, 2015	Year ended March 31, 2015	5 months ended May 31, 2015
	€m	€m	€m	€m	€m
Short-term employee benefits	2.0	2.1	1.3	—	1.9
Contributions to money purchase pension plans	—	—	—	—	0.2
Share-based payment	1.4	0.9	0.1	—	2.2
Long-term incentive scheme	—	—	—	—	17.4
Compensation for loss of office	0.4	—	—	—	—
Non-Executive Director fees	0.3	0.2	0.1	0.2	—
Total Directors’ and executive officers' compensation	4.1	3.2	1.5	0.2	21.7

All significant management decision making authority is vested within the Board of Directors and the executive team, therefore key management are considered to be the Directors and executive Officers.

In the year endedDecember 31, 2017, two executive Officers were accruing benefits under share based payment schemes (year ended December 31, 2016: three).

Predecessor Non-Executive Directors were paid through payroll and are included within the table above but were not disclosed separately.

In the predecessor period, there were eight directors in respect of whose qualifying services shares were received under long term incentive schemes, including the highest paid director.

	Successor	Successor	Successor	Successor	Predecessor
	Year ended December 31, 2017	Year ended December 31, 2016	9 months ended December 31, 2015	Year ended March 31, 2015	5 months ended May 31, 2015
Retirement benefits are accruing to the following number of directors under:
Money purchase schemes	2	1	1	—	4

F-34

10) Finance income and costs

		Successor		Successor		Successor		Successor	Predecessor
		Year ended December 31, 2017		Year ended December 31, 2016		9 months ended December 31, 2015		Year ended March 31, 2015	5 months ended May 31, 2015
	Note	€m		€m		€m		€m	€m
Interest income		0.2		5.9		4.4		—	2.0
Gain on derivatives		7.0		—		4.3		—	—
Net foreign exchange gains on translation of financial assets and liabilities		—		18.3		—		0.1	—
Finance income		7.2		24.2		8.7		0.1	2.0
Accrued interest		—		—		—		—	(60.2	)
Cash pay interest expense		(54.0	)	(68.7	)	(38.8	)	—	(35.4	)
Cross-currency interest rate swaps: cash flow hedges, transfer from equity		3.9		—		—		—	—
Other interest expense		—		(2.8	)	—		—	—
Net pension interest costs		(3.6	)	(4.1	)	(1.9	)	—	(0.7	)
Amortization of borrowing costs		(2.7	)	(5.0	)	(2.1	)	—	(0.9	)
Net foreign exchange losses on translation of financial assets and liabilities		(3.9	)	—		(0.5	)	—	(20.5	)
Interest on unwinding of discounted items		(1.2	)	(1.4	)	—		—	—
Loss on derivatives		—		(4.3	)	—		—	—
Financing costs incurred in amendment of terms of debt(1)		(20.1	)	—		(0.9	)	—	—
Finance costs		(81.6	)	(86.3	)	(44.2	)	—	(117.7	)
Net finance (costs)/income		(74.4	)	(62.1	)	(35.5	)	0.1	(115.7	)

(1)     A one-off charge of €20.1 million was incurred as a consequence of the refinancing in May 2017 and repricing in December 2017. Of this, deferred transaction costs of €15.7 million relating to the previous senior debt were written off.

11) Taxation

		Successor		Successor		Successor		Successor	Predecessor
		Year ended December 31, 2017		Year ended December 31, 2016		9 months ended December 31, 2015		Year ended March 31, 2015	5 months ended May 31, 2015
	Note	€m		€m		€m		€m	€m
Current tax expense
Current tax on profits/loss for the period		(37.5	)	(58.9	)	(18.0	)	—	(41.2	)
Adjustments in respect of prior periods		3.2		(0.6	)	(2.3	)	—	15.2
		(34.3	)	(59.5	)	(20.3	)	—	(26.0	)
Deferred tax income/(expense)
Origination and reversal of temporary differences		(2.1	)	12.9		10.4		—	(14.9	)
Impact of change in tax rates		4.4		7.0		22.2		—	—
	16	2.3		19.9		32.6		—	(14.9	)
Total tax (expense)/credit		(32.0	)	(39.6	)	12.3		—	(40.9	)

F-35

Reconciliation of effective tax rate:

	Successor		Successor		Successor		Successor		Predecessor
	Year ended December 31, 2017		Year ended December 31, 2016		9 months ended December 31, 2015		Year ended March 31, 2015		5 months ended May 31, 2015
	€m		€m		€m		€m		€m
Profit/(loss) before tax	168.5		76.0		(349.6	)	(167.5	)	(87.1	)
Tax (charge)/credit at the standard UK corporation tax rate 19.25% (2016: 20%; 2015: 20.25%)	(32.5	)	(15.2	)	70.8		33.9		17.6
Difference in tax rates	(10.0	)	(10.0	)	(67.5	)	(33.9	)	(4.6	)
Non tax deductible interest	4.4		—		(9.9	)	—		(8.7	)
Other income and expenses not taxable or deductible	16.8		(7.4	)	1.0		—		(21.6	)
Unrecognized tax assets	(19.3	)	(1.8	)	(2.1	)	—		(30.9	)
Provisions for uncertainties	1.0		(11.6	)	0.1		—		(7.9	)
Impact of change in deferred tax rates	4.4		7.0		22.2		—		—
Prior period adjustment	3.2		(0.6	)	(2.3	)	—		15.2
Total tax (expense)/credit	(32.0	)	(39.6	)	12.3		—		(40.9	)

Effective tax rates

Successor

The effective tax rate for the year endedDecember 31, 2017 was 19% (year ended December 31, 2016: 52.1%). The change is principally caused by expenses which are not tax deductible, partially offset by the non-recognition of deferred tax assets on certain tax losses. Effective from and including January 12, 2016, the Company become a resident in the United Kingdom for United Kingdom tax purposes.

The Company operates in many different jurisdictions and in some of these, certain matters are under discussion with local tax authorities. These discussions are often complex and can take many years to resolve. Accruals for tax contingencies require management to make estimates and judgments with respect to the ultimate outcome of a tax audit, and actual results could vary from these estimates. Where tax exposures can be quantified, a provision is made based on best estimates and management’s judgments. Given the inherent uncertainties in assessing the outcomes of these exposures (which can sometimes be binary in nature), the Company could, in future years, experience adjustments to this provision.

Management believes that the Company’s position on all open matters including those in current discussion with local tax authorities is robust and that the Company is appropriately provided.

Following the enactment of the Finance Act 2016, the standard rate of corporation tax in the UK is 19.25% for 2017 (2016: 20%). The standard rate of corporation tax in the UK reduced from 20% to 19% with effect from April 1, 2017 and will reduce by a further 2% to 17% from April 1 2020. As the reductions to 19% and 17% were substantially enacted on September 6, 2016, these rates are reflected in these financial statements.

The tax (credit)/charge relating to components of other comprehensive income is as follows:

F-36

Successor

		Before tax		Tax charge/ (credit)		After tax
Year ended December 31, 2017	Note	€m		€m		€m
Remeasurement of post-employment benefit liabilities		(2.9	)	2.0		(0.9	)
Net investment hedge		0.8		—		0.8
Cash flow hedges		16.4		(5.0	)	11.4
Other comprehensive loss		14.3		(3.0	)	11.3
Current tax		—		—		—
Deferred tax	16	—		(3.0	)	—
		—		(3.0	)	—
		Before tax		Tax charge		After tax
Year ended December 31, 2016	Note	€m		€m		€m
Remeasurement of post-employment benefit liabilities		23.6		6.3		29.9
Net investment hedge		0.5		—		0.5
Cash flow hedges		(10.1	)	2.8		(7.3	)
Other comprehensive loss		14.0		9.1		23.1
Current tax		—		—		—
Deferred tax	16	—		9.1		—
		—		9.1		—
		Before tax		Tax charge		After tax
Nine months ended December 31, 2015	Note	€m		€m		€m
Remeasurement of post-employment benefit liabilities		(19.4	)	6.1		(13.3	)
Net investment hedge		4.4		—		4.4
Cash flow hedges		(1.6	)	0.5		(1.1	)
Other comprehensive (income)/loss		(16.6	)	6.6		(10.0	)
Current tax		—		—		—
Deferred tax	16	—		6.6		—
		—		6.6		—

Predecessor
		Before tax		Tax credit		After tax
5 months ended May 31, 2015	Note	€m		€m		€m
Remeasurement of post-employment benefit liabilities		2.5		(0.7	)	1.8
Net investment hedge		(44.7	)	—		(44.7	)
Cash flow hedges		—		—		—
Other comprehensive income		(42.2	)	(0.7	)	(42.9	)
Current tax		—		—		—
Deferred tax	16	—		(0.7	)	—
		—		(0.7	)	—

F-37

12) Property, plant and equipment

	Land and buildings		Plant and equipment		Computer equipment		Total
	€m		€m		€m		€m
SUCCESSOR
Cost
Balance at December 31, 2015	119.2		221.8		2.4		343.4
Acquisitions through business combinations	—		2.5		—		2.5
Additions	3.3		34.3		0.4		38.0
Transfer to intangible assets (note 13)	(1.7	)	1.1		—		(0.6	)
Disposals	(2.7	)	(0.6	)	—		(3.3	)
Effect of movements in foreign exchange	(7.6	)	(28.8	)	—		(36.4	)
Balance at December 31, 2016	110.5		230.3		2.8		343.6
Additions	11.6		26.0		0.4		38.0
Disposals	(0.1	)	(1.1	)	—		(1.2	)
Effect of movements in foreign exchange	(4.6	)	(12.7	)	—		(17.3	)
Balance at December 31, 2017	117.4		242.5		3.2		363.1
Accumulated depreciation and impairment
Balance at December 31, 2015	3.4		21.4		0.4		25.2
Depreciation	6.5		35.7		1.1		43.3
Impairment	(0.2	)	1.6		—		1.4
Transfers	—		0.2		(0.2	)	—
Effect of movements in foreign exchange	(3.9	)	(20.5	)	(0.1	)	(24.5	)
Balance at December 31, 2016	5.8		38.4		1.2		45.4
Depreciation	6.1		28.9		0.9		35.9
Impairment	—		0.3		—		0.3
Effect of movements in foreign exchange	(3.7	)	(10.2	)	—		(13.9	)
Balance at December 31, 2017	8.2		57.4		2.1		67.7
Net book value December 31, 2015	115.8		200.4		2.0		318.2
Net book value December 31, 2016	104.7		191.9		1.6		298.2
Net book value December 31, 2017	109.2		185.1		1.1		295.4

Leased equipment

The Company leased items of machinery in Sweden under finance leases which were disposed of in the year ended December 31, 2017 and so the net carrying amount of those leased assets is nil (December 31, 2016: €0.8 million).

Security

Borrowings have been provided by a syndicate of third party lenders, (the “Syndicate”). The Syndicate together with holders of the bond issue have security over the assets of the ‘guarantor group’. The ‘Guarantor Group’ consists of those companies which individually have more than 5% of consolidated total assets or EBITDA (as defined in the Senior Facilities Agreement) of the Company and in total comprise more than 80% of consolidated total assets or EBITDA at any testing date.

F-38

13) Goodwill and Intangibles

	Goodwill	Brands	Computer software		Customer relationships	Others		Total
	€m	€m	€m		€m	€m		€m
Cost
Balance at December 31, 2015	1,676.8	1,688.9	11.0		31.0	0.2		3,407.9
Acquisitions through business combinations	68.8	—	—		—	(0.2	)	68.6
Additions	—	—	4.4		—	—		4.4
Transfer from tangible assets (note 12)	—	—	0.6		—	—		0.6
Effect of movements in foreign exchange	—	—	(1.3	)	—	—		(1.3	)
Balance at December 31, 2016	1,745.6	1,688.9	14.7		31.0	—		3,480.2
Additions	—	—	4.6		—	—		4.6
Effect of movements in foreign exchange	—	—	(1.0	)	—	—		(1.0	)
Balance at December 31, 2017	1,745.6	1,688.9	18.3		31.0	—		3,483.8

	Goodwill	Brands	Computer software		Customer relationships	Others	Total
	€m	€m	€m		€m	€m	€m
Accumulated amortization and impairment
Balance at December 31, 2015	—	0.1	1.0		0.4	—	1.5
Amortization	—	0.7	4.9		2.2	—	7.8
Effect of movements in foreign exchange	—	—	(1.3	)	—	—	(1.3	)
Balance at December 31, 2016	—	0.8	4.6		2.6	—	8.0
Amortization	—	0.7	3.6		2.2	—	6.5
Effect of movements in foreign exchange	—	—	(0.7	)	—	—	(0.7	)
Balance at December 31, 2017	—	1.5	7.5		4.8	—	13.8
Net book value December 31, 2015	1,676.8	1,688.8	10.0		30.6	0.2	3,406.4
Net book value December 31, 2016	1,745.6	1,688.1	10.1		28.4	—	3,472.2
Net book value December 31, 2017	1,745.6	1,687.4	10.8		26.2	—	3,470.0

Amortization of €6.5 million (December 31, 2016: €7.8 million; December 31, 2015: €1.5 million) is included in ‘other operating expenses’ in the Consolidated Statement of Profit or Loss.

All goodwill, brands and customer relationship values have been allocated to the frozen cash generating unit.

The Company’s goodwill, brand and customer relationships values have been allocated based on the enterprise value at acquisition of each cash generating unit (“CGU”). Goodwill is monitored at an operating segment level. As required by IAS 36 “Impairment of Assets”, an annual review of the carrying amount of the goodwill and the indefinite life brands is carried out to identify whether there is any impairment to these carrying values. This is done by means of comparison of the carrying values to the value in use of the CGU. Value in use is calculated as the net present value of the projected risk-adjusted cash flows of each CGU.

Key assumptions

The values for the key assumptions were arrived at by taking into consideration detailed historical information and comparison to external sources where appropriate, such as market rates for discount factors.

• Budgeted cash flows: the calculation of value in use has been based on the cash flow forecasts by management for 2018 to 2020. The trends in these forecasts have been extrapolated to produce 2021 and 2022 forecast cash flows. Beyond 2022 the same assumptions have been applied for future periods in the absence of longer term detailed forecasts. These plans have been prepared and approved by management, and incorporate past performance of the entities acquired in the period, historical growth rates and projections of developments in key markets.

F-39

• Sales: projected sales are built up with reference to markets and product platforms. They incorporate past performance, historical growth rates and projections of developments in key markets.

• Adjusted EBITDA Margin: projected margins reflect historical performance.

• Capital expenditure forecast reflects one-off additional capital expenditure required in order to integrate the operations of the Findus acquisition.

• Discount rate: a pre-tax discount rate of 8.0% (2016: 8.0%) was applied to the cash flows. This discount rate has been calculated using a capital asset pricing model using observable market data, including the share price of Nomad Foods Limited.

• Long-term growth rates: as required by IAS 36, growth rates for the period after the detailed forecasts are based on past performance. The growth rate used in the testing was 1.0% (2016: 0.5%). These rates do not reflect the long-term assumptions used by the Company for investment planning.

Sensitivity to changes in assumptions

Impairment was not required at either December 31, 2017 or December 31, 2016. In each case the valuations derived from the discounted cash flow model indicate a sufficient amount of headroom for which any reasonably possible change to key assumptions is unlikely to result in an impairment of the related goodwill.

14) Acquisitions

On January 17, 2018 we entered into an agreement to acquire Green Isle Foods Ltd. including the Goodfella's and San Marco brands, in an all cash deal valued at £200 million (approximately €225 million). We anticipate this acquisition to be completed in the second quarter of 2018 and we expect this will enlarge our portfolio of brands to include the number one and number two market share positions within the frozen pizza category in Ireland and the UK, a successful frozen private label pizza business, and two frozen pizza manufacturing facilities. The purchase price of the acquisition is expected to be funded through cash on hand. The Company will disclose the impact of this acquisition once successfully completed. See Note 38, Significant events after the Statement of Financial Position date.

F-40

15) Investments

The following are the Company's significant investments as of December 31, 2017.

	Activity	Country of incorporation	Class of shares held	Ownership as of
				Dec 31, 2017
Nomad Foods Europe Holdings Limited	Holding	England	Ordinary	100%
Nomad Foods Europe Holdco Limited	Holding	England	Ordinary	100%
Nomad Foods Europe Finco Limited	Holding	England	Ordinary	100%
Nomad Foods Europe Midco Limited	Holding/ Finance	England	Ordinary	100%
Nomad Foods Bondco Plc	Finance	England	Ordinary	100%
Nomad Foods Lux S.à.r.l.	Finance	Luxembourg	Ordinary	100%
Nomad Foods Europe Limited	Management	England	Ordinary	100%
Birds Eye Limited	Trading	England	Ordinary	100%
Nomad Foods Europe Finance Limited	Finance	England	Ordinary	100%
Birds Eye Ireland Limited	Trading	Republic of Ireland	Ordinary	100%
Iglo Holding GmbH	Holding	Germany	Ordinary	100%
Iglo Nederland B.V.	Trading	Netherlands	Ordinary	100%
Iglo Belgium S.A.	Trading	Belgium	Ordinary	100%
Iglo Portugal	Trading	Portugal	Ordinary	100%
Iglo Austria Holdings GmbH	Holding	Austria	Ordinary	100%
C.S.I. Compagnia Surgelati Italiana S.R.L	Trading	Italy	Ordinary	100%
Findus Sverige Holdings AB	Holding	Sweden	Ordinary	100%
Iglo GmbH	Trading	Germany	Ordinary	100%
Frozen Fish International GmbH	Trading	Germany	Ordinary	100%
Liberator Germany Newco GmbH	Property	Germany	Ordinary	100%
Iglo Austria GmbH	Trading	Austria	Ordinary	100%
Findus Sverige AB	Trading	Sweden	Ordinary	100%
Frionor Sverige AB	Holding	Sweden	Ordinary	100%
Findus Holdings France SAS	Holding	France	Ordinary	100%
Findus France SAS	Trading	France	Ordinary	100%
Findus Espana SLU	Trading	Spain	Ordinary	100%
Findus Danmark A/S	Trading	Denmark	Ordinary	100%
Findus Finland Oy	Trading	Finland	Ordinary	100%
Findus Norge AS	Trading	Norway	Ordinary	100%

F-41

16) Deferred tax assets and liabilities

Recognized deferred tax assets and liabilities

Deferred tax assets and liabilities are attributable to the following:

	Dec 31, 2017					Dec 31, 2016
	Assets	Liabilities		Total		Assets	Liabilities		Total
	€m	€m		€m		€m	€m		€m
Property, plant and equipment	13.5	(28.7	)	(15.2	)	10.3	(33.6	)	(23.3	)
Intangible assets	0.1	(295.1	)	(295.0	)	—	(291.3	)	(291.3	)
Employee benefits	28.2	—		28.2		27.8	(0.1	)	27.7
Tax value of loss carry forwards	15.6	—		15.6		18.9	—		18.9
Derivative financial instruments	0.9	0.5		1.4		—	(3.3	)	(3.3	)
Other	6.0	(4.4	)	1.6		7.9	(4.9	)	3.0
Tax assets/(liabilities)	64.3	(327.7	)	(263.4	)	64.9	(333.2	)	(268.3	)

Deferred income tax assets are recognized for tax loss carry-forwards to the extent that the realization of the related tax benefit through future taxable profits is probable.

Deferred tax assets that the Company has not recognized in the financial statements amount to €65.3 million (December 31, 2016: €56.3 million). These deferred tax assets have not been recognized as the likelihood of recovery is not probable. A deferred tax asset on tax losses acquired from the Iglo Group was not recognized at the acquisition date. During 2016, following discussions with tax authorities, the group revised its assessment of the likely recovery of these losses and a resulting deferred tax asset has now been recognized.

The aggregate deferred tax relating to items that have been credited directly to equity is €3.0 million (December 31, 2016: charge of €9.1 million).

Movement in deferred tax during the year:

	Opening balance Jan 1 2017		Acquired in business combinations	Recognized  in Statement of Profit or Loss		Recognized in Other Comprehensive Income		Movement in foreign exchange		Closing balance Dec 31, 2017
	€m		€m	€m		€m		€m		€m
Property, plant and equipment	(23.3	)	—	8.2		—		(0.1	)	(15.2	)
Intangible assets	(291.3	)	—	(3.7	)	—		—		(295.0	)
Employee benefits	27.7		—	2.5		(2.0	)	—		28.2
Tax value of loss carry forwards	18.9		—	(3.0	)	—		(0.3	)	15.6
Derivative financial instruments	(3.3	)	—	(0.3	)	5.0		—		1.4
Other	3.0		—	(1.4	)	—		—		1.6
Total deferred tax	(268.3	)	—	2.3		3.0		(0.4	)	(263.4	)

F-42

	Opening balance Jan 1 2016		Acquired in business combinations		Recognized in Statement of Profit or Loss		Recognized in Other Comprehensive Income		Movement in foreign exchange		Closing balance Dec 31 2016
	€m		€m		€m		€m		€m		€m
Property, plant and equipment	(5.3	)	(0.3	)	(17.2	)	—		(0.5	)	(23.3	)
Intangible assets	(315.8	)	—		24.1		—		0.4		(291.3	)
Employee benefits	32.7		—		1.3		(6.3	)	—		27.7
Tax value of loss carry forwards	—		—		18.9		—		—		18.9
Derivative financial instruments	0.2		—		(0.7	)	(2.8	)	—		(3.3	)
Other	9.5		—		(6.5	)	—		—		3.0
Total deferred tax	(278.7	)	(0.3	)	19.9		(9.1	)	(0.1	)	(268.3	)

17) Inventories

	Successor	Successor
	Dec 31, 2017	Dec 31, 2016
	€m	€m
Raw materials and consumables	82.9	97.7
Work in progress	41.0	41.7
Finished goods and goods for resale	183.0	185.6
Total inventories	306.9	325.0

During the year endedDecember 31, 2017€7.6 million (year ended December 31, 2016€6.4 million, nine months ended December 31, 2015: €3.5 million; year ended March 31, 2015: nil) was charged to the Consolidated Statement of Profit or Loss for the write down of inventories.

18) Trade and other receivables

	Successor	Successor
	Dec 31, 2017	Dec 31, 2016
Current assets	€m	€m
Trade receivables	94.7	92.3
Prepayments and accrued income	10.1	8.0
Other receivables	19.7	26.1
Tax receivable	22.6	9.3
Total current trade and other receivables	147.1	135.7
Non-current assets
Other receivables	4.3	0.4
Total non-current trade and other receivables	4.3	0.4
Total trade and other receivables	151.4	136.1

Trade receivables, prepayments and other receivables, except for those defined as non-current, are expected to be recovered in less than 12 months. Other receivables includes VAT receivable.

F-43

The ageing of trade receivables is detailed below:

	Gross	Impaired		Net
December 31, 2017	€m	€m		€m
Not past due	243.4	—		243.4
Past due less than 1 month	35.6	(0.7	)	34.9
Past due 1 to 3 months	4.8	(0.3	)	4.5
Past due 3 to 6 months	0.2	(0.2	)	—
Past due more than 6 months	5.3	(4.9	)	0.4
Sub-total	289.3	(6.1	)	283.2
Reduction in trade-terms*				(188.5	)
Total trade receivables				94.7
	Gross	Impaired		Net
December 31, 2016	€m	€m		€m
Not past due	229.4	—		229.4
Past due less than 1 month	9.8	(0.1	)	9.7
Past due 1 to 3 months	0.9	(0.2	)	0.7
Past due 3 to 6 months	0.9	(0.1	)	0.8
Past due more than 6 months	6.3	(6.0	)	0.3
Sub-total	247.3	(6.4	)	240.9
Reduction in trade-terms*				(148.6	)
Total trade receivables				92.3

* Refer to Note 4(a). Reduction in trade term amounts are primarily not past due.

All impaired trade receivables have been provided to the extent that they are believed not to be recoverable.

The maximum exposure to credit risk at the reporting date is the fair value of each class of receivable. The Company does not hold any collateral as security.

19) Indemnification assets

	Successor		Successor
	Dec 31, 2017		Dec 31, 2016
	€m		€m
Related to Iglo Acquisition at start of the period	2.1		10.2
Reclassified from Other receivables	—		1.2
Release of indemnified provision	(2.1	)	(9.3	)
Related to Iglo Acquisition at end of the period	—		2.1
Related to Findus Acquisition at start of the period	63.4		67.6
Acquisition accounting adjustment	—		6.2
Remeasurement of indemnification assets	10.4		(10.4	)
Related to Findus Acquisition at end of the period	73.8		63.4
Total indemnification assets	73.8		65.5

As part of the acquisition of the Iglo Group and the Findus Group, the Company inherited several contingent liabilities for which the sellers have provided an indemnity. To the extent that the liability has been recognized in the balance sheet, an indemnification asset has been recognized. As part of the agreement to repurchase shares on June 12, 2017, as discussed in Note 25, the indemnities in relation to the Iglo acquisition were canceled. As a consequence, the indemnification asset of €2.1 million previously recognized has been released.

In total, €73.8 million of liabilities are covered by the indemnification assets as at December 31, 2017 (December 31, 2016: €65.5 million). The asset recognized in relation to the Findus Group has been limited to the original value of shares held in escrow following the completion of the acquisition.

F-44

The indemnification asset recognized in relation to the Findus Group is secured by shares held in escrow, so that the value of the assets may, in the future, be restricted to the value of these shares as at the balance sheet date. As at the December 31, 2017, €73.8 million (December 31, 2016: €63.4 million) of the indemnification assets relate to the acquisition of the Findus Group for which 6,964,417 shares are held in escrow and are valued at $16.91 (€14.13) (December 31, 2016: 6,964,417shares valued at $9.57 (€9.10)) each.

20) Cash and cash equivalents

	Successor	Successor
	Dec 31, 2017	Dec 31, 2016
	€m	€m
Cash and cash equivalents	219.0	325.3
Restricted cash	0.2	4.2
Total cash and cash equivalents	219.2	329.5
Bank overdrafts	—	—
Cash and cash equivalents per Statement of Cash Flows	219.2	329.5

‘Cash and cash equivalents’ comprise cash balances and call deposits. Restricted cash comprises money that is primarily reserved for a specific purpose and therefore not available for immediate or general business use. Of the restricted cash totaling €4.2 million at December 31, 2016, €3.6 million was due to French company law requirements.

21) Loans and borrowings

The repayment profile of the syndicated and other loans held by the Company is as follows:

	Successor		Successor
	Dec 31, 2017		Dec 31, 2016
	€m		€m
Current liabilities/(assets)
Syndicated loans	5.1		—
Less deferred borrowing costs to be amortized within 1 year	(1.8	)	(5.0	)
Total due in less than one year	3.3		(5.0	)
Non-current liabilities
Syndicated loans	1,004.4		964.2
2020 floating rate senior secured notes	—		500.0
2024 fixed rate senior secured notes	400.0		—
Less deferred borrowing costs to be amortized in 2-5 years	(7.2	)	(12.4	)
Less deferred borrowing costs to be amortized in more than 5 years	(2.1	)	—
Total due after more than one year	1,395.1		1,451.8
Total borrowings	1,398.4		1,446.8

F-45

The table below shows details of individual loans:

	Successor		Successor
	Dec 31, 2017		Dec 31, 2016
	€m		€m
Current liabilities/(assets)-syndicated loans	5.1		—
Less deferred borrowing costs to be amortized within 1 year	(1.8	)	(5.0	)
Total current loans and borrowings	3.3		(5.0	)
Non-current liabilities-syndicated loans and secured notes
2020 floating rate senior secured notes	—		500.0
2024 fixed rate senior secured notes	400.0		—
Senior C1 EUR	—		363.3
Senior C2 GBP	—		275.9
Senior C3 EUR	—		325.0
Senior B3 EUR	500.0		—
Senior B4 USD	504.4		—
Less deferred borrowing costs to be amortized in 2—5 years	(7.2	)	(12.4	)
Less deferred borrowing costs to be amortized in more than 5 years	(2.1	)	—
Total non-current loans and borrowings	1,395.1		1,451.8
Total borrowings	1,398.4		1,446.8
Borrowings under the syndicated loan facility and floating rate notes	1,398.4		1,446.8

The interest rate on all other loans and the floating rate senior secured notes are re-priced within one year to the relevant Euribor or Libor rate.

On May 3, 2017 the Company completed a refinancing of its Senior debt with a syndicate of banks. All Senior debt as at the balance sheet date was repaid and replaced with new Senior Euro debt of €500.0 million and Senior USD debt of $610.0 million. Both are repayable on May 15, 2024, although the Senior USD debt requires a repayment of $6.1 million of principal each year until 2024, beginning May 15, 2018. The existing revolving credit facility was also replaced with a new €80.0 million facility, which is available until May 15, 2023 and will be utilized to support existing letters of credit and bank guarantees and certain other ancillary facilities outside of the Senior debt.

In order to match its underlying cash flows the Company has entered into a number of cross-currency interest rate swaps. In exchange for $610.0 million the Company has received €299.3 million and £226.7 million. The derivatives are designed to minimize the exposure to movements in foreign currency exchange rates and movements in interest rates. In exchange for receiving cash flows in USD matching the payments of principal and interest due under the Senior USD debt, the Company will pay fixed amounts of interest and principal on notional amounts of GBP and EUR. All of the USD to EUR swaps have been designated as a cash flow hedge whilst EUR to GBP swaps to the value of £187.6 million have been designated as a net investment hedge.

Concurrent to the refinancing, the Company through its indirect, wholly-owned subsidiary, Nomad Foods BondCo Plc, repaid the senior secured notes due 2020 and successfully completed a private offering of €400.0 million aggregate principal amount of 3.25% senior secured notes due May 15, 2024 (the “Notes”). Interest on the Notes has accrued from the date of issue, payable semi-annually in arrears on May 15 and November 15, commencing on November 15, 2017. Both the new Senior debt and the notes are guaranteed on a senior basis by the Company and certain subsidiaries thereof and are secured with equal ranking against certain assets of the Company. Eligible transaction costs of approximately €9.8 million have been capitalized as part of the refinancing and will be amortized over the life of the debt. As a consequence of the debt extinguishment, deferred borrowing costs relating to the old senior

debt of €15.7 million have been written off to the Statement of Profit or Loss in May 2017 (see Note 10).

On December 20, 2017 we further amended and restated our Senior Facilities Agreement to reprice our $610.0 million and €500.0 million term loan facilities. The margin was reduced by 50 basis points on the U.S. Dollar-denominated term loan and 25 basis points on the Euro-denominated term loan. There were no changes to the maturity dates of the term loan facilities as a result of this amendment. We also established a $50.0 million incremental term loan facility and a €58.0 million incremental term loan facility. These amendments were accounted for as a modification of the existing loan. On January 31, 2018, the $50.0 million incremental term loan facility was fully drawn and on February 9, 2018, the €58.0 million incremental term loan facility was fully drawn. Eligible transaction costs of approximately €2.5 million have been capitalized as part of this amendment and will be amortized over the life of the debt.

F-46

In addition to this the Company has a multicurrency revolving credit facility of €80.0 million. This facility is available until May 2023. As at December 31, 2017€14.0 million (December 31, 2016: €13.2 million) has been utilized for letters of credit, overdrafts, customer bonds and bank guarantees against the revolving credit facility.

Guarantees and secured assets

The Syndicate of lenders that finance the Company’s Senior debt, have security over the assets of the “Guarantor Group”. The Guarantor Group consists of those companies which individually have more than 5% of consolidated total assets or EBITDA (as defined in the Senior Facilities Agreement) of the Company and in total comprise more than 80% of consolidated total assets or EBITDA at any testing date.

In connection with its pension scheme, Findus Sverige AB, a 100% owned subsidiary, is required to obtain credit insurance with PRI Pensionsgaranti (“PRI”), a credit insurance company which provides insurance annually against the risk of a sponsoring company’s insolvency. In connection with such credit insurance, as at December 31, 2017 Findus Sverige AB has granted floating charges over certain assets in favor of PRI in an amount of SEK 300 million (€30.5 million) (December 31, 2016: €31.3 million) and Nomad Foods Limited has issued a parent guarantee to PRI which will not exceed SEK 495 million (€50.3 million) (December 31, 2016: €45.9 million) at any time and has an end date of March 31, 2019.

Capitalization of transaction costs

Fees paid on the establishment of loan facilities are recognized as transaction costs of the loan to the extent that it is probable that some or all of the facility will be drawn down. In this case, the fee is deferred until the draw-down occurs.

22) Trade and other payables

	Successor	Successor
	Dec 31, 2017	Dec 31, 2016
Current liabilities	€m	€m
Trade payables	328.9	345.0
Accruals and deferred income	109.6	92.4
Social security and other taxes	18.2	19.3
Other payables	17.7	13.7
Finance lease obligations	—	0.6
Financial payables	3.1	1.7
Total current trade and other payables	477.5	472.7
Non-current liabilities
Finance lease obligations	—	1.0
Accruals and deferred income	1.8	—
Total non-current trade and other payables	1.8	1.0
Total trade and other payables	479.3	473.7

Finance lease obligations

The Company had no finance lease obligations for the year ended December 31, 2017.

	Future minimum lease payments		Interest		Present value of minimum lease payments
€m	Dec 31, 2017	Dec 31, 2016	Dec 31, 2017	Dec 31, 2016	Dec 31, 2017	Dec 31, 2016
Less than one year	—	0.7	—	0.1	—	0.6
Between one and five years	—	1.1	—	0.1	—	1.0
More than five years	—	—	—	—	—	—
	—	1.8	—	0.2	—	1.6

F-47

23) Employee benefits

The Company operates defined benefit pension plans in Germany, Italy, Sweden and Austria, as well as various defined contribution plans in other countries. All of these schemes were inherited from the Predecessor or acquired from the Findus Group.

i. Defined contribution plans

Successor

The total expense relating to defined contribution plans for the year ended December 31, 2017 was €8.5 million (year ended December 31, 2016: €9.6 million, €4.4 million for the nine months ended December 31, 2015, nil for the year ended March 31, 2015).

Predecessor

The total expense relating to defined contribution plans for the five months period ended May 31, 2015 was €2.4 million.

ii. Defined benefit plans

The Company operates partially funded defined benefit pension plans in Germany and Austria as well as unfunded plans in Sweden and Italy. In addition, an unfunded post-retirement medical plan is operated in Austria. In Germany and Italy long term service awards are in operation and various other countries provide other employee benefits.

	Successor	Successor
	Dec 31, 2017	Dec 31, 2016
	€m	€m
Total employee benefit obligations-Germany	117.5	121.8
Total employee benefit obligations-Sweden	59.8	56.7
Total employee benefit obligations-Italy	5.3	5.1
Total employee benefit obligations-Austria	2.8	4.2
Sub-total	185.4	187.8
Total net employee benefit obligations-other countries	3.0	3.1
Total net employee benefit obligations	188.4	190.9

The obligation of €3.0 million (December 31, 2016: €3.1 million) in respect of other countries is the aggregate of a number of different types of minor schemes, each one not being considered material individually or in aggregate. Consequently detailed disclosure of these schemes is not provided.

The amount included in the Statement of Financial Position arising from the Company’s obligations in respect of its defined benefit retirement plans and post-employment benefits is as follows:

Successor

	Defined benefit retirement plans		Post-employment medical benefits and other benefits	Total
December 31, 2017	€m		€m	€m
Present value of unfunded defined benefit obligations	65.7		4.9	70.6
Present value of funded defined benefit obligations	196.1		—	196.1
Subtotal present value of defined benefit obligations	261.8		4.9	266.7
Fair value of plan assets	(81.3	)	—	(81.3	)
Recognized liability for net defined benefit obligations	180.5		4.9	185.4

F-48

	Defined benefit retirement plans		Post-employment medical benefits and other benefits	Total
December 31, 2016	€m		€m	€m
Present value of unfunded defined benefit obligations	62.5		4.9	67.4
Present value of funded defined benefit obligations	200.2		—	200.2
Subtotal present value of defined benefit obligations	262.7		4.9	267.6
Fair value of plan assets	(79.8	)	—	(79.8	)
Recognized liability for net defined benefit obligations	182.9		4.9	187.8

Movements in recognized liability for net defined benefit obligations:

	Defined benefit retirement plans		Post-employment medical benefits and other benefits		Total
	€m		€m		€m
Opening balance January 1, 2017	182.9		4.9		187.8
Current service cost	4.1		(0.1	)	4.0
Interest cost	3.5		0.1		3.6
Actuarial gains	(2.9	)	—		(2.9	)
Contributions to plan	(0.5	)	—		(0.5	)
Benefits paid	(4.9	)	—		(4.9	)
Exchange adjustments	(1.7	)	—		(1.7	)
As at December 31, 2017	180.5		4.9		185.4
	Defined benefit retirement plans		Post-employment medical benefits and other benefits		Total
	€m		€m		€m
Opening balance January 1, 2016	159.4		5.7		165.1
Current service cost	3.9		(0.4	)	3.5
Interest cost	3.9		0.1		4.0
Actuarial losses	23.6		—		23.6
Contributions to plan	(0.5	)	—		(0.5	)
Benefits paid	(5.1	)	(0.3	)	(5.4	)
Exchange adjustments	(2.3	)	(0.2	)	(2.5	)
As at December 31, 2016	182.9		4.9		187.8

F-49

Movements in present value of defined benefit obligations:

	Defined benefit retirement plans		Post-employment medical benefits and other benefits		Total
	€m		€m		€m
Opening balance January 1, 2017	262.7		4.9		267.6
Current service cost	4.1		(0.1	)	4.0
Interest cost	4.9		0.1		5.0
Actuarial experience losses	0.5		—		0.5
Actuarial losses arising from changes in financial assumptions	1.5		—		1.5
Actuarial gains arising from changes in demographic assumptions	(3.0	)	—		(3.0	)
Contributions to plan	0.3		—		0.3
Benefits paid	(7.5	)	—		(7.5	)
Exchange adjustments	(1.7	)	—		(1.7	)
As at December 31, 2017	261.8		4.9		266.7
	Defined benefit retirement plans		Post-employment medical benefits and other benefits		Total
	€m		€m		€m
Opening balance January 1, 2016	238.3		5.7		244.0
Current service cost	3.9		(0.4	)	3.5
Interest cost	5.8		0.1		5.9
Actuarial experience gains	(0.3	)	—		(0.3	)
Actuarial losses arising from changes in financial assumptions	24.5		—		24.5
Contributions to plan	0.5		—		0.5
Benefits paid	(7.7	)	(0.3	)	(8.0	)
Exchange adjustments	(2.3	)	(0.2	)	(2.5	)
As at December 31, 2016	262.7		4.9		267.6

Movements in fair value of plan assets of defined benefit retirement plans:

	2017
	€m
Opening balance January 1, 2017	79.8
Interest income	1.4
Actuarial gains arising from the return on plan assets, excluding interest income	1.9
Contributions by employer	0.5
Contributions by members	0.3
Benefits paid	(2.6	)
As at December 31, 2017	81.3

F-50

	2016
	€m
Opening balance January 1, 2016	78.9
Interest income	1.9
Actuarial gains arising from the return on plan assets, excluding interest income	0.6
Contributions by employer	0.5
Contributions by members	0.5
Benefits paid	(2.6	)
As at December 31, 2016	79.8

Expense recognized in the Consolidated Statement of Profit or Loss:

	Defined benefit retirement plans	Post-employment medical benefits and other benefits		Total
	2017	2017		2017
	€m	€m		€m
Current service cost	4.1	(0.1	)	4.0
Interest cost	3.5	0.1		3.6
For the year ended December 31, 2017	7.6	—		7.6

	Defined benefit retirement plans	Post-employment medical benefits and other benefits		Total
	2016	2016		2016
	€m	€m		€m
Current service cost	3.9	(0.4	)	3.5
Interest cost	3.9	0.1		4.0
For the year ended December 31, 2016	7.8	(0.3	)	7.5

Current service cost is allocated between cost of sales and other operating expenses. Interest on net defined benefit obligation is disclosed in net financing costs.

Amount recognized in the Consolidated Statement of Comprehensive Income:

	Year ended December 31, 2017		Year ended December 31, 2016
	€m		€m
Actuarial experience losses/(gains)	0.5		(0.3	)
Actuarial losses arising from changes in financial assumptions	1.5		24.5
Actuarial gains arising from changes in demographic assumptions	(3.0	)	—
Actuarial gains arising from the return on plan assets, excluding interest income	(1.9	)	(0.6	)
Total actuarial (gains)/losses	(2.9	)	23.6
	2017		2016
	€m		€m
Cumulative amount of actuarial losses recognized in Consolidated Statement of Comprehensive Income	1.3		4.2

F-51

The fair value of plan assets, all at quoted prices are as follows:

	Dec 31, 2017	Dec 31, 2016
	€m	€m
Equities	17.4	15.1
Debt instruments	51.3	51.7
Property	8.9	9.6
Other	3.7	3.4
Total	81.3	79.8

	Defined benefit retirement plans								Post-employment medical benefits and other benefits
December 31, 2017	Germany		Sweden		Austria		Italy		Germany		Austria
Discount rate	1.95	%	2.4	%	2.2	%	1.2	%	1.15	%	0.9	%
Inflation rate	2.0	%	1.9	%	2.0	%	1.5	%	2.0	%	2.0	%
Rate of increase in salaries	2.8	%	2.25	%	3.0	%	—		2.8	%	3.0	%
Rate of increase for pensions in payment	1%-2%		2.25	%	1.7	%	—		—		—
Long term medical cost of inflation	—		—		—		—		—		2.0	%

	Defined benefit retirement plans								Post-employment medical benefits and other benefits
December 31, 2016	Germany		Sweden		Austria		Italy		Germany		Austria
Discount rate	1.8	%	2.5	%	1.0	%	1.5	%	1.2	%	1.0	%
Inflation rate	2.0	%	1.25	%	1.7	%	1.5	%	2.0	%	1.7	%
Rate of increase in salaries	2.5	%	2.25	%	3.0	%	—		2.5	%	3.0	%
Rate of increase for pensions in payment	1%-2%		2.25	%	1.7	%	—		—		—
Long term medical cost of inflation	—		—		—		—		—		2.0	%

In valuing the liabilities of the pension fund at December 31, 2017 and December 31, 2016, mortality assumptions have been made as indicated below. The assumptions relating to longevity underlying the pension liabilities at the financial year end date are based on standard actuarial mortality tables and include an allowance for future improvements in longevity. The assumptions are based on the following mortality tables:

• Germany: Richttafeln 2005

• Sweden: DUS 14 (2016: PRI)

• Austria: AVO 2008 P ANG

• Italy: RG48

These four references are to the specific standard rates of mortality that are published and widely used in each country for the use of actuarial assessment of pension liabilities and take account of local current and future average life expectancy.

December 31, 2017 (years)	Germany	Sweden	Austria	Italy
Retiring at the end of the year:
Male	20	22	21	20
Female	24	24	25	20

December 31, 2016 (years)	Germany	Sweden	Austria	Italy
Retiring at the end of the year:
Male	20	23	21	20
Female	24	25	25	24

F-52

The history of experience adjustments from inception of the Company for the defined benefit retirement plans is as follows:

	Dec 31, 2017		Dec 31, 2016		9 months ended December 31, 2015
	€m		€m		€m
Present value of defined benefit obligations	261.8		262.7		238.3
Fair value of plan assets	(81.3	)	(79.8	)	(78.9	)
Asset ceiling	—		—		—
Recognized liability in the scheme	180.5		182.9		159.4
Experience losses/(gains) on scheme liabilities	0.5		(0.3	)	(1.6	)
Experience (gains)/losses on scheme assets	(1.9	)	(0.6	)	0.5

Post-employment medical benefits- sensitivity analysis

The effect of a 1% movement in the assumed medical cost trend rate is not significant.

Defined benefit obligation- sensitivity analysis

The effect of a 1% movement in the discount rate for the year ended December 31, 2017 is as follows:

	Increase		Decrease
	€m		€m
Effect on the post-employment benefit obligation	(42.3	)	55.8

There are no deficit elimination plans for any of the defined benefit schemes. Expected contributions and payments to post-employment benefit plans for the period ending December 31, 2017 are €5.8 million (December 31, 2016: €5.7 million). The weighted average duration of the defined benefit obligations is 18.3 years.

F-53

24) Provisions

Successor

	Restructuring		Onerous/ unfavorable contracts		Provisions related to other taxes		Contingent consideration		Other		Total
	€m		€m		€m		€m		€m		€m
Balance at December 31, 2015	21.0		—		31.8		17.4		16.5		86.7
Additional provision in the period	60.2		34.7		—		—		5.3		100.2
Release of provision	(5.2	)	—		(9.8	)	—		(2.6	)	(17.6	)
Adjustment to provisions acquired through business combinations	—		47.3		2.5		—		2.7		52.5
Utilization of provision	(16.7	)	(2.5	)	—		(8.0	)	(2.2	)	(29.4	)
Unwinding of discounting	—		0.8		—		0.6		—		1.4
Foreign exchange	(0.2	)	0.3		—		—		(0.2	)	(0.1	)
Balance at December 31, 2016	59.1		80.6		24.5		10.0		19.5		193.7
Additional provision in the period	30.9		—		5.8		—		6.6		43.3
Release of provision	(0.1	)	—		(12.2	)	—		(1.2	)	(13.5	)
Transfer between categories	—		—		(2.1	)	—		2.1		—
Utilization of provision	(63.6	)	(3.9	)	(5.8	)	—		(8.4	)	(81.7	)
Unwinding of discounting	—		0.8		—		0.4		—		1.2
Foreign exchange	—		(2.1	)	—		—		(0.1	)	(2.2	)
Balance at December 31, 2017	26.3		75.4		10.2		10.4		18.5		140.8
Current											68.0
Non-current											72.8
Total											140.8

Restructuring

The €26.3 million (2016: €59.1 million) provision relates to committed plans for certain restructuring activities of exceptional nature which are due to be completed within the next 18 months. A provision of €18.4 million has been recognized in the year ended December 31, 2017 for reorganizational activities arising from the implementation of Nomad's strategic vision across the Company. An additional provision of €12.5 million has been recognized in the year ended December 31, 2017 for restructuring costs associated with the closure of the facility in Bjuv where production has now ceased. The amounts have been provided based on the latest information available on the likely remaining expenditure required to complete the committed plans. €63.6 million has been utilized in the year ended December 31, 2017 which mainly relates to the closure of the production facilities in Bjuv as well as for reorganizational activities arising from the implementation of Nomad's strategic vision across the Company.

Onerous/unfavorable contracts

Of the onerous/unfavorable contracts provision, €72.5 million is held in relation to a lease in Bjuv, Sweden. The factory is now vacant and the Company currently anticipates the warehouse space will not be fully utilized by the Company or other third parties, so the lease has been identified as being onerous.

The ability for the Company to offset the unavoidable costs associated with the unutilized portion of the facility with future rental income is highly uncertain and difficult to accurately estimate. The provision has been assessed to be the best estimate of the net unavoidable costs based on the latest information available. This provision is frequently reassessed by management and may change significantly over time.

F-54

The provision is calculated using a discounted cash flow which is subject to a high level of estimation uncertainty. The most significant assumptions are the ability to sublease the facility, the Company’s own use of the facility, the discount rate and inflation. Of these, the ability to sublease the facility or a change to the Company’s usage of the facility are based on management’s best estimate and are a matter of judgment. The provision is highly sensitive to changes in these assumptions as changes can lead to either a material increase or decrease in the provision. The discount rate is based on the risk free rate in Sweden, estimated by management to be 1% (2016: 1%). The inflation rate is also assumed to be 1% (2016: 1%). A 0.5% change in either of these assumptions will increase or decrease the provision by up to 6%.

Furthermore, an independent valuation of the lease performed as part of the acquisition accounting for the November 2, 2015 acquisition of the Findus Group identified that the lease payments were in excess of market rates, deeming the contract to be unfavorable. This provision will be utilized over the duration of the lease.

The remaining provision of €2.9 million relates to a service contract covering the same warehouse facility.

Provisions relating to other taxes

The €10.2 million (2016: €24.5 million) provision relates to other taxes due to tax authorities after tax investigations within certain operating subsidiaries within the Nomad Group. Developments in the year have led to an additional €5.8 million provision being created which has been offset by a release of €12.2 million. €5.8 million was utilized in the year ended December 31, 2017 as a result of the conclusion of a legacy sales tax dispute.

Contingent consideration

As at December 31, 2017, the provision for contingent consideration comprised of €8.9 million and €1.5 million relating to the acquisition of La Cocinera and the Lutosa brand respectively.

During the year ended December 31, 2017, a €0.4 million charge has been recognized relating to the unwinding of discounting on deferred consideration for the La Cocinera acquisition which occurred in Spain in April 2015. The consideration payable is dependent on specific future events and performance conditions being met. The payment is deferred until April 2020 but must be paid earlier if certain decisions are made by the Company. There was negligible movement on the contingent consideration provided for the Lutosa brand (under license until 2020), which was acquired in Belgium in 2014 and payable in 2019.

Other

Other provisions include €5.6 million (2016: €6.1 million) of potential obligations in Italy, €3.1 million (€3.2 million) for asset retirement obligations recognized as part of the Findus acquisition, €2.7 million (2016: €2.8 million) professional fees in respect of the above mentioned tax investigations and other obligations from previous accounting periods.

25) Share capital and reserves

Share capital and capital reserve

	As at Dec 31, 2017		As at Dec 31, 2016
	€m		€m
Authorized:
Unlimited number of Ordinary Shares with nil nominal value issued at $10.00 per share	n/a		n/a
Unlimited number of Founder Preferred Shares with nil nominal value issued at $10 per share	n/a		n/a
Issued and fully paid:
165,291,546 (December 31, 2016: 182,088,622) Ordinary Shares with nil nominal value	1,626.9		1,803.4
1,500,000 (December 31, 2016: 1,500,000) Founder Preferred Shares with nil nominal value	10.6		10.6
Total share capital and capital reserve	1,637.5		1,814.0
Listing and share transaction costs	(13.8	)	(13.3	)
Total net share capital and capital reserve	1,623.7		1,800.7

F-55

Ordinary Shares

	Issued and Repurchased Ordinary shares  (in millions)
Balance at December 31, 2015	178.4
Shares issued in the period	3.7
Balance at December 31, 2016	182.1
Shares issued in the year	—
Shares repurchased and canceled in the year	(16.8	)
Balance at December 31, 2017	165.3

The Company issued 121.5 million Ordinary Shares between April 1, 2015 and September 30, 2015. Of these, 13.7 million were issued as a partial non-cash consideration for the acquisition of the Iglo Group on June 1, 2015, 75.7 million were issued through a private placement on May 26, 2015 and a further 15.4 million were issued through a subsequent private placement on July 8, 2015. 16.7 million Ordinary Shares were issued from the early exercise of warrants.

On November 2, 2015 Nomad issued 8.4 million shares as a partial non-cash consideration for the acquisition of Findus Sverige AB and its subsidiaries. 

On November 27, 2015, the Company issued a further 13,104 shares to key management employees acquired through a bonus issue scheme.

On January 12, 2016, the Company issued a share dividend of 3.6 million Ordinary Shares (the “Founder Preferred Share Dividend”) pursuant to the terms of the outstanding founder preferred shares of the Company (the “Founder Preferred Shares”). See the ‘Founder Preferred Shares’ section of this note below for additional information.

In July 2016, the Company issued 23,212 Ordinary Shares in settlement of the Non-Executive Directors restricted share awards. These shares, granted at a share price of $11.50 on December 7, 2015, vested on June 16, 2016 and were issued in July at a share price of $8.98. Of the total 34,780 number of shares vesting, 11,568 shares were held back from issue by the Company as settlement towards personal tax liabilities arising on the vested shares. Following this issuance, the Company had 182,088,622 Ordinary Shares outstanding.

In June 2017, the Company issued 46,296 Ordinary Shares in settlement of the Non-Executive Directors restricted share awards. These shares, granted at a share price of $8.98 on June 16, 2016, vested on June 19, 2017 and were issued at a share price of $14.38. Of the total 55,680 number of shares vesting, 9,384 shares were held back from issue by the Company as settlement towards personal tax liabilities arising on the vested shares.

On June 12, 2017, the Company entered into an agreement to repurchase 9,779,729 of its shares beneficially owned by funds advised by Permira Advisers LLP ("Permira") at a purchase price of $10.75 per share, which was a 25% discount to the closing price of Nomad Foods ordinary shares on June 9, 2017. The aggregate purchase price of approximately $105.1 million (€93.9 million) was funded from the Company's cash on hand and the shares were retired on June 12, 2017. The transaction related to a final settlement of indemnity claims against an affiliate of Permira, which are legacy tax matters that predate the Company's acquisition of the Iglo Group in 2015.

On September 11, 2017, the Company entered into an agreement to repurchase 7,063,643 shares of 33,333,334 ordinary shares being sold in an underwritten secondary public offering by selling Shareholders, Pershing Square Capital Management, L.P. (“Pershing Square”), at a per-share purchase price equal to $14.16 per ordinary share. As such, 26,269,691 ordinary shares of the 33,333,334 ordinary shares sold by the Selling Shareholders were sold to the public. The Company did not sell any ordinary shares in the offering and did not receive any of the proceeds from the offering. The aggregate purchase price of approximately $100.0 million (€83.2 million) was funded from the Company's cash on hand and the repurchased shares were retired on September 11, 2017. As part of the transaction, the Company incurred €0.5 million of fees, which were recognized directly within Capital reserve.

Following the issuance and subsequent repurchases of shares in 2017, the Company had 165,291,546 Ordinary Shares outstanding.

F-56

Listing and share transaction costs

As at December 31, 2017, listing and share transaction costs, which includes the total cost of admission and share issuance expenses on initial public offering, as well as costs associated with share repurchases was €13.8 million and are disclosed as a deduction directly against the capital reserve.

	€m
At December 31, 2015	13.3
Placement fees	—
At December 31, 2016	13.3
Share transaction costs	0.5
At December 31, 2017	13.8

Founder Preferred Shares Annual Dividend Amount and Warrant Redemption Amount

Nomad’s issued Founder Preferred Share capital consists of 1,500,000 Founder Preferred Shares. There are no Founder Preferred Shares held in Treasury. Founder Preferred Shares confer upon the holder the following:

1. the right to one vote per Founder Preferred Share on all matters to be voted on by shareholders generally and vote together with the holders of ordinary shares;

2. commencing on January 1, 2015 and for each financial year thereafter:

a. once the average price per ordinary share for the Dividend Determination Period, ie. the last ten consecutive trading days of a year is at least $11.50 (which condition has been satisfied for the year ended December 31, 2015), the right to receive a Founder Preferred Shares Annual Dividend Amount (as more fully described below), payable in Ordinary Shares or cash, at the Company’s sole option; and

b. the right to receive dividends and other distributions as may be declared from time to time by the Company’s board of directors with respect to the Ordinary Shares (such dividends to be distributed among the holders of Founder Preferred Shares, as if for such purpose the Founder Preferred Shares had been converted into Ordinary Shares immediately prior to such distribution) plus an amount equal to 20% of the dividend which would be distributable on such number of Ordinary Shares equal to the Preferred Share Dividend Equivalent (as defined below); and

3. in addition to amounts payable pursuant to clause 2 above, the right, together with the holders of Ordinary Shares, to receive such portion of all amounts available for distribution and from time to time distributed by way of dividend or otherwise at such time as determined by the Directors; and

4. the right to an equal share (with the holders of Ordinary Shares on a share for share basis) in the distribution of the surplus assets of Nomad on its liquidation as are attributable to the Founder Preferred Shares; and

5. the ability to convert into Ordinary Shares on a 1-for-1 basis (mandatorily upon a Change of Control or the seventh full financial year after an acquisition).

On January 12, 2016 the Company’s Board of Directors approved a share dividend to the Founder Entities of an aggregate of 3,620,510 Ordinary Shares pursuant to the terms of the outstanding Founder Preferred Shares of the Company at a Dividend Price of $11.4824. Because the average price per Ordinary Share was at least $11.50 for the last ten consecutive trading days of 2015, the holders of the Founder Preferred Shares were entitled to receive the Founder Preferred Share Annual Dividend Amount.

F-57

No Founder Preferred Shares Annual Dividend Amount was due as at December 31, 2016 as the average price per ordinary share for the last ten consecutive trading days of the year did not reach the 2015 Dividend Price of $11.482.

On December 29, 2017, the Company’s Board of Directors approved a share dividend of an aggregate of 8,705,890 ordinary shares calculated as 20% of the increase in the market price of our ordinary shares compared to 2015 dividend price of $11.4824 multiplied by Preferred Share Dividend Equivalent. The Dividend Price used to calculate the Annual Dividend Amount was $16.6516 (calculated based upon the volume weighted average price for the last ten consecutive trading days of 2017) and the ordinary shares underlying the Founder Preferred Share Dividend were issued on January 2, 2018.

See Note 27 for further information.

Warrants

On April 11, 2014 in conjunction with its initial public offering, Nomad issued an aggregate 50,000,000 Warrants to purchasers of both its Ordinary and Founder Preferred Shares. In addition, 75,000 Warrants in aggregate were issued to Non-Executive directors as part of their appointment as directors. Each Warrant entitled its holder to subscribe for one-third of an ordinary share upon exercise (subject to any prior adjustment in accordance with the terms and conditions set out in the Warrant Instrument). Warrant holders were required therefore (subject to any prior adjustment) to hold and validly exercise three Warrants and pay $11.50 per Ordinary Share in order to receive one Ordinary Share.

The Warrants were also subject to mandatory redemption at $0.01 per Warrant if at any time the volume-weighted average price per ordinary share equaled or exceeded $18.00 (subject to any prior adjustment in accordance with the terms and conditions set out in the Warrant Instrument) for a period of ten consecutive trading days.

On May 6, 2015 In connection with the Iglo acquisition, the Company obtained the consent of over 75% of the holders of outstanding Warrants to an amendment to the terms of the Warrants in order to provide that the subscription period for the Warrants, which previously would have expired on the third anniversary of the Company’s consummation of its first acquisition, would instead expire on the consummation of the Iglo Group acquisition (except in certain limited circumstances, in which case, such holder will be permitted to exercise his, her or its Warrants until the date that is 30 days following the date of Readmission). The Warrant Amendment was thereby effective on May 6, 2015.

The remaining warrants that were issued by the Company in conjunction with its initial public offering in April 2014 were redeemed in the nine months ended December 31, 2015 and a credit of €0.4 million was recognized in the Consolidated Statement of Profit or Loss.

26) Share-based compensation reserve

Successor

The Company's discretionary share award scheme, the LTIP, enables the Company’s Compensation Committee to make grants (“Awards”) in the form of rights over ordinary shares, to any Director, Non-Executive Director or employee of the Company. However, it is the Committee’s current intention that Awards be granted only to Directors and senior management, whilst recognizing a separate annual Restricted Stock Award for Non-Executive Directors.

All Awards are to be settled by physical delivery of shares. Note 8b sets out the Non-Executive Director and Director and Senior Management Restricted share awards.

Non-Executive Director Restricted Share Awards

The Non-Executive Directors restricted share awards, granted at a share price of $11.50 on December 7, 2015, vested on June 16, 2016 and 23,212 ordinary shares were issued in July at a share price of $8.98, resulting in a €0.3 million reduction in the share based compensation reserve for the year ended December 31, 2016.

The Non-Executive Directors restricted share awards granted at a share price of $8.98 on June 16, 2016 vested on June 19, 2017 and were issued at a share price of $14.38, resulting in a €0.3 million increase in the share based compensation reserve. Of the total 55,680 number of shares vesting, 9,384 shares were held back from issue by the Company as settlement towards personal tax liabilities arising on the vested shares for the year ended December 31, 2017.

F-58

On June 19, 2017, current Non-Executive Directors were granted 41,724 restricted share awards at a share price of $14.38. On August 22, 2017, two new Non-Executive Directors were granted a pro-rata 11,774 restricted share awards at the same share price and vesting conditions as the previous grant.

The total charge within the Statement of Consolidated Profit or Loss for the year ended December 31, 2017 for Non-Executive Director stock compensation awards was €0.8 million and €0.6 million for the year ended December 31, 2016. The Director and senior management stock compensation charge reported within the Consolidated Statement of Profit or Loss for the year ended December 31, 2017 was €1.8 million (year ended December 31, 2016: €0.6 million).

	Share based compensation reserve
	€m
Balance as of January 1, 2017	1.0
Non-Executive Director restricted share awards charge	0.8
Directors and Senior Management share awards charge	1.8
Vesting of Non-Executive Director restricted shares	(0.7	)
Balance as of December 31, 2017	2.9

27) Founder Preferred Shares Dividend Reserve

Nomad has issued Founder Preferred Shares to its Founder Entities. A summary of the key terms of the Founder Preferred Shares is set out in Note 25.

The Founder Preferred Shares Annual Dividend Amount is structured to provide a dividend based on the future appreciation of the market value of the ordinary shares, thus aligning the interests of the Founders with those of the investors on a long term basis. Commencing in 2015, the Founder Preferred Share Annual Dividend Amount became payable because the Company’s volume weighted average ordinary share price was above $11.50 for the last ten consecutive trading days of the 2015 financial year.

Accordingly, the conditions of the Founder Preferred Shares Annual Dividend Amount for 2015 were met. On January 12, 2016, the Company's Board of Directors approved a share dividend (the “Founder Preferred Share Dividend”) of an aggregate of 3,620,510 ordinary shares calculated as 20% of the increase in the market price of our ordinary shares compared to the initial public offering price of $10.00 multiplied by 140,220,619 (the “Preferred Share Dividend Equivalent”). The Preferred Share Dividend Equivalent is equal to the number of ordinary shares outstanding immediately following the Iglo Acquisition, but excluding the 13.7 million ordinary shares issued to the seller of the Iglo Group. The dividend price (“Dividend Price”) used to calculate the Annual Dividend Amount was $11.4824 (calculated based upon the volume weighted average price for the last ten consecutive trading days of 2015) and the ordinary shares underlying the Founder Preferred Share Dividend were issued on January 12, 2016.

The conditions of the Founder Preferred Shares Annual Dividend Amount for 2016 were not met and consequently no Founder Preferred Share Dividend was approved for issue.

The conditions of the Founder Preferred Shares Annual Dividend Amount for 2017 were met. On December 29, 2017, the Company’s Board of Directors approved a share dividend of an aggregate of 8,705,890 ordinary shares calculated as 20% of the increase in the market price of our ordinary shares compared to 2015 dividend price of $11.4824 multiplied by Preferred Share Dividend Equivalent. The Dividend Price used to calculate the Annual Dividend Amount was $16.6516 (calculated based upon the volume weighted average price for the last ten consecutive trading days of 2017) and the ordinary shares underlying the Founder Preferred Share Dividend were issued on January 2, 2018.

In future years, the Preferred Shares Annual Dividend amount will be determined with reference to the Dividend Determination Period of a financial year, ie the last ten consecutive trading days and calculated as 20% of the increase in the volume weighted average share price of our ordinary shares across the determination period compared to the highest price previously used in calculating the Founder Preferred Share Annual Dividend Amounts multiplied by the Annual Dividend Amount (currently $16.6516). The Founder Preferred Shares Annual Dividend Amount is paid for so long as the Founder Preferred Shares remain outstanding. The Founder Preferred Shares automatically convert on the last day of the seventh full financial year following completion of the acquisition of the Iglo Group or upon a change of control, unless in the case of a change of control, the independent Directors determine otherwise.

F-59

The amounts used for the purposes of calculating the Founder Preferred Shares Annual Dividend Amount and the relevant numbers of ordinary shares are subject to such adjustments for share splits, share dividends and certain other recapitalization events as the Directors in their absolute discretion determine to be fair and reasonable in the event of a consolidation or sub-division of the ordinary shares in issue, as determined in accordance with Nomad Foods’ Memorandum and Articles of Association.

Dividends on the Founder Preferred Shares are payable until the Founder Preferred Shares are converted into Ordinary Shares. The Founder Preferred Shares automatically convert on a one for one basis (i) on the last day of the seventh full financial year following our acquisition of Iglo Foods (or if such day is not a trading day, the next trading day) or (ii) in the event of a change of control (unless the independent directors of our board of directors determine otherwise). The holders of Founder Preferred Shares may also be converted to Ordinary shares on a one for one basis at the option of the holder. In the event of an automatic conversion, a dividend on the Founder Preferred Shares shall be payable with respect to the shorted dividend year on the trading day immediately prior to the conversion. In the event of an optional conversion by the holder, no dividend on the Founder Preferred Shares shall be payable with respect to the year in which the conversion occurred.

	Founder Preferred Shares Dividend Reserve
	€m
Balance as of January 1, 2017	493.4
Settlement of dividend through share issue	—
Balance as of December 31, 2017	493.4

Prior to June 1, 2015 the Founder Preferred Shares Annual Dividend Amounts were valued and recognized as a liability under IFRS 2. The fair value of the liability at each balance sheet date was valued using a Monte Carlo simulation and any difference in fair value was recorded as an expense through the Consolidated Statement of Profit or Loss. An expense of €349 million was recognized for the nine months ended December 31, 2015 (€165.8 million for the year ended March 31, 2015).

Upon completion of the acquisition of the Iglo Group on June 1, 2015, the Company intended that the Founder Preferred Shares Annual Dividend Amount would be equity settled. Accordingly, the Founder Preferred Shares Annual Dividend Amount as of June 1, 2015 of €531.5 million (the “Founder Preferred Shares Dividend reserve”) was classified as equity and no further revaluations will be required or recorded.

28) Translation reserve

The translation reserve comprises all foreign exchange differences arising from the translation of the financial statements of foreign operations, as well as from the translation of liabilities that hedge the Company’s net investment in a foreign subsidiary.

29) Cash flow hedging reserve

The hedging reserve comprises the effective portion of the cumulative net change in the fair value of cash flow hedging instruments related to hedged transactions that have not yet occurred. The reserve relating to forward currency contracts will be reclassified to the Statement of Profit or Loss within 12 months whilst the reserve relating to the cross currency interest rate swaps will be reclassified over the life of the instruments.

The table below shows the movement in the cash flow hedging reserve during the year or period, including the gains or losses arising on the revaluation of hedging instruments during the year or period and the amount reclassified from other comprehensive income to the Consolidated Statement of Profit or Loss in the year.

F-60

	Successor		Successor		Successor	Successor	Predecessor
	Year ended December 31, 2017		Year ended December 31, 2016		9 months ended December 31, 2015	Year ended March 31, 2015	5 months ended May 31, 2015
	€m		€m		€m	€m	€m
(Losses)/gains arising in the revaluation of hedge instruments	(76.5	)	14.2		1.6	—	—
Less: Gains/(losses) reclassified to the Consolidated Statement of Profit or Loss	60.1		(4.1	)	—	—	—
Total	(16.4	)	10.1		1.6	—	—

30) Earnings/(loss) per share

Basic earnings/(loss) per share

	Successor	Successor	Successor		Successor		Predecessor
	Year ended December 31, 2017	Year ended December 31, 2016	9 months ended December 31, 2015		Year ended March 31, 2015		5 months ended May 31, 2015
Net profit/(loss) attributable to shareholders (€m)	136.5	36.4	(337.3	)	(167.5	)	(128.0	)
Weighted average Ordinary Shares and Founder Preferred Shares	176,080,272	183,518,743	145,590,810		50,025,000		n.p.
Basic earnings/(loss) per share (€’s)	0.78	0.20	(2.32	)	(3.35	)	n.p.

n.p. not presented

For the year ended December 31, 2017, basic earnings per share is calculated by dividing the profit attributable to the shareholders of the Company of €136.5 million (year ended December 31, 2016: €36.4 million, nine months ended December 31, 2015: €337.3 million loss) by the weighted average number of ordinary shares of 174,580,272 (December 31, 2016: 182,018,743, 9 months ended December 31, 2015: 144,090,810) and Founder Preferred Shares of 1,500,000 (December 31, 2016: 1,500,000, 9 months ended December 31, 2015: 1,500,000).

Diluted earnings/(loss) per share

	Successor	Successor	Successor		Successor		Predecessor
	Year ended December 31, 2017	Year ended December 31, 2016	9 months ended December 31, 2015		Year ended March 31, 2015		5 months ended May 31, 2015
Net profit/(loss) attributable to shareholders (€m)	136.5	36.4	(337.3	)	(167.5	)	(128.0	)
Weighted average Ordinary Shares and Founder Preferred Shares	184,786,162	183,528,621	145,590,810		50,025,000		n.p.
Diluted earnings/(loss) per share (€’s)	0.74	0.20	(2.32	)	(3.35	)	n.p.

n.p. not presented

For the year ended December 31, 2017, the number of shares in the diluted earnings per share calculation include 8,705,890 shares for the dilutive impact of the Ordinary shares to settle the Founder Preferred Shares Annual Dividend for the year ended December 31, 2017, which were issued in January 2018. Refer to Notes 27 and 38 for further details. There is no adjustment to the profit/(loss) attributable to shareholders.

F-61

31) Reconciliation of liabilities arising from financing activities

The table below details changes in the Company's liabilities arising from financing activities, including both cash and non-cash changes. Liabilities arising from financing activities are those for which cash flows were, or future cash flows will be classified in the Company's consolidated statements of cash flows from financing activities.

		Cash movements			Non-cash movements
	Opening balance as of December 31, 2016	Cash inflow (1)	Cash outflow (2)		Interest accretion	Exchange movement		Fair value changes		Other non-cash adjustments	Closing balance as of December 31, 2017
	€m	€m	€m		€m	€m		€m		€m	€m
Total loans and borrowings (Note 21)	1,446.8	1,470.5	(1,469.5	)	—	(55.7	)	—		6.3	1,398.4
Total finance lease obligations (Note 22)	1.6	—	(1.6	)	—	—		—		—	—
Financial payables (Note 22)	1.7	—	(53.3	)	54.0	0.7		—		—	3.1
Derivatives: (Net) Fair value of forward foreign exchange and currency swap contracts FVPTL	0.3	3.9	—		—	—		(3.5	)	—	0.7
Derivatives: (Net) Fair value of cross currency interest rate swaps	—	4.5	(2.3	)	—	—		40.6		—	42.8

(1) Cash inflows of €4.5 million from cross currency interest rate swaps are part of effective cash flow hedging relationships and are presented within interest paid within the Consolidated Statements of Cash Flows.

(2) Cash outflows of €2.3 million from cross currency interest rate swaps are not part of a cash flow hedge and are presented within proceeds on settlement of derivatives within the Consolidated Statements of Cash Flows.

Note: IFRS 16 Leases becomes effective as of January 1 2019, at which point operating lease liabilities will also appear in the information presented

F-62

32) Cash flows from operating activities

		Successor		Successor		Successor		Successor		Predecessor
		Year ended December 31, 2017		Year ended December 31, 2016		9 months ended December 31, 2015		Year ended March 31, 2015		5 months ended May 31, 2015
	Note	€m		€m		€m		€m		€m
Cash flows from operating activities
Profit/(loss) for the period		136.5		36.4		(337.3	)	(167.5	)	(128.0	)
Adjustments for:
Exceptional items	7	37.2		134.5		58.1		0.7		84.3
Non-cash charge related to Founder Preferred Shares Annual Dividend Amount		—		—		349.0		165.8		—
Non-cash (charge)/credit related to Warrant Redemption Liability		—		—		(0.4	)	0.4		—
Non-cash fair value purchase price adjustment of inventory		—		—		37.0		—		—
Non-cash cash flow hedge reserve acquisition accounting adjustment		—		—		4.9		—		—
Non-cash Chairman and Independent Non-Executive Director fees		—		—		—		0.2		—
Unrealized gain on portfolio investments		—		—		—		(0.1	)	—
Share based payments expense		2.6		1.2		—		—		—
Depreciation charge	12	35.9		43.3		20.3		—		11.3
Amortization	13	6.5		7.8		1.5		—		1.2
Loss on disposal of property, plant and equipment		0.5		0.7		—		—		—
Finance costs	10	81.6		86.3		44.2		—		117.7
Finance income	10	(7.2	)	(24.2	)	(8.7	)	—		(2.0	)
Taxation	11	32.0		39.6		(12.3	)	—		40.9
Operating cash flow before changes in working capital, provisions and exceptional items		325.6		325.6		156.3		(0.5	)	125.4
Decrease/(increase) in inventories		16.7		(18.1	)	(15.9	)	—		28.3
(Increase)/decrease in trade and other receivables		(1.6	)	(8.8	)	64.3		—		(8.5	)
Increase/(decrease) in trade and other payables		18.1		60.8		(44.0	)	0.7		(41.0	)
Decrease in employee benefit and other provisions		(0.3	)	(3.3	)	(1.5	)	—		(2.0	)
Cash generated from operations before tax and exceptional items		358.5		356.2		159.2		0.2		102.2

33) Financial risk management

a) Overall risk management policy

The Company’s activities expose it to a variety of financial risks, including currency risk, interest rate risk, credit risk and liquidity risk.

The Company’s overall risk management program focuses on minimizing potential adverse effects on the Company’s financial performance. The Company uses derivative financial instruments to hedge certain risk exposures.

Risk management is led by senior management and is mainly carried out by a central treasury department which identifies, evaluates and hedges financial risks in close cooperation with the Company’s operating units.

F-63

b) Market risk (including currency risk and interest rate risk)

In managing market risks, the Company aims to minimize the impact of short term fluctuations on the Company’s earnings. Over the longer term, however, permanent changes in foreign exchange rates and interest rates will have an impact on consolidated earnings.

Currency risk Foreign currency risk on assets and liabilities in currencies other than functional currency

Description The Company is exposed to foreign exchange risk arising from the translation of assets and liabilities denominated in currencies other than the Euro. This affects particularly Nomad’s U.S. Dollar loans and cross currency interest rate swaps and Nomad's GBP loans and cross currency interest rate swaps.

The U.S. Dollar and GBP value of these liabilities is retranslated at closing exchange rates into Euro for inclusion in the financial statements. Fluctuations in the value of these liabilities are caused by variations in the closing EUR-USD and EUR-GBP exchange rates.

Prior to April 21, 2017, 80% of the Company's Pound Sterling loans were designated as net investment hedges against the Company's investment in its subsidiaries in the UK.  From April 21, 2017, the existing Sterling loans were settled and USD debt of $610 million was entered into. In order to match its underlying cash flows the Company has entered into a number of cross-currency interest rate swaps. In exchange for $610.0 million the Company received €570.5 million which has been designated as cash flow hedges. Of the €570.5 million, €271.2 million was swapped to £226.7 million. 82.8% of the Company’s Pound Sterling cross currency interest rate swaps are designated as hedges against the Company’s investment in its subsidiaries in the UK.

Mitigation & Impact on Any foreign exchange movement resulting from the translation of $610m term loan to Euros

Statement of Financial is offset with the translation of the receive U.S. Dollar, pay Euro cross currency interest rate

Position / Equity / swaps. Gains/losses on the cross currency interest rate swap are released from cash flow

Income Statement hedge reserve to match the gain or losses on the U.S. Dollar debt as they impact profit and loss.

From April 21, 2017, 82.8% of the Company’s Pound Sterling cross currency interest rate swaps are designated as hedges against the Company’s investment in its subsidiaries in the UK. In 2016 and up until April 21, 2017 80% of the Company's Pound Sterling loans were designated as hedges against the Company's investment in its subsidiaries in the UK. As at December 31, 2017, this represented 93.1% of the net assets held in GBP (2016: 99%).

The impact of the net investment hedge is taken directly to equity via the foreign currency translation reserve. The amount taken to this reserve which arose on the retranslation of the cross currency interest rate swaps was a gain of €12.4 million and from the translation of the GBP loans in place was a loss of €4.3 million. In 2016 the amount taken to this reserve which arose on the translation of Sterling loans was a €35.4 million gain, (2015: €6.8 million gain). There was no material ineffectiveness in the net investment hedge in either 2017 or 2016.

Sensitivity analysis During 2017, the Euro strengthened by 3.9% (2016: strengthened by 13.8%) against Sterling.

The notional amount of Pound Sterling cross currency interest rate swaps designated as hedges is £187.6m, the gain of €12.4 million resulted from a 5.8% movement in the GBP-EUR foreign exchange rate. A 1% movement in the GBP-EUR foreign exchange rate would result in a gain or loss of €2.2 million which would be taken to equity.

Hedge accounting is not applied to 17.2% of the Company's Pound Sterling cross currency interest rate swaps. A 1% movement in the GBP-EUR foreign exchange rate would result in a gain or loss of €0.4 million.

F-64

In addition, the impact on the related interest charge would be to decrease or increase the charge by €0.1 million, €0.1 million and €0.2 million for each 1% change in the exchange rate in 2017 and 2016 and 2015 respectively.

Currency risk Foreign currency risk on purchases

The Company is exposed to foreign exchange risk where a business unit makes purchases in a currency other than the functional currency of that entity.

For the Company, the most significant of these exposures is the purchase of fish inventories in U.S. Dollars and the purchase of goods and services in Euros by the UK and the Nordics.

Mitigation & Impact on The Company’s policy is to reduce this risk by using foreign exchange forward contracts

Statement of Financial which are designated as cash flow hedges. These contracts all have a maturity of less

Position / Equity / than one year. The fair value of the U.S. Dollars forward contracts with reference to

Income Statement non-USD functional currencies as at December 31, 2017 is an asset of €6.5 million (2016: €11.0 million asset). All forecast transactions are still expected to occur.

As at December 31, 2017, 69.8% (2016: 98%, 2015: 69%) of forecast future U.S. Dollar payments for the next twelve months were hedged through the use of forward contracts and existing cash. A proportion of the forward contracts have been designated as cash flow hedges.

The fair value of the Euro forward contracts with reference to non-Euro functional currencies as at December 31, 2017 is €1.5 million (2016: €1.1 million).

As at December 31, 2017, 68% (2016: 86.9%, 2015: 58%) of forecast future net euro payments for the next twelve months were hedged through the use of forward contracts and existing cash. A proportion of the forward contracts have been designated as cash flow hedges over forecast purchases.

Sensitivity analysis During 2017, the Euro strengthened by 3.9% against Sterling, and strengthened by 13.9% against the U.S.Dollar and strengthened by 2.7% against the Swedish Krona.

On an annualized 2017 basis, for each 1% that the Euro strengthens or weakens against Sterling, assuming all other variables remain constant, the impact relating to these purchases would be to increase or decrease the Company’s profit or loss before tax by approximately €0.7 million (2016: €0.6 million, 2015: €0.5 million), excluding the impact of any forward contracts.

On an annualized 2017 basis, for each 1% that the Euro strengthens or weakens against the U.S.Dollar, assuming all other variables remain constant, the impact would be to increase or decrease the Company’s profit or loss before tax by approximately €2.4 million (2016: €2.2 million, 2015: €2.2 million), excluding the impact of any forward contracts.

On an annualized 2017 basis, for each 1% that the Euro strengthens or weakens against Swedish Krona, assuming all other variables remain constant, the impact relating to these purchases would be to increase or decrease the Company’s profit or loss before tax by approximately €0.7 million (2016: €0.4 million, 2015: €0.5 million), excluding the impact of any forward contracts.

We do not expect purchase levels to be materially different in the coming year.

F-65

Interest rate risk

Description The Company has significant levels of floating rate borrowings and is therefore exposed to the impact of interest rate fluctuations.

Mitigation & Impact on

Equity / Income Statement The Company’s policy on interest rate risk is designed to limit the Company’s exposure to fluctuating interest rates. In 2017 the Company entered into a €400 million7 year fixed rate Bond, floating rate senior Euro debt of €500 million and floating rate senior USD of $610 million. The company also entered into cross currency interest rate swaps to swap its floating USD term loans to fixed Euros or Sterling.

During 2017 the weighted average fixed rate of the Company's interest cash flows in Sterling was 65.8% (2016: 157%) and the weighted average fixed rate of the Company's Euro interest cash flows was 38.9% (2016: 66%). As at December 31, 2017 this was 100% and 58.3% respectively.

Sensitivity analysis In 2017, one month GBP LIBOR rates increased by 0.25 percentage points (2016: 0.25 percentage points decrease) and there were no significant changes in three month EURIBOR rates (2016: decreased by 0.15 percentage points). Negative interest rates are treated as 0% for the purpose of the interest applied on the senior loans.

If interest rates were greater than 1%, an increase or decrease of one percentage point in the interest rate charge on borrowings would correspondingly decrease or increase the Company’s profit/(loss) before tax by approximately €5.1 million (2016: €14.8 million, 2015: €14.5 million).

c) Credit risk

Description Credit risk arises on cash and cash equivalents and derivative financial instruments with banks and financial institutions, as well as on credit exposures to customers. See Note 18 for analysis of the trade receivables balance and Note 20 for analysis of the cash and cash equivalents balance.

Mitigation The Company limits counterparty exposures by monitoring each counterparty carefully and where possible, setting credit limits by reference to published ratings. The Company limits its exposure to individual financial institutions by spreading forward foreign exchange contracts, cross currency interest rate swaps and surplus cash deposits between several institutions.

The credit quality of customers is assessed taking into account their financial position, past experience and other factors. Credit limits are set for customers and regularly monitored. The Company aims to ensure that the maximum exposure to one financial institution does not exceed €150.0 million and that the long term credit rating does not fall below High Single A.

d) Liquidity risk

Description The Company is exposed to the risk that it is unable to meet its commitments as they fall due. The Company has financial conditions imposed by its lenders which it must achieve in order to maintain its current level of borrowings. A single net debt covenant is carried out quarterly and at the end of each financial year. There have been no breaches of the covenants throughout the year.

Mitigation The Company ensures that it has sufficient cash and available funding through regular cash flow and covenant forecasting. In addition, the Company has access to a revolving credit facility of €80.0 million, expiring in May 2023. This is available to finance working capital requirements and for general corporate purposes. Currently €14.0 million is utilized for letters of credit, overdrafts, customer bonds and bank guarantees.

F-66

Capital risk management

Nomad’s objectives when managing capital (currently consisting of share capital and share premium) are to safeguard Nomad’s ability to continue as a going concern in order to provide returns for shareholders and benefits for other stakeholders and to maintain an optimal capital structure to reduce the cost of capital. In order to maintain or adjust the capital structure, Nomad may adjust the amount of dividends paid to shareholders, return capital to shareholders or issue new shares.

Maturity analysis

The tables below show a maturity analysis of contractual undiscounted cash flows, showing items at the earliest date on which the Company could be required to pay the liability:

2017	2018		2019		2020		2021		2022		Over 5 years	Total
	€m		€m		€m		€m		€m		€m	€m
Borrowings-principal	5.1		5.1		5.1		5.1		5.1		1,384.0	1,409.5
Borrowings-interest	46.3		46.0		46.0		45.7		45.5		62.9	292.4
Forward contracts Sell	484.0		—		—		—		—		—	484.0
Forward contracts Buy	(479.6	)	—		—		—		—		—	(479.6	)
Cross Currency Interest Rate Swaps Pay	29.1		28.7		28.6		28.4		801.4		—	916.2
Cross Currency Interest Rate Swaps Receive	(32.0	)	(31.6	)	(31.4	)	(31.2	)	(759.3	)	—	(885.5	)
Trade and other payables excluding non-financial liabilities	441.6		—		—		—		—		—	441.6
Total	494.5		48.2		48.3		48.0		92.7		1,446.9	2,178.6

2016	2017		2018	2019	2020	2021	Over 5 years	Total
	€m		€m	€m	€m	€m	€m	€m
Borrowings-principal	—		—	—	1,464.2	—	—	1,464.2
Borrowings-interest	59.7		60.0	60.9	29.9	—	—	210.5
Forward contracts Sell	367.8		—	—	—	—	—	367.8
Forward contracts Buy	(381.3	)	—	—	—	—	—	(381.3	)
Trade and other payables excluding non-financial liabilities	439.1		—	—	—	—	—	439.1
Total	485.3		60.0	60.9	1,494.1	—	—	2,100.3

The 2016 table has been amended to include the Forward contract Buy amount.

34) Financial instruments

a) Categories of financial instruments

The following table shows the carrying amount of each Statement of Financial Position class split into the relevant category of financial instrument as defined in IAS 39 “Financial Instruments: Recognition & Measurement”.

F-67

	Cash and cash equivalents	Loans and receivables	Derivatives at fair value through profit or loss		Derivatives used for hedging (see (c))		Financial liabilities at amortized cost		Total
2017	€m	€m	€m		€m		€m		€m
Assets
Trade receivables	—	94.7	—		—		—		94.7
Derivative financial instruments	—	—	3.2		17.5		—		20.7
Cash and cash equivalents	219.2	—	—		—		—		219.2
Liabilities
Trade and other payables excluding non-financial liabilities	—	—	—		—		(441.6	)	(441.6	)
Derivative financial instruments	—	—	(0.7	)	(68.5	)	—		(69.2	)
Loans and borrowings (note 1)	—	—	—		—		(1,409.5	)	(1,409.5	)
Total	219.2	94.7	2.5		(51.0	)	(1,851.1	)	(1,585.7	)

Note 1: Loans and borrowings excludes €11.1 million of deferred borrowing costs which are included within €1,398.4 million of total loans and borrowings in Note 21.

	Cash and cash equivalents	Loans and receivables	Derivatives at fair value through profit or loss	Derivatives used for hedging (see (c))		Financial liabilities at amortized cost		Total
2016	€m	€m	€m	€m		€m		€m
Assets
Trade receivables	—	92.3	—	—		—		92.3
Derivative financial instruments	—	—	—	13.1		—		13.1
Cash and cash equivalents	329.5	—	—	—		—		329.5
Liabilities
Trade and other payables excluding non-financial liabilities	—	—	—	—		(439.1	)	(439.1	)
Derivative financial instruments	—	—	—	(1.4	)	—		(1.4	)
Loans and borrowings (note 2)	—	—	—	—		(1,464.2	)	(1,464.2	)
Total	329.5	92.3	—	11.7		(1,903.3	)	(1,469.8	)

Note 2: Loans and borrowings excludes €12.4 million of deferred borrowing costs which are included within €1,451.8 million of total non-current loans and borrowings in Note 21.

b) Fair values

Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. In determining fair value, Nomad uses various methods including market, income and cost approaches. Based on these approaches, Nomad utilizes certain assumptions that market participants would use in pricing the asset or liability, including assumptions about risk and the risks inherent in the inputs to the valuation technique. These inputs may be readily observable, market corroborated, or generally unobservable inputs. Nomad utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs. Based on the observability of the inputs used in the valuation techniques Nomad is required to provide the following information according to the fair value hierarchy. The fair value hierarchy ranks the quality and reliability of the information used to determine fair values.

Financial assets and liabilities carried at fair value will be classified and disclosed in one of the following three categories:

Level 1—Quoted prices for identical assets and liabilities traded in active exchange markets, such as the New York Stock Exchange.

F-68

Level 2—Observable inputs other than Level 1 including quoted prices for similar assets or liabilities, quoted prices in less active markets, or other observable inputs that can be corroborated by observable market data. Level 2 also includes derivative contracts whose value is determined using a pricing model with observable market inputs or can be derived principally from or corroborated by observable market data.

Level 3—Unobservable inputs supported by little or no market activity for financial instruments whose value is determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which the determination of fair value requires significant management judgment or estimation; also includes observable inputs for nonbinding single dealer quotes not corroborated by observable market data. Where market information is not available to support internal valuations, reviews of third party valuations are performed.

While Nomad believes its valuation methods are appropriate and consistent with other market participants, the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different estimate of fair value at the reporting date.

The following is a description of the valuation methodologies and assumptions used for estimating the fair values of financial instruments held by the Company.

(i) Derivative financial instruments

Derivative financial instruments are held at fair value. There is no difference between carrying value and fair value. The financial instruments are not traded in an active market and so the fair value of these instruments is determined from the implied forward rate. The valuation technique utilized by the Company maximizes the use of observable market data where it is available. All significant inputs required to fair value the instrument are observable. The Company has classified its derivative financial instruments as level 2 instruments as defined in IFRS 13 ‘Fair value measurement’.

Gains in the year from foreign exchange forward contracts designated as fair value through the Consolidated Statements of Profit or Loss amounted to €nil (2016: €1.0 million, 2015: €9.1 million).

Gains in the year from foreign exchange swap contracts used for liquidity purposes designated as fair value through the Consolidated Statements of Profit or Loss amounted to €3.5 million (2016: €4.3 million loss, 2015: €nil).

Gains in the year from cross currency interest rate swap contracts designated as fair value through the Consolidated Statement of Profit or Loss amounted to €3.9m (2016: €nil, 2015: €nil).

(ii) Trade and other payables/receivables

The notional amount of trade and other payables/receivables are deemed to be carried at fair value, short term and settled in cash.

(iii) Cash and cash equivalents/overdrafts

The carrying value of cash is deemed to equal fair value.

(iv)Interest bearing loans and liabilities

The fair value of secured notes is determined by reference to price quotations in the active market in which they are traded. They are classified as level 1 instruments. The fair value of the senior loans is calculated by discounting the expected future cash flows at the year end’s prevailing interest rates. They are classified as level 2 instruments.

F-69

	Fair value		Carrying value
	Dec 31, 2017	Dec 31, 2016	Dec 31, 2017		Dec 31, 2016
	€m	€m	€m		€m
Senior loans	—	970.3	—		964.2
2020 floating rate senior secured notes	—	505.2	—		500.0
Senior EUR/USD loans	1,012.7	—	1,009.5		—
2024 fixed rate senior secured notes	412.2	—	400.0		—
Less deferred borrowing costs	—	—	(11.1	)	(17.4	)
	1,424.9	1,475.5	1,398.4		1,446.8

c) Derivatives

The notional principal amounts of the outstanding forward foreign exchange contracts at December 31, 2017 were €484.0 million (December 31, 2016: €367.8 million). The notional principal amounts of the outstanding cross currency interest rate swaps as at December 31, 2017 were €826.2 million (pay) and €780.7 million (receive). The following table presents the fair value of derivatives as at December 31, 2017. 43.4% (December 31, 2016: 68.9%) of the notional principal amount of forward foreign exchange contracts relates to USD contracts and 26.0% (December 31, 2016: 22%) of the notional principal amount of forward foreign exchange contracts relates to EUR contracts for the UK and Nordic subsidiaries. 30.6% of the notional principal amount of forward foreign exchange contracts relates to FX swaps for liquidity purposes.

	As at Dec 31, 2017		As at Dec 31, 2016
	€m		€m
Cross Currency Interest Rate Swaps	18.6		—
Forward foreign exchange contracts	2.1		13.1
Total assets	20.7		13.1
Cross Currency Interest Rate Swaps	(61.4	)	—
Forward foreign exchange contracts	(7.8	)	(1.4	)
Total liabilities	(69.2	)	(1.4	)
Total	(48.5	)	11.7

Offsetting of derivatives

Derivative contracts are held under International Swaps and Derivatives Association (ISDA) agreements with financial institutions. An ISDA is an enforceable master netting agreement that permits the Company to settle net in the event of default.

The following table sets out the carrying amounts of recognized financial instruments that are subject to the above agreements.

	Gross amount of financial instruments as presented upon balance sheet		Related financial instruments that are offset		Net amount
As at Dec 31, 2017	€m		€m		€m
Derivatives - assets	20.7		(20.7	)	—
Derivatives - liabilities	(69.2	)	20.7		(48.5	)

F-70

	Gross amount of financial instruments as presented upon balance sheet		Related financial instruments that are offset		Net amount
As at Dec 31, 2016	€m		€m		€m
Derivatives - assets	13.1		(1.4	)	11.7
Derivatives - liabilities	(1.4	)	1.4		—

35) Operating leases

The Company leases certain buildings, plant and equipment under operating leases. The agreements do not share common characteristics across the Company.

Non-cancellable operating lease rentals relate to total future aggregate minimum lease payments and are payable as follows:

	As at Dec 31, 2017	As at Dec 31, 2016
	€m	€m
Less than one year	17.8	18.3
Between one and three years	26.1	29.6
Between three and five years	17.8	22.0
More than five years	106.6	109.7
Total	168.3	179.6

Non-cancellable operating leases relate to equipment, motor vehicles and land and buildings and may be subject to contractual annual increases linked to inflation indices. The payments shown above exclude the impact of these contractual increases which cannot be reliably estimated.

Findus Sverige AB has a long lease for a factory and cold-store that expires in 2040. This accounts for €115.8 million of the lease payments. As explained in note 24, this lease has been identified as being onerous and so a provision of €72.5 million has been recognized in respect of the onerous part of the lease.

36) Capital commitments

Capital expenditure contracted for at the end of the reporting period but not yet incurred is as follows:

	As at Dec 31, 2017	As at Dec 31, 2016
	€m	€m
Property, plant and equipment	3.0	8.1
Intangible assets	2.6	5.4
Total	5.6	13.5

37)         Related parties

Founder Preferred Shares

Each of the Founder Entities holds 750,000 shares of Founder Preferred Shares issued at $10.00 per share. The Founder Preferred Shares were intended to incentivize the Founders to achieve Nomad’s objectives. In addition to providing long term capital, the Founder Preferred Shares are structured to provide a dividend based on the future appreciation of the market value of the ordinary shares thus aligning the interests of the Founders with those of the holders of ordinary shares on a long term basis. The Founder Preferred Shares are also intended to encourage the Founders to grow Nomad following the Iglo Acquisition and to maximize value for holders of ordinary shares. On January 12, 2016, the Company approved a 2015 Founder Preferred Share Dividend with respect to 2015 in an aggregate of 3,620,510 ordinary shares payable to the Founder Entities.

F-71

The conditions of the Founder Preferred Shares Annual Dividend Amount for 2016 were not met and consequently no Founder Preferred Share Dividend was approved for issue.

The conditions of the Founder Preferred Shares Annual Dividend Amount for 2017 were met. On December 29, 2017, the Company’s Board of Directors approved a share dividend of an aggregate of 8,705,890 ordinary shares calculated as 20% of the increase in the market price of our ordinary shares compared to 2015 dividend price of $11.4824 multiplied by Preferred Share Dividend Equivalent. The Dividend Price used to calculate the Annual Dividend Amount was $16.6516 (calculated based upon the volume weighted average price for the last ten consecutive trading days of 2017) and the ordinary shares underlying the Founder Preferred Share Dividend were issued on January 2, 2018.

Advisory Services Agreements

On June 15, 2015, the Company entered into an Advisory Services Agreement with Mariposa Capital, LLC, an affiliate of Mr. Franklin, and TOMS Capital LLC, an affiliate of Mr. Gottesman. Pursuant to the terms of the Advisory Services Agreement, Mariposa Capital, LLC and TOMS Capital LLC provide high-level strategic advice and guidance to the Company. Under the terms of the Advisory Services Agreement, Mariposa Capital, LLC and TOMS Capital LLC are entitled to receive an aggregate annual fee equal to $2.0 million, payable in quarterly installments. This agreement expires on June 1st annually and will be automatically renewed for successive one-year terms unless any party notifies the other parties in writing of its intention not to renew the agreement no later than 90 days prior to the expiration of the term. The agreement may only be terminated by the Company upon a vote of a majority of its directors. In the event that the agreement is terminated by the Company, the effective date of the termination will be six months following the expiration of the initial term or a renewal term, as the case may be.

Expenses of €130,454 and €232,379 for certain travel costs of Mariposa Capital, LLC and TOMS Capital LLC respectively in the year ending December 31, 2017 were reimbursed (year ended December 31, 2016: €153,186 and €233,627 respectively).

Directors and Key Management

All significant management decision making authority is vested within the Board of Directors and the executive team, therefore key management are considered to be the Directors and Executive Officers. Their remuneration has been disclosed in Note 9.

On September 11, 2017, the Company entered into an agreement to repurchase shares being sold in an underwritten secondary public offering by selling Shareholders, Pershing Square Capital Management, L.P. (“Pershing Square”). See Note 25 for a description of the transaction.

As part of the sale of the Iglo Group to Nomad Foods Limited, former Executive Officer and Non-Executive Director, Paul Kenyon and former Executive Officer, Tania Howarth each acquired shares in Nomad Foods Limited from Birds Eye Iglo Group LP Inc. Mr. Kenyon acquired 37,060 shares and Ms. Howarth acquired 38,956 shares at a price of $10.50 (€9.71) per share which was deemed to be at fair value. On June 12, 2017, Nomad repurchased 9,779,729 of our shares beneficially owned by Permira Funds ("Permira Repurchase") at a purchase price of $10.75 (approximately €9.60) per share, which represents a 25% discount to the closing price of our ordinary shares on June 9, 2017, for an aggregate purchase price of $105.1 million (approximately €93.9 million), in final settlement of indemnity claims against an affiliate of Permira Funds, of legacy tax matters that predated the Iglo Acquisition. In connection with the Permira Repurchase (and upon removal of certain transfer restrictions relating to their shares), Mr. Kenyon and Ms. Howath sold 26,372 and 27,721, shares, respectively.

Lord Myners of Truro CBE, a Non-Executive Director, holds 72,028 ordinary shares in Nomad Foods Limited which includes 50,000 ordinary shares granted pursuant to a five-year option that expires on June 2, 2020 at a purchase price of $11.50 per share.

As described in Note 8(b), certain of the Non-Executive Directors are eligible to an annual restricted stock grant issued under the LTIP which will vest on the earlier to occur of the date of the Company’s annual meeting of shareholders or thirteen months from the date of grant.

F-72

The Non-Executive Directors restricted share awards, granted at a share price of $11.50 on December 7, 2015, vested on June 16, 2016 and were issued in July at a share price of $8.98. Of the total 34,780 number of shares vesting, 11,568 shares were held back from issue by the Company as settlement towards personal tax liabilities arising on the vested shares. The total charge for restricted share awards granted in 2015 within the Statement of Consolidated Profit or Loss for the year ended December 31, 2016 for this stock compensation award was €0.3 million (nine months ended December 31, 2015: €0.1 million).

The Non-Executive Directors restricted share awards granted on June 16, 2016, which consisted of 55,680 shares at a share price of $8.98, vested on June 19, 2017 and were issued at a share price of $14.38, resulting in a €0.3 million increase in the share based compensation reserve. Of the total 55,680 number of shares vesting, 9,384 shares were held back from issue by the Company as settlement towards personal tax liabilities arising on the vested shares. The total charge for restricted share awards granted in 2016 within the Statement of Consolidated Profit or Loss for the year ended ended December 31, 2017 for this stock compensation award was €0.5 million (year ended December 31, 2016 : €0.3 million).

On June 19, 2017, Non-Executive Directors were granted 41,724 restricted share awards at a share price of $14.38. On August 22, 2017, two new Non-Executive Directors were granted a pro-rata 11,774 restricted share awards at the same share price and vesting conditions as the previous grant. The total charge for restricted share awards granted in 2017 within the Statement of Consolidated Profit or Loss for the year ended ended December 31, 2017 for this stock compensation award was €0.4 million.

The total charge for Non-Executive Director grants within the Statement of Consolidated Profit or Loss for the year endedDecember 31, 2017 for stock compensation awards was €0.8 million (Year ended December 31, 2016: €0.6 million; Nine months ended December 31, 2015: €0.1 million).

As part of its long term incentive initiatives, the company has 4,927,000 restricted shares to the management team (the “Management Share Awards”). The Directors and Executive Officers have all been awarded shares. The associated performance metrics and valuation method is detailed in Note 8(b).

38)         Significant events after the Statement of Financial Position date

On December 29, 2017, we approved a 2017 Founder Preferred Share Dividend in an aggregate of 8,705,890 ordinary shares. The dividend price used to calculate the 2017 Founder Preferred Shares Annual Dividend Amount was $16.6516 (calculated based upon the volume weighted average price for the last ten trading days of 2017) and the Ordinary Shares were issued on January 2, 2018.

On January 17, 2018 we entered into an agreement to acquire Green Isle Foods Ltd. including the Goodfella's and San Marco brands, in an all cash deal valued at £200 million (approximately €225 million). We anticipate this acquisition to be completed in the second quarter of 2018 and we expect this will enlarge our portfolio of brands to include the number one and number two market share positions within the frozen pizza category in Ireland and the UK, a successful frozen private label pizza business, and two frozen pizza manufacturing facilities. The purchase price of the acquisition is expected to be funded through cash on hand.

In 2016, we announced the closure of our factory and pea processing operations in Bjuv, Sweden, and operations ceased in the first half of 2017 with production transferred to other factories in the Group’s network. In early 2018, we signed an agreement with Foodhills AB who will acquire the buildings and parts of the premises with the intention to develop a food production area. Legal handover of the site is scheduled for March 1, 2018. The purchase price could be up to 85 million SEK (approximately €8.6 million), but is subject to liabilities and warranties in the framework of the transaction.

F-73

Item 19. Exhibits

The following exhibits are filed as part of this annual report:

EXHIBIT INDEX

		Incorporation by Reference
Exhibit  No.	Exhibit Description	Form	Exhibit  No.	Period Covered or Date of Filing	Included in this Annual Report
1.1	Amended and Restated Memorandum and Articles of Association	6-K (001-37669)	99.1	1/14/2016
2.1	Registration Rights Agreement dated as of June 1, 2015 among Nomad Holdings Limited, Birds Eye Iglo Limited Partnership Inc, Mariposa Acquisition II, LLC, TOMS Acquisition I LLC, TOMS Capital Investments LLC and funds managed by Pershing Square.	F-1 (333-208181)	4.1	11/24/2015
2.2	Indenture dated as of May 3, 2017 among Nomad Foods Bondco PLC, Nomad Foods Limited, Deutsche Trustee Company Limited, Deutsche Bank AG, London Branch, Deutsche Bank Luxembourg S.A., and Credit Suisse AG, London Branch and the Subsidiary Guarantors named therein.	6-K (001-37669)	99.3	5/3/2017
4.1	Share Sale and Purchase Agreement, dated as of October 29, 2015, among Liongem Sweden 1 AB, Iglo Foods Group Limited and Nomad Foods Limited	F-1 (333-208181)	2.2	11/24/2015
4.2	Senior Facilities Agreement, originally dated July 3, 2014, as amended and restated from time to time including pursuant to the 2017 Amendment and Restatement Agreement for Nomad Foods Limited with Credit Suisse AG, London Branch, Deutsche Bank AG, London Branch, Goldman Sachs Bank USA and UBS Limited.	6-K (001-37669)	99.1	5/3/2017
4.3	Intercreditor Agreement, originally dated as of July 3, 2014, as amended and restated from time to time including, pursuant to the 2017 Amendment and Restatement Agreement among Nomad Foods Limited, Credit Suisse AG, London Branch, Deutsche Bank Company Limited and certain entities named therein.	6-K (001-37669)	99.2	5/3/2017
4.4	Senior Facilities Agreement, originally dated July 3, 2014, as amended and restated from time to time including pursuant to the December 2017 Amendment and Restatement Agreement for Nomad Foods Limited with Credit Suisse International, Deutsche Bank AG, London Branch, Goldman Sachs Bank USA, UBS Limited and Credit Suisse AG, London Branch.	6-K (001-37669)	99.1	12/20/2017
4.5	Nomad Foods Limited Long-Term 2015 Incentive Plan	F-1 (333-208181)	10.2	11/24/2015
4.6	Service Agreement between the Company and Stéfan Descheemaeker.	F-1 (333-208181)	10.3	11/24/2015
4.7	Service Agreement, dated as of February 15, 2018, between the Company and Samy Zekhout.				X
4.8	Contract of Employment, dated as of September 4, 2015, between the Company and Paul Kenyon	F-1 (333-208181)	10.4	11/24/2015
4.9	Contract of Employment, dated as of January 5, 2007, between Tania Howarth and the Company, and related Letter Agreement	20-F  (001-37669)	4.9	4/1/2016

F-74

		Incorporation by Reference
Exhibit  No.	Exhibit Description	Form	Exhibit  No.	Period Covered or Date of Filing	Included in this  Annual Report
4.10	Advisory Services Agreement, dated as of June 15, 2015, among Nomad Foods Limited, Mariposa Capital, LLC and TOMS Capital LLC	F-1 (333-208181)	10.5	11/24/2015
8.1	List of Significant Subsidiaries				X
12.1	Rule 13a-14(a)/15d-14(a) Certification of Chief Executive Officer				X
12.2	Rule 13a-14(a)/15d-14(a) Certification of Chief Financial Officer				X
13.1	Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.				X
13.2	Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.				X
15.1	Consent of PricewaterhouseCoopers LLP				X
101.INS	XBRL Instance Document				X
101.SCH	XBRL Taxonomy Extension Schema Document				X
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document				X
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document				X
101.LAB	XBRL Taxonomy Extension Label Linkbase Document				X
101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document				X

F-75

SIGNATURES

The registrant hereby certifies that it meets all of the requirements for filing on Form 20-F and that it has duly caused and authorized the undersigned to sign this Annual Report on Form 20-F on its behalf.

Date:    March 22, 2018

NOMAD FOODS LIMITED

By: /s/ Jason Ashton                                                 

Name: Jason Ashton

Title:    Interim Chief Financial Officer

F-76

EX-4.7

Exhibit 4.7

DATED 15 FEBRUARY2018

NOMAD FOODS EUROPE LIMITED

AND

SAMY ZEKHOUT

AND

NOMAD FOODS LIMITED

SERVICE AGREEMENT

THIS AGREEMENT is made the     15TH    day of     FEBRUARY    2018

BETWEEN:

(1) NOMAD FOODS EUROPE LIMITED, a company incorporated in England and Wales (registered number 05879466) whose registered office is at 1 New Square, Bedfont Lakes Business Park, Feltham, Middlesex, TW14 8HA (the "Company"); and

(2) SAMY ZEKHOUT of XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX (the "Executive"); and

(3) NOMAD FOODS LIMITED incorporated in the British Virgin Islands with Company Number 1818482, whose registered office is Nemours Chambers, Road Town, Tortola, British Virgin Islands (“Nomad”)

NOW IT IS AGREED that the Company shall employ the Executive on the following terms and conditions:

1. COMMENCEMENT AND TERM

1.1 The Executive's employment under this Agreement shall commence on [1st April 2018] (the "Commencement Date") at Work Level 5 (further details of the Company’s work levels are available from Human Resources).

1.2 The employment of the Executive shall (subject to the provisions of this Agreement) be for an indefinite period terminable by either party giving the other not less than 6 months' notice in writing, such notice to expire at any time.

1.3 The Executive’s employment is conditional on receipt of references and a medical report, in both cases satisfactory to the Company.

2. EXECUTIVE'S DUTIES

2.1    The Executive shall during the continuance of the contract of employment:

2.1.1 serve to the best of his ability in the capacity of Chief Finance Officer and as a director of the Company and Nomad;

2.1.2 report to Stefan Descheemaeker, CEO or such other person as the Board of Directors of Nomad may specify (the “Board”);

2.1.3 faithfully and diligently perform such duties and exercise such powers consistent with them as the Board (or anyone authorised by the Board) may from time to time properly and reasonably assign to or confer upon him;

2.1.4 comply with the reasonable instructions of the Board from time to time; and

2.1.5 do all in his power to protect promote develop and extend the business interests and reputation of the Group.

2.2    The Executive shall also be appointed to the Board of Directors of Nomad:

2.2.1 The Executive shall not be entitled to any additional compensation or fees (from the Company, Nomad or otherwise) as a result of such appointment, nor shall it give rise to an employment relationship with Nomad;

2.2.2 Removal from the Board of Nomad shall not (1) give rise to any breach of contract by the Company or any Associated Company and (2) in itself affect the Executive’s employment with the Company; and

2.2.3 The Executive’s appointment and any re-appointment as a Director is subject to Nomad’s memorandum and articles of association (as amended from time to time) (the "Articles"). Nothing in this letter will be taken to exclude or vary the Articles as they apply to you as a Director of Nomad. The Executive shall, during the appointment (i) act as a Director of Nomad and comply with all obligations on the Executive under British Virgin Islands law (including but without limitation the BVI Business Companies Act (the "BVI Companies Act") and all applicable provisions of common law) and regulations or any other applicable laws and regulations in the Executive’s positions as such including, without limitation, the rules of the New York Stock Exchange or any other stock exchanges on which Nomad shares are listed and/or traded, (ii) comply with the Articles, (iii) abide by any statutory, fiduciary or common-law duties to Nomad and (iv) not do anything that would cause the Executive to be disqualified from acting as a Director.

2.3 The Executive shall unless prevented by sickness, injury or other incapacity or as otherwise agreed by the Board and subject to this Agreement devote the whole of his time attention and abilities during his working hours (which shall be normal business hours and such additional hours as may be reasonably necessary for the proper performance of his duties) to the business and affairs of the Group. The Executive acknowledges that he has unmeasured working time for the purposes of Regulation 20 of the Working Time Regulations.

2.4 The Executive shall work at the Company's offices at Bedfont Lakes, Middlesex or such other place of business of the Group which the Board may reasonably require for the proper performance of his duties and the Executive may be required to travel both inside and outside of the UK on the business of the Group.

2.5 The Executive shall not during the continuance of this Agreement without the prior written consent of the Board of Nomad (such consent not to be unreasonably withheld or delayed) directly or indirectly carry on or be engaged concerned or interested in any other business trade or occupation otherwise than as a holder directly or through nominees of either not more than 3 per cent in aggregate of any class of shares, debentures or other securities in issue from time to time of any company which are for the time being quoted or dealt in on any recognised investment exchange (as defined by Section 285 of the Financial Services and Markets Act 2001) or passive shareholdings for investment purposes in companies which do not at the relevant time compete or otherwise conflict with the business of the Company or any Associated Company PROVIDED THAT it is acknowledged that the Executive has an existing involvement with the following companies: Siamab; Detechtion; N12 Technologies; Bin1Ate; Rental Beast; SwapOnz; Briggs and Algama. On the basis of the information currently available it is acknowledged that these interests are non-competitive and/or do not conflict with the business of the Company or any Associated Company. The Executive agrees that he shall not increase the level of interest or activity in the listed concerns, nor take on any other interests that would conflict with this clause 2.5.

2.6 Following the service of notice by either party to terminate the Executive's employment, or if the Executive purports to terminate this Agreement in breach of contract, the Board may require the Executive not to perform any services for a defined period or until the termination of his employment. During this period:

2.6.1 the Company shall not be obliged to provide any work, or vest any powers in the Executive, who shall have no right to perform any services for the Company and the Board may appoint a replacement to carry out the Executive's duties and responsibilities;

2.6.2 the Executive shall continue to receive his salary and contractual benefits in the usual way;

2.6.3 the Executive shall remain an employee of the Company and (save as varied by the operation of this clause) be bound by the terms of this Agreement, particularly in relation to any duties of confidentiality and fidelity;

2.6.4 the Executive shall use all reasonable endeavours to remain contactable at all times during normal working hours by telephone and shall remain ready to attend work on reasonable notice (if so required by the Company);

2.6.5 the Executive shall not engage in any activities or other occupation (whether paid or unpaid) in breach of his obligations under this Agreement. In particular, the Executive shall not directly or indirectly or on behalf of (or together with) any other person, firm or company be, or prepare to be, concerned or otherwise interested in any other business or activity which is or will be or is likely to be in competition with the business of the Company or any of its Associated Companies;

2.6.6 the Executive shall not access any premises of the Company or any Associated Company;

2.6.7 the Executive shall not contact any officer, employee, consultant, shareholder, client, customer, employee, agent, distributor or other business contact of the Company or any Associated Company save in a social context and with the prior, written consent of the Board, such consent not to be unreasonably withheld;

2.6.8 the Company reserves the right to suspend or cancel access to the Company intranet, email and other systems and reserves the right to require the return of all Company property, including PC and mobile phone;

2.6.9 the Executive shall cease to be an authorised signatory of the Company or hold a Power of Attorney for the Company (if requested in writing by the Company);

2.6.10 the Executive shall take all accrued holiday (in respect of the period up until the Termination Date) and no contractual holiday entitlement shall accrue;

2.6.11 the Executive shall not make any public statements in relation to the Company or any Associated Company or its or their officers or employees.

2.7 The Company shall be able to suspend the Executive for so long as it considers reasonable, in order to investigate a complaint made against him.

3. SALARY, BONUS AND EQUITY

3.1 The Company shall pay to the Executive a base salary (which shall accrue from day to day) at the rate of £425,000 per annum, subject to all applicable withholdings. The Executive shall not be entitled to any directors' fees for service on the board of the Company or any Associated Company. The salary shall be payable by equal monthly instalments by credit transfer to the Executive's bank or building society account.

3.2 The salary payable to the Executive under clause 3.1 shall be reviewed by the compensation committee of the Board annually, the first such review to take place in April 2019 at the time the Company normally reviews salaries for senior management and may (if at all), be increased by such amount as the compensation committee of the Board may in its absolute discretion decide and notify to the Executive in writing. For the avoidance of doubt, the Executive's salary shall not be decreased on any review.

3.3 The Executive shall be entitled to participate in the discretionary Performance Bonus Plan for 2018. The Performance Bonus Plan runs from January to December each year. The Company reserves the right to set targets as it sees fit and to withdraw the Performance Bonus Plan at any point, with no obligation to replace. As his role is at Work Level 5, the Executive's target annual discretionary bonus shall be 100% of his base salary with an opportunity to increase this to 200% depending on business performance. For the avoidance of doubt, entitlement to bonus accrues on a daily basis and a payment in one year does not create any entitlement to receive a further bonus payment. No bonus shall be payable when the Executive is no longer employed, or under notice, as at 31 December save that where the Executive’s employment ends during a bonus year, the Company shall (in its absolute discretion and taking account of any such facts or circumstances as it sees fit) give consideration to a pro rata bonus payment. Any 2018 bonus would be paid pro-rata calculated as from the Commencement Date. Any bonus is usually declared in January and payable in the April payroll, subject to the accounts audit.

3.4 The Company shall grant the Executive the following award under the Nomad Foods 2015 Long Term Incentive Plan (Issue 4): within 2 months following the Commencement Date, an award of 300,000 ordinary shares as incentive compensation, subject to performance based vesting conditions as set forth in a share grant award agreement.

4. BENEFITS

4.1 The Company shall pay for the benefit of the Executive an annual contribution of 10% of base annual salary, provided that the Executive contributes 4.5% of base annual salary, into the Company’s Defined Contribution Group Pension Plan. A contracting-out certificate is not currently in force in respect of the employment of the Executive. If the Executive notifies the Company in writing within two weeks of the Commencement Date, it shall pay monthly in lieu the equivalent of 10% of base annual salary to the Executive, subject to the usual deductions.

4.2    The Company shall pay, in respect of the Executive, premiums to a:

4.2.1 private medical insurance scheme in respect of the Executive and the Executive’s dependants with whom the Executive lives on a daily basis;

4.2.2 permanent health insurance scheme (offering 75% of base salary);

4.2.3 life assurance scheme (3 times salary)

4.3 with such level of benefits as the Board shall in its absolute discretion decide. The Executive's participation in such schemes is subject to (1) the premiums for the Executive's cover being at such a rate that the Company considers reasonable (2) any statutory or other regulatory limit applicable to such premium (3) the insurer accepting the Executive for cover and (4) the rules of the relevant scheme and the rules of the insurance policy of the relevant insurance provider from time to time in force.

4.4 The Company reserves the right to (1) change the provider of any of the benefits available under this clause and (2) alter the level of coverage available to the Executive at any time. The Company shall only be obliged to make payments to the Executive under the permanent health scheme if and to the extent it has received payment from the insurance provider for that purpose. The Company shall have no liability in the event that insurance cover is refused, or any conditions or limitations are applied, by the provider. The Company shall be under no obligation to take any action to enforce the terms of any insurance policy or challenge any decision of the relevant policy provider.

4.5 Subject to the Executive’s compliance with the Company’s Car Policies and Road Risk Safety Management Programme, the Company shall pay to the Executive a monthly car allowance (the “Car Allowance”) of £1100 paid by equal monthly instalments in arrears, subject to applicable deductions. Provided that the Executive notifies the Company in writing within 2 weeks of the date of this Agreement, the Company will make a payment to the Executive together with the first salary payment, of £13,200 (subject to applicable deductions) in lieu of the first year of Car Allowance.

4.6 The Executive shall be entitled to 25 days paid holiday in each of the Company's holiday years in addition to the 8 public and bank holidays. On termination the Executive shall be paid in lieu of any untaken holiday entitlement (if any) or shall he obliged to repay any holiday pay received in excess of the Executive's entitlement (if any). One day's pay for the purposes of this clause shall be calculated at the rate of 1/260^th of the Executive's annual salary.

4.7 Holiday shall be taken at such times as are approved by the Board and may not be carried forward from one holiday year to the next without the approval of the Board (which will not be unreasonably withheld or delayed). The Company may require the Executive to take any holiday due to him at any time after notice of termination has been served by either party.

4.8 In the event that the Executive is unable to carry out his duties by reason of sickness or injury he shall, subject to compliance with the Company's procedures relating to notification and certification periods, be entitled to statutory sick pay in accordance with the relevant statutory rules. In addition, the Company will continue to make payments of salary to the Executive (subject to credit for any statutory sick pay

and any payment to the Executive of benefit under any permanent health insurance scheme provided by the Company) and continue to provide the benefits provided for in this Agreement for all periods of such incapacity up to a maximum of 26 weeks of such incapacity in any period of 52 weeks. To the extent that any sickness or injury is caused by the negligence or breach of duty of any third party and the Executive makes a claim for damages against such third party any payments or benefits provided under this clause shall be deemed a loan by the Company and recoverable to the extent that a judgement is obtained and satisfied.

4.9 The Company shall reimburse the Executive for all reasonable vouched for travelling and similar out-of-pocket expenses incurred in the discharge of his duties subject to the Company's expenses policy in force from time to time.

4.10 The Executive shall undergo an examination by a registered medical practitioner nominated by the Company at such times as the Company may reasonably request and at the expense of the Company, and hereby consents to the medical adviser disclosing the results of the examination to the Company and shall provide the Company with such formal consents as may be reasonably requested for this purpose and shall co-operate in ensuring the prompt delivery to the Company of any such report.

4.11 If the Executive shall be a director of the Company or any Associated Company (save for Nomad), the Company shall pay premiums to a directors and officers liability insurance policy which offers cover for the Executive in respect of any office he may hold in the Company or any Associated Company. Such cover shall be on no less favourable terms than are applicable to other offices of the Company or any Associated Company.

5. COMPANY PROPERTY AND CONFIDENTIALITY

In this clause, "Intellectual Property Rights" shall mean all patents, rights to Inventions, copyright and related rights, trademarks, service marks, trade, business and domain names, rights in trade dress, rights in get-up and goodwill or to sue for passing off, design rights and registered designs, rights in confidential information (including know-how) and database rights in each case whether registered or unregistered and any other intellectual property rights and including all applications for and renewals or extensions of such rights in any part of the world. "Inventions" shall mean any invention, idea, discovery, improvement, development or innovation, whether or not patentable or capable of registration, and whether or not recorded in any medium.

5.1 The Executive acknowledges that all Intellectual Property Rights subsisting developed by the Executive in the course of his employment (whether or not during working hours or using Company resources) shall belong to the Company absolutely. To the extent that they do not automatically vest in the Company, the Executive shall hold them on trust for the Company.

5.2 The Executive shall give the Company full details in writing of all Inventions and of all works embodying Intellectual Property Rights made wholly or partially by him at any time in the course of his employment which relate wholly or partly to the business of the Company or any Associated Company.

5.3 The Executive hereby irrevocably waives all moral rights under the Copyright Designs and Patents Act 1988 (and any similar or equivalent rights in other jurisdictions) in relation to any existing or future works created by him in the course of his employment.

5.4 The Executive acknowledges that the client and candidate databases of the Company and any Associated Company are their key assets and all intellectual property rights in such and their contents are and shall remain at all times the property of the Company. Any databases created by the Executive in the course of his employment shall be the property of the Company and the Executive agrees to take any such steps as may be necessary to assign such rights to the Company.

5.5 The Executive shall not copy or download in any format or use in whole or part the contents of any Company or Associated Company database (except as required by law or in the proper performance of the Executive’s duties for the Company).

5.6 During his employment with the Company and thereafter the Executive shall not use any databases or any other intellectual property rights owned by the Company or any Associated Company directly

or indirectly to procure a commercial benefit to himself or another party or to create a commercial detriment to the Company or any Associated Company.

5.7 On the termination of the Executive’s employment (or earlier if requested):

5.7.1 the Executive will immediately cease to use all databases owned by the Company or any Associated Company and/or by him in the course of his employment; and

5.7.2 the Executive shall forthwith surrender to a representative of the Company all documents and other materials including discs and memory sticks which contain any copies or extracts from databases owned by the Group and delete all electronic copies or extracts of the databases or their contents.

5.8 The Executive acknowledges that he shall become aware of and have access to Confidential Information. "Confidential Information" shall mean trade secrets and confidential information (howsoever stored) relating to the Company, Associated Companies, its and their businesses and its and their past, current or prospective clients or customers, including information relating to finances, business transactions, research activities, dealings and affairs and prospective business transactions, Board decisions, customers (including customer lists, customer requirements and their identity), existing and planned product lines, price lists and pricing structures (including discounts, special prices or special contract terms offered to or agreed with customers), technology used by the Company or any Associated Company in their products and services, business plans, sales and marketing information, plans and strategies, computer systems, source codes and software, directors and information relating to employees, suppliers, licensors, agents, distributors or contractors. This shall include information expressly designated by the Company or any Associated Company as being confidential.

5.9 The Executive shall not (save as required by law or in the proper performance of his duties) either during his employment or after its termination (for whatever reason) use or disclose to any person, company or other organisation whatsoever, and shall use his reasonable endeavours to prevent the publication or disclosure of, any Confidential Information.

5.10 This clause shall not apply to:

5.11    use or disclosure authorised by the Company or required by law;

5.12 any information which is already in, or comes into, the public domain other than through the unauthorised disclosure of the Executive.

5.11 On the Termination Date (or earlier if so requested by the Company), the Executive shall return all property of the Company and any Associated Company in his possession, custody or control, including his company credit cards, books, keys, notes, correspondence, codes, security passes, computer software and hardware (including laptops and hard disks), papers, drawings, designs, records and mobile telephones and all information (on whatever media and wherever located) relating to the business and affairs of the Company or any Associated Company or its or their clients. For the avoidance of doubt, this clause shall not prevent the Executive retaining his own property and information.

5.12 This clause survives the termination of this Agreement and the Executive’s employment under it, howsoever caused.

6. TERMINATION

6.1 The Company may not terminate this Agreement in circumstances which would prejudice the Executive's entitlement under any permanent health insurance scheme in respect of which the Company or any Associated Company pays or has paid premiums for the Executive in which the Executive participates and either he:

6.1.1is in actual receipt of benefits thereunder; or

6.1.2is not in receipt of benefits but the Executive is absent from work by reason of sickness or injury in circumstances where it is reasonably foreseeable that he may be entitled to payments under the Company's PHI scheme as a consequence of the sickness or injury causing his absence

save pursuant to clause 6.3 below or by reason of redundancy.

6.2 The Company may terminate the Executive's employment at any time by serving a notice under this clause stating that the Company is exercising its rights under this clause and stating that it will pay to the Executive within 14 days a sum equal to the basic salary (as at the date of this Agreement) in lieu of any required period of notice less deductions for income tax and National Insurance, provided always that if the Company should decide not to exercise its rights under this clause, the Executive shall not be entitled to enforce the payment referred to as a contractual debt nor as liquidated damages and his sole remedy shall be a claim in damages in respect of any unexpired period of notice. For the avoidance of doubt, such payment shall not include (1) any bonus that might otherwise be due during the relevant period; (2) any benefits which the Executive might have been entitled to receive during the period; or (3) any payment in respect of holiday entitlement which may have accrued during that period.

6.3 The Company shall at all times be entitled to terminate this Agreement and the Executive's employment forthwith without any payment by way of compensation, damages, payment in lieu of notice or otherwise if the Executive:

6.3.1     is guilty of any gross misconduct; or

6.3.2 commits any serious, material or repeated breach or non-observance of any of the terms or conditions of this Agreement; or

6.3.3 materially neglects or refuses to carry out any of his duties or to comply with any material reasonable and lawful instruction of the Company; or

6.3.4 has a bankruptcy order made against him or makes any arrangement with or for the benefit of his creditors; or

6.3.5 is charged with or convicted of any criminal offence (other than an offence under any road traffic legislation for which a fine or non-custodial penalty is imposed); or

6.3.6 is disqualified from acting as a director or resigns as a director of the Company or any Associated Company without the prior written approval of the Company; or

6.3.7 is disqualified from membership of, or is subject to any disciplinary sanction by, any professional or other body, membership of which is relevant to his employment under this Agreement; or

6.3.8 is guilty of any fraud or dishonesty or acts in any way which in the reasonable opinion of the Company brings the Company or any Associated Company into material disrepute, or is materially adverse to its or their interests; or

6.3.9 fails materially to comply with any policy of the Company or any Associated Company including its rules relating to the use of its electronic communications systems; or

6.3.10 materially breaches the Company’s policies and procedures dealing with the Bribery Act 2010 whether or not criminal or other sanctions are imposed; or

6.3.11 enters into any transaction or behaves in any other way which constitutes an offence for the purposes of Part V of the Criminal Justice Act 1993 or which constitutes market abuse for the purposes of Part VIII of FSMA.

The rights of the Company under clause are without prejudice to any other rights that it may have at law to terminate this Agreement or to accept a breach by the Executive as having brought it to an end. Any delay by the Company in exercising its rights to terminate shall not constitute a waiver thereof.

6.4 If the employment of the Executive is transferred to an Associated Company by reason of the liquidation of the Company for the purposes of reconstruction or amalgamation or as part of any arrangement for the amalgamation or reconstruction of the Company not involving insolvency and the Executive is offered employment with any concern or undertaking resulting from such reconstruction or amalgamation on the same terms and conditions (save for the identity of the employer) as this Agreement the Executive shall have no claim against the Company in respect of such transfer or termination.

6.5 On termination (or once notice has been served by either party and the Company has exercised its rights under clause 2.6 of this Agreement), the Executive shall:

(a) at the request of the Board immediately resign from any office held by him in the Group (including Nomad) without claim for compensation (without prejudice to any claims he may have for damages for breach of this Agreement) and in the event of his failure to do so the Company is irrevocably authorised to appoint some person in his name and on his behalf to sign and deliver such resignations to the Board; and

(b) immediately repay all outstanding debts and loans due to the Company or any Associated Company and the Company is hereby authorised to deduct from any monies due to the Executive a sum in repayment of all or any part of any such debts or loans.

7. EXECUTIVE'S COVENANTS

7.1    For the purpose of this clause 7:

"the Business" means any business carried on by the Group at the Termination Date and with which the Executive has been concerned to a material extent in the 12 months immediately preceding such termination or the date on which the Company exercises its rights under clause 2.6 (whichever is the earlier);

references to "Associated Companies" shall only be reference to Associated Companies in respect of which the Executive has carried out material duties in the period of 12 months prior to the Termination Date or the date on which the Company has exercised its rights under clause 2.6 (whichever is the earlier);

"Restricted Person" shall mean any person who or which has at any time during the period of 12 months immediately preceding the Termination Date or the date on which the Company exercises its rights under clause 2.6 (whichever is the earlier) done business with the Company or any Associated Company as customer or client or distributor or consultant and with whom or which the Executive shall have had material dealings, contact with or responsibility for during the course of the employment;

"Key Employee" shall mean any person who at the Termination Date or the date on which the Company exercises its rights under clause 2.6 (whichever is the earlier) is employed or engaged by the Group, with whom the Executive has had material contact and (a) is employed or engaged in a senior capacity and/or (b) is in the possession of confidential information belonging to the Group and/or (c) is directly managed by or reports to the Executive.

7.2 The Executive acknowledges that during the course of the employment with the Company that he will receive and have access to Confidential Information of the Group and that he will have influence over and connection with customers, clients and employees of the Group with which the Executive comes in contact during the employment and accordingly he is willing to enter into the covenants described in clauses 7.3 and 7.4 in order to provide the Group with reasonable protection for its interests.

7.3 The Executive covenants with the Company that he will not in connection with the carrying on of any business in competition with the Business for the period of 12 months after the Termination Date without the prior written consent of the Board either alone or jointly with or on behalf of any person directly or indirectly:

7.3.1    canvass, solicit or approach or cause to be canvassed or solicited or approached for orders in respect of any services provided and/or any goods sold by the Group any Restricted Person;

7.3.2    solicit or entice away or endeavour to solicit or entice away from the Group, or employ or engage, any Key Employee.

7.4 The Executive covenants with the Company that he will not for the period of 12 months after the Termination Date without the prior written consent of the Board either alone or jointly with or on behalf of any person directly or indirectly carry on or set up or be employed or engaged by or otherwise assist in or be interested in any capacity (save as a shareholder of not more than 1% in aggregate of any class of shares, debentures or other securities of any company which are quoted on or dealt in any recognised investment exchange) in a business anywhere within the United Kingdom, Italy, Germany, Austria, the Netherlands, Belgium, Portugal, France, Ireland, Sweden, Norway, Denmark, Finland and Spain and such other areas in which the Company or any Associated Company carries on business or plans to carry on business (and in which plans the Executive has been involved) at the Termination Date and in respect of which the Executive shall have carried out material duties or been materially engaged or concerned at any time during the period of 12 months immediately preceding the Termination Date which is (or is likely to be) in competition with the Business; save that the Executive's continued involvement in the companies listed in the proviso to clause 2.5 shall not be in breach of this clause; and save that it is acknowledged that any company which earns no more than fifteen percent (15%) of its annual revenues from a line of business in frozen food manufacture shall not be considered to be in competition with the Business.

7.5 The periods during which clauses 7.3 and 7.4 are expressed to operate shall each be reduced by such period as the Executive shall have complied during his notice period with a direction to perform no duties and/or not to enter all or any premises of the Group pursuant to clause 2.6.

7.6 The covenants contained in clauses 7.3.1 and 7.3.2 and 7.4 are intended to be separate and severable and enforceable as such.

7.7 While the aforesaid restrictions are considered by the parties to be reasonable in all the circumstances, it is agreed that if any restriction shall be adjudged to be void or ineffective for whatever reason but would be adjudged to be valid and effective if part of the wording thereof were deleted the said restrictions shall apply with such modifications as may be necessary to make them valid and effective.

8. STATUTORY PARTICULARS

8.1    The Executive's period of continuous employment commenced on the Commencement Date.

8.2 There is no formal disciplinary procedure in relation to the Executive's employment. The Executive shall be expected to maintain the highest standards of integrity and behaviour.

8.3 If the Executive is not satisfied with any disciplinary decision taken in relation to him, he may apply in writing within 14 days of that decision to the Board whose decision shall be final.

8.4 If the Executive has any grievance in relation to his employment he may raise it in writing with the Board whose decision shall be final.

8.5 There are no collective agreements applicable to the Executive's employment.

8.6 This clause 8 is not intended to be of contractual effect.

9. MISCELLANEOUS

9.1 The Executive hereby warrants that by virtue of entering into this Agreement he is not and will not be in breach of any express or implied terms of any contract, court order or of any other obligation legally binding upon him.

9.2 Any benefits provided by the Company to the Executive or his family which are not expressly referred to in this Agreement shall be regarded as ex gratis benefits provided at the entire discretion of the Company and shall not form part of the Executive's contract of employment.

9.3 The Company shall be entitled without notice to the Executive at any time during the Executive's employment and upon termination to set off and/or make deductions from the Executive's salary or from any other sums due to the Executive from the Company or any Associated Company in respect of any overpayment of any kind made to the Executive or in respect of any outstanding debt or other sum due from him.

9.4 A person who is not a party to this Agreement has no right under the Contracts (Rights of Third Parties) Act 1999 to enforce any term of this Agreement.

10. DEFINITIONS AND INTERPRETATION

10.1    In this Agreement unless the context otherwise requires:

"Associated Company" means any company which is a holding company or a subsidiary of the Company or a subsidiary of the Company's holding company and "holding company" and "subsidiary" shall have the meanings given by s.1159 Companies Act 2006 or as amended from time to time and "Associated Companies" shall be construed accordingly;

"Group" means the Company and the Associated Companies;

"Termination Date" means the last day of the Executive's employment with the Company under this Agreement.

10.2 In this Agreement the headings are for convenience only and shall not affect its construction or interpretation. References to clauses are references to clauses in this Agreement and references to a person shall where the context permits include reference to a corporate body or an unincorporated body of persons. Any word which denotes the singular shall where the context permits include the plural and vice versa and any word which denotes the masculine gender shall where the context permits include the feminine and/or the neuter genders and vice versa. Any reference to a statutory provision shall be deemed to include a reference to any statutory amendment modification or re-enactment.

10.3 This Agreement contains the entire understanding between the parties and supersedes all (if any) subsisting agreements arrangements and understandings (written or oral) relating to the employment of the Executive which such agreements, arrangements and understandings shall be deemed to have been terminated by mutual consent. The Executive warrants that he has not entered into this Agreement in reliance on any warranty representation or undertaking of any nature whatsoever which is not contained in or specifically incorporated in this Agreement.

10.4 Any amendments to this Agreement shall only be valid if set out in writing and signed by both parties.

10.5 This Agreement is governed by and shall be construed in accordance with the law of England and Wales and is subject to the exclusive jurisdiction of the Courts of England and Wales.

EXECUTION

The parties have shown their acceptance of the terms of this Deed by executing it as a deed below.

EXECUTED as a deed by a Director, duly authorised for and on behalf of the Company, in the presence of:	) ) /s/ Stéfan Descheemaeker )
Signature of Witness:	/s/ Jackie Facey
Name of Witness:	Jackie Facey
Address of Witness:	XXXXXXXXXXXXXXXXXXXX
Occupation of Witness:	Executive Assistant

EXECUTED as a deed by Samy Zekhout in the presence of:	) /s/ Samy Zekhout
Signature of Witness:	/s/ Annie Bauve-Zekhout
Name of Witness:	Annie Bauve-Zekhout
Address of Witness:	XXXXXXXXXXXXXXXXXXXX
Occupation of Witness:	N/A

EXECUTED as a deed by a Director, duly authorised for and on behalf of Nomad, in the presence of:	) /s/ Stéfan Descheemaeker
Signature of Witness:	/s/ Jackie Facey
Name of Witness:	Jackie Facey
Address of Witness:	XXXXXXXXXXXXXXXXXXXX
Occupation of Witness:	Executive Assistant

EX-8.1

Exhibit 8.1

SIGNIFICANT SUBSIDIARIES OF NOMAD FOODS LIMITED

Name	Activity	Country of   incorporation	Ownership as  of Dec 31 2017
Nomad Foods Europe Holdings Limited	Holding	England	100%
Nomad Foods Europe Holdco Limited	Holding	England	100%
Nomad Foods Europe Finco Limited	Holding	England	100%
Nomad Foods Europe Midco Limited	Holding/Finance	England	100%
Nomad Foods Bondco Plc	Finance	England	100%
Nomad Foods Lux S.à.r.l.	Finance	Luxembourg	100%
Nomad Foods Europe Limited	Management	England	100%
Birds Eye Limited	Trading	England	100%
Nomad Foods Europe Finance Limited	Finance	England	100%
Birds Eye Ireland Limited	Trading	Republic of Ireland	100%
Iglo Holding GmbH	Holding	Germany	100%
Iglo Nederland B.V.	Trading	Netherlands	100%
Iglo Belgium S.A.	Trading	Belgium	100%
Iglo Portugal	Trading	Portugal	100%
Iglo Austria Holdings GmbH	Holding	Austria	100%
C.S.I. Compagnia Surgelati Italiana S.R.L	Trading	Italy	100%
Findus Sverige Holdings AB	Holding	Sweden	100%
Iglo GmbH	Trading	Germany	100%
Frozen Fish International GmbH	Trading	Germany	100%
Liberator Germany Newco GmbH	Property	Germany	100%
Iglo Austria GmbH	Trading	Austria	100%
Findus Sverige AB	Trading	Sweden	100%
Frionor Sverige AB	Holding	Sweden	100%
Findus Holdings France SAS	Holding	France	100%
Findus France SAS	Trading	France	100%
Findus Espana SLU	Trading	Spain	100%
Findus Danmark A/S	Trading	Denmark	100%
Findus Finland Oy	Trading	Finland	100%
Findus Norge AS	Trading	Norway	100%

EX-12.1

Exhibit 12.1

CERTIFICATION

I, Stéfan Descheemaeker, certify that:

1.    I have reviewed this annual report on Form 20-F of Nomad Foods Limited;

 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report;

4. The company’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the company and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the company’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the company’s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the company’s internal control over financial reporting; and

 5. The company’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the company’s auditors and the audit committee of the company’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the company’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the company’s internal control over financial reporting.

Date:  March 22, 2018

/s/ Stéfan Descheemaeker

Stéfan Descheemaeker

Chief Executive Officer

EX-12.2

Exhibit 12.2

CERTIFICATION

I, Jason Ashton, certify that:

1.    I have reviewed this annual report on Form 20-F of Nomad Foods Limited;

 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report;

4. The company’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the company and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the company’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the company’s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the company’s internal control over financial reporting; and

 5. The company’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the company’s auditors and the audit committee of the company’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the company’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the company’s internal control over financial reporting.

Date:  March 22, 2018

/s/ Jason Ashton

Jason Ashton

Interim Chief Financial Officer

EX-13.1

Exhibit 13.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with this annual report on Form 20-F of Nomad Foods Limited (the “Company”) for the year ended December 31, 2017 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Stéfan Descheemaeker, Chief Executive Officer of the Company, hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(i) The Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934, as amended; and

(ii) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date:  March 22, 2018

/s/ Stéfan Descheemaeker

Stéfan Descheemaeker

Chief Executive Officer

(Principal Executive Officer)

The foregoing certification is being furnished solely pursuant to 18 U.S.C. Section 1350 and is not being filed as part of this Report.

EX-13.2

Exhibit 13.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with this annual report on Form 20-F of Nomad Foods Limited (the “Company”) for the year ended December 31, 2017 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Jason Ashton, Interim Chief Financial Officer of the Company, hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(i) The Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934, as amended; and

(ii) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date:  March 22, 2018

/s/ Jason Ashton

Jason Ashton

Interim Chief Financial Officer

(Principal Financial Officer)

The foregoing certification is being furnished solely pursuant to 18 U.S.C. Section 1350 and is not being filed as part of this Report.

EX-15.1

Exhibit 15.1

Consent of Independent Registered Public Accounting Firm

We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (No. 333-211095) and the Registration Statement on Form F-3/A (No. 333-217044), as amended, of Nomad Foods Limited of our report dated March 22, 2018 relating to the financial statements, and the effectiveness of internal control over financial reporting, which appears in this Form 20-F.

/s/ PricewaterhouseCoopers LLP

London, United Kingdom

March 22, 2018

XML

Document and Entity Information	12 Months Ended
	Dec. 31, 2017 shares
Document And Entity Information [Abstract]
Document Type	20-F
Amendment Flag	false
Document Period End Date	Dec. 31, 2017
Document Fiscal Year Focus	2017
Document Fiscal Period Focus	FY
Entity Current Reporting Status	Yes
Entity Well-known Seasoned Issuer	No
Entity Registrant Name	Nomad Foods Ltd.
Entity Central Index Key	0001651717
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding	165,291,546

XML

Consolidated Statements of Financial Position - EUR (€) € in Millions	Dec. 31, 2017	Dec. 31, 2016
Non-current assets
Goodwill	€ 1,745.6	€ 1,745.6
Intangibles	1,724.4	1,726.6
Property, plant and equipment	295.4	298.2
Other receivables	4.3	0.4
Derivative financial instruments	18.6	0.0
Deferred tax assets	64.3	64.9
Total non-current assets	3,852.6	3,835.7
Current assets
Cash and cash equivalents	219.2	329.5
Inventories	306.9	325.0
Trade and other receivables	147.1	135.7
Indemnification assets	73.8	65.5
Capitalized borrowing costs	0.0	5.0
Derivative financial instruments	2.1	13.1
Total current assets	749.1	873.8
Assets	4,601.7	4,709.5
Current liabilities
Trade and other payables	477.5	472.7
Current tax payable	145.3	162.3
Provisions	68.0	116.7
Loans and borrowings	3.3	0.0
Derivative financial instruments	7.8	1.4
Total current liabilities	701.9	753.1
Non-current liabilities
Loans and borrowings	1,395.1	1,451.8
Employee benefits	188.4	190.9
Trade and other payables	1.8	1.0
Provisions	72.8	77.0
Derivative financial instruments	61.4	0.0
Deferred tax liabilities	327.7	333.2
Total non-current liabilities	2,047.2	2,053.9
Total liabilities	2,749.1	2,807.0
Net assets	1,852.6	1,902.5
Equity attributable to equity holders
Share capital	0.0	0.0
Capital reserve	1,623.7	1,800.7
Share-based compensation reserve	2.9	1.0
Founder Preferred Shares Dividend Reserve	493.4	493.4
Translation reserve	83.2	84.0
Cash flow hedging reserve	(3.0)	8.4
Accumulated deficit reserve	(347.6)	(485.0)
Total equity	€ 1,852.6	€ 1,902.5

XML

Consolidated Statements of Profit or Loss - EUR (€) € in Millions	5 Months Ended	9 Months Ended	12 Months Ended
	May 31, 2015	Dec. 31, 2015	Dec. 31, 2017	Dec. 31, 2016	Mar. 31, 2015
Statement [Line Items]
Revenue		€ 894.2	€ 1,956.6	€ 1,927.7	€ 0.0
Cost of sales		(663.0)	(1,357.2)	(1,356.7)	0.0
Gross profit		231.2	599.4	571.0	0.0
Other operating expenses		(138.6)	(319.3)	(298.4)	(0.7)
Charge related to Founder Preferred Shares Annual Dividend Amount		(349.0)	0.0	0.0	(165.8)
Credit/(charge) related to Warrant Redemption Liability		0.4	0.0	0.0	(0.4)
Exceptional items		(58.1)	(37.2)	(134.5)	(0.7)
Operating profit/(loss)		(314.1)	242.9	138.1	(167.6)
Finance income		8.7	7.2	24.2	0.1
Finance costs		(44.2)	(81.6)	(86.3)	0.0
Net finance (costs)/income		(35.5)	(74.4)	(62.1)	0.1
Profit/(loss) before tax		(349.6)	168.5	76.0	(167.5)
Taxation		12.3	(32.0)	(39.6)	0.0
Profit/(loss) for the period		€ (337.3)	€ 136.5	€ 36.4	€ (167.5)
Earnings per share:
Basic earnings/(loss) per share (in euros per share)		€ (2.32)	€ 0.78	€ 0.20	€ (3.35)
Diluted earnings/(loss) per share (in euros per share)		€ (2.32)	€ 0.74	€ 0.20	€ (3.35)
Predecessor
Statement [Line Items]
Revenue	€ 640.3
Cost of sales	(417.9)
Gross profit	222.4
Other operating expenses	(109.5)
Charge related to Founder Preferred Shares Annual Dividend Amount	0.0
Credit/(charge) related to Warrant Redemption Liability	0.0
Exceptional items	(84.3)
Operating profit/(loss)	28.6
Finance income	2.0
Finance costs	(117.7)
Net finance (costs)/income	(115.7)
Profit/(loss) before tax	(87.1)
Taxation	(40.9)
Profit/(loss) for the period	€ (128.0)

XML

Consolidated Statements of Comprehensive Income - EUR (€) € in Millions	5 Months Ended	9 Months Ended	12 Months Ended
	May 31, 2015	Dec. 31, 2015	Dec. 31, 2017	Dec. 31, 2016	Mar. 31, 2015
Statement of Comprehensive Income [Line Items]
Profit/(loss) for the period		€ (337.3)	€ 136.5	€ 36.4	€ (167.5)
Other comprehensive (loss)/income:
Actuarial gains/(losses) on defined benefit pension plans		19.4	2.9	(23.6)	0.0
Taxation (charge)/credit on remeasurement of defined benefit pension plans		(6.1)	(2.0)	(6.3)	0.0
Items not reclassified to the Consolidated Statement of Profit or Loss		13.3	0.9	(29.9)	0.0
Foreign currency (loss) / gain		(1.7)	0.0	0.0	88.9
Loss on investment in foreign subsidiary, net of hedge		(2.7)	(0.8)	(0.5)	0.0
Effective portion of changes in fair value of cash flow hedges		1.6	(16.4)	10.1	0.0
Taxation credit/(charge) relating to components of other comprehensive income		(0.5)	5.0	(2.8)	0.0
Items that may be subsequently reclassified to the Consolidated Statement of Profit or Loss		(3.3)	(12.2)	6.8	88.9
Other comprehensive (loss)/income for the period, net of tax		10.0	(11.3)	(23.1)	88.9
Total comprehensive income/(loss) for the period attributable to Owners of the Parent Company		€ (327.3)	€ 125.2	€ 13.3	€ (78.6)
Predecessor
Statement of Comprehensive Income [Line Items]
Profit/(loss) for the period	€ (128.0)
Other comprehensive (loss)/income:
Actuarial gains/(losses) on defined benefit pension plans	(2.5)
Taxation (charge)/credit on remeasurement of defined benefit pension plans	0.7
Items not reclassified to the Consolidated Statement of Profit or Loss	(1.8)
Foreign currency (loss) / gain	44.7
Loss on investment in foreign subsidiary, net of hedge	0.0
Effective portion of changes in fair value of cash flow hedges	0.0
Taxation credit/(charge) relating to components of other comprehensive income	0.0
Items that may be subsequently reclassified to the Consolidated Statement of Profit or Loss	44.7
Other comprehensive (loss)/income for the period, net of tax	42.9
Total comprehensive income/(loss) for the period attributable to Owners of the Parent Company	€ (85.1)

XML

Consolidated Statements of Changes in Equity - EUR (€) € in Millions	Total	Share capital	Capital reserve	Share based compensation reserve	Founder preferred shares dividend reserve	Translation reserve	Cash flow hedging reserve	Accumulated deficit reserve	Ordinary shares	Ordinary shares Capital reserve	Founder Preferred shares	Founder Preferred shares Capital reserve	Founder Preferred shares Founder preferred shares dividend reserve
Equity, beginning balance at Mar. 31, 2014	€ 0.0	€ 0.0	€ 0.0	€ 0.0	€ 0.0	€ 0.0	€ 0.0	€ 0.0
Profit/(loss) for the period	(167.5)							(167.5)
Other comprehensive income for the year	88.9					88.9
Total comprehensive income/(loss) for the period attributable to Owners of the Parent Company	(78.6)					88.9		(167.5)
Issue of shares									€ 350.9	€ 350.9	€ 10.6	€ 10.6
Listing and share transaction costs	(8.0)		(8.0)
Total transaction with owners, recognized directly in equity	353.5		353.5
Equity, ending balance at Mar. 31, 2015	274.9	0.0	353.5	0.0	0.0	88.9	0.0	(167.5)
Profit/(loss) for the period	(337.3)							(337.3)
Other comprehensive income for the year	10.0					(4.4)	1.1	13.3
Total comprehensive income/(loss) for the period attributable to Owners of the Parent Company	(327.3)					(4.4)	1.1	(324.0)
Issue of shares									1,414.2	1,414.2
Listing and share transaction costs	(5.3)		(5.3)
Founder Preferred Shares Annual Dividend Amount											531.5		€ 531.5
Share based payment charge	0.1			0.1
Total transaction with owners, recognized directly in equity	1,940.5		1,408.9	0.1	531.5
Equity, ending balance at Dec. 31, 2015	1,888.1	0.0	1,762.4	0.1	531.5	84.5	1.1	(491.5)
Profit/(loss) for the period	36.4							36.4
Other comprehensive income for the year	(23.1)					(0.5)	7.3	(29.9)
Total comprehensive income/(loss) for the period attributable to Owners of the Parent Company	13.3					(0.5)	7.3	6.5
Issue of shares									€ 0.2	€ 0.2
Listing and share transaction costs	0.0
Founder Preferred Shares Annual Dividend Amount											€ 0.0	€ 38.1	(38.1)
Vesting of Non-Executive Restricted Stock award	(0.3)			(0.3)
Share based payment charge	1.2			1.2
Total transaction with owners, recognized directly in equity	1.1		38.3	0.9	(38.1)
Equity, ending balance at Dec. 31, 2016	1,902.5	0.0	1,800.7	1.0	493.4	84.0	8.4	(485.0)
Profit/(loss) for the period	136.5							136.5
Other comprehensive income for the year	(11.3)					(0.8)	(11.4)	0.9
Total comprehensive income/(loss) for the period attributable to Owners of the Parent Company	125.2					(0.8)	(11.4)	137.4
Repurchase of ordinary shares	(177.1)		(177.1)
Listing and share transaction costs	(0.5)		(0.5)
Founder Preferred Shares Annual Dividend Amount													€ 0.0
Vesting of Non-Executive Restricted Stock award	(0.1)		0.6	(0.7)
Share based payment charge	2.6			2.6
Total transaction with owners, recognized directly in equity	(175.1)		(177.0)	1.9
Equity, ending balance at Dec. 31, 2017	€ 1,852.6	€ 0.0	€ 1,623.7	€ 2.9	€ 493.4	€ 83.2	€ (3.0)	€ (347.6)

XML

Consolidated Statements of Cash Flows € in Millions, $ in Millions	5 Months Ended	9 Months Ended	12 Months Ended
	May 31, 2015 EUR (€)	Dec. 31, 2015 EUR (€)	Dec. 31, 2017 EUR (€)	Dec. 31, 2016 EUR (€)	Mar. 31, 2015 EUR (€)
Statement [Line Items]
Cash generated from operations before tax and exceptional items		€ 159.2	€ 358.5	€ 356.2	€ 0.2
Cash flows relating to exceptional items		(91.6)	(99.5)	(49.2)	(0.7)
Tax paid		(19.6)	(65.2)	(24.9)	0.0
Net cash flows from/(used in) operating activities		48.0	193.8	282.1	(0.5)
Cash flows from investing activities
Contingent consideration for purchase of Frudesa brand		0.0	0.0	(8.0)	0.0
Purchase of property, plant and equipment		(19.3)	(38.0)	(38.0)	0.0
Purchase of intangibles		(2.1)	(4.6)	(4.4)	0.0
Purchase of portfolio investments		0.0	0.0	0.0	(478.8)
Redemption of portfolio investments		312.1	0.0	0.0	183.2
Net cash used in investing activities		(959.8)	(42.6)	(50.4)	(295.6)
Cash flows from financing activities
Proceeds from issuance of Founder Preferred Shares		0.0	0.0	0.0	10.6
Proceeds from issuance of Ordinary Shares		1,171.8	0.0	0.0	350.9
Costs of admission		(5.3)	0.0	0.0	(8.0)
Loans from Founder Entities for incorporation		0.0	0.0	0.0	0.1
Repayment of loans to Founder Entities		0.0	0.0	0.0	(0.1)
Proceeds from new loans and notes		325.0	1,470.5	0.0	0.0
Repayment of loan principal		(490.0)	(1,469.5)	0.0	0.0
Payment of finance leases		0.0	(1.6)	(0.7)	0.0
Payment of financing fees		(14.0)	(16.7)	0.0	0.0
Repurchase of ordinary shares		0.0	(177.6)	0.0	0.0
Proceeds/(loss) on settlement of derivatives		4.3	1.6	(4.0)	0.0
Interest paid		(40.8)	(48.8)	(70.9)	0.0
Interest received		1.5	0.3	7.9	0.0
Net cash (used in)/from financing activities		952.5	(241.8)	(67.7)	353.5
Net (decrease)/increase in cash and cash equivalents		40.7	(90.6)	164.0	57.4
Cash and cash equivalents at beginning of period		126.8	329.5	186.1	0.0
Effect of exchange rate fluctuations		18.6	(19.7)	(20.6)	69.4
Cash and cash equivalents at end of period		186.1	219.2	329.5	126.8
Recognized liability for net defined benefit obligations		165.1	185.4	187.8
Iglo
Cash flows from investing activities
Purchase of business, net of cash acquired		(693.6)	0.0	0.0	0.0
Findus
Cash flows from investing activities
Purchase of business, net of cash acquired		€ (556.9)	€ 0.0	€ 0.0	0.0
Predecessor
Statement [Line Items]
Cash generated from operations before tax and exceptional items	€ 102.2
Cash flows relating to exceptional items	(6.2)				€ (0.7)
Tax paid	(17.3)
Net cash flows from/(used in) operating activities	78.7
Cash flows from investing activities
Contingent consideration for purchase of Frudesa brand	0.0
Purchase of property, plant and equipment	(6.0)
Purchase of intangibles	(0.3)
Purchase of portfolio investments	0.0
Redemption of portfolio investments	0.0
Net cash used in investing activities	(6.3)
Cash flows from financing activities
Proceeds from issuance of Founder Preferred Shares	0.0
Proceeds from issuance of Ordinary Shares	0.0
Costs of admission	0.0
Loans from Founder Entities for incorporation	0.0
Repayment of loans to Founder Entities	0.0
Proceeds from new loans and notes	0.0
Repayment of loan principal	0.0
Payment of finance leases	0.0
Payment of financing fees	0.0
Repurchase of ordinary shares	0.0
Proceeds/(loss) on settlement of derivatives	0.0
Interest paid	(31.4)
Interest received	2.0
Net cash (used in)/from financing activities	(29.4)
Net (decrease)/increase in cash and cash equivalents	43.0
Cash and cash equivalents at beginning of period	219.2
Effect of exchange rate fluctuations	6.2
Cash and cash equivalents at end of period	268.4
Predecessor | Iglo
Cash flows from investing activities
Purchase of business, net of cash acquired	0.0
Predecessor | Findus
Cash flows from investing activities
Purchase of business, net of cash acquired	€ 0.0

XML

General information

12 Months Ended

Dec. 31, 2017

General Information About Financial Statements [Abstract]

General information

General information

Nomad Foods Limited (the “Company” or “Nomad”) was incorporated in the British Virgin Islands on April 1, 2014. The address of Nomad’s registered office is Nemours Chambers, Road Town, Tortola, British Virgin Islands. The Company is domiciled for tax in the United Kingdom.

Nomad Foods (NYSE: NOMD) is a leading frozen foods company building a global portfolio of best-in-class food companies and brands within the frozen category and in the future across the broader food sector. Nomad produces, markets and distributes brands in 17 countries and has the leading market share in Western Europe. The Company’s portfolio of leading frozen food brands includes Birds Eye, Iglo, and Findus.

XML

Basis of preparation

12 Months Ended

Dec. 31, 2017

Basis Of Presentation [Abstract]

Basis of preparation

Basis of preparation

The consolidated financial statements of Nomad and its subsidiaries (the “Company” or “Nomad”, or the “Successor”) and the consolidated financial statements of Nomad Foods Europe Holdings Limited (previously “Iglo Foods Holdings Limited”) (the “Predecessor”) have been prepared in accordance with International Financial Reporting Standards issued by the International Accounting Standards Board. These consolidated financial statements are also in accordance with International Financial Reporting Standards as adopted by the European Union.

On June 1, 2015 Nomad Foods Limited (previously “Nomad Holdings Limited”) acquired Iglo Foods Holding Ltd (the “Iglo Group” and the “Iglo Acquisition”). Nomad Foods Limited is listed on the New York Stock Exchange and Iglo Foods Holdings Limited, a direct subsidiary of Nomad, is considered to be the “Predecessor” of Nomad Foods Limited (the “Successor”), as prior to the Iglo Acquisition, Nomad Foods Limited had no operations.

On November 2, 2015 the Company acquired Findus Sverige AB and its subsidiaries (the “Findus Group” and the “Findus Acquisition”). The acquired business included operations across continental Europe with leading market positions in France, Sweden and Spain along with the intellectual and commercialization rights to the Findus, Lutosa (until 2020) and La Cocinera brands in their respective markets.

On January 1, 2017, the Company adopted the following relevant amendments to IFRS. Neither of these have any impact on the results or financial position of the Company.

– Amendments to IAS 7 “Disclosure Initiative”; for which additional disclosures have been made for changes in liabilities arising from financing activities; and

– Amendments to IAS 12 "Recognition of Deferred Tax Assets for Unrealised Losses"

Refer to 3.22 for more information on new IFRSs not yet adopted.

The Company’s financial statements and notes are presented in the reporting currency of millions of Euros. Upon the acquisition of the Iglo Group on June 1, 2015, Nomad changed its functional and presentational currency from U.S. Dollars to Euros because this is the functional and presentational currency of the Iglo Group, which comprised all of Nomad’s operations at that time. All financial information has been rounded to the nearest €0.1 million, except where otherwise indicated.

On May 28, 2015 the Company changed its year end reporting date from March 31 to December 31 to align with the historical reporting calendar of the Iglo Group. This change has no impact on the financial statements and notes included herein. Fiscal year 2015 is a nine month period for the Company, which might not be comparable to the full year comparative amounts.

The consolidated financial statements were approved for issuance by the Board of Directors of Nomad Foods Limited on March 20, 2018. The Directors have, at the time of approving the financial statements, a reasonable expectation that Nomad has adequate resources to continue in operational existence for the foreseeable future given the cash funds available and the current forecast cash outflows. Thus, Nomad continues to adopt the going concern basis of accounting in preparing the financial statements.

XML

Accounting policies

12 Months Ended

Dec. 31, 2017

Accounting Policies, Changes in Accounting Estimates and Errors [Abstract]

Accounting policies

Accounting policies

The accounting policies set out below have, unless otherwise stated, been applied consistently.

Judgments made by the Directors in the application of these accounting policies that have a significant effect on the financial statements and key sources of estimation uncertainty are discussed in Note 4.

3.1 Measurement convention

The financial statements are prepared on the historical cost basis with the exception of derivative financial instruments, business combinations, share based payments, and founder preferred shares which are stated at fair value.

3.2 Business combination

The Company uses the acquisition method to account for business combinations. The consideration transferred for the acquisition of a subsidiary is the fair value of the assets transferred, the liabilities incurred and the equity interest issued by the Company. The consideration transferred includes the fair value of any asset or liability resulting from a contingent consideration arrangement. Identifiable assets acquired and liabilities and contingent liabilities assumed in a business combination are measured initially at their fair values at the acquisition date. Acquisition-related costs are expensed as incurred.

Where selling shareholders have contractually agreed to indemnify Nomad Foods Limited for contingent liabilities, an indemnification asset is recognized equivalent to the fair value of the liability recognized by Nomad. The indemnification asset is deducted from consideration transferred for the business combination. The indemnification asset value will subsequently be revised where revisions are made to the value of the liability or where there are doubts over the ability to recover losses from the selling shareholders.

3.3 Basis of consolidation

The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. Intercompany balances and transactions, and any unrealized income and expenses arising from intra-group transactions are eliminated. Accounting policies are applied consistently across the Company.

Subsidiaries are all entities (including structured entities) over which Nomad has control; directly or indirectly. The Company controls an entity when the Company is exposed to, or has rights to, variable returns from its involvement with the entity and has the ability to affect those returns through its power over the entity. Subsidiaries are fully consolidated from the date on which control is transferred to the Company. They are deconsolidated from the date that control ceases.

3.4 Foreign currency

i) Foreign currency transactions

Transactions in foreign currencies (currencies other than the functional currency) are translated into the functional currency at the foreign exchange rate ruling at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are translated into the functional currency at the foreign exchange rate ruling the financial year end. Foreign exchange gains and losses resulting from the settlement of such transactions and from the translation of monetary assets and liabilities denominated in foreign currencies at year end exchange rates are generally recognized in profit or loss. They are deferred in equity if they relate to qualifying cash flow hedges, qualifying net investment hedges or are attributable to part of a net investment in a foreign operation.

Non-monetary assets and liabilities in a foreign currency are translated into the functional currency to establish historical cost, using the exchange rate at the date of the transaction. Non-monetary assets and liabilities denominated in foreign currencies that are stated at fair value are translated at foreign exchange rates ruling at the date the fair value was determined. Translation differences on assets and liabilities carried at fair value are reported as part of the fair value gain or loss.

The revenues and expenses of foreign operations are translated at an average rate for the period (unless this is not a reasonable approximation of the cumulative effect of the rates prevailing on the transaction dates, in which case income and expenses are translated at the dates of the transaction).

ii) Assets and liabilities of foreign operations

For the purposes of presenting consolidated financial statements, the assets and liabilities of foreign operations, including goodwill and fair value adjustments arising on consolidation, are translated at foreign exchange rates ruling at the financial year endedDecember 31, 2017 of £1:€1.13 (December 31, 2016: £1:€1.17, December 31, 2015: £1:€1.36). The revenues and expenses of foreign operations are translated at an average rate for the period where this rate approximates to the foreign exchange rates ruling at the dates of the transactions.

Foreign exchange gains and losses that relate to these assets and liabilities are presented in the Consolidated Statement of Profit or Loss within ‘finance income or costs’, except where hedge accounting applies.

iii) Net investment in foreign operations

Exchange differences arising from the translation of foreign operations and of related qualifying hedges are taken directly to the translation reserve within equity. They are realized through the Consolidated Statement of Profit or Loss upon disposal of the related foreign operation.

3.5 Goodwill

Goodwill represents amounts arising on acquisition of subsidiaries. Goodwill is the difference between the cost of the acquisition and the fair value of the net identifiable assets acquired.

Goodwill is stated at cost less any accumulated impairment losses. Gains and losses on the disposal of an entity include the carrying amount of goodwill relating to the entity sold.

Goodwill is allocated to the cash-generating unit and is not monitored below the operating segment unit. Goodwill is not amortized but is tested annually for impairment. Refer to 3.7 for discussion on cash-generating units.

3.6 Other intangible assets

Intangible assets acquired separately are recorded at cost and those acquired as part of a business combination are recorded at fair value as at the date of acquisition.

i) Computer software

Capitalized software costs include the cost of acquired computer software licenses and costs that are directly associated with the design, construction and testing of such software where this relates to a major business system. Costs associated with identifying, sourcing, evaluating or maintaining computer software are recognized as an expense within other operating expenses as incurred.

The assets are stated at cost less accumulated amortization and impairment losses. Software costs are amortized by equal monthly installments over their estimated useful economic life of five to seven years once the software is capable of being brought into use.

ii) Brands

Based on the market position of the brands, the significant levels of investment in advertising and promoting the brands, and the fact that they have been established for over 50 years, the Directors consider that the Birds Eye, Iglo and Findus brands have indefinite lives. Therefore these brands are not amortized, but instead held at historical cost less provision for any impairment.

The La Cocinera and Lutosa brands (Lutosa used under license until 2020) are deemed to not have an indefinite life and are being amortized by equal monthly installments within other operating expenses over 10 and 6 years respectively.

iii) Customer relationships

Long standing Food Service customer relationships have been identified as intangible assets as part of the Findus Acquisition. These are deemed to not have an indefinite life and are being amortized by equal monthly installments within other operating expenses over 14 years.

3.7 Impairment of non-current assets

The carrying amounts of the Company’s non-current assets are reviewed annually to determine whether there is any indication of impairment. If any such indication exists, the asset’s recoverable amount is estimated. Impairment losses are recognized in the Consolidated Statement of Profit or Loss in the period in which they arise. For goodwill and assets that have an indefinite useful life an impairment review is performed at least annually.

Assets that are subject to amortization are reviewed for impairment whenever events or changes in circumstances indicate that the net carrying amount may not be recoverable. An impairment loss is recognized whenever the carrying amount of an asset or its cash-generating unit exceeds its recoverable amount.

i) Calculation of recoverable amount

Recoverable amount is the greater of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows of the business are discounted to their present value using a discount rate that reflects current market assessments of the time value of money and the risks specific to the asset. For an asset that does not generate largely independent cash inflows, the recoverable amount is determined for the cash-generating unit to which the asset belongs.

ii) Allocation of impairment losses

Impairment losses recognized in respect of cash-generating units are allocated first to reduce the carrying amount of any goodwill allocated to cash-generating units then to reduce the carrying amount of the other assets in the unit on a pro rata basis. A cash-generating unit is the smallest identifiable group of assets that generates cash inflows that are largely independent of the cash inflows from other assets or groups of assets.

iii) Reversals of impairment

An impairment loss in respect of goodwill is not reversed. In respect of other assets, an impairment loss is reversed when there is an indication that the impairment loss may no longer exist and there has been a change in the estimates used to determine the recoverable amount. An impairment loss is reversed only to the extent that the asset’s carrying amount does not exceed the carrying amount that would have been determined, net of depreciation or amortization, if no impairment loss had been recognized.

3.8 Property, plant and equipment

i) Owned assets

Property, plant and equipment are stated at cost less accumulated depreciation and impairment losses. Cost includes the original purchase price of the asset and the costs attributable to bringing the asset to its working condition for its intended use.

Where parts of an item of property, plant and equipment have different useful lives, they are accounted for as separate items of property, plant and equipment.

ii) Leased assets

Leases in which the Company assumes substantially all the risks and rewards of ownership of the leased asset are classified as ‘finance leases’. Where land and buildings are held under finance leases the accounting treatment of the land is considered separately from that of the buildings. Leased assets acquired by way of finance lease are stated at an amount equal to the lower of their fair value and the present value of the minimum lease payments at inception of the lease, less accumulated depreciation and impairment losses.

All other leases are classified as ‘operating leases’.

iii) Depreciation

Depreciation is charged to the Consolidated Statement of Profit or Loss on a straight line basis over the shorter of the lease term and the estimated useful lives of each part of an item of property, plant and equipment once the item is brought into use. Land is not depreciated. The estimated useful lives are as follows:

• Buildings 40 years

• Plant and equipment 5 to 14 years

• Computer equipment 3 to 5 years

The assets’ residual values and useful lives are reviewed on a frequent basis.

3.9 Inventories

Inventories are stated at the lower of cost and net realizable value. Cost is based on the weighted average principle and includes expenditure incurred in acquiring the inventories and bringing them to their existing location and condition. Inventories that are acquired through business combinations are fair valued at the time of acquisition. In the case of manufactured inventories and work in progress, cost includes an appropriate share of direct costs and overheads based on normal operating capacity. Provision is made for slow moving, obsolete and defective inventories.

3.10 Employee benefits

i) Defined contribution plans

Obligations for contributions to defined contribution pension plans are recognized as an expense in the Consolidated Statement of Profit or Loss as incurred. Prepaid contributions are recognized as an asset to the extent that a cash refund or reduction in the future payments is available.

ii) Defined benefit plans

The Company’s net obligation in respect of defined benefit pension plans and other post-employment benefits is calculated separately for each plan by estimating the amount of future benefit that employees have earned in return for their service in the current and prior periods. That net obligation is discounted to determine its present value. The calculation is performed by a qualified actuary using the projected unit credit method.

The current service cost of the defined benefit plan, recognized in the Consolidated Statement of Profit or Loss in staff costs included within Operating profit/(loss), except where included in the cost of an asset, reflects the increase in the defined benefit obligation resulting from employee service in the current year, benefit changes, curtailments and settlements.

Actuarial gains and losses arising from experience adjustments and changes in actuarial assumptions are charged or credited to equity in Other Comprehensive Income in the period in which they arise.

The net interest cost is calculated by applying the discount rate to the net balance of the defined benefit obligation and the fair value of plan assets. This cost is included in employee benefit expense in the Consolidated Statement of Profit or Loss.

Past service cost is recognized immediately.

iii) Share-based payment schemes

Employee benefits given through share-based payment schemes are discussed further in section 3.15 within Accounting policies.

3.11 Founder Preferred Shares

Nomad Foods issued Founder Preferred Shares to both TOMS Acquisition I, LLC and Mariposa Acquisition II, LLC (collectively the “Founder Entities”) in connection with its initial public offering in April 2014. Holders of the Founder Preferred Shares are entitled to receive annual dividend amounts subject to certain performance conditions (the “Founder Preferred Shares Dividend Amount”). The instrument and its component parts were analyzed under IFRS 2. The Company intends that any future Founder Preferred Shares Annual Dividend Amount will be equity settled. Accordingly, the Founder Preferred Shares Annual Dividend Amount as of June 1, 2015 of €531.5 million (the “Founder Preferred Shares Dividend reserve”) was classified as equity and no further revaluations will be required or recorded.

Should a Founder Preferred Share Annual Dividend Amount become due and payable, the market value of any dividend paid will be deducted from the Founder Preferred Shares Dividend reserve, with any excess deducted from the accumulated profit/(deficit) reserve within equity.

3.12 Provisions

Provisions are recognized when the Company has a legal or constructive present obligation as a result of a past event and it is probable that the Company will be required to settle that obligation. Provisions are measured at the Directors’ best estimate of the expenditure required to settle the obligation at the financial year end date and are discounted to present value where the effect is material.

Where it is not possible to make a reliable estimate of the estimated financial effect of a provision, appropriate disclosure of the resulting contingent liability is made, but no provision is recognized.

The Company is currently in discussions with the tax authorities in one of its markets regarding the treatment of the acquisition of the Iglo Group in 2006 by the previous owners. The Company has an indemnity in respect of this tax issue, but has not recognized an indemnification asset or a provision for this matter.

3.13 Financial instruments

Financial assets and liabilities are recognized in the Company’s Statement of Financial Position when the Company becomes a party to the contractual provisions of the instrument.

i) Trade receivables

Trade receivables are measured at initial recognition at fair value and are subsequently measured at amortized cost using the effective interest method, less any impairment. Since trade receivables are due within one year, this equates to initial carrying value less any impairment.

Appropriate allowances for estimated irrecoverable amounts are recognized in the Consolidated Statement of Profit or Loss when there is objective evidence that the asset is impaired.

Trade receivables are presented net of customer rebate balances.

ii) Cash and cash equivalents

Cash and cash equivalents comprise of cash balances and call deposits.

iii) Loans and borrowings

a. Valuation

Interest bearing borrowings are recognized initially at fair value less attributable transaction costs.

Subsequent to initial recognition, interest bearing loans and borrowings are stated at amortized cost with any difference between cost and redemption value being recognized in the Consolidated Statement of Profit or Loss over the expected period of the borrowings.

b. Capitalization of transaction costs

Fees paid on the establishment of loan facilities are recognized as transaction costs of the loan to the extent that it is probable that some or all of the facility will be drawn down. In this case, the fee is deferred until the draw-down occurs.

iv) Trade payables

Trade payables are measured at initial recognition at fair value and are subsequently measured at amortized cost using the effective interest method. Since trade payables are largely due within one year, this equates to initial carrying value.

v) Derivative financial instruments and hedge accounting

Derivative financial instruments are recognized at fair value. When a derivative financial instrument is not designated in a hedge relationship that qualifies for hedge accounting, all changes in its fair value are recognized immediately in the Consolidated Statement of Profit or Loss. However, where derivatives qualify for hedge accounting, recognition of any resultant gain or loss depends on the nature of the item being hedged.

The fair value of derivative financial instruments is determined using forward rates at the balance sheet date, with the resulting value discounted back to present value.

Cross currency interest rate swaps are managed based on their net exposure to credit risks. The Company has used the exception in IFRS 13 to allow this group of derivatives to be measured on a net basis by each counterpart.

a.    Cash flow hedges

Where a derivative financial instrument is designated as a hedge of the variability in cash flows of a recognized asset or liability, or a highly probable forecast transaction, the effective part of any gain or loss on the derivative financial instrument is recognized directly in the cash flow hedging reserve. Any ineffective portion of the hedge is recognized immediately in the Consolidated Statement of Profit or Loss.

When a hedging instrument expires or is sold, terminated or exercised, or the entity revokes designation of the hedge relationship but the hedged forecast transaction is still expected to occur, the cumulative gain or loss at that point remains in equity and is recognized when the transaction occurs. If the hedged transaction is no longer expected to take place, the cumulative unrealized gain or loss recognized in equity is recognized in the Consolidated Statement of Profit or Loss immediately.

b. Net investment hedges

Foreign currency differences arising on the retranslation of a financial liability designated as a hedge of a net investment in a foreign operation are recognized in Other Comprehensive Income to the extent that the hedge is effective, and are presented in the translation reserve within equity. To the extent that the hedge is ineffective, such differences are recognized in the Consolidated Statement of Profit or Loss. When the hedged net investment is disposed of, the relevant amount in the translation reserve is transferred to the Consolidated Statement of Profit or Loss as part of the gain or loss on disposal.

3.14 Revenue

Revenue comprises sales of goods after deduction of discounts, sales taxes and excludes intra-company sales. Discounts given by the Company include rebates, price reductions and incentives given to customers, promotional couponing and trade communication costs. At each financial year end date any discount incurred, but not yet invoiced, is estimated and accrued.

Revenue is recognized when the title and risk of loss of the underlying products have been transferred to the customer, at which point the sale price is fixed or determinable. This completes the revenue-earning process specifically that an arrangement exists, delivery has occurred, ownership has transferred, the price is determined and collectability is reasonably assured. The timing of the transfer of risks and rewards varies depending on the individual terms of the sales agreement. A provision for payment discounts and product return allowances, which is estimated based upon the Company’s historical performance, management’s experience and current economic trends, is recorded as a reduction of sales in the same period that the revenue is recognized.

Trade promotions, consisting primarily of customer pricing allowances and merchandising funds and customer coupons are offered through various programs to customers and consumers. Sales are recorded net of estimated trade promotion spending, which is recognized as incurred at the time of sale. Certain retailers require the payment of slotting fees in order to obtain space for the Company’s products on the retailers’ store shelves. The fees are recognized as reductions of revenue on the date a liability to the retailer is created. These amounts are included in the determination of net sales. Accruals for expected pay-outs under these programs are included within trade receivables or trade payables in the Consolidated Statement of Financial Position. Coupon redemption costs are also recognized as reductions of net sales when the coupons are issued. Estimates of trade promotion expense and coupon redemption costs are based upon programs offered, timing of those offers, estimated redemption/usage rates from historical performance, management’s experience and current economic trends.

Trade marketing expense is comprised of amounts paid to retailers for programs designed to promote our products and are classified in the Consolidated Statement of Profit or Loss as a reduction of revenue.

3.15 Share based payments

Successor

Nomad Foods 2015 Long Term Incentive Plan

The Nomad Foods 2015 Long Term Incentive Plan (the “LTIP”), which incorporates an annual Non-Executive Directors Restricted Stock Scheme, falls within the provisions of IFRS 2 “Share-based Payment” and awards under the LTIP represent equity settled share based payments. A charge is taken to the Consolidated Statement of Profit or Loss for the difference between the fair value of the shares at grant date and the amount subscribed, spread over the vesting period.

Share based payment arrangements in which Nomad receives goods or services as consideration for its own equity instruments are accounted for as equity-settled share based payment transactions, regardless of how the equity instruments are obtained by Nomad.

The grant date fair value of share-based payment awards granted to any Director or employee is recognized as an associated expense, with a corresponding increase in equity, over the period that any Director or employee becomes unconditionally entitled to the awards.

The fair value of the awards granted is measured using a valuation model, taking into account the terms and conditions upon which the awards were granted. The amount recognized as an expense is adjusted to reflect the actual number of awards for which the related service and non-market vesting conditions are expected to be met, such that the amount ultimately recognized as an expense is based on the number of awards that do meet the related service and non-market performance conditions at the vesting date. For share-based payment awards with non-vesting conditions, the grant date fair value of the share-based payment is measured to reflect such conditions and there is no true-up for differences between expected and actual outcomes.

See Note 8b for further information on the Company’s share-based payment arrangements and details of the valuation model used.

Predecessor

At the end of each reporting period, the Iglo Group revised its estimates of the number of interests that were expected to vest based on the non-market vesting conditions. It recognized the impact of the revision to original estimates, if any, in the Consolidated Statement of Profit or Loss, with a corresponding adjustment to equity.

Other management incentive schemes

If schemes fall outside the scope of IFRS 2, since they are not related to the price or value of equity instruments, but do fall within the scope of IAS 19 “Employee Benefits”, an annual charge is taken over the service period based on an estimate of the amount of future benefit employees will earn in return for their service.

3.16 Interest income

Interest income is recognized in the Consolidated Statement of Profit or Loss on an accruals basis using the effective interest method.

3.17 Expenses

i) Operating lease payments

Payments made under operating leases are recognized in the Consolidated Statement of Profit or Loss on a straight line basis over the term of the lease. Lease incentives received are recognized on a straight line basis in the Consolidated Statement of Profit or Loss as an integral part of the total lease expense.

ii) Borrowing costs

Unless capitalized as part of the cost of borrowing (see Note 3.13(iii)), borrowing costs are recognized in the Consolidated Statement of Profit or Loss in the period in which they are incurred.

iii) Exceptional items

The separate reporting of exceptional items which are presented as exceptional within the relevant Consolidated Statement of Profit or Loss category, helps provide an indication of the Company’s underlying business performance. Exceptional items have been identified and presented by virtue of their size, nature or incidence. In determining whether an event or transaction is specific, management considers quantitative as well as qualitative factors such as the frequency or predictability of occurrence. Exceptional items comprise restructuring costs, impairments or reversal of impairments of intangible assets, operational restructuring, integration and acquisition costs relating to new acquisitions, investigation of strategic opportunities and other items, costs relating to certain management incentive plans and other significant items (see Note 7).

iv) Research and development

Expenditure on research activities is recognized in the Consolidated Statement of Profit or Loss as an expense as incurred.

3.18 Taxation

Tax on the profit or loss for the year comprises current and deferred tax. Tax is recognized in the Consolidated Statement of Profit and Loss except to the extent that it relates to items recognized directly in equity, in which case it is recognized in equity.

Current tax is the expected tax payable on the taxable income for the year, using tax rates enacted or substantively enacted at the financial year end date, and any adjustment to tax payable in respect of previous years. Where tax exposures can be quantified, an accrual for uncertain tax positions is made based on the best estimates and management’s judgments. Given the inherent uncertainties in assessing the outcomes of these exposures (which can sometimes be binary in nature), the Company could in future periods experience adjustments to these accruals.

Deferred tax is provided on temporary differences between the carrying amounts of assets and liabilities recognized for financial reporting purposes and the amounts used for taxation purposes on an undiscounted basis. The following temporary differences are not provided for: the initial recognition of goodwill; the initial recognition of assets or liabilities that affect neither accounting nor taxable profit other than in a business combination, and differences relating to investments in subsidiaries to the extent that they will probably not reverse in the foreseeable future. The amount of deferred tax provided is based on the expected manner of realization or settlement of the carrying amount of assets and liabilities, using tax rates enacted or substantively enacted at the financial year end date.

A deferred tax asset is recognized only to the extent that it is probable that future taxable profits will be available against which the asset can be utilized.

3.19 Segment reporting

The Chief Operating Decision Maker (“CODM”) has been determined to be the Chief Executive Officer as he is primarily responsible for the allocation of resources to the segments and the assessment of performance of the segments.

Nomad’s operations are organized into one operating unit, ‘Frozen’, which comprises all the brands, as well as the factories, private label business units and certain corporate overheads. The CODM primarily uses (“Adjusted EBITDA”), disclosed in Note 5, as the key measure of the segment’s results. Adjusted EBITDA is EBITDA adjusted to exclude (when they occur) exited markets, chart of account (“CoA”) alignments and exceptional items such as restructuring charges, goodwill and intangible asset impairment charges, the impact of share based payment charges, charges relating to the Founder Preferred Shares Annual Dividend Amount, charges relating to the redemption of warrants and other unusual or non-recurring items.

EBITDA, disclosed in Note 5, is defined as profit/(loss) for the period before taxation, net financing costs, depreciation and amortization.

3.20 Onerous contracts provisions

Where the costs of fulfilling a contract exceed the economic benefits that the Company expects to receive from it, an onerous contract provision is recognized for the net unavoidable costs. In estimating the net unavoidable costs, management estimate foreseeable income that may be received and offset this against the minimum future cash outflows from fulfilling the contract. All cash flows are discounted at an appropriate discount rate.

3.21 Unfavorable contracts

Unfavorable contracts recognized from business combinations are classified as a liability, discounted and recognized over the term of the underlying contract as a reduction in the associated expense.

3.22 IFRSs not yet adopted

At the date of authorization of these financial statements, the following Standards and Interpretations, which have not been applied in the financial statements, were in issue but not yet effective:

• IFRS 9 ‘Financial Instruments’ addresses the classification, measurement and recognition of financial assets and financial liabilities and replaces IAS 39. The standard reduces the complexity of the current rules on financial instruments as mandated in IAS 39. IFRS 9 replaces the ‘incurred loss model’ in IAS 39 with an ‘expected credit loss’ model. The standard also introduces new presentation and disclosure requirements. The standard also introduces new hedge accounting rules although the adoption of these is optional so that the hedge accounting rules under IAS 39 may continue to be applied. The effective date for the adoption of IFRS 9 is annual periods beginning on or after 1 January 2018. Except for hedge accounting, retrospective application is required but providing comparative information is not compulsory. For hedge accounting, the requirements are generally applied prospectively, with some limited exceptions.

The Group has completed its assessment of the effects of transition to IFRS 9. The impacts that have been identified on adopting IFRS 9 on the Group are detailed below.

–Classification and measurement: IFRS 9 establishes a principle based approach for classification of financial assets based on cash flow characteristics of the asset and the business model in which an asset is held as well as changes to the measurement of financial liabilities held at FVTPL. The change in classification does not affect the accounting recognition of financial assets presented in these financial statements and the impact of the change in measurement on financial liabilities as at December 31, 2017 is €nil.

–Impairment: The significant financial assets held that are affected by the impairment losses recognised under IFRS 9 are trade receivables, for which the gross balance as at December 31, 2017 is €289.0 million with an impairment provision of €5.8 million. Management has performed an assessment of the impairment of trade receivables under IFRS 9 using Expected Credit Losses derived from actual credit losses experienced in the past. Based on this assessment, the impairment provision was found to be comparable to the existing provision, with no material difference.

–Hedge accounting: The Group has elected not to apply IFRS 9 for hedge accounting.

• IFRS 15 ‘Revenue from contracts with customers’ outlines a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance. The core principle of the new standard is for companies to recognize revenue to depict the transfer of goods or services to customers in amounts that reflect the consideration to which the company expects to be entitled in exchange for those goods or services.

Management has assessed the effects of applying the new standard on the Company’s financial statements and has identified that the presentation of contract assets and contract liabilities will need to be changed. Specifically, adoption of IFRS 15 will result in additional disclosures in our footnotes around discounts and trade marketing expenses as of 1 January 2018 in relation to trade terms which are currently included in other balance sheet line items.

The Company has quantified that there is no material impact on revenue recognition by applying this standard. The Company will apply the standard using the modified retrospective approach which means that any cumulative impact of the adoption identified would have been be recognized in retained earnings as of January 1, 2018 and that comparatives will not be restated.

• IFRS 16 ‘Leases’ sets out the principles for the recognition, measurement, presentation and disclosure of leases and replaces IAS 17 ‘Leases’. The standard introduces a single lessee accounting model and requires a lessee to recognize assets and liabilities for all leases with a term of more than 12 months, unless the underlying asset is of low value. The Standard also contains enhanced disclosure requirements for lessees. This IFRS will become effective for accounting periods starting on January 1, 2019 with early application permitted for companies applying IFRS 15 ‘Revenue from Contracts with Customers’.

The Company is still assessing the full impact of the new IFRS 16 Standard. However, it is expected that there will be an increase in assets and liabilities as a result of the adoption of the new standard.

XML

Critical accounting estimates and judgments

12 Months Ended

Dec. 31, 2017

Accounting Policies, Changes in Accounting Estimates and Errors [Abstract]

Critical accounting estimates and judgments

Critical accounting estimates and judgments

The preparation of financial statements in accordance with IFRS requires the use of estimates. It also requires management to exercise judgment in applying the accounting policies. The key areas involving a higher degree of judgment or complexity, or areas where assumptions are significant to the consolidated financial statements are highlighted under the relevant note. Critical accounting estimates and judgments are listed below:

a) Discounts and trade marketing expense

Discounts given by the Company include rebates, price reductions and incentives given to customers, promotional couponing and trade communication costs. Each customer has a unique agreement that is governed by a combination of observable and unobservable performance conditions.

At each financial year end date any discount incurred but not yet invoiced is estimated, based on historical trends and rebate contracts with customers, and accrued as ‘trade terms’. The balance of the reduction in trade receivables for trade terms as of December 31, 2017 is disclosed in Note 18.

In certain cases the estimate for discounts requires the use of forecast information for future trading periods and so there arises a degree of estimation uncertainty. These estimates are sensitive to variances between actual results and forecasts. The current accruals reflect the Company’s best estimate of these forecasts.

Trade marketing expense is comprised of amounts paid to retailers for programs designed to promote Company products. The ultimate costs of these programs can depend upon retailer performance and is the subject of significant management estimates. The Company records as a reduction in revenue, the estimated ultimate cost of the program in the period during which the program occurs and is based upon the programs offered, timing of those offers, estimated retailer performance based on history, management’s experience and current economic trends.

b) Business combinations

The Company is required to recognize separately, at the acquisition date, the identifiable assets, liabilities and contingent liabilities acquired or assumed in a business combination at their fair values. This involves judgment over whether intangible assets can be separately identified as well as an estimate of fair value of all assets and liabilities acquired. Such estimates are based on valuation techniques, which require considerable judgment in forecasting future cash flows and developing other assumptions. These estimates are based on information available on the acquisition date and assumptions that have been deemed reasonable by management. The following judgments, estimates and assumptions can materially affect our financial position and profit:

• The fair value of intangible and tangible assets that are subject to depreciation or amortization in future periods.

• Future changes to the assumptions used in estimating the value of assets and liabilities may result in additional expenses or income.

c) Carrying value of goodwill and brands

Determining whether goodwill and brands are impaired requires an estimation of the value in use of the cash generating unit to which goodwill and brands have been allocated. The value in use calculation requires the entity to estimate the future cash flows expected to arise from the cash generating unit and a suitable discount rate in order to calculate present value. Details of impairment reviews are provided in Note 13.

d) Employee benefit obligation

The Group operates a number of defined benefit pension schemes and post-employment benefit schemes which are valued by estimating the amount of future benefit that employees have earned in return for their service in the current and prior periods. Each Scheme has an actuarial valuation performed and is dependent on a series of assumptions See Note 23 for details of these assumptions and a sensitivity analysis on material assumptions.

e) Uncertain tax positions

Where tax exposures can be quantified, an accrual for uncertain tax positions is made based on best estimates and management’s judgments with regard to the amounts expected to be paid to the relevant tax authority. Given the inherent uncertainties in assessing the outcomes of these exposures (which can sometimes be binary in nature), the Company could in future periods experience adjustments to these accruals. The factors considered include the progress of discussions with the tax authorities and the level of documentary support for historical positions taken by previous owners.

f) Onerous contracts

Where the costs of fulfilling a contract exceed the economic benefits that the Company expects to receive from it, an onerous contract provision is recognized for the net unavoidable costs. In estimating the net unavoidable costs, management estimate foreseeable income that may be received and offset this against the minimum future cash outflows from fulfilling the contract. All cash flows are discounted at an appropriate discount rate.

Estimating future income is highly judgmental and is based on management’s best estimate. Onerous contracts are presented as provisions in Note 24.

g) Fair value of derivative financial instruments.

Note 34 includes details of the fair value of the derivative instruments that the Company holds at each balance sheet period. Management has estimated the fair value of these instruments by using valuations based on discounted cash flow calculations.

h) Share-based payments

At the end of each reporting period, the Company, in estimating its share-based payment charge, assesses and revises its estimates of the number of interests that are expected to vest based on the non-market vesting conditions. Note 8b contains details of these assumptions and of the valuation model used.

XML

Segment reporting

12 Months Ended

Dec. 31, 2017

Operating Segments [Abstract]

Segment reporting

Segment reporting

Nomad has one reporting and operating segment, ‘Frozen’, reflected in the segment presentation below for the periods presented. Historical financial information of the predecessor has been re-presented as if it was one single operating segment for comparative purposes.

Segment Adjusted EBITDA

		Successor	Successor	Successor		Successor		Predecessor
		Year ended December 31, 2017	Year ended December 31, 2016	9 months ended December 31, 2015		Year ended March 31, 2015		5 months ended May 31, 2015
	Note	€m	€m	€m		€m		€m
Profit/(loss) for the period		136.5	36.4	(337.3	)	(167.5	)	(128.0	)
Taxation		32.0	39.6	(12.3	)	—		40.9
Net financing costs/(income)		74.4	62.1	35.5		(0.1	)	115.7
Depreciation	12	35.9	43.3	20.3		—		11.3
Amortization	13	6.5	7.8	1.5		—		1.2
EBITDA		285.3	189.2	(292.3	)	(167.6	)	41.1
Net purchase-price adjustment-inventory step up		—	—	37.0		—		—
Net purchase-price adjustment for cash flow hedge accounting		—	—	4.9		—		—
Charge related to Founder Preferred Shares Annual Dividend Amount	27	—	—	349.0		165.8		—
(Credit)/charge relating to Warrant Redemption Liability	25	—	—	(0.4	)	0.4		—
Exceptional items	7	37.2	134.5	58.1		0.7		84.3
Other add-backs		5.6	1.2	—		—		—
Adjusted EBITDA		328.1	324.9	156.3		(0.7	)	125.4
Unallocated corporate costs		—	—	2.5		0.7		—
Frozen Adjusted EBITDA		328.1	324.9	158.8		—		125.4

Other add-backs include the elimination of share-based payment charges of €2.6 million (2016: €1.2 million) and elimination of M&A related investigation costs, professional fees, transaction costs and purchase accounting related valuations of €3.0 million. We exclude these costs because we do not believe they are indicative of our normal operating costs, can vary significantly in amount and frequency, and are unrelated to our underlying operating performance.

No information on segment assets or liabilities is presented to the CODM.

Product information

Management considers the products it sells belong to one category, being ‘Frozen’.

Geographical information

External revenue by geography

	Successor	Successor	Successor	Successor	Predecessor
	Year ended December 31, 2017	Year ended December 31, 2016	9 months ended December 31, 2015	Year ended March 31, 2015	5 months ended May 31, 2015
	€m	€m	€m	€m	€m
United Kingdom	411.9	437.5	288.6	—	225.0
Italy	371.4	348.5	205.2	—	169.7
Germany	300.3	267.8	150.0	—	124.2
Sweden	208.0	218.2	35.5	—	—
France	170.0	168.9	41.0	—	—
Norway	123.3	122.6	19.6	—	—
Austria	96.7	92.9	51.8	—	45.0
Spain	81.2	82.6	13.1	—	—
Rest of Europe	193.8	188.7	89.4	—	76.4
Total external revenue by geography	1,956.6	1,927.7	894.2	—	640.3

Non-current assets by geography

	Successor	Successor
	December 31, 2017	December 31, 2016
	€m	€m
Germany	126.4	118.0
United Kingdom	94.8	77.5
Italy	55.0	59.1
Sweden	26.5	44.6
France	16.7	18.4
Norway	15.7	13.3
Rest of Europe	20.2	6.1
Total non-current assets by geography	355.3	337.0

Non-current assets exclude deferred tax assets, goodwill and brands which are not bound to one geographical area.

XML

Operating profit/(loss)

12 Months Ended

Dec. 31, 2017

Analysis of income and expense [abstract]

Operating profit/(loss)

Operating profit/(loss)

Operating profit /(loss) is stated after charging:

		Successor		Successor		Successor	Successor	Predecessor
		Year ended December 31, 2017		Year ended December 31, 2016		9 months ended December 31, 2015	Year ended March 31, 2015	5 months ended May 31, 2015
	Note	€m		€m		€m	€m	€m
Staff costs	8	257.4		264.5		160.2	—	88.8
Depreciation of property, plant and equipment	12	35.9		43.3		20.3	—	11.3
Impairment of property, plant and equipment	12	0.3		1.4		3.2	—	—
Impairment of goodwill and brands	13	—		—		—	—	55.0
Amortization of software and brands	13	6.5		7.8		1.5	—	1.2
Operating lease charges		15.0		14.6		4.2	—	3.2
Exchange (gains)/losses		(1.2	)	(3.3	)	5.2	88.9	(9.0	)
Fair value loss on financial assets at fair value through profit and loss		—		—		4.9	—	—
Research & development expenditure		15.4		13.3		12.1	—	7.2
Inventories recognized as an expense within cost of goods sold		1,273.3		1,282.6		608.9	—	389.3

XML

Exceptional items

12 Months Ended

Dec. 31, 2017

Analysis of income and expense [abstract]

Exceptional items

Exceptional items

Exceptional items are made up as follows:

	Successor		Successor		Successor		Successor	Predecessor
	Year ended December 31, 2017		Year ended December 31, 2016		9 months ended December 31 2015		Year ended March 31, 2015	5 months ended May 31, 2015
	€m		€m		€m		€m	€m
Investigation of strategic opportunities (1)	18.8		7.0		7.7		—	1.3
Supply chain reconfiguration (2)	14.0		84.3		—		—	—
Findus Group integration costs (3)	15.1		29.6		4.5		—	—
Costs related to transactions (4)	3.2		4.8		34.1		0.7	3.8
Costs related to long-term management incentive plans (5)	—		1.9		3.5		—	22.9
Other restructuring costs (6)	—		(1.0	)	8.9		—	—
Cisterna fire net (income)/costs (7)	—		(4.3	)	(2.5	)	—	1.3
Impairment of intangible assets (8)	—		—		—		—	55.0
Settlement of legacy matters (9)	(5.6	)	1.8		1.9		—	—
Remeasurement of indemnification assets (10)	(8.3	)	10.4		—		—	—
Total exceptional items	37.2		134.5		58.1		0.7	84.3

(1) Investigation of strategic opportunities

Successor

The Company incurred charges of €18.8 millionin the year endedDecember 31, 2017 in relation to the implementation of the Nomad strategic vision, which primarily relates to changes to the organizational structure to align behind core products and implement net revenue management initiatives (2016: €7.0 million, 2015: €7.7 million). The prior periods exclude costs associated with legacy matters which are now allocated to (9), which has reduced the 2016 charge from €8.8 million to €7.0 million and the 2015 charge from €9.6 million to €7.7 million.

Predecessor

For the five months ended May 31, 2015 the Iglo Group incurred charges of €1.3 millionin relation to a strategic review of the Iglo Group’s operations and other items. The charges include costs incurred as a result of the decision to cease marketing its products in Romania, Slovakia and Turkey on November 27, 2014, amounts in relation to tax matters from previous accounting periods and costs related to the implementation of the Better Meals Together strategy.

(2) Supply chain reconfiguration

Successor

Supply chain reconfiguration relates to large scale restructuring projects undertaken by the Company to optimize the supply chain. A charge of €14.0 million has been incurred in relation to restructuring activities for the year endedDecember 31, 2017, which relates to the closure of the Bjuv manufacturing facility.

A charge of €84.3 million was incurred in the year ended December 31, 2016, of which €54.0 million was incurred in relation to restructuring activities, primarily relating to the closure of the Bjuv manufacturing facility. A further €30.3 million was incurred for an onerous contract that relates to the renegotiation of the Company’s agreements with a third party for the use of a warehouse facility.

(3) Findus Group integration costs

Successor

Following the acquisition of the Findus Group on November 2, 2015, the Company initiated a substantial integration project. Costs of €15.1 million have been incurred in the year endedDecember 31, 2017. For the year ended December 31, 2016 costs of €29.6 million were incurred. For the nine months ended December 31, 2015 costs of €4.5 million were incurred. Costs incurred in 2017 primarily relate to the rollout of the Nomad ERP system.

(4) Costs related to transactions

Successor

The charge for the year endedDecember 31, 2017, relates to enhanced control compliance procedures in territories. For the year ended December 31, 2016 and the nine months ended December 31, 2015, costs related to transactions primarily relates to the acquisition of the Iglo Group. For the year ended March 31, 2015 the Iglo Group incurred a charge of €0.7 million in relation to acquisition and sale transactions.

Predecessor

In 2015, a €3.8 million charge was incurred relating to the payment of registration tax assessed as a result of the CSI (Findus Italy) acquisition. The Iglo Group appealed the rulings and elected to pay the assessed taxes in order to avoid incurring penalties and interest.

(5) Costs related to long-term management incentive plans

Successor

Subsequent to the sale of Iglo and specific to the terms of a Predecessor incentive scheme, management participated in an incentive scheme for which the Company incurred charges €1.9 million in the year ended December 31, 2016 and €3.5 million in the nine months ended December 31, 2015. Refer to Note 8 for more details on the management incentive scheme which ended in May 2016.

Predecessor

The Iglo Acquisition on June 1, 2015 was a triggering event under the main incentive schemes following which the majority of management incentive schemes provisions were paid. The completion of the sale was a triggering event under the cash settled schemes.

A charge of €22.9 million in the five months ended May 31, 2015 represents an accelerated charge to align the cumulative charges recognized to the amount that was paid in June 2015 of €19.7 million. In addition, as a result of the terms of the sale, vesting of the equity settled share based payment scheme was accelerated. The non-cash charge of €3.2 million in the five months ended May 31, 2015 reflects the vesting of non-forfeited interests in this scheme. There were no associated exercises made in relation to the scheme due to the fact that market performance conditions were not met.

(6) Other restructuring costs

Successor

A credit of €1.0 million was recognized in the year endedDecember 31, 2016 related to the release of provisions for restructuring activities in the UK and German factories. For the nine months ended December 31, 2015, costs related to restructuring activities in the German, UK and Italian factories were €8.9 million.

(7) Cisterna fire net (income)/costs

Successor

A €4.3 million net income was recognized for the year ended December 31, 2016 in relation to the August 2014 fire insurance claim in the Italian production facility. A €2.5 million net income was recognized for the nine months ended December 31, 2015.

Predecessor

In the five months ended May 31, 2015 , the Iglo Group incurred charges of €1.3 million in relation to a fire in August 2014 in the Italian production facility which produces Findus branded stock for sale in Italy. The charges include the cost of stock damaged by the fire, the impairment of property as well as ongoing incremental costs incurred as a result of the disruption to operations. The Company has insurance policies in place covering the stock, property and loss of earnings for which claims are almost complete. The proceeds of these claims could not be recognized until the recoverable amount was judged to be virtually certain. No further costs are expected to arise from this incident and any future income from insurance claims is expected to be insignificant.

(8) Impairment of intangible assets

Predecessor

As a result of circumstances identified during the five months ended May 31, 2015 it was noted that the recoverable amount of the Italian intangible assets held prior to the Iglo Acquisition were lower than the values previously carried in the Iglo accounts. Therefore the carrying values were adjusted and an impairment charge of €55.0 million was recognized in the five months ended May 31, 2015.

(9) Settlement of legacy matters

Successor

A net income of €5.6 million has been recognized in liabilities relating to periods prior to acquisition of the Findus and Iglo businesses by the Company (charge of €1.8 million in the year ended December 31, 2016, charge of €1.9 million in the nine months ended December 31, 2015). These were previously classified within Investigation and implementation of strategic opportunities and other items and have been reclassified into this line for all successor periods presented.

The credit includes a charge of €3.9 million associated with settlements of tax audits, offset by gains of €4.2 million from the reassessment of sales tax provisions, €1.2 million from the reassessment of interest on sales tax provisions, a €2.8 million gain on a legacy pension plan in Norway and a €1.3 million gain on disposal of a non-operational factory.

(10) Remeasurement of indemnification assets

Successor

Remeasurement of the indemnification assets relates to the movement in value of shares held in escrow as part of the consideration on the acquisition of the Findus Group as well as the release of indemnification assets associated with the acquisition of the Iglo Group as discussed in Note 19.

Tax impact of exceptional items

The tax impact of the exceptional items amounts to a credit of €13.8 million in the year endedDecember 31, 2017 (year ended December 31, 2016: credit of €8.8 million, nine months ended December 31, 2015: credit of €6.1 million, year ended March 31, 2015: €nil, five months ended May 31, 2015: credit of €22.0 million).

Cash flow impact of exceptional items

Included in the Consolidated Statements of Cash Flows for the year endedDecember 31, 2017 is €99.5 million (year ended December 31, 2016: €49.2 million, nine months ended December 31, 2015: €91.6 million, year ended March 31, 2015: €0.7 million, 5 months ended May 31, 2015: €6.2 million) of cash outflows relating to exceptional items. This includes cash flows related to the above items as well as the cash impact of the settlement of provisions brought forward from previous accounting periods.

XML

Payroll costs, share based payments and management incentive schemes

12 Months Ended

Dec. 31, 2017

Employee Benefits And Share-Based Payments [Abstract]

Payroll costs, share based payments and management incentive schemes

Payroll costs, share based payments and management incentive schemes

(a) Payroll costs

The average number of persons employed by the Company (excluding non-Executive Directors) is analyzed and set out below:

	Successor	Successor	Successor	Successor	Predecessor
	Year ended December 31, 2017	Year ended December 31, 2016	9 months ended December 31, 2015	Year ended March 31, 2015	5 months ended May 31, 2015
Production	2,285	2,627	2,605	—	1,635
Administration, distribution & sales	1,572	1,571	1,767	—	1,047
Total number of employees	3,857	4,198	4,372	—	2,682

For the year ended March 31, 2015, the Successor did not have any operations or employees and accordingly no compensation or benefits were paid.

The table below discloses the Company’s aggregate payroll costs of these persons. Payroll costs exclude long term management incentive scheme and share based payment costs, but includes bonus costs, in particular those associated with a non-cash bonus for key management employees, whereby 13,104 Ordinary shares of the Company were issued to the recipients’ on November 27, 2015.

	Successor	Successor	Successor	Successor	Predecessor
	Year ended December 31, 2017	Year ended December 31, 2016	9 months ended December 31, 2015	Year ended March 31, 2015	5 months ended May 31, 2015
	€m	€m	€m	€m	€m
Wages and salaries	200.8	205.4	126.7	—	72.1
Social security costs	42.0	45.9	27.5	—	12.5
Other pension costs	14.6	13.2	6.0	—	4.2
Total payroll costs	257.4	264.5	160.2	—	88.8

(b) Share based payments

Successor

During 2015, the Company established a discretionary share award scheme, the LTIP, which enables the Company’s Compensation Committee to make grants (“Awards”) in the form of rights over ordinary shares, to any Director, Non-Executive Director or employee of the Company. However, it is the Committee’s current intention that Awards be granted only to Directors and senior management, whilst recognizing a separate annual Restricted Stock Award for Non-Executive Directors.

All Awards are to be settled by physical delivery of shares.

Non-Executive Director Restricted Share Awards

In accordance with the Board approved independent Non-Executive Director compensation guidelines, each independent Non-Executive Director is granted $100,000 of restricted shares annually on the date of the annual general meeting, valued at the closing market price for such shares on this date. The restricted shares vest on the earlier to occur of the date of the Company’s annual meeting of shareholders or thirteen months from the date of grant.

The Non-Executive Directors restricted share awards, granted at a share price of $11.50 on December 7, 2015, vested on June 16, 2016 and were issued in July 2016 at a share price of $8.98. Of the total 34,780 number of shares vesting, 11,568 shares were held back from issue by the Company as settlement towards personal tax liabilities arising on the vested shares.

The Non-Executive Directors restricted share awards granted on June 16, 2016, which consisted of 55,680 shares at a share price of $8.98, vested on June 19, 2017 and were issued at a share price of $14.38, resulting in a €0.3 million increase in the share based compensation reserve. Of the total 55,680 number of shares vesting, 9,384 shares were held back from issue by the Company as settlement towards personal tax liabilities arising on the vested shares.

On June 19, 2017, Non-Executive Directors were granted 41,724 restricted share awards at a share price of $14.38. On August 22, 2017, two new Non-Executive Directors were granted a pro-rata 11,774 restricted share awards at the same share price and vesting conditions as the previous grant.

The total charge for Non-Executive Director grants within the Statement of Consolidated Profit or Loss for the year endedDecember 31, 2017 for stock compensation awards was €0.8 million (year ended December 31, 2016: €0.6 million; nine months ended December 31, 2015: €0.1 million).

Director and Senior Management Share Awards

As part of its long term incentive initiatives, the Company has issued 4,927,000 restricted shares to the management team (the “Management Share Awards”). 3,837,000 shares (net of 770,000 forfeitures in the period) are currently allocated for the January 1, “2016” grant and a further 1,090,000 shares (including 485,000 new awards granted in the period) have been allocated for the January 1, “2017” grant. Relevant to each grant, half of the awards are contingent upon achieving a benchmark market share price and the other half of the awards will vest provided one of a range of cumulative EBITDA performance targets is met over a four year period. If the share price benchmark is met, the shares for this portion of the awards will vest 50% over a two year period and 50% over a four year period. For the 2016 grant, the two year period is through to January 1, 2018 and the four year period through to January 1, 2020. For the 2017 grant, the two year period is through to January 1, 2019 and the four year period through to January 1, 2021. The other half of the 2016 and 2017 awards will vest on January 1, 2020 and January 1, 2021 respectively provided one of a range of cumulative EBITDA performance targets is met over a four year period from January 1, 2016 to December 31, 2019 for the 2016 grant and from January 1, 2017 to December 31, 2020 for the 2017 grant.

The stock compensation charge reported within the Consolidated Statement of Profit or Loss for the year endedDecember 31, 2017 related to the management plan is €1.8 million (year ended December 31, 2016: €0.6 million; nine months ended December 31, 2015: €nil)

The Company calculates the cost of the Management Share Awards based upon their fair value using the Monte Carlo Model, which is considered to be the most appropriate methodology considering the restricted shares only vest once the market performance conditions have been satisfied, as well as expected exercise period and the payment of dividends by the Company. Following a revision to the January 1, 2016 award EBITDA Performance Target Conditions and updating for scheme leavers, the inputs and assumptions underlying the Monte Carlo models for both awards are now as follows:

	January 1, 2016 award			January 1, 2017 award
Grant date price	$	12.00		$	9.57
Exercise price	$	—		$	—
Expected life of restricted share	3.02 – 4.00 years			3.11 – 4.00 years
Expected volatility of the share price	20.0		%	23.0		%
Dividend yield expected	—		%	—		%
Risk free rate	1.59		%	1.83		%
Employee exit rate	16.0		%	16.0		%
EBITDA Performance Target Condition	5.0%-75.0%			5.0%-75.0%

The expected volatility of the share price inputs of 20.0% and 23.0% were estimated by referencing selected quoted companies which are considered to exhibit some degree of comparability with the Company, as the Company has only been listed for approximately two years at the time of the 2017 grant.

Based on the revised assessment in the current period of fair value and the number of shares expected to vest, the total fair value in respect of the Restricted Shares as at the January 1, 2016 grant date is $6.3 million (€5.9 million) and $0.6 million (€0.6 million) as at the January 1, 2017 grant date.

	Share based compensation reserve
	€m
Balance as of January 1, 2017	1.0
Non-Executive Director restricted share awards charge	0.8
Directors and Senior Management share awards charge	1.8
Vesting of Non-Executive Director restricted shares	(0.7)
Balance as of December 31, 2017	2.9

Initial Options

On April 11, 2014 Lord Myners, Alun Cathcart (resigned February 2016) and Guy Yamen (resigned June 2015), all Non-Executive Directors, were granted options (“Initial Options”) to purchase a maximum of 125,000 Ordinary Shares at an exercise price of $11.50 per ordinary share (subject to such adjustment to the number of Ordinary Shares and/or the exercise price as the Directors consider appropriate in accordance with the terms of the Initial Option Deeds in respect of an issue of Ordinary Shares by way of a dividend or distribution to holders of Ordinary Shares, a subdivision or consolidation or any other variation to the share capital of Nomad, as determined by the Directors).

The awards are now exercisable within a five year period, which commenced on the trading day immediately following the Iglo Group acquisition on June 1, 2015. Nomad has calculated the cost of the Initial Options based upon their fair value and taking into account the vesting period and using the Black-Scholes methodology. The valuation of the Initial Options has been based on the following assumptions:

– market value of Ordinary Shares at the grant date of $10.00;

– an exercise price of $11.50;

– 1 year expected time to acquisition;

– probability of acquisition of 61%;

– volatility of 17.03%; and

– a risk free interest rate of 0.84%.

Such securities and awards have been accounted for in accordance with “IFRS 2—Share Based Payment”. Based on the preceding assumptions, the total value for the Initial Options is €0.06 million. There were no forfeitures at the grant date and the expense was recognized over an estimated 2-year period ended on April 1, 2016.

Predecessor

In prior years for the Predecessor, certain employees of the Predecessor were offered the opportunity to participate in one of several Predecessor share schemes through which they could subscribe for shares of the Permira Partnership, the ultimate controlling party of the Predecessor. These schemes were accounted for under IFRS 2 “Share Based Payments” and represented equity settled share based payments.

Due to the sale of the Iglo Group, the vesting of the equity settled share based payment scheme was accelerated. The resulting €3.2 million charge to the Consolidated Statement of Profit or Loss for the five months ended May 31, 2015, reflected the accelerated vesting of non-forfeited interests in the scheme. The plans were equity settled.

(c) Management incentive schemes

Successor

Subsequent to the sale of Iglo and specific to the terms of a Predecessor incentive scheme, €1.9 million was charged to the Consolidated Statement of Profit or Loss during the year endedDecember 31, 2016. €3.5 million was charged in the nine month period to December 31, 2015. This scheme ended in May 2016.

Predecessor

Certain members of the Predecessor’s management team previously participated in certain incentive schemes. The completion of the sale of the Iglo Group to the Company on June 1, 2015 was a triggering event under the cash settled schemes. The resulting €19.7 million charge to the Consolidated Statement of Profit or Loss for the five months ended May 31, 2015, reflected the acceleration of the charges to align the cumulative charges recognized to the amount that was paid in June 2015.

XML

Directors and Key Management compensation

12 Months Ended

Dec. 31, 2017

Related Party [Abstract]

Directors and Key Management compensation

Directors and Key Management compensation

	Successor	Successor	Successor	Successor	Predecessor
	Year ended December 31, 2017	Year ended December 31, 2016	9 months ended December 31, 2015	Year ended March 31, 2015	5 months ended May 31, 2015
	€m	€m	€m	€m	€m
Short-term employee benefits	2.0	2.1	1.3	—	1.9
Contributions to money purchase pension plans	—	—	—	—	0.2
Share-based payment	1.4	0.9	0.1	—	2.2
Long-term incentive scheme	—	—	—	—	17.4
Compensation for loss of office	0.4	—	—	—	—
Non-Executive Director fees	0.3	0.2	0.1	0.2	—
Total Directors’ and executive officers' compensation	4.1	3.2	1.5	0.2	21.7

All significant management decision making authority is vested within the Board of Directors and the executive team, therefore key management are considered to be the Directors and executive Officers.

In the year endedDecember 31, 2017, two executive Officers were accruing benefits under share based payment schemes (year ended December 31, 2016: three).

Predecessor Non-Executive Directors were paid through payroll and are included within the table above but were not disclosed separately.

In the predecessor period, there were eight directors in respect of whose qualifying services shares were received under long term incentive schemes, including the highest paid director.

	Successor	Successor	Successor	Successor	Predecessor
	Year ended December 31, 2017	Year ended December 31, 2016	9 months ended December 31, 2015	Year ended March 31, 2015	5 months ended May 31, 2015
Retirement benefits are accruing to the following number of directors under:
Money purchase schemes	2	1	1	—	4

XML

Finance income and costs

12 Months Ended

Dec. 31, 2017

Analysis of income and expense [abstract]

Finance income and costs

Finance income and costs

		Successor		Successor		Successor		Successor	Predecessor
		Year ended December 31, 2017		Year ended December 31, 2016		9 months ended December 31, 2015		Year ended March 31, 2015	5 months ended May 31, 2015
	Note	€m		€m		€m		€m	€m
Interest income		0.2		5.9		4.4		—	2.0
Gain on derivatives		7.0		—		4.3		—	—
Net foreign exchange gains on translation of financial assets and liabilities		—		18.3		—		0.1	—
Finance income		7.2		24.2		8.7		0.1	2.0
Accrued interest		—		—		—		—	(60.2	)
Cash pay interest expense		(54.0	)	(68.7	)	(38.8	)	—	(35.4	)
Cross-currency interest rate swaps: cash flow hedges, transfer from equity		3.9		—		—		—	—
Other interest expense		—		(2.8	)	—		—	—
Net pension interest costs		(3.6	)	(4.1	)	(1.9	)	—	(0.7	)
Amortization of borrowing costs		(2.7	)	(5.0	)	(2.1	)	—	(0.9	)
Net foreign exchange losses on translation of financial assets and liabilities		(3.9	)	—		(0.5	)	—	(20.5	)
Interest on unwinding of discounted items		(1.2	)	(1.4	)	—		—	—
Loss on derivatives		—		(4.3	)	—		—	—
Financing costs incurred in amendment of terms of debt(1)		(20.1	)	—		(0.9	)	—	—
Finance costs		(81.6	)	(86.3	)	(44.2	)	—	(117.7	)
Net finance (costs)/income		(74.4	)	(62.1	)	(35.5	)	0.1	(115.7	)

(1)     A one-off charge of €20.1 million was incurred as a consequence of the refinancing in May 2017 and repricing in December 2017. Of this, deferred transaction costs of €15.7 million relating to the previous senior debt were written off.

XML

Taxation

12 Months Ended

Dec. 31, 2017

Income Taxes [Abstract]

Taxation

Taxation

		Successor		Successor		Successor		Successor	Predecessor
		Year ended December 31, 2017		Year ended December 31, 2016		9 months ended December 31, 2015		Year ended March 31, 2015	5 months ended May 31, 2015
	Note	€m		€m		€m		€m	€m
Current tax expense
Current tax on profits/loss for the period		(37.5	)	(58.9	)	(18.0	)	—	(41.2	)
Adjustments in respect of prior periods		3.2		(0.6	)	(2.3	)	—	15.2
		(34.3	)	(59.5	)	(20.3	)	—	(26.0	)
Deferred tax income/(expense)
Origination and reversal of temporary differences		(2.1	)	12.9		10.4		—	(14.9	)
Impact of change in tax rates		4.4		7.0		22.2		—	—
	16	2.3		19.9		32.6		—	(14.9	)
Total tax (expense)/credit		(32.0	)	(39.6	)	12.3		—	(40.9	)

Reconciliation of effective tax rate:

	Successor		Successor		Successor		Successor		Predecessor
	Year ended December 31, 2017		Year ended December 31, 2016		9 months ended December 31, 2015		Year ended March 31, 2015		5 months ended May 31, 2015
	€m		€m		€m		€m		€m
Profit/(loss) before tax	168.5		76.0		(349.6	)	(167.5	)	(87.1	)
Tax (charge)/credit at the standard UK corporation tax rate 19.25% (2016: 20%; 2015: 20.25%)	(32.5	)	(15.2	)	70.8		33.9		17.6
Difference in tax rates	(10.0	)	(10.0	)	(67.5	)	(33.9	)	(4.6	)
Non tax deductible interest	4.4		—		(9.9	)	—		(8.7	)
Other income and expenses not taxable or deductible	16.8		(7.4	)	1.0		—		(21.6	)
Unrecognized tax assets	(19.3	)	(1.8	)	(2.1	)	—		(30.9	)
Provisions for uncertainties	1.0		(11.6	)	0.1		—		(7.9	)
Impact of change in deferred tax rates	4.4		7.0		22.2		—		—
Prior period adjustment	3.2		(0.6	)	(2.3	)	—		15.2
Total tax (expense)/credit	(32.0	)	(39.6	)	12.3		—		(40.9	)

Effective tax rates

Successor

The effective tax rate for the year endedDecember 31, 2017 was 19% (year ended December 31, 2016: 52.1%). The change is principally caused by expenses which are not tax deductible, partially offset by the non-recognition of deferred tax assets on certain tax losses. Effective from and including January 12, 2016, the Company become a resident in the United Kingdom for United Kingdom tax purposes.

The Company operates in many different jurisdictions and in some of these, certain matters are under discussion with local tax authorities. These discussions are often complex and can take many years to resolve. Accruals for tax contingencies require management to make estimates and judgments with respect to the ultimate outcome of a tax audit, and actual results could vary from these estimates. Where tax exposures can be quantified, a provision is made based on best estimates and management’s judgments. Given the inherent uncertainties in assessing the outcomes of these exposures (which can sometimes be binary in nature), the Company could, in future years, experience adjustments to this provision.

Management believes that the Company’s position on all open matters including those in current discussion with local tax authorities is robust and that the Company is appropriately provided.

Following the enactment of the Finance Act 2016, the standard rate of corporation tax in the UK is 19.25% for 2017 (2016: 20%). The standard rate of corporation tax in the UK reduced from 20% to 19% with effect from April 1, 2017 and will reduce by a further 2% to 17% from April 1 2020. As the reductions to 19% and 17% were substantially enacted on September 6, 2016, these rates are reflected in these financial statements.

The tax (credit)/charge relating to components of other comprehensive income is as follows:

Successor

		Before tax		Tax charge/ (credit)		After tax
Year ended December 31, 2017	Note	€m		€m		€m
Remeasurement of post-employment benefit liabilities		(2.9	)	2.0		(0.9	)
Net investment hedge		0.8		—		0.8
Cash flow hedges		16.4		(5.0	)	11.4
Other comprehensive loss		14.3		(3.0	)	11.3
Current tax		—		—		—
Deferred tax	16	—		(3.0	)	—
		—		(3.0	)	—
		Before tax		Tax charge		After tax
Year ended December 31, 2016	Note	€m		€m		€m
Remeasurement of post-employment benefit liabilities		23.6		6.3		29.9
Net investment hedge		0.5		—		0.5
Cash flow hedges		(10.1	)	2.8		(7.3	)
Other comprehensive loss		14.0		9.1		23.1
Current tax		—		—		—
Deferred tax	16	—		9.1		—
		—		9.1		—
		Before tax		Tax charge		After tax
Nine months ended December 31, 2015	Note	€m		€m		€m
Remeasurement of post-employment benefit liabilities		(19.4	)	6.1		(13.3	)
Net investment hedge		4.4		—		4.4
Cash flow hedges		(1.6	)	0.5		(1.1	)
Other comprehensive (income)/loss		(16.6	)	6.6		(10.0	)
Current tax		—		—		—
Deferred tax	16	—		6.6		—
		—		6.6		—

Predecessor
		Before tax		Tax credit		After tax
5 months ended May 31, 2015	Note	€m		€m		€m
Remeasurement of post-employment benefit liabilities		2.5		(0.7	)	1.8
Net investment hedge		(44.7	)	—		(44.7	)
Cash flow hedges		—		—		—
Other comprehensive income		(42.2	)	(0.7	)	(42.9	)
Current tax		—		—		—
Deferred tax	16	—		(0.7	)	—
		—		(0.7	)	—

Deferred tax assets and liabilities

Recognized deferred tax assets and liabilities

Deferred tax assets and liabilities are attributable to the following:

	Dec 31, 2017					Dec 31, 2016
	Assets	Liabilities		Total		Assets	Liabilities		Total
	€m	€m		€m		€m	€m		€m
Property, plant and equipment	13.5	(28.7	)	(15.2	)	10.3	(33.6	)	(23.3	)
Intangible assets	0.1	(295.1	)	(295.0	)	—	(291.3	)	(291.3	)
Employee benefits	28.2	—		28.2		27.8	(0.1	)	27.7
Tax value of loss carry forwards	15.6	—		15.6		18.9	—		18.9
Derivative financial instruments	0.9	0.5		1.4		—	(3.3	)	(3.3	)
Other	6.0	(4.4	)	1.6		7.9	(4.9	)	3.0
Tax assets/(liabilities)	64.3	(327.7	)	(263.4	)	64.9	(333.2	)	(268.3	)

Deferred income tax assets are recognized for tax loss carry-forwards to the extent that the realization of the related tax benefit through future taxable profits is probable.

Deferred tax assets that the Company has not recognized in the financial statements amount to €65.3 million (December 31, 2016: €56.3 million). These deferred tax assets have not been recognized as the likelihood of recovery is not probable. A deferred tax asset on tax losses acquired from the Iglo Group was not recognized at the acquisition date. During 2016, following discussions with tax authorities, the group revised its assessment of the likely recovery of these losses and a resulting deferred tax asset has now been recognized.

The aggregate deferred tax relating to items that have been credited directly to equity is €3.0 million (December 31, 2016: charge of €9.1 million).

Movement in deferred tax during the year:

	Opening balance Jan 1 2017		Acquired in business combinations	Recognized  in Statement of Profit or Loss		Recognized in Other Comprehensive Income		Movement in foreign exchange		Closing balance Dec 31, 2017
	€m		€m	€m		€m		€m		€m
Property, plant and equipment	(23.3	)	—	8.2		—		(0.1	)	(15.2	)
Intangible assets	(291.3	)	—	(3.7	)	—		—		(295.0	)
Employee benefits	27.7		—	2.5		(2.0	)	—		28.2
Tax value of loss carry forwards	18.9		—	(3.0	)	—		(0.3	)	15.6
Derivative financial instruments	(3.3	)	—	(0.3	)	5.0		—		1.4
Other	3.0		—	(1.4	)	—		—		1.6
Total deferred tax	(268.3	)	—	2.3		3.0		(0.4	)	(263.4	)

	Opening balance Jan 1 2016		Acquired in business combinations		Recognized in Statement of Profit or Loss		Recognized in Other Comprehensive Income		Movement in foreign exchange		Closing balance Dec 31 2016
	€m		€m		€m		€m		€m		€m
Property, plant and equipment	(5.3	)	(0.3	)	(17.2	)	—		(0.5	)	(23.3	)
Intangible assets	(315.8	)	—		24.1		—		0.4		(291.3	)
Employee benefits	32.7		—		1.3		(6.3	)	—		27.7
Tax value of loss carry forwards	—		—		18.9		—		—		18.9
Derivative financial instruments	0.2		—		(0.7	)	(2.8	)	—		(3.3	)
Other	9.5		—		(6.5	)	—		—		3.0
Total deferred tax	(278.7	)	(0.3	)	19.9		(9.1	)	(0.1	)	(268.3	)

XML

Property, plant and equipment

12 Months Ended

Dec. 31, 2017

Property, plant and equipment [abstract]

Property, plant and equipment

Property, plant and equipment

	Land and buildings		Plant and equipment		Computer equipment		Total
	€m		€m		€m		€m
SUCCESSOR
Cost
Balance at December 31, 2015	119.2		221.8		2.4		343.4
Acquisitions through business combinations	—		2.5		—		2.5
Additions	3.3		34.3		0.4		38.0
Transfer to intangible assets (note 13)	(1.7	)	1.1		—		(0.6	)
Disposals	(2.7	)	(0.6	)	—		(3.3	)
Effect of movements in foreign exchange	(7.6	)	(28.8	)	—		(36.4	)
Balance at December 31, 2016	110.5		230.3		2.8		343.6
Additions	11.6		26.0		0.4		38.0
Disposals	(0.1	)	(1.1	)	—		(1.2	)
Effect of movements in foreign exchange	(4.6	)	(12.7	)	—		(17.3	)
Balance at December 31, 2017	117.4		242.5		3.2		363.1
Accumulated depreciation and impairment
Balance at December 31, 2015	3.4		21.4		0.4		25.2
Depreciation	6.5		35.7		1.1		43.3
Impairment	(0.2	)	1.6		—		1.4
Transfers	—		0.2		(0.2	)	—
Effect of movements in foreign exchange	(3.9	)	(20.5	)	(0.1	)	(24.5	)
Balance at December 31, 2016	5.8		38.4		1.2		45.4
Depreciation	6.1		28.9		0.9		35.9
Impairment	—		0.3		—		0.3
Effect of movements in foreign exchange	(3.7	)	(10.2	)	—		(13.9	)
Balance at December 31, 2017	8.2		57.4		2.1		67.7
Net book value December 31, 2015	115.8		200.4		2.0		318.2
Net book value December 31, 2016	104.7		191.9		1.6		298.2
Net book value December 31, 2017	109.2		185.1		1.1		295.4

Leased equipment

The Company leased items of machinery in Sweden under finance leases which were disposed of in the year ended December 31, 2017 and so the net carrying amount of those leased assets is nil (December 31, 2016: €0.8 million).

Security

Borrowings have been provided by a syndicate of third party lenders, (the “Syndicate”). The Syndicate together with holders of the bond issue have security over the assets of the ‘guarantor group’. The ‘Guarantor Group’ consists of those companies which individually have more than 5% of consolidated total assets or EBITDA (as defined in the Senior Facilities Agreement) of the Company and in total comprise more than 80% of consolidated total assets or EBITDA at any testing date.

XML

Goodwill and Intangibles

12 Months Ended

Dec. 31, 2017

Intangible assets and goodwill [abstract]

Goodwill and Intangibles

Goodwill and Intangibles

	Goodwill	Brands	Computer software		Customer relationships	Others		Total
	€m	€m	€m		€m	€m		€m
Cost
Balance at December 31, 2015	1,676.8	1,688.9	11.0		31.0	0.2		3,407.9
Acquisitions through business combinations	68.8	—	—		—	(0.2	)	68.6
Additions	—	—	4.4		—	—		4.4
Transfer from tangible assets (note 12)	—	—	0.6		—	—		0.6
Effect of movements in foreign exchange	—	—	(1.3	)	—	—		(1.3	)
Balance at December 31, 2016	1,745.6	1,688.9	14.7		31.0	—		3,480.2
Additions	—	—	4.6		—	—		4.6
Effect of movements in foreign exchange	—	—	(1.0	)	—	—		(1.0	)
Balance at December 31, 2017	1,745.6	1,688.9	18.3		31.0	—		3,483.8

	Goodwill	Brands	Computer software		Customer relationships	Others	Total
	€m	€m	€m		€m	€m	€m
Accumulated amortization and impairment
Balance at December 31, 2015	—	0.1	1.0		0.4	—	1.5
Amortization	—	0.7	4.9		2.2	—	7.8
Effect of movements in foreign exchange	—	—	(1.3	)	—	—	(1.3	)
Balance at December 31, 2016	—	0.8	4.6		2.6	—	8.0
Amortization	—	0.7	3.6		2.2	—	6.5
Effect of movements in foreign exchange	—	—	(0.7	)	—	—	(0.7	)
Balance at December 31, 2017	—	1.5	7.5		4.8	—	13.8
Net book value December 31, 2015	1,676.8	1,688.8	10.0		30.6	0.2	3,406.4
Net book value December 31, 2016	1,745.6	1,688.1	10.1		28.4	—	3,472.2
Net book value December 31, 2017	1,745.6	1,687.4	10.8		26.2	—	3,470.0

Amortization of €6.5 million (December 31, 2016: €7.8 million; December 31, 2015: €1.5 million) is included in ‘other operating expenses’ in the Consolidated Statement of Profit or Loss.

All goodwill, brands and customer relationship values have been allocated to the frozen cash generating unit.

The Company’s goodwill, brand and customer relationships values have been allocated based on the enterprise value at acquisition of each cash generating unit (“CGU”). Goodwill is monitored at an operating segment level. As required by IAS 36 “Impairment of Assets”, an annual review of the carrying amount of the goodwill and the indefinite life brands is carried out to identify whether there is any impairment to these carrying values. This is done by means of comparison of the carrying values to the value in use of the CGU. Value in use is calculated as the net present value of the projected risk-adjusted cash flows of each CGU.

Key assumptions

The values for the key assumptions were arrived at by taking into consideration detailed historical information and comparison to external sources where appropriate, such as market rates for discount factors.

• Budgeted cash flows: the calculation of value in use has been based on the cash flow forecasts by management for 2018 to 2020. The trends in these forecasts have been extrapolated to produce 2021 and 2022 forecast cash flows. Beyond 2022 the same assumptions have been applied for future periods in the absence of longer term detailed forecasts. These plans have been prepared and approved by management, and incorporate past performance of the entities acquired in the period, historical growth rates and projections of developments in key markets.

• Sales: projected sales are built up with reference to markets and product platforms. They incorporate past performance, historical growth rates and projections of developments in key markets.

• Adjusted EBITDA Margin: projected margins reflect historical performance.

• Capital expenditure forecast reflects one-off additional capital expenditure required in order to integrate the operations of the Findus acquisition.

• Discount rate: a pre-tax discount rate of 8.0% (2016: 8.0%) was applied to the cash flows. This discount rate has been calculated using a capital asset pricing model using observable market data, including the share price of Nomad Foods Limited.

• Long-term growth rates: as required by IAS 36, growth rates for the period after the detailed forecasts are based on past performance. The growth rate used in the testing was 1.0% (2016: 0.5%). These rates do not reflect the long-term assumptions used by the Company for investment planning.

Sensitivity to changes in assumptions

Impairment was not required at either December 31, 2017 or December 31, 2016. In each case the valuations derived from the discounted cash flow model indicate a sufficient amount of headroom for which any reasonably possible change to key assumptions is unlikely to result in an impairment of the related goodwill.

XML

Acquisitions

12 Months Ended

Dec. 31, 2017

Business Combinations1 [Abstract]

Acquisitions

Acquisitions

On January 17, 2018 we entered into an agreement to acquire Green Isle Foods Ltd. including the Goodfella's and San Marco brands, in an all cash deal valued at £200 million (approximately €225 million). We anticipate this acquisition to be completed in the second quarter of 2018 and we expect this will enlarge our portfolio of brands to include the number one and number two market share positions within the frozen pizza category in Ireland and the UK, a successful frozen private label pizza business, and two frozen pizza manufacturing facilities. The purchase price of the acquisition is expected to be funded through cash on hand. The Company will disclose the impact of this acquisition once successfully completed. See Note 38, Significant events after the Statement of Financial Position date.

Indemnification assets

	Successor		Successor
	Dec 31, 2017		Dec 31, 2016
	€m		€m
Related to Iglo Acquisition at start of the period	2.1		10.2
Reclassified from Other receivables	—		1.2
Release of indemnified provision	(2.1	)	(9.3	)
Related to Iglo Acquisition at end of the period	—		2.1
Related to Findus Acquisition at start of the period	63.4		67.6
Acquisition accounting adjustment	—		6.2
Remeasurement of indemnification assets	10.4		(10.4	)
Related to Findus Acquisition at end of the period	73.8		63.4
Total indemnification assets	73.8		65.5

As part of the acquisition of the Iglo Group and the Findus Group, the Company inherited several contingent liabilities for which the sellers have provided an indemnity. To the extent that the liability has been recognized in the balance sheet, an indemnification asset has been recognized. As part of the agreement to repurchase shares on June 12, 2017, as discussed in Note 25, the indemnities in relation to the Iglo acquisition were canceled. As a consequence, the indemnification asset of €2.1 million previously recognized has been released.

In total, €73.8 million of liabilities are covered by the indemnification assets as at December 31, 2017 (December 31, 2016: €65.5 million). The asset recognized in relation to the Findus Group has been limited to the original value of shares held in escrow following the completion of the acquisition.

The indemnification asset recognized in relation to the Findus Group is secured by shares held in escrow, so that the value of the assets may, in the future, be restricted to the value of these shares as at the balance sheet date. As at the December 31, 2017, €73.8 million (December 31, 2016: €63.4 million) of the indemnification assets relate to the acquisition of the Findus Group for which 6,964,417 shares are held in escrow and are valued at $16.91 (€14.13) (December 31, 2016: 6,964,417shares valued at $9.57 (€9.10)) each.

XML

Investments

12 Months Ended

Dec. 31, 2017

Interests in Other Entities [Abstract]

Investments

Investments

The following are the Company's significant investments as of December 31, 2017.

	Activity	Country of incorporation	Class of shares held	Ownership as of
				Dec 31, 2017
Nomad Foods Europe Holdings Limited	Holding	England	Ordinary	100%
Nomad Foods Europe Holdco Limited	Holding	England	Ordinary	100%
Nomad Foods Europe Finco Limited	Holding	England	Ordinary	100%
Nomad Foods Europe Midco Limited	Holding/ Finance	England	Ordinary	100%
Nomad Foods Bondco Plc	Finance	England	Ordinary	100%
Nomad Foods Lux S.à.r.l.	Finance	Luxembourg	Ordinary	100%
Nomad Foods Europe Limited	Management	England	Ordinary	100%
Birds Eye Limited	Trading	England	Ordinary	100%
Nomad Foods Europe Finance Limited	Finance	England	Ordinary	100%
Birds Eye Ireland Limited	Trading	Republic of Ireland	Ordinary	100%
Iglo Holding GmbH	Holding	Germany	Ordinary	100%
Iglo Nederland B.V.	Trading	Netherlands	Ordinary	100%
Iglo Belgium S.A.	Trading	Belgium	Ordinary	100%
Iglo Portugal	Trading	Portugal	Ordinary	100%
Iglo Austria Holdings GmbH	Holding	Austria	Ordinary	100%
C.S.I. Compagnia Surgelati Italiana S.R.L	Trading	Italy	Ordinary	100%
Findus Sverige Holdings AB	Holding	Sweden	Ordinary	100%
Iglo GmbH	Trading	Germany	Ordinary	100%
Frozen Fish International GmbH	Trading	Germany	Ordinary	100%
Liberator Germany Newco GmbH	Property	Germany	Ordinary	100%
Iglo Austria GmbH	Trading	Austria	Ordinary	100%
Findus Sverige AB	Trading	Sweden	Ordinary	100%
Frionor Sverige AB	Holding	Sweden	Ordinary	100%
Findus Holdings France SAS	Holding	France	Ordinary	100%
Findus France SAS	Trading	France	Ordinary	100%
Findus Espana SLU	Trading	Spain	Ordinary	100%
Findus Danmark A/S	Trading	Denmark	Ordinary	100%
Findus Finland Oy	Trading	Finland	Ordinary	100%
Findus Norge AS	Trading	Norway	Ordinary	100%

XML

Deferred tax assets and liabilities

12 Months Ended

Dec. 31, 2017

Disclosure of income tax [Abstract]

Deferred tax assets and liabilities

Taxation

		Successor		Successor		Successor		Successor	Predecessor
		Year ended December 31, 2017		Year ended December 31, 2016		9 months ended December 31, 2015		Year ended March 31, 2015	5 months ended May 31, 2015
	Note	€m		€m		€m		€m	€m
Current tax expense
Current tax on profits/loss for the period		(37.5	)	(58.9	)	(18.0	)	—	(41.2	)
Adjustments in respect of prior periods		3.2		(0.6	)	(2.3	)	—	15.2
		(34.3	)	(59.5	)	(20.3	)	—	(26.0	)
Deferred tax income/(expense)
Origination and reversal of temporary differences		(2.1	)	12.9		10.4		—	(14.9	)
Impact of change in tax rates		4.4		7.0		22.2		—	—
	16	2.3		19.9		32.6		—	(14.9	)
Total tax (expense)/credit		(32.0	)	(39.6	)	12.3		—	(40.9	)

Reconciliation of effective tax rate:

	Successor		Successor		Successor		Successor		Predecessor
	Year ended December 31, 2017		Year ended December 31, 2016		9 months ended December 31, 2015		Year ended March 31, 2015		5 months ended May 31, 2015
	€m		€m		€m		€m		€m
Profit/(loss) before tax	168.5		76.0		(349.6	)	(167.5	)	(87.1	)
Tax (charge)/credit at the standard UK corporation tax rate 19.25% (2016: 20%; 2015: 20.25%)	(32.5	)	(15.2	)	70.8		33.9		17.6
Difference in tax rates	(10.0	)	(10.0	)	(67.5	)	(33.9	)	(4.6	)
Non tax deductible interest	4.4		—		(9.9	)	—		(8.7	)
Other income and expenses not taxable or deductible	16.8		(7.4	)	1.0		—		(21.6	)
Unrecognized tax assets	(19.3	)	(1.8	)	(2.1	)	—		(30.9	)
Provisions for uncertainties	1.0		(11.6	)	0.1		—		(7.9	)
Impact of change in deferred tax rates	4.4		7.0		22.2		—		—
Prior period adjustment	3.2		(0.6	)	(2.3	)	—		15.2
Total tax (expense)/credit	(32.0	)	(39.6	)	12.3		—		(40.9	)

Effective tax rates

Successor

The effective tax rate for the year endedDecember 31, 2017 was 19% (year ended December 31, 2016: 52.1%). The change is principally caused by expenses which are not tax deductible, partially offset by the non-recognition of deferred tax assets on certain tax losses. Effective from and including January 12, 2016, the Company become a resident in the United Kingdom for United Kingdom tax purposes.

The Company operates in many different jurisdictions and in some of these, certain matters are under discussion with local tax authorities. These discussions are often complex and can take many years to resolve. Accruals for tax contingencies require management to make estimates and judgments with respect to the ultimate outcome of a tax audit, and actual results could vary from these estimates. Where tax exposures can be quantified, a provision is made based on best estimates and management’s judgments. Given the inherent uncertainties in assessing the outcomes of these exposures (which can sometimes be binary in nature), the Company could, in future years, experience adjustments to this provision.

Management believes that the Company’s position on all open matters including those in current discussion with local tax authorities is robust and that the Company is appropriately provided.

Following the enactment of the Finance Act 2016, the standard rate of corporation tax in the UK is 19.25% for 2017 (2016: 20%). The standard rate of corporation tax in the UK reduced from 20% to 19% with effect from April 1, 2017 and will reduce by a further 2% to 17% from April 1 2020. As the reductions to 19% and 17% were substantially enacted on September 6, 2016, these rates are reflected in these financial statements.

The tax (credit)/charge relating to components of other comprehensive income is as follows:

Successor

		Before tax		Tax charge/ (credit)		After tax
Year ended December 31, 2017	Note	€m		€m		€m
Remeasurement of post-employment benefit liabilities		(2.9	)	2.0		(0.9	)
Net investment hedge		0.8		—		0.8
Cash flow hedges		16.4		(5.0	)	11.4
Other comprehensive loss		14.3		(3.0	)	11.3
Current tax		—		—		—
Deferred tax	16	—		(3.0	)	—
		—		(3.0	)	—
		Before tax		Tax charge		After tax
Year ended December 31, 2016	Note	€m		€m		€m
Remeasurement of post-employment benefit liabilities		23.6		6.3		29.9
Net investment hedge		0.5		—		0.5
Cash flow hedges		(10.1	)	2.8		(7.3	)
Other comprehensive loss		14.0		9.1		23.1
Current tax		—		—		—
Deferred tax	16	—		9.1		—
		—		9.1		—
		Before tax		Tax charge		After tax
Nine months ended December 31, 2015	Note	€m		€m		€m
Remeasurement of post-employment benefit liabilities		(19.4	)	6.1		(13.3	)
Net investment hedge		4.4		—		4.4
Cash flow hedges		(1.6	)	0.5		(1.1	)
Other comprehensive (income)/loss		(16.6	)	6.6		(10.0	)
Current tax		—		—		—
Deferred tax	16	—		6.6		—
		—		6.6		—

Predecessor
		Before tax		Tax credit		After tax
5 months ended May 31, 2015	Note	€m		€m		€m
Remeasurement of post-employment benefit liabilities		2.5		(0.7	)	1.8
Net investment hedge		(44.7	)	—		(44.7	)
Cash flow hedges		—		—		—
Other comprehensive income		(42.2	)	(0.7	)	(42.9	)
Current tax		—		—		—
Deferred tax	16	—		(0.7	)	—
		—		(0.7	)	—

Deferred tax assets and liabilities

Recognized deferred tax assets and liabilities

Deferred tax assets and liabilities are attributable to the following:

	Dec 31, 2017					Dec 31, 2016
	Assets	Liabilities		Total		Assets	Liabilities		Total
	€m	€m		€m		€m	€m		€m
Property, plant and equipment	13.5	(28.7	)	(15.2	)	10.3	(33.6	)	(23.3	)
Intangible assets	0.1	(295.1	)	(295.0	)	—	(291.3	)	(291.3	)
Employee benefits	28.2	—		28.2		27.8	(0.1	)	27.7
Tax value of loss carry forwards	15.6	—		15.6		18.9	—		18.9
Derivative financial instruments	0.9	0.5		1.4		—	(3.3	)	(3.3	)
Other	6.0	(4.4	)	1.6		7.9	(4.9	)	3.0
Tax assets/(liabilities)	64.3	(327.7	)	(263.4	)	64.9	(333.2	)	(268.3	)

Deferred income tax assets are recognized for tax loss carry-forwards to the extent that the realization of the related tax benefit through future taxable profits is probable.

Deferred tax assets that the Company has not recognized in the financial statements amount to €65.3 million (December 31, 2016: €56.3 million). These deferred tax assets have not been recognized as the likelihood of recovery is not probable. A deferred tax asset on tax losses acquired from the Iglo Group was not recognized at the acquisition date. During 2016, following discussions with tax authorities, the group revised its assessment of the likely recovery of these losses and a resulting deferred tax asset has now been recognized.

The aggregate deferred tax relating to items that have been credited directly to equity is €3.0 million (December 31, 2016: charge of €9.1 million).

Movement in deferred tax during the year:

	Opening balance Jan 1 2017		Acquired in business combinations	Recognized  in Statement of Profit or Loss		Recognized in Other Comprehensive Income		Movement in foreign exchange		Closing balance Dec 31, 2017
	€m		€m	€m		€m		€m		€m
Property, plant and equipment	(23.3	)	—	8.2		—		(0.1	)	(15.2	)
Intangible assets	(291.3	)	—	(3.7	)	—		—		(295.0	)
Employee benefits	27.7		—	2.5		(2.0	)	—		28.2
Tax value of loss carry forwards	18.9		—	(3.0	)	—		(0.3	)	15.6
Derivative financial instruments	(3.3	)	—	(0.3	)	5.0		—		1.4
Other	3.0		—	(1.4	)	—		—		1.6
Total deferred tax	(268.3	)	—	2.3		3.0		(0.4	)	(263.4	)

	Opening balance Jan 1 2016		Acquired in business combinations		Recognized in Statement of Profit or Loss		Recognized in Other Comprehensive Income		Movement in foreign exchange		Closing balance Dec 31 2016
	€m		€m		€m		€m		€m		€m
Property, plant and equipment	(5.3	)	(0.3	)	(17.2	)	—		(0.5	)	(23.3	)
Intangible assets	(315.8	)	—		24.1		—		0.4		(291.3	)
Employee benefits	32.7		—		1.3		(6.3	)	—		27.7
Tax value of loss carry forwards	—		—		18.9		—		—		18.9
Derivative financial instruments	0.2		—		(0.7	)	(2.8	)	—		(3.3	)
Other	9.5		—		(6.5	)	—		—		3.0
Total deferred tax	(278.7	)	(0.3	)	19.9		(9.1	)	(0.1	)	(268.3	)

XML

Inventories

12 Months Ended

Dec. 31, 2017

Inventories [Abstract]

Inventories

Inventories

	Successor	Successor
	Dec 31, 2017	Dec 31, 2016
	€m	€m
Raw materials and consumables	82.9	97.7
Work in progress	41.0	41.7
Finished goods and goods for resale	183.0	185.6
Total inventories	306.9	325.0

During the year endedDecember 31, 2017€7.6 million (year ended December 31, 2016€6.4 million, nine months ended December 31, 2015: €3.5 million; year ended March 31, 2015: nil) was charged to the Consolidated Statement of Profit or Loss for the write down of inventories.

XML

Trade and other receivables

12 Months Ended

Dec. 31, 2017

Subclassifications of assets, liabilities and equities [abstract]

Trade and other receivables

Trade and other receivables

	Successor	Successor
	Dec 31, 2017	Dec 31, 2016
Current assets	€m	€m
Trade receivables	94.7	92.3
Prepayments and accrued income	10.1	8.0
Other receivables	19.7	26.1
Tax receivable	22.6	9.3
Total current trade and other receivables	147.1	135.7
Non-current assets
Other receivables	4.3	0.4
Total non-current trade and other receivables	4.3	0.4
Total trade and other receivables	151.4	136.1

Trade receivables, prepayments and other receivables, except for those defined as non-current, are expected to be recovered in less than 12 months. Other receivables includes VAT receivable.

The ageing of trade receivables is detailed below:

	Gross	Impaired		Net
December 31, 2017	€m	€m		€m
Not past due	243.4	—		243.4
Past due less than 1 month	35.6	(0.7	)	34.9
Past due 1 to 3 months	4.8	(0.3	)	4.5
Past due 3 to 6 months	0.2	(0.2	)	—
Past due more than 6 months	5.3	(4.9	)	0.4
Sub-total	289.3	(6.1	)	283.2
Reduction in trade-terms*				(188.5	)
Total trade receivables				94.7
	Gross	Impaired		Net
December 31, 2016	€m	€m		€m
Not past due	229.4	—		229.4
Past due less than 1 month	9.8	(0.1	)	9.7
Past due 1 to 3 months	0.9	(0.2	)	0.7
Past due 3 to 6 months	0.9	(0.1	)	0.8
Past due more than 6 months	6.3	(6.0	)	0.3
Sub-total	247.3	(6.4	)	240.9
Reduction in trade-terms*				(148.6	)
Total trade receivables				92.3

* Refer to Note 4(a). Reduction in trade term amounts are primarily not past due.

All impaired trade receivables have been provided to the extent that they are believed not to be recoverable.

The maximum exposure to credit risk at the reporting date is the fair value of each class of receivable. The Company does not hold any collateral as security.

XML

Indemnification assets

12 Months Ended

Dec. 31, 2017

Business Combinations1 [Abstract]

Indemnification assets

Acquisitions

On January 17, 2018 we entered into an agreement to acquire Green Isle Foods Ltd. including the Goodfella's and San Marco brands, in an all cash deal valued at £200 million (approximately €225 million). We anticipate this acquisition to be completed in the second quarter of 2018 and we expect this will enlarge our portfolio of brands to include the number one and number two market share positions within the frozen pizza category in Ireland and the UK, a successful frozen private label pizza business, and two frozen pizza manufacturing facilities. The purchase price of the acquisition is expected to be funded through cash on hand. The Company will disclose the impact of this acquisition once successfully completed. See Note 38, Significant events after the Statement of Financial Position date.

Indemnification assets

	Successor		Successor
	Dec 31, 2017		Dec 31, 2016
	€m		€m
Related to Iglo Acquisition at start of the period	2.1		10.2
Reclassified from Other receivables	—		1.2
Release of indemnified provision	(2.1	)	(9.3	)
Related to Iglo Acquisition at end of the period	—		2.1
Related to Findus Acquisition at start of the period	63.4		67.6
Acquisition accounting adjustment	—		6.2
Remeasurement of indemnification assets	10.4		(10.4	)
Related to Findus Acquisition at end of the period	73.8		63.4
Total indemnification assets	73.8		65.5

As part of the acquisition of the Iglo Group and the Findus Group, the Company inherited several contingent liabilities for which the sellers have provided an indemnity. To the extent that the liability has been recognized in the balance sheet, an indemnification asset has been recognized. As part of the agreement to repurchase shares on June 12, 2017, as discussed in Note 25, the indemnities in relation to the Iglo acquisition were canceled. As a consequence, the indemnification asset of €2.1 million previously recognized has been released.

In total, €73.8 million of liabilities are covered by the indemnification assets as at December 31, 2017 (December 31, 2016: €65.5 million). The asset recognized in relation to the Findus Group has been limited to the original value of shares held in escrow following the completion of the acquisition.

The indemnification asset recognized in relation to the Findus Group is secured by shares held in escrow, so that the value of the assets may, in the future, be restricted to the value of these shares as at the balance sheet date. As at the December 31, 2017, €73.8 million (December 31, 2016: €63.4 million) of the indemnification assets relate to the acquisition of the Findus Group for which 6,964,417 shares are held in escrow and are valued at $16.91 (€14.13) (December 31, 2016: 6,964,417shares valued at $9.57 (€9.10)) each.

XML

Cash and cash equivalents

12 Months Ended

Dec. 31, 2017

Subclassifications of assets, liabilities and equities [abstract]

Cash and cash equivalents

Cash and cash equivalents

	Successor	Successor
	Dec 31, 2017	Dec 31, 2016
	€m	€m
Cash and cash equivalents	219.0	325.3
Restricted cash	0.2	4.2
Total cash and cash equivalents	219.2	329.5
Bank overdrafts	—	—
Cash and cash equivalents per Statement of Cash Flows	219.2	329.5

‘Cash and cash equivalents’ comprise cash balances and call deposits. Restricted cash comprises money that is primarily reserved for a specific purpose and therefore not available for immediate or general business use. Of the restricted cash totaling €4.2 million at December 31, 2016, €3.6 million was due to French company law requirements.

XML

Loans and borrowings

12 Months Ended

Dec. 31, 2017

Financial Instruments [Abstract]

Loans and borrowings

Loans and borrowings

The repayment profile of the syndicated and other loans held by the Company is as follows:

	Successor		Successor
	Dec 31, 2017		Dec 31, 2016
	€m		€m
Current liabilities/(assets)
Syndicated loans	5.1		—
Less deferred borrowing costs to be amortized within 1 year	(1.8	)	(5.0	)
Total due in less than one year	3.3		(5.0	)
Non-current liabilities
Syndicated loans	1,004.4		964.2
2020 floating rate senior secured notes	—		500.0
2024 fixed rate senior secured notes	400.0		—
Less deferred borrowing costs to be amortized in 2-5 years	(7.2	)	(12.4	)
Less deferred borrowing costs to be amortized in more than 5 years	(2.1	)	—
Total due after more than one year	1,395.1		1,451.8
Total borrowings	1,398.4		1,446.8

The table below shows details of individual loans:

	Successor		Successor
	Dec 31, 2017		Dec 31, 2016
	€m		€m
Current liabilities/(assets)-syndicated loans	5.1		—
Less deferred borrowing costs to be amortized within 1 year	(1.8	)	(5.0	)
Total current loans and borrowings	3.3		(5.0	)
Non-current liabilities-syndicated loans and secured notes
2020 floating rate senior secured notes	—		500.0
2024 fixed rate senior secured notes	400.0		—
Senior C1 EUR	—		363.3
Senior C2 GBP	—		275.9
Senior C3 EUR	—		325.0
Senior B3 EUR	500.0		—
Senior B4 USD	504.4		—
Less deferred borrowing costs to be amortized in 2—5 years	(7.2	)	(12.4	)
Less deferred borrowing costs to be amortized in more than 5 years	(2.1	)	—
Total non-current loans and borrowings	1,395.1		1,451.8
Total borrowings	1,398.4		1,446.8
Borrowings under the syndicated loan facility and floating rate notes	1,398.4		1,446.8

The interest rate on all other loans and the floating rate senior secured notes are re-priced within one year to the relevant Euribor or Libor rate.

On May 3, 2017 the Company completed a refinancing of its Senior debt with a syndicate of banks. All Senior debt as at the balance sheet date was repaid and replaced with new Senior Euro debt of €500.0 million and Senior USD debt of $610.0 million. Both are repayable on May 15, 2024, although the Senior USD debt requires a repayment of $6.1 million of principal each year until 2024, beginning May 15, 2018. The existing revolving credit facility was also replaced with a new €80.0 million facility, which is available until May 15, 2023 and will be utilized to support existing letters of credit and bank guarantees and certain other ancillary facilities outside of the Senior debt.

In order to match its underlying cash flows the Company has entered into a number of cross-currency interest rate swaps. In exchange for $610.0 million the Company has received €299.3 million and £226.7 million. The derivatives are designed to minimize the exposure to movements in foreign currency exchange rates and movements in interest rates. In exchange for receiving cash flows in USD matching the payments of principal and interest due under the Senior USD debt, the Company will pay fixed amounts of interest and principal on notional amounts of GBP and EUR. All of the USD to EUR swaps have been designated as a cash flow hedge whilst EUR to GBP swaps to the value of £187.6 million have been designated as a net investment hedge.

Concurrent to the refinancing, the Company through its indirect, wholly-owned subsidiary, Nomad Foods BondCo Plc, repaid the senior secured notes due 2020 and successfully completed a private offering of €400.0 million aggregate principal amount of 3.25% senior secured notes due May 15, 2024 (the “Notes”). Interest on the Notes has accrued from the date of issue, payable semi-annually in arrears on May 15 and November 15, commencing on November 15, 2017. Both the new Senior debt and the notes are guaranteed on a senior basis by the Company and certain subsidiaries thereof and are secured with equal ranking against certain assets of the Company. Eligible transaction costs of approximately €9.8 million have been capitalized as part of the refinancing and will be amortized over the life of the debt. As a consequence of the debt extinguishment, deferred borrowing costs relating to the old senior

debt of €15.7 million have been written off to the Statement of Profit or Loss in May 2017 (see Note 10).

On December 20, 2017 we further amended and restated our Senior Facilities Agreement to reprice our $610.0 million and €500.0 million term loan facilities. The margin was reduced by 50 basis points on the U.S. Dollar-denominated term loan and 25 basis points on the Euro-denominated term loan. There were no changes to the maturity dates of the term loan facilities as a result of this amendment. We also established a $50.0 million incremental term loan facility and a €58.0 million incremental term loan facility. These amendments were accounted for as a modification of the existing loan. On January 31, 2018, the $50.0 million incremental term loan facility was fully drawn and on February 9, 2018, the €58.0 million incremental term loan facility was fully drawn. Eligible transaction costs of approximately €2.5 million have been capitalized as part of this amendment and will be amortized over the life of the debt.

In addition to this the Company has a multicurrency revolving credit facility of €80.0 million. This facility is available until May 2023. As at December 31, 2017€14.0 million (December 31, 2016: €13.2 million) has been utilized for letters of credit, overdrafts, customer bonds and bank guarantees against the revolving credit facility.

Guarantees and secured assets

The Syndicate of lenders that finance the Company’s Senior debt, have security over the assets of the “Guarantor Group”. The Guarantor Group consists of those companies which individually have more than 5% of consolidated total assets or EBITDA (as defined in the Senior Facilities Agreement) of the Company and in total comprise more than 80% of consolidated total assets or EBITDA at any testing date.

In connection with its pension scheme, Findus Sverige AB, a 100% owned subsidiary, is required to obtain credit insurance with PRI Pensionsgaranti (“PRI”), a credit insurance company which provides insurance annually against the risk of a sponsoring company’s insolvency. In connection with such credit insurance, as at December 31, 2017 Findus Sverige AB has granted floating charges over certain assets in favor of PRI in an amount of SEK 300 million (€30.5 million) (December 31, 2016: €31.3 million) and Nomad Foods Limited has issued a parent guarantee to PRI which will not exceed SEK 495 million (€50.3 million) (December 31, 2016: €45.9 million) at any time and has an end date of March 31, 2019.

Capitalization of transaction costs

Fees paid on the establishment of loan facilities are recognized as transaction costs of the loan to the extent that it is probable that some or all of the facility will be drawn down. In this case, the fee is deferred until the draw-down occurs.

XML

Trade and other payables

12 Months Ended

Dec. 31, 2017

Subclassifications of assets, liabilities and equities [abstract]

Trade and other payables

Trade and other payables

	Successor	Successor
	Dec 31, 2017	Dec 31, 2016
Current liabilities	€m	€m
Trade payables	328.9	345.0
Accruals and deferred income	109.6	92.4
Social security and other taxes	18.2	19.3
Other payables	17.7	13.7
Finance lease obligations	—	0.6
Financial payables	3.1	1.7
Total current trade and other payables	477.5	472.7
Non-current liabilities
Finance lease obligations	—	1.0
Accruals and deferred income	1.8	—
Total non-current trade and other payables	1.8	1.0
Total trade and other payables	479.3	473.7

Finance lease obligations

The Company had no finance lease obligations for the year ended December 31, 2017.

	Future minimum lease payments		Interest		Present value of minimum lease payments
€m	Dec 31, 2017	Dec 31, 2016	Dec 31, 2017	Dec 31, 2016	Dec 31, 2017	Dec 31, 2016
Less than one year	—	0.7	—	0.1	—	0.6
Between one and five years	—	1.1	—	0.1	—	1.0
More than five years	—	—	—	—	—	—
	—	1.8	—	0.2	—	1.6

XML

Employee benefits

12 Months Ended

Dec. 31, 2017

Employee Benefits [Abstract]

Employee benefits

Employee benefits

The Company operates defined benefit pension plans in Germany, Italy, Sweden and Austria, as well as various defined contribution plans in other countries. All of these schemes were inherited from the Predecessor or acquired from the Findus Group.

i. Defined contribution plans

Successor

The total expense relating to defined contribution plans for the year ended December 31, 2017 was €8.5 million (year ended December 31, 2016: €9.6 million, €4.4 million for the nine months ended December 31, 2015, nil for the year ended March 31, 2015).

Predecessor

The total expense relating to defined contribution plans for the five months period ended May 31, 2015 was €2.4 million.

ii. Defined benefit plans

The Company operates partially funded defined benefit pension plans in Germany and Austria as well as unfunded plans in Sweden and Italy. In addition, an unfunded post-retirement medical plan is operated in Austria. In Germany and Italy long term service awards are in operation and various other countries provide other employee benefits.

	Successor	Successor
	Dec 31, 2017	Dec 31, 2016
	€m	€m
Total employee benefit obligations-Germany	117.5	121.8
Total employee benefit obligations-Sweden	59.8	56.7
Total employee benefit obligations-Italy	5.3	5.1
Total employee benefit obligations-Austria	2.8	4.2
Sub-total	185.4	187.8
Total net employee benefit obligations-other countries	3.0	3.1
Total net employee benefit obligations	188.4	190.9

The obligation of €3.0 million (December 31, 2016: €3.1 million) in respect of other countries is the aggregate of a number of different types of minor schemes, each one not being considered material individually or in aggregate. Consequently detailed disclosure of these schemes is not provided.

The amount included in the Statement of Financial Position arising from the Company’s obligations in respect of its defined benefit retirement plans and post-employment benefits is as follows:

Successor

	Defined benefit retirement plans		Post-employment medical benefits and other benefits	Total
December 31, 2017	€m		€m	€m
Present value of unfunded defined benefit obligations	65.7		4.9	70.6
Present value of funded defined benefit obligations	196.1		—	196.1
Subtotal present value of defined benefit obligations	261.8		4.9	266.7
Fair value of plan assets	(81.3	)	—	(81.3	)
Recognized liability for net defined benefit obligations	180.5		4.9	185.4

	Defined benefit retirement plans		Post-employment medical benefits and other benefits	Total
December 31, 2016	€m		€m	€m
Present value of unfunded defined benefit obligations	62.5		4.9	67.4
Present value of funded defined benefit obligations	200.2		—	200.2
Subtotal present value of defined benefit obligations	262.7		4.9	267.6
Fair value of plan assets	(79.8	)	—	(79.8	)
Recognized liability for net defined benefit obligations	182.9		4.9	187.8

Movements in recognized liability for net defined benefit obligations:

	Defined benefit retirement plans		Post-employment medical benefits and other benefits		Total
	€m		€m		€m
Opening balance January 1, 2017	182.9		4.9		187.8
Current service cost	4.1		(0.1	)	4.0
Interest cost	3.5		0.1		3.6
Actuarial gains	(2.9	)	—		(2.9	)
Contributions to plan	(0.5	)	—		(0.5	)
Benefits paid	(4.9	)	—		(4.9	)
Exchange adjustments	(1.7	)	—		(1.7	)
As at December 31, 2017	180.5		4.9		185.4
	Defined benefit retirement plans		Post-employment medical benefits and other benefits		Total
	€m		€m		€m
Opening balance January 1, 2016	159.4		5.7		165.1
Current service cost	3.9		(0.4	)	3.5
Interest cost	3.9		0.1		4.0
Actuarial losses	23.6		—		23.6
Contributions to plan	(0.5	)	—		(0.5	)
Benefits paid	(5.1	)	(0.3	)	(5.4	)
Exchange adjustments	(2.3	)	(0.2	)	(2.5	)
As at December 31, 2016	182.9		4.9		187.8

Movements in present value of defined benefit obligations:

	Defined benefit retirement plans		Post-employment medical benefits and other benefits		Total
	€m		€m		€m
Opening balance January 1, 2017	262.7		4.9		267.6
Current service cost	4.1		(0.1	)	4.0
Interest cost	4.9		0.1		5.0
Actuarial experience losses	0.5		—		0.5
Actuarial losses arising from changes in financial assumptions	1.5		—		1.5
Actuarial gains arising from changes in demographic assumptions	(3.0	)	—		(3.0	)
Contributions to plan	0.3		—		0.3
Benefits paid	(7.5	)	—		(7.5	)
Exchange adjustments	(1.7	)	—		(1.7	)
As at December 31, 2017	261.8		4.9		266.7
	Defined benefit retirement plans		Post-employment medical benefits and other benefits		Total
	€m		€m		€m
Opening balance January 1, 2016	238.3		5.7		244.0
Current service cost	3.9		(0.4	)	3.5
Interest cost	5.8		0.1		5.9
Actuarial experience gains	(0.3	)	—		(0.3	)
Actuarial losses arising from changes in financial assumptions	24.5		—		24.5
Contributions to plan	0.5		—		0.5
Benefits paid	(7.7	)	(0.3	)	(8.0	)
Exchange adjustments	(2.3	)	(0.2	)	(2.5	)
As at December 31, 2016	262.7		4.9		267.6

Movements in fair value of plan assets of defined benefit retirement plans:

	2017
	€m
Opening balance January 1, 2017	79.8
Interest income	1.4
Actuarial gains arising from the return on plan assets, excluding interest income	1.9
Contributions by employer	0.5
Contributions by members	0.3
Benefits paid	(2.6	)
As at December 31, 2017	81.3

	2016
	€m
Opening balance January 1, 2016	78.9
Interest income	1.9
Actuarial gains arising from the return on plan assets, excluding interest income	0.6
Contributions by employer	0.5
Contributions by members	0.5
Benefits paid	(2.6	)
As at December 31, 2016	79.8

Expense recognized in the Consolidated Statement of Profit or Loss:

	Defined benefit retirement plans	Post-employment medical benefits and other benefits		Total
	2017	2017		2017
	€m	€m		€m
Current service cost	4.1	(0.1	)	4.0
Interest cost	3.5	0.1		3.6
For the year ended December 31, 2017	7.6	—		7.6

	Defined benefit retirement plans	Post-employment medical benefits and other benefits		Total
	2016	2016		2016
	€m	€m		€m
Current service cost	3.9	(0.4	)	3.5
Interest cost	3.9	0.1		4.0
For the year ended December 31, 2016	7.8	(0.3	)	7.5

Current service cost is allocated between cost of sales and other operating expenses. Interest on net defined benefit obligation is disclosed in net financing costs.

Amount recognized in the Consolidated Statement of Comprehensive Income:

	Year ended December 31, 2017		Year ended December 31, 2016
	€m		€m
Actuarial experience losses/(gains)	0.5		(0.3	)
Actuarial losses arising from changes in financial assumptions	1.5		24.5
Actuarial gains arising from changes in demographic assumptions	(3.0	)	—
Actuarial gains arising from the return on plan assets, excluding interest income	(1.9	)	(0.6	)
Total actuarial (gains)/losses	(2.9	)	23.6
	2017		2016
	€m		€m
Cumulative amount of actuarial losses recognized in Consolidated Statement of Comprehensive Income	1.3		4.2

The fair value of plan assets, all at quoted prices are as follows:

	Dec 31, 2017	Dec 31, 2016
	€m	€m
Equities	17.4	15.1
Debt instruments	51.3	51.7
Property	8.9	9.6
Other	3.7	3.4
Total	81.3	79.8

	Defined benefit retirement plans								Post-employment medical benefits and other benefits
December 31, 2017	Germany		Sweden		Austria		Italy		Germany		Austria
Discount rate	1.95	%	2.4	%	2.2	%	1.2	%	1.15	%	0.9	%
Inflation rate	2.0	%	1.9	%	2.0	%	1.5	%	2.0	%	2.0	%
Rate of increase in salaries	2.8	%	2.25	%	3.0	%	—		2.8	%	3.0	%
Rate of increase for pensions in payment	1%-2%		2.25	%	1.7	%	—		—		—
Long term medical cost of inflation	—		—		—		—		—		2.0	%

	Defined benefit retirement plans								Post-employment medical benefits and other benefits
December 31, 2016	Germany		Sweden		Austria		Italy		Germany		Austria
Discount rate	1.8	%	2.5	%	1.0	%	1.5	%	1.2	%	1.0	%
Inflation rate	2.0	%	1.25	%	1.7	%	1.5	%	2.0	%	1.7	%
Rate of increase in salaries	2.5	%	2.25	%	3.0	%	—		2.5	%	3.0	%
Rate of increase for pensions in payment	1%-2%		2.25	%	1.7	%	—		—		—
Long term medical cost of inflation	—		—		—		—		—		2.0	%

In valuing the liabilities of the pension fund at December 31, 2017 and December 31, 2016, mortality assumptions have been made as indicated below. The assumptions relating to longevity underlying the pension liabilities at the financial year end date are based on standard actuarial mortality tables and include an allowance for future improvements in longevity. The assumptions are based on the following mortality tables:

• Germany: Richttafeln 2005

• Sweden: DUS 14 (2016: PRI)

• Austria: AVO 2008 P ANG

• Italy: RG48

These four references are to the specific standard rates of mortality that are published and widely used in each country for the use of actuarial assessment of pension liabilities and take account of local current and future average life expectancy.

December 31, 2017 (years)	Germany	Sweden	Austria	Italy
Retiring at the end of the year:
Male	20	22	21	20
Female	24	24	25	20

December 31, 2016 (years)	Germany	Sweden	Austria	Italy
Retiring at the end of the year:
Male	20	23	21	20
Female	24	25	25	24

The history of experience adjustments from inception of the Company for the defined benefit retirement plans is as follows:

	Dec 31, 2017		Dec 31, 2016		9 months ended December 31, 2015
	€m		€m		€m
Present value of defined benefit obligations	261.8		262.7		238.3
Fair value of plan assets	(81.3	)	(79.8	)	(78.9	)
Asset ceiling	—		—		—
Recognized liability in the scheme	180.5		182.9		159.4
Experience losses/(gains) on scheme liabilities	0.5		(0.3	)	(1.6	)
Experience (gains)/losses on scheme assets	(1.9	)	(0.6	)	0.5

Post-employment medical benefits- sensitivity analysis

The effect of a 1% movement in the assumed medical cost trend rate is not significant.

Defined benefit obligation- sensitivity analysis

The effect of a 1% movement in the discount rate for the year ended December 31, 2017 is as follows:

	Increase		Decrease
	€m		€m
Effect on the post-employment benefit obligation	(42.3	)	55.8

There are no deficit elimination plans for any of the defined benefit schemes. Expected contributions and payments to post-employment benefit plans for the period ending December 31, 2017 are €5.8 million (December 31, 2016: €5.7 million). The weighted average duration of the defined benefit obligations is 18.3 years.

XML

Provisions

12 Months Ended

Dec. 31, 2017

Other Provisions, Contingent Liabilities and Contingent Assets [Abstract]

Provisions

Provisions

Successor

	Restructuring		Onerous/ unfavorable contracts		Provisions related to other taxes		Contingent consideration		Other		Total
	€m		€m		€m		€m		€m		€m
Balance at December 31, 2015	21.0		—		31.8		17.4		16.5		86.7
Additional provision in the period	60.2		34.7		—		—		5.3		100.2
Release of provision	(5.2	)	—		(9.8	)	—		(2.6	)	(17.6	)
Adjustment to provisions acquired through business combinations	—		47.3		2.5		—		2.7		52.5
Utilization of provision	(16.7	)	(2.5	)	—		(8.0	)	(2.2	)	(29.4	)
Unwinding of discounting	—		0.8		—		0.6		—		1.4
Foreign exchange	(0.2	)	0.3		—		—		(0.2	)	(0.1	)
Balance at December 31, 2016	59.1		80.6		24.5		10.0		19.5		193.7
Additional provision in the period	30.9		—		5.8		—		6.6		43.3
Release of provision	(0.1	)	—		(12.2	)	—		(1.2	)	(13.5	)
Transfer between categories	—		—		(2.1	)	—		2.1		—
Utilization of provision	(63.6	)	(3.9	)	(5.8	)	—		(8.4	)	(81.7	)
Unwinding of discounting	—		0.8		—		0.4		—		1.2
Foreign exchange	—		(2.1	)	—		—		(0.1	)	(2.2	)
Balance at December 31, 2017	26.3		75.4		10.2		10.4		18.5		140.8
Current											68.0
Non-current											72.8
Total											140.8

Restructuring

The €26.3 million (2016: €59.1 million) provision relates to committed plans for certain restructuring activities of exceptional nature which are due to be completed within the next 18 months. A provision of €18.4 million has been recognized in the year ended December 31, 2017 for reorganizational activities arising from the implementation of Nomad's strategic vision across the Company. An additional provision of €12.5 million has been recognized in the year ended December 31, 2017 for restructuring costs associated with the closure of the facility in Bjuv where production has now ceased. The amounts have been provided based on the latest information available on the likely remaining expenditure required to complete the committed plans. €63.6 million has been utilized in the year ended December 31, 2017 which mainly relates to the closure of the production facilities in Bjuv as well as for reorganizational activities arising from the implementation of Nomad's strategic vision across the Company.

Onerous/unfavorable contracts

Of the onerous/unfavorable contracts provision, €72.5 million is held in relation to a lease in Bjuv, Sweden. The factory is now vacant and the Company currently anticipates the warehouse space will not be fully utilized by the Company or other third parties, so the lease has been identified as being onerous.

The ability for the Company to offset the unavoidable costs associated with the unutilized portion of the facility with future rental income is highly uncertain and difficult to accurately estimate. The provision has been assessed to be the best estimate of the net unavoidable costs based on the latest information available. This provision is frequently reassessed by management and may change significantly over time.

The provision is calculated using a discounted cash flow which is subject to a high level of estimation uncertainty. The most significant assumptions are the ability to sublease the facility, the Company’s own use of the facility, the discount rate and inflation. Of these, the ability to sublease the facility or a change to the Company’s usage of the facility are based on management’s best estimate and are a matter of judgment. The provision is highly sensitive to changes in these assumptions as changes can lead to either a material increase or decrease in the provision. The discount rate is based on the risk free rate in Sweden, estimated by management to be 1% (2016: 1%). The inflation rate is also assumed to be 1% (2016: 1%). A 0.5% change in either of these assumptions will increase or decrease the provision by up to 6%.

Furthermore, an independent valuation of the lease performed as part of the acquisition accounting for the November 2, 2015 acquisition of the Findus Group identified that the lease payments were in excess of market rates, deeming the contract to be unfavorable. This provision will be utilized over the duration of the lease.

The remaining provision of €2.9 million relates to a service contract covering the same warehouse facility.

Provisions relating to other taxes

The €10.2 million (2016: €24.5 million) provision relates to other taxes due to tax authorities after tax investigations within certain operating subsidiaries within the Nomad Group. Developments in the year have led to an additional €5.8 million provision being created which has been offset by a release of €12.2 million. €5.8 million was utilized in the year ended December 31, 2017 as a result of the conclusion of a legacy sales tax dispute.

Contingent consideration

As at December 31, 2017, the provision for contingent consideration comprised of €8.9 million and €1.5 million relating to the acquisition of La Cocinera and the Lutosa brand respectively.

During the year ended December 31, 2017, a €0.4 million charge has been recognized relating to the unwinding of discounting on deferred consideration for the La Cocinera acquisition which occurred in Spain in April 2015. The consideration payable is dependent on specific future events and performance conditions being met. The payment is deferred until April 2020 but must be paid earlier if certain decisions are made by the Company. There was negligible movement on the contingent consideration provided for the Lutosa brand (under license until 2020), which was acquired in Belgium in 2014 and payable in 2019.

Other

Other provisions include €5.6 million (2016: €6.1 million) of potential obligations in Italy, €3.1 million (€3.2 million) for asset retirement obligations recognized as part of the Findus acquisition, €2.7 million (2016: €2.8 million) professional fees in respect of the above mentioned tax investigations and other obligations from previous accounting periods.

XML

Share capital and reserves

12 Months Ended

Dec. 31, 2017

Share Capital, Reserves and Other Equity Interest [Abstract]

Share capital and reserves

Share capital and reserves

Share capital and capital reserve

	As at Dec 31, 2017		As at Dec 31, 2016
	€m		€m
Authorized:
Unlimited number of Ordinary Shares with nil nominal value issued at $10.00 per share	n/a		n/a
Unlimited number of Founder Preferred Shares with nil nominal value issued at $10 per share	n/a		n/a
Issued and fully paid:
165,291,546 (December 31, 2016: 182,088,622) Ordinary Shares with nil nominal value	1,626.9		1,803.4
1,500,000 (December 31, 2016: 1,500,000) Founder Preferred Shares with nil nominal value	10.6		10.6
Total share capital and capital reserve	1,637.5		1,814.0
Listing and share transaction costs	(13.8	)	(13.3	)
Total net share capital and capital reserve	1,623.7		1,800.7

Ordinary Shares

	Issued and Repurchased Ordinary shares  (in millions)
Balance at December 31, 2015	178.4
Shares issued in the period	3.7
Balance at December 31, 2016	182.1
Shares issued in the year	—
Shares repurchased and canceled in the year	(16.8	)
Balance at December 31, 2017	165.3

The Company issued 121.5 million Ordinary Shares between April 1, 2015 and September 30, 2015. Of these, 13.7 million were issued as a partial non-cash consideration for the acquisition of the Iglo Group on June 1, 2015, 75.7 million were issued through a private placement on May 26, 2015 and a further 15.4 million were issued through a subsequent private placement on July 8, 2015. 16.7 million Ordinary Shares were issued from the early exercise of warrants.

On November 2, 2015 Nomad issued 8.4 million shares as a partial non-cash consideration for the acquisition of Findus Sverige AB and its subsidiaries. 

On November 27, 2015, the Company issued a further 13,104 shares to key management employees acquired through a bonus issue scheme.

On January 12, 2016, the Company issued a share dividend of 3.6 million Ordinary Shares (the “Founder Preferred Share Dividend”) pursuant to the terms of the outstanding founder preferred shares of the Company (the “Founder Preferred Shares”). See the ‘Founder Preferred Shares’ section of this note below for additional information.

In July 2016, the Company issued 23,212 Ordinary Shares in settlement of the Non-Executive Directors restricted share awards. These shares, granted at a share price of $11.50 on December 7, 2015, vested on June 16, 2016 and were issued in July at a share price of $8.98. Of the total 34,780 number of shares vesting, 11,568 shares were held back from issue by the Company as settlement towards personal tax liabilities arising on the vested shares. Following this issuance, the Company had 182,088,622 Ordinary Shares outstanding.

In June 2017, the Company issued 46,296 Ordinary Shares in settlement of the Non-Executive Directors restricted share awards. These shares, granted at a share price of $8.98 on June 16, 2016, vested on June 19, 2017 and were issued at a share price of $14.38. Of the total 55,680 number of shares vesting, 9,384 shares were held back from issue by the Company as settlement towards personal tax liabilities arising on the vested shares.

On June 12, 2017, the Company entered into an agreement to repurchase 9,779,729 of its shares beneficially owned by funds advised by Permira Advisers LLP ("Permira") at a purchase price of $10.75 per share, which was a 25% discount to the closing price of Nomad Foods ordinary shares on June 9, 2017. The aggregate purchase price of approximately $105.1 million (€93.9 million) was funded from the Company's cash on hand and the shares were retired on June 12, 2017. The transaction related to a final settlement of indemnity claims against an affiliate of Permira, which are legacy tax matters that predate the Company's acquisition of the Iglo Group in 2015.

On September 11, 2017, the Company entered into an agreement to repurchase 7,063,643 shares of 33,333,334 ordinary shares being sold in an underwritten secondary public offering by selling Shareholders, Pershing Square Capital Management, L.P. (“Pershing Square”), at a per-share purchase price equal to $14.16 per ordinary share. As such, 26,269,691 ordinary shares of the 33,333,334 ordinary shares sold by the Selling Shareholders were sold to the public. The Company did not sell any ordinary shares in the offering and did not receive any of the proceeds from the offering. The aggregate purchase price of approximately $100.0 million (€83.2 million) was funded from the Company's cash on hand and the repurchased shares were retired on September 11, 2017. As part of the transaction, the Company incurred €0.5 million of fees, which were recognized directly within Capital reserve.

Following the issuance and subsequent repurchases of shares in 2017, the Company had 165,291,546 Ordinary Shares outstanding.

Listing and share transaction costs

As at December 31, 2017, listing and share transaction costs, which includes the total cost of admission and share issuance expenses on initial public offering, as well as costs associated with share repurchases was €13.8 million and are disclosed as a deduction directly against the capital reserve.

	€m
At December 31, 2015	13.3
Placement fees	—
At December 31, 2016	13.3
Share transaction costs	0.5
At December 31, 2017	13.8

Founder Preferred Shares Annual Dividend Amount and Warrant Redemption Amount

Nomad’s issued Founder Preferred Share capital consists of 1,500,000 Founder Preferred Shares. There are no Founder Preferred Shares held in Treasury. Founder Preferred Shares confer upon the holder the following:

1. the right to one vote per Founder Preferred Share on all matters to be voted on by shareholders generally and vote together with the holders of ordinary shares;

2. commencing on January 1, 2015 and for each financial year thereafter:

a. once the average price per ordinary share for the Dividend Determination Period, ie. the last ten consecutive trading days of a year is at least $11.50 (which condition has been satisfied for the year ended December 31, 2015), the right to receive a Founder Preferred Shares Annual Dividend Amount (as more fully described below), payable in Ordinary Shares or cash, at the Company’s sole option; and

b. the right to receive dividends and other distributions as may be declared from time to time by the Company’s board of directors with respect to the Ordinary Shares (such dividends to be distributed among the holders of Founder Preferred Shares, as if for such purpose the Founder Preferred Shares had been converted into Ordinary Shares immediately prior to such distribution) plus an amount equal to 20% of the dividend which would be distributable on such number of Ordinary Shares equal to the Preferred Share Dividend Equivalent (as defined below); and

3. in addition to amounts payable pursuant to clause 2 above, the right, together with the holders of Ordinary Shares, to receive such portion of all amounts available for distribution and from time to time distributed by way of dividend or otherwise at such time as determined by the Directors; and

4. the right to an equal share (with the holders of Ordinary Shares on a share for share basis) in the distribution of the surplus assets of Nomad on its liquidation as are attributable to the Founder Preferred Shares; and

5. the ability to convert into Ordinary Shares on a 1-for-1 basis (mandatorily upon a Change of Control or the seventh full financial year after an acquisition).

On January 12, 2016 the Company’s Board of Directors approved a share dividend to the Founder Entities of an aggregate of 3,620,510 Ordinary Shares pursuant to the terms of the outstanding Founder Preferred Shares of the Company at a Dividend Price of $11.4824. Because the average price per Ordinary Share was at least $11.50 for the last ten consecutive trading days of 2015, the holders of the Founder Preferred Shares were entitled to receive the Founder Preferred Share Annual Dividend Amount.

No Founder Preferred Shares Annual Dividend Amount was due as at December 31, 2016 as the average price per ordinary share for the last ten consecutive trading days of the year did not reach the 2015 Dividend Price of $11.482.

On December 29, 2017, the Company’s Board of Directors approved a share dividend of an aggregate of 8,705,890 ordinary shares calculated as 20% of the increase in the market price of our ordinary shares compared to 2015 dividend price of $11.4824 multiplied by Preferred Share Dividend Equivalent. The Dividend Price used to calculate the Annual Dividend Amount was $16.6516 (calculated based upon the volume weighted average price for the last ten consecutive trading days of 2017) and the ordinary shares underlying the Founder Preferred Share Dividend were issued on January 2, 2018.

See Note 27 for further information.

Warrants

On April 11, 2014 in conjunction with its initial public offering, Nomad issued an aggregate 50,000,000 Warrants to purchasers of both its Ordinary and Founder Preferred Shares. In addition, 75,000 Warrants in aggregate were issued to Non-Executive directors as part of their appointment as directors. Each Warrant entitled its holder to subscribe for one-third of an ordinary share upon exercise (subject to any prior adjustment in accordance with the terms and conditions set out in the Warrant Instrument). Warrant holders were required therefore (subject to any prior adjustment) to hold and validly exercise three Warrants and pay $11.50 per Ordinary Share in order to receive one Ordinary Share.

The Warrants were also subject to mandatory redemption at $0.01 per Warrant if at any time the volume-weighted average price per ordinary share equaled or exceeded $18.00 (subject to any prior adjustment in accordance with the terms and conditions set out in the Warrant Instrument) for a period of ten consecutive trading days.

On May 6, 2015 In connection with the Iglo acquisition, the Company obtained the consent of over 75% of the holders of outstanding Warrants to an amendment to the terms of the Warrants in order to provide that the subscription period for the Warrants, which previously would have expired on the third anniversary of the Company’s consummation of its first acquisition, would instead expire on the consummation of the Iglo Group acquisition (except in certain limited circumstances, in which case, such holder will be permitted to exercise his, her or its Warrants until the date that is 30 days following the date of Readmission). The Warrant Amendment was thereby effective on May 6, 2015.

The remaining warrants that were issued by the Company in conjunction with its initial public offering in April 2014 were redeemed in the nine months ended December 31, 2015 and a credit of €0.4 million was recognized in the Consolidated Statement of Profit or Loss.

XML

Share-based compensation reserve

12 Months Ended

Dec. 31, 2017

Share Capital, Reserves and Other Equity Interest [Abstract]

Share-based compensation reserve

Share-based compensation reserve

Successor

The Company's discretionary share award scheme, the LTIP, enables the Company’s Compensation Committee to make grants (“Awards”) in the form of rights over ordinary shares, to any Director, Non-Executive Director or employee of the Company. However, it is the Committee’s current intention that Awards be granted only to Directors and senior management, whilst recognizing a separate annual Restricted Stock Award for Non-Executive Directors.

All Awards are to be settled by physical delivery of shares. Note 8b sets out the Non-Executive Director and Director and Senior Management Restricted share awards.

Non-Executive Director Restricted Share Awards

The Non-Executive Directors restricted share awards, granted at a share price of $11.50 on December 7, 2015, vested on June 16, 2016 and 23,212 ordinary shares were issued in July at a share price of $8.98, resulting in a €0.3 million reduction in the share based compensation reserve for the year ended December 31, 2016.

The Non-Executive Directors restricted share awards granted at a share price of $8.98 on June 16, 2016 vested on June 19, 2017 and were issued at a share price of $14.38, resulting in a €0.3 million increase in the share based compensation reserve. Of the total 55,680 number of shares vesting, 9,384 shares were held back from issue by the Company as settlement towards personal tax liabilities arising on the vested shares for the year ended December 31, 2017.

On June 19, 2017, current Non-Executive Directors were granted 41,724 restricted share awards at a share price of $14.38. On August 22, 2017, two new Non-Executive Directors were granted a pro-rata 11,774 restricted share awards at the same share price and vesting conditions as the previous grant.

The total charge within the Statement of Consolidated Profit or Loss for the year ended December 31, 2017 for Non-Executive Director stock compensation awards was €0.8 million and €0.6 million for the year ended December 31, 2016. The Director and senior management stock compensation charge reported within the Consolidated Statement of Profit or Loss for the year ended December 31, 2017 was €1.8 million (year ended December 31, 2016: €0.6 million).

	Share based compensation reserve
	€m
Balance as of January 1, 2017	1.0
Non-Executive Director restricted share awards charge	0.8
Directors and Senior Management share awards charge	1.8
Vesting of Non-Executive Director restricted shares	(0.7	)
Balance as of December 31, 2017	2.9

Founder Preferred Shares Dividend Reserve

Nomad has issued Founder Preferred Shares to its Founder Entities. A summary of the key terms of the Founder Preferred Shares is set out in Note 25.

The Founder Preferred Shares Annual Dividend Amount is structured to provide a dividend based on the future appreciation of the market value of the ordinary shares, thus aligning the interests of the Founders with those of the investors on a long term basis. Commencing in 2015, the Founder Preferred Share Annual Dividend Amount became payable because the Company’s volume weighted average ordinary share price was above $11.50 for the last ten consecutive trading days of the 2015 financial year.

Accordingly, the conditions of the Founder Preferred Shares Annual Dividend Amount for 2015 were met. On January 12, 2016, the Company's Board of Directors approved a share dividend (the “Founder Preferred Share Dividend”) of an aggregate of 3,620,510 ordinary shares calculated as 20% of the increase in the market price of our ordinary shares compared to the initial public offering price of $10.00 multiplied by 140,220,619 (the “Preferred Share Dividend Equivalent”). The Preferred Share Dividend Equivalent is equal to the number of ordinary shares outstanding immediately following the Iglo Acquisition, but excluding the 13.7 million ordinary shares issued to the seller of the Iglo Group. The dividend price (“Dividend Price”) used to calculate the Annual Dividend Amount was $11.4824 (calculated based upon the volume weighted average price for the last ten consecutive trading days of 2015) and the ordinary shares underlying the Founder Preferred Share Dividend were issued on January 12, 2016.

The conditions of the Founder Preferred Shares Annual Dividend Amount for 2016 were not met and consequently no Founder Preferred Share Dividend was approved for issue.

The conditions of the Founder Preferred Shares Annual Dividend Amount for 2017 were met. On December 29, 2017, the Company’s Board of Directors approved a share dividend of an aggregate of 8,705,890 ordinary shares calculated as 20% of the increase in the market price of our ordinary shares compared to 2015 dividend price of $11.4824 multiplied by Preferred Share Dividend Equivalent. The Dividend Price used to calculate the Annual Dividend Amount was $16.6516 (calculated based upon the volume weighted average price for the last ten consecutive trading days of 2017) and the ordinary shares underlying the Founder Preferred Share Dividend were issued on January 2, 2018.

In future years, the Preferred Shares Annual Dividend amount will be determined with reference to the Dividend Determination Period of a financial year, ie the last ten consecutive trading days and calculated as 20% of the increase in the volume weighted average share price of our ordinary shares across the determination period compared to the highest price previously used in calculating the Founder Preferred Share Annual Dividend Amounts multiplied by the Annual Dividend Amount (currently $16.6516). The Founder Preferred Shares Annual Dividend Amount is paid for so long as the Founder Preferred Shares remain outstanding. The Founder Preferred Shares automatically convert on the last day of the seventh full financial year following completion of the acquisition of the Iglo Group or upon a change of control, unless in the case of a change of control, the independent Directors determine otherwise.

The amounts used for the purposes of calculating the Founder Preferred Shares Annual Dividend Amount and the relevant numbers of ordinary shares are subject to such adjustments for share splits, share dividends and certain other recapitalization events as the Directors in their absolute discretion determine to be fair and reasonable in the event of a consolidation or sub-division of the ordinary shares in issue, as determined in accordance with Nomad Foods’ Memorandum and Articles of Association.

Dividends on the Founder Preferred Shares are payable until the Founder Preferred Shares are converted into Ordinary Shares. The Founder Preferred Shares automatically convert on a one for one basis (i) on the last day of the seventh full financial year following our acquisition of Iglo Foods (or if such day is not a trading day, the next trading day) or (ii) in the event of a change of control (unless the independent directors of our board of directors determine otherwise). The holders of Founder Preferred Shares may also be converted to Ordinary shares on a one for one basis at the option of the holder. In the event of an automatic conversion, a dividend on the Founder Preferred Shares shall be payable with respect to the shorted dividend year on the trading day immediately prior to the conversion. In the event of an optional conversion by the holder, no dividend on the Founder Preferred Shares shall be payable with respect to the year in which the conversion occurred.

	Founder Preferred Shares Dividend Reserve
	€m
Balance as of January 1, 2017	493.4
Settlement of dividend through share issue	—
Balance as of December 31, 2017	493.4

Prior to June 1, 2015 the Founder Preferred Shares Annual Dividend Amounts were valued and recognized as a liability under IFRS 2. The fair value of the liability at each balance sheet date was valued using a Monte Carlo simulation and any difference in fair value was recorded as an expense through the Consolidated Statement of Profit or Loss. An expense of €349 million was recognized for the nine months ended December 31, 2015 (€165.8 million for the year ended March 31, 2015).

Upon completion of the acquisition of the Iglo Group on June 1, 2015, the Company intended that the Founder Preferred Shares Annual Dividend Amount would be equity settled. Accordingly, the Founder Preferred Shares Annual Dividend Amount as of June 1, 2015 of €531.5 million (the “Founder Preferred Shares Dividend reserve”) was classified as equity and no further revaluations will be required or recorded.

Translation reserve

The translation reserve comprises all foreign exchange differences arising from the translation of the financial statements of foreign operations, as well as from the translation of liabilities that hedge the Company’s net investment in a foreign subsidiary.

Cash flow hedging reserve

The hedging reserve comprises the effective portion of the cumulative net change in the fair value of cash flow hedging instruments related to hedged transactions that have not yet occurred. The reserve relating to forward currency contracts will be reclassified to the Statement of Profit or Loss within 12 months whilst the reserve relating to the cross currency interest rate swaps will be reclassified over the life of the instruments.

The table below shows the movement in the cash flow hedging reserve during the year or period, including the gains or losses arising on the revaluation of hedging instruments during the year or period and the amount reclassified from other comprehensive income to the Consolidated Statement of Profit or Loss in the year.

	Successor		Successor		Successor	Successor	Predecessor
	Year ended December 31, 2017		Year ended December 31, 2016		9 months ended December 31, 2015	Year ended March 31, 2015	5 months ended May 31, 2015
	€m		€m		€m	€m	€m
(Losses)/gains arising in the revaluation of hedge instruments	(76.5	)	14.2		1.6	—	—
Less: Gains/(losses) reclassified to the Consolidated Statement of Profit or Loss	60.1		(4.1	)	—	—	—
Total	(16.4	)	10.1		1.6	—	—

XML

Founder Preferred Shares Dividend Reserve

12 Months Ended

Dec. 31, 2017

Share Capital, Reserves and Other Equity Interest [Abstract]

Translation reserve

Share-based compensation reserve

Successor

The Company's discretionary share award scheme, the LTIP, enables the Company’s Compensation Committee to make grants (“Awards”) in the form of rights over ordinary shares, to any Director, Non-Executive Director or employee of the Company. However, it is the Committee’s current intention that Awards be granted only to Directors and senior management, whilst recognizing a separate annual Restricted Stock Award for Non-Executive Directors.

All Awards are to be settled by physical delivery of shares. Note 8b sets out the Non-Executive Director and Director and Senior Management Restricted share awards.

Non-Executive Director Restricted Share Awards

The Non-Executive Directors restricted share awards, granted at a share price of $11.50 on December 7, 2015, vested on June 16, 2016 and 23,212 ordinary shares were issued in July at a share price of $8.98, resulting in a €0.3 million reduction in the share based compensation reserve for the year ended December 31, 2016.

The Non-Executive Directors restricted share awards granted at a share price of $8.98 on June 16, 2016 vested on June 19, 2017 and were issued at a share price of $14.38, resulting in a €0.3 million increase in the share based compensation reserve. Of the total 55,680 number of shares vesting, 9,384 shares were held back from issue by the Company as settlement towards personal tax liabilities arising on the vested shares for the year ended December 31, 2017.

On June 19, 2017, current Non-Executive Directors were granted 41,724 restricted share awards at a share price of $14.38. On August 22, 2017, two new Non-Executive Directors were granted a pro-rata 11,774 restricted share awards at the same share price and vesting conditions as the previous grant.

The total charge within the Statement of Consolidated Profit or Loss for the year ended December 31, 2017 for Non-Executive Director stock compensation awards was €0.8 million and €0.6 million for the year ended December 31, 2016. The Director and senior management stock compensation charge reported within the Consolidated Statement of Profit or Loss for the year ended December 31, 2017 was €1.8 million (year ended December 31, 2016: €0.6 million).

	Share based compensation reserve
	€m
Balance as of January 1, 2017	1.0
Non-Executive Director restricted share awards charge	0.8
Directors and Senior Management share awards charge	1.8
Vesting of Non-Executive Director restricted shares	(0.7	)
Balance as of December 31, 2017	2.9

Founder Preferred Shares Dividend Reserve

Nomad has issued Founder Preferred Shares to its Founder Entities. A summary of the key terms of the Founder Preferred Shares is set out in Note 25.

The Founder Preferred Shares Annual Dividend Amount is structured to provide a dividend based on the future appreciation of the market value of the ordinary shares, thus aligning the interests of the Founders with those of the investors on a long term basis. Commencing in 2015, the Founder Preferred Share Annual Dividend Amount became payable because the Company’s volume weighted average ordinary share price was above $11.50 for the last ten consecutive trading days of the 2015 financial year.

Accordingly, the conditions of the Founder Preferred Shares Annual Dividend Amount for 2015 were met. On January 12, 2016, the Company's Board of Directors approved a share dividend (the “Founder Preferred Share Dividend”) of an aggregate of 3,620,510 ordinary shares calculated as 20% of the increase in the market price of our ordinary shares compared to the initial public offering price of $10.00 multiplied by 140,220,619 (the “Preferred Share Dividend Equivalent”). The Preferred Share Dividend Equivalent is equal to the number of ordinary shares outstanding immediately following the Iglo Acquisition, but excluding the 13.7 million ordinary shares issued to the seller of the Iglo Group. The dividend price (“Dividend Price”) used to calculate the Annual Dividend Amount was $11.4824 (calculated based upon the volume weighted average price for the last ten consecutive trading days of 2015) and the ordinary shares underlying the Founder Preferred Share Dividend were issued on January 12, 2016.

The conditions of the Founder Preferred Shares Annual Dividend Amount for 2016 were not met and consequently no Founder Preferred Share Dividend was approved for issue.

The conditions of the Founder Preferred Shares Annual Dividend Amount for 2017 were met. On December 29, 2017, the Company’s Board of Directors approved a share dividend of an aggregate of 8,705,890 ordinary shares calculated as 20% of the increase in the market price of our ordinary shares compared to 2015 dividend price of $11.4824 multiplied by Preferred Share Dividend Equivalent. The Dividend Price used to calculate the Annual Dividend Amount was $16.6516 (calculated based upon the volume weighted average price for the last ten consecutive trading days of 2017) and the ordinary shares underlying the Founder Preferred Share Dividend were issued on January 2, 2018.

In future years, the Preferred Shares Annual Dividend amount will be determined with reference to the Dividend Determination Period of a financial year, ie the last ten consecutive trading days and calculated as 20% of the increase in the volume weighted average share price of our ordinary shares across the determination period compared to the highest price previously used in calculating the Founder Preferred Share Annual Dividend Amounts multiplied by the Annual Dividend Amount (currently $16.6516). The Founder Preferred Shares Annual Dividend Amount is paid for so long as the Founder Preferred Shares remain outstanding. The Founder Preferred Shares automatically convert on the last day of the seventh full financial year following completion of the acquisition of the Iglo Group or upon a change of control, unless in the case of a change of control, the independent Directors determine otherwise.

The amounts used for the purposes of calculating the Founder Preferred Shares Annual Dividend Amount and the relevant numbers of ordinary shares are subject to such adjustments for share splits, share dividends and certain other recapitalization events as the Directors in their absolute discretion determine to be fair and reasonable in the event of a consolidation or sub-division of the ordinary shares in issue, as determined in accordance with Nomad Foods’ Memorandum and Articles of Association.

Dividends on the Founder Preferred Shares are payable until the Founder Preferred Shares are converted into Ordinary Shares. The Founder Preferred Shares automatically convert on a one for one basis (i) on the last day of the seventh full financial year following our acquisition of Iglo Foods (or if such day is not a trading day, the next trading day) or (ii) in the event of a change of control (unless the independent directors of our board of directors determine otherwise). The holders of Founder Preferred Shares may also be converted to Ordinary shares on a one for one basis at the option of the holder. In the event of an automatic conversion, a dividend on the Founder Preferred Shares shall be payable with respect to the shorted dividend year on the trading day immediately prior to the conversion. In the event of an optional conversion by the holder, no dividend on the Founder Preferred Shares shall be payable with respect to the year in which the conversion occurred.

	Founder Preferred Shares Dividend Reserve
	€m
Balance as of January 1, 2017	493.4
Settlement of dividend through share issue	—
Balance as of December 31, 2017	493.4

Prior to June 1, 2015 the Founder Preferred Shares Annual Dividend Amounts were valued and recognized as a liability under IFRS 2. The fair value of the liability at each balance sheet date was valued using a Monte Carlo simulation and any difference in fair value was recorded as an expense through the Consolidated Statement of Profit or Loss. An expense of €349 million was recognized for the nine months ended December 31, 2015 (€165.8 million for the year ended March 31, 2015).

Upon completion of the acquisition of the Iglo Group on June 1, 2015, the Company intended that the Founder Preferred Shares Annual Dividend Amount would be equity settled. Accordingly, the Founder Preferred Shares Annual Dividend Amount as of June 1, 2015 of €531.5 million (the “Founder Preferred Shares Dividend reserve”) was classified as equity and no further revaluations will be required or recorded.

Translation reserve

The translation reserve comprises all foreign exchange differences arising from the translation of the financial statements of foreign operations, as well as from the translation of liabilities that hedge the Company’s net investment in a foreign subsidiary.

Cash flow hedging reserve

The hedging reserve comprises the effective portion of the cumulative net change in the fair value of cash flow hedging instruments related to hedged transactions that have not yet occurred. The reserve relating to forward currency contracts will be reclassified to the Statement of Profit or Loss within 12 months whilst the reserve relating to the cross currency interest rate swaps will be reclassified over the life of the instruments.

The table below shows the movement in the cash flow hedging reserve during the year or period, including the gains or losses arising on the revaluation of hedging instruments during the year or period and the amount reclassified from other comprehensive income to the Consolidated Statement of Profit or Loss in the year.

	Successor		Successor		Successor	Successor	Predecessor
	Year ended December 31, 2017		Year ended December 31, 2016		9 months ended December 31, 2015	Year ended March 31, 2015	5 months ended May 31, 2015
	€m		€m		€m	€m	€m
(Losses)/gains arising in the revaluation of hedge instruments	(76.5	)	14.2		1.6	—	—
Less: Gains/(losses) reclassified to the Consolidated Statement of Profit or Loss	60.1		(4.1	)	—	—	—
Total	(16.4	)	10.1		1.6	—	—

XML

Translation reserve

12 Months Ended

Dec. 31, 2017

Share Capital, Reserves and Other Equity Interest [Abstract]

Translation reserve

Share-based compensation reserve

Successor

The Company's discretionary share award scheme, the LTIP, enables the Company’s Compensation Committee to make grants (“Awards”) in the form of rights over ordinary shares, to any Director, Non-Executive Director or employee of the Company. However, it is the Committee’s current intention that Awards be granted only to Directors and senior management, whilst recognizing a separate annual Restricted Stock Award for Non-Executive Directors.

All Awards are to be settled by physical delivery of shares. Note 8b sets out the Non-Executive Director and Director and Senior Management Restricted share awards.

Non-Executive Director Restricted Share Awards

The Non-Executive Directors restricted share awards, granted at a share price of $11.50 on December 7, 2015, vested on June 16, 2016 and 23,212 ordinary shares were issued in July at a share price of $8.98, resulting in a €0.3 million reduction in the share based compensation reserve for the year ended December 31, 2016.

The Non-Executive Directors restricted share awards granted at a share price of $8.98 on June 16, 2016 vested on June 19, 2017 and were issued at a share price of $14.38, resulting in a €0.3 million increase in the share based compensation reserve. Of the total 55,680 number of shares vesting, 9,384 shares were held back from issue by the Company as settlement towards personal tax liabilities arising on the vested shares for the year ended December 31, 2017.

On June 19, 2017, current Non-Executive Directors were granted 41,724 restricted share awards at a share price of $14.38. On August 22, 2017, two new Non-Executive Directors were granted a pro-rata 11,774 restricted share awards at the same share price and vesting conditions as the previous grant.

The total charge within the Statement of Consolidated Profit or Loss for the year ended December 31, 2017 for Non-Executive Director stock compensation awards was €0.8 million and €0.6 million for the year ended December 31, 2016. The Director and senior management stock compensation charge reported within the Consolidated Statement of Profit or Loss for the year ended December 31, 2017 was €1.8 million (year ended December 31, 2016: €0.6 million).

	Share based compensation reserve
	€m
Balance as of January 1, 2017	1.0
Non-Executive Director restricted share awards charge	0.8
Directors and Senior Management share awards charge	1.8
Vesting of Non-Executive Director restricted shares	(0.7	)
Balance as of December 31, 2017	2.9

Founder Preferred Shares Dividend Reserve

Nomad has issued Founder Preferred Shares to its Founder Entities. A summary of the key terms of the Founder Preferred Shares is set out in Note 25.

The Founder Preferred Shares Annual Dividend Amount is structured to provide a dividend based on the future appreciation of the market value of the ordinary shares, thus aligning the interests of the Founders with those of the investors on a long term basis. Commencing in 2015, the Founder Preferred Share Annual Dividend Amount became payable because the Company’s volume weighted average ordinary share price was above $11.50 for the last ten consecutive trading days of the 2015 financial year.

Accordingly, the conditions of the Founder Preferred Shares Annual Dividend Amount for 2015 were met. On January 12, 2016, the Company's Board of Directors approved a share dividend (the “Founder Preferred Share Dividend”) of an aggregate of 3,620,510 ordinary shares calculated as 20% of the increase in the market price of our ordinary shares compared to the initial public offering price of $10.00 multiplied by 140,220,619 (the “Preferred Share Dividend Equivalent”). The Preferred Share Dividend Equivalent is equal to the number of ordinary shares outstanding immediately following the Iglo Acquisition, but excluding the 13.7 million ordinary shares issued to the seller of the Iglo Group. The dividend price (“Dividend Price”) used to calculate the Annual Dividend Amount was $11.4824 (calculated based upon the volume weighted average price for the last ten consecutive trading days of 2015) and the ordinary shares underlying the Founder Preferred Share Dividend were issued on January 12, 2016.

The conditions of the Founder Preferred Shares Annual Dividend Amount for 2016 were not met and consequently no Founder Preferred Share Dividend was approved for issue.

The conditions of the Founder Preferred Shares Annual Dividend Amount for 2017 were met. On December 29, 2017, the Company’s Board of Directors approved a share dividend of an aggregate of 8,705,890 ordinary shares calculated as 20% of the increase in the market price of our ordinary shares compared to 2015 dividend price of $11.4824 multiplied by Preferred Share Dividend Equivalent. The Dividend Price used to calculate the Annual Dividend Amount was $16.6516 (calculated based upon the volume weighted average price for the last ten consecutive trading days of 2017) and the ordinary shares underlying the Founder Preferred Share Dividend were issued on January 2, 2018.

In future years, the Preferred Shares Annual Dividend amount will be determined with reference to the Dividend Determination Period of a financial year, ie the last ten consecutive trading days and calculated as 20% of the increase in the volume weighted average share price of our ordinary shares across the determination period compared to the highest price previously used in calculating the Founder Preferred Share Annual Dividend Amounts multiplied by the Annual Dividend Amount (currently $16.6516). The Founder Preferred Shares Annual Dividend Amount is paid for so long as the Founder Preferred Shares remain outstanding. The Founder Preferred Shares automatically convert on the last day of the seventh full financial year following completion of the acquisition of the Iglo Group or upon a change of control, unless in the case of a change of control, the independent Directors determine otherwise.

The amounts used for the purposes of calculating the Founder Preferred Shares Annual Dividend Amount and the relevant numbers of ordinary shares are subject to such adjustments for share splits, share dividends and certain other recapitalization events as the Directors in their absolute discretion determine to be fair and reasonable in the event of a consolidation or sub-division of the ordinary shares in issue, as determined in accordance with Nomad Foods’ Memorandum and Articles of Association.

Dividends on the Founder Preferred Shares are payable until the Founder Preferred Shares are converted into Ordinary Shares. The Founder Preferred Shares automatically convert on a one for one basis (i) on the last day of the seventh full financial year following our acquisition of Iglo Foods (or if such day is not a trading day, the next trading day) or (ii) in the event of a change of control (unless the independent directors of our board of directors determine otherwise). The holders of Founder Preferred Shares may also be converted to Ordinary shares on a one for one basis at the option of the holder. In the event of an automatic conversion, a dividend on the Founder Preferred Shares shall be payable with respect to the shorted dividend year on the trading day immediately prior to the conversion. In the event of an optional conversion by the holder, no dividend on the Founder Preferred Shares shall be payable with respect to the year in which the conversion occurred.

	Founder Preferred Shares Dividend Reserve
	€m
Balance as of January 1, 2017	493.4
Settlement of dividend through share issue	—
Balance as of December 31, 2017	493.4

Prior to June 1, 2015 the Founder Preferred Shares Annual Dividend Amounts were valued and recognized as a liability under IFRS 2. The fair value of the liability at each balance sheet date was valued using a Monte Carlo simulation and any difference in fair value was recorded as an expense through the Consolidated Statement of Profit or Loss. An expense of €349 million was recognized for the nine months ended December 31, 2015 (€165.8 million for the year ended March 31, 2015).

Upon completion of the acquisition of the Iglo Group on June 1, 2015, the Company intended that the Founder Preferred Shares Annual Dividend Amount would be equity settled. Accordingly, the Founder Preferred Shares Annual Dividend Amount as of June 1, 2015 of €531.5 million (the “Founder Preferred Shares Dividend reserve”) was classified as equity and no further revaluations will be required or recorded.

Translation reserve

The translation reserve comprises all foreign exchange differences arising from the translation of the financial statements of foreign operations, as well as from the translation of liabilities that hedge the Company’s net investment in a foreign subsidiary.

Cash flow hedging reserve

The hedging reserve comprises the effective portion of the cumulative net change in the fair value of cash flow hedging instruments related to hedged transactions that have not yet occurred. The reserve relating to forward currency contracts will be reclassified to the Statement of Profit or Loss within 12 months whilst the reserve relating to the cross currency interest rate swaps will be reclassified over the life of the instruments.

The table below shows the movement in the cash flow hedging reserve during the year or period, including the gains or losses arising on the revaluation of hedging instruments during the year or period and the amount reclassified from other comprehensive income to the Consolidated Statement of Profit or Loss in the year.

	Successor		Successor		Successor	Successor	Predecessor
	Year ended December 31, 2017		Year ended December 31, 2016		9 months ended December 31, 2015	Year ended March 31, 2015	5 months ended May 31, 2015
	€m		€m		€m	€m	€m
(Losses)/gains arising in the revaluation of hedge instruments	(76.5	)	14.2		1.6	—	—
Less: Gains/(losses) reclassified to the Consolidated Statement of Profit or Loss	60.1		(4.1	)	—	—	—
Total	(16.4	)	10.1		1.6	—	—

XML

Cash flow hedging reserve

12 Months Ended

Dec. 31, 2017

Share Capital, Reserves and Other Equity Interest [Abstract]

Cash flow hedging reserve

Share-based compensation reserve

Successor

The Company's discretionary share award scheme, the LTIP, enables the Company’s Compensation Committee to make grants (“Awards”) in the form of rights over ordinary shares, to any Director, Non-Executive Director or employee of the Company. However, it is the Committee’s current intention that Awards be granted only to Directors and senior management, whilst recognizing a separate annual Restricted Stock Award for Non-Executive Directors.

All Awards are to be settled by physical delivery of shares. Note 8b sets out the Non-Executive Director and Director and Senior Management Restricted share awards.

Non-Executive Director Restricted Share Awards

The Non-Executive Directors restricted share awards, granted at a share price of $11.50 on December 7, 2015, vested on June 16, 2016 and 23,212 ordinary shares were issued in July at a share price of $8.98, resulting in a €0.3 million reduction in the share based compensation reserve for the year ended December 31, 2016.

The Non-Executive Directors restricted share awards granted at a share price of $8.98 on June 16, 2016 vested on June 19, 2017 and were issued at a share price of $14.38, resulting in a €0.3 million increase in the share based compensation reserve. Of the total 55,680 number of shares vesting, 9,384 shares were held back from issue by the Company as settlement towards personal tax liabilities arising on the vested shares for the year ended December 31, 2017.

On June 19, 2017, current Non-Executive Directors were granted 41,724 restricted share awards at a share price of $14.38. On August 22, 2017, two new Non-Executive Directors were granted a pro-rata 11,774 restricted share awards at the same share price and vesting conditions as the previous grant.

The total charge within the Statement of Consolidated Profit or Loss for the year ended December 31, 2017 for Non-Executive Director stock compensation awards was €0.8 million and €0.6 million for the year ended December 31, 2016. The Director and senior management stock compensation charge reported within the Consolidated Statement of Profit or Loss for the year ended December 31, 2017 was €1.8 million (year ended December 31, 2016: €0.6 million).

	Share based compensation reserve
	€m
Balance as of January 1, 2017	1.0
Non-Executive Director restricted share awards charge	0.8
Directors and Senior Management share awards charge	1.8
Vesting of Non-Executive Director restricted shares	(0.7	)
Balance as of December 31, 2017	2.9

Founder Preferred Shares Dividend Reserve

Nomad has issued Founder Preferred Shares to its Founder Entities. A summary of the key terms of the Founder Preferred Shares is set out in Note 25.

The Founder Preferred Shares Annual Dividend Amount is structured to provide a dividend based on the future appreciation of the market value of the ordinary shares, thus aligning the interests of the Founders with those of the investors on a long term basis. Commencing in 2015, the Founder Preferred Share Annual Dividend Amount became payable because the Company’s volume weighted average ordinary share price was above $11.50 for the last ten consecutive trading days of the 2015 financial year.

Accordingly, the conditions of the Founder Preferred Shares Annual Dividend Amount for 2015 were met. On January 12, 2016, the Company's Board of Directors approved a share dividend (the “Founder Preferred Share Dividend”) of an aggregate of 3,620,510 ordinary shares calculated as 20% of the increase in the market price of our ordinary shares compared to the initial public offering price of $10.00 multiplied by 140,220,619 (the “Preferred Share Dividend Equivalent”). The Preferred Share Dividend Equivalent is equal to the number of ordinary shares outstanding immediately following the Iglo Acquisition, but excluding the 13.7 million ordinary shares issued to the seller of the Iglo Group. The dividend price (“Dividend Price”) used to calculate the Annual Dividend Amount was $11.4824 (calculated based upon the volume weighted average price for the last ten consecutive trading days of 2015) and the ordinary shares underlying the Founder Preferred Share Dividend were issued on January 12, 2016.

The conditions of the Founder Preferred Shares Annual Dividend Amount for 2016 were not met and consequently no Founder Preferred Share Dividend was approved for issue.

The conditions of the Founder Preferred Shares Annual Dividend Amount for 2017 were met. On December 29, 2017, the Company’s Board of Directors approved a share dividend of an aggregate of 8,705,890 ordinary shares calculated as 20% of the increase in the market price of our ordinary shares compared to 2015 dividend price of $11.4824 multiplied by Preferred Share Dividend Equivalent. The Dividend Price used to calculate the Annual Dividend Amount was $16.6516 (calculated based upon the volume weighted average price for the last ten consecutive trading days of 2017) and the ordinary shares underlying the Founder Preferred Share Dividend were issued on January 2, 2018.

In future years, the Preferred Shares Annual Dividend amount will be determined with reference to the Dividend Determination Period of a financial year, ie the last ten consecutive trading days and calculated as 20% of the increase in the volume weighted average share price of our ordinary shares across the determination period compared to the highest price previously used in calculating the Founder Preferred Share Annual Dividend Amounts multiplied by the Annual Dividend Amount (currently $16.6516). The Founder Preferred Shares Annual Dividend Amount is paid for so long as the Founder Preferred Shares remain outstanding. The Founder Preferred Shares automatically convert on the last day of the seventh full financial year following completion of the acquisition of the Iglo Group or upon a change of control, unless in the case of a change of control, the independent Directors determine otherwise.

The amounts used for the purposes of calculating the Founder Preferred Shares Annual Dividend Amount and the relevant numbers of ordinary shares are subject to such adjustments for share splits, share dividends and certain other recapitalization events as the Directors in their absolute discretion determine to be fair and reasonable in the event of a consolidation or sub-division of the ordinary shares in issue, as determined in accordance with Nomad Foods’ Memorandum and Articles of Association.

Dividends on the Founder Preferred Shares are payable until the Founder Preferred Shares are converted into Ordinary Shares. The Founder Preferred Shares automatically convert on a one for one basis (i) on the last day of the seventh full financial year following our acquisition of Iglo Foods (or if such day is not a trading day, the next trading day) or (ii) in the event of a change of control (unless the independent directors of our board of directors determine otherwise). The holders of Founder Preferred Shares may also be converted to Ordinary shares on a one for one basis at the option of the holder. In the event of an automatic conversion, a dividend on the Founder Preferred Shares shall be payable with respect to the shorted dividend year on the trading day immediately prior to the conversion. In the event of an optional conversion by the holder, no dividend on the Founder Preferred Shares shall be payable with respect to the year in which the conversion occurred.

	Founder Preferred Shares Dividend Reserve
	€m
Balance as of January 1, 2017	493.4
Settlement of dividend through share issue	—
Balance as of December 31, 2017	493.4

Prior to June 1, 2015 the Founder Preferred Shares Annual Dividend Amounts were valued and recognized as a liability under IFRS 2. The fair value of the liability at each balance sheet date was valued using a Monte Carlo simulation and any difference in fair value was recorded as an expense through the Consolidated Statement of Profit or Loss. An expense of €349 million was recognized for the nine months ended December 31, 2015 (€165.8 million for the year ended March 31, 2015).

Upon completion of the acquisition of the Iglo Group on June 1, 2015, the Company intended that the Founder Preferred Shares Annual Dividend Amount would be equity settled. Accordingly, the Founder Preferred Shares Annual Dividend Amount as of June 1, 2015 of €531.5 million (the “Founder Preferred Shares Dividend reserve”) was classified as equity and no further revaluations will be required or recorded.

Translation reserve

The translation reserve comprises all foreign exchange differences arising from the translation of the financial statements of foreign operations, as well as from the translation of liabilities that hedge the Company’s net investment in a foreign subsidiary.

Cash flow hedging reserve

The hedging reserve comprises the effective portion of the cumulative net change in the fair value of cash flow hedging instruments related to hedged transactions that have not yet occurred. The reserve relating to forward currency contracts will be reclassified to the Statement of Profit or Loss within 12 months whilst the reserve relating to the cross currency interest rate swaps will be reclassified over the life of the instruments.

The table below shows the movement in the cash flow hedging reserve during the year or period, including the gains or losses arising on the revaluation of hedging instruments during the year or period and the amount reclassified from other comprehensive income to the Consolidated Statement of Profit or Loss in the year.

	Successor		Successor		Successor	Successor	Predecessor
	Year ended December 31, 2017		Year ended December 31, 2016		9 months ended December 31, 2015	Year ended March 31, 2015	5 months ended May 31, 2015
	€m		€m		€m	€m	€m
(Losses)/gains arising in the revaluation of hedge instruments	(76.5	)	14.2		1.6	—	—
Less: Gains/(losses) reclassified to the Consolidated Statement of Profit or Loss	60.1		(4.1	)	—	—	—
Total	(16.4	)	10.1		1.6	—	—

XML

Earnings/(loss) per share

12 Months Ended

Dec. 31, 2017

Earnings per share [abstract]

Earnings/(loss) per share

Earnings/(loss) per share

Basic earnings/(loss) per share

	Successor	Successor	Successor		Successor		Predecessor
	Year ended December 31, 2017	Year ended December 31, 2016	9 months ended December 31, 2015		Year ended March 31, 2015		5 months ended May 31, 2015
Net profit/(loss) attributable to shareholders (€m)	136.5	36.4	(337.3	)	(167.5	)	(128.0	)
Weighted average Ordinary Shares and Founder Preferred Shares	176,080,272	183,518,743	145,590,810		50,025,000		n.p.
Basic earnings/(loss) per share (€’s)	0.78	0.20	(2.32	)	(3.35	)	n.p.

n.p. not presented

For the year ended December 31, 2017, basic earnings per share is calculated by dividing the profit attributable to the shareholders of the Company of €136.5 million (year ended December 31, 2016: €36.4 million, nine months ended December 31, 2015: €337.3 million loss) by the weighted average number of ordinary shares of 174,580,272 (December 31, 2016: 182,018,743, 9 months ended December 31, 2015: 144,090,810) and Founder Preferred Shares of 1,500,000 (December 31, 2016: 1,500,000, 9 months ended December 31, 2015: 1,500,000).

Diluted earnings/(loss) per share

	Successor	Successor	Successor		Successor		Predecessor
	Year ended December 31, 2017	Year ended December 31, 2016	9 months ended December 31, 2015		Year ended March 31, 2015		5 months ended May 31, 2015
Net profit/(loss) attributable to shareholders (€m)	136.5	36.4	(337.3	)	(167.5	)	(128.0	)
Weighted average Ordinary Shares and Founder Preferred Shares	184,786,162	183,528,621	145,590,810		50,025,000		n.p.
Diluted earnings/(loss) per share (€’s)	0.74	0.20	(2.32	)	(3.35	)	n.p.

n.p. not presented

For the year ended December 31, 2017, the number of shares in the diluted earnings per share calculation include 8,705,890 shares for the dilutive impact of the Ordinary shares to settle the Founder Preferred Shares Annual Dividend for the year ended December 31, 2017, which were issued in January 2018. Refer to Notes 27 and 38 for further details. There is no adjustment to the profit/(loss) attributable to shareholders.

XML

Reconciliation of liabilities arising from financing activities

12 Months Ended

Dec. 31, 2017

Disclosure of reconciliation of liabilities arising from financing activities [abstract]

Reconciliation of liabilities arising from financing activities

Reconciliation of liabilities arising from financing activities

The table below details changes in the Company's liabilities arising from financing activities, including both cash and non-cash changes. Liabilities arising from financing activities are those for which cash flows were, or future cash flows will be classified in the Company's consolidated statements of cash flows from financing activities.

		Cash movements			Non-cash movements
	Opening balance as of December 31, 2016	Cash inflow (1)	Cash outflow (2)		Interest accretion	Exchange movement		Fair value changes		Other non-cash adjustments	Closing balance as of December 31, 2017
	€m	€m	€m		€m	€m		€m		€m	€m
Total loans and borrowings (Note 21)	1,446.8	1,470.5	(1,469.5	)	—	(55.7	)	—		6.3	1,398.4
Total finance lease obligations (Note 22)	1.6	—	(1.6	)	—	—		—		—	—
Financial payables (Note 22)	1.7	—	(53.3	)	54.0	0.7		—		—	3.1
Derivatives: (Net) Fair value of forward foreign exchange and currency swap contracts FVPTL	0.3	3.9	—		—	—		(3.5	)	—	0.7
Derivatives: (Net) Fair value of cross currency interest rate swaps	—	4.5	(2.3	)	—	—		40.6		—	42.8

(1) Cash inflows of €4.5 million from cross currency interest rate swaps are part of effective cash flow hedging relationships and are presented within interest paid within the Consolidated Statements of Cash Flows.

(2) Cash outflows of €2.3 million from cross currency interest rate swaps are not part of a cash flow hedge and are presented within proceeds on settlement of derivatives within the Consolidated Statements of Cash Flows.

Note: IFRS 16 Leases becomes effective as of January 1 2019, at which point operating lease liabilities will also appear in the information presented

XML

Cash flows from operating activities

12 Months Ended

Dec. 31, 2017

Cash Flow Statement [Abstract]

Cash flows from operating activities

Cash flows from operating activities

		Successor		Successor		Successor		Successor		Predecessor
		Year ended December 31, 2017		Year ended December 31, 2016		9 months ended December 31, 2015		Year ended March 31, 2015		5 months ended May 31, 2015
	Note	€m		€m		€m		€m		€m
Cash flows from operating activities
Profit/(loss) for the period		136.5		36.4		(337.3	)	(167.5	)	(128.0	)
Adjustments for:
Exceptional items	7	37.2		134.5		58.1		0.7		84.3
Non-cash charge related to Founder Preferred Shares Annual Dividend Amount		—		—		349.0		165.8		—
Non-cash (charge)/credit related to Warrant Redemption Liability		—		—		(0.4	)	0.4		—
Non-cash fair value purchase price adjustment of inventory		—		—		37.0		—		—
Non-cash cash flow hedge reserve acquisition accounting adjustment		—		—		4.9		—		—
Non-cash Chairman and Independent Non-Executive Director fees		—		—		—		0.2		—
Unrealized gain on portfolio investments		—		—		—		(0.1	)	—
Share based payments expense		2.6		1.2		—		—		—
Depreciation charge	12	35.9		43.3		20.3		—		11.3
Amortization	13	6.5		7.8		1.5		—		1.2
Loss on disposal of property, plant and equipment		0.5		0.7		—		—		—
Finance costs	10	81.6		86.3		44.2		—		117.7
Finance income	10	(7.2	)	(24.2	)	(8.7	)	—		(2.0	)
Taxation	11	32.0		39.6		(12.3	)	—		40.9
Operating cash flow before changes in working capital, provisions and exceptional items		325.6		325.6		156.3		(0.5	)	125.4
Decrease/(increase) in inventories		16.7		(18.1	)	(15.9	)	—		28.3
(Increase)/decrease in trade and other receivables		(1.6	)	(8.8	)	64.3		—		(8.5	)
Increase/(decrease) in trade and other payables		18.1		60.8		(44.0	)	0.7		(41.0	)
Decrease in employee benefit and other provisions		(0.3	)	(3.3	)	(1.5	)	—		(2.0	)
Cash generated from operations before tax and exceptional items		358.5		356.2		159.2		0.2		102.2

XML

Financial risk management

12 Months Ended

Dec. 31, 2017

Financial Instruments [Abstract]

Financial risk management

Financial risk management

a) Overall risk management policy

The Company’s activities expose it to a variety of financial risks, including currency risk, interest rate risk, credit risk and liquidity risk.

The Company’s overall risk management program focuses on minimizing potential adverse effects on the Company’s financial performance. The Company uses derivative financial instruments to hedge certain risk exposures.

Risk management is led by senior management and is mainly carried out by a central treasury department which identifies, evaluates and hedges financial risks in close cooperation with the Company’s operating units.

b) Market risk (including currency risk and interest rate risk)

In managing market risks, the Company aims to minimize the impact of short term fluctuations on the Company’s earnings. Over the longer term, however, permanent changes in foreign exchange rates and interest rates will have an impact on consolidated earnings.

Currency risk Foreign currency risk on assets and liabilities in currencies other than functional currency

Description The Company is exposed to foreign exchange risk arising from the translation of assets and liabilities denominated in currencies other than the Euro. This affects particularly Nomad’s U.S. Dollar loans and cross currency interest rate swaps and Nomad's GBP loans and cross currency interest rate swaps.

The U.S. Dollar and GBP value of these liabilities is retranslated at closing exchange rates into Euro for inclusion in the financial statements. Fluctuations in the value of these liabilities are caused by variations in the closing EUR-USD and EUR-GBP exchange rates.

Prior to April 21, 2017, 80% of the Company's Pound Sterling loans were designated as net investment hedges against the Company's investment in its subsidiaries in the UK.  From April 21, 2017, the existing Sterling loans were settled and USD debt of $610 million was entered into. In order to match its underlying cash flows the Company has entered into a number of cross-currency interest rate swaps. In exchange for $610.0 million the Company received €570.5 million which has been designated as cash flow hedges. Of the €570.5 million, €271.2 million was swapped to £226.7 million. 82.8% of the Company’s Pound Sterling cross currency interest rate swaps are designated as hedges against the Company’s investment in its subsidiaries in the UK.

Mitigation & Impact on Any foreign exchange movement resulting from the translation of $610m term loan to Euros

Statement of Financial is offset with the translation of the receive U.S. Dollar, pay Euro cross currency interest rate

Position / Equity / swaps. Gains/losses on the cross currency interest rate swap are released from cash flow

Income Statement hedge reserve to match the gain or losses on the U.S. Dollar debt as they impact profit and loss.

From April 21, 2017, 82.8% of the Company’s Pound Sterling cross currency interest rate swaps are designated as hedges against the Company’s investment in its subsidiaries in the UK. In 2016 and up until April 21, 2017 80% of the Company's Pound Sterling loans were designated as hedges against the Company's investment in its subsidiaries in the UK. As at December 31, 2017, this represented 93.1% of the net assets held in GBP (2016: 99%).

The impact of the net investment hedge is taken directly to equity via the foreign currency translation reserve. The amount taken to this reserve which arose on the retranslation of the cross currency interest rate swaps was a gain of €12.4 million and from the translation of the GBP loans in place was a loss of €4.3 million. In 2016 the amount taken to this reserve which arose on the translation of Sterling loans was a €35.4 million gain, (2015: €6.8 million gain). There was no material ineffectiveness in the net investment hedge in either 2017 or 2016.

Sensitivity analysis During 2017, the Euro strengthened by 3.9% (2016: strengthened by 13.8%) against Sterling.

The notional amount of Pound Sterling cross currency interest rate swaps designated as hedges is £187.6m, the gain of €12.4 million resulted from a 5.8% movement in the GBP-EUR foreign exchange rate. A 1% movement in the GBP-EUR foreign exchange rate would result in a gain or loss of €2.2 million which would be taken to equity.

Hedge accounting is not applied to 17.2% of the Company's Pound Sterling cross currency interest rate swaps. A 1% movement in the GBP-EUR foreign exchange rate would result in a gain or loss of €0.4 million.

In addition, the impact on the related interest charge would be to decrease or increase the charge by €0.1 million, €0.1 million and €0.2 million for each 1% change in the exchange rate in 2017 and 2016 and 2015 respectively.

Currency risk Foreign currency risk on purchases

The Company is exposed to foreign exchange risk where a business unit makes purchases in a currency other than the functional currency of that entity.

For the Company, the most significant of these exposures is the purchase of fish inventories in U.S. Dollars and the purchase of goods and services in Euros by the UK and the Nordics.

Mitigation & Impact on The Company’s policy is to reduce this risk by using foreign exchange forward contracts

Statement of Financial which are designated as cash flow hedges. These contracts all have a maturity of less

Position / Equity / than one year. The fair value of the U.S. Dollars forward contracts with reference to

Income Statement non-USD functional currencies as at December 31, 2017 is an asset of €6.5 million (2016: €11.0 million asset). All forecast transactions are still expected to occur.

As at December 31, 2017, 69.8% (2016: 98%, 2015: 69%) of forecast future U.S. Dollar payments for the next twelve months were hedged through the use of forward contracts and existing cash. A proportion of the forward contracts have been designated as cash flow hedges.

The fair value of the Euro forward contracts with reference to non-Euro functional currencies as at December 31, 2017 is €1.5 million (2016: €1.1 million).

As at December 31, 2017, 68% (2016: 86.9%, 2015: 58%) of forecast future net euro payments for the next twelve months were hedged through the use of forward contracts and existing cash. A proportion of the forward contracts have been designated as cash flow hedges over forecast purchases.

Sensitivity analysis During 2017, the Euro strengthened by 3.9% against Sterling, and strengthened by 13.9% against the U.S.Dollar and strengthened by 2.7% against the Swedish Krona.

On an annualized 2017 basis, for each 1% that the Euro strengthens or weakens against Sterling, assuming all other variables remain constant, the impact relating to these purchases would be to increase or decrease the Company’s profit or loss before tax by approximately €0.7 million (2016: €0.6 million, 2015: €0.5 million), excluding the impact of any forward contracts.

On an annualized 2017 basis, for each 1% that the Euro strengthens or weakens against the U.S.Dollar, assuming all other variables remain constant, the impact would be to increase or decrease the Company’s profit or loss before tax by approximately €2.4 million (2016: €2.2 million, 2015: €2.2 million), excluding the impact of any forward contracts.

On an annualized 2017 basis, for each 1% that the Euro strengthens or weakens against Swedish Krona, assuming all other variables remain constant, the impact relating to these purchases would be to increase or decrease the Company’s profit or loss before tax by approximately €0.7 million (2016: €0.4 million, 2015: €0.5 million), excluding the impact of any forward contracts.

We do not expect purchase levels to be materially different in the coming year.

Interest rate risk

Description The Company has significant levels of floating rate borrowings and is therefore exposed to the impact of interest rate fluctuations.

Mitigation & Impact on

Equity / Income Statement The Company’s policy on interest rate risk is designed to limit the Company’s exposure to fluctuating interest rates. In 2017 the Company entered into a €400 million7 year fixed rate Bond, floating rate senior Euro debt of €500 million and floating rate senior USD of $610 million. The company also entered into cross currency interest rate swaps to swap its floating USD term loans to fixed Euros or Sterling.

During 2017 the weighted average fixed rate of the Company's interest cash flows in Sterling was 65.8% (2016: 157%) and the weighted average fixed rate of the Company's Euro interest cash flows was 38.9% (2016: 66%). As at December 31, 2017 this was 100% and 58.3% respectively.

Sensitivity analysis In 2017, one month GBP LIBOR rates increased by 0.25 percentage points (2016: 0.25 percentage points decrease) and there were no significant changes in three month EURIBOR rates (2016: decreased by 0.15 percentage points). Negative interest rates are treated as 0% for the purpose of the interest applied on the senior loans.

If interest rates were greater than 1%, an increase or decrease of one percentage point in the interest rate charge on borrowings would correspondingly decrease or increase the Company’s profit/(loss) before tax by approximately €5.1 million (2016: €14.8 million, 2015: €14.5 million).

c) Credit risk

Description Credit risk arises on cash and cash equivalents and derivative financial instruments with banks and financial institutions, as well as on credit exposures to customers. See Note 18 for analysis of the trade receivables balance and Note 20 for analysis of the cash and cash equivalents balance.

Mitigation The Company limits counterparty exposures by monitoring each counterparty carefully and where possible, setting credit limits by reference to published ratings. The Company limits its exposure to individual financial institutions by spreading forward foreign exchange contracts, cross currency interest rate swaps and surplus cash deposits between several institutions.

The credit quality of customers is assessed taking into account their financial position, past experience and other factors. Credit limits are set for customers and regularly monitored. The Company aims to ensure that the maximum exposure to one financial institution does not exceed €150.0 million and that the long term credit rating does not fall below High Single A.

d) Liquidity risk

Description The Company is exposed to the risk that it is unable to meet its commitments as they fall due. The Company has financial conditions imposed by its lenders which it must achieve in order to maintain its current level of borrowings. A single net debt covenant is carried out quarterly and at the end of each financial year. There have been no breaches of the covenants throughout the year.

Mitigation The Company ensures that it has sufficient cash and available funding through regular cash flow and covenant forecasting. In addition, the Company has access to a revolving credit facility of €80.0 million, expiring in May 2023. This is available to finance working capital requirements and for general corporate purposes. Currently €14.0 million is utilized for letters of credit, overdrafts, customer bonds and bank guarantees.

Capital risk management

Nomad’s objectives when managing capital (currently consisting of share capital and share premium) are to safeguard Nomad’s ability to continue as a going concern in order to provide returns for shareholders and benefits for other stakeholders and to maintain an optimal capital structure to reduce the cost of capital. In order to maintain or adjust the capital structure, Nomad may adjust the amount of dividends paid to shareholders, return capital to shareholders or issue new shares.

Maturity analysis

The tables below show a maturity analysis of contractual undiscounted cash flows, showing items at the earliest date on which the Company could be required to pay the liability:

2017	2018		2019		2020		2021		2022		Over 5 years	Total
	€m		€m		€m		€m		€m		€m	€m
Borrowings-principal	5.1		5.1		5.1		5.1		5.1		1,384.0	1,409.5
Borrowings-interest	46.3		46.0		46.0		45.7		45.5		62.9	292.4
Forward contracts Sell	484.0		—		—		—		—		—	484.0
Forward contracts Buy	(479.6	)	—		—		—		—		—	(479.6	)
Cross Currency Interest Rate Swaps Pay	29.1		28.7		28.6		28.4		801.4		—	916.2
Cross Currency Interest Rate Swaps Receive	(32.0	)	(31.6	)	(31.4	)	(31.2	)	(759.3	)	—	(885.5	)
Trade and other payables excluding non-financial liabilities	441.6		—		—		—		—		—	441.6
Total	494.5		48.2		48.3		48.0		92.7		1,446.9	2,178.6

2016	2017		2018	2019	2020	2021	Over 5 years	Total
	€m		€m	€m	€m	€m	€m	€m
Borrowings-principal	—		—	—	1,464.2	—	—	1,464.2
Borrowings-interest	59.7		60.0	60.9	29.9	—	—	210.5
Forward contracts Sell	367.8		—	—	—	—	—	367.8
Forward contracts Buy	(381.3	)	—	—	—	—	—	(381.3	)
Trade and other payables excluding non-financial liabilities	439.1		—	—	—	—	—	439.1
Total	485.3		60.0	60.9	1,494.1	—	—	2,100.3

The 2016 table has been amended to include the Forward contract Buy amount.

XML

Financial instruments

12 Months Ended

Dec. 31, 2017

Financial Instruments [Abstract]

Financial instruments

Financial instruments

a) Categories of financial instruments

The following table shows the carrying amount of each Statement of Financial Position class split into the relevant category of financial instrument as defined in IAS 39 “Financial Instruments: Recognition & Measurement”.

	Cash and cash equivalents	Loans and receivables	Derivatives at fair value through profit or loss		Derivatives used for hedging (see (c))		Financial liabilities at amortized cost		Total
2017	€m	€m	€m		€m		€m		€m
Assets
Trade receivables	—	94.7	—		—		—		94.7
Derivative financial instruments	—	—	3.2		17.5		—		20.7
Cash and cash equivalents	219.2	—	—		—		—		219.2
Liabilities
Trade and other payables excluding non-financial liabilities	—	—	—		—		(441.6	)	(441.6	)
Derivative financial instruments	—	—	(0.7	)	(68.5	)	—		(69.2	)
Loans and borrowings (note 1)	—	—	—		—		(1,409.5	)	(1,409.5	)
Total	219.2	94.7	2.5		(51.0	)	(1,851.1	)	(1,585.7	)

Note 1: Loans and borrowings excludes €11.1 million of deferred borrowing costs which are included within €1,398.4 million of total loans and borrowings in Note 21.

	Cash and cash equivalents	Loans and receivables	Derivatives at fair value through profit or loss	Derivatives used for hedging (see (c))		Financial liabilities at amortized cost		Total
2016	€m	€m	€m	€m		€m		€m
Assets
Trade receivables	—	92.3	—	—		—		92.3
Derivative financial instruments	—	—	—	13.1		—		13.1
Cash and cash equivalents	329.5	—	—	—		—		329.5
Liabilities
Trade and other payables excluding non-financial liabilities	—	—	—	—		(439.1	)	(439.1	)
Derivative financial instruments	—	—	—	(1.4	)	—		(1.4	)
Loans and borrowings (note 2)	—	—	—	—		(1,464.2	)	(1,464.2	)
Total	329.5	92.3	—	11.7		(1,903.3	)	(1,469.8	)

Note 2: Loans and borrowings excludes €12.4 million of deferred borrowing costs which are included within €1,451.8 million of total non-current loans and borrowings in Note 21.

b) Fair values

Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. In determining fair value, Nomad uses various methods including market, income and cost approaches. Based on these approaches, Nomad utilizes certain assumptions that market participants would use in pricing the asset or liability, including assumptions about risk and the risks inherent in the inputs to the valuation technique. These inputs may be readily observable, market corroborated, or generally unobservable inputs. Nomad utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs. Based on the observability of the inputs used in the valuation techniques Nomad is required to provide the following information according to the fair value hierarchy. The fair value hierarchy ranks the quality and reliability of the information used to determine fair values.

Financial assets and liabilities carried at fair value will be classified and disclosed in one of the following three categories:

Level 1—Quoted prices for identical assets and liabilities traded in active exchange markets, such as the New York Stock Exchange.

Level 2—Observable inputs other than Level 1 including quoted prices for similar assets or liabilities, quoted prices in less active markets, or other observable inputs that can be corroborated by observable market data. Level 2 also includes derivative contracts whose value is determined using a pricing model with observable market inputs or can be derived principally from or corroborated by observable market data.

Level 3—Unobservable inputs supported by little or no market activity for financial instruments whose value is determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which the determination of fair value requires significant management judgment or estimation; also includes observable inputs for nonbinding single dealer quotes not corroborated by observable market data. Where market information is not available to support internal valuations, reviews of third party valuations are performed.

While Nomad believes its valuation methods are appropriate and consistent with other market participants, the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different estimate of fair value at the reporting date.

The following is a description of the valuation methodologies and assumptions used for estimating the fair values of financial instruments held by the Company.

(i) Derivative financial instruments

Derivative financial instruments are held at fair value. There is no difference between carrying value and fair value. The financial instruments are not traded in an active market and so the fair value of these instruments is determined from the implied forward rate. The valuation technique utilized by the Company maximizes the use of observable market data where it is available. All significant inputs required to fair value the instrument are observable. The Company has classified its derivative financial instruments as level 2 instruments as defined in IFRS 13 ‘Fair value measurement’.

Gains in the year from foreign exchange forward contracts designated as fair value through the Consolidated Statements of Profit or Loss amounted to €nil (2016: €1.0 million, 2015: €9.1 million).

Gains in the year from foreign exchange swap contracts used for liquidity purposes designated as fair value through the Consolidated Statements of Profit or Loss amounted to €3.5 million (2016: €4.3 million loss, 2015: €nil).

Gains in the year from cross currency interest rate swap contracts designated as fair value through the Consolidated Statement of Profit or Loss amounted to €3.9m (2016: €nil, 2015: €nil).

(ii) Trade and other payables/receivables

The notional amount of trade and other payables/receivables are deemed to be carried at fair value, short term and settled in cash.

(iii) Cash and cash equivalents/overdrafts

The carrying value of cash is deemed to equal fair value.

(iv)Interest bearing loans and liabilities

The fair value of secured notes is determined by reference to price quotations in the active market in which they are traded. They are classified as level 1 instruments. The fair value of the senior loans is calculated by discounting the expected future cash flows at the year end’s prevailing interest rates. They are classified as level 2 instruments.

	Fair value		Carrying value
	Dec 31, 2017	Dec 31, 2016	Dec 31, 2017		Dec 31, 2016
	€m	€m	€m		€m
Senior loans	—	970.3	—		964.2
2020 floating rate senior secured notes	—	505.2	—		500.0
Senior EUR/USD loans	1,012.7	—	1,009.5		—
2024 fixed rate senior secured notes	412.2	—	400.0		—
Less deferred borrowing costs	—	—	(11.1	)	(17.4	)
	1,424.9	1,475.5	1,398.4		1,446.8

c) Derivatives

The notional principal amounts of the outstanding forward foreign exchange contracts at December 31, 2017 were €484.0 million (December 31, 2016: €367.8 million). The notional principal amounts of the outstanding cross currency interest rate swaps as at December 31, 2017 were €826.2 million (pay) and €780.7 million (receive). The following table presents the fair value of derivatives as at December 31, 2017. 43.4% (December 31, 2016: 68.9%) of the notional principal amount of forward foreign exchange contracts relates to USD contracts and 26.0% (December 31, 2016: 22%) of the notional principal amount of forward foreign exchange contracts relates to EUR contracts for the UK and Nordic subsidiaries. 30.6% of the notional principal amount of forward foreign exchange contracts relates to FX swaps for liquidity purposes.

	As at Dec 31, 2017		As at Dec 31, 2016
	€m		€m
Cross Currency Interest Rate Swaps	18.6		—
Forward foreign exchange contracts	2.1		13.1
Total assets	20.7		13.1
Cross Currency Interest Rate Swaps	(61.4	)	—
Forward foreign exchange contracts	(7.8	)	(1.4	)
Total liabilities	(69.2	)	(1.4	)
Total	(48.5	)	11.7

Offsetting of derivatives

Derivative contracts are held under International Swaps and Derivatives Association (ISDA) agreements with financial institutions. An ISDA is an enforceable master netting agreement that permits the Company to settle net in the event of default.

The following table sets out the carrying amounts of recognized financial instruments that are subject to the above agreements.

	Gross amount of financial instruments as presented upon balance sheet		Related financial instruments that are offset		Net amount
As at Dec 31, 2017	€m		€m		€m
Derivatives - assets	20.7		(20.7	)	—
Derivatives - liabilities	(69.2	)	20.7		(48.5	)

	Gross amount of financial instruments as presented upon balance sheet		Related financial instruments that are offset		Net amount
As at Dec 31, 2016	€m		€m		€m
Derivatives - assets	13.1		(1.4	)	11.7
Derivatives - liabilities	(1.4	)	1.4		—

XML

Operating leases

12 Months Ended

Dec. 31, 2017

Leases1 [Abstract]

Operating leases

Operating leases

The Company leases certain buildings, plant and equipment under operating leases. The agreements do not share common characteristics across the Company.

Non-cancellable operating lease rentals relate to total future aggregate minimum lease payments and are payable as follows:

	As at Dec 31, 2017	As at Dec 31, 2016
	€m	€m
Less than one year	17.8	18.3
Between one and three years	26.1	29.6
Between three and five years	17.8	22.0
More than five years	106.6	109.7
Total	168.3	179.6

Non-cancellable operating leases relate to equipment, motor vehicles and land and buildings and may be subject to contractual annual increases linked to inflation indices. The payments shown above exclude the impact of these contractual increases which cannot be reliably estimated.

Findus Sverige AB has a long lease for a factory and cold-store that expires in 2040. This accounts for €115.8 million of the lease payments. As explained in note 24, this lease has been identified as being onerous and so a provision of €72.5 million has been recognized in respect of the onerous part of the lease.

XML

Capital commitments

12 Months Ended

Dec. 31, 2017

Additional information [abstract]

Capital commitments

Capital commitments

Capital expenditure contracted for at the end of the reporting period but not yet incurred is as follows:

	As at Dec 31, 2017	As at Dec 31, 2016
	€m	€m
Property, plant and equipment	3.0	8.1
Intangible assets	2.6	5.4
Total	5.6	13.5

XML

Related parties

12 Months Ended

Dec. 31, 2017

Related Party [Abstract]

Related parties

Related parties

Founder Preferred Shares

Each of the Founder Entities holds 750,000 shares of Founder Preferred Shares issued at $10.00 per share. The Founder Preferred Shares were intended to incentivize the Founders to achieve Nomad’s objectives. In addition to providing long term capital, the Founder Preferred Shares are structured to provide a dividend based on the future appreciation of the market value of the ordinary shares thus aligning the interests of the Founders with those of the holders of ordinary shares on a long term basis. The Founder Preferred Shares are also intended to encourage the Founders to grow Nomad following the Iglo Acquisition and to maximize value for holders of ordinary shares. On January 12, 2016, the Company approved a 2015 Founder Preferred Share Dividend with respect to 2015 in an aggregate of 3,620,510 ordinary shares payable to the Founder Entities.

The conditions of the Founder Preferred Shares Annual Dividend Amount for 2016 were not met and consequently no Founder Preferred Share Dividend was approved for issue.

The conditions of the Founder Preferred Shares Annual Dividend Amount for 2017 were met. On December 29, 2017, the Company’s Board of Directors approved a share dividend of an aggregate of 8,705,890 ordinary shares calculated as 20% of the increase in the market price of our ordinary shares compared to 2015 dividend price of $11.4824 multiplied by Preferred Share Dividend Equivalent. The Dividend Price used to calculate the Annual Dividend Amount was $16.6516 (calculated based upon the volume weighted average price for the last ten consecutive trading days of 2017) and the ordinary shares underlying the Founder Preferred Share Dividend were issued on January 2, 2018.

Advisory Services Agreements

On June 15, 2015, the Company entered into an Advisory Services Agreement with Mariposa Capital, LLC, an affiliate of Mr. Franklin, and TOMS Capital LLC, an affiliate of Mr. Gottesman. Pursuant to the terms of the Advisory Services Agreement, Mariposa Capital, LLC and TOMS Capital LLC provide high-level strategic advice and guidance to the Company. Under the terms of the Advisory Services Agreement, Mariposa Capital, LLC and TOMS Capital LLC are entitled to receive an aggregate annual fee equal to $2.0 million, payable in quarterly installments. This agreement expires on June 1st annually and will be automatically renewed for successive one-year terms unless any party notifies the other parties in writing of its intention not to renew the agreement no later than 90 days prior to the expiration of the term. The agreement may only be terminated by the Company upon a vote of a majority of its directors. In the event that the agreement is terminated by the Company, the effective date of the termination will be six months following the expiration of the initial term or a renewal term, as the case may be.

Expenses of €130,454 and €232,379 for certain travel costs of Mariposa Capital, LLC and TOMS Capital LLC respectively in the year ending December 31, 2017 were reimbursed (year ended December 31, 2016: €153,186 and €233,627 respectively).

Directors and Key Management

All significant management decision making authority is vested within the Board of Directors and the executive team, therefore key management are considered to be the Directors and Executive Officers. Their remuneration has been disclosed in Note 9.

On September 11, 2017, the Company entered into an agreement to repurchase shares being sold in an underwritten secondary public offering by selling Shareholders, Pershing Square Capital Management, L.P. (“Pershing Square”). See Note 25 for a description of the transaction.

As part of the sale of the Iglo Group to Nomad Foods Limited, former Executive Officer and Non-Executive Director, Paul Kenyon and former Executive Officer, Tania Howarth each acquired shares in Nomad Foods Limited from Birds Eye Iglo Group LP Inc. Mr. Kenyon acquired 37,060 shares and Ms. Howarth acquired 38,956 shares at a price of $10.50 (€9.71) per share which was deemed to be at fair value. On June 12, 2017, Nomad repurchased 9,779,729 of our shares beneficially owned by Permira Funds ("Permira Repurchase") at a purchase price of $10.75 (approximately €9.60) per share, which represents a 25% discount to the closing price of our ordinary shares on June 9, 2017, for an aggregate purchase price of $105.1 million (approximately €93.9 million), in final settlement of indemnity claims against an affiliate of Permira Funds, of legacy tax matters that predated the Iglo Acquisition. In connection with the Permira Repurchase (and upon removal of certain transfer restrictions relating to their shares), Mr. Kenyon and Ms. Howath sold 26,372 and 27,721, shares, respectively.

Lord Myners of Truro CBE, a Non-Executive Director, holds 72,028 ordinary shares in Nomad Foods Limited which includes 50,000 ordinary shares granted pursuant to a five-year option that expires on June 2, 2020 at a purchase price of $11.50 per share.

As described in Note 8(b), certain of the Non-Executive Directors are eligible to an annual restricted stock grant issued under the LTIP which will vest on the earlier to occur of the date of the Company’s annual meeting of shareholders or thirteen months from the date of grant.

The Non-Executive Directors restricted share awards, granted at a share price of $11.50 on December 7, 2015, vested on June 16, 2016 and were issued in July at a share price of $8.98. Of the total 34,780 number of shares vesting, 11,568 shares were held back from issue by the Company as settlement towards personal tax liabilities arising on the vested shares. The total charge for restricted share awards granted in 2015 within the Statement of Consolidated Profit or Loss for the year ended December 31, 2016 for this stock compensation award was €0.3 million (nine months ended December 31, 2015: €0.1 million).

The Non-Executive Directors restricted share awards granted on June 16, 2016, which consisted of 55,680 shares at a share price of $8.98, vested on June 19, 2017 and were issued at a share price of $14.38, resulting in a €0.3 million increase in the share based compensation reserve. Of the total 55,680 number of shares vesting, 9,384 shares were held back from issue by the Company as settlement towards personal tax liabilities arising on the vested shares. The total charge for restricted share awards granted in 2016 within the Statement of Consolidated Profit or Loss for the year ended ended December 31, 2017 for this stock compensation award was €0.5 million (year ended December 31, 2016 : €0.3 million).

On June 19, 2017, Non-Executive Directors were granted 41,724 restricted share awards at a share price of $14.38. On August 22, 2017, two new Non-Executive Directors were granted a pro-rata 11,774 restricted share awards at the same share price and vesting conditions as the previous grant. The total charge for restricted share awards granted in 2017 within the Statement of Consolidated Profit or Loss for the year ended ended December 31, 2017 for this stock compensation award was €0.4 million.

The total charge for Non-Executive Director grants within the Statement of Consolidated Profit or Loss for the year endedDecember 31, 2017 for stock compensation awards was €0.8 million (Year ended December 31, 2016: €0.6 million; Nine months ended December 31, 2015: €0.1 million).

As part of its long term incentive initiatives, the company has 4,927,000 restricted shares to the management team (the “Management Share Awards”). The Directors and Executive Officers have all been awarded shares. The associated performance metrics and valuation method is detailed in Note 8(b).

XML

Significant events after the Statement of Financial Position date

12 Months Ended

Dec. 31, 2017

Events After Reporting Period [Abstract]

Significant events after the Statement of Financial Position date

Significant events after the Statement of Financial Position date

On December 29, 2017, we approved a 2017 Founder Preferred Share Dividend in an aggregate of 8,705,890 ordinary shares. The dividend price used to calculate the 2017 Founder Preferred Shares Annual Dividend Amount was $16.6516 (calculated based upon the volume weighted average price for the last ten trading days of 2017) and the Ordinary Shares were issued on January 2, 2018.

On January 17, 2018 we entered into an agreement to acquire Green Isle Foods Ltd. including the Goodfella's and San Marco brands, in an all cash deal valued at £200 million (approximately €225 million). We anticipate this acquisition to be completed in the second quarter of 2018 and we expect this will enlarge our portfolio of brands to include the number one and number two market share positions within the frozen pizza category in Ireland and the UK, a successful frozen private label pizza business, and two frozen pizza manufacturing facilities. The purchase price of the acquisition is expected to be funded through cash on hand.

In 2016, we announced the closure of our factory and pea processing operations in Bjuv, Sweden, and operations ceased in the first half of 2017 with production transferred to other factories in the Group’s network. In early 2018, we signed an agreement with Foodhills AB who will acquire the buildings and parts of the premises with the intention to develop a food production area. Legal handover of the site is scheduled for March 1, 2018. The purchase price could be up to 85 million SEK (approximately €8.6 million), but is subject to liabilities and warranties in the framework of the transaction.

XML

Accounting policies (Policies)

12 Months Ended

Dec. 31, 2017

Accounting Policies, Changes in Accounting Estimates and Errors [Abstract]

Measurement convention

Measurement convention

The financial statements are prepared on the historical cost basis with the exception of derivative financial instruments, business combinations, share based payments, and founder preferred shares which are stated at fair value.

Business combination

Business combination

The Company uses the acquisition method to account for business combinations. The consideration transferred for the acquisition of a subsidiary is the fair value of the assets transferred, the liabilities incurred and the equity interest issued by the Company. The consideration transferred includes the fair value of any asset or liability resulting from a contingent consideration arrangement. Identifiable assets acquired and liabilities and contingent liabilities assumed in a business combination are measured initially at their fair values at the acquisition date. Acquisition-related costs are expensed as incurred.

Where selling shareholders have contractually agreed to indemnify Nomad Foods Limited for contingent liabilities, an indemnification asset is recognized equivalent to the fair value of the liability recognized by Nomad. The indemnification asset is deducted from consideration transferred for the business combination. The indemnification asset value will subsequently be revised where revisions are made to the value of the liability or where there are doubts over the ability to recover losses from the selling shareholders.

Basis of consolidation

Basis of consolidation

The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. Intercompany balances and transactions, and any unrealized income and expenses arising from intra-group transactions are eliminated. Accounting policies are applied consistently across the Company.

Subsidiaries are all entities (including structured entities) over which Nomad has control; directly or indirectly. The Company controls an entity when the Company is exposed to, or has rights to, variable returns from its involvement with the entity and has the ability to affect those returns through its power over the entity. Subsidiaries are fully consolidated from the date on which control is transferred to the Company. They are deconsolidated from the date that control ceases.

Foreign currency

Foreign currency

i) Foreign currency transactions

Transactions in foreign currencies (currencies other than the functional currency) are translated into the functional currency at the foreign exchange rate ruling at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are translated into the functional currency at the foreign exchange rate ruling the financial year end. Foreign exchange gains and losses resulting from the settlement of such transactions and from the translation of monetary assets and liabilities denominated in foreign currencies at year end exchange rates are generally recognized in profit or loss. They are deferred in equity if they relate to qualifying cash flow hedges, qualifying net investment hedges or are attributable to part of a net investment in a foreign operation.

Non-monetary assets and liabilities in a foreign currency are translated into the functional currency to establish historical cost, using the exchange rate at the date of the transaction. Non-monetary assets and liabilities denominated in foreign currencies that are stated at fair value are translated at foreign exchange rates ruling at the date the fair value was determined. Translation differences on assets and liabilities carried at fair value are reported as part of the fair value gain or loss.

The revenues and expenses of foreign operations are translated at an average rate for the period (unless this is not a reasonable approximation of the cumulative effect of the rates prevailing on the transaction dates, in which case income and expenses are translated at the dates of the transaction).

ii) Assets and liabilities of foreign operations

For the purposes of presenting consolidated financial statements, the assets and liabilities of foreign operations, including goodwill and fair value adjustments arising on consolidation, are translated at foreign exchange rates ruling at the financial year endedDecember 31, 2017 of £1:€1.13 (December 31, 2016: £1:€1.17, December 31, 2015: £1:€1.36). The revenues and expenses of foreign operations are translated at an average rate for the period where this rate approximates to the foreign exchange rates ruling at the dates of the transactions.

Foreign exchange gains and losses that relate to these assets and liabilities are presented in the Consolidated Statement of Profit or Loss within ‘finance income or costs’, except where hedge accounting applies.

iii) Net investment in foreign operations

Exchange differences arising from the translation of foreign operations and of related qualifying hedges are taken directly to the translation reserve within equity. They are realized through the Consolidated Statement of Profit or Loss upon disposal of the related foreign operation.

Goodwill

Goodwill

Goodwill represents amounts arising on acquisition of subsidiaries. Goodwill is the difference between the cost of the acquisition and the fair value of the net identifiable assets acquired.

Goodwill is stated at cost less any accumulated impairment losses. Gains and losses on the disposal of an entity include the carrying amount of goodwill relating to the entity sold.

Goodwill is allocated to the cash-generating unit and is not monitored below the operating segment unit. Goodwill is not amortized but is tested annually for impairment.

Other intangible assets

Other intangible assets

Intangible assets acquired separately are recorded at cost and those acquired as part of a business combination are recorded at fair value as at the date of acquisition.

i) Computer software

Capitalized software costs include the cost of acquired computer software licenses and costs that are directly associated with the design, construction and testing of such software where this relates to a major business system. Costs associated with identifying, sourcing, evaluating or maintaining computer software are recognized as an expense within other operating expenses as incurred.

The assets are stated at cost less accumulated amortization and impairment losses. Software costs are amortized by equal monthly installments over their estimated useful economic life of five to seven years once the software is capable of being brought into use.

ii) Brands

Based on the market position of the brands, the significant levels of investment in advertising and promoting the brands, and the fact that they have been established for over 50 years, the Directors consider that the Birds Eye, Iglo and Findus brands have indefinite lives. Therefore these brands are not amortized, but instead held at historical cost less provision for any impairment.

The La Cocinera and Lutosa brands (Lutosa used under license until 2020) are deemed to not have an indefinite life and are being amortized by equal monthly installments within other operating expenses over 10 and 6 years respectively.

iii) Customer relationships

Long standing Food Service customer relationships have been identified as intangible assets as part of the Findus Acquisition. These are deemed to not have an indefinite life and are being amortized by equal monthly installments within other operating expenses over 14 years.

Impairment of non-current assets

Impairment of non-current assets

The carrying amounts of the Company’s non-current assets are reviewed annually to determine whether there is any indication of impairment. If any such indication exists, the asset’s recoverable amount is estimated. Impairment losses are recognized in the Consolidated Statement of Profit or Loss in the period in which they arise. For goodwill and assets that have an indefinite useful life an impairment review is performed at least annually.

Assets that are subject to amortization are reviewed for impairment whenever events or changes in circumstances indicate that the net carrying amount may not be recoverable. An impairment loss is recognized whenever the carrying amount of an asset or its cash-generating unit exceeds its recoverable amount.

i) Calculation of recoverable amount

Recoverable amount is the greater of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows of the business are discounted to their present value using a discount rate that reflects current market assessments of the time value of money and the risks specific to the asset. For an asset that does not generate largely independent cash inflows, the recoverable amount is determined for the cash-generating unit to which the asset belongs.

ii) Allocation of impairment losses

Impairment losses recognized in respect of cash-generating units are allocated first to reduce the carrying amount of any goodwill allocated to cash-generating units then to reduce the carrying amount of the other assets in the unit on a pro rata basis. A cash-generating unit is the smallest identifiable group of assets that generates cash inflows that are largely independent of the cash inflows from other assets or groups of assets.

iii) Reversals of impairment

An impairment loss in respect of goodwill is not reversed. In respect of other assets, an impairment loss is reversed when there is an indication that the impairment loss may no longer exist and there has been a change in the estimates used to determine the recoverable amount. An impairment loss is reversed only to the extent that the asset’s carrying amount does not exceed the carrying amount that would have been determined, net of depreciation or amortization, if no impairment loss had been recognized.

Property, plant and equipment

Property, plant and equipment

i) Owned assets

Property, plant and equipment are stated at cost less accumulated depreciation and impairment losses. Cost includes the original purchase price of the asset and the costs attributable to bringing the asset to its working condition for its intended use.

Where parts of an item of property, plant and equipment have different useful lives, they are accounted for as separate items of property, plant and equipment.

ii) Leased assets

Leases in which the Company assumes substantially all the risks and rewards of ownership of the leased asset are classified as ‘finance leases’. Where land and buildings are held under finance leases the accounting treatment of the land is considered separately from that of the buildings. Leased assets acquired by way of finance lease are stated at an amount equal to the lower of their fair value and the present value of the minimum lease payments at inception of the lease, less accumulated depreciation and impairment losses.

All other leases are classified as ‘operating leases’.

iii) Depreciation

Depreciation is charged to the Consolidated Statement of Profit or Loss on a straight line basis over the shorter of the lease term and the estimated useful lives of each part of an item of property, plant and equipment once the item is brought into use. Land is not depreciated. The estimated useful lives are as follows:

• Buildings 40 years

• Plant and equipment 5 to 14 years

• Computer equipment 3 to 5 years

The assets’ residual values and useful lives are reviewed on a frequent basis.

Inventories

Inventories

Inventories are stated at the lower of cost and net realizable value. Cost is based on the weighted average principle and includes expenditure incurred in acquiring the inventories and bringing them to their existing location and condition. Inventories that are acquired through business combinations are fair valued at the time of acquisition. In the case of manufactured inventories and work in progress, cost includes an appropriate share of direct costs and overheads based on normal operating capacity. Provision is made for slow moving, obsolete and defective inventories.

Employee benefits

Employee benefits

i) Defined contribution plans

Obligations for contributions to defined contribution pension plans are recognized as an expense in the Consolidated Statement of Profit or Loss as incurred. Prepaid contributions are recognized as an asset to the extent that a cash refund or reduction in the future payments is available.

ii) Defined benefit plans

The Company’s net obligation in respect of defined benefit pension plans and other post-employment benefits is calculated separately for each plan by estimating the amount of future benefit that employees have earned in return for their service in the current and prior periods. That net obligation is discounted to determine its present value. The calculation is performed by a qualified actuary using the projected unit credit method.

The current service cost of the defined benefit plan, recognized in the Consolidated Statement of Profit or Loss in staff costs included within Operating profit/(loss), except where included in the cost of an asset, reflects the increase in the defined benefit obligation resulting from employee service in the current year, benefit changes, curtailments and settlements.

Actuarial gains and losses arising from experience adjustments and changes in actuarial assumptions are charged or credited to equity in Other Comprehensive Income in the period in which they arise.

The net interest cost is calculated by applying the discount rate to the net balance of the defined benefit obligation and the fair value of plan assets. This cost is included in employee benefit expense in the Consolidated Statement of Profit or Loss.

Past service cost is recognized immediately.

Founder Preferred Shares

Founder Preferred Shares

Nomad Foods issued Founder Preferred Shares to both TOMS Acquisition I, LLC and Mariposa Acquisition II, LLC (collectively the “Founder Entities”) in connection with its initial public offering in April 2014. Holders of the Founder Preferred Shares are entitled to receive annual dividend amounts subject to certain performance conditions (the “Founder Preferred Shares Dividend Amount”). The instrument and its component parts were analyzed under IFRS 2. The Company intends that any future Founder Preferred Shares Annual Dividend Amount will be equity settled. Accordingly, the Founder Preferred Shares Annual Dividend Amount as of June 1, 2015 of €531.5 million (the “Founder Preferred Shares Dividend reserve”) was classified as equity and no further revaluations will be required or recorded.

Should a Founder Preferred Share Annual Dividend Amount become due and payable, the market value of any dividend paid will be deducted from the Founder Preferred Shares Dividend reserve, with any excess deducted from the accumulated profit/(deficit) reserve within equity.

Provisions/Onerous contracts provisions

Provisions

Provisions are recognized when the Company has a legal or constructive present obligation as a result of a past event and it is probable that the Company will be required to settle that obligation. Provisions are measured at the Directors’ best estimate of the expenditure required to settle the obligation at the financial year end date and are discounted to present value where the effect is material.

Where it is not possible to make a reliable estimate of the estimated financial effect of a provision, appropriate disclosure of the resulting contingent liability is made, but no provision is recognized.

Onerous contracts provisions

Where the costs of fulfilling a contract exceed the economic benefits that the Company expects to receive from it, an onerous contract provision is recognized for the net unavoidable costs. In estimating the net unavoidable costs, management estimate foreseeable income that may be received and offset this against the minimum future cash outflows from fulfilling the contract. All cash flows are discounted at an appropriate discount rate.

Financial instruments

Financial instruments

Financial assets and liabilities are recognized in the Company’s Statement of Financial Position when the Company becomes a party to the contractual provisions of the instrument.

i) Trade receivables

Trade receivables are measured at initial recognition at fair value and are subsequently measured at amortized cost using the effective interest method, less any impairment. Since trade receivables are due within one year, this equates to initial carrying value less any impairment.

Appropriate allowances for estimated irrecoverable amounts are recognized in the Consolidated Statement of Profit or Loss when there is objective evidence that the asset is impaired.

Trade receivables are presented net of customer rebate balances.

ii) Cash and cash equivalents

Cash and cash equivalents comprise of cash balances and call deposits.

iii) Loans and borrowings

a. Valuation

Interest bearing borrowings are recognized initially at fair value less attributable transaction costs.

Subsequent to initial recognition, interest bearing loans and borrowings are stated at amortized cost with any difference between cost and redemption value being recognized in the Consolidated Statement of Profit or Loss over the expected period of the borrowings.

b. Capitalization of transaction costs

Fees paid on the establishment of loan facilities are recognized as transaction costs of the loan to the extent that it is probable that some or all of the facility will be drawn down. In this case, the fee is deferred until the draw-down occurs.

iv) Trade payables

Trade payables are measured at initial recognition at fair value and are subsequently measured at amortized cost using the effective interest method. Since trade payables are largely due within one year, this equates to initial carrying value.

v) Derivative financial instruments and hedge accounting

Derivative financial instruments are recognized at fair value. When a derivative financial instrument is not designated in a hedge relationship that qualifies for hedge accounting, all changes in its fair value are recognized immediately in the Consolidated Statement of Profit or Loss. However, where derivatives qualify for hedge accounting, recognition of any resultant gain or loss depends on the nature of the item being hedged.

The fair value of derivative financial instruments is determined using forward rates at the balance sheet date, with the resulting value discounted back to present value.

Cross currency interest rate swaps are managed based on their net exposure to credit risks. The Company has used the exception in IFRS 13 to allow this group of derivatives to be measured on a net basis by each counterpart.

a.    Cash flow hedges

Where a derivative financial instrument is designated as a hedge of the variability in cash flows of a recognized asset or liability, or a highly probable forecast transaction, the effective part of any gain or loss on the derivative financial instrument is recognized directly in the cash flow hedging reserve. Any ineffective portion of the hedge is recognized immediately in the Consolidated Statement of Profit or Loss.

When a hedging instrument expires or is sold, terminated or exercised, or the entity revokes designation of the hedge relationship but the hedged forecast transaction is still expected to occur, the cumulative gain or loss at that point remains in equity and is recognized when the transaction occurs. If the hedged transaction is no longer expected to take place, the cumulative unrealized gain or loss recognized in equity is recognized in the Consolidated Statement of Profit or Loss immediately.

b. Net investment hedges

Foreign currency differences arising on the retranslation of a financial liability designated as a hedge of a net investment in a foreign operation are recognized in Other Comprehensive Income to the extent that the hedge is effective, and are presented in the translation reserve within equity. To the extent that the hedge is ineffective, such differences are recognized in the Consolidated Statement of Profit or Loss. When the hedged net investment is disposed of, the relevant amount in the translation reserve is transferred to the Consolidated Statement of Profit or Loss as part of the gain or loss on disposal.

Revenue

Revenue

Revenue comprises sales of goods after deduction of discounts, sales taxes and excludes intra-company sales. Discounts given by the Company include rebates, price reductions and incentives given to customers, promotional couponing and trade communication costs. At each financial year end date any discount incurred, but not yet invoiced, is estimated and accrued.

Revenue is recognized when the title and risk of loss of the underlying products have been transferred to the customer, at which point the sale price is fixed or determinable. This completes the revenue-earning process specifically that an arrangement exists, delivery has occurred, ownership has transferred, the price is determined and collectability is reasonably assured. The timing of the transfer of risks and rewards varies depending on the individual terms of the sales agreement. A provision for payment discounts and product return allowances, which is estimated based upon the Company’s historical performance, management’s experience and current economic trends, is recorded as a reduction of sales in the same period that the revenue is recognized.

Trade promotions, consisting primarily of customer pricing allowances and merchandising funds and customer coupons are offered through various programs to customers and consumers. Sales are recorded net of estimated trade promotion spending, which is recognized as incurred at the time of sale. Certain retailers require the payment of slotting fees in order to obtain space for the Company’s products on the retailers’ store shelves. The fees are recognized as reductions of revenue on the date a liability to the retailer is created. These amounts are included in the determination of net sales. Accruals for expected pay-outs under these programs are included within trade receivables or trade payables in the Consolidated Statement of Financial Position. Coupon redemption costs are also recognized as reductions of net sales when the coupons are issued. Estimates of trade promotion expense and coupon redemption costs are based upon programs offered, timing of those offers, estimated redemption/usage rates from historical performance, management’s experience and current economic trends.

Trade marketing expense is comprised of amounts paid to retailers for programs designed to promote our products and are classified in the Consolidated Statement of Profit or Loss as a reduction of revenue.

Share based payments

Share based payments

Successor

Nomad Foods 2015 Long Term Incentive Plan

The Nomad Foods 2015 Long Term Incentive Plan (the “LTIP”), which incorporates an annual Non-Executive Directors Restricted Stock Scheme, falls within the provisions of IFRS 2 “Share-based Payment” and awards under the LTIP represent equity settled share based payments. A charge is taken to the Consolidated Statement of Profit or Loss for the difference between the fair value of the shares at grant date and the amount subscribed, spread over the vesting period.

Share based payment arrangements in which Nomad receives goods or services as consideration for its own equity instruments are accounted for as equity-settled share based payment transactions, regardless of how the equity instruments are obtained by Nomad.

The grant date fair value of share-based payment awards granted to any Director or employee is recognized as an associated expense, with a corresponding increase in equity, over the period that any Director or employee becomes unconditionally entitled to the awards.

The fair value of the awards granted is measured using a valuation model, taking into account the terms and conditions upon which the awards were granted. The amount recognized as an expense is adjusted to reflect the actual number of awards for which the related service and non-market vesting conditions are expected to be met, such that the amount ultimately recognized as an expense is based on the number of awards that do meet the related service and non-market performance conditions at the vesting date. For share-based payment awards with non-vesting conditions, the grant date fair value of the share-based payment is measured to reflect such conditions and there is no true-up for differences between expected and actual outcomes.

See Note 8b for further information on the Company’s share-based payment arrangements and details of the valuation model used.

Predecessor

At the end of each reporting period, the Iglo Group revised its estimates of the number of interests that were expected to vest based on the non-market vesting conditions. It recognized the impact of the revision to original estimates, if any, in the Consolidated Statement of Profit or Loss, with a corresponding adjustment to equity.

Other management incentive schemes

If schemes fall outside the scope of IFRS 2, since they are not related to the price or value of equity instruments, but do fall within the scope of IAS 19 “Employee Benefits”, an annual charge is taken over the service period based on an estimate of the amount of future benefit employees will earn in return for their service.

Interest income

Interest income

Interest income is recognized in the Consolidated Statement of Profit or Loss on an accruals basis using the effective interest method.

Expenses

Expenses

i) Operating lease payments

Payments made under operating leases are recognized in the Consolidated Statement of Profit or Loss on a straight line basis over the term of the lease. Lease incentives received are recognized on a straight line basis in the Consolidated Statement of Profit or Loss as an integral part of the total lease expense.

ii) Borrowing costs

Unless capitalized as part of the cost of borrowing (see Note 3.13(iii)), borrowing costs are recognized in the Consolidated Statement of Profit or Loss in the period in which they are incurred.

iii) Exceptional items

The separate reporting of exceptional items which are presented as exceptional within the relevant Consolidated Statement of Profit or Loss category, helps provide an indication of the Company’s underlying business performance. Exceptional items have been identified and presented by virtue of their size, nature or incidence. In determining whether an event or transaction is specific, management considers quantitative as well as qualitative factors such as the frequency or predictability of occurrence. Exceptional items comprise restructuring costs, impairments or reversal of impairments of intangible assets, operational restructuring, integration and acquisition costs relating to new acquisitions, investigation of strategic opportunities and other items, costs relating to certain management incentive plans and other significant items (see Note 7).

iv) Research and development

Expenditure on research activities is recognized in the Consolidated Statement of Profit or Loss as an expense as incurred.

Taxation

Taxation

Tax on the profit or loss for the year comprises current and deferred tax. Tax is recognized in the Consolidated Statement of Profit and Loss except to the extent that it relates to items recognized directly in equity, in which case it is recognized in equity.

Current tax is the expected tax payable on the taxable income for the year, using tax rates enacted or substantively enacted at the financial year end date, and any adjustment to tax payable in respect of previous years. Where tax exposures can be quantified, an accrual for uncertain tax positions is made based on the best estimates and management’s judgments. Given the inherent uncertainties in assessing the outcomes of these exposures (which can sometimes be binary in nature), the Company could in future periods experience adjustments to these accruals.

Deferred tax is provided on temporary differences between the carrying amounts of assets and liabilities recognized for financial reporting purposes and the amounts used for taxation purposes on an undiscounted basis. The following temporary differences are not provided for: the initial recognition of goodwill; the initial recognition of assets or liabilities that affect neither accounting nor taxable profit other than in a business combination, and differences relating to investments in subsidiaries to the extent that they will probably not reverse in the foreseeable future. The amount of deferred tax provided is based on the expected manner of realization or settlement of the carrying amount of assets and liabilities, using tax rates enacted or substantively enacted at the financial year end date.

A deferred tax asset is recognized only to the extent that it is probable that future taxable profits will be available against which the asset can be utilized.

Segment reporting

Segment reporting

The Chief Operating Decision Maker (“CODM”) has been determined to be the Chief Executive Officer as he is primarily responsible for the allocation of resources to the segments and the assessment of performance of the segments.

Nomad’s operations are organized into one operating unit, ‘Frozen’, which comprises all the brands, as well as the factories, private label business units and certain corporate overheads. The CODM primarily uses (“Adjusted EBITDA”), disclosed in Note 5, as the key measure of the segment’s results. Adjusted EBITDA is EBITDA adjusted to exclude (when they occur) exited markets, chart of account (“CoA”) alignments and exceptional items such as restructuring charges, goodwill and intangible asset impairment charges, the impact of share based payment charges, charges relating to the Founder Preferred Shares Annual Dividend Amount, charges relating to the redemption of warrants and other unusual or non-recurring items.

Unfavorable contracts

Unfavorable contracts

Unfavorable contracts recognized from business combinations are classified as a liability, discounted and recognized over the term of the underlying contract as a reduction in the associated expense.

IFRSs not yet adopted

IFRSs not yet adopted

At the date of authorization of these financial statements, the following Standards and Interpretations, which have not been applied in the financial statements, were in issue but not yet effective:

• IFRS 9 ‘Financial Instruments’ addresses the classification, measurement and recognition of financial assets and financial liabilities and replaces IAS 39. The standard reduces the complexity of the current rules on financial instruments as mandated in IAS 39. IFRS 9 replaces the ‘incurred loss model’ in IAS 39 with an ‘expected credit loss’ model. The standard also introduces new presentation and disclosure requirements. The standard also introduces new hedge accounting rules although the adoption of these is optional so that the hedge accounting rules under IAS 39 may continue to be applied. The effective date for the adoption of IFRS 9 is annual periods beginning on or after 1 January 2018. Except for hedge accounting, retrospective application is required but providing comparative information is not compulsory. For hedge accounting, the requirements are generally applied prospectively, with some limited exceptions.

The Group has completed its assessment of the effects of transition to IFRS 9. The impacts that have been identified on adopting IFRS 9 on the Group are detailed below.

–Classification and measurement: IFRS 9 establishes a principle based approach for classification of financial assets based on cash flow characteristics of the asset and the business model in which an asset is held as well as changes to the measurement of financial liabilities held at FVTPL. The change in classification does not affect the accounting recognition of financial assets presented in these financial statements and the impact of the change in measurement on financial liabilities as at December 31, 2017 is €nil.

–Impairment: The significant financial assets held that are affected by the impairment losses recognised under IFRS 9 are trade receivables, for which the gross balance as at December 31, 2017 is €289.0 million with an impairment provision of €5.8 million. Management has performed an assessment of the impairment of trade receivables under IFRS 9 using Expected Credit Losses derived from actual credit losses experienced in the past. Based on this assessment, the impairment provision was found to be comparable to the existing provision, with no material difference.

–Hedge accounting: The Group has elected not to apply IFRS 9 for hedge accounting.

• IFRS 15 ‘Revenue from contracts with customers’ outlines a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance. The core principle of the new standard is for companies to recognize revenue to depict the transfer of goods or services to customers in amounts that reflect the consideration to which the company expects to be entitled in exchange for those goods or services.

Management has assessed the effects of applying the new standard on the Company’s financial statements and has identified that the presentation of contract assets and contract liabilities will need to be changed. Specifically, adoption of IFRS 15 will result in additional disclosures in our footnotes around discounts and trade marketing expenses as of 1 January 2018 in relation to trade terms which are currently included in other balance sheet line items.

The Company has quantified that there is no material impact on revenue recognition by applying this standard. The Company will apply the standard using the modified retrospective approach which means that any cumulative impact of the adoption identified would have been be recognized in retained earnings as of January 1, 2018 and that comparatives will not be restated.

• IFRS 16 ‘Leases’ sets out the principles for the recognition, measurement, presentation and disclosure of leases and replaces IAS 17 ‘Leases’. The standard introduces a single lessee accounting model and requires a lessee to recognize assets and liabilities for all leases with a term of more than 12 months, unless the underlying asset is of low value. The Standard also contains enhanced disclosure requirements for lessees. This IFRS will become effective for accounting periods starting on January 1, 2019 with early application permitted for companies applying IFRS 15 ‘Revenue from Contracts with Customers’.

XML

Segment reporting (Tables)

12 Months Ended

Dec. 31, 2017

Operating Segments [Abstract]

Segment As Adjusted EBITDA

Segment Adjusted EBITDA

		Successor	Successor	Successor		Successor		Predecessor
		Year ended December 31, 2017	Year ended December 31, 2016	9 months ended December 31, 2015		Year ended March 31, 2015		5 months ended May 31, 2015
	Note	€m	€m	€m		€m		€m
Profit/(loss) for the period		136.5	36.4	(337.3	)	(167.5	)	(128.0	)
Taxation		32.0	39.6	(12.3	)	—		40.9
Net financing costs/(income)		74.4	62.1	35.5		(0.1	)	115.7
Depreciation	12	35.9	43.3	20.3		—		11.3
Amortization	13	6.5	7.8	1.5		—		1.2
EBITDA		285.3	189.2	(292.3	)	(167.6	)	41.1
Net purchase-price adjustment-inventory step up		—	—	37.0		—		—
Net purchase-price adjustment for cash flow hedge accounting		—	—	4.9		—		—
Charge related to Founder Preferred Shares Annual Dividend Amount	27	—	—	349.0		165.8		—
(Credit)/charge relating to Warrant Redemption Liability	25	—	—	(0.4	)	0.4		—
Exceptional items	7	37.2	134.5	58.1		0.7		84.3
Other add-backs		5.6	1.2	—		—		—
Adjusted EBITDA		328.1	324.9	156.3		(0.7	)	125.4
Unallocated corporate costs		—	—	2.5		0.7		—
Frozen Adjusted EBITDA		328.1	324.9	158.8		—		125.4

External Revenue and Non-current Assets by Geography

External revenue by geography

	Successor	Successor	Successor	Successor	Predecessor
	Year ended December 31, 2017	Year ended December 31, 2016	9 months ended December 31, 2015	Year ended March 31, 2015	5 months ended May 31, 2015
	€m	€m	€m	€m	€m
United Kingdom	411.9	437.5	288.6	—	225.0
Italy	371.4	348.5	205.2	—	169.7
Germany	300.3	267.8	150.0	—	124.2
Sweden	208.0	218.2	35.5	—	—
France	170.0	168.9	41.0	—	—
Norway	123.3	122.6	19.6	—	—
Austria	96.7	92.9	51.8	—	45.0
Spain	81.2	82.6	13.1	—	—
Rest of Europe	193.8	188.7	89.4	—	76.4
Total external revenue by geography	1,956.6	1,927.7	894.2	—	640.3

Non-current assets by geography

	Successor	Successor
	December 31, 2017	December 31, 2016
	€m	€m
Germany	126.4	118.0
United Kingdom	94.8	77.5
Italy	55.0	59.1
Sweden	26.5	44.6
France	16.7	18.4
Norway	15.7	13.3
Rest of Europe	20.2	6.1
Total non-current assets by geography	355.3	337.0

XML

Operating profit/(loss) (Tables)

12 Months Ended

Dec. 31, 2017

Analysis of income and expense [abstract]

Disclosure of Detailed Information About Profit (Loss) from Operating Activities

Operating profit /(loss) is stated after charging:

		Successor		Successor		Successor	Successor	Predecessor
		Year ended December 31, 2017		Year ended December 31, 2016		9 months ended December 31, 2015	Year ended March 31, 2015	5 months ended May 31, 2015
	Note	€m		€m		€m	€m	€m
Staff costs	8	257.4		264.5		160.2	—	88.8
Depreciation of property, plant and equipment	12	35.9		43.3		20.3	—	11.3
Impairment of property, plant and equipment	12	0.3		1.4		3.2	—	—
Impairment of goodwill and brands	13	—		—		—	—	55.0
Amortization of software and brands	13	6.5		7.8		1.5	—	1.2
Operating lease charges		15.0		14.6		4.2	—	3.2
Exchange (gains)/losses		(1.2	)	(3.3	)	5.2	88.9	(9.0	)
Fair value loss on financial assets at fair value through profit and loss		—		—		4.9	—	—
Research & development expenditure		15.4		13.3		12.1	—	7.2
Inventories recognized as an expense within cost of goods sold		1,273.3		1,282.6		608.9	—	389.3

XML

Exceptional items (Tables)

12 Months Ended

Dec. 31, 2017

Analysis of income and expense [abstract]

Schedule of Exceptional Items

Exceptional items are made up as follows:

	Successor		Successor		Successor		Successor	Predecessor
	Year ended December 31, 2017		Year ended December 31, 2016		9 months ended December 31 2015		Year ended March 31, 2015	5 months ended May 31, 2015
	€m		€m		€m		€m	€m
Investigation of strategic opportunities (1)	18.8		7.0		7.7		—	1.3
Supply chain reconfiguration (2)	14.0		84.3		—		—	—
Findus Group integration costs (3)	15.1		29.6		4.5		—	—
Costs related to transactions (4)	3.2		4.8		34.1		0.7	3.8
Costs related to long-term management incentive plans (5)	—		1.9		3.5		—	22.9
Other restructuring costs (6)	—		(1.0	)	8.9		—	—
Cisterna fire net (income)/costs (7)	—		(4.3	)	(2.5	)	—	1.3
Impairment of intangible assets (8)	—		—		—		—	55.0
Settlement of legacy matters (9)	(5.6	)	1.8		1.9		—	—
Remeasurement of indemnification assets (10)	(8.3	)	10.4		—		—	—
Total exceptional items	37.2		134.5		58.1		0.7	84.3

XML

Payroll costs, share based payments and management incentive schemes (Tables)

12 Months Ended

Dec. 31, 2017

Employee Benefits And Share-Based Payments [Abstract]

Disclosure of Employee Information

The average number of persons employed by the Company (excluding non-Executive Directors) is analyzed and set out below:

	Successor	Successor	Successor	Successor	Predecessor
	Year ended December 31, 2017	Year ended December 31, 2016	9 months ended December 31, 2015	Year ended March 31, 2015	5 months ended May 31, 2015
Production	2,285	2,627	2,605	—	1,635
Administration, distribution & sales	1,572	1,571	1,767	—	1,047
Total number of employees	3,857	4,198	4,372	—	2,682

Disclosure of Employee Benefit Expense

The table below discloses the Company’s aggregate payroll costs of these persons. Payroll costs exclude long term management incentive scheme and share based payment costs, but includes bonus costs, in particular those associated with a non-cash bonus for key management employees, whereby 13,104 Ordinary shares of the Company were issued to the recipients’ on November 27, 2015.

	Successor	Successor	Successor	Successor	Predecessor
	Year ended December 31, 2017	Year ended December 31, 2016	9 months ended December 31, 2015	Year ended March 31, 2015	5 months ended May 31, 2015
	€m	€m	€m	€m	€m
Wages and salaries	200.8	205.4	126.7	—	72.1
Social security costs	42.0	45.9	27.5	—	12.5
Other pension costs	14.6	13.2	6.0	—	4.2
Total payroll costs	257.4	264.5	160.2	—	88.8

Inputs and Assumptions Underlying the Monte Carlo Model

Following a revision to the January 1, 2016 award EBITDA Performance Target Conditions and updating for scheme leavers, the inputs and assumptions underlying the Monte Carlo models for both awards are now as follows:

	January 1, 2016 award			January 1, 2017 award
Grant date price	$	12.00		$	9.57
Exercise price	$	—		$	—
Expected life of restricted share	3.02 – 4.00 years			3.11 – 4.00 years
Expected volatility of the share price	20.0		%	23.0		%
Dividend yield expected	—		%	—		%
Risk free rate	1.59		%	1.83		%
Employee exit rate	16.0		%	16.0		%
EBITDA Performance Target Condition	5.0%-75.0%			5.0%-75.0%

Disclosure of Share Based Compensation Reserve

	Share based compensation reserve
	€m
Balance as of January 1, 2017	1.0
Non-Executive Director restricted share awards charge	0.8
Directors and Senior Management share awards charge	1.8
Vesting of Non-Executive Director restricted shares	(0.7)
Balance as of December 31, 2017	2.9

XML

Directors and Key Management compensation (Tables)

12 Months Ended

Dec. 31, 2017

Related Party [Abstract]

Disclosure of transactions between related parties

	Successor	Successor	Successor	Successor	Predecessor
	Year ended December 31, 2017	Year ended December 31, 2016	9 months ended December 31, 2015	Year ended March 31, 2015	5 months ended May 31, 2015
	€m	€m	€m	€m	€m
Short-term employee benefits	2.0	2.1	1.3	—	1.9
Contributions to money purchase pension plans	—	—	—	—	0.2
Share-based payment	1.4	0.9	0.1	—	2.2
Long-term incentive scheme	—	—	—	—	17.4
Compensation for loss of office	0.4	—	—	—	—
Non-Executive Director fees	0.3	0.2	0.1	0.2	—
Total Directors’ and executive officers' compensation	4.1	3.2	1.5	0.2	21.7

	Successor	Successor	Successor	Successor	Predecessor
	Year ended December 31, 2017	Year ended December 31, 2016	9 months ended December 31, 2015	Year ended March 31, 2015	5 months ended May 31, 2015
Retirement benefits are accruing to the following number of directors under:
Money purchase schemes	2	1	1	—	4

XML

Finance income and costs (Tables)

12 Months Ended

Dec. 31, 2017

Analysis of income and expense [abstract]

Schedule of Finance income and costs

		Successor		Successor		Successor		Successor	Predecessor
		Year ended December 31, 2017		Year ended December 31, 2016		9 months ended December 31, 2015		Year ended March 31, 2015	5 months ended May 31, 2015
	Note	€m		€m		€m		€m	€m
Interest income		0.2		5.9		4.4		—	2.0
Gain on derivatives		7.0		—		4.3		—	—
Net foreign exchange gains on translation of financial assets and liabilities		—		18.3		—		0.1	—
Finance income		7.2		24.2		8.7		0.1	2.0
Accrued interest		—		—		—		—	(60.2	)
Cash pay interest expense		(54.0	)	(68.7	)	(38.8	)	—	(35.4	)
Cross-currency interest rate swaps: cash flow hedges, transfer from equity		3.9		—		—		—	—
Other interest expense		—		(2.8	)	—		—	—
Net pension interest costs		(3.6	)	(4.1	)	(1.9	)	—	(0.7	)
Amortization of borrowing costs		(2.7	)	(5.0	)	(2.1	)	—	(0.9	)
Net foreign exchange losses on translation of financial assets and liabilities		(3.9	)	—		(0.5	)	—	(20.5	)
Interest on unwinding of discounted items		(1.2	)	(1.4	)	—		—	—
Loss on derivatives		—		(4.3	)	—		—	—
Financing costs incurred in amendment of terms of debt(1)		(20.1	)	—		(0.9	)	—	—
Finance costs		(81.6	)	(86.3	)	(44.2	)	—	(117.7	)
Net finance (costs)/income		(74.4	)	(62.1	)	(35.5	)	0.1	(115.7	)

(1)     A one-off charge of €20.1 million was incurred as a consequence of the refinancing in May 2017 and repricing in December 2017. Of this, deferred transaction costs of €15.7 million relating to the previous senior debt were written off.

XML

Taxation (Tables)

12 Months Ended

Dec. 31, 2017

Income Taxes [Abstract]

Components Of Tax Expense (Benefit)

		Successor		Successor		Successor		Successor	Predecessor
		Year ended December 31, 2017		Year ended December 31, 2016		9 months ended December 31, 2015		Year ended March 31, 2015	5 months ended May 31, 2015
	Note	€m		€m		€m		€m	€m
Current tax expense
Current tax on profits/loss for the period		(37.5	)	(58.9	)	(18.0	)	—	(41.2	)
Adjustments in respect of prior periods		3.2		(0.6	)	(2.3	)	—	15.2
		(34.3	)	(59.5	)	(20.3	)	—	(26.0	)
Deferred tax income/(expense)
Origination and reversal of temporary differences		(2.1	)	12.9		10.4		—	(14.9	)
Impact of change in tax rates		4.4		7.0		22.2		—	—
	16	2.3		19.9		32.6		—	(14.9	)
Total tax (expense)/credit		(32.0	)	(39.6	)	12.3		—	(40.9	)

Reconciliation Of Effective Tax Rate

Reconciliation of effective tax rate:

	Successor		Successor		Successor		Successor		Predecessor
	Year ended December 31, 2017		Year ended December 31, 2016		9 months ended December 31, 2015		Year ended March 31, 2015		5 months ended May 31, 2015
	€m		€m		€m		€m		€m
Profit/(loss) before tax	168.5		76.0		(349.6	)	(167.5	)	(87.1	)
Tax (charge)/credit at the standard UK corporation tax rate 19.25% (2016: 20%; 2015: 20.25%)	(32.5	)	(15.2	)	70.8		33.9		17.6
Difference in tax rates	(10.0	)	(10.0	)	(67.5	)	(33.9	)	(4.6	)
Non tax deductible interest	4.4		—		(9.9	)	—		(8.7	)
Other income and expenses not taxable or deductible	16.8		(7.4	)	1.0		—		(21.6	)
Unrecognized tax assets	(19.3	)	(1.8	)	(2.1	)	—		(30.9	)
Provisions for uncertainties	1.0		(11.6	)	0.1		—		(7.9	)
Impact of change in deferred tax rates	4.4		7.0		22.2		—		—
Prior period adjustment	3.2		(0.6	)	(2.3	)	—		15.2
Total tax (expense)/credit	(32.0	)	(39.6	)	12.3		—		(40.9	)

Income Tax Relating to Components Of Other Comprehensive Income

The tax (credit)/charge relating to components of other comprehensive income is as follows:

Successor

		Before tax		Tax charge/ (credit)		After tax
Year ended December 31, 2017	Note	€m		€m		€m
Remeasurement of post-employment benefit liabilities		(2.9	)	2.0		(0.9	)
Net investment hedge		0.8		—		0.8
Cash flow hedges		16.4		(5.0	)	11.4
Other comprehensive loss		14.3		(3.0	)	11.3
Current tax		—		—		—
Deferred tax	16	—		(3.0	)	—
		—		(3.0	)	—
		Before tax		Tax charge		After tax
Year ended December 31, 2016	Note	€m		€m		€m
Remeasurement of post-employment benefit liabilities		23.6		6.3		29.9
Net investment hedge		0.5		—		0.5
Cash flow hedges		(10.1	)	2.8		(7.3	)
Other comprehensive loss		14.0		9.1		23.1
Current tax		—		—		—
Deferred tax	16	—		9.1		—
		—		9.1		—
		Before tax		Tax charge		After tax
Nine months ended December 31, 2015	Note	€m		€m		€m
Remeasurement of post-employment benefit liabilities		(19.4	)	6.1		(13.3	)
Net investment hedge		4.4		—		4.4
Cash flow hedges		(1.6	)	0.5		(1.1	)
Other comprehensive (income)/loss		(16.6	)	6.6		(10.0	)
Current tax		—		—		—
Deferred tax	16	—		6.6		—
		—		6.6		—

Predecessor
		Before tax		Tax credit		After tax
5 months ended May 31, 2015	Note	€m		€m		€m
Remeasurement of post-employment benefit liabilities		2.5		(0.7	)	1.8
Net investment hedge		(44.7	)	—		(44.7	)
Cash flow hedges		—		—		—
Other comprehensive income		(42.2	)	(0.7	)	(42.9	)
Current tax		—		—		—
Deferred tax	16	—		(0.7	)	—
		—		(0.7	)	—

XML

Property, plant and equipment (Tables)

12 Months Ended

Dec. 31, 2017

Property, plant and equipment [abstract]

Property, plant and equipment

	Land and buildings		Plant and equipment		Computer equipment		Total
	€m		€m		€m		€m
SUCCESSOR
Cost
Balance at December 31, 2015	119.2		221.8		2.4		343.4
Acquisitions through business combinations	—		2.5		—		2.5
Additions	3.3		34.3		0.4		38.0
Transfer to intangible assets (note 13)	(1.7	)	1.1		—		(0.6	)
Disposals	(2.7	)	(0.6	)	—		(3.3	)
Effect of movements in foreign exchange	(7.6	)	(28.8	)	—		(36.4	)
Balance at December 31, 2016	110.5		230.3		2.8		343.6
Additions	11.6		26.0		0.4		38.0
Disposals	(0.1	)	(1.1	)	—		(1.2	)
Effect of movements in foreign exchange	(4.6	)	(12.7	)	—		(17.3	)
Balance at December 31, 2017	117.4		242.5		3.2		363.1
Accumulated depreciation and impairment
Balance at December 31, 2015	3.4		21.4		0.4		25.2
Depreciation	6.5		35.7		1.1		43.3
Impairment	(0.2	)	1.6		—		1.4
Transfers	—		0.2		(0.2	)	—
Effect of movements in foreign exchange	(3.9	)	(20.5	)	(0.1	)	(24.5	)
Balance at December 31, 2016	5.8		38.4		1.2		45.4
Depreciation	6.1		28.9		0.9		35.9
Impairment	—		0.3		—		0.3
Effect of movements in foreign exchange	(3.7	)	(10.2	)	—		(13.9	)
Balance at December 31, 2017	8.2		57.4		2.1		67.7
Net book value December 31, 2015	115.8		200.4		2.0		318.2
Net book value December 31, 2016	104.7		191.9		1.6		298.2
Net book value December 31, 2017	109.2		185.1		1.1		295.4

XML

Goodwill and Intangibles (Tables)

12 Months Ended

Dec. 31, 2017

Intangible assets and goodwill [abstract]

Disclosure of reconciliation of changes in intangible assets and goodwill

	Goodwill	Brands	Computer software		Customer relationships	Others		Total
	€m	€m	€m		€m	€m		€m
Cost
Balance at December 31, 2015	1,676.8	1,688.9	11.0		31.0	0.2		3,407.9
Acquisitions through business combinations	68.8	—	—		—	(0.2	)	68.6
Additions	—	—	4.4		—	—		4.4
Transfer from tangible assets (note 12)	—	—	0.6		—	—		0.6
Effect of movements in foreign exchange	—	—	(1.3	)	—	—		(1.3	)
Balance at December 31, 2016	1,745.6	1,688.9	14.7		31.0	—		3,480.2
Additions	—	—	4.6		—	—		4.6
Effect of movements in foreign exchange	—	—	(1.0	)	—	—		(1.0	)
Balance at December 31, 2017	1,745.6	1,688.9	18.3		31.0	—		3,483.8

	Goodwill	Brands	Computer software		Customer relationships	Others	Total
	€m	€m	€m		€m	€m	€m
Accumulated amortization and impairment
Balance at December 31, 2015	—	0.1	1.0		0.4	—	1.5
Amortization	—	0.7	4.9		2.2	—	7.8
Effect of movements in foreign exchange	—	—	(1.3	)	—	—	(1.3	)
Balance at December 31, 2016	—	0.8	4.6		2.6	—	8.0
Amortization	—	0.7	3.6		2.2	—	6.5
Effect of movements in foreign exchange	—	—	(0.7	)	—	—	(0.7	)
Balance at December 31, 2017	—	1.5	7.5		4.8	—	13.8
Net book value December 31, 2015	1,676.8	1,688.8	10.0		30.6	0.2	3,406.4
Net book value December 31, 2016	1,745.6	1,688.1	10.1		28.4	—	3,472.2
Net book value December 31, 2017	1,745.6	1,687.4	10.8		26.2	—	3,470.0

XML

Investments (Tables)

12 Months Ended

Dec. 31, 2017

Interests in Other Entities [Abstract]

Disclosure of Significant Investments

The following are the Company's significant investments as of December 31, 2017.

	Activity	Country of incorporation	Class of shares held	Ownership as of
				Dec 31, 2017
Nomad Foods Europe Holdings Limited	Holding	England	Ordinary	100%
Nomad Foods Europe Holdco Limited	Holding	England	Ordinary	100%
Nomad Foods Europe Finco Limited	Holding	England	Ordinary	100%
Nomad Foods Europe Midco Limited	Holding/ Finance	England	Ordinary	100%
Nomad Foods Bondco Plc	Finance	England	Ordinary	100%
Nomad Foods Lux S.à.r.l.	Finance	Luxembourg	Ordinary	100%
Nomad Foods Europe Limited	Management	England	Ordinary	100%
Birds Eye Limited	Trading	England	Ordinary	100%
Nomad Foods Europe Finance Limited	Finance	England	Ordinary	100%
Birds Eye Ireland Limited	Trading	Republic of Ireland	Ordinary	100%
Iglo Holding GmbH	Holding	Germany	Ordinary	100%
Iglo Nederland B.V.	Trading	Netherlands	Ordinary	100%
Iglo Belgium S.A.	Trading	Belgium	Ordinary	100%
Iglo Portugal	Trading	Portugal	Ordinary	100%
Iglo Austria Holdings GmbH	Holding	Austria	Ordinary	100%
C.S.I. Compagnia Surgelati Italiana S.R.L	Trading	Italy	Ordinary	100%
Findus Sverige Holdings AB	Holding	Sweden	Ordinary	100%
Iglo GmbH	Trading	Germany	Ordinary	100%
Frozen Fish International GmbH	Trading	Germany	Ordinary	100%
Liberator Germany Newco GmbH	Property	Germany	Ordinary	100%
Iglo Austria GmbH	Trading	Austria	Ordinary	100%
Findus Sverige AB	Trading	Sweden	Ordinary	100%
Frionor Sverige AB	Holding	Sweden	Ordinary	100%
Findus Holdings France SAS	Holding	France	Ordinary	100%
Findus France SAS	Trading	France	Ordinary	100%
Findus Espana SLU	Trading	Spain	Ordinary	100%
Findus Danmark A/S	Trading	Denmark	Ordinary	100%
Findus Finland Oy	Trading	Finland	Ordinary	100%
Findus Norge AS	Trading	Norway	Ordinary	100%

XML

Deferred tax assets and liabilities (Tables)

12 Months Ended

Dec. 31, 2017

Disclosure of income tax [Abstract]

Schedule of Deferred Tax Assets and Liabilities

Movement in deferred tax during the year:

	Opening balance Jan 1 2017		Acquired in business combinations	Recognized  in Statement of Profit or Loss		Recognized in Other Comprehensive Income		Movement in foreign exchange		Closing balance Dec 31, 2017
	€m		€m	€m		€m		€m		€m
Property, plant and equipment	(23.3	)	—	8.2		—		(0.1	)	(15.2	)
Intangible assets	(291.3	)	—	(3.7	)	—		—		(295.0	)
Employee benefits	27.7		—	2.5		(2.0	)	—		28.2
Tax value of loss carry forwards	18.9		—	(3.0	)	—		(0.3	)	15.6
Derivative financial instruments	(3.3	)	—	(0.3	)	5.0		—		1.4
Other	3.0		—	(1.4	)	—		—		1.6
Total deferred tax	(268.3	)	—	2.3		3.0		(0.4	)	(263.4	)

	Opening balance Jan 1 2016		Acquired in business combinations		Recognized in Statement of Profit or Loss		Recognized in Other Comprehensive Income		Movement in foreign exchange		Closing balance Dec 31 2016
	€m		€m		€m		€m		€m		€m
Property, plant and equipment	(5.3	)	(0.3	)	(17.2	)	—		(0.5	)	(23.3	)
Intangible assets	(315.8	)	—		24.1		—		0.4		(291.3	)
Employee benefits	32.7		—		1.3		(6.3	)	—		27.7
Tax value of loss carry forwards	—		—		18.9		—		—		18.9
Derivative financial instruments	0.2		—		(0.7	)	(2.8	)	—		(3.3	)
Other	9.5		—		(6.5	)	—		—		3.0
Total deferred tax	(278.7	)	(0.3	)	19.9		(9.1	)	(0.1	)	(268.3	)

Deferred tax assets and liabilities are attributable to the following:

	Dec 31, 2017					Dec 31, 2016
	Assets	Liabilities		Total		Assets	Liabilities		Total
	€m	€m		€m		€m	€m		€m
Property, plant and equipment	13.5	(28.7	)	(15.2	)	10.3	(33.6	)	(23.3	)
Intangible assets	0.1	(295.1	)	(295.0	)	—	(291.3	)	(291.3	)
Employee benefits	28.2	—		28.2		27.8	(0.1	)	27.7
Tax value of loss carry forwards	15.6	—		15.6		18.9	—		18.9
Derivative financial instruments	0.9	0.5		1.4		—	(3.3	)	(3.3	)
Other	6.0	(4.4	)	1.6		7.9	(4.9	)	3.0
Tax assets/(liabilities)	64.3	(327.7	)	(263.4	)	64.9	(333.2	)	(268.3	)

XML

Inventories (Tables)

12 Months Ended

Dec. 31, 2017

Inventories [Abstract]

Schedule of inventories

	Successor	Successor
	Dec 31, 2017	Dec 31, 2016
	€m	€m
Raw materials and consumables	82.9	97.7
Work in progress	41.0	41.7
Finished goods and goods for resale	183.0	185.6
Total inventories	306.9	325.0

XML

Trade and other receivables (Tables)

12 Months Ended

Dec. 31, 2017

Subclassifications of assets, liabilities and equities [abstract]

Schedule of Trade and Other Receivables

	Successor	Successor
	Dec 31, 2017	Dec 31, 2016
Current assets	€m	€m
Trade receivables	94.7	92.3
Prepayments and accrued income	10.1	8.0
Other receivables	19.7	26.1
Tax receivable	22.6	9.3
Total current trade and other receivables	147.1	135.7
Non-current assets
Other receivables	4.3	0.4
Total non-current trade and other receivables	4.3	0.4
Total trade and other receivables	151.4	136.1

Disclosure of Aging Trade Receivables

The ageing of trade receivables is detailed below:

	Gross	Impaired		Net
December 31, 2017	€m	€m		€m
Not past due	243.4	—		243.4
Past due less than 1 month	35.6	(0.7	)	34.9
Past due 1 to 3 months	4.8	(0.3	)	4.5
Past due 3 to 6 months	0.2	(0.2	)	—
Past due more than 6 months	5.3	(4.9	)	0.4
Sub-total	289.3	(6.1	)	283.2
Reduction in trade-terms*				(188.5	)
Total trade receivables				94.7
	Gross	Impaired		Net
December 31, 2016	€m	€m		€m
Not past due	229.4	—		229.4
Past due less than 1 month	9.8	(0.1	)	9.7
Past due 1 to 3 months	0.9	(0.2	)	0.7
Past due 3 to 6 months	0.9	(0.1	)	0.8
Past due more than 6 months	6.3	(6.0	)	0.3
Sub-total	247.3	(6.4	)	240.9
Reduction in trade-terms*				(148.6	)
Total trade receivables				92.3

* Refer to Note 4(a). Reduction in trade term amounts are primarily not past due.

XML

Indemnification assets (Tables)

12 Months Ended

Dec. 31, 2017

Business Combinations1 [Abstract]

Disclosure of Detailed Information About Indemnification Assets

	Successor		Successor
	Dec 31, 2017		Dec 31, 2016
	€m		€m
Related to Iglo Acquisition at start of the period	2.1		10.2
Reclassified from Other receivables	—		1.2
Release of indemnified provision	(2.1	)	(9.3	)
Related to Iglo Acquisition at end of the period	—		2.1
Related to Findus Acquisition at start of the period	63.4		67.6
Acquisition accounting adjustment	—		6.2
Remeasurement of indemnification assets	10.4		(10.4	)
Related to Findus Acquisition at end of the period	73.8		63.4
Total indemnification assets	73.8		65.5

XML

Cash and cash equivalents (Tables)

12 Months Ended

Dec. 31, 2017

Subclassifications of assets, liabilities and equities [abstract]

Schedule of Cash and Cash Equivalents per Statement of Cash Flows

	Successor	Successor
	Dec 31, 2017	Dec 31, 2016
	€m	€m
Cash and cash equivalents	219.0	325.3
Restricted cash	0.2	4.2
Total cash and cash equivalents	219.2	329.5
Bank overdrafts	—	—
Cash and cash equivalents per Statement of Cash Flows	219.2	329.5

XML

Loans and borrowings (Tables)

12 Months Ended

Dec. 31, 2017

Financial Instruments [Abstract]

Repayment Profile and Individual Loan Details

The repayment profile of the syndicated and other loans held by the Company is as follows:

	Successor		Successor
	Dec 31, 2017		Dec 31, 2016
	€m		€m
Current liabilities/(assets)
Syndicated loans	5.1		—
Less deferred borrowing costs to be amortized within 1 year	(1.8	)	(5.0	)
Total due in less than one year	3.3		(5.0	)
Non-current liabilities
Syndicated loans	1,004.4		964.2
2020 floating rate senior secured notes	—		500.0
2024 fixed rate senior secured notes	400.0		—
Less deferred borrowing costs to be amortized in 2-5 years	(7.2	)	(12.4	)
Less deferred borrowing costs to be amortized in more than 5 years	(2.1	)	—
Total due after more than one year	1,395.1		1,451.8
Total borrowings	1,398.4		1,446.8

The table below shows details of individual loans:

	Successor		Successor
	Dec 31, 2017		Dec 31, 2016
	€m		€m
Current liabilities/(assets)-syndicated loans	5.1		—
Less deferred borrowing costs to be amortized within 1 year	(1.8	)	(5.0	)
Total current loans and borrowings	3.3		(5.0	)
Non-current liabilities-syndicated loans and secured notes
2020 floating rate senior secured notes	—		500.0
2024 fixed rate senior secured notes	400.0		—
Senior C1 EUR	—		363.3
Senior C2 GBP	—		275.9
Senior C3 EUR	—		325.0
Senior B3 EUR	500.0		—
Senior B4 USD	504.4		—
Less deferred borrowing costs to be amortized in 2—5 years	(7.2	)	(12.4	)
Less deferred borrowing costs to be amortized in more than 5 years	(2.1	)	—
Total non-current loans and borrowings	1,395.1		1,451.8
Total borrowings	1,398.4		1,446.8
Borrowings under the syndicated loan facility and floating rate notes	1,398.4		1,446.8

XML

Trade and other payables (Tables)

12 Months Ended

Dec. 31, 2017

Subclassifications of assets, liabilities and equities [abstract]

Disclosure of Detailed Information About Trade and Other Payables

	Successor	Successor
	Dec 31, 2017	Dec 31, 2016
Current liabilities	€m	€m
Trade payables	328.9	345.0
Accruals and deferred income	109.6	92.4
Social security and other taxes	18.2	19.3
Other payables	17.7	13.7
Finance lease obligations	—	0.6
Financial payables	3.1	1.7
Total current trade and other payables	477.5	472.7
Non-current liabilities
Finance lease obligations	—	1.0
Accruals and deferred income	1.8	—
Total non-current trade and other payables	1.8	1.0
Total trade and other payables	479.3	473.7

Disclosure of Finance Lease Obligations

	Future minimum lease payments		Interest		Present value of minimum lease payments
€m	Dec 31, 2017	Dec 31, 2016	Dec 31, 2017	Dec 31, 2016	Dec 31, 2017	Dec 31, 2016
Less than one year	—	0.7	—	0.1	—	0.6
Between one and five years	—	1.1	—	0.1	—	1.0
More than five years	—	—	—	—	—	—
	—	1.8	—	0.2	—	1.6

Non-cancellable operating lease rentals relate to total future aggregate minimum lease payments and are payable as follows:

	As at Dec 31, 2017	As at Dec 31, 2016
	€m	€m
Less than one year	17.8	18.3
Between one and three years	26.1	29.6
Between three and five years	17.8	22.0
More than five years	106.6	109.7
Total	168.3	179.6

XML

Employee benefits (Tables)

12 Months Ended

Dec. 31, 2017

Employee Benefits [Abstract]

Disclosure of Net Defined Benefit Liability (Asset)

	Successor	Successor
	Dec 31, 2017	Dec 31, 2016
	€m	€m
Total employee benefit obligations-Germany	117.5	121.8
Total employee benefit obligations-Sweden	59.8	56.7
Total employee benefit obligations-Italy	5.3	5.1
Total employee benefit obligations-Austria	2.8	4.2
Sub-total	185.4	187.8
Total net employee benefit obligations-other countries	3.0	3.1
Total net employee benefit obligations	188.4	190.9

	Defined benefit retirement plans		Post-employment medical benefits and other benefits	Total
December 31, 2017	€m		€m	€m
Present value of unfunded defined benefit obligations	65.7		4.9	70.6
Present value of funded defined benefit obligations	196.1		—	196.1
Subtotal present value of defined benefit obligations	261.8		4.9	266.7
Fair value of plan assets	(81.3	)	—	(81.3	)
Recognized liability for net defined benefit obligations	180.5		4.9	185.4

	Defined benefit retirement plans		Post-employment medical benefits and other benefits	Total
December 31, 2016	€m		€m	€m
Present value of unfunded defined benefit obligations	62.5		4.9	67.4
Present value of funded defined benefit obligations	200.2		—	200.2
Subtotal present value of defined benefit obligations	262.7		4.9	267.6
Fair value of plan assets	(79.8	)	—	(79.8	)
Recognized liability for net defined benefit obligations	182.9		4.9	187.8

Movements in recognized liability for net defined benefit obligations:

	Defined benefit retirement plans		Post-employment medical benefits and other benefits		Total
	€m		€m		€m
Opening balance January 1, 2017	182.9		4.9		187.8
Current service cost	4.1		(0.1	)	4.0
Interest cost	3.5		0.1		3.6
Actuarial gains	(2.9	)	—		(2.9	)
Contributions to plan	(0.5	)	—		(0.5	)
Benefits paid	(4.9	)	—		(4.9	)
Exchange adjustments	(1.7	)	—		(1.7	)
As at December 31, 2017	180.5		4.9		185.4
	Defined benefit retirement plans		Post-employment medical benefits and other benefits		Total
	€m		€m		€m
Opening balance January 1, 2016	159.4		5.7		165.1
Current service cost	3.9		(0.4	)	3.5
Interest cost	3.9		0.1		4.0
Actuarial losses	23.6		—		23.6
Contributions to plan	(0.5	)	—		(0.5	)
Benefits paid	(5.1	)	(0.3	)	(5.4	)
Exchange adjustments	(2.3	)	(0.2	)	(2.5	)
As at December 31, 2016	182.9		4.9		187.8

Movements in present value of defined benefit obligations:

	Defined benefit retirement plans		Post-employment medical benefits and other benefits		Total
	€m		€m		€m
Opening balance January 1, 2017	262.7		4.9		267.6
Current service cost	4.1		(0.1	)	4.0
Interest cost	4.9		0.1		5.0
Actuarial experience losses	0.5		—		0.5
Actuarial losses arising from changes in financial assumptions	1.5		—		1.5
Actuarial gains arising from changes in demographic assumptions	(3.0	)	—		(3.0	)
Contributions to plan	0.3		—		0.3
Benefits paid	(7.5	)	—		(7.5	)
Exchange adjustments	(1.7	)	—		(1.7	)
As at December 31, 2017	261.8		4.9		266.7
	Defined benefit retirement plans		Post-employment medical benefits and other benefits		Total
	€m		€m		€m
Opening balance January 1, 2016	238.3		5.7		244.0
Current service cost	3.9		(0.4	)	3.5
Interest cost	5.8		0.1		5.9
Actuarial experience gains	(0.3	)	—		(0.3	)
Actuarial losses arising from changes in financial assumptions	24.5		—		24.5
Contributions to plan	0.5		—		0.5
Benefits paid	(7.7	)	(0.3	)	(8.0	)
Exchange adjustments	(2.3	)	(0.2	)	(2.5	)
As at December 31, 2016	262.7		4.9		267.6

The history of experience adjustments from inception of the Company for the defined benefit retirement plans is as follows:

	Dec 31, 2017		Dec 31, 2016		9 months ended December 31, 2015
	€m		€m		€m
Present value of defined benefit obligations	261.8		262.7		238.3
Fair value of plan assets	(81.3	)	(79.8	)	(78.9	)
Asset ceiling	—		—		—
Recognized liability in the scheme	180.5		182.9		159.4
Experience losses/(gains) on scheme liabilities	0.5		(0.3	)	(1.6	)
Experience (gains)/losses on scheme assets	(1.9	)	(0.6	)	0.5

Disclosure of Fair Value of Plan Assets

Movements in fair value of plan assets of defined benefit retirement plans:

	2017
	€m
Opening balance January 1, 2017	79.8
Interest income	1.4
Actuarial gains arising from the return on plan assets, excluding interest income	1.9
Contributions by employer	0.5
Contributions by members	0.3
Benefits paid	(2.6	)
As at December 31, 2017	81.3

	2016
	€m
Opening balance January 1, 2016	78.9
Interest income	1.9
Actuarial gains arising from the return on plan assets, excluding interest income	0.6
Contributions by employer	0.5
Contributions by members	0.5
Benefits paid	(2.6	)
As at December 31, 2016	79.8

The fair value of plan assets, all at quoted prices are as follows:

	Dec 31, 2017	Dec 31, 2016
	€m	€m
Equities	17.4	15.1
Debt instruments	51.3	51.7
Property	8.9	9.6
Other	3.7	3.4
Total	81.3	79.8

Disclosure of Expense Recognized in Consolidated Statement of Profit or Loss

Expense recognized in the Consolidated Statement of Profit or Loss:

	Defined benefit retirement plans	Post-employment medical benefits and other benefits		Total
	2017	2017		2017
	€m	€m		€m
Current service cost	4.1	(0.1	)	4.0
Interest cost	3.5	0.1		3.6
For the year ended December 31, 2017	7.6	—		7.6

	Defined benefit retirement plans	Post-employment medical benefits and other benefits		Total
	2016	2016		2016
	€m	€m		€m
Current service cost	3.9	(0.4	)	3.5
Interest cost	3.9	0.1		4.0
For the year ended December 31, 2016	7.8	(0.3	)	7.5

Disclosure of Amount Recognized In Consolidated Statement of Comprehensive Income

Amount recognized in the Consolidated Statement of Comprehensive Income:

	Year ended December 31, 2017		Year ended December 31, 2016
	€m		€m
Actuarial experience losses/(gains)	0.5		(0.3	)
Actuarial losses arising from changes in financial assumptions	1.5		24.5
Actuarial gains arising from changes in demographic assumptions	(3.0	)	—
Actuarial gains arising from the return on plan assets, excluding interest income	(1.9	)	(0.6	)
Total actuarial (gains)/losses	(2.9	)	23.6
	2017		2016
	€m		€m
Cumulative amount of actuarial losses recognized in Consolidated Statement of Comprehensive Income	1.3		4.2

Disclosure of Actuarial Assumptions

December 31, 2017 (years)	Germany	Sweden	Austria	Italy
Retiring at the end of the year:
Male	20	22	21	20
Female	24	24	25	20

December 31, 2016 (years)	Germany	Sweden	Austria	Italy
Retiring at the end of the year:
Male	20	23	21	20
Female	24	25	25	24

	Defined benefit retirement plans								Post-employment medical benefits and other benefits
December 31, 2017	Germany		Sweden		Austria		Italy		Germany		Austria
Discount rate	1.95	%	2.4	%	2.2	%	1.2	%	1.15	%	0.9	%
Inflation rate	2.0	%	1.9	%	2.0	%	1.5	%	2.0	%	2.0	%
Rate of increase in salaries	2.8	%	2.25	%	3.0	%	—		2.8	%	3.0	%
Rate of increase for pensions in payment	1%-2%		2.25	%	1.7	%	—		—		—
Long term medical cost of inflation	—		—		—		—		—		2.0	%

	Defined benefit retirement plans								Post-employment medical benefits and other benefits
December 31, 2016	Germany		Sweden		Austria		Italy		Germany		Austria
Discount rate	1.8	%	2.5	%	1.0	%	1.5	%	1.2	%	1.0	%
Inflation rate	2.0	%	1.25	%	1.7	%	1.5	%	2.0	%	1.7	%
Rate of increase in salaries	2.5	%	2.25	%	3.0	%	—		2.5	%	3.0	%
Rate of increase for pensions in payment	1%-2%		2.25	%	1.7	%	—		—		—
Long term medical cost of inflation	—		—		—		—		—		2.0	%

Disclosure of the Effect of a 1% Movement in the Discount Rate

The effect of a 1% movement in the discount rate for the year ended December 31, 2017 is as follows:

	Increase		Decrease
	€m		€m
Effect on the post-employment benefit obligation	(42.3	)	55.8

XML

Provisions (Tables)

12 Months Ended

Dec. 31, 2017

Other Provisions, Contingent Liabilities and Contingent Assets [Abstract]

Disclosure of Detailed Information About Provisions

	Restructuring		Onerous/ unfavorable contracts		Provisions related to other taxes		Contingent consideration		Other		Total
	€m		€m		€m		€m		€m		€m
Balance at December 31, 2015	21.0		—		31.8		17.4		16.5		86.7
Additional provision in the period	60.2		34.7		—		—		5.3		100.2
Release of provision	(5.2	)	—		(9.8	)	—		(2.6	)	(17.6	)
Adjustment to provisions acquired through business combinations	—		47.3		2.5		—		2.7		52.5
Utilization of provision	(16.7	)	(2.5	)	—		(8.0	)	(2.2	)	(29.4	)
Unwinding of discounting	—		0.8		—		0.6		—		1.4
Foreign exchange	(0.2	)	0.3		—		—		(0.2	)	(0.1	)
Balance at December 31, 2016	59.1		80.6		24.5		10.0		19.5		193.7
Additional provision in the period	30.9		—		5.8		—		6.6		43.3
Release of provision	(0.1	)	—		(12.2	)	—		(1.2	)	(13.5	)
Transfer between categories	—		—		(2.1	)	—		2.1		—
Utilization of provision	(63.6	)	(3.9	)	(5.8	)	—		(8.4	)	(81.7	)
Unwinding of discounting	—		0.8		—		0.4		—		1.2
Foreign exchange	—		(2.1	)	—		—		(0.1	)	(2.2	)
Balance at December 31, 2017	26.3		75.4		10.2		10.4		18.5		140.8
Current											68.0
Non-current											72.8
Total											140.8

XML

Share capital and reserves (Tables)

12 Months Ended

Dec. 31, 2017

Share Capital, Reserves and Other Equity Interest [Abstract]

Schedule of Share Capital and Capital Reserve

Share capital and capital reserve

	As at Dec 31, 2017		As at Dec 31, 2016
	€m		€m
Authorized:
Unlimited number of Ordinary Shares with nil nominal value issued at $10.00 per share	n/a		n/a
Unlimited number of Founder Preferred Shares with nil nominal value issued at $10 per share	n/a		n/a
Issued and fully paid:
165,291,546 (December 31, 2016: 182,088,622) Ordinary Shares with nil nominal value	1,626.9		1,803.4
1,500,000 (December 31, 2016: 1,500,000) Founder Preferred Shares with nil nominal value	10.6		10.6
Total share capital and capital reserve	1,637.5		1,814.0
Listing and share transaction costs	(13.8	)	(13.3	)
Total net share capital and capital reserve	1,623.7		1,800.7

Ordinary Shares

	Issued and Repurchased Ordinary shares  (in millions)
Balance at December 31, 2015	178.4
Shares issued in the period	3.7
Balance at December 31, 2016	182.1
Shares issued in the year	—
Shares repurchased and canceled in the year	(16.8	)
Balance at December 31, 2017	165.3

Summary of Listing and Share Transaction Costs

	€m
At December 31, 2015	13.3
Placement fees	—
At December 31, 2016	13.3
Share transaction costs	0.5
At December 31, 2017	13.8

XML

Share-based compensation reserve (Tables)

12 Months Ended

Dec. 31, 2017

Share Capital, Reserves and Other Equity Interest [Abstract]

Disclosure of detailed information about reserves within equity

	Share based compensation reserve
	€m
Balance as of January 1, 2017	1.0
Non-Executive Director restricted share awards charge	0.8
Directors and Senior Management share awards charge	1.8
Vesting of Non-Executive Director restricted shares	(0.7	)
Balance as of December 31, 2017	2.9

	Founder Preferred Shares Dividend Reserve
	€m
Balance as of January 1, 2017	493.4
Settlement of dividend through share issue	—
Balance as of December 31, 2017	493.4

XML

Founder Preferred Shares Dividend Reserve (Tables)

12 Months Ended

Dec. 31, 2017

Share Capital, Reserves and Other Equity Interest [Abstract]

Disclosure of classes of share capital

	Share based compensation reserve
	€m
Balance as of January 1, 2017	1.0
Non-Executive Director restricted share awards charge	0.8
Directors and Senior Management share awards charge	1.8
Vesting of Non-Executive Director restricted shares	(0.7	)
Balance as of December 31, 2017	2.9

	Founder Preferred Shares Dividend Reserve
	€m
Balance as of January 1, 2017	493.4
Settlement of dividend through share issue	—
Balance as of December 31, 2017	493.4

XML

Cash flow hedging reserve (Tables)

12 Months Ended

Dec. 31, 2017

Share Capital, Reserves and Other Equity Interest [Abstract]

Movement in cash flow hedging reserve

The table below shows the movement in the cash flow hedging reserve during the year or period, including the gains or losses arising on the revaluation of hedging instruments during the year or period and the amount reclassified from other comprehensive income to the Consolidated Statement of Profit or Loss in the year.

	Successor		Successor		Successor	Successor	Predecessor
	Year ended December 31, 2017		Year ended December 31, 2016		9 months ended December 31, 2015	Year ended March 31, 2015	5 months ended May 31, 2015
	€m		€m		€m	€m	€m
(Losses)/gains arising in the revaluation of hedge instruments	(76.5	)	14.2		1.6	—	—
Less: Gains/(losses) reclassified to the Consolidated Statement of Profit or Loss	60.1		(4.1	)	—	—	—
Total	(16.4	)	10.1		1.6	—	—

XML

Earnings/(loss) per share (Tables)

12 Months Ended

Dec. 31, 2017

Earnings per share [abstract]

Basic and diluted earnings/(loss) per share

Basic earnings/(loss) per share

	Successor	Successor	Successor		Successor		Predecessor
	Year ended December 31, 2017	Year ended December 31, 2016	9 months ended December 31, 2015		Year ended March 31, 2015		5 months ended May 31, 2015
Net profit/(loss) attributable to shareholders (€m)	136.5	36.4	(337.3	)	(167.5	)	(128.0	)
Weighted average Ordinary Shares and Founder Preferred Shares	176,080,272	183,518,743	145,590,810		50,025,000		n.p.
Basic earnings/(loss) per share (€’s)	0.78	0.20	(2.32	)	(3.35	)	n.p.

n.p. not presented

Diluted earnings/(loss) per share

	Successor	Successor	Successor		Successor		Predecessor
	Year ended December 31, 2017	Year ended December 31, 2016	9 months ended December 31, 2015		Year ended March 31, 2015		5 months ended May 31, 2015
Net profit/(loss) attributable to shareholders (€m)	136.5	36.4	(337.3	)	(167.5	)	(128.0	)
Weighted average Ordinary Shares and Founder Preferred Shares	184,786,162	183,528,621	145,590,810		50,025,000		n.p.
Diluted earnings/(loss) per share (€’s)	0.74	0.20	(2.32	)	(3.35	)	n.p.

n.p. not presented

XML

Reconciliation of liabilities arising from financing activities (Tables)

12 Months Ended

Dec. 31, 2017

Disclosure of reconciliation of liabilities arising from financing activities [abstract]

Disclosure of reconciliation of liabilities arising from financing activities [text block]

The table below details changes in the Company's liabilities arising from financing activities, including both cash and non-cash changes. Liabilities arising from financing activities are those for which cash flows were, or future cash flows will be classified in the Company's consolidated statements of cash flows from financing activities.

		Cash movements			Non-cash movements
	Opening balance as of December 31, 2016	Cash inflow (1)	Cash outflow (2)		Interest accretion	Exchange movement		Fair value changes		Other non-cash adjustments	Closing balance as of December 31, 2017
	€m	€m	€m		€m	€m		€m		€m	€m
Total loans and borrowings (Note 21)	1,446.8	1,470.5	(1,469.5	)	—	(55.7	)	—		6.3	1,398.4
Total finance lease obligations (Note 22)	1.6	—	(1.6	)	—	—		—		—	—
Financial payables (Note 22)	1.7	—	(53.3	)	54.0	0.7		—		—	3.1
Derivatives: (Net) Fair value of forward foreign exchange and currency swap contracts FVPTL	0.3	3.9	—		—	—		(3.5	)	—	0.7
Derivatives: (Net) Fair value of cross currency interest rate swaps	—	4.5	(2.3	)	—	—		40.6		—	42.8

(1) Cash inflows of €4.5 million from cross currency interest rate swaps are part of effective cash flow hedging relationships and are presented within interest paid within the Consolidated Statements of Cash Flows.

(2) Cash outflows of €2.3 million from cross currency interest rate swaps are not part of a cash flow hedge and are presented within proceeds on settlement of derivatives within the Consolidated Statements of Cash Flows.

XML

Cash flows from operating activities (Tables)

12 Months Ended

Dec. 31, 2017

Cash Flow Statement [Abstract]

Schedule of cash flow disclosures

		Successor		Successor		Successor		Successor		Predecessor
		Year ended December 31, 2017		Year ended December 31, 2016		9 months ended December 31, 2015		Year ended March 31, 2015		5 months ended May 31, 2015
	Note	€m		€m		€m		€m		€m
Cash flows from operating activities
Profit/(loss) for the period		136.5		36.4		(337.3	)	(167.5	)	(128.0	)
Adjustments for:
Exceptional items	7	37.2		134.5		58.1		0.7		84.3
Non-cash charge related to Founder Preferred Shares Annual Dividend Amount		—		—		349.0		165.8		—
Non-cash (charge)/credit related to Warrant Redemption Liability		—		—		(0.4	)	0.4		—
Non-cash fair value purchase price adjustment of inventory		—		—		37.0		—		—
Non-cash cash flow hedge reserve acquisition accounting adjustment		—		—		4.9		—		—
Non-cash Chairman and Independent Non-Executive Director fees		—		—		—		0.2		—
Unrealized gain on portfolio investments		—		—		—		(0.1	)	—
Share based payments expense		2.6		1.2		—		—		—
Depreciation charge	12	35.9		43.3		20.3		—		11.3
Amortization	13	6.5		7.8		1.5		—		1.2
Loss on disposal of property, plant and equipment		0.5		0.7		—		—		—
Finance costs	10	81.6		86.3		44.2		—		117.7
Finance income	10	(7.2	)	(24.2	)	(8.7	)	—		(2.0	)
Taxation	11	32.0		39.6		(12.3	)	—		40.9
Operating cash flow before changes in working capital, provisions and exceptional items		325.6		325.6		156.3		(0.5	)	125.4
Decrease/(increase) in inventories		16.7		(18.1	)	(15.9	)	—		28.3
(Increase)/decrease in trade and other receivables		(1.6	)	(8.8	)	64.3		—		(8.5	)
Increase/(decrease) in trade and other payables		18.1		60.8		(44.0	)	0.7		(41.0	)
Decrease in employee benefit and other provisions		(0.3	)	(3.3	)	(1.5	)	—		(2.0	)
Cash generated from operations before tax and exceptional items		358.5		356.2		159.2		0.2		102.2

XML

Financial risk management (Tables)

12 Months Ended

Dec. 31, 2017

Financial Instruments [Abstract]

Disclosure of maturity analysis for non-derivative financial liabilities [text block]

The tables below show a maturity analysis of contractual undiscounted cash flows, showing items at the earliest date on which the Company could be required to pay the liability:

2017	2018		2019		2020		2021		2022		Over 5 years	Total
	€m		€m		€m		€m		€m		€m	€m
Borrowings-principal	5.1		5.1		5.1		5.1		5.1		1,384.0	1,409.5
Borrowings-interest	46.3		46.0		46.0		45.7		45.5		62.9	292.4
Forward contracts Sell	484.0		—		—		—		—		—	484.0
Forward contracts Buy	(479.6	)	—		—		—		—		—	(479.6	)
Cross Currency Interest Rate Swaps Pay	29.1		28.7		28.6		28.4		801.4		—	916.2
Cross Currency Interest Rate Swaps Receive	(32.0	)	(31.6	)	(31.4	)	(31.2	)	(759.3	)	—	(885.5	)
Trade and other payables excluding non-financial liabilities	441.6		—		—		—		—		—	441.6
Total	494.5		48.2		48.3		48.0		92.7		1,446.9	2,178.6

2016	2017		2018	2019	2020	2021	Over 5 years	Total
	€m		€m	€m	€m	€m	€m	€m
Borrowings-principal	—		—	—	1,464.2	—	—	1,464.2
Borrowings-interest	59.7		60.0	60.9	29.9	—	—	210.5
Forward contracts Sell	367.8		—	—	—	—	—	367.8
Forward contracts Buy	(381.3	)	—	—	—	—	—	(381.3	)
Trade and other payables excluding non-financial liabilities	439.1		—	—	—	—	—	439.1
Total	485.3		60.0	60.9	1,494.1	—	—	2,100.3

Disclosure of maturity analysis for derivative financial liabilities [text block]

The tables below show a maturity analysis of contractual undiscounted cash flows, showing items at the earliest date on which the Company could be required to pay the liability:

2017	2018		2019		2020		2021		2022		Over 5 years	Total
	€m		€m		€m		€m		€m		€m	€m
Borrowings-principal	5.1		5.1		5.1		5.1		5.1		1,384.0	1,409.5
Borrowings-interest	46.3		46.0		46.0		45.7		45.5		62.9	292.4
Forward contracts Sell	484.0		—		—		—		—		—	484.0
Forward contracts Buy	(479.6	)	—		—		—		—		—	(479.6	)
Cross Currency Interest Rate Swaps Pay	29.1		28.7		28.6		28.4		801.4		—	916.2
Cross Currency Interest Rate Swaps Receive	(32.0	)	(31.6	)	(31.4	)	(31.2	)	(759.3	)	—	(885.5	)
Trade and other payables excluding non-financial liabilities	441.6		—		—		—		—		—	441.6
Total	494.5		48.2		48.3		48.0		92.7		1,446.9	2,178.6

2016	2017		2018	2019	2020	2021	Over 5 years	Total
	€m		€m	€m	€m	€m	€m	€m
Borrowings-principal	—		—	—	1,464.2	—	—	1,464.2
Borrowings-interest	59.7		60.0	60.9	29.9	—	—	210.5
Forward contracts Sell	367.8		—	—	—	—	—	367.8
Forward contracts Buy	(381.3	)	—	—	—	—	—	(381.3	)
Trade and other payables excluding non-financial liabilities	439.1		—	—	—	—	—	439.1
Total	485.3		60.0	60.9	1,494.1	—	—	2,100.3

XML

Financial instruments (Tables)

12 Months Ended

Dec. 31, 2017

Financial Instruments [Abstract]

Disclosure of Financial Assets

The following table shows the carrying amount of each Statement of Financial Position class split into the relevant category of financial instrument as defined in IAS 39 “Financial Instruments: Recognition & Measurement”.

	Cash and cash equivalents	Loans and receivables	Derivatives at fair value through profit or loss		Derivatives used for hedging (see (c))		Financial liabilities at amortized cost		Total
2017	€m	€m	€m		€m		€m		€m
Assets
Trade receivables	—	94.7	—		—		—		94.7
Derivative financial instruments	—	—	3.2		17.5		—		20.7
Cash and cash equivalents	219.2	—	—		—		—		219.2
Liabilities
Trade and other payables excluding non-financial liabilities	—	—	—		—		(441.6	)	(441.6	)
Derivative financial instruments	—	—	(0.7	)	(68.5	)	—		(69.2	)
Loans and borrowings (note 1)	—	—	—		—		(1,409.5	)	(1,409.5	)
Total	219.2	94.7	2.5		(51.0	)	(1,851.1	)	(1,585.7	)

Note 1: Loans and borrowings excludes €11.1 million of deferred borrowing costs which are included within €1,398.4 million of total loans and borrowings in Note 21.

	Cash and cash equivalents	Loans and receivables	Derivatives at fair value through profit or loss	Derivatives used for hedging (see (c))		Financial liabilities at amortized cost		Total
2016	€m	€m	€m	€m		€m		€m
Assets
Trade receivables	—	92.3	—	—		—		92.3
Derivative financial instruments	—	—	—	13.1		—		13.1
Cash and cash equivalents	329.5	—	—	—		—		329.5
Liabilities
Trade and other payables excluding non-financial liabilities	—	—	—	—		(439.1	)	(439.1	)
Derivative financial instruments	—	—	—	(1.4	)	—		(1.4	)
Loans and borrowings (note 2)	—	—	—	—		(1,464.2	)	(1,464.2	)
Total	329.5	92.3	—	11.7		(1,903.3	)	(1,469.8	)

Note 2: Loans and borrowings excludes €12.4 million of deferred borrowing costs which are included within €1,451.8 million of total non-current loans and borrowings in Note 21.

Disclosure of Financial Liabilities

The following table shows the carrying amount of each Statement of Financial Position class split into the relevant category of financial instrument as defined in IAS 39 “Financial Instruments: Recognition & Measurement”.

	Cash and cash equivalents	Loans and receivables	Derivatives at fair value through profit or loss		Derivatives used for hedging (see (c))		Financial liabilities at amortized cost		Total
2017	€m	€m	€m		€m		€m		€m
Assets
Trade receivables	—	94.7	—		—		—		94.7
Derivative financial instruments	—	—	3.2		17.5		—		20.7
Cash and cash equivalents	219.2	—	—		—		—		219.2
Liabilities
Trade and other payables excluding non-financial liabilities	—	—	—		—		(441.6	)	(441.6	)
Derivative financial instruments	—	—	(0.7	)	(68.5	)	—		(69.2	)
Loans and borrowings (note 1)	—	—	—		—		(1,409.5	)	(1,409.5	)
Total	219.2	94.7	2.5		(51.0	)	(1,851.1	)	(1,585.7	)

Note 1: Loans and borrowings excludes €11.1 million of deferred borrowing costs which are included within €1,398.4 million of total loans and borrowings in Note 21.

	Cash and cash equivalents	Loans and receivables	Derivatives at fair value through profit or loss	Derivatives used for hedging (see (c))		Financial liabilities at amortized cost		Total
2016	€m	€m	€m	€m		€m		€m
Assets
Trade receivables	—	92.3	—	—		—		92.3
Derivative financial instruments	—	—	—	13.1		—		13.1
Cash and cash equivalents	329.5	—	—	—		—		329.5
Liabilities
Trade and other payables excluding non-financial liabilities	—	—	—	—		(439.1	)	(439.1	)
Derivative financial instruments	—	—	—	(1.4	)	—		(1.4	)
Loans and borrowings (note 2)	—	—	—	—		(1,464.2	)	(1,464.2	)
Total	329.5	92.3	—	11.7		(1,903.3	)	(1,469.8	)

Note 2: Loans and borrowings excludes €12.4 million of deferred borrowing costs which are included within €1,451.8 million of total non-current loans and borrowings in Note 21.

	Fair value		Carrying value
	Dec 31, 2017	Dec 31, 2016	Dec 31, 2017		Dec 31, 2016
	€m	€m	€m		€m
Senior loans	—	970.3	—		964.2
2020 floating rate senior secured notes	—	505.2	—		500.0
Senior EUR/USD loans	1,012.7	—	1,009.5		—
2024 fixed rate senior secured notes	412.2	—	400.0		—
Less deferred borrowing costs	—	—	(11.1	)	(17.4	)
	1,424.9	1,475.5	1,398.4		1,446.8

Disclosure of Derivatives

	As at Dec 31, 2017		As at Dec 31, 2016
	€m		€m
Cross Currency Interest Rate Swaps	18.6		—
Forward foreign exchange contracts	2.1		13.1
Total assets	20.7		13.1
Cross Currency Interest Rate Swaps	(61.4	)	—
Forward foreign exchange contracts	(7.8	)	(1.4	)
Total liabilities	(69.2	)	(1.4	)
Total	(48.5	)	11.7

Disclosure of Carrying Amount of Recognized Financial Instruments

The following table sets out the carrying amounts of recognized financial instruments that are subject to the above agreements.

	Gross amount of financial instruments as presented upon balance sheet		Related financial instruments that are offset		Net amount
As at Dec 31, 2017	€m		€m		€m
Derivatives - assets	20.7		(20.7	)	—
Derivatives - liabilities	(69.2	)	20.7		(48.5	)

	Gross amount of financial instruments as presented upon balance sheet		Related financial instruments that are offset		Net amount
As at Dec 31, 2016	€m		€m		€m
Derivatives - assets	13.1		(1.4	)	11.7
Derivatives - liabilities	(1.4	)	1.4		—

XML

Operating leases (Tables)

12 Months Ended

Dec. 31, 2017

Leases1 [Abstract]

Non-cancellable Operating Lease Rentals Related to Total Future Aggregate Minimum Lease Payments

	Future minimum lease payments		Interest		Present value of minimum lease payments
€m	Dec 31, 2017	Dec 31, 2016	Dec 31, 2017	Dec 31, 2016	Dec 31, 2017	Dec 31, 2016
Less than one year	—	0.7	—	0.1	—	0.6
Between one and five years	—	1.1	—	0.1	—	1.0
More than five years	—	—	—	—	—	—
	—	1.8	—	0.2	—	1.6

Non-cancellable operating lease rentals relate to total future aggregate minimum lease payments and are payable as follows:

	As at Dec 31, 2017	As at Dec 31, 2016
	€m	€m
Less than one year	17.8	18.3
Between one and three years	26.1	29.6
Between three and five years	17.8	22.0
More than five years	106.6	109.7
Total	168.3	179.6

XML

Capital commitments (Tables)

12 Months Ended

Dec. 31, 2017

Additional information [abstract]

Schedule of capital commitments

Capital expenditure contracted for at the end of the reporting period but not yet incurred is as follows:

	As at Dec 31, 2017	As at Dec 31, 2016
	€m	€m
Property, plant and equipment	3.0	8.1
Intangible assets	2.6	5.4
Total	5.6	13.5

XML

General information (Details)	Dec. 31, 2017 country
General Information About Financial Statements [Abstract]
Number of countries in which entity produces, markets and distributes brands	17

XML

Accounting policies (Details) € in Millions	12 Months Ended
	Dec. 31, 2017 EUR (€) segment	Dec. 31, 2016 EUR (€)	Dec. 31, 2015	Jun. 01, 2015 EUR (€)
Accounting Policies, Changes in Accounting Estimates and Errors [Abstract]
Foreign exchange rate	1.13	1.17	1.36
Disclosure of detailed information about property, plant and equipment [line items]
Trade receivables	€ 283.2	€ 240.9
Founder Preferred Shares Dividend Reserve	€ 493.4	493.4		€ 531.5
Number of operating segments | segment	1
Trade receivables provision	€ 5.8
Cost
Disclosure of detailed information about property, plant and equipment [line items]
Trade receivables	€ 289.3	€ 247.3
Buildings
Disclosure of detailed information about property, plant and equipment [line items]
Estimated useful life	40 years
Plant and equipment | Bottom of range
Disclosure of detailed information about property, plant and equipment [line items]
Estimated useful life	5 years
Plant and equipment | Top of range
Disclosure of detailed information about property, plant and equipment [line items]
Estimated useful life	14 years
Computer equipment | Bottom of range
Disclosure of detailed information about property, plant and equipment [line items]
Estimated useful life	3 years
Computer equipment | Top of range
Disclosure of detailed information about property, plant and equipment [line items]
Estimated useful life	5 years
Computer software | Bottom of range
Disclosure of detailed information about intangible assets [line items]
Intangible assets useful life	5 years
Computer software | Top of range
Disclosure of detailed information about intangible assets [line items]
Intangible assets useful life	7 years
Brands
Disclosure of detailed information about intangible assets [line items]
Years established	50 years
Brands | La Cocinera
Disclosure of detailed information about intangible assets [line items]
Intangible assets useful life	10 years
Brands | Lutosa
Disclosure of detailed information about intangible assets [line items]
Intangible assets useful life	6 years
Customer relationships
Disclosure of detailed information about intangible assets [line items]
Intangible assets useful life	14 years

XML

Segment reporting - Additional Information (Details) € in Millions	9 Months Ended	12 Months Ended
	Dec. 31, 2015 EUR (€)	Dec. 31, 2017 EUR (€) segment	Dec. 31, 2016 EUR (€)	Mar. 31, 2015 EUR (€)
Operating Segments [Abstract]
Number of operating segments | segment		1
Share-based payment charges	€ 0.0	€ 2.6	€ 1.2	€ 0.0
Adjustments for acquisition related costs		€ 3.0

XML

Segment reporting - Segment as Adjusted EBITDA (Details) - EUR (€) € in Millions	5 Months Ended	9 Months Ended	12 Months Ended
	May 31, 2015	Dec. 31, 2015	Dec. 31, 2017	Dec. 31, 2016	Mar. 31, 2015
Disclosure of operating segments [line items]
Profit/(loss) for the period		€ (337.3)	€ 136.5	€ 36.4	€ (167.5)
Taxation		(12.3)	32.0	39.6	0.0
Net financing costs/(income)		35.5	74.4	62.1	(0.1)
Depreciation		20.3	35.9	43.3	0.0
Amortization		1.5	6.5	7.8	0.0
EBITDA		(292.3)	285.3	189.2	(167.6)
(Credit)/charge relating to Warrant Redemption Liability		(0.4)	0.0	0.0	0.4
Exceptional items		58.1	37.2	134.5	0.7
Adjusted EBITDA		158.8	328.1	324.9	0.0
Material reconciling items
Disclosure of operating segments [line items]
Net purchase-price adjustment-inventory step up		37.0	0.0	0.0	0.0
Net purchase-price adjustment for cash flow hedge accounting		4.9	0.0	0.0	0.0
Charge related to Founder Preferred Shares Annual Dividend Amount		349.0	0.0	0.0	165.8
(Credit)/charge relating to Warrant Redemption Liability		(0.4)	0.0	0.0	0.4
Exceptional items		58.1	37.2	134.5	0.7
Other add-backs		0.0	5.6	1.2	0.0
Adjusted EBITDA		156.3	328.1	324.9	(0.7)
Unallocated
Disclosure of operating segments [line items]
Adjusted EBITDA		€ 2.5	€ 0.0	€ 0.0	€ 0.7
Predecessor
Disclosure of operating segments [line items]
Profit/(loss) for the period	€ (128.0)
Taxation	40.9
Net financing costs/(income)	115.7
Depreciation	11.3
Amortization	1.2
EBITDA	41.1
(Credit)/charge relating to Warrant Redemption Liability	0.0
Exceptional items	84.3
Adjusted EBITDA	125.4
Predecessor | Material reconciling items
Disclosure of operating segments [line items]
Net purchase-price adjustment-inventory step up	0.0
Net purchase-price adjustment for cash flow hedge accounting	0.0
Charge related to Founder Preferred Shares Annual Dividend Amount	0.0
(Credit)/charge relating to Warrant Redemption Liability	0.0
Exceptional items	84.3
Other add-backs	0.0
Adjusted EBITDA	125.4
Predecessor | Unallocated
Disclosure of operating segments [line items]
Adjusted EBITDA	€ 0.0

XML

Segment reporting - Geographical information (Details) - EUR (€) € in Millions	5 Months Ended	9 Months Ended	12 Months Ended
	May 31, 2015	Dec. 31, 2015	Dec. 31, 2017	Dec. 31, 2016	Mar. 31, 2015
Disclosure of geographical areas [line items]
Revenue		€ 894.2	€ 1,956.6	€ 1,927.7	€ 0.0
Non-current assets			355.3	337.0
United Kingdom
Disclosure of geographical areas [line items]
Revenue		288.6	411.9	437.5	0.0
Non-current assets			94.8	77.5
Italy
Disclosure of geographical areas [line items]
Revenue		205.2	371.4	348.5	0.0
Non-current assets			55.0	59.1
Germany
Disclosure of geographical areas [line items]
Revenue		150.0	300.3	267.8	0.0
Non-current assets			126.4	118.0
Sweden
Disclosure of geographical areas [line items]
Revenue		35.5	208.0	218.2	0.0
Non-current assets			26.5	44.6
France
Disclosure of geographical areas [line items]
Revenue		41.0	170.0	168.9	0.0
Non-current assets			16.7	18.4
Norway
Disclosure of geographical areas [line items]
Revenue		19.6	123.3	122.6	0.0
Non-current assets			15.7	13.3
Austria
Disclosure of geographical areas [line items]
Revenue		51.8	96.7	92.9	0.0
Spain
Disclosure of geographical areas [line items]
Revenue		13.1	81.2	82.6	0.0
Rest of Europe
Disclosure of geographical areas [line items]
Revenue		€ 89.4	193.8	188.7	€ 0.0
Non-current assets			€ 20.2	€ 6.1
Predecessor
Disclosure of geographical areas [line items]
Revenue	€ 640.3
Predecessor | United Kingdom
Disclosure of geographical areas [line items]
Revenue	225.0
Predecessor | Italy
Disclosure of geographical areas [line items]
Revenue	169.7
Predecessor | Germany
Disclosure of geographical areas [line items]
Revenue	124.2
Predecessor | Sweden
Disclosure of geographical areas [line items]
Revenue	0.0
Predecessor | France
Disclosure of geographical areas [line items]
Revenue	0.0
Predecessor | Norway
Disclosure of geographical areas [line items]
Revenue	0.0
Predecessor | Austria
Disclosure of geographical areas [line items]
Revenue	45.0
Predecessor | Spain
Disclosure of geographical areas [line items]
Revenue	0.0
Predecessor | Rest of Europe
Disclosure of geographical areas [line items]
Revenue	€ 76.4

XML

Operating profit/(loss) (Details) - EUR (€) € in Millions	5 Months Ended	9 Months Ended	12 Months Ended
	May 31, 2015	Dec. 31, 2015	Dec. 31, 2017	Dec. 31, 2016	Mar. 31, 2015
Disclosure of Operating Profit (Loss) [Line Items]
Staff costs		€ 160.2	€ 257.4	€ 264.5	€ 0.0
Depreciation of property, plant and equipment		20.3	35.9	43.3	0.0
Impairment of property, plant and equipment		3.2	0.3	1.4	0.0
Impairment of goodwill and brands		0.0	0.0	0.0	0.0
Amortization of software and brands		1.5	6.5	7.8	0.0
Operating lease charges		4.2	15.0	14.6	0.0
Exchange (gains)/losses		5.2	(1.2)	(3.3)	88.9
Fair value loss on financial assets at fair value through profit and loss		4.9	0.0	0.0	0.0
Research & development expenditure		12.1	15.4	13.3	0.0
Inventories recognized as an expense within cost of goods sold		€ 608.9	€ 1,273.3	€ 1,282.6	€ 0.0
Predecessor
Disclosure of Operating Profit (Loss) [Line Items]
Staff costs	€ 88.8
Depreciation of property, plant and equipment	11.3
Impairment of property, plant and equipment	0.0
Impairment of goodwill and brands	55.0
Amortization of software and brands	1.2
Operating lease charges	3.2
Exchange (gains)/losses	(9.0)
Fair value loss on financial assets at fair value through profit and loss	0.0
Research & development expenditure	7.2
Inventories recognized as an expense within cost of goods sold	€ 389.3

XML

Exceptional items (Details) - EUR (€) € in Millions	5 Months Ended	9 Months Ended	12 Months Ended
	May 31, 2015	Dec. 31, 2015	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015	Mar. 31, 2015
Unusual Or Infrequent Item1 [Line Items]
Investigation of strategic opportunities		€ 7.7	€ 18.8	€ 7.0	€ 7.7	€ 0.0
Supply chain reconfiguration		0.0	14.0	84.3		0.0
Findus Group integration costs		4.5	15.1	29.6		0.0
Costs related to transactions		34.1	3.2	4.8		0.7
Costs related to long-term management incentive plans		3.5	0.0	1.9		0.0
Other restructuring costs		8.9	0.0	(1.0)		0.0
Cisterna fire net (income)/costs		(2.5)	0.0	(4.3)		0.0
Impairment of intangible assets		0.0	0.0	0.0		0.0
Settlement of legacy matters		1.9	(5.6)	1.8		0.0
Remeasurement of indemnification assets		0.0	(8.3)	10.4		0.0
Adjustments For Exceptional Items		€ 58.1	€ 37.2	€ 134.5		€ 0.7
Predecessor
Unusual Or Infrequent Item1 [Line Items]
Investigation of strategic opportunities	€ 1.3
Supply chain reconfiguration	0.0
Findus Group integration costs	0.0
Costs related to transactions	3.8
Costs related to long-term management incentive plans	22.9
Other restructuring costs	0.0
Cisterna fire net (income)/costs	1.3
Impairment of intangible assets	55.0
Settlement of legacy matters	0.0
Remeasurement of indemnification assets	0.0
Adjustments For Exceptional Items	€ 84.3

XML

Exceptional items - Additional Information (Details) - EUR (€) € in Millions	5 Months Ended	9 Months Ended	12 Months Ended
	May 31, 2015	Dec. 31, 2015	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015	Mar. 31, 2015
Analysis Of Income And Expense [Line Items]
Investigation of strategic opportunities and other items		€ 7.7	€ 18.8	€ 7.0	€ 7.7	€ 0.0
Restructuring activities charges			14.0
Supply chain reconfiguration		0.0	14.0	84.3		0.0
Restructuring reconfiguration charge				54.0
Supply chain reconfiguration provision				30.3
Integration costs		4.5	15.1	29.6		0.0
Costs related to transactions		34.1	3.2	4.8		0.7
Long-term incentive scheme		3.5	0.0	1.9		0.0
Other restructuring costs (credits)		8.9	0.0	(1.0)		0.0
Income from reimbursements under insurance policies		2.5	0.0	4.3		0.0
Impairment of intangible assets		0.0	0.0	0.0		0.0
Income (charge) related to legacy matters		(1.9)	5.6	(1.8)		0.0
Charge associated with settlements of tax audits			3.9
Gain from reassessment of sales tax provision			4.2
Gain from reassessment of interest on sales tax provision			1.2
Gain on legacy pension plan			2.8
Gain on disposal of non-operational factory			1.3
Tax impact of exceptional items		6.1	13.8	8.8
Cash flows used relating to exceptional items		€ 91.6	€ 99.5	49.2		0.7
Predecessor
Analysis Of Income And Expense [Line Items]
Investigation of strategic opportunities and other items	€ 1.3
Supply chain reconfiguration	0.0
Integration costs	0.0
Costs related to transactions	3.8
Long-term incentive scheme	22.9
Payment of accelerated charge to align the cumulative charges	19.7
Non-cash charge to reflect the vesting of non-forfeited interests	3.2
Other restructuring costs (credits)	0.0
Income from reimbursements under insurance policies	(1.3)
Impairment of intangible assets	55.0
Income (charge) related to legacy matters	0.0
Tax impact of exceptional items	22.0					0.0
Cash flows used relating to exceptional items	€ 6.2					€ 0.7
Previously stated
Analysis Of Income And Expense [Line Items]
Investigation of strategic opportunities and other items				€ 8.8	€ 9.6

XML

Payroll costs, share based payments and management incentive schemes - Information About the Number of Persons Employed by the Company (Details) - employee	5 Months Ended	9 Months Ended	12 Months Ended
	May 31, 2015	Dec. 31, 2015	Dec. 31, 2017	Dec. 31, 2016	Mar. 31, 2015
Employee Information [Line Items]
Average number of employees		4,372	3,857	4,198	0
Production
Employee Information [Line Items]
Average number of employees		2,605	2,285	2,627	0
Administration, distribution & sales
Employee Information [Line Items]
Average number of employees		1,767	1,572	1,571	0
Predecessor
Employee Information [Line Items]
Average number of employees	2,682
Predecessor | Production
Employee Information [Line Items]
Average number of employees	1,635
Predecessor | Administration, distribution & sales
Employee Information [Line Items]
Average number of employees	1,047

XML

Payroll costs, share based payments and management incentive schemes - Number of Persons Employed by the Company (Details) - EUR (€) € in Millions	5 Months Ended	9 Months Ended	12 Months Ended
	May 31, 2015	Dec. 31, 2015	Dec. 31, 2017	Dec. 31, 2016	Mar. 31, 2015
Employee Information [Line Items]
Wages and salaries		€ 126.7	€ 200.8	€ 205.4	€ 0.0
Social security costs		27.5	42.0	45.9	0.0
Other pension costs		6.0	14.6	13.2	0.0
Total payroll costs		€ 160.2	€ 257.4	€ 264.5	€ 0.0
Predecessor
Employee Information [Line Items]
Wages and salaries	€ 72.1
Social security costs	12.5
Other pension costs	4.2
Total payroll costs	€ 88.8

XML

Payroll costs, share based payments and management incentive schemes - Inputs and Assumptions Underlying the Monte Carlo Model (Details) - Restricted Shares - USD ($)		12 Months Ended
	Dec. 07, 2015	Dec. 31, 2017
Disclosure of terms and conditions of share-based payment arrangement [line items]
Exercise price (in dollars per share)	$ 11.50
January 1, 2016
Disclosure of terms and conditions of share-based payment arrangement [line items]
Grant date price (in usd)		$ 12.00
Exercise price (in dollars per share)		$ 0.00
Expected volatility of the share price		20.00%
Dividend yield expected		0.00%
Risk free rate		1.59%
Employee exit rate		16.00%
January 1, 2016 | Minimum
Disclosure of terms and conditions of share-based payment arrangement [line items]
Expected life of restricted share		3 years 7 days
EBITDA Performance Target Condition		5.00%
January 1, 2016 | Maximum
Disclosure of terms and conditions of share-based payment arrangement [line items]
Expected life of restricted share		4 years
EBITDA Performance Target Condition		75.00%
January 1, 2017
Disclosure of terms and conditions of share-based payment arrangement [line items]
Grant date price (in usd)		$ 9.57
Exercise price (in dollars per share)		$ 0.00
Expected volatility of the share price		23.00%
Dividend yield expected		0.00%
Risk free rate		1.83%
Employee exit rate		16.00%
January 1, 2017 | Minimum
Disclosure of terms and conditions of share-based payment arrangement [line items]
Expected life of restricted share		3 years 1 month 10 days
EBITDA Performance Target Condition		5.00%
January 1, 2017 | Maximum
Disclosure of terms and conditions of share-based payment arrangement [line items]
Expected life of restricted share		4 years
EBITDA Performance Target Condition		75.00%

XML

Payroll costs, share based payments and management incentive schemes - Share based compensation reserve (Details) - EUR (€) € in Millions		9 Months Ended	12 Months Ended
	Jun. 19, 2017	Dec. 31, 2015	Dec. 31, 2017	Dec. 31, 2016
Disclosure of reserves within equity [line items]
Beginning balance, Reserve of share-based payments			€ 1.0
Increase through share-based payment transactions		€ 0.1	2.6	€ 1.2
Vesting of Non-Executive Director restricted shares			0.1	0.3
Ending balance, Reserve of share-based payments			2.9	1.0
Share based compensation reserve
Disclosure of reserves within equity [line items]
Beginning balance, Reserve of share-based payments			1.0
Vesting of Non-Executive Director restricted shares	€ (0.3)		(0.7)	0.3
Ending balance, Reserve of share-based payments			2.9	€ 1.0
Non-Executive Director | Share based compensation reserve
Disclosure of reserves within equity [line items]
Increase through share-based payment transactions			0.8
Key management personnel | Share based compensation reserve
Disclosure of reserves within equity [line items]
Increase through share-based payment transactions			€ 1.8

XML

Payroll costs, share based payments and management incentive schemes - Restricted Share Awards (Details)						9 Months Ended	12 Months Ended
	Aug. 22, 2017 shares director	Jun. 19, 2017 EUR (€) shares	Jun. 19, 2017 USD ($) shares $ / shares	Jun. 16, 2016 USD ($) shares	Dec. 07, 2015 USD ($)	Dec. 31, 2015 EUR (€)	Dec. 31, 2017 EUR (€) shares	Dec. 31, 2017 USD ($) shares	Dec. 31, 2016 EUR (€)	Jul. 31, 2016 $ / shares
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]
Number of Non-executive Directors granted awards | director	2
Share price (in dollars per share) | $ / shares										$ 8.98
Share based payment charge | €						€ 100,000	€ 2,600,000		€ 1,200,000
Restricted Shares
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]
Exercise price (in dollars per share) | $					$ 11.50
Non-Executive Director
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]
Share-based payment expense | €						100,000	800,000		600,000
Non-Executive Director | Restricted Shares
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]
Number of shares issued per director | $								$ 100,000
Exercise price (in dollars per share) | $			$ 14.38	$ 8.98	$ 11.50
Share price (in dollars per share) | $ / shares			$ 14.38							$ 8.98
Number of shares vested		55,680	55,680	34,780
Shares paid for tax withholding for share based compensation		9,384	9,384	11,568
Number of shares granted	11,774	41,724	41,724	55,680
Share-based payment expense | €							800,000		600,000
Key management personnel
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]
Share-based payment expense | €							€ 1,800,000		600,000
Key management personnel | Restricted Shares
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]
Number of shares issued							4,927,000	4,927,000
January 1, 2016 | Restricted Shares
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]
Exercise price (in dollars per share) | $								$ 0.00
Expected volatility of the share price							20.00%	20.00%
January 1, 2017 | Restricted Shares
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]
Exercise price (in dollars per share) | $								$ 0.00
Expected volatility of the share price							23.00%	23.00%
Key management personnel | Restricted Shares
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]
Share-based payment expense | €						0	€ 1,800,000		600,000
Key management personnel | January 1, 2016 | Restricted Shares
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]
Number of shares allocated							3,837,000	3,837,000
Number of other equity instruments forfeited in share-based payment arrangement							770,000	770,000
Fair value							€ 5,900,000	$ 6,300,000
Key management personnel | January 1, 2017 | Restricted Shares
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]
Number of shares granted							485,000	485,000
Number of shares allocated							1,090,000	1,090,000
Fair value							€ 600,000	$ 600,000
Key management personnel | 50% over a 2 year period | Restricted Shares
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]
Vesting percentage							50.00%	50.00%
Vesting period							2 years	2 years
Key management personnel | 50% over a 2 year period | January 1, 2016 | Restricted Shares
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]
Vesting period							2 years	2 years
Key management personnel | 50% over a 2 year period | January 1, 2017 | Restricted Shares
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]
Vesting period							2 years	2 years
Key management personnel | 50% over a 4 year period | Restricted Shares
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]
Vesting percentage							50.00%	50.00%
Vesting period							4 years	4 years
Key management personnel | 50% over a 4 year period | January 1, 2016 | Restricted Shares
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]
Vesting period							4 years	4 years
Key management personnel | 50% over a 4 year period | January 1, 2017 | Restricted Shares
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]
Vesting period							4 years	4 years
Share based compensation reserve
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]
Share based payment charge | €						€ 100,000	€ 2,600,000		€ 1,200,000
Share based compensation reserve | Non-Executive Director | Restricted Shares
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]
Share based payment charge | €		€ 300,000

XML

Payroll costs, share based payments and management incentive schemes - Initial Options (Details) € in Thousands			5 Months Ended	9 Months Ended	12 Months Ended
	Apr. 01, 2016	Apr. 11, 2014 USD ($) shares	May 31, 2015 EUR (€)	Dec. 31, 2015 EUR (€)	Dec. 31, 2017 EUR (€) year	Dec. 31, 2017 USD ($) year	Dec. 31, 2016 EUR (€)	Apr. 11, 2014 EUR (€) shares
Non-Executive Director
Disclosure of terms and conditions of share-based payment arrangement [line items]
Weighted average remaining contractual life of outstanding share options | year					5	5
Market value at grant date (in usd) | $						$ 10.00
Expected time to acquisition					1 year	1 year
Probability of acquisition					61.00%	61.00%
Expected volatility					17.03%	17.03%
Risk free interest rate					0.84%	0.84%
Number of share options forfeited | shares		0
Share-based payment expense				€ 100	€ 800		€ 600
Non-Executive Director | Stock Option
Disclosure of terms and conditions of share-based payment arrangement [line items]
Value of options								€ 60
Expense recognition period	2 years
Ordinary shares | Non-Executive Director
Disclosure of terms and conditions of share-based payment arrangement [line items]
Number of shares authorised | shares								125,000
Exercise price of share options granted (in usd) | $		$ 11.50
Predecessor | Stock Option
Disclosure of terms and conditions of share-based payment arrangement [line items]
Share-based payment expense			€ 3,200

XML

Payroll costs, share based payments and management incentive schemes - Management Incentive Schemes (Details) - EUR (€) € in Millions	5 Months Ended	9 Months Ended	12 Months Ended
	May 31, 2015	Dec. 31, 2015	Dec. 31, 2017	Dec. 31, 2016	Mar. 31, 2015
Disclosure of terms and conditions of share-based payment arrangement [line items]
Long-term incentive scheme		€ 3.5	€ 0.0	€ 1.9	€ 0.0
Predecessor
Disclosure of terms and conditions of share-based payment arrangement [line items]
Long-term incentive scheme	€ 22.9
Iglo | Predecessor
Disclosure of terms and conditions of share-based payment arrangement [line items]
Long-term incentive scheme	€ 19.7

XML

Directors and Key Management compensation (Details) - EUR (€) € in Millions	5 Months Ended	9 Months Ended	12 Months Ended
	May 31, 2015	Dec. 31, 2015	Dec. 31, 2017	Dec. 31, 2016	Mar. 31, 2015
Disclosure of transactions between related parties [line items]
Short-term employee benefits		€ 1.3	€ 2.0	€ 2.1	€ 0.0
Contributions to money purchase pension plans		0.0	0.0	0.0	0.0
Share-based payment		0.1	1.4	0.9	0.0
Long-term incentive scheme		0.0	0.0	0.0	0.0
Compensation for loss of office		0.0	0.4	0.0	0.0
Non-Executive Director fees		0.1	0.3	0.2	0.2
Total Directors’ and executive officers' compensation		€ 1.5	€ 4.1	€ 3.2	€ 0.2
Predecessor
Disclosure of transactions between related parties [line items]
Short-term employee benefits	€ 1.9
Contributions to money purchase pension plans	0.2
Share-based payment	2.2
Long-term incentive scheme	17.4
Compensation for loss of office	0.0
Non-Executive Director fees	0.0
Total Directors’ and executive officers' compensation	€ 21.7

XML

Directors and Key Management compensation - Additional Information (Details)	5 Months Ended	9 Months Ended	12 Months Ended
	May 31, 2015 director	Dec. 31, 2015 director	Dec. 31, 2017 director executive_officer	Dec. 31, 2016 director executive_officer	Mar. 31, 2015 director
Disclosure of transactions between related parties [line items]
Number of executive Officers accruing benefits under share-based payment schemes | executive_officer			2	3
Number of directors accruing benefits under money purchase schemes		1	2	1	0
Predecessor
Disclosure of transactions between related parties [line items]
Number of directors who qualifying service shares were received under long term incentive schemes	8
Number of directors accruing benefits under money purchase schemes	4

XML

Finance income and costs (Details) - EUR (€) € in Millions	5 Months Ended	8 Months Ended	9 Months Ended	12 Months Ended
	May 31, 2015	Dec. 31, 2017	Dec. 31, 2015	Dec. 31, 2017	Dec. 31, 2016	Mar. 31, 2015
Disclosure Of Finance Income (Cost) [Line Items]
Interest income			€ 4.4	€ 0.2	€ 5.9	€ 0.0
Gain on derivatives			4.3	7.0	0.0	0.0
Net foreign exchange gains on translation of financial assets and liabilities			0.0	0.0	18.3	0.1
Finance income			8.7	7.2	24.2	0.1
Accrued interest			0.0	0.0	0.0	0.0
Cash pay interest expense			(38.8)	(54.0)	(68.7)	0.0
Cross-currency interest rate swaps: cash flow hedges, transfer from equity			0.0	3.9	0.0	0.0
Other interest expense			0.0	0.0	(2.8)	0.0
Net pension interest costs			(1.9)	(3.6)	(4.1)	0.0
Amortization of borrowing costs			(2.1)	(2.7)	(5.0)	0.0
Net foreign exchange losses on translation of financial assets and liabilities			(0.5)	(3.9)	0.0	0.0
Interest on unwinding of discounted items			0.0	(1.2)	(1.4)	0.0
Loss on derivatives			0.0	0.0	(4.3)	0.0
Financing costs incurred in amendment of terms of debt		€ (20.1)	(0.9)	(20.1)	0.0	0.0
Finance costs			(44.2)	(81.6)	(86.3)	0.0
Net finance (costs)/income			€ (35.5)	€ (74.4)	€ (62.1)	€ 0.1
Deferred transaction costs written off		€ 15.7
Predecessor
Disclosure Of Finance Income (Cost) [Line Items]
Interest income	€ 2.0
Gain on derivatives	0.0
Net foreign exchange gains on translation of financial assets and liabilities	0.0
Finance income	2.0
Accrued interest	(60.2)
Cash pay interest expense	(35.4)
Cross-currency interest rate swaps: cash flow hedges, transfer from equity	0.0
Other interest expense	0.0
Net pension interest costs	(0.7)
Amortization of borrowing costs	(0.9)
Net foreign exchange losses on translation of financial assets and liabilities	(20.5)
Interest on unwinding of discounted items	0.0
Loss on derivatives	0.0
Financing costs incurred in amendment of terms of debt	0.0
Finance costs	(117.7)
Net finance (costs)/income	€ (115.7)

XML

Taxation - Components of Tax Expense (Income) (Details) - EUR (€) € in Millions	5 Months Ended	9 Months Ended	12 Months Ended
	May 31, 2015	Dec. 31, 2015	Dec. 31, 2017	Dec. 31, 2016	Mar. 31, 2015
Components Of Tax Expense [Line Items]
Current tax on profits/loss for the period		€ (18.0)	€ (37.5)	€ (58.9)	€ 0.0
Adjustments in respect of prior periods		(2.3)	3.2	(0.6)	0.0
Total current tax expense and adjustments		(20.3)	(34.3)	(59.5)	0.0
Origination and reversal of temporary differences		10.4	(2.1)	12.9	0.0
Impact of change in tax rates		22.2	4.4	7.0	0.0
Total deferred tax expense and adjustments		32.6	2.3	19.9	0.0
Total tax (expense)/credit		€ 12.3	€ (32.0)	€ (39.6)	€ 0.0
Predecessor
Components Of Tax Expense [Line Items]
Current tax on profits/loss for the period	€ (41.2)
Adjustments in respect of prior periods	15.2
Total current tax expense and adjustments	(26.0)
Origination and reversal of temporary differences	(14.9)
Impact of change in tax rates	0.0
Total deferred tax expense and adjustments	(14.9)
Total tax (expense)/credit	€ (40.9)

XML

Taxation - Reconciliation of Effective Tax Rate (Details) - EUR (€) € in Millions	5 Months Ended	9 Months Ended	12 Months Ended
	May 31, 2015	Dec. 31, 2015	Dec. 31, 2017	Dec. 31, 2016	Mar. 31, 2015
Components Of Tax Expense [Line Items]
Profit/(loss) before tax		€ (349.6)	€ 168.5	€ 76.0	€ (167.5)
Tax (charge)/credit at the standard UK corporation tax rate 19.25% (2016: 20%; 2015: 20.25%)		70.8	(32.5)	(15.2)	33.9
Difference in tax rates		(67.5)	(10.0)	(10.0)	(33.9)
Non tax deductible interest		(9.9)	4.4	0.0	0.0
Other income and expenses not taxable or deductible		1.0	16.8	(7.4)	0.0
Unrecognized tax assets		(2.1)	(19.3)	(1.8)	0.0
Provisions for uncertainties		0.1	1.0	(11.6)	0.0
Impact of change in deferred tax rates		22.2	4.4	7.0	0.0
Prior period adjustment		(2.3)	3.2	(0.6)	0.0
Total tax (expense)/credit		€ 12.3	€ (32.0)	€ (39.6)	€ 0.0
Standard tax rate		20.25%	19.25%	20.00%
Effective tax rate			19.00%	52.10%
Predecessor
Components Of Tax Expense [Line Items]
Profit/(loss) before tax	€ (87.1)
Tax (charge)/credit at the standard UK corporation tax rate 19.25% (2016: 20%; 2015: 20.25%)	17.6
Difference in tax rates	(4.6)
Non tax deductible interest	(8.7)
Other income and expenses not taxable or deductible	(21.6)
Unrecognized tax assets	(30.9)
Provisions for uncertainties	(7.9)
Impact of change in deferred tax rates	0.0
Prior period adjustment	15.2
Total tax (expense)/credit	€ (40.9)

XML

Taxation - Tax charge/(credit) Relating To Components Of Other Comprehensive Income (Details) - EUR (€) € in Millions	5 Months Ended	9 Months Ended	12 Months Ended
	May 31, 2015	Dec. 31, 2015	Dec. 31, 2017	Dec. 31, 2016	Mar. 31, 2015
Components Of Tax Expense [Line Items]
Remeasurement of post-employment benefit liabilities, before tax		€ (19.4)	€ (2.9)	€ 23.6	€ 0.0
Remeasurement of post-employment benefit liabilities, tax charge/(credit)		6.1	2.0	6.3	0.0
Remeasurement of post-employment benefit liabilities, after tax		(13.3)	(0.9)	29.9
Net investment hedge, before tax		4.4	0.8	0.5
Net investment hedge, tax charge/(credit)		0.0	0.0	0.0
Net investment hedge, after tax		4.4	0.8	0.5
Cash flow hedges, before tax		(1.6)	16.4	(10.1)	0.0
Cash flow hedges, tax charge/(credit)		0.5	(5.0)	2.8
Cash flow hedges, after tax		(1.1)	11.4	(7.3)
Other comprehensive (income)/loss, before tax		(16.6)	14.3	14.0
Other comprehensive (income)/loss, tax charges/(credits)		6.6	(3.0)	9.1
Other comprehensive (income)/loss, after tax		(10.0)	11.3	23.1	€ (88.9)
Current and deferred tax relating to items charged or credited directly to equity [abstract]
Current tax		0.0	0.0	0.0
Deferred tax		6.6	(3.0)	9.1
Total current and deferred tax		€ 6.6	€ (3.0)	€ 9.1
Predecessor
Components Of Tax Expense [Line Items]
Remeasurement of post-employment benefit liabilities, before tax	€ 2.5
Remeasurement of post-employment benefit liabilities, tax charge/(credit)	(0.7)
Remeasurement of post-employment benefit liabilities, after tax	1.8
Net investment hedge, before tax	(44.7)
Net investment hedge, tax charge/(credit)	0.0
Net investment hedge, after tax	(44.7)
Cash flow hedges, before tax	0.0
Cash flow hedges, tax charge/(credit)	0.0
Cash flow hedges, after tax	0.0
Other comprehensive (income)/loss, before tax	(42.2)
Other comprehensive (income)/loss, tax charges/(credits)	(0.7)
Other comprehensive (income)/loss, after tax	(42.9)
Current and deferred tax relating to items charged or credited directly to equity [abstract]
Current tax	0.0
Deferred tax	(0.7)
Total current and deferred tax	€ (0.7)

XML

Property, plant and equipment (Details) - EUR (€) € in Millions	9 Months Ended	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2017	Dec. 31, 2016	Mar. 31, 2015
Reconciliation of changes in property, plant and equipment [abstract]
Property, plant and equipment		€ 298.2	€ 318.2
Depreciation	€ (20.3)	(35.9)	(43.3)	€ 0.0
Impairment	(3.2)	(0.3)	(1.4)	€ 0.0
Property, plant and equipment	318.2	295.4	298.2
Cost
Reconciliation of changes in property, plant and equipment [abstract]
Property, plant and equipment		343.6	343.4
Acquisitions through business combinations			2.5
Additions		38.0	38.0
Transfers			(0.6)
Disposals		(1.2)	(3.3)
Effect of movements in foreign exchange		(17.3)	(36.4)
Property, plant and equipment	343.4	363.1	343.6
Accumulated depreciation and impairment
Reconciliation of changes in property, plant and equipment [abstract]
Property, plant and equipment		(45.4)	(25.2)
Depreciation		35.9	43.3
Impairment		0.3	1.4
Transfers			0.0
Effect of movements in foreign exchange		13.9	24.5
Property, plant and equipment	(25.2)	(67.7)	(45.4)
Land and buildings
Reconciliation of changes in property, plant and equipment [abstract]
Property, plant and equipment		104.7	115.8
Property, plant and equipment	115.8	109.2	104.7
Land and buildings | Cost
Reconciliation of changes in property, plant and equipment [abstract]
Property, plant and equipment		110.5	119.2
Acquisitions through business combinations			0.0
Additions		11.6	3.3
Transfers			(1.7)
Disposals		(0.1)	(2.7)
Effect of movements in foreign exchange		(4.6)	(7.6)
Property, plant and equipment	119.2	117.4	110.5
Land and buildings | Accumulated depreciation and impairment
Reconciliation of changes in property, plant and equipment [abstract]
Property, plant and equipment		(5.8)	(3.4)
Depreciation		6.1	6.5
Impairment		0.0	(0.2)
Transfers			0.0
Effect of movements in foreign exchange		3.7	3.9
Property, plant and equipment	(3.4)	(8.2)	(5.8)
Plant and equipment
Reconciliation of changes in property, plant and equipment [abstract]
Property, plant and equipment		191.9	200.4
Property, plant and equipment	200.4	185.1	191.9
Plant and equipment | Cost
Reconciliation of changes in property, plant and equipment [abstract]
Property, plant and equipment		230.3	221.8
Acquisitions through business combinations			2.5
Additions		26.0	34.3
Transfers			1.1
Disposals		(1.1)	(0.6)
Effect of movements in foreign exchange		(12.7)	(28.8)
Property, plant and equipment	221.8	242.5	230.3
Plant and equipment | Accumulated depreciation and impairment
Reconciliation of changes in property, plant and equipment [abstract]
Property, plant and equipment		(38.4)	(21.4)
Depreciation		28.9	35.7
Impairment		0.3	1.6
Transfers			(0.2)
Effect of movements in foreign exchange		10.2	20.5
Property, plant and equipment	(21.4)	(57.4)	(38.4)
Computer equipment
Reconciliation of changes in property, plant and equipment [abstract]
Property, plant and equipment		1.6	2.0
Property, plant and equipment	2.0	1.1	1.6
Computer equipment | Cost
Reconciliation of changes in property, plant and equipment [abstract]
Property, plant and equipment		2.8	2.4
Acquisitions through business combinations			0.0
Additions		0.4	0.4
Transfers			0.0
Disposals		0.0	0.0
Effect of movements in foreign exchange		0.0	0.0
Property, plant and equipment	2.4	3.2	2.8
Computer equipment | Accumulated depreciation and impairment
Reconciliation of changes in property, plant and equipment [abstract]
Property, plant and equipment		(1.2)	(0.4)
Depreciation		0.9	1.1
Impairment		0.0	0.0
Transfers			0.2
Effect of movements in foreign exchange		0.0	0.1
Property, plant and equipment	€ (0.4)	€ (2.1)	€ (1.2)

XML

Property, plant and equipment - Additional Information (Details) - EUR (€)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Disclosure of detailed information about property, plant and equipment [line items]
Percentage of consolidated gross assets or adjusted EBITDA held individually by companies in Guarantor Group	5.00%
Percentage of consolidated gross assets or adjusted EBITDA held by Guarantor Group in total	80.00%
Machinery
Disclosure of detailed information about property, plant and equipment [line items]
Recognised finance lease as assets	€ 0	€ 800,000

XML

Goodwill and Intangibles - Cost (Details) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Reconciliation of changes in intangible assets and goodwill [abstract]
Intangible assets and goodwill	€ 3,472.2	€ 3,406.4
Intangible assets and goodwill	3,470.0	3,472.2
Cost
Reconciliation of changes in intangible assets and goodwill [abstract]
Intangible assets and goodwill	3,480.2	3,407.9
Acquisitions through business combinations		68.6
Additions	4.6	4.4
Transfer from tangible assets (note 12)		0.6
Effect of movements in foreign exchange	(1.0)	(1.3)
Intangible assets and goodwill	3,483.8	3,480.2
Goodwill
Reconciliation of changes in intangible assets and goodwill [abstract]
Intangible assets and goodwill	1,745.6	1,676.8
Intangible assets and goodwill	1,745.6	1,745.6
Goodwill | Cost
Reconciliation of changes in intangible assets and goodwill [abstract]
Intangible assets and goodwill	1,745.6	1,676.8
Acquisitions through business combinations		68.8
Additions	0.0	0.0
Transfer from tangible assets (note 12)		0.0
Effect of movements in foreign exchange	0.0	0.0
Intangible assets and goodwill	1,745.6	1,745.6
Brands
Reconciliation of changes in intangible assets and goodwill [abstract]
Intangible assets and goodwill	1,688.1	1,688.8
Intangible assets and goodwill	1,687.4	1,688.1
Brands | Cost
Reconciliation of changes in intangible assets and goodwill [abstract]
Intangible assets and goodwill	1,688.9	1,688.9
Acquisitions through business combinations		0.0
Additions	0.0	0.0
Transfer from tangible assets (note 12)		0.0
Effect of movements in foreign exchange	0.0	0.0
Intangible assets and goodwill	1,688.9	1,688.9
Computer software
Reconciliation of changes in intangible assets and goodwill [abstract]
Intangible assets and goodwill	10.1	10.0
Intangible assets and goodwill	10.8	10.1
Computer software | Cost
Reconciliation of changes in intangible assets and goodwill [abstract]
Intangible assets and goodwill	14.7	11.0
Acquisitions through business combinations		0.0
Additions	4.6	4.4
Transfer from tangible assets (note 12)		0.6
Effect of movements in foreign exchange	(1.0)	(1.3)
Intangible assets and goodwill	18.3	14.7
Customer relationships
Reconciliation of changes in intangible assets and goodwill [abstract]
Intangible assets and goodwill	28.4	30.6
Intangible assets and goodwill	26.2	28.4
Customer relationships | Cost
Reconciliation of changes in intangible assets and goodwill [abstract]
Intangible assets and goodwill	31.0	31.0
Acquisitions through business combinations		0.0
Additions	0.0	0.0
Transfer from tangible assets (note 12)		0.0
Effect of movements in foreign exchange	0.0	0.0
Intangible assets and goodwill	31.0	31.0
Others
Reconciliation of changes in intangible assets and goodwill [abstract]
Intangible assets and goodwill	0.0	0.2
Intangible assets and goodwill	0.0	0.0
Others | Cost
Reconciliation of changes in intangible assets and goodwill [abstract]
Intangible assets and goodwill	0.0	0.2
Acquisitions through business combinations		(0.2)
Additions	0.0	0.0
Transfer from tangible assets (note 12)		0.0
Effect of movements in foreign exchange	0.0	0.0
Intangible assets and goodwill	€ 0.0	€ 0.0

XML

Goodwill and Intangibles - Accumulated Amortization and Impairment (Details) - EUR (€) € in Millions	9 Months Ended	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2017	Dec. 31, 2016	Mar. 31, 2015
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill		€ (3,472.2)	€ (3,406.4)
Amortisation, intangible assets other than goodwill	€ (1.5)	(6.5)	(7.8)	€ 0.0
Intangible assets and goodwill	(3,406.4)	(3,470.0)	(3,472.2)
Intangible assets and goodwill	3,406.4	3,472.2	3,406.4
Accumulated depreciation and impairment
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill		8.0	1.5
Amortisation, intangible assets other than goodwill	1.5	6.5	7.8
Increase (decrease) through net exchange differences, intangible assets and goodwill		(0.7)	(1.3)
Intangible assets and goodwill	1.5	13.8	8.0
Intangible assets and goodwill	(1.5)	(8.0)	(1.5)
Goodwill
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill		(1,745.6)	(1,676.8)
Intangible assets and goodwill	(1,676.8)	(1,745.6)	(1,745.6)
Intangible assets and goodwill	1,676.8	1,745.6	1,676.8
Goodwill | Accumulated depreciation and impairment
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill		0.0	0.0
Amortisation, intangible assets other than goodwill		0.0	0.0
Increase (decrease) through net exchange differences, intangible assets and goodwill		0.0	0.0
Intangible assets and goodwill	0.0	0.0	0.0
Intangible assets and goodwill	0.0	0.0	0.0
Customer relationships
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill		(28.4)	(30.6)
Intangible assets and goodwill	(30.6)	(26.2)	(28.4)
Intangible assets and goodwill	30.6	28.4	30.6
Customer relationships | Accumulated depreciation and impairment
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill		2.6	0.4
Amortisation, intangible assets other than goodwill		2.2	2.2
Increase (decrease) through net exchange differences, intangible assets and goodwill		0.0	0.0
Intangible assets and goodwill	0.4	4.8	2.6
Intangible assets and goodwill	(0.4)	(2.6)	(0.4)
Brands
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill		(1,688.1)	(1,688.8)
Intangible assets and goodwill	(1,688.8)	(1,687.4)	(1,688.1)
Intangible assets and goodwill	1,688.8	1,688.1	1,688.8
Brands | Accumulated depreciation and impairment
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill		0.8	0.1
Amortisation, intangible assets other than goodwill		0.7	0.7
Increase (decrease) through net exchange differences, intangible assets and goodwill		0.0	0.0
Intangible assets and goodwill	0.1	1.5	0.8
Intangible assets and goodwill	(0.1)	(0.8)	(0.1)
Computer software
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill		(10.1)	(10.0)
Intangible assets and goodwill	(10.0)	(10.8)	(10.1)
Intangible assets and goodwill	10.0	10.1	10.0
Computer software | Accumulated depreciation and impairment
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill		4.6	1.0
Amortisation, intangible assets other than goodwill		3.6	4.9
Increase (decrease) through net exchange differences, intangible assets and goodwill		(0.7)	(1.3)
Intangible assets and goodwill	1.0	7.5	4.6
Intangible assets and goodwill	(1.0)	(4.6)	(1.0)
Others
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill		0.0	(0.2)
Intangible assets and goodwill	(0.2)	0.0	0.0
Intangible assets and goodwill	0.2	0.0	0.2
Others | Accumulated depreciation and impairment
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill		0.0	0.0
Amortisation, intangible assets other than goodwill		0.0	0.0
Increase (decrease) through net exchange differences, intangible assets and goodwill		0.0	0.0
Intangible assets and goodwill	0.0	0.0	0.0
Intangible assets and goodwill	€ 0.0	€ 0.0	€ 0.0

XML

Goodwill and Intangibles - Additional Information (Details) - EUR (€) € in Millions	9 Months Ended	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2017	Dec. 31, 2016	Mar. 31, 2015
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Amortization	€ (1.5)	€ (6.5)	€ (7.8)	€ 0.0
Discount rate		8.00%	8.00%
Long-term growth rate		1.00%	0.50%
Accumulated depreciation and impairment
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Amortization	€ 1.5	€ 6.5	€ 7.8

XML

Acquisitions (Details) - 3 months ended Jun. 30, 2018 - Forecast - Goodfella's Pizza € in Millions, £ in Millions	EUR (€) facility	GBP (£)
Disclosure of detailed information about business combination [line items]
Cash transferred	€ 225	£ 200
Number of frozen pizza manufacturing facilities	2

XML

Investments (Details)	12 Months Ended
	Dec. 31, 2017
Nomad Foods Europe Holdings Limited
Disclosure of subsidiaries [line items]
Ownership	100.00%
Nomad Foods Europe Holdco Limited
Disclosure of subsidiaries [line items]
Ownership	100.00%
Nomad Foods Europe Finco Limited
Disclosure of subsidiaries [line items]
Ownership	100.00%
Nomad Foods Europe Midco Limited
Disclosure of subsidiaries [line items]
Ownership	100.00%
Nomad Foods Bondco Plc
Disclosure of subsidiaries [line items]
Ownership	100.00%
Nomad Foods Lux S.à.r.l.
Disclosure of subsidiaries [line items]
Ownership	100.00%
Nomad Foods Europe Limited
Disclosure of subsidiaries [line items]
Ownership	100.00%
Birds Eye Limited
Disclosure of subsidiaries [line items]
Ownership	100.00%
Nomad Foods Europe Finance Limited
Disclosure of subsidiaries [line items]
Ownership	100.00%
Birds Eye Ireland Limited
Disclosure of subsidiaries [line items]
Ownership	100.00%
Iglo Holding GmbH
Disclosure of subsidiaries [line items]
Ownership	100.00%
Iglo Nederland B.V.
Disclosure of subsidiaries [line items]
Ownership	100.00%
Iglo Belgium S.A.
Disclosure of subsidiaries [line items]
Ownership	100.00%
Iglo Portugal
Disclosure of subsidiaries [line items]
Ownership	100.00%
Iglo Austria Holdings GmbH
Disclosure of subsidiaries [line items]
Ownership	100.00%
C.S.I. Compagnia Surgelati Italiana S.R.L
Disclosure of subsidiaries [line items]
Ownership	100.00%
Findus Sverige Holdings AB
Disclosure of subsidiaries [line items]
Ownership	100.00%
Iglo GmbH
Disclosure of subsidiaries [line items]
Ownership	100.00%
Frozen Fish International GmbH
Disclosure of subsidiaries [line items]
Ownership	100.00%
Liberator Germany Newco GmbH
Disclosure of subsidiaries [line items]
Ownership	100.00%
Iglo Austria GmbH
Disclosure of subsidiaries [line items]
Ownership	100.00%
Findus Sverige AB
Disclosure of subsidiaries [line items]
Ownership	100.00%
Frionor Sverige AB
Disclosure of subsidiaries [line items]
Ownership	100.00%
Findus Holdings France SAS
Disclosure of subsidiaries [line items]
Ownership	100.00%
Findus France SAS
Disclosure of subsidiaries [line items]
Ownership	100.00%
Findus Espana SLU
Disclosure of subsidiaries [line items]
Ownership	100.00%
Findus Danmark A/S
Disclosure of subsidiaries [line items]
Ownership	100.00%
Findus Finland Oy
Disclosure of subsidiaries [line items]
Ownership	100.00%
Findus Norge AS
Disclosure of subsidiaries [line items]
Ownership	100.00%

XML

Deferred tax assets and liabilities - Summary of Deferred Tax Assets and Liabilities (Details) - EUR (€) € in Millions	9 Months Ended	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2017	Dec. 31, 2016
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]
Deferred tax assets		€ 64.3	€ 64.9
Deferred tax liabilities		(327.7)	(333.2)
Tax assets/(liabilities)	€ (278.7)	(263.4)	(268.3)
Deferred tax assets not recognized in the financial statements		65.3	56.3
Deferred tax items credited (charged) to equity	(6.6)	3.0	(9.1)
Property, plant and equipment
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]
Deferred tax assets		13.5	10.3
Deferred tax liabilities		(28.7)	(33.6)
Tax assets/(liabilities)	(5.3)	(15.2)	(23.3)
Intangible assets
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]
Deferred tax assets		0.1	0.0
Deferred tax liabilities		(295.1)	(291.3)
Tax assets/(liabilities)	(315.8)	(295.0)	(291.3)
Employee benefits
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]
Deferred tax assets		28.2	27.8
Deferred tax liabilities		0.0	(0.1)
Tax assets/(liabilities)	32.7	28.2	27.7
Tax value of loss carry forwards
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]
Deferred tax assets		15.6	18.9
Deferred tax liabilities		0.0	0.0
Tax assets/(liabilities)	0.0	15.6	18.9
Derivative financial instruments
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]
Deferred tax assets		0.9	0.0
Deferred tax liabilities		0.5	(3.3)
Tax assets/(liabilities)	0.2	1.4	(3.3)
Other
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]
Deferred tax assets		6.0	7.9
Deferred tax liabilities		(4.4)	(4.9)
Tax assets/(liabilities)	€ 9.5	€ 1.6	€ 3.0

XML

Deferred tax assets and liabilities - Changes in Deferred tax (Details) - EUR (€) € in Millions	9 Months Ended	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2017	Dec. 31, 2016
Reconciliation of changes in deferred tax liability (asset) [abstract]
Opening balance		€ (268.3)	€ (278.7)
Changes in deferred tax liability (asset) [abstract]
Acquired in business combinations		0.0	(0.3)
Recognized in Statement of Profit or Loss		2.3	19.9
Recognized in Other Comprehensive Income	€ (6.6)	3.0	(9.1)
Movement in foreign exchange		(0.4)	(0.1)
Closing balance	(278.7)	(263.4)	(268.3)
Property, plant and equipment
Reconciliation of changes in deferred tax liability (asset) [abstract]
Opening balance		(23.3)	(5.3)
Changes in deferred tax liability (asset) [abstract]
Acquired in business combinations		0.0	(0.3)
Recognized in Statement of Profit or Loss		8.2	(17.2)
Movement in foreign exchange		(0.1)	(0.5)
Closing balance	(5.3)	(15.2)	(23.3)
Intangible assets
Reconciliation of changes in deferred tax liability (asset) [abstract]
Opening balance		(291.3)	(315.8)
Changes in deferred tax liability (asset) [abstract]
Recognized in Statement of Profit or Loss		(3.7)	24.1
Movement in foreign exchange			0.4
Closing balance	(315.8)	(295.0)	(291.3)
Employee benefits
Reconciliation of changes in deferred tax liability (asset) [abstract]
Opening balance		27.7	32.7
Changes in deferred tax liability (asset) [abstract]
Recognized in Statement of Profit or Loss		2.5	1.3
Recognized in Other Comprehensive Income		(2.0)	(6.3)
Closing balance	32.7	28.2	27.7
Tax value of loss carry forwards
Reconciliation of changes in deferred tax liability (asset) [abstract]
Opening balance		18.9	0.0
Changes in deferred tax liability (asset) [abstract]
Recognized in Statement of Profit or Loss		(3.0)	18.9
Movement in foreign exchange		(0.3)
Closing balance	0.0	15.6	18.9
Derivative financial instruments
Reconciliation of changes in deferred tax liability (asset) [abstract]
Opening balance		(3.3)	0.2
Changes in deferred tax liability (asset) [abstract]
Recognized in Statement of Profit or Loss		(0.3)	(0.7)
Recognized in Other Comprehensive Income		5.0	(2.8)
Closing balance	0.2	1.4	(3.3)
Other
Reconciliation of changes in deferred tax liability (asset) [abstract]
Opening balance		3.0	9.5
Changes in deferred tax liability (asset) [abstract]
Recognized in Statement of Profit or Loss		(1.4)	(6.5)
Closing balance	€ 9.5	€ 1.6	€ 3.0

XML

Inventories (Details) - EUR (€)	9 Months Ended	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2017	Dec. 31, 2016	Mar. 31, 2015
Inventories [Abstract]
Raw materials and consumables		€ 82,900,000	€ 97,700,000
Work in progress		41,000,000	41,700,000
Finished goods and goods for resale		183,000,000	185,600,000
Total inventories		306,900,000	325,000,000
Inventory write-down	€ 3,500,000	€ 7,600,000	€ 6,400,000	€ 0

XML

Trade and other receivables (Details) - EUR (€) € in Millions	Dec. 31, 2017	Dec. 31, 2016
Current assets
Trade receivables	€ 94.7	€ 92.3
Prepayments and accrued income	10.1	8.0
Other receivables	19.7	26.1
Tax receivable	22.6	9.3
Total current trade and other receivables	147.1	135.7
Non-current assets
Other receivables	4.3	0.4
Total non-current trade and other receivables	4.3	0.4
Total trade and other receivables	€ 151.4	€ 136.1

XML

Trade and other receivables - Aging of Trade Receivables (Details) - EUR (€) € in Millions	Dec. 31, 2017	Dec. 31, 2016
Trade Receivables [Line Items]
Trade receivables	€ 283.2	€ 240.9
Reduction in trade-terms	(188.5)	(148.6)
Total trade receivables	94.7	92.3
Not past due
Trade Receivables [Line Items]
Trade receivables	243.4	229.4
Past due less than 1 month
Trade Receivables [Line Items]
Trade receivables	34.9	9.7
Past due 1 to 3 months
Trade Receivables [Line Items]
Trade receivables	4.5	0.7
Past due 3 to 6 months
Trade Receivables [Line Items]
Trade receivables	0.0	0.8
Past due more than 6 months
Trade Receivables [Line Items]
Trade receivables	0.4	0.3
Gross
Trade Receivables [Line Items]
Trade receivables	289.3	247.3
Gross | Not past due
Trade Receivables [Line Items]
Trade receivables	243.4	229.4
Gross | Past due less than 1 month
Trade Receivables [Line Items]
Trade receivables	35.6	9.8
Gross | Past due 1 to 3 months
Trade Receivables [Line Items]
Trade receivables	4.8	0.9
Gross | Past due 3 to 6 months
Trade Receivables [Line Items]
Trade receivables	0.2	0.9
Gross | Past due more than 6 months
Trade Receivables [Line Items]
Trade receivables	5.3	6.3
Impaired
Trade Receivables [Line Items]
Trade receivables	(6.1)	(6.4)
Impaired | Not past due
Trade Receivables [Line Items]
Trade receivables	0.0	0.0
Impaired | Past due less than 1 month
Trade Receivables [Line Items]
Trade receivables	(0.7)	(0.1)
Impaired | Past due 1 to 3 months
Trade Receivables [Line Items]
Trade receivables	(0.3)	(0.2)
Impaired | Past due 3 to 6 months
Trade Receivables [Line Items]
Trade receivables	(0.2)	(0.1)
Impaired | Past due more than 6 months
Trade Receivables [Line Items]
Trade receivables	€ (4.9)	€ (6.0)

XML

Indemnification assets (Details) - EUR (€) € in Millions		12 Months Ended
	Jun. 12, 2017	Dec. 31, 2017	Dec. 31, 2016
Disclosure of detailed information about business combination [line items]
Indemnification asset, beginning balance		€ 65.5
Indemnification asset, ending balance		73.8	€ 65.5
Iglo
Disclosure of detailed information about business combination [line items]
Indemnification asset, beginning balance		2.1	10.2
Reclassified from Other receivables		0.0	1.2
Release of indemnified provision	€ (2.1)	(2.1)	(9.3)
Indemnification asset, ending balance		0.0	2.1
Findus
Disclosure of detailed information about business combination [line items]
Indemnification asset, beginning balance		63.4	67.6
Acquisition accounting adjustment		0.0	6.2
Remeasurement of indemnification assets		10.4	(10.4)
Indemnification asset, ending balance		€ 73.8	€ 63.4

XML

Indemnification assets - Additional Information (Details) € / shares in Units, € in Millions		12 Months Ended
	Jun. 12, 2017 EUR (€)	Dec. 31, 2017 EUR (€) € / shares shares	Dec. 31, 2016 EUR (€) € / shares shares	Dec. 31, 2017 $ / shares	Dec. 31, 2016 $ / shares	Dec. 31, 2015 EUR (€)
Disclosure of detailed information about business combination [line items]
Indemnification assets		€ 73.8	€ 65.5
Iglo
Disclosure of detailed information about business combination [line items]
Release of indemnified provision	€ 2.1	2.1	9.3
Indemnification assets		0.0	2.1			€ 10.2
Findus
Disclosure of detailed information about business combination [line items]
Indemnification assets		€ 73.8	€ 63.4			€ 67.6
Shares held in escrow as a result of indemnification asset | shares		6,964,417	6,964,417
Value of shares held in escrow as a result of indemnification asset (price per share) | (per share)		€ 14.13	€ 9.10	$ 16.91	$ 9.57

XML

Cash and cash equivalents (Details) - EUR (€) € in Millions	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015	Mar. 31, 2015	Mar. 31, 2014
Subclassifications of assets, liabilities and equities [abstract]
Cash and cash equivalents	€ 219.0	€ 325.3
Restricted cash	0.2	4.2
Total cash and cash equivalents	219.2	329.5	€ 186.1	€ 126.8	€ 0.0
Bank overdrafts	0.0	0.0
Cash and cash equivalents per Statement of Cash Flows	€ 219.2	329.5
Restricted cash, foreign law requirement		€ 3.6

XML

Loans and borrowings - Repayment Profile (Details) - EUR (€) € in Millions	Dec. 31, 2017	May 03, 2017	Dec. 31, 2016
Disclosure of detailed information about borrowings [line items]
Total current loans and borrowings	€ 3.3		€ 0.0
Loans and borrowings	1,395.1		1,451.8
Borrowings	1,398.4		1,446.8
Gross | Syndicated loans
Disclosure of detailed information about borrowings [line items]
Total current loans and borrowings	5.1		0.0
Loans and borrowings	1,004.4		964.2
Gross | 2020 floating rate senior secured notes
Disclosure of detailed information about borrowings [line items]
Loans and borrowings	0.0		500.0
Gross | 2024 fixed rate senior secured notes
Disclosure of detailed information about borrowings [line items]
Loans and borrowings	400.0		0.0
Deferred borrowing costs
Disclosure of detailed information about borrowings [line items]
Loans and borrowings	(11.1)		(12.4)
Deferred borrowing costs | 2024 fixed rate senior secured notes
Disclosure of detailed information about borrowings [line items]
Borrowings		€ 9.8
Deferred borrowing costs | Less than one year
Disclosure of detailed information about borrowings [line items]
Total current loans and borrowings	(1.8)		(5.0)
Deferred borrowing costs | 2 to 5 years
Disclosure of detailed information about borrowings [line items]
Loans and borrowings	(7.2)		(12.4)
Deferred borrowing costs | More than five years
Disclosure of detailed information about borrowings [line items]
Loans and borrowings	€ (2.1)		€ 0.0

XML

Loans and borrowings - Details of Individual Loans (Details) - EUR (€) € in Millions	Dec. 31, 2017	May 03, 2017	Dec. 31, 2016
Disclosure of detailed information about borrowings [line items]
Total current loans and borrowings	€ 3.3		€ 0.0
Total non-current loans and borrowings	1,395.1		1,451.8
Borrowings	1,398.4		1,446.8
Gross | Syndicated loans
Disclosure of detailed information about borrowings [line items]
Total current loans and borrowings	5.1		0.0
Total non-current loans and borrowings	1,004.4		964.2
Gross | 2020 floating rate senior secured notes
Disclosure of detailed information about borrowings [line items]
Total non-current loans and borrowings	0.0		500.0
Gross | 2024 fixed rate senior secured notes
Disclosure of detailed information about borrowings [line items]
Total non-current loans and borrowings	400.0		0.0
Gross | Senior C1 EUR
Disclosure of detailed information about borrowings [line items]
Total non-current loans and borrowings	0.0		363.3
Gross | Senior C2 GBP
Disclosure of detailed information about borrowings [line items]
Total non-current loans and borrowings	0.0		275.9
Gross | Senior C3 EUR
Disclosure of detailed information about borrowings [line items]
Total non-current loans and borrowings	0.0		325.0
Gross | Senior B3 EUR
Disclosure of detailed information about borrowings [line items]
Total non-current loans and borrowings	500.0		0.0
Gross | Senior B4 USD
Disclosure of detailed information about borrowings [line items]
Total non-current loans and borrowings	504.4		0.0
Deferred borrowing costs
Disclosure of detailed information about borrowings [line items]
Total non-current loans and borrowings	(11.1)		(12.4)
Deferred borrowing costs | 2024 fixed rate senior secured notes
Disclosure of detailed information about borrowings [line items]
Borrowings		€ 9.8
Less than one year | Deferred borrowing costs
Disclosure of detailed information about borrowings [line items]
Total current loans and borrowings	(1.8)		(5.0)
2 to 5 years | Deferred borrowing costs
Disclosure of detailed information about borrowings [line items]
Total non-current loans and borrowings	(7.2)		(12.4)
More than five years | Deferred borrowing costs
Disclosure of detailed information about borrowings [line items]
Total non-current loans and borrowings	€ (2.1)		€ 0.0

XML

Loans and borrowings - Additional Information (Details) £ in Millions, kr in Millions		8 Months Ended	12 Months Ended
	May 03, 2017 EUR (€)	Dec. 31, 2017 EUR (€)	Dec. 31, 2017 USD ($)	Jan. 31, 2018 USD ($)	Dec. 31, 2017 GBP (£)	Dec. 31, 2017 USD ($)	Dec. 31, 2017 SEK (kr)	Dec. 20, 2017 EUR (€)	Dec. 20, 2017 USD ($)	May 03, 2017 USD ($)	Apr. 21, 2017 EUR (€)	Apr. 21, 2017 USD ($)	Dec. 31, 2016 EUR (€)	Dec. 31, 2016 USD ($)
Disclosure of detailed information about borrowings [line items]
Line of credit facility, maximum borrowing capacity	€ 80,000,000.0
Borrowings		€ 1,398,400,000											€ 1,446,800,000
Deferred transaction costs written off		€ 15,700,000
Percentage of consolidated gross assets or adjusted EBITDA held individually by companies in Guarantor Group			5.00%
Percentage of consolidated gross assets or adjusted EBITDA held by Guarantor Group in total			80.00%
Guarantee amount						$ 50,300,000	kr 495							$ 45,900,000
Findus Sverige AB
Disclosure of detailed information about borrowings [line items]
Guarantee amount						30,500,000	kr 300							31,300,000
Senior USD Debt
Disclosure of detailed information about borrowings [line items]
Notional amount | $						$ 610,000,000			$ 610,000,000.0	$ 610,000,000.0		$ 610,000,000.0
Annual principal payment	6,100,000
Borrowings | $				$ 50,000,000
Reduction in interest rate		0.50%			0.50%	0.50%	0.50%
Incremental term loan | $									$ 50,000,000.0
Senior EURO Debt
Disclosure of detailed information about borrowings [line items]
Notional amount	500,000,000.0	€ 500,000,000						€ 500,000,000.0
Borrowings | $				$ 58,000,000
Reduction in interest rate		0.25%			0.25%	0.25%	0.25%
Incremental term loan								58,000,000.0
2024 fixed rate senior secured notes
Disclosure of detailed information about borrowings [line items]
Notional amount	€ 400,000,000.0	€ 400,000,000
Interest rate	3.25%									3.25%
2020 floating rate senior secured notes
Disclosure of detailed information about borrowings [line items]
Deferred transaction costs written off	€ 15,700,000
Revolving Credit Facility
Disclosure of detailed information about borrowings [line items]
Line of credit facility, maximum borrowing capacity		80,000,000.0
Letters of credit, overdrafts, customer bonds and bank guarantees utilized against the credit facility | $						$ 14,000,000								$ 13,200,000
Deferred borrowing costs | 2024 fixed rate senior secured notes
Disclosure of detailed information about borrowings [line items]
Borrowings	€ 9,800,000
Deferred borrowing costs | Senior US Debt and Senior Euro Debt
Disclosure of detailed information about borrowings [line items]
Borrowings								€ 2,500,000
Derivative financial instruments | Cross currency interest rate swap | Cash flow hedges
Disclosure of detailed information about borrowings [line items]
Notional amount		€ 299,300,000			£ 226.7						€ 570,500,000
Payment for cross currency interest rate swaps | $			$ 610,000,000
Derivative financial instruments | Cross currency interest rate swap | Hedges of net investment in foreign operations
Disclosure of detailed information about borrowings [line items]
Notional amount | £					£ 187.6
Findus Sverige AB
Disclosure of detailed information about borrowings [line items]
Proportion of ownership interest in subsidiary			100.00%

XML

Trade and other payables (Details) - EUR (€) € in Millions	Dec. 31, 2017	Dec. 31, 2016
Current liabilities
Trade payables	€ 328.9	€ 345.0
Accruals and deferred income	109.6	92.4
Social security and other taxes	18.2	19.3
Other payables	17.7	13.7
Finance lease obligations	0.0	0.6
Financial payables	3.1	1.7
Total current trade and other payables	477.5	472.7
Non-current liabilities
Finance lease obligations	0.0	1.0
Accruals and deferred income	1.8	0.0
Total non-current trade and other payables	1.8	1.0
Total trade and other payables	€ 479.3	€ 473.7

XML

Trade and other payables - Additional Information (Details)	Dec. 31, 2017 EUR (€)
Subclassifications of assets, liabilities and equities [abstract]
Current finance lease liabilities	€ 0

XML

Trade and other payables - Finance lease obligations (Details) - EUR (€) € in Millions	Dec. 31, 2017	Dec. 31, 2016
Disclosure of finance lease and operating lease by lessee [line items]
Future minimum lease payments	€ 0.0	€ 1.8
Interest	0.0	0.2
Present value of minimum lease payments	0.0	1.6
Less than one year
Disclosure of finance lease and operating lease by lessee [line items]
Future minimum lease payments	0.0	0.7
Interest	0.0	0.1
Present value of minimum lease payments	0.0	0.6
Between one and five years
Disclosure of finance lease and operating lease by lessee [line items]
Future minimum lease payments	0.0	1.1
Interest	0.0	0.1
Present value of minimum lease payments	0.0	1.0
More than five years
Disclosure of finance lease and operating lease by lessee [line items]
Future minimum lease payments	0.0	0.0
Interest	0.0	0.0
Present value of minimum lease payments	€ 0.0	€ 0.0

XML

Employee benefits - Additional Information (Details)	5 Months Ended	9 Months Ended	12 Months Ended
	May 31, 2015 EUR (€)	Dec. 31, 2015 EUR (€)	Dec. 31, 2017 EUR (€) year	Dec. 31, 2016 EUR (€)	Mar. 31, 2015 EUR (€)
Disclosure of defined benefit plans [line items]
Post-employment benefit expense, defined contribution plans		€ 4,400,000	€ 8,500,000	€ 9,600,000	€ 0
Recognized liability for net defined benefit obligations		165,100,000	185,400,000	187,800,000
Estimate of contributions expected to be paid to plan for next annual reporting period			€ 5,800,000	5,700,000
Weighted average duration of defined benefit obligation | year			18.3
Predecessor
Disclosure of defined benefit plans [line items]
Post-employment benefit expense, defined contribution plans	€ 2,400,000
Present value of defined benefit obligation
Disclosure of defined benefit plans [line items]
Recognized liability for net defined benefit obligations		€ 244,000,000	€ 266,700,000	267,600,000
Foreign defined benefit plans | Present value of defined benefit obligation
Disclosure of defined benefit plans [line items]
Recognized liability for net defined benefit obligations			188,400,000	190,900,000
Foreign defined benefit plans | Other countries | Present value of defined benefit obligation
Disclosure of defined benefit plans [line items]
Recognized liability for net defined benefit obligations			€ 3,000,000	€ 3,100,000

XML

Employee benefits - Defined Benefit Plans (Details) - EUR (€) € in Millions	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Disclosure of defined benefit plans [line items]
Recognized liability for net defined benefit obligations	€ 185.4	€ 187.8	€ 165.1
Present value of defined benefit obligation
Disclosure of defined benefit plans [line items]
Recognized liability for net defined benefit obligations	266.7	267.6	€ 244.0
Foreign defined benefit plans | Present value of defined benefit obligation
Disclosure of defined benefit plans [line items]
Recognized liability for net defined benefit obligations	188.4	190.9
Foreign defined benefit plans | Present value of defined benefit obligation | Germany
Disclosure of defined benefit plans [line items]
Recognized liability for net defined benefit obligations	117.5	121.8
Foreign defined benefit plans | Present value of defined benefit obligation | Sweden
Disclosure of defined benefit plans [line items]
Recognized liability for net defined benefit obligations	59.8	56.7
Foreign defined benefit plans | Present value of defined benefit obligation | Italy
Disclosure of defined benefit plans [line items]
Recognized liability for net defined benefit obligations	5.3	5.1
Foreign defined benefit plans | Present value of defined benefit obligation | Austria
Disclosure of defined benefit plans [line items]
Recognized liability for net defined benefit obligations	2.8	4.2
Foreign defined benefit plans | Present value of defined benefit obligation | Sub-total
Disclosure of defined benefit plans [line items]
Recognized liability for net defined benefit obligations	185.4	187.8
Foreign defined benefit plans | Present value of defined benefit obligation | Other countries
Disclosure of defined benefit plans [line items]
Recognized liability for net defined benefit obligations	€ 3.0	€ 3.1

XML

Employee benefits - Amount Included in the Statement of Financial Position Arising from the Company's Obligations (Details) - EUR (€) € in Millions	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Disclosure of defined benefit plans [line items]
Net defined benefit liability (asset)	€ 185.4	€ 187.8	€ 165.1
Present value of defined benefit obligation
Disclosure of defined benefit plans [line items]
Net defined benefit liability (asset)	266.7	267.6	244.0
Plan assets
Disclosure of defined benefit plans [line items]
Net defined benefit liability (asset)	(81.3)	(79.8)
Defined benefit retirement plans
Disclosure of defined benefit plans [line items]
Net defined benefit liability (asset)	180.5	182.9	159.4
Defined benefit retirement plans | Present value of defined benefit obligation
Disclosure of defined benefit plans [line items]
Net defined benefit liability (asset)	261.8	262.7	238.3
Defined benefit retirement plans | Plan assets
Disclosure of defined benefit plans [line items]
Net defined benefit liability (asset)	(81.3)	(79.8)	(78.9)
Post-employment medical benefits and other benefits
Disclosure of defined benefit plans [line items]
Net defined benefit liability (asset)	4.9	4.9	5.7
Post-employment medical benefits and other benefits | Present value of defined benefit obligation
Disclosure of defined benefit plans [line items]
Net defined benefit liability (asset)	4.9	4.9	€ 5.7
Post-employment medical benefits and other benefits | Plan assets
Disclosure of defined benefit plans [line items]
Net defined benefit liability (asset)	0.0	0.0
Unfunded Plan | Present value of defined benefit obligation
Disclosure of defined benefit plans [line items]
Net defined benefit liability (asset)	70.6	67.4
Unfunded Plan | Defined benefit retirement plans | Present value of defined benefit obligation
Disclosure of defined benefit plans [line items]
Net defined benefit liability (asset)	65.7	62.5
Unfunded Plan | Post-employment medical benefits and other benefits | Present value of defined benefit obligation
Disclosure of defined benefit plans [line items]
Net defined benefit liability (asset)	4.9	4.9
Funded Plan | Present value of defined benefit obligation
Disclosure of defined benefit plans [line items]
Net defined benefit liability (asset)	196.1	200.2
Funded Plan | Defined benefit retirement plans | Present value of defined benefit obligation
Disclosure of defined benefit plans [line items]
Net defined benefit liability (asset)	196.1	200.2
Funded Plan | Post-employment medical benefits and other benefits | Present value of defined benefit obligation
Disclosure of defined benefit plans [line items]
Net defined benefit liability (asset)	€ 0.0	€ 0.0

XML

Employee benefits - Movements in Recognized Liability for Net Defined Benefit Obligations (Details) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Disclosure of net defined benefit liability (asset) [line items]
Net defined benefit liability (asset)	€ 187.8	€ 165.1
Current service cost	4.0	3.5
Interest cost	3.6	4.0
Actuarial (gains) losses	(2.9)	23.6
Actuarial experience (gains) losses	0.5	(0.3)
Actuarial losses arising from changes in financial assumptions	1.5	24.5
Actuarial gains arising from changes in demographic assumptions	(3.0)	0.0
Contributions to plan	(0.5)	(0.5)
Benefits paid	(4.9)	(5.4)
Exchange adjustments	(1.7)	(2.5)
Net defined benefit liability (asset)	185.4	187.8
Defined benefit retirement plans
Disclosure of net defined benefit liability (asset) [line items]
Net defined benefit liability (asset)	182.9	159.4
Current service cost	4.1	3.9
Interest cost	3.5	3.9
Actuarial (gains) losses	(2.9)	23.6
Contributions to plan	(0.5)	(0.5)
Benefits paid	(4.9)	(5.1)
Exchange adjustments	(1.7)	(2.3)
Net defined benefit liability (asset)	180.5	182.9
Post-employment medical benefits and other benefits
Disclosure of net defined benefit liability (asset) [line items]
Net defined benefit liability (asset)	4.9	5.7
Current service cost	(0.1)	(0.4)
Interest cost	0.1	0.1
Actuarial (gains) losses	0.0	0.0
Contributions to plan	0.0	0.0
Benefits paid	0.0	(0.3)
Exchange adjustments	0.0	(0.2)
Net defined benefit liability (asset)	4.9	4.9
Present value of defined benefit obligation
Disclosure of net defined benefit liability (asset) [line items]
Net defined benefit liability (asset)	267.6	244.0
Current service cost	4.0	3.5
Interest cost	5.0	5.9
Actuarial experience (gains) losses	0.5	(0.3)
Actuarial losses arising from changes in financial assumptions	1.5	24.5
Actuarial gains arising from changes in demographic assumptions	(3.0)
Contributions to plan	0.3	0.5
Benefits paid	(7.5)	(8.0)
Exchange adjustments	(1.7)	(2.5)
Net defined benefit liability (asset)	266.7	267.6
Present value of defined benefit obligation | Defined benefit retirement plans
Disclosure of net defined benefit liability (asset) [line items]
Net defined benefit liability (asset)	262.7	238.3
Current service cost	4.1	3.9
Interest cost	4.9	5.8
Actuarial experience (gains) losses	0.5	(0.3)
Actuarial losses arising from changes in financial assumptions	1.5	24.5
Actuarial gains arising from changes in demographic assumptions	(3.0)
Contributions to plan	0.3	0.5
Benefits paid	(7.5)	(7.7)
Exchange adjustments	(1.7)	(2.3)
Net defined benefit liability (asset)	261.8	262.7
Present value of defined benefit obligation | Post-employment medical benefits and other benefits
Disclosure of net defined benefit liability (asset) [line items]
Net defined benefit liability (asset)	4.9	5.7
Current service cost	(0.1)	(0.4)
Interest cost	0.1	0.1
Actuarial experience (gains) losses	0.0	0.0
Actuarial losses arising from changes in financial assumptions	0.0	0.0
Actuarial gains arising from changes in demographic assumptions	0.0
Contributions to plan	0.0	0.0
Benefits paid	0.0	(0.3)
Exchange adjustments	0.0	(0.2)
Net defined benefit liability (asset)	€ 4.9	€ 4.9

XML

Employee benefits - Movement in Fair Value of Plan Assets (Details) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Reconciliation of changes in net assets available for benefits [abstract]
Plan assets, beginning balance	€ (187.8)	€ (165.1)
Interest income	(3.6)	(4.0)
Actuarial gains arising from the return on plan assets, excluding interest income	(1.9)	(0.6)
Benefits paid	(4.9)	(5.4)
Plan assets, ending balance	(185.4)	(187.8)
Defined benefit retirement plans
Reconciliation of changes in net assets available for benefits [abstract]
Plan assets, beginning balance	(182.9)	(159.4)
Interest income	(3.5)	(3.9)
Benefits paid	(4.9)	(5.1)
Plan assets, ending balance	(180.5)	(182.9)
Plan assets
Reconciliation of changes in net assets available for benefits [abstract]
Plan assets, beginning balance	79.8
Plan assets, ending balance	81.3	79.8
Plan assets | Defined benefit retirement plans
Reconciliation of changes in net assets available for benefits [abstract]
Plan assets, beginning balance	79.8	78.9
Interest income	1.4	1.9
Actuarial gains arising from the return on plan assets, excluding interest income	1.9	0.6
Contributions by employer	0.5	0.5
Contributions by members	0.3	0.5
Benefits paid	(2.6)	(2.6)
Plan assets, ending balance	€ 81.3	€ 79.8

XML

Employee benefits - Expense Recognized (Details) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Disclosure of net defined benefit liability (asset) [line items]
Current service cost	€ 4.0	€ 3.5
Interest cost	3.6	4.0
Post-employment benefit expense	7.6	7.5
Defined benefit retirement plans
Disclosure of net defined benefit liability (asset) [line items]
Current service cost	4.1	3.9
Interest cost	3.5	3.9
Post-employment benefit expense	7.6	7.8
Post-employment medical benefits and other benefits
Disclosure of net defined benefit liability (asset) [line items]
Current service cost	(0.1)	(0.4)
Interest cost	0.1	0.1
Post-employment benefit expense	€ 0.0	€ (0.3)

XML

Employee benefits - Amount recognized in the Consolidated Statement of Comprehensive Income (Details) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Employee Benefits [Abstract]
Actuarial experience losses/(gains)	€ 0.5	€ (0.3)
Actuarial losses arising from changes in financial assumptions	1.5	24.5
Actuarial gains arising from changes in demographic assumptions	(3.0)	0.0
Actuarial gains arising from the return on plan assets, excluding interest income	(1.9)	(0.6)
Total actuarial (gains)/losses	(2.9)	23.6
Cumulative amount of actuarial losses recognized in Consolidated Statement of Comprehensive Income	€ 1.3	€ 4.2

XML

Employee benefits - Fair Value of Plan Assets (Details) - EUR (€) € in Millions	Dec. 31, 2017	Dec. 31, 2016
Employee Benefits [Abstract]
Equities	€ 17.4	€ 15.1
Debt instruments	51.3	51.7
Property	8.9	9.6
Other	3.7	3.4
Total	€ 81.3	€ 79.8

XML

Employee benefits - Actuarial Assumptions (Details)	Dec. 31, 2017	Dec. 31, 2016
Germany | Defined benefit retirement plans
Disclosure of sensitivity analysis for actuarial assumptions [line items]
Discount rate	1.95%	1.80%
Inflation rate	2.00%	2.00%
Rate of increase in salaries	2.80%	2.50%
Long term medical cost of inflation	0.00%	0.00%
Germany | Post-employment medical benefits and other benefits
Disclosure of sensitivity analysis for actuarial assumptions [line items]
Discount rate	1.15%	1.20%
Inflation rate	2.00%	2.00%
Rate of increase in salaries	2.80%	2.50%
Rate of increase for pensions in payment	0.00%	0.00%
Long term medical cost of inflation	0.00%	0.00%
Sweden | Defined benefit retirement plans
Disclosure of sensitivity analysis for actuarial assumptions [line items]
Discount rate	2.40%	2.50%
Inflation rate	1.90%	1.25%
Rate of increase in salaries	2.25%	2.25%
Rate of increase for pensions in payment	2.25%	2.25%
Long term medical cost of inflation	0.00%	0.00%
Austria | Defined benefit retirement plans
Disclosure of sensitivity analysis for actuarial assumptions [line items]
Discount rate	2.20%	1.00%
Inflation rate	2.00%	1.70%
Rate of increase in salaries	3.00%	3.00%
Rate of increase for pensions in payment	1.70%	1.70%
Long term medical cost of inflation	0.00%	0.00%
Austria | Post-employment medical benefits and other benefits
Disclosure of sensitivity analysis for actuarial assumptions [line items]
Discount rate	0.90%	1.00%
Inflation rate	2.00%	1.70%
Rate of increase in salaries	3.00%	3.00%
Rate of increase for pensions in payment	0.00%	0.00%
Long term medical cost of inflation	2.00%	2.00%
Italy
Disclosure of sensitivity analysis for actuarial assumptions [line items]
Discount rate	1.20%	1.50%
Inflation rate	1.50%	1.50%
Rate of increase in salaries	0.00%	0.00%
Rate of increase for pensions in payment	0.00%	0.00%
Long term medical cost of inflation	0.00%	0.00%
Bottom of range | Germany | Defined benefit retirement plans
Disclosure of sensitivity analysis for actuarial assumptions [line items]
Rate of increase for pensions in payment	1.00%	1.00%
Top of range | Germany | Defined benefit retirement plans
Disclosure of sensitivity analysis for actuarial assumptions [line items]
Rate of increase for pensions in payment	2.00%	2.00%

XML

Employee benefits - Average Life Expectancy After Retirement (Details) - Defined benefit retirement plans	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Germany
Disclosure of defined benefit plans [line items]
Male	20 years	20 years
Female	24 years	24 years
Sweden
Disclosure of defined benefit plans [line items]
Male	22 years	23 years
Female	24 years	25 years
Austria
Disclosure of defined benefit plans [line items]
Male	21 years	21 years
Female	25 years	25 years
Italy
Disclosure of defined benefit plans [line items]
Male	20 years	20 years
Female	20 years	24 years

XML

Employee benefits - History of Experience Adjustments From Inception (Details) - EUR (€) € in Millions	9 Months Ended	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2017	Dec. 31, 2016
Disclosure of net defined benefit liability (asset) [line items]
Recognized liability for net defined benefit obligations	€ 165.1	€ 185.4	€ 187.8
Present value of defined benefit obligation
Disclosure of net defined benefit liability (asset) [line items]
Recognized liability for net defined benefit obligations	244.0	266.7	267.6
Fair value of plan assets
Disclosure of net defined benefit liability (asset) [line items]
Recognized liability for net defined benefit obligations		(81.3)	(79.8)
Defined benefit retirement plans
Disclosure of net defined benefit liability (asset) [line items]
Recognized liability for net defined benefit obligations	159.4	180.5	182.9
Experience losses/(gains) on scheme liabilities	(1.6)	0.5	(0.3)
Experience (gains)/losses on scheme assets	0.5	(1.9)	(0.6)
Defined benefit retirement plans | Present value of defined benefit obligation
Disclosure of net defined benefit liability (asset) [line items]
Recognized liability for net defined benefit obligations	238.3	261.8	262.7
Defined benefit retirement plans | Fair value of plan assets
Disclosure of net defined benefit liability (asset) [line items]
Recognized liability for net defined benefit obligations	(78.9)	(81.3)	(79.8)
Defined benefit retirement plans | Asset ceiling
Disclosure of net defined benefit liability (asset) [line items]
Recognized liability for net defined benefit obligations	€ 0.0	€ 0.0	€ 0.0

XML

Employee benefits - Defined Benefit Obligation Sensitivity Analysis (Details) - Discount rate € in Millions	Dec. 31, 2017 EUR (€)
Disclosure of sensitivity analysis for actuarial assumptions [line items]
Percentage of reasonably possible increase in actuarial assumption	1.00%
Percentage of reasonably possible decrease in actuarial assumption	1.00%
Effect on the post-employment benefit obligation with a 1% increase	€ (42.3)
Effect on the post-employment benefit obligation with a 1% decrease	€ 55.8

XML

Provisions (Details) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Reconciliation of changes in other provisions [abstract]
Provisions, beginning balance	€ 193.7	€ 86.7
Additional provision in the period	43.3	100.2
Release of provision	(13.5)	(17.6)
Adjustment to provisions acquired through business combinations		52.5
Transfer between categories	0.0
Utilization of provision	(81.7)	(29.4)
Unwinding of discounting	1.2	1.4
Foreign exchange	(2.2)	(0.1)
Provisions, ending balance	140.8	193.7
Current	68.0	116.7
Non-current	72.8	77.0
Provisions	140.8
Restructuring
Reconciliation of changes in other provisions [abstract]
Provisions, beginning balance	59.1	21.0
Additional provision in the period	30.9	60.2
Release of provision	(0.1)	(5.2)
Adjustment to provisions acquired through business combinations		0.0
Transfer between categories	0.0
Utilization of provision	(63.6)	(16.7)
Unwinding of discounting	0.0	0.0
Foreign exchange	0.0	(0.2)
Provisions, ending balance	26.3	59.1
Onerous/ unfavorable contracts
Reconciliation of changes in other provisions [abstract]
Provisions, beginning balance	80.6	0.0
Additional provision in the period	0.0	34.7
Release of provision	0.0	0.0
Adjustment to provisions acquired through business combinations		47.3
Transfer between categories	0.0
Utilization of provision	(3.9)	(2.5)
Unwinding of discounting	0.8	0.8
Foreign exchange	(2.1)	0.3
Provisions, ending balance	75.4	80.6
Provisions related to other taxes
Reconciliation of changes in other provisions [abstract]
Provisions, beginning balance	24.5	31.8
Additional provision in the period	5.8	0.0
Release of provision	(12.2)	(9.8)
Adjustment to provisions acquired through business combinations		2.5
Transfer between categories	(2.1)
Utilization of provision	(5.8)	0.0
Unwinding of discounting	0.0	0.0
Foreign exchange	0.0	0.0
Provisions, ending balance	10.2	24.5
Contingent consideration
Reconciliation of changes in other provisions [abstract]
Provisions, beginning balance	10.0	17.4
Additional provision in the period	0.0	0.0
Release of provision	0.0	0.0
Adjustment to provisions acquired through business combinations		0.0
Transfer between categories	0.0
Utilization of provision	0.0	(8.0)
Unwinding of discounting	0.4	0.6
Foreign exchange	0.0	0.0
Provisions, ending balance	10.4	10.0
Other
Reconciliation of changes in other provisions [abstract]
Provisions, beginning balance	19.5	16.5
Additional provision in the period	6.6	5.3
Release of provision	(1.2)	(2.6)
Adjustment to provisions acquired through business combinations		2.7
Transfer between categories	2.1
Utilization of provision	(8.4)	(2.2)
Unwinding of discounting	0.0	0.0
Foreign exchange	(0.1)	(0.2)
Provisions, ending balance	€ 18.5	€ 19.5

XML

Provisions - Additional Information (Details) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Disclosure of other provisions [line items]
Provisions	€ 140.8	€ 193.7	€ 86.7
Additional provision in the period	43.3	100.2
Provision used	81.7	29.4
Release of provision	13.5	17.6
Unwinding of discounting	1.2	1.4
Restructuring
Disclosure of other provisions [line items]
Provisions	€ 26.3	59.1	21.0
Estimated completion of activities, period	18 months
Additional provision in the period	€ 30.9	60.2
Provision used	63.6	16.7
Release of provision	0.1	5.2
Unwinding of discounting	0.0	0.0
Strategic reorganization
Disclosure of other provisions [line items]
Additional provision in the period	18.4
Provisions related to other taxes
Disclosure of other provisions [line items]
Provisions	10.2	24.5	31.8
Additional provision in the period	5.8	0.0
Provision used	5.8	0.0
Release of provision	12.2	9.8
Unwinding of discounting	0.0	0.0
Contingent consideration
Disclosure of other provisions [line items]
Provisions	10.4	10.0	17.4
Additional provision in the period	0.0	0.0
Provision used	0.0	8.0
Release of provision	0.0	0.0
Unwinding of discounting	0.4	0.6
Other provision
Disclosure of other provisions [line items]
Provisions	18.5	19.5	€ 16.5
Additional provision in the period	6.6	5.3
Provision used	8.4	2.2
Release of provision	1.2	2.6
Unwinding of discounting	0.0	0.0
Professional fees related to tax investigations and other obligations
Disclosure of other provisions [line items]
Provisions	2.7	2.8
Italy | Other provision
Disclosure of other provisions [line items]
Provisions	5.6	6.1
La Cocinera | Contingent consideration
Disclosure of other provisions [line items]
Provisions	8.9
Lutosa | Contingent consideration
Disclosure of other provisions [line items]
Provisions	1.5
Findus | Contingent consideration
Disclosure of other provisions [line items]
Unwinding of discounting	0.4
Findus | Asset retirement obligation
Disclosure of other provisions [line items]
Provisions	3.1	€ 3.2
Bjuv Facility | Sweden | Restructuring
Disclosure of other provisions [line items]
Additional provision in the period	12.5
Bjuv Facility | Sweden | Onerous/unfavorable contracts - lease
Disclosure of other provisions [line items]
Provisions	€ 72.5
Discount rate	1.00%	1.00%
Inflation rate	1.00%	1.00%
Increase (decrease) in risk free rate or inflation rate assumptions, percentage change	0.50%
Effect of 0.5% increase (decrease) in risk free rate or inflation rate assumptions	6.00%
Bjuv Facility | Sweden | Onerous/unfavorable contracts - service contract
Disclosure of other provisions [line items]
Provisions	€ 2.9

XML

Share capital and reserves - Schedule of Share Capital and Capital Reserve (Details) € in Millions	Dec. 31, 2017 EUR (€) shares	Dec. 31, 2017 $ / shares	Dec. 31, 2016 EUR (€) shares	Dec. 31, 2016 $ / shares	Dec. 31, 2015 EUR (€)
Disclosure of classes of share capital [line items]
Total share capital and capital reserve	€ 1,637.5		€ 1,814.0
Listing and share transaction costs	(13.8)		(13.3)		€ (13.3)
Total net share capital and capital reserve	1,623.7		1,800.7
Ordinary shares
Disclosure of classes of share capital [line items]
Total share capital and capital reserve	1,626.9		1,803.4
Founder Preferred shares
Disclosure of classes of share capital [line items]
Total share capital and capital reserve	€ 10.6		€ 10.6
Issued Capital and Capital Reserve | Ordinary shares
Disclosure of classes of share capital [line items]
Par value per share (in USD per share) | $ / shares		$ 10.00		$ 10.00
Number of shares issued and fully paid (in shares) | shares	165,291,546		182,088,622
Issued Capital and Capital Reserve | Founder Preferred shares
Disclosure of classes of share capital [line items]
Par value per share (in USD per share) | $ / shares		$ 10.00		$ 10.00
Number of shares issued and fully paid (in shares) | shares	1,500,000		1,500,000

XML

Share capital and reserves - Ordinary Shares (Details) - shares			6 Months Ended	12 Months Ended
	Jun. 12, 2017	Jan. 12, 2016	Sep. 30, 2015	Dec. 31, 2017	Dec. 31, 2016
Reconciliation of number of shares outstanding [abstract]
Shares issued in the period (in shares)			121,500,000
Ordinary shares
Reconciliation of number of shares outstanding [abstract]
Number of shares outstanding, beginning balance (in shares)				182,100,000	178,400,000
Shares issued in the period (in shares)		13,700,000		0	3,700,000
Shares repurchased and canceled in the year	(9,779,729)			(16,800,000)
Number of shares outstanding, ending balance (in shares)				165,291,546	182,100,000

XML

Share capital and reserves - Ordinary Shares Narrative (Details) € / shares in Units, $ / shares in Units, € in Millions															1 Months Ended		6 Months Ended	9 Months Ended	12 Months Ended
	Dec. 29, 2017 shares	Sep. 11, 2017 EUR (€) shares	Sep. 11, 2017 USD ($) shares	Jun. 19, 2017 USD ($) shares $ / shares	Jun. 12, 2017 EUR (€) € / shares shares	Jun. 12, 2017 USD ($) shares	Jun. 16, 2016 USD ($) shares	Jan. 12, 2016 $ / shares shares	Dec. 07, 2015 USD ($)	Nov. 27, 2015 shares	Nov. 02, 2015 shares	Jul. 08, 2015 shares	Jun. 01, 2015 shares	May 26, 2015 shares	Jun. 30, 2017 shares	Jul. 31, 2016 $ / shares shares	Sep. 30, 2015 shares	Dec. 31, 2015 EUR (€) shares	Dec. 31, 2017 EUR (€) shares	Dec. 31, 2016 EUR (€) shares	Mar. 31, 2015 EUR (€)	Sep. 11, 2017 $ / shares	Jun. 12, 2017 $ / shares	Jun. 09, 2017	Aug. 01, 2016 shares
Disclosure of classes of share capital [line items]
Shares issued in the period (in shares)																	121,500,000
Share dividend issued (in shares)								3,600,000
Share price (in dollars per share) | $ / shares																$ 8.98
Share price (in dollars per share) | (per share)					€ 9.60																		$ 10.75
Share price discount																								25.00%
Payments to acquire or redeem entity's shares					€ 93.9	$ 105,100,000												€ 0.0	€ 177.6	€ 0.0	€ 0.0
Listing and share transaction costs | €																		€ 13.3	€ 13.8	€ 13.3
Restricted Shares
Disclosure of classes of share capital [line items]
Shares issued in the period (in shares)																23,212
Exercise price (in dollars per share) | $									$ 11.50
Key management personnel
Disclosure of classes of share capital [line items]
Shares issued in the period (in shares)										13,104
Non-Executive Director | Restricted Shares
Disclosure of classes of share capital [line items]
Shares issued in the period (in shares)															46,296	23,212
Share price (in dollars per share) | $ / shares				$ 14.38												$ 8.98
Exercise price (in dollars per share) | $				$ 14.38			$ 8.98		$ 11.50
Number of shares vested				55,680			34,780
Shares paid for tax withholding for share based compensation				9,384			11,568
Iglo
Disclosure of classes of share capital [line items]
Shares issued in the period (in shares)													13,700,000
Findus
Disclosure of classes of share capital [line items]
Shares issued in the period (in shares)											8,400,000
Private Placement
Disclosure of classes of share capital [line items]
Shares issued in the period (in shares)												15,400,000		75,700,000
Warrant
Disclosure of classes of share capital [line items]
Shares issued in the period (in shares)																	16,700,000
Secondary Public Offering By Selling Shareholders
Disclosure of classes of share capital [line items]
Number of shares sold		33,333,334	33,333,334
Sale of stock, price per share (in dollars per share) | $ / shares																						$ 14.16
Secondary Public Offering By Selling Shareholders Sold To Public
Disclosure of classes of share capital [line items]
Number of shares sold		26,269,691	26,269,691
Ordinary shares
Disclosure of classes of share capital [line items]
Shares issued in the period (in shares)								13,700,000											0	3,700,000
Share dividend issued (in shares)	8,705,890							3,620,510
Share price (in dollars per share) | $ / shares								$ 10.00
Number of shares outstanding																		178,400,000	165,291,546	182,100,000					182,088,622
Shares repurchased and canceled					9,779,729	9,779,729													16,800,000
Ordinary shares | Secondary Public Offering By Selling Shareholders
Disclosure of classes of share capital [line items]
Shares repurchased and canceled		7,063,643	7,063,643
Payments to acquire or redeem entity's shares		€ 83.2	$ 100,000,000
Listing and share transaction costs | €		€ 0.5

XML

Share capital and reserves - Listing and Share Transaction Costs (Details) - EUR (€) € in Millions	9 Months Ended	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2017	Dec. 31, 2016	Mar. 31, 2015
Share Capital, Reserves and Other Equity Interest [Abstract]
Share issue related cost, beginning balance		€ 13.3	€ 13.3
Share issue related cost	€ 5.3	0.5	0.0	€ 8.0
Share issue related cost, ending balance	€ 13.3	€ 13.8	€ 13.3

XML

Share capital and reserves - Founder Preferred Shares Annual Dividend Amount and Warrant Redemption Amount (Details)				12 Months Ended
	Dec. 29, 2017 $ / shares shares	Jan. 12, 2016 $ / shares shares	Apr. 11, 2014	Dec. 31, 2017 vote shares	Dec. 31, 2016 € / shares	Dec. 31, 2015 $ / shares
Disclosure of classes of share capital [line items]
Number of votes per Founder Preferred Share | vote				1
Preference shares, dividend payment terms, weighted average share price, minimum term required				10 days		10 days
Preferred stock, conversion terms, weighted average share price (in dollars per share) | $ / shares						$ 11.50
Percentage increase in dividend price	20.00%	20.00%		20.00%
Preference shares, conversion ratio			1			1
Founder preferred shares annual dividend amount		3,600,000
Dividends recognised as distributions to owners per share (in dollars per share) | (per share)	$ 16.6516	$ 11.4824			€ 11.482	$ 11.4824
Founder Preferred shares
Disclosure of classes of share capital [line items]
Number of shares issued				1,500,000
Ordinary shares
Disclosure of classes of share capital [line items]
Founder preferred shares annual dividend amount	8,705,890	3,620,510

XML

Share capital and reserves - Warrants (Details) € in Millions			9 Months Ended	12 Months Ended
	May 06, 2015	Apr. 11, 2014 warrant $ / shares shares	Dec. 31, 2015 EUR (€)	Dec. 31, 2017 EUR (€)	Dec. 31, 2016 EUR (€)	Dec. 31, 2015	Mar. 31, 2015 EUR (€)
Disclosure of classes of share capital [line items]
Warrants issued | shares		50,000,000
Warrant conversion rate | warrant		3
Preference shares, conversion ratio		1				1
Mandatory redemption amount (in dollars per share)		$ 0.01
Per share amount exceeded for mandatory redemption (in dollars per share)		$ 18.00
Mandatory redemption period, term		10 days
Credit related to Warrant Redemption Liability | €			€ 0.4	€ 0.0	€ 0.0		€ (0.4)
Ordinary shares
Disclosure of classes of share capital [line items]
Exercise price of warrants (in dollars per share)		$ 11.50
Non-Executive Director
Disclosure of classes of share capital [line items]
Warrants issued | shares		75,000
Iglo
Disclosure of classes of share capital [line items]
Percentage of outstanding warrant holders obtained to amend warrant term	75.00%
Warrant exercise term following Readmission	30 days

XML

Share-based compensation reserve (Details) - EUR (€) € in Millions		9 Months Ended	12 Months Ended
	Jun. 19, 2017	Dec. 31, 2015	Dec. 31, 2017	Dec. 31, 2016
Disclosure of reserves within equity [line items]
Beginning balance, Reserve of share-based payments			€ 1.0
Increase through share-based payment transactions		€ 0.1	2.6	€ 1.2
Vesting of Non-Executive Director restricted shares			0.1	0.3
Ending balance, Reserve of share-based payments			2.9	1.0
Share based compensation reserve
Disclosure of reserves within equity [line items]
Beginning balance, Reserve of share-based payments			1.0
Vesting of Non-Executive Director restricted shares	€ (0.3)		(0.7)	0.3
Ending balance, Reserve of share-based payments			2.9	€ 1.0
Non-Executive Director | Share based compensation reserve
Disclosure of reserves within equity [line items]
Increase through share-based payment transactions			0.8
Key management personnel | Share based compensation reserve
Disclosure of reserves within equity [line items]
Increase through share-based payment transactions			€ 1.8

XML

Share-based compensation reserve - Additional Information (Details) $ / shares in Units, € in Millions							1 Months Ended		6 Months Ended	9 Months Ended	12 Months Ended
	Aug. 22, 2017 shares director	Jun. 19, 2017 EUR (€) shares	Jun. 19, 2017 USD ($) shares $ / shares	Jun. 16, 2016 USD ($) shares	Dec. 07, 2015 USD ($)	Nov. 27, 2015 shares	Jun. 30, 2017 shares	Jul. 31, 2016 $ / shares shares	Sep. 30, 2015 shares	Dec. 31, 2015 EUR (€)	Dec. 31, 2017 EUR (€)	Dec. 31, 2016 EUR (€)
Disclosure of reserves within equity [line items]
Number of Non-executive Directors granted awards | director	2
Shares issued									121,500,000
Share price (in dollars per share) | $ / shares								$ 8.98
Increase (reduction) in share based compensation reserve | €											€ (0.1)	€ (0.3)
Share based compensation reserve
Disclosure of reserves within equity [line items]
Increase (reduction) in share based compensation reserve | €		€ 0.3									0.7	(0.3)
Restricted Shares
Disclosure of reserves within equity [line items]
Exercise price (in dollars per share) | $					$ 11.50
Shares issued								23,212
Non-Executive Director
Disclosure of reserves within equity [line items]
Non-Executive Director restricted share awards charge | €										€ 0.1	0.8	0.6
Non-Executive Director | Restricted Shares
Disclosure of reserves within equity [line items]
Exercise price (in dollars per share) | $			$ 14.38	$ 8.98	$ 11.50
Shares issued							46,296	23,212
Share price (in dollars per share) | $ / shares			$ 14.38					$ 8.98
Number of shares vested		55,680	55,680	34,780
Shares paid for tax withholding for share based compensation		9,384	9,384	11,568
Number of shares granted	11,774	41,724	41,724	55,680
Non-Executive Director restricted share awards charge | €											0.8	0.6
Key management personnel
Disclosure of reserves within equity [line items]
Shares issued						13,104
Non-Executive Director restricted share awards charge | €											€ 1.8	€ 0.6

XML

Founder Preferred Shares Dividend Reserve - Additional Information (Details) € / shares in Units, € in Millions				6 Months Ended	9 Months Ended	12 Months Ended
	Dec. 29, 2017 $ / shares shares	Jan. 12, 2016 $ / shares shares	Apr. 11, 2014	Sep. 30, 2015 shares	Dec. 31, 2015 EUR (€)	Dec. 31, 2017 EUR (€) shares	Dec. 31, 2016 EUR (€) € / shares shares	Dec. 31, 2015 $ / shares	Mar. 31, 2015 EUR (€)	Jul. 31, 2016 $ / shares	Jun. 01, 2015 EUR (€)
Disclosure of classes of share capital [line items]
Preferred stock, conversion terms, weighted average share price (in dollars per share) | $ / shares								$ 11.50
Preference shares, dividend payment terms, weighted average share price, minimum term required						10 days		10 days
Share dividend issued (in shares)		3,600,000
Percentage increase in dividend price	20.00%	20.00%				20.00%
Share price (in dollars per share) | $ / shares										$ 8.98
Preferred share dividend equivalent		140,220,619
Shares issued in the period (in shares)				121,500,000
Dividend price per share (in dollars per share) | (per share)	$ 16.6516	$ 11.4824					€ 11.482	$ 11.4824
Charge related to Founder Preferred Shares Annual Dividend Amount | €					€ 349.0	€ 0.0	€ 0.0		€ 165.8
Founder Preferred Shares Dividend Reserve | €						€ 493.4	€ 493.4				€ 531.5
Preference shares, conversion ratio			1					1
Ordinary shares
Disclosure of classes of share capital [line items]
Share dividend issued (in shares)	8,705,890	3,620,510
Share price (in dollars per share) | $ / shares		$ 10.00
Shares issued in the period (in shares)		13,700,000				0	3,700,000

XML

Founder Preferred Shares Dividend Reserve (Details) - Founder Preferred shares - EUR (€) € in Millions	9 Months Ended	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2017	Dec. 31, 2016
Disclosure of classes of share capital [line items]
Settlement of dividend through share issue	€ (531.5)		€ 0.0
Founder preferred shares dividend reserve
Disclosure of classes of share capital [line items]
Equity, beginning balance		€ 493.4
Settlement of dividend through share issue	€ (531.5)	0.0	38.1
Equity, ending balance		€ 493.4	€ 493.4

XML

Cash flow hedging reserve (Details) - EUR (€) € in Millions	5 Months Ended	9 Months Ended	12 Months Ended
	May 31, 2015	Dec. 31, 2015	Dec. 31, 2017	Dec. 31, 2016	Mar. 31, 2015
Disclosure of detailed information about hedges [line items]
(Losses)/gains arising in the revaluation of hedge instruments		€ 1.6	€ (76.5)	€ 14.2	€ 0.0
Less: Gains/(losses) reclassified to the Consolidated Statement of Profit or Loss		0.0	60.1	(4.1)	0.0
Total		€ 1.6	€ (16.4)	€ 10.1	€ 0.0
Predecessor
Disclosure of detailed information about hedges [line items]
(Losses)/gains arising in the revaluation of hedge instruments	€ 0.0
Less: Gains/(losses) reclassified to the Consolidated Statement of Profit or Loss	0.0
Total	€ 0.0

XML

Earnings/(loss) per share (Details) - EUR (€) € / shares in Units, € in Millions	5 Months Ended	9 Months Ended	12 Months Ended
	May 31, 2015	Dec. 31, 2015	Dec. 31, 2017	Dec. 31, 2016	Mar. 31, 2015
Earnings per share [line items]
Net profit/(loss) attributable to shareholders (€m)		€ (337.3)	€ 136.5	€ 36.4	€ (167.5)
Weighted average Ordinary Shares and Founder Preferred Shares		145,590,810	176,080,272	183,518,743	50,025,000
Basic earnings/(loss) per share (in euros per share)		€ (2.32)	€ 0.78	€ 0.20	€ (3.35)
Weighted average Ordinary Shares and Founder Preferred Shares		145,590,810	184,786,162	183,528,621	50,025,000
Diluted earnings/(loss) per share (in euros per share)		€ (2.32)	€ 0.74	€ 0.20	€ (3.35)
Predecessor
Earnings per share [line items]
Net profit/(loss) attributable to shareholders (€m)	€ (128.0)

XML

Earnings/(loss) per share - Additional Information (Details) - EUR (€) € in Millions	9 Months Ended	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2017	Dec. 31, 2016	Mar. 31, 2015
Earnings per share [abstract]
Net profit/(loss) attributable to shareholders (€m)	€ (337.3)	€ 136.5	€ 36.4	€ (167.5)
Weighted average number of ordinary shares (in shares)	144,090,810	174,580,272	182,018,743
Weighted average number of founder preferred shares (in shares)	1,500,000	1,500,000	1,500,000
Adjusted shares for dilutive impact of 2016 non-executive restricted stock awards (in shares)		8,705,890

XML

Reconciliation of liabilities arising from financing activities (Details) - EUR (€) € in Millions	9 Months Ended	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2017	Dec. 31, 2016	Mar. 31, 2015
Disclosure of reconciliation of liabilities arising from financing activities [line items]
Interest paid	€ 40.8	€ 48.8	€ 70.9	€ 0.0
Payments for the settlement of derivative instruments	€ (4.3)	(1.6)	4.0	€ 0.0
Total loans and borrowings (Note 21)
Disclosure of reconciliation of liabilities arising from financing activities [line items]
Opening balance		1,446.8
Cash inflow		1,470.5
Cash outflow		(1,469.5)
Interest accretion		0.0
Exchange movement		(55.7)
Fair value changes		0.0
Other non-cash adjustments		6.3
Closing balance		1,398.4	1,446.8
Total finance lease obligations (Note 22)
Disclosure of reconciliation of liabilities arising from financing activities [line items]
Opening balance		1.6
Cash inflow		0.0
Cash outflow		(1.6)
Interest accretion		0.0
Exchange movement		0.0
Fair value changes		0.0
Other non-cash adjustments		0.0
Closing balance		0.0	1.6
Financial payables (Note 22)
Disclosure of reconciliation of liabilities arising from financing activities [line items]
Opening balance		1.7
Cash inflow		0.0
Cash outflow		(53.3)
Interest accretion		54.0
Exchange movement		0.7
Fair value changes		0.0
Other non-cash adjustments		0.0
Closing balance		3.1	1.7
Forward foreign exchange and currency swap contract | Derivatives
Disclosure of reconciliation of liabilities arising from financing activities [line items]
Opening balance		0.3
Cash inflow		3.9
Cash outflow		0.0
Interest accretion		0.0
Exchange movement		0.0
Fair value changes		(3.5)
Other non-cash adjustments		0.0
Closing balance		0.7	0.3
Cross currency interest rate swap
Disclosure of reconciliation of liabilities arising from financing activities [line items]
Interest paid		4.5
Payments for the settlement of derivative instruments		2.3
Cross currency interest rate swap | Derivatives
Disclosure of reconciliation of liabilities arising from financing activities [line items]
Opening balance		0.0
Cash inflow		4.5
Cash outflow		(2.3)
Interest accretion		0.0
Exchange movement		0.0
Fair value changes		40.6
Other non-cash adjustments		0.0
Closing balance		€ 42.8	€ 0.0

XML

Cash flows from operating activities (Details) - EUR (€) € in Millions	5 Months Ended	9 Months Ended	12 Months Ended
	May 31, 2015	Dec. 31, 2015	Dec. 31, 2017	Dec. 31, 2016	Mar. 31, 2015
Cash flows from operating activities
Net profit/(loss) attributable to shareholders (€m)		€ (337.3)	€ 136.5	€ 36.4	€ (167.5)
Adjustments for:
Exceptional items		58.1	37.2	134.5	0.7
Non-cash charge related to Founder Preferred Shares Annual Dividend Amount		349.0	0.0	0.0	165.8
Non-cash (charge)/credit related to Warrant Redemption Liability		(0.4)	0.0	0.0	0.4
Non-cash fair value purchase price adjustment of inventory		37.0	0.0	0.0	0.0
Non-cash cash flow hedge reserve acquisition accounting adjustment		4.9	0.0	0.0	0.0
Non-cash Chairman and Independent Non-Executive Director fees		0.0	0.0	0.0	0.2
Unrealized gain on portfolio investments		0.0	0.0	0.0	(0.1)
Share based payments expense		0.0	2.6	1.2	0.0
Depreciation charge		20.3	35.9	43.3	0.0
Amortization		1.5	6.5	7.8	0.0
Loss on disposal of property, plant and equipment		0.0	0.5	0.7	0.0
Finance costs		44.2	81.6	86.3	0.0
Finance income		(8.7)	(7.2)	(24.2)	0.0
Taxation		(12.3)	32.0	39.6	0.0
Operating cash flow before changes in working capital, provisions and exceptional items		156.3	325.6	325.6	(0.5)
Decrease/(increase) in inventories		(15.9)	16.7	(18.1)	0.0
(Increase)/decrease in trade and other receivables		64.3	(1.6)	(8.8)	0.0
Increase/(decrease) in trade and other payables		(44.0)	18.1	60.8	0.7
Decrease in employee benefit and other provisions		(1.5)	(0.3)	(3.3)	0.0
Cash generated from operations before tax and exceptional items		€ 159.2	€ 358.5	€ 356.2	€ 0.2
Predecessor
Cash flows from operating activities
Net profit/(loss) attributable to shareholders (€m)	€ (128.0)
Adjustments for:
Exceptional items	84.3
Non-cash charge related to Founder Preferred Shares Annual Dividend Amount	0.0
Non-cash (charge)/credit related to Warrant Redemption Liability	0.0
Non-cash fair value purchase price adjustment of inventory	0.0
Non-cash cash flow hedge reserve acquisition accounting adjustment	0.0
Non-cash Chairman and Independent Non-Executive Director fees	0.0
Unrealized gain on portfolio investments	0.0
Share based payments expense	0.0
Depreciation charge	11.3
Amortization	1.2
Loss on disposal of property, plant and equipment	0.0
Finance costs	117.7
Finance income	(2.0)
Taxation	40.9
Operating cash flow before changes in working capital, provisions and exceptional items	125.4
Decrease/(increase) in inventories	28.3
(Increase)/decrease in trade and other receivables	(8.5)
Increase/(decrease) in trade and other payables	(41.0)
Decrease in employee benefit and other provisions	(2.0)
Cash generated from operations before tax and exceptional items	€ 102.2

XML

Financial risk management - Additional Information (Details) £ in Millions	9 Months Ended	12 Months Ended
	Dec. 31, 2015 EUR (€)	Dec. 31, 2017 EUR (€)	Dec. 31, 2016 EUR (€)	Dec. 31, 2015	Dec. 31, 2017 GBP (£)	Dec. 31, 2017 USD ($)	Dec. 20, 2017 EUR (€)	Dec. 20, 2017 USD ($)	May 03, 2017 EUR (€)	May 03, 2017 USD ($)	Apr. 21, 2017 EUR (€)	Apr. 21, 2017 GBP (£)	Apr. 21, 2017 USD ($)	Apr. 20, 2017
Disclosure of nature and extent of risks arising from financial instruments [line items]
Line of credit facility, maximum borrowing capacity									€ 80,000,000.0
Interest rate risk
Disclosure of nature and extent of risks arising from financial instruments [line items]
Sensitivity analysis for types of market risk, reasonably possible change in risk variable, percent		1.00%
Sensitivity analysis for types of market risk, reasonably possible change in risk variable, impact on pre-tax earnings	€ 14,500,000	€ 5,100,000	€ 14,800,000
Credit risk
Disclosure of nature and extent of risks arising from financial instruments [line items]
Maximum exposure to credit risk		150,000,000
Liquidity risk
Disclosure of nature and extent of risks arising from financial instruments [line items]
Line of credit facility, maximum borrowing capacity		€ 80,000,000
Letters of credit, overdrafts, customer bonds and bank guarantees utilized against the credit facility | $						$ 14,000,000
Pound Sterling | Currency risk
Disclosure of nature and extent of risks arising from financial instruments [line items]
Sensitivity analysis for types of market risk, actual change in risk variable, percent		3.90%	13.80%
US dollar | Currency risk
Disclosure of nature and extent of risks arising from financial instruments [line items]
Sensitivity analysis for types of market risk, actual change in risk variable, percent		13.90%
Swedish Krona | Currency risk
Disclosure of nature and extent of risks arising from financial instruments [line items]
Sensitivity analysis for types of market risk, actual change in risk variable, percent		2.70%
LIBOR | Interest rate risk
Disclosure of nature and extent of risks arising from financial instruments [line items]
Increase (decrease) in interest rate		0.25%	(0.25%)		0.25%	0.25%
EURIBOR | Interest rate risk
Disclosure of nature and extent of risks arising from financial instruments [line items]
Increase (decrease) in interest rate		(0.15%)			(0.15%)	(0.15%)
Cross currency interest rate swap | Pound Sterling | Currency risk
Disclosure of nature and extent of risks arising from financial instruments [line items]
Sensitivity analysis for types of market risk, reasonably possible change in risk variable, impact on interest charge	200,000	€ 100,000	€ 100,000
Foreign exchange forward contract | Pound Sterling | Currency risk
Disclosure of nature and extent of risks arising from financial instruments [line items]
Sensitivity analysis for types of market risk, reasonably possible change in risk variable, percent		1.00%
Sensitivity analysis for types of market risk, reasonably possible change in risk variable, impact on pre-tax earnings	500,000	€ 700,000	600,000
Foreign exchange forward contract | US dollar | Currency risk
Disclosure of nature and extent of risks arising from financial instruments [line items]
Sensitivity analysis for types of market risk, reasonably possible change in risk variable, percent		1.00%
Sensitivity analysis for types of market risk, reasonably possible change in risk variable, impact on pre-tax earnings	2,200,000	€ 2,400,000	2,200,000
Foreign exchange forward contract | Swedish Krona | Currency risk
Disclosure of nature and extent of risks arising from financial instruments [line items]
Sensitivity analysis for types of market risk, reasonably possible change in risk variable, percent		1.00%
Sensitivity analysis for types of market risk, reasonably possible change in risk variable, impact on pre-tax earnings	€ 500,000	€ 700,000	400,000
Derivative financial instruments | Foreign exchange forward contract
Disclosure of nature and extent of risks arising from financial instruments [line items]
Notional amount		€ 484,000,000	€ 367,800,000
Derivative financial instruments | Foreign exchange forward contract | US dollar | Currency risk
Disclosure of nature and extent of risks arising from financial instruments [line items]
Percentage of financial instruments designated as hedging instruments	69.00%	69.80%	98.00%	69.00%	69.80%	69.80%
Financial asset		€ 6,500,000	€ 11,000,000
Derivative financial instruments | Foreign exchange forward contract | Euro | Currency risk
Disclosure of nature and extent of risks arising from financial instruments [line items]
Percentage of financial instruments designated as hedging instruments	58.00%	68.00%	86.90%	58.00%	68.00%	68.00%
Financial asset		€ 1,500,000	€ 1,100,000
Cross currency interest rate swap | Pound Sterling | Currency risk
Disclosure of nature and extent of risks arising from financial instruments [line items]
Sensitivity analysis for types of market risk, reasonably possible change in risk variable, percent		1.00%	1.00%	1.00%
Sensitivity analysis for types of market risk, reasonably possible change in risk variable, impact on pre-tax earnings		€ 400,000
Percentage of financial instruments not designated as hedging		17.20%			17.20%	17.20%
Hedges of net investment in foreign operations | Cross currency interest rate swap
Disclosure of nature and extent of risks arising from financial instruments [line items]
Gain (loss) on hedge ineffectiveness		€ 0	€ 0
Hedges of net investment in foreign operations | Cross currency interest rate swap | Pound Sterling
Disclosure of nature and extent of risks arising from financial instruments [line items]
Percentage of financial instruments designated as hedging instruments		82.80%			82.80%	82.80%
Hedges of net investment in foreign operations | Cross currency interest rate swap | Pound Sterling | Currency risk
Disclosure of nature and extent of risks arising from financial instruments [line items]
Notional amount | £					£ 187.6
Risk exposure associated with instruments sharing characteristic, concentration percentage			99.00%
Gains (losses) on hedges of net investments in foreign operations, net of tax		€ 12,400,000
Sensitivity analysis for types of market risk, actual change in risk variable, percent		5.80%
Sensitivity analysis for types of market risk, reasonably possible change in risk variable, percent		1.00%
Risk exposure associated with instruments sharing characteristic		€ 2,200,000
Hedges of net investment in foreign operations | Loans and Borrowings | Pound Sterling
Disclosure of nature and extent of risks arising from financial instruments [line items]
Percentage of financial instruments designated as hedging instruments											80.00%	80.00%	80.00%	80.00%
Hedges of net investment in foreign operations | Loans and Borrowings | Pound Sterling | Currency risk
Disclosure of nature and extent of risks arising from financial instruments [line items]
Risk exposure associated with instruments sharing characteristic, concentration percentage		93.10%			93.10%	93.10%
Gains (losses) on hedges of net investments in foreign operations, net of tax		€ (4,300,000)
Gain on retranslation of loans	€ 6,800,000		€ 35,400,000
Hedges of net investment in foreign operations | Derivative financial instruments | Cross currency interest rate swap
Disclosure of nature and extent of risks arising from financial instruments [line items]
Notional amount | £					£ 187.6
Cash flow hedges | Derivative financial instruments | Cross currency interest rate swap
Disclosure of nature and extent of risks arising from financial instruments [line items]
Notional amount		€ 299,300,000			£ 226.7						€ 570,500,000
Amount exchanged from											€ 271,200,000
Amount exchanged to | £												£ 226.7
Cash flow hedges | Derivative financial instruments | Cross currency interest rate swap | Pound Sterling | Interest rate risk
Disclosure of nature and extent of risks arising from financial instruments [line items]
Average rate of hedging instrument		100.00%			100.00%	100.00%
Cash flow hedges | Derivative financial instruments | Cross currency interest rate swap | Euro | Interest rate risk
Disclosure of nature and extent of risks arising from financial instruments [line items]
Average rate of hedging instrument		58.30%			58.30%	58.30%
Senior USD Debt
Disclosure of nature and extent of risks arising from financial instruments [line items]
Notional amount | $						$ 610,000,000		$ 610,000,000.0		$ 610,000,000.0			$ 610,000,000.0
2024 fixed rate senior secured notes
Disclosure of nature and extent of risks arising from financial instruments [line items]
Notional amount		€ 400,000,000							€ 400,000,000.0
Interest rate									3.25%	3.25%
Debt instrument term		7 years
Senior EURO Debt
Disclosure of nature and extent of risks arising from financial instruments [line items]
Notional amount		€ 500,000,000					€ 500,000,000.0		€ 500,000,000.0
Weighted average | Cash flow hedges | Derivative financial instruments | Cross currency interest rate swap | Pound Sterling | Interest rate risk
Disclosure of nature and extent of risks arising from financial instruments [line items]
Average rate of hedging instrument		65.80%	157.00%		65.80%	65.80%
Weighted average | Cash flow hedges | Derivative financial instruments | Cross currency interest rate swap | Euro | Interest rate risk
Disclosure of nature and extent of risks arising from financial instruments [line items]
Average rate of hedging instrument		38.90%	66.00%		38.90%	38.90%
Bottom of range | Interest rate risk
Disclosure of nature and extent of risks arising from financial instruments [line items]
Interest rate		0.00%			0.00%	0.00%

XML

Financial risk management - Maturity Analysis (Details) - EUR (€) € in Millions	Dec. 31, 2017	Dec. 31, 2016
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows	€ 2,178.6	€ 2,100.3
2017 / 2018
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows	494.5	485.3
2018 / 2019
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows	48.2	60.0
2019 / 2020
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows	48.3	60.9
2020 / 2021
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows	48.0	1,494.1
2021 / 2022
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows	92.7	0.0
Over 5 years
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows	1,446.9	0.0
Borrowings-principal
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows	1,409.5	1,464.2
Borrowings-principal | 2017 / 2018
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows	5.1	0.0
Borrowings-principal | 2018 / 2019
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows	5.1	0.0
Borrowings-principal | 2019 / 2020
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows	5.1	0.0
Borrowings-principal | 2020 / 2021
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows	5.1	1,464.2
Borrowings-principal | 2021 / 2022
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows	5.1	0.0
Borrowings-principal | Over 5 years
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows	1,384.0	0.0
Borrowings-interest
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows	292.4	210.5
Borrowings-interest | 2017 / 2018
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows	46.3	59.7
Borrowings-interest | 2018 / 2019
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows	46.0	60.0
Borrowings-interest | 2019 / 2020
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows	46.0	60.9
Borrowings-interest | 2020 / 2021
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows	45.7	29.9
Borrowings-interest | 2021 / 2022
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows	45.5	0.0
Borrowings-interest | Over 5 years
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows	62.9	0.0
Trade and other payables excluding non-financial liabilities
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows	441.6	439.1
Trade and other payables excluding non-financial liabilities | 2017 / 2018
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows	441.6	439.1
Trade and other payables excluding non-financial liabilities | 2018 / 2019
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows	0.0	0.0
Trade and other payables excluding non-financial liabilities | 2019 / 2020
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows	0.0	0.0
Trade and other payables excluding non-financial liabilities | 2020 / 2021
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows	0.0	0.0
Trade and other payables excluding non-financial liabilities | 2021 / 2022
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows	0.0	0.0
Trade and other payables excluding non-financial liabilities | Over 5 years
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows	0.0	0.0
Sell | Forward contracts
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows	484.0	367.8
Sell | Forward contracts | 2017 / 2018
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows	484.0	367.8
Sell | Forward contracts | 2018 / 2019
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows	0.0	0.0
Sell | Forward contracts | 2019 / 2020
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows	0.0	0.0
Sell | Forward contracts | 2020 / 2021
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows	0.0	0.0
Sell | Forward contracts | 2021 / 2022
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows	0.0	0.0
Sell | Forward contracts | Over 5 years
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows	0.0	0.0
Sell | Cross currency interest rate swap
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows	916.2
Sell | Cross currency interest rate swap | 2017 / 2018
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows	29.1
Sell | Cross currency interest rate swap | 2018 / 2019
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows	28.7
Sell | Cross currency interest rate swap | 2019 / 2020
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows	28.6
Sell | Cross currency interest rate swap | 2020 / 2021
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows	28.4
Sell | Cross currency interest rate swap | 2021 / 2022
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows	801.4
Sell | Cross currency interest rate swap | Over 5 years
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows	0.0
Pay | Forward contracts
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows	(479.6)	(381.3)
Pay | Forward contracts | 2017 / 2018
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows	(479.6)	(381.3)
Pay | Forward contracts | 2018 / 2019
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows	0.0	0.0
Pay | Forward contracts | 2019 / 2020
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows	0.0	0.0
Pay | Forward contracts | 2020 / 2021
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows	0.0	0.0
Pay | Forward contracts | 2021 / 2022
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows	0.0	0.0
Pay | Forward contracts | Over 5 years
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows	0.0	€ 0.0
Pay | Cross currency interest rate swap
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows	(885.5)
Pay | Cross currency interest rate swap | 2017 / 2018
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows	(32.0)
Pay | Cross currency interest rate swap | 2018 / 2019
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows	(31.6)
Pay | Cross currency interest rate swap | 2019 / 2020
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows	(31.4)
Pay | Cross currency interest rate swap | 2020 / 2021
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows	(31.2)
Pay | Cross currency interest rate swap | 2021 / 2022
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows	(759.3)
Pay | Cross currency interest rate swap | Over 5 years
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows	€ 0.0

XML

Financial instruments - Categories of Financial Instruments (Details) - EUR (€) € in Millions	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015	Mar. 31, 2015	Mar. 31, 2014
Disclosure Of Financial Assets And Liabilities [Table] [Line Items]
Cash and cash equivalents	€ 219.2	€ 329.5	€ 186.1	€ 126.8	€ 0.0
Loans and receivables	94.7	92.3
Financial liabilities at amortised cost	(1,851.1)	(1,903.3)
Financial assets (liabilities) at fair value through profit or loss	2.5	0.0
Financial assets (liabilities) at fair value through other comprehensive income	(51.0)	11.7
Total	(1,585.7)	(1,469.8)
Total non-current loans and borrowings	1,395.1	1,451.8
Borrowings	1,398.4	1,446.8
Trade and other payables excluding non-financial liabilities
Disclosure Of Financial Assets And Liabilities [Table] [Line Items]
Financial liabilities at fair value through profit or loss	0.0	0.0
Financial liabilities at fair value through other comprehensive income	0.0	0.0
Financial liabilities at amortised cost	(441.6)	(439.1)
Financial liabilities	(441.6)	(439.1)
Derivative financial instruments
Disclosure Of Financial Assets And Liabilities [Table] [Line Items]
Financial liabilities at fair value through profit or loss	(0.7)	0.0
Financial liabilities at fair value through other comprehensive income	(68.5)	(1.4)
Financial liabilities at amortised cost	0.0	0.0
Financial liabilities	(69.2)	(1.4)
Loans and borrowings
Disclosure Of Financial Assets And Liabilities [Table] [Line Items]
Financial liabilities at fair value through profit or loss	0.0	0.0
Financial liabilities at fair value through other comprehensive income	0.0	0.0
Financial liabilities at amortised cost	(1,409.5)	(1,464.2)
Financial liabilities	(1,409.5)	(1,464.2)
Trade receivables
Disclosure Of Financial Assets And Liabilities [Table] [Line Items]
Cash and cash equivalents	0.0	0.0
Loans and receivables	94.7	92.3
Financial assets at fair value through profit or loss	0.0	0.0
Financial assets at fair value through other comprehensive income	0.0	0.0
Financial assets	94.7	92.3
Derivative financial instruments
Disclosure Of Financial Assets And Liabilities [Table] [Line Items]
Cash and cash equivalents	0.0	0.0
Loans and receivables	0.0	0.0
Financial assets at fair value through profit or loss	3.2	0.0
Financial assets at fair value through other comprehensive income	17.5	13.1
Financial assets	20.7	13.1
Cash and cash equivalents
Disclosure Of Financial Assets And Liabilities [Table] [Line Items]
Cash and cash equivalents	219.2	329.5
Loans and receivables	0.0	0.0
Financial assets at fair value through profit or loss	0.0	0.0
Financial assets at fair value through other comprehensive income	0.0	0.0
Financial assets	219.2	329.5
Deferred borrowing costs
Disclosure Of Financial Assets And Liabilities [Table] [Line Items]
Total non-current loans and borrowings	€ (11.1)	€ (12.4)

XML

Financial instruments - Derivative Financial Instruments (Details) - EUR (€)	9 Months Ended	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2017	Dec. 31, 2016
Foreign exchange forward contract
Disclosure of financial assets [line items]
Gains (losses) on change in fair value of derivatives	€ 9,100,000	€ 0	€ 1,000,000
Foreign exchange swap
Disclosure of financial assets [line items]
Gains (losses) on change in fair value of derivatives	0
Cross currency interest rate swap
Disclosure of financial assets [line items]
Gains (losses) on change in fair value of derivatives	€ 0	3,900,000	0
Cash flow hedges | Foreign exchange swap
Disclosure of financial assets [line items]
Gains (losses) on change in fair value of derivatives		€ 3,500,000	€ (4,300,000)

XML

Financial instruments - Cash and cash equivalents/overdrafts (Details) - Total loans and borrowings (Note 21) - EUR (€) € in Millions	Dec. 31, 2017	Dec. 31, 2016
Disclosure of fair value measurement of liabilities [line items]
Financial liabilities, at fair value	€ 1,424.9	€ 1,475.5
Financial liabilities, carrying value	1,398.4	1,446.8
Senior loans
Disclosure of fair value measurement of liabilities [line items]
Financial liabilities, carrying value	0.0	964.2
2020 floating rate senior secured notes
Disclosure of fair value measurement of liabilities [line items]
Financial liabilities, carrying value	0.0	500.0
Senior EUR/USD loans
Disclosure of fair value measurement of liabilities [line items]
Financial liabilities, carrying value	1,009.5	0.0
2024 fixed rate senior secured notes
Disclosure of fair value measurement of liabilities [line items]
Financial liabilities, carrying value	400.0	0.0
Level 2 | Senior loans
Disclosure of fair value measurement of liabilities [line items]
Financial liabilities, at fair value	0.0	970.3
Level 2 | Senior EUR/USD loans
Disclosure of fair value measurement of liabilities [line items]
Financial liabilities, at fair value	1,012.7	0.0
Level 1 | 2020 floating rate senior secured notes
Disclosure of fair value measurement of liabilities [line items]
Financial liabilities, at fair value	0.0	505.2
Level 1 | 2024 fixed rate senior secured notes
Disclosure of fair value measurement of liabilities [line items]
Financial liabilities, at fair value	412.2	0.0
Deferred borrowing costs
Disclosure of fair value measurement of liabilities [line items]
Financial liabilities, at fair value	0.0	0.0
Financial liabilities, carrying value	€ (11.1)	€ (17.4)

XML

Financial instruments - Derivatives (Details) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Derivative financial instruments
Disclosure of detailed information about financial instruments [line items]
Total assets	€ 20.7	€ 13.1
Total liabilities	(69.2)	(1.4)
Total	€ (48.5)	11.7
Foreign exchange forward contract
Disclosure of detailed information about financial instruments [line items]
Percentage of principal amount relating to foreign currency	30.60%
Foreign exchange forward contract | Derivative financial instruments
Disclosure of detailed information about financial instruments [line items]
Notional amount	€ 484.0	367.8
Total assets	2.1	13.1
Total liabilities	€ (7.8)	€ (1.4)
Foreign exchange forward contract | USD
Disclosure of detailed information about financial instruments [line items]
Fair value of derivative, percentage of notional amount	43.40%	68.90%
Foreign exchange forward contract | Euro
Disclosure of detailed information about financial instruments [line items]
Fair value of derivative, percentage of notional amount	26.00%	22.00%
Cross currency interest rate swap | Derivative financial instruments
Disclosure of detailed information about financial instruments [line items]
Total assets	€ 18.6	€ 0.0
Total liabilities	(61.4)	€ 0.0
Pay | Cross currency interest rate swap | Derivative financial instruments
Disclosure of detailed information about financial instruments [line items]
Notional amount	826.2
Receive | Cross currency interest rate swap | Derivative financial instruments
Disclosure of detailed information about financial instruments [line items]
Notional amount	€ 780.7

XML

Financial instruments - Offsetting of Derivatives (Details) - EUR (€) € in Millions	Dec. 31, 2017	Dec. 31, 2016
Derivatives - assets
Gross amount of financial instruments as presented upon balance sheet	€ 20.7	€ 13.1
Related financial instruments that are offset	(20.7)	(1.4)
Net amount	0.0	11.7
Derivatives - liabilities
Gross amount of financial instruments as presented upon balance sheet	(69.2)	(1.4)
Related financial instruments that are offset	20.7	1.4
Net amount	€ (48.5)	€ 0.0

XML

Operating leases - Non-cancellable Operating Lease Rentals (Details) - EUR (€) € in Millions	Dec. 31, 2017	Dec. 31, 2016
Disclosure of maturity analysis of operating lease payments [line items]
Minimum lease payments payable under non-cancellable operating lease	€ 168.3	€ 179.6
Less than one year
Disclosure of maturity analysis of operating lease payments [line items]
Minimum lease payments payable under non-cancellable operating lease	17.8	18.3
Between one and three years
Disclosure of maturity analysis of operating lease payments [line items]
Minimum lease payments payable under non-cancellable operating lease	26.1	29.6
Between three and five years
Disclosure of maturity analysis of operating lease payments [line items]
Minimum lease payments payable under non-cancellable operating lease	17.8	22.0
More than five years
Disclosure of maturity analysis of operating lease payments [line items]
Minimum lease payments payable under non-cancellable operating lease	€ 106.6	€ 109.7

XML

Operating leases - Additional Information (Details) - EUR (€) € in Millions	Dec. 31, 2017	Dec. 31, 2016
Disclosure of other provisions [line items]
Minimum lease payments payable under non-cancellable operating lease	€ 168.3	€ 179.6
Findus Sverige AB
Disclosure of other provisions [line items]
Minimum lease payments payable under non-cancellable operating lease	115.8
Other provisions	€ 72.5

XML

Capital commitments (Details) - EUR (€) € in Millions	Dec. 31, 2017	Dec. 31, 2016
Capital Commitment [Line Items]
Total capital commitments	€ 5.6	€ 13.5
Property, plant and equipment
Capital Commitment [Line Items]
Total capital commitments	3.0	8.1
Intangible assets
Capital Commitment [Line Items]
Total capital commitments	€ 2.6	€ 5.4

XML

Related parties (Details) € / shares in Units, $ / shares in Units, € in Thousands												1 Months Ended	9 Months Ended	12 Months Ended
	Dec. 29, 2017 $ / shares shares	Aug. 22, 2017 shares director	Jun. 19, 2017 EUR (€) shares	Jun. 19, 2017 USD ($) shares $ / shares	Jun. 12, 2017 EUR (€) € / shares shares	Jun. 12, 2017 USD ($) shares	Jun. 16, 2016 USD ($) shares	Jan. 12, 2016 $ / shares shares	Dec. 07, 2015 USD ($)	Jun. 15, 2015 EUR (€)	Apr. 11, 2014	Jun. 30, 2017 shares	Dec. 31, 2015 EUR (€)	Dec. 31, 2017 EUR (€) shares year	Dec. 31, 2016 EUR (€) € / shares	Dec. 31, 2015 $ / shares	Mar. 31, 2015 EUR (€)	Dec. 31, 2017 $ / shares shares	Jun. 12, 2017 $ / shares	Jun. 09, 2017	Jul. 31, 2016 $ / shares	Nov. 27, 2015 shares	Jun. 01, 2015 € / shares shares	Jun. 01, 2015 $ / shares shares
Disclosure of transactions between related parties [line items]
Share price (in dollars per share) | $ / shares																					$ 8.98
Share dividend issued (in shares)								3,600,000
Percentage increase in dividend price	20.00%							20.00%						20.00%
Dividends recognised as distributions to owners per share (in dollars per share) | (per share)	$ 16.6516							$ 11.4824							€ 11.482	$ 11.4824
Mandatory redemption period, term											10 days
Number of Non-executive Directors granted awards | director		2
Vesting of Non-Executive Restricted Stock award | €														€ (100)	€ (300)
Share price (in dollars per share) | (per share)					€ 9.60														$ 10.75
Share price discount																				25.00%
Payments to acquire or redeem entity's shares					€ 93,900	$ 105,100,000							€ 0	177,600	0		€ 0
Key management personnel
Disclosure of transactions between related parties [line items]
Share-based payment expense | €														1,800	600
Non-Executive Director
Disclosure of transactions between related parties [line items]
Share-based payment expense | €													100	€ 800	600
Founder Preferred shares
Disclosure of transactions between related parties [line items]
Number of shares issued																		1,500,000
Founder Preferred shares | Founder Entities
Disclosure of transactions between related parties [line items]
Number of shares issued																		750,000
Share price (in dollars per share) | $ / shares																		$ 10.00
Ordinary shares
Disclosure of transactions between related parties [line items]
Share price (in dollars per share) | $ / shares								$ 10.00
Share dividend issued (in shares)	8,705,890							3,620,510
Shares repurchased and canceled					9,779,729	9,779,729								16,800,000
Ordinary shares | Founder Entities
Disclosure of transactions between related parties [line items]
Share dividend issued (in shares)	8,705,890							3,620,510
Ordinary shares | Key management personnel
Disclosure of transactions between related parties [line items]
Number of shares issued																						13,104
Restricted Shares
Disclosure of transactions between related parties [line items]
Exercise price (in dollars per share) | $									$ 11.50
Restricted Shares | Key management personnel
Disclosure of transactions between related parties [line items]
Number of shares issued																		4,927,000
Restricted Shares | Non-Executive Director
Disclosure of transactions between related parties [line items]
Share price (in dollars per share) | $ / shares				$ 14.38																	$ 8.98
Exercise price (in dollars per share) | $				$ 14.38			$ 8.98		$ 11.50
Number of shares vested			55,680	55,680			34,780
Shares paid for tax withholding for share based compensation			9,384	9,384			11,568
Share-based payment expense | €														€ 800	600
Number of shares granted		11,774	41,724	41,724			55,680
Mariposa Capital and TOMS Capital | Affiliate Of Founder Entities
Disclosure of transactions between related parties [line items]
Advisory Services Agreement, annual fee | €										€ 2,000
Advisory Services Agreement, renewal term										1 year
Advisory Services Agreement, expiration notice term										90 days
Advisory Services Agreement, termination term										6 months
Mariposa Capital | Affiliate Of Founder Entities
Disclosure of transactions between related parties [line items]
Travel expenses reimbursed to related party | €														130,454	153,186
TOMS Capital | Affiliate Of Founder Entities
Disclosure of transactions between related parties [line items]
Travel expenses reimbursed to related party | €														€ 232,379	233,627
Lord Myners | Non-Executive Director
Disclosure of transactions between related parties [line items]
Option life | year														5
Lord Myners | Ordinary shares | Non-Executive Director
Disclosure of transactions between related parties [line items]
Number of shares issued																		72,028
Share price (in dollars per share) | $ / shares																		$ 11.50
Number of share options granted														50,000
Iglo | Paul Kenyon | Key management personnel
Disclosure of transactions between related parties [line items]
Number of shares issued																							37,060	37,060
Share price (in dollars per share) | (per share)																							€ 9.71	$ 10.50
Number of shares sold												26,372
Iglo | Tania Howarth | Key management personnel
Disclosure of transactions between related parties [line items]
Number of shares issued																							38,956	38,956
Share price (in dollars per share) | (per share)																							€ 9.71	$ 10.50
Number of shares sold												27,721
December 7, 2015 | Restricted Shares | Non-Executive Director
Disclosure of transactions between related parties [line items]
Share-based payment expense | €													€ 100		300
June 16, 2016 | Restricted Shares | Non-Executive Director
Disclosure of transactions between related parties [line items]
Share-based payment expense | €														€ 500	300
June 19, 2017 and August 22, 2017 | Restricted Shares | Non-Executive Director
Disclosure of transactions between related parties [line items]
Share-based payment expense | €														400
Share based compensation reserve
Disclosure of transactions between related parties [line items]
Vesting of Non-Executive Restricted Stock award | €			€ 300											€ 700	€ (300)

XML

Significant events after the Statement of Financial Position date (Details) € / shares in Units, € in Millions, £ in Millions, kr in Millions			3 Months Ended		12 Months Ended
	Dec. 29, 2017 $ / shares shares	Jan. 12, 2016 $ / shares shares	Mar. 31, 2018 EUR (€)	Mar. 31, 2018 SEK (kr)	Dec. 31, 2016 € / shares	Dec. 31, 2015 $ / shares	Jun. 30, 2018 EUR (€)	Jun. 30, 2018 GBP (£)
Disclosure of detailed information about business combination [line items]
Share dividend issued (in shares)		3,600,000
Dividend price per share (in dollars per share) | (per share)	$ 16.6516	$ 11.4824			€ 11.482	$ 11.4824
Green Isle Foods Ltd
Disclosure of detailed information about business combination [line items]
Cash transferred							€ 225.0	£ 200
Ordinary shares
Disclosure of detailed information about business combination [line items]
Share dividend issued (in shares)	8,705,890	3,620,510
Foodhills AB
Disclosure of detailed information about business combination [line items]
Selling price of factory closure			€ 8.6	kr 85